<SEC-DOCUMENT>0000355019-22-000042.txt : 20220928
<SEC-HEADER>0000355019-22-000042.hdr.sgml : 20220928
<ACCEPTANCE-DATETIME>20220928151626
ACCESSION NUMBER:		0000355019-22-000042
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220928
DATE AS OF CHANGE:		20220928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		221275420

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>fonar_10-k.htm
<DESCRIPTION>FONAR CORPORATION FORM 10-K FOR YEAR ENDED JUNE 30, 2022
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:FONR="http://fonar.com/20220630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_FONR_fonar.com_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20210701_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<body style="font: 11pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2022-06-30" id="xdx2ixbrl0075" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl0155" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0446" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PaymentsOnNotesReceivableFromEmployeeStockholders" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PaymentsOnNotesReceivableFromEmployeeStockholders" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PaymentsOnNotesReceivableFromEmployeeStockholders" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0526" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxCreditsAndAdjustments" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CompensatoryElementOfStockIssuances" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0581" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0584" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0587" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0591" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0602" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfImagingCenter" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfNoncontrollingInterests" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0654" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0873" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0895" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesAddedAcquisition" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0984" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0987" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl0990" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl0991" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CostsIncurredOnUncompletedContracts" contextRef="AsOf2022-06-30" id="xdx2ixbrl1000" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:EstimatedEarnings" contextRef="AsOf2022-06-30" id="xdx2ixbrl1003" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CostsAndEstimatedEarningsOnUncompletedContracts" contextRef="AsOf2022-06-30" id="xdx2ixbrl1006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BillingsToDate" contextRef="AsOf2022-06-30" id="xdx2ixbrl1009" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" contextRef="AsOf2022-06-30" id="xdx2ixbrl1012" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl1112" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2021-07-01to2022-06-30" id="xdx2ixbrl1271" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="xdx2ixbrl1406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="xdx2ixbrl1407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="xdx2ixbrl1408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30_custom_NotePayable2Member" id="xdx2ixbrl1454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30_custom_NotePayable3Member" id="xdx2ixbrl1460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30_custom_NotePayable3Member" id="xdx2ixbrl1461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" id="xdx2ixbrl1525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl1651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1770" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember" id="xdx2ixbrl1970" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember" id="xdx2ixbrl1977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="xdx2ixbrl1981" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1985" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember" id="xdx2ixbrl1988" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember" id="xdx2ixbrl1993" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="xdx2ixbrl1997" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl2000" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl2001" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20220630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-07-01to2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-01_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-01_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-01_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-01_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember51888171">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember51888218">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_DiagnosticImagingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMEquityMember_custom_ClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-012013-02-13_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-01</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:OutsideInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-01</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-03-05_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-08_custom_HDMMember_custom_ClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_NotePayable3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-012016-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ABillingCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:ABillingCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_BensonhurstMRILimitedPartnershipMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:CovenantNotToCompeteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-26_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>FONR:Integer</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001768" toRefs="Footnote001844"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1770" toRefs="Footnote001844"></ix:relationship>
  <ix:relationship fromRefs="Fact001772" toRefs="Footnote001844"></ix:relationship>
  <ix:relationship fromRefs="Fact001809" toRefs="Footnote001844"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1811" toRefs="Footnote001844"></ix:relationship>
  <ix:relationship fromRefs="Fact001813" toRefs="Footnote001844"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1970" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="Fact001976" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="Fact001980" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1984" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1988" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="Fact001992" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="Fact001996" toRefs="Footnote002003"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl2000" toRefs="Footnote002003"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 11pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font-size: 14pt">&#160;</span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">WASHINGTON,
D.C. 20549</span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 18pt">FORM <span id="xdx_908_edei--DocumentType_c20210701__20220630_z9nnoggaJVwb"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:DocumentType">10-K</ix:nonNumeric></span></span></p>

<p style="margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 12pt"><span id="xdx_90B_edei--DocumentAnnualReport_c20210701__20220630_zzkmtnnyRqrf"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span>
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>For the fiscal year ended</b> <b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20210701__20220630_z0cwIPe9za3g"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_90D_edei--CurrentFiscalYearEndDate_c20210701__20220630_z16mM3MSPPe1"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>,
2022</ix:nonNumeric></span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">OR</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 12pt"><span id="xdx_90B_edei--DocumentTransitionReport_c20210701__20220630_zUeNstDj8Tn7"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">&#160;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">For the transition period from _____________
to _____________</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Commission File No. <span id="xdx_90D_edei--EntityFileNumber_c20210701__20220630" title="Entity File Number"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><img src="fonar_logo.jpg" alt="" style="height: 21.75pt; width: 144.75pt" /></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 5%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; width: 90%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 24pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20210701__20220630_zdFtFzmf9Yte"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; width: 5%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(Exact name of registrant as specified in its charter)</span></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif; text-transform: uppercase"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20210701__20220630" title="Entity Incorporation, State or Country Code"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20210701__20220630_zhFAAIeoE3w2"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(State of incorporation)</span></td>
    <td>&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(IRS Employer Identification Number)</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 5%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; width: 47%; padding-left: 5.4pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20210701__20220630" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressCityOrTown_c20210701__20220630" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20210701__20220630" title="Entity Address, State or Province"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; width: 41%; padding-left: 5.4pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_edei--EntityAddressPostalZipCode_c20210701__20220630_zmcNGhjU7sxe"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td>
    <td style="width: 5%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(Address of principal executive offices)</span></td>
    <td>&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(Zip Code)</span></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 20%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; width: 60%; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_edei--CityAreaCode_c20210701__20220630_zjreVHPYWiU7"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20210701__20220630_zJjiWG1qMhY6"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; width: 20%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">(Registrant&#8217;s telephone number, including area code)</span></td>
    <td>&#160;</td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Securities registered pursuant to Section 12(b) of the Act:</span></td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Common Stock, par value $.0001 per share</span></td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Securities registered pursuant to Section 12(g) of the Act:</span></td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">None</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top">&#160;</td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_900_edei--EntityWellKnownSeasonedIssuer_c20210701__20220630" title="Entity Well-known Seasoned Issuer"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span><span style="font-family: Arial, Helvetica, Sans-Serif">
..</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_90C_edei--EntityVoluntaryFilers_c20210701__20220630" title="Entity Voluntary Filers"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span> <span style="font-family: Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-indent: 0pt; text-align: center">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-indent: 0pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_902_edei--EntityCurrentReportingStatus_c20210701__20220630" title="Entity Current Reporting Status"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span><span style="font-family: Arial, Helvetica, Sans-Serif">
No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Arial, Helvetica, Sans-Serif">
..</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <span id="xdx_907_edei--EntityInteractiveDataCurrent_c20210701__20220630_zp6C10wtErof"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span><span style="font-family: Arial, Helvetica, Sans-Serif">
No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark if disclosure of delinquent filers, pursuant to Item 405 of Regulation S-K, &#167;229.405 of this Chapter, is not
contained, and will not be contained, to the best of the registrant&#8217;s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this 10-K or any amendment to the Form 10-K. </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of
&#8220;large accelerated filer&#8221;, &#8220;accelerated filer and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the
Exchange Act. (Check one):</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 33%; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Large accelerated filer&#160;</span><span style="font: 11pt Segoe UI Symbol,sans-serif">&#9744;</span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 34%; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Accelerated filer </span><span style="font: 11pt Segoe UI Symbol,sans-serif">&#9744;</span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 33%; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_edei--EntityFilerCategory_c20210701__20220630_zd3KOUqmIqb3"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> </span><span style="font: 11pt Segoe UI Symbol,sans-serif">&#9746;</span></td></tr>
<tr style="vertical-align: top">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Smaller reporting company </span><span style="font: 11pt Segoe UI Symbol,sans-serif"><span id="xdx_90F_edei--EntitySmallBusiness_c20210701__20220630_zuVXw0LRnRZe"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Emerging Growth Company </span><span style="font: 11pt Segoe UI Symbol,sans-serif"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20210701__20220630_zUKiRTSTGLH3"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: justify">&#160;</td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Arial, Helvetica, Sans-Serif">
<span id="xdx_90E_edei--EntityShellCompany_c20210701__20220630" title="Entity Shell Company"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The aggregate market value of the shares of
Common Stock held by non-affiliates as of December 31, 2021 based on the closing price of $14.98 per share on such date as reported
on the NASDAQ System, was approximately $<span id="xdx_905_edei--EntityPublicFloat_iI_pn3n3_dm_c20211231_zksvteH4oFNf" title="Entity Public Float"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">95.0</ix:nonFraction></span> million. The other outstanding classes do not have a readily determinable market
value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of September 1, 2022, <span id="xdx_908_edei--EntityCommonStockSharesOutstanding_iI_c20220901__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLsY5QY03Sq5" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-09-01_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span> shares of
Common Stock, <span id="xdx_90D_edei--EntityCommonStockSharesOutstanding_iI_c20220901__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zJqUGntYAk5a" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-09-01_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span> shares of Class B Common Stock, <span id="xdx_903_edei--EntityCommonStockSharesOutstanding_iI_c20220901__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIxMjk0sA5li" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-09-01_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span> shares of Class C Common Stock and <span id="xdx_907_edei--EntityCommonStockSharesOutstanding_iI_c20220901__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zR1vARvgXsfd" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-09-01_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span> shares of Class A Non-voting
Preferred Stock of the registrant were outstanding.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">DOCUMENTS INCORPORATED BY REFERENCE</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NONE</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom; width: 10%"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 10%"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 2%"><span style="font-size: 11pt">&#160;</span></td>
    <td style="border-bottom: windowtext 1pt solid; vertical-align: bottom; width: 66%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">FORM
    10-K ITEMS</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: windowtext 1pt solid; text-align: center; vertical-align: top; width: 10%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">PAGE</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">PART I</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 1.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_001"><span style="font-family: Arial, Helvetica, Sans-Serif">Business</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">4</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 1A.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_002"><span style="font-family: Arial, Helvetica, Sans-Serif">Risk
    Factors</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">30</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 1B.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_003"><span style="font-family: Arial, Helvetica, Sans-Serif">Unresolved
    Staff Comments</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">33</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 2.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_004"><span style="font-family: Arial, Helvetica, Sans-Serif">Properties</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">33</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 3.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_005"><span style="font-family: Arial, Helvetica, Sans-Serif">Legal
    Proceedings</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">33</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 4.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_006"><span style="font-family: Arial, Helvetica, Sans-Serif">Mine
    Safety Disclosures</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">33</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">PART II</span></td>
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 5.</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-size: 11pt"><a href="#a_007"><span style="font-family: Arial, Helvetica, Sans-Serif">Market for Registrant&#8217;s
    Common Equity, Related Stockholder Matters</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">33</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 6.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_008"><span style="font-family: Arial, Helvetica, Sans-Serif">Selected
    Financial Data</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">35</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 7.</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-size: 11pt"><a href="#a_009"><span style="font-family: Arial, Helvetica, Sans-Serif">Management&#8217;s Discussion
    and Analysis of Financial Condition and Results of Operations</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">37</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 8.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_010"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
    Statements</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">45</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 9.</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-size: 11pt"><a href="#a_011"><span style="font-family: Arial, Helvetica, Sans-Serif">Changes in and Disagreements
    with Accountants on Accounting and Financial Disclosure</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">90</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 9A.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_012"><span style="font-family: Arial, Helvetica, Sans-Serif">Controls
    and Procedures</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">90</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 9B.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_013"><span style="font-family: Arial, Helvetica, Sans-Serif">Other
    Information</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">91</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">PART III</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 10.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_014"><span style="font-family: Arial, Helvetica, Sans-Serif">Directors
    and Executive Officers</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">91</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 11.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_015"><span style="font-family: Arial, Helvetica, Sans-Serif">Executive
    Compensation</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">94</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 12.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_016"><span style="font-family: Arial, Helvetica, Sans-Serif">Security
    Ownership of Certain Beneficial Owners and Management</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">97</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 13.</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td><span style="font-size: 11pt"><a href="#a_017"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain Relationships
    and Related Transactions, and Director Independence</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">99</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 14.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_018"><span style="font-family: Arial, Helvetica, Sans-Serif">Principal
    Accountant Fees and Services</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">100</span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">PART IV</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Item 15.</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 11pt"><a href="#a_019"><span style="font-family: Arial, Helvetica, Sans-Serif">Exhibits</span></a></span></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">101</span></td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">PART I</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_001"></span>ITEM 1. BUSINESS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">GENERAL</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar Corporation, sometimes referred to as
the &#8220;Company&#8221; or &#8220;Fonar&#8221;, is a Delaware corporation which was incorporated on July 17, 1978. Our address
is 110 Marcus Drive, Melville, New York 11747 and our telephone number is 631-694-2929. Fonar also maintains a website at www.fonar.com.
Fonar provides copies of its filings with the Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K and amendments to
these reports to stockholders on request.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We conduct our business in two segments. Our
medical equipment segment is conducted directly through Fonar. Our physician management and diagnostic services segment is conducted
through our subsidiary Health Management Corporation of America<span style="color: red"><b> </b></span>(&#8220;HMCA&#8221;). HMCA
provides management services, administrative services, billing and collection services, credentialing services, contract negotiations,
compliance consulting, purchasing, IT services, hiring, conducting interviews and managing personnel, storage of medical records,
office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged
in diagnostic imaging. In addition to acting as a management company, HMCA owns and operates five diagnostic imaging facilities
in Florida, where the corporate practice of medicine is permitted.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar is engaged in the business of designing,
manufacturing, selling and servicing magnetic resonance imaging scanners, also referred to as &#8220;MRI&#8221; or &#8220;MR&#8221;
scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions
and injuries. Fonar&#8217;s founders built the first MRI scanner in 1977 and Fonar introduced the first commercial MRI scanner
in 1980. Fonar is also the originator of the iron-core non-superconductive and permanent magnet MRI technology.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s iron frame technology made Fonar
the originator of &#8220;open&#8221; MRI scanners. We introduced the first &#8220;open&#8221; MRI in 1980. Since that time we have
concentrated on further application of our &#8220;open&#8221; MRI, introducing most recently the Upright&#174; Multi-Position&#8482;&#8221;
MRI scanner (also referred to as the &#8220;Upright&#174;&#8221; or &#8220;Stand-Up&#174;&#8221; MRI scanner) and the Fonar 360&#8482;
MRI scanner. The Fonar 360&#8482; MRI is not presently being marketed.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 17 to the Consolidated Financial Statements
for separate financial information regarding our medical equipment and physician and diagnostic management services segments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">FORWARD LOOKING STATEMENTS.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain statements made in this Annual Report
on Form 10-K are &#8220;forward-looking statements&#8221;, within the meaning of the Private Securities Litigation Reform Act of
1995, regarding the plans and objectives of Management for future operations. Such statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from
any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking
statements are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based,
in part, on assumptions involving the expansion of business. These assumptions involve judgments with respect to, among other things,
future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking statements
are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this Annual Report will prove to be accurate. In light of the significant uncertainties inherent in our
forward-looking statements, the inclusion of such information should not be regarded as a representation by us or any other person
that our objectives and plans will be achieved.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We must now take into account is the COVID-19
virus, which adds additional uncertainties to future expectations. Although the impact will be negative, the severity, duration
and recurrence of new strains of the COVID-19 virus adds a new dimension to the challenges and uncertainty facing our business
and the world economy in general.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">THE UPRIGHT&#174; MRI SCANNER</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI scanner is the product
we are presently promoting. The Upright&#174; MRI (also known as the &#8220;Stand-Up&#174; MRI&#8221;) is a &#8220;whole-body&#8221;
MRI, meaning it can be used to scan any part her back, the Upright&#174; MRI permits MRI scans to be taken in a weight-bearing state.
Patients can be scanned while standing, sitting, bending or lying down. This means that an abnormality or injury, such as a slipped
disk, may be scanned in a weight-bearing posture, which more often than not is the position in which patients experience pain.
An adjustable bed allows patients to stand, sit or lie on their backs, sides or stomachs. The Upright&#174; MRI is by design a non-claustrophobic
MRI scanner. We have introduced the name &#8220;Upright&#174;&#8221; as an alternative to &#8220;Stand-Up&#174;&#8221; because of
the multiplicity of positions in which the patient may be scanned where the patient is not standing.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of June 30, 2022, HMCA manages a total of
41 MRI scanners. Twenty-six (26) MRI scanners are located in New York and fifteen (15) which are located in Florida. We believe
that the utilization of Fonar UPRIGHT&#174; MRI scanning systems has been a significant factor in maintaining the patient volume
of the scanning facilities and our ability to cope with the effects of the COVID-19 pandemic.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">MEDICAL EQUIPMENT SEGMENT</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">PRODUCTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fonar Upright&#174; MRI is a weight-bearing
whole-body open MRI system which enables positional MRI (pMRI&#174;) applications. Operating at a magnetic field strength of 0.6
Tesla, the scanner is a powerful, diagnostically versatile and cost-effective open MRI that provides a broad range of clinical
capabilities and a complete set of imaging protocols. Patients can be scanned standing, bending, sitting, upright at an intermediate
angle and in the conventional recumbent position. This multi-positional MRI system accommodates an unrestricted range of motion
for flexion, extension, lateral bending, and rotation studies of the cervical (upper) and lumbar (lower) spine. Previously difficult
patient scanning positions can be achieved and compared using the system&#8217;s MRI-compatible, three-dimensional, motorized patient
handling system. The system&#8217;s lift and tilt functions deliver the targeted anatomical region to the center of the magnet.
True image orientation is assured, regardless of the rotation angle, via computer read-back of the table&#8217;s position.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There is considerable evidence that the weight-bearing
Upright&#174; MRI provides medical benefits not duplicated by any other MRI scanner because patient positioning plays a critical
role in accurately detecting clinically significant pathology.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For instance, the Fonar Upright&#174; technology
has demonstrated its key value on patients with the Arnold-Chiari Syndrome, which is believed to affect 200,000 to 500,000 Americans.
In this syndrome, brain stem compression and subsequent severe neurological symptoms occur in these patients, when because of weakness
in the support tissues within the skull, the brain stem descends and is compressed and entrapped at the base of the skull in the
foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the skull. The brain structures
&#8220;entrapped&#8221; in Chiari Syndrome are the lowest lying structures of the brain, the tonsils of the cerebellum. The Chiari
Syndrome is therefore alternately named Cerebellar Tonsillar Ectopia (CTE) indicating the displacement (ectopia) of these Cerebellar
tonsils in this syndrome. Classic symptoms of the Chiari Syndrome include the &#8220;drop attack,&#8221; where the patient unexpectedly
experiences an explosive rush at the base of the brain which runs down the body to the extremities, causing the patient to collapse
in a temporary neuromuscular paralysis. These symptoms subside when the patient is lying down. Conventional lie-down MRI scanners
cannot make an adequate evaluation of the pathology since the patient&#8217;s pathology is most visible and the symptoms are most
acute when the patient is scanned in the upright weight-bearing position.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A publication in the Journal &#8220;Brain Injury&#8221;
(Brain Injury 2010, 24 (7-8) 988-994) of 1,200 neck pain patients reported that the fallen cerebellar tonsils of the brain (CTE)
were missed 75% of the time when the patient was scanned only in the recumbent position. It is critical to have an image of the
patient in an upright position so that the neurosurgeons can fully evaluate the brain stem and choose the most appropriate surgical
approach for an operative repair.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The study was published by 10 authors from distinguished
universities in the United States and around the world. The study reported that Cerebellar Tonsillar Ectopia Herniation (CTE) was
missed 75% of the time when the patient was scanned lying down instead of upright. At the current rate of 1,000,000 automobile
whiplash injuries in the U.S. per year, 750,000 patients each year would have the pathology responsible for their symptoms go undetected
if they were examined solely in a conventional recumbent-only MRI.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI has also demonstrated its
value for patients suffering from scoliosis. Scoliosis patients typically have been subjected to routine x-ray exams for years
and must be imaged upright for an adequate evaluation of their scoliosis. Because the patient must be standing for the exam, an
x-ray machine has been the only modality that could provide that service. The Upright&#174; MRI is the only MRI scanner that allows
the patient to stand during the MRI exam. Fonar has developed a new RF receiver and scanning protocol that for the first time allows
scoliosis patients to obtain diagnostic pictures of their spines without the risks of x-rays. A study by the National Cancer Institute
(2000) of 5,466 women with scoliosis reported a 70% increase in breast cancer resulting from 24.7 chest x-rays these patients received
on average in the course of their scoliosis treatment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other important new applications are Upright&#174;
imaging of the pelvic floor and abdomen to image prolapses and inguinal hernias. Fonar has also developed the first non-invasive
method to image the prostate: the patient simply sits on a flat, seat-like coil.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI is also the world&#8217;s
most non-claustrophobic whole-body MRI scanner. Frequently, patients can simply walk into the magnet, stand or sit for their scans
and then walk out. The magnet&#8217;s front-open and top-open design provides an unprecedented degree of comfort because there
is nothing in front of the patient&#8217;s face except a large (42&#8221;) flat-screen TV that is mounted on the wall. The default
position for the bed is a tilt back of six degrees that minimizes patient motion. Special RF receiver coil fixtures, a patient
seat, Velcro straps, and transpolar stabilizing bars are also used to keep the patient comfortable and motionless throughout the
scanning process.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Full-range-of-motion studies of the joints in
multiple directions are possible, an especially useful feature for sports injuries. Full range of motion cines, or movies, of the
lumbar spine can also be achieved under full body weight.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fonar Upright&#174; MRI operates at a significantly
higher magnetic field strength than earlier open MRIs that preceded it, and, therefore, benefits from more of the MRI image-producing
signal needed to make high-quality MRI images.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar maximizes image quality through an optimal
combination of image signal to noise (S/N) and contrast-to noise (C/N) ratios. Technical improvements incorporated into the scanner
design include increased image processing speed, high-S/N Organ Specific(TM) RF receiver coils, high performance front-end electronics
featuring high-speed, wide-dynamic-range analog-to-digital conversion and a miniaturized ultra-low-noise pre-amplifier, high-speed
automatic tuning, bandwidth-optimized pulse sequences, multi-bandwidth sequences, and off-center FOV imaging capability.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to the signal-to-noise ratio, however,
a major determinant of image quality that must be considered is contrast, the quality that enables reading physicians to clearly
distinguish adjacent, and sometimes minute, anatomical structures from their surroundings. This quality is measured by contrast-to-noise
ratios (C/N). Unlike S/N, which increases with increasing field strength, relaxometry studies have shown that C/N peaks in the
mid-field range and actually falls off precipitously at higher field strengths. The Upright&#174; MRI scanners operate squarely
in the optimum C/N range.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR&#8217;s scanners are equipped with a variety
of software features which enhance versatility and diagnostic capability. For example, SMART&#8482; scanning allows for same-scan
customization of multi-slice scans, each slice with its own thickness, resolution, angle and position. This is an important feature
for scanning parts of the body that include small-structure sub-regions requiring finer slice parameters. There is also Multi-Angle
Oblique&#8482; (MAO) imaging, and oblique imaging.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During fiscal 2022, sales of our Upright&#174;
MRI scanners accounted for approximately 0.1% of our total revenues and 0.8% of our medical equipment revenues, as compared to
0.8% of total revenues and 10.0% of medical equipment revenues in fiscal 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR&#8217;s principal marketing efforts with
respect to its products have been focused on the Upright&#174; MRI, which we believe is a particularly unique product. It is the
only MRI scanner which is both open and allows for weight-bearing imaging. We expect to continue our focus on the Upright&#174;
MRI in the immediate future.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The materials and components used in the manufacture
of our products (circuit boards, computer hardware components, electrical components, steel and plastic) are generally available
at competitive prices. We have not had difficulty acquiring such materials.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PRODUCT MARKETING</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The principal markets for the Company&#8217;s
scanners are private diagnostic imaging centers and hospitals.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We use internal personnel and independent manufacturer&#8217;s
representatives for domestic and foreign markets. None of Fonar&#8217;s competitors are entitled or been licensed to make the Fonar
Upright&#174; MRI scanner.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s Website includes interactive product
information for interested customers.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During fiscal 2022 and previously sales were
made to foreign customers. CEO Matthias Schulz of Medserena, Fonar&#8217;s principal foreign sales representative and distributor,
has said, &#8220;The large number of requests coming from our physicians in Germany are arising because of the special medical
need for FONAR&#8217;s unique technology. This is in spite of an intensely active MRI market in Germany, where there are already
many conventional lie-down MRIs installed.&#8221;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s marketing strategy has been designed
to reach key purchasing decision makers with information concerning the Upright&#174; MRI. This has led to many inquiries and to
some sales of the Upright&#174; MRI scanner and is intended to increase Fonar&#8217;s presence in the medical market. Fonar focuses
on four target audiences: neurosurgeons, orthopaedic surgeons, radiologists and physicians in general.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 67px; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">1)</span></td>
    <td style="width: 5px; text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Neurosurgeons and Orthopaedic Surgeons: These are the surgeons who can most benefit from the superior diagnostic benefits of the Fonar Upright&#174; MRI with its Multi-Position&#174; MRI diagnostic ability.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">2)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Radiologists: These physicians can now offer a new Multi-Position&#174;, weight-bearing MRI modality to their referring physicians.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">3)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">All Physicians: The vast number of doctors who send patients for MRI&#8217;s need to be aware of the diagnostic advantages of the Fonar Upright&#174; Multi-Position&#8482;.</span></td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our advertising for Fonar and HMCA re-enforces
the unique value provided by Fonar MRI scanners. We have increased internet awareness of our product by driving patient traffic
to the Upright&#174; scanning centers we manage via the Fonar website (www.fonar.com) as well as by creating Websites for each HMCA
location. These websites give prospective customers of Upright&#174; MRI scanners a view of operating Upright&#174; MRI centers and
highlight the benefits of using an Upright&#174; MRI scanner. A complete list of the sites managed by HMCA can be found at HMCA&#8217;s
website, hmca.com.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">SERVICE AND UPGRADES FOR MRI SCANNERS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our customer base of installed scanners has
been and will continue to be an additional source of income, independent of direct sales.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Income is generated from the installed base
in two principal areas, namely, service and upgrades. Service and maintenance revenues from our external installed base were approximately
$7.7 million in both fiscal 2022 and fiscal 2021. Our objective is to maintain service revenues at present levels or better, based
on the longevity of the technology, and the refurbishments and upgrades which keep the scanners competitive with the latest techniques.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We also anticipate that our scanners will result
in upgrades income in future fiscal years. The potential for upgrades income, originates in the versatility and productivity of
the Upright&#174; Imaging technology. New medical uses for MRI technology are constantly being discovered and are anticipated for
the Upright&#174; Imaging technology as well. New features can often be added to the scanner by the implementation of little more
than versatile new software packages, which when coupled with hardware upgrades can add years of useful life to the scanner.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">RESEARCH AND DEVELOPMENT</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the fiscal year ended June 30, 2022,
we incurred expenditures of $1,494,181, none of which were capitalized, on research and development, as compared to $1,635,979,
none of which were capitalized, during the fiscal year ended June 30, 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development activities have focused
principally on software improvements to the user interface of the MRI scanner. The Windows-based Sympulse&#8482; platform controls
all of the functions of the Upright&#174; scanner except those of the versatile, multi-position patient table. Separate, dedicated,
motion-control software is used to maneuver the Upright&#174; bed, and development of this software is ongoing as well.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">While software improvements to the user interface
are important in their own right, significant value is added to the MRI scanner by the modification of existing protocols for examining
various parts of the body, and the development of new protocols that utilize new underlying capabilities of the pulse sequence
software. Over time, FONAR users have become accustomed to the steady improvement in the recommended clinical protocols that accompany
new software releases. More significantly, in recent years we have seen increasing adoption of FONAR-recommended clinical protocols
over those developed on site. This is a testament to the superior image quality they produce in attractively short scan times.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The development of clinically practical scan
protocols and software depends on close contact between research and development scientists and engineers, and end users. That
close contact is facilitated in part by the relationship with HMCA and the scanning centers. In addition to that collaboration,
R&amp;D staff have pursued a variety of novel and Upright&#174; MRI-specific research projects. It is anticipated that these will
ultimately lead to new applications that are made available to existing customers as upgrade add-ons to their machines. For example,
phase-contrast imaging techniques originally developed for angiography have recently been applied to cerebro-spinal fluid (CSF)
flow. Analysis of CSF flow in upright and recumbent postures may prove to be of significant value in the evaluation of a variety
of disorders.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">BACKLOG</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our backlog of unfilled orders at September
8, 2022 was approximately $844,000, as compared to $62,000 at September 15, 2021. It is expected that the existing backlog of orders
will be filled during the 2023 fiscal year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PATENTS AND LICENSES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We currently have numerous patents in effect
which relate to the technology and components of our MRI scanners. We believe that these patents, and the know-how we have developed,
are material to our business.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">One of our patents, issued in the name of Dr.
Damadian and licensed to Fonar, was United States patent No. 3,789,832, Apparatus and Method for Detecting Cancer in Tissue, also
referred to in this report as the &#8220;1974 Patent&#8221;. The 1974 Patent was the first MRI patent issued by the United States
Patent Office. The development of our MRI scanners has been based upon the 1974 Patent, and we believe that the 1974 Patent was
the first of its kind to utilize MR to scan the human body and to detect cancer. The 1974 Patent was extended beyond its original
17-year term and expired in February, 1992.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have significantly enhanced our patent position
within the industry and now possess a substantial patent portfolio which provides us, under the aegis of United States patent law,
&#8220;the exclusive right to make, use and sell&#8221; many of the scanner features which Fonar pioneered and which are now incorporated
in most MRI scanners sold by the industry. As of June 30, 2022, 223 patents had been issued to Fonar, and approximately 10 patents
were pending. A number of Fonar&#8217;s existing patents specifically relate to protecting Fonar&#8217;s position in the Upright
MRI market. The patents further enhance Dr. Damadian&#8217;s pioneer patent, the 1974 Patent, that initiated the MRI industry and
provided the original invention of MRI scanning. The terms of the patents in Fonar&#8217;s portfolio extend to various times.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We also have patent cross-licensing agreements
with other MRI manufacturers. We have not licensed, however, any technology relating to Upright&#174; MRI scanning.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PRODUCT COMPETITION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">MRI SCANNERS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">MRI takes advantage of the nuclear magnetic
resonance signal elicited from the body&#8217;s tissues and the exceptional sensitivity of this signal for detecting disease discovered
by Fonar. Much of the serious disease of the body occurs in the soft tissue of vital organs. The maximum contrast available by
x-ray with which to discriminate disease is 4%. Brain cancers differ from surrounding healthy brain by only 1.6% while the contrast
in the brain by MRI is 25 times greater at 40%. X-ray contrasts among the body&#8217;s soft tissues are maximally 4%. Their contrast
by MRI is 32.5 times greater (130%).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The soft tissue contrasts with which to distinguish
cancers on images by MRI are up to 180%. In the case of cancer these contrasts can be even more marked making cancers readily visible
and detectable anywhere in the body. This is because the nuclear resonance signals from the body&#8217;s normal soft tissue vital
organs, differ so dramatically from each other (e.g. small intestine 257 milliseconds, brain 595 milliseconds). Liver cancer and
healthy liver signals differ by 180% for example.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A majority of the MRI scanners in use in hospitals
and outpatient facilities and at mobile sites in the United States are based on high field (1.5 - 3.0 Tesla) air core superconducting
magnet technology.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Open MRIs manufactured by Fonar&#8217;s competitors,
are recumbent-only machines based on Fonar&#8217;s original iron-frame vertical magnetic field magnet design. These systems have
been manufactured and sold by many of our largest competitors over the years. They generally operate at low field strengths (0.2
- 0.35 Tesla). Their prevalence in the marketplace has led to the perception in the medical community that Open MRIs are useful
only for anxious and claustrophobic patients, that the Open MRI&#8217;s image quality is poor, and that the scan times are long.
Recently our competitors have introduced higher field strength Open MRI products (0.5 &#8211; 1.2 Tesla). Significantly better
imaging performance (especially at 1.2 T) compared to the low field strength systems, is beginning to change that perception. However,
Fonar continues to maintain its competitive advantage at 0.6 Tesla due to our front-open non-claustrophobic configuration in which
there is nothing in front of the patient&#8217;s face, and our unique ability to scan patients in weight-bearing positions. It
is also noteworthy that our horizontal transaxial magnetic field allows the Upright MRI, in contrast to the recumbent-only Open
MRIs, to use the same flat planar-style radiofrequency receiver coil as the high-field MRI systems to image the lumbar and thoracic
spine.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright MRI uses the same configuration
RF receiver coil as a high-field MRI system to image the spine other Open MRIs cannot do this. (This is because of the rule in
MRI that the axis of symmetry of the RF receiver coil should be perpendicular to the direction of the main magnetic field). The
upright patient sits comfortably with his back against a flat (&#8220;planar&#8221;) RF receiver coil in our horizontal transaxial
magnetic field. In contrast, the vertical magnetic field in the recumbent-only Open MRI precludes the use of this type of receiver
coil.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Relative to the high-field systems, the Upright
MRI has two major competitive advantages:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Sometimes patient positioning is more consequential
than a small increase in the image resolution and decrease in the scan time. As it is critical for physicians to not &#8220;miss&#8221;
anything in the images, they recognize that the position-dependent pathology visualized with the Upright MRI will be invisible
(&#8220;missed&#8221;) if their patients are scanned at a higher field strength.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Image artifacts arising from metal implants
such as surgical screws are diminished with the 0.6 Tesla Upright MRI compared to those from the high-field MRIs. It is well known
that such artifacts get smaller as the MRI magnet&#8217;s field strength is reduced, so the anatomy adjacent to implanted hardware
will be less obscured with the Upright MRI. This is particularly valuable for surgeons referring their postoperative patients for
diagnostic imaging studies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar faces competition within the MRI industry
from such firms as General Electric Company, Philips N.V., Toshiba Corporation, Hitachi Corporation and Siemens A.G. Most competitors
have marketing and financial resources more substantial than those available to us. They have in the past, and may in the future,
heavily discount the sales price of their scanners. Such competitors sell both high field air core superconducting MRI scanners
and iron frame products. Fonar&#8217;s original iron frame design, ultimately imitated by Fonar&#8217;s competitors to duplicate
Fonar&#8217;s origination of &#8220;Open&#8221; MRI magnets, gave rise to current patent protected Upright&#174; MRI technology
with the result that Fonar today is the unique and only supplier of the highest field MRI magnets (0.6 Tesla) that are not superconducting,
do not use liquid helium and are not therefore susceptible to severe consequences and downtime cause by a system quench.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The iron frame, because it controls the magnetic
lines of force and places them where wanted and removes them from where not wanted, provides a more versatile magnet design than
is possible with air core magnets. Air core magnets contain no iron but consist entirely of turns of current carrying wire.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar expects to be the leader in weight-bearing
and positional MRI for providing dynamic visualization of body parts including the spine and extremities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">OTHER IMAGING MODALITIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s MRI scanners also compete with
other diagnostic imaging systems, all of which are based upon the ability of energy waves to penetrate human tissue and to be detected
by either photographic film or electronic devices for presentation of an image on a display monitor. Three different kinds of energy
waves - X-ray, gamma and sound - are used in medical imaging techniques which compete with MRI medical scanning, the first two
of which involve exposing the patient to potentially harmful radiation. These other imaging modalities compete with MRI products
on the basis of specific applications.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">X-rays are the most common energy source used
in imaging the body and are employed in three imaging modalities:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">1.</td><td>Conventional X-ray systems, the oldest method of imaging, are typically used to image bones and teeth. The image resolution
of adjacent structures that have high contrast, such as bone adjacent to soft tissue, is excellent, while the discrimination between
soft tissue organs is poor because of the nearly equivalent penetration of x-rays.</td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">2.</td><td>Computerized Tomography, also referred to as &#8220;CT&#8221;, systems couple computers to x-ray instruments to produce cross-sectional
images of particular large organs or areas of the body. The CT scanner addresses the need for images, not available by conventional
radiography, that display anatomic relationships spatially. However, CT images are generally limited to the transverse plane and
cannot readily be obtained in the two other planes, sagittal and coronal. Improved picture resolution is available at the expense
of increased exposure to x-rays from multiple projections. Furthermore, the pictures obtained by this method are computer reconstructions
of a series of projections and, once diseased tissue has been detected, CT scanning cannot be focused for more detailed pictorial
analysis or obtain a chemical analysis.</td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">3.</td><td>Digital radiography systems add computer image processing capability to conventional x-ray systems. Digital radiography can
be used in a number of diagnostic procedures which provide continuous imaging of a particular area with enhanced image quality
and reduced patient exposure to radiation.</td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">4.</td><td>Nuclear medicine systems, which are based upon the detection of gamma radiation generated by radioactive pharmaceuticals introduced
into the body, are used to provide information concerning soft tissue and internal body organs and particularly to examine organ
function over time.</td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">5.</td><td>Ultrasound systems emit, detect and process high frequency sound waves reflected from organ boundaries and tissue interfaces
to generate images of soft tissue and internal body organs. Although the images are substantially less detailed than those obtainable
with x-ray methods, ultrasound is generally considered harmless and therefore has found particular use in imaging the pregnant
uterus.</td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">6.</td><td style="text-align: justify">X-ray machines, ultrasound machines, digital radiography systems and nuclear medicine compete with
the MRI scanners by offering significantly lower price and space requirements. However, Fonar believes that the utility of the
images produced by its MRI scanners is generally superior to the utility of the images produced by those other methodologies.</td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">GOVERNMENT REGULATION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA Regulation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Food and Drug Administration in accordance
with Title 21 of the Code of Federal Regulations regulates the manufacturing and marketing of Fonar&#8217;s MRI scanners. The regulations
can be classified as either pre-market or post-market. The pre-market requirements include obtaining marketing clearance, proper
device labeling, establishment registration and device listing. Once the products are on the market, Fonar must comply with post-market
surveillance controls. These requirements include the Quality Systems Regulation, or &#8220;QSR&#8221;, also known as Current Good
Manufacturing Practices or CGMPs, and Medical Device Reporting, also referred to as MDR regulations. The QSR is a quality assurance
requirement that covers the design, packaging, labeling and manufacturing of a medical device. The MDR regulation is an adverse
event-reporting program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Classes of Products</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Under the Medical Device Amendments of 1976
to the Federal Food, Drug and Cosmetic Act, all medical devices are classified by the FDA into one of three classes. A Class I
device is subject only to general controls, such as labeling requirements and manufacturing practices; a Class II device must comply
with certain performance standards established by the FDA; and a Class III device must obtain pre-market approval from the FDA
prior to commercial marketing. Fonar&#8217;s products are Class II devices. Class II devices are subject to &#8220;General Controls&#8221;;
General Controls include:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">1.</td><td style="text-align: justify">Establishment registration of companies which are required to register under 21 CFR Part 807.20,
such as manufacturers, distributors, re-packagers and re-labelers.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">2.</td><td style="text-align: justify">Medical device listing with FDA of devices to be marketed.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">3.</td><td style="text-align: justify">Manufacturing devices in accordance with the Current Good Manufacturing Practices Quality System
Regulation in 21 CFR Part 820.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">4.</td><td style="text-align: justify">Labeling devices in accordance with labeling regulations in 21 CFR Part 801 or 809.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">5.</td><td style="text-align: justify">Submission of a Premarket Notification, pursuant to 510(k), before marketing a device.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to complying with general controls,
Class II devices are also subject to special controls. Special controls may include special labeling requirements, guidance documents,
mandatory performance standards and post-market surveillance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On October 3, 2000 Fonar received FDA clearance
for the Upright&#174; MRI under the name &#8220;Indomitable&#8221;.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Premarketing Submission</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Each person who wants to market Class I, II
and some III devices intended for human use in the U.S. must submit a 510(k) to FDA at least 90 days before marketing unless the
device is exempt from 510(k) requirements. A 510(k) is a pre-marketing submission made to FDA to demonstrate that the device to
be marketed is as safe and effective, that is, substantially equivalent, SE, to a legally marketed device that is not subject to
pre-market approval, PMA. Applicants must compare their 510(k) device to one or more similar devices currently on the U.S. market
and make and support their substantial equivalency claims.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FDA is committed to a 90-day clearance after
submission of a 510(k), provided the 510(k) is complete and there is no need to submit additional information or data.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The 510(k) is essentially a brief statement
and description of the product. As Fonar&#8217;s scanner products are Class II products, there are no pre-market data requirements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An investigational device exemption, also referred
to as IDE, allows the investigational device to be used in a clinical study pending FDA clearance in order to collect safety and
effectiveness data required to support the Premarket Approval, also referred to as PMA, application or a Premarket Notification
pursuant to 510(k), submission to the FDA. Clinical studies are most often conducted to support a PMA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the most part, however, we have not found
it necessary to utilize IDE&#8217;s. The standard 90 day clearance for our new MRI scanner products classified as Class II products
makes the IDE unnecessary, particularly in view of the time and effort involved in compiling the information necessary to support
an IDE.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Quality System Regulation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Quality Management System is applicable
to the design, manufacture, administration of installation and servicing of magnetic resonance imaging scanner systems. The FDA
has authority to conduct detailed inspections of manufacturing plants, to establish Good Manufacturing Practices which must be
followed in the manufacture of medical devices, to require periodic reporting of product defects and to prohibit the exportation
of medical devices that do not comply with the law.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical Device Reporting Regulation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Manufacturers must report all MDR reportable
events to the FDA. Each manufacturer must review and evaluate all complaints to determine whether the complaint represents an event
which is required to be reported to FDA. Section 820.3(b) of the Quality Systems regulation defines a complaint as, &#8220;any
written, electronic or oral communication that alleges deficiencies related to the identity, quality, durability, reliability,
safety, effectiveness, or performance of a device after it is released for distribution.&#8221;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A report is required when a manufacturer becomes
aware of information that reasonably suggests that one of their marketed devices has or may have caused or contributed to a death,
serious injury, or has malfunctioned and that the device or a similar device marketed by the manufacturer would be likely to cause
or contribute to a death or serious injury if the malfunction were to recur.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Malfunctions are not reportable if they are
not likely to result in a death, serious injury or other significant adverse event experience.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A malfunction which is or can be corrected during
routine service or device maintenance still must be reported if the recurrence of the malfunction is likely to cause or contribute
to a death or serious injury if it were to recur.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have established and maintained written procedures
for implementation of the MDR regulation. These procedures include internal systems that:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">provide for timely and effective identification, communication
and evaluation of adverse events;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">provide a standardized review process and procedures
for determining whether or not an event is reportable; and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">provide procedures to insure the timely transmission
of complete reports.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">These procedures also include documentation
and record keeping requirements for:information that was evaluated to determine if an event was reportable;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">all medical device reports and information submitted
to the FDA;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">any information that was evaluated during preparation
of annual certification reports; and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">systems that ensure access to information that facilitates
timely follow up and inspection by FDA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA Enforcement</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA may take the following actions to enforce
the MDR regulation:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA-Initiated or Voluntary Recalls</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Recalls are regulatory actions that remove a
hazardous, potentially hazardous, or a misbranded product from the marketplace. Recalls are also used to convey additional information
to the user concerning the safe use of the product. Either FDA or the manufacturer can initiate recalls.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There are three classifications, i.e., I, II,
or III, assigned by the Food and Drug Administration to a particular product recall to indicate the relative degree of health hazard
presented by the product being recalled.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class I</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Is a situation in which there is a reasonable
probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class II</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure
to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious
adverse health consequences is remote.&#8195;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class III</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure
to, a violative product is not likely to cause adverse health consequences.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar has initiated six voluntary recalls. Five
of the recalls were Class II and one was Class III. The recalls involved making minor corrections to the product in the field.
Frequently, corrections which are made at the site of the device are called field corrections as opposed to recalls.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Civil Money Penalties</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FDA, after an appropriate hearing, may impose
civil money penalties for violations of the FD&amp;C Act that relate to medical devices. In determining the amount of a civil penalty,
FDA will take into account the nature, circumstances, extent, and gravity of the violations, the violator&#8217;s ability to pay,
the effect on the violator&#8217;s ability to continue to do business, and any history of prior violations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Warning Letters</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FDA issues written communications to a firm,
indicating that the firm may incur more severe sanctions if the violations described in the letter are not corrected. Warning letters
are issued to cause prompt correction of violations that pose a hazard to health or that involve economic deception. The FDA generally
issues the letters before pursuing more severe sanctions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Seizure</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A seizure is a civil court action against a
specific quantity of goods which enables the FDA to remove these goods from commercial channels. After seizure, no one may tamper
with the goods except by permission of the court. The court usually gives the owner or claimant of the seized merchandise approximately
30 days to decide a course of action. If they take no action, the court will recommend disposal of the goods. If the owner decides
to contest the government&#8217;s charges, the court will schedule the case for trial. A third option allows the owner of the goods
to request permission of the court to bring the goods into compliance with the law. The owner of the goods is required to provide
a bond or, security deposit, to assure that they will perform the orders of the court, and the owner must pay for FDA supervision
of any activities by the company to bring the goods into compliance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Citation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A citation is a formal warning to a firm of
intent to prosecute the firm if violations of the FD&amp;C Act are not corrected. It provides the firm an opportunity to convince
FDA not to prosecute.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Injunction</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An injunction is a civil action filed by FDA
against an individual or company. Usually, FDA files an injunction to stop a company from continuing to manufacture, package or
distribute products that are in violation of the law.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Prosecution</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Prosecution is a criminal action filed by FDA
against a company or individual charging violation of the law for past practices.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign and Export Regulation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We obtain approvals as necessary in connection
with the sales of our products in foreign countries. In some cases, FDA approval has been sufficient for foreign sales as well.
Our standard practice has been to require either the distributor or the customer to obtain any such foreign approvals or licenses
which may be required.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Legally marketed devices that comply with the
requirements of the Food Drug &amp; Cosmetic Act require a Certificate to Foreign Government issued by the FDA for export. Other
devices that do not meet the requirements of the FD&amp;C Act but comply with the laws of a foreign government require a Certificate
of Exportability issued by the FDA. All products which we sell have FDA clearance and would fall into the first category.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign governments have differing requirements
concerning the import of medical devices into their respective jurisdictions. The European Union, also referred to as EU, has some
essential requirements described in the EU&#8217;s Medical Device Directive, also referred to as MDD. In order to export to one
of these countries, we must meet the essential requirements of the MDD and any additional requirements of the importing country.
The essential requirements are similar to some of the requirements mandated by the FDA. In addition the MDD requires that we enlist
a Notified Body to examine and assess our documentation, a Technical Construction File, and verify that the product has been manufactured
in conformity with the documentation. The notified body must carry out or arrange for the inspections and tests necessary to verify
that the product complies with the essential requirements of the MDD, including safety performance and Electromagnetic Compatibility,
also referred to as EMC. Also required is a Quality System, ISO-13485, assessment by the Notified Body. We were approved for ISO
13485 certification for its Quality Management System in April, 2003.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We received clearance to sell the Upright&#174;
MRI scanners in the EU in May, 2002.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other countries require that their own testing
laboratories perform an evaluation of our devices. This requires that we must bring the foreign agency&#8217;s personnel to the
USA to perform the evaluation at our expense before exporting.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Some countries, including many in Latin America
and Africa, have very few regulatory requirements, beyond FDA clearance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">To date, Fonar has been able to comply with
all foreign regulatory requirements applicable to its export sales.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PHYSICIAN AND DIAGNOSTIC SERVICES MANAGEMENT
BUSINESS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Health Diagnostics Management, LLC (HDM) is
owned by Health Management Corporation of America (70.8%) and investors (29.2%). Health Management Corporation of America is owned
100% by Fonar Corporation. During the current fiscal year, the Company purchased non-controlling interests from the minority shareholders
for $546,000.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HDM operates under the assumed name &#8220;Health
Management Company of America&#8221; (&#8220;HMCA&#8221;).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The combined business (HDM and Health Management
Corporation of America) will be referred to as &#8220;HMCA&#8221; for all periods before and after July 1, 2015, unless otherwise
indicated.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA provides comprehensive non-medical management
services to diagnostic imaging facilities. These services include administrative services, billing and collection services, credentialing
services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision
and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting,
assistance with compliance matters and the development and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of June 30, 2022, HMCA managed a total of
41 MRI scanners of which twenty-six (26) scanners are located in New York and fifteen (15) scanners are located in Florida. For
the 2022 fiscal year, the revenues HMCA recognized from the MRI facilities has increased to $89.4 million from $80.9 million in
fiscal 2021. Five of the facilities in Florida are owned by HMCA subsidiaries, where the corporate practice of medicine is permitted.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe the utilization of FONAR Upright&#174;
MRI scanning systems, which are produced under the protection of our patents, accounts for the historically robust patient volume
at the scanning facilities and, most recently, our steady recovery from the effects of the COVID-19 pandemic. During fiscal 2022,
a scanner was added in New York, NY along with an additional scanner in this location, and an additional scanner was installed
in Pembroke Pines, Florida</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA GROWTH STRATEGY</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s growth strategy focuses on upgrading
and expanding the existing facilities it manages and expanding the number of facilities it either owns or manages for its clients,
including new sites. In connection with improving the performance of the facilities, we have added high field MRI scanners, extremity
scanners and x-ray machines to the Upright&#174; MRI scanners at certain of the sites where such additional diagnostic imaging modalities
are expected to produce the greatest return. In addition we plan to install two new facilities in fiscal 2023: one in New York
and one in Florida.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PHYSICIAN AND DIAGNOSTIC MANAGEMENT SERVICES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s services to the facilities it manages
encompass substantially all of their business operations. Each facility is controlled, however, not by HMCA, but by the physician
owner, or in the case of the four Florida sites owned by HMCA subsidiaries, by the medical director. All medical services are performed
by physicians and other medical personnel under the physician-owner&#8217;s supervision. HMCA is the management company and performs
services of a non-medical nature. These services include:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1. Offices and Equipment. HMCA identifies, negotiates
leases for and/or provides office space and equipment to its clients. This includes technologically sophisticated medical equipment.
HMCA also provides improvements to leaseholds, assistance in site selection and advice on improving, updating, expanding and adapting
to new technology.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2. Personnel. HMCA staffs all the non-medical
positions of its clients with its own employees, eliminating the client&#8217;s need to interview, train and manage non-medical
employees. HMCA processes the necessary tax, insurance and other documentation relating to employees.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3. Administrative. HMCA assists in the scheduling
of patient appointments, purchasing of office and medical supplies and equipment and handling of reporting, accounting, processing
and filing systems. It prepares and files the physician portions of complex applications to enable its clients to participate in
managed care programs and to qualify for insurance reimbursement. HMCA assists the clients to implement programs and procedures
to ensure full and timely regulatory compliance and appropriate cost reimbursement under no-fault insurance and Workers&#8217;
Compensation guidelines, as well as compliance with other applicable governmental requirements and regulations, including HIPAA
and other privacy requirements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">4. Billing and Collections.
HMCA is responsible for the billing and collection of revenues from third-party payors including those governed by No-Fault and
Workers&#8217; Compensation statutes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">5. Cost Saving Programs. Based on available
volume discounts, HMCA seeks to assist in obtaining favorable pricing for office and medical supplies, medical imaging film, equipment,
contrast agents, such as gadolinuim, and magnavist and other inventory for its clients.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">6. Diagnostic Imaging and Ancillary Services.
HMCA can offer access to diagnostic imaging equipment through diagnostic imaging facilities it manages. The Company is expanding
the ancillary services offered in its network to include x-rays, and other MRI equipment such as high-field (1.5 or 3.0 Tesla magnet
strength) MRI scanners and extremity MRI scanners.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">7. Marketing Strategies. HMCA is responsible
for developing and proposing marketing plans for its clients.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">8. Expansion Plans. HMCA assists the clients
in developing expansion plans including the opening of new or replacement facilities where appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s objective is to free physicians
from as many non-medical duties as is practicable, allowing physicians to spend less time on business and administrative matters
and more time practicing medicine.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The exceptions to this general model of operation
are five of the facilities located in Florida. These Florida facilities are owned by limited liability companies which, as our
subsidiaries, conduct their operations directly and bill and collect their fees from the patients and third party payors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The facilities enter into contracts with third
party payors, including managed care companies. None of HMCA&#8217;s clients, however, participate in any capitated plans or other
risk sharing arrangements. Capitated plans are those HMO programs where the provider is paid a flat monthly fee per patient.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The management fees payable by the facilities
to HMCA are flat monthly fees. In fiscal 2021, the aggregate amount of management fees was $4,897,720 per month. In fiscal 2022,
the aggregate amount of management fees was $4,865,443 per month.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fees under the management agreements are subject
to adjustment by mutual agreement on an annual basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Damadian owns three HMCA-managed MRI facilities
in Florida. The fees for these three sites in Florida owned by Dr. Damadian are flat monthly fees which are subject to adjustment
by mutual agreement on an annual basis. In fiscal 2022, the aggregate monthly amount of management fees payable to HMCA by these
sites was $995,825 as compared to $931,561 in fiscal 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Florida facilities owned by HMCA subsidiaries
directly bill their patients or the patients&#8217; insurance carriers. Patient fees net of provision for bad debts were $29,582,238
in fiscal 2022 as compared to $23,307,389 in fiscal 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA had previously contracted with an outside
billing company (located in Melville, New York) to perform billing and collection for their clients&#8217; No-Fault and Workers&#8217;
Compensation business. The fixed monthly fees were $85,000 for HMCA in part of fiscal 2021. This contract was terminated as of
January 1, 2021. The Company also entered into a one year renewable agreement to provide IT services to the billing company for
a monthly fee of $23,884.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA MARKETING</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s marketing strategy is to expand
the business and improve the facilities which it manages. HMCA is seeking to increase the number of locations of those facilities
where market conditions are promising and to promote growth of our clients&#8217; and Florida subsidiaries&#8217; patient volume
and revenue.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">DIAGNOSTIC IMAGING FACILITIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Diagnostic imaging facilities managed by HMCA
provide diagnostic imaging services to patients referred by physicians. The facilities are operated in a manner which eliminates
the admission and other administrative inconveniences of in-hospital diagnostic imaging services. Imaging services are performed
in an outpatient setting by trained medical technologists under the direction of physicians. Following diagnostic procedures, the
images are reviewed by the interpreting physicians who prepare reports of these tests and their findings. The vast majority of
reports for the New York facilities are transcribed by HMCA personnel and the remainder are outsourced to professional transcription
services. Reports for the Florida facilities are outsourced to professional transcription services.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA develops marketing programs and educational
programs in an effort to establish and maintain referring physician relationships for our clients and Florida subsidiaries.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Managed care providers are an important factor
in the diagnostic imaging industry. To further its position, HMCA is seeking to expand the imaging modalities offered at its managed
and owned diagnostic imaging facilities. Five facilities in New York and seven facilities in Florida have two or more MRI scanners.
One facility in New York and two in Florida also perform X-rays. During fiscal 2022, a second MRI was installed at our Pembroke
Pines, Florida facility and in one of our New York, NY facilities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">REIMBURSEMENT</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s clients receive reimbursements
for their services through Medicare, Medicaid, managed care, private commercial insurance, third party administrators, Workers&#8217;
Compensation, No-Fault and other insurance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medicare</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Medicare program provides reimbursement
for hospitalization, physician, diagnostic and certain other services to eligible persons 65 years of age and over and certain
other individuals. Providers are paid by the federal government in accordance with regulations promulgated by the Department of
Health and Human Services, HSS, and generally accept the payment with nominal deductible and co-insurance amounts required to be
paid by the service recipient, as payment in full. Hospital inpatient services are reimbursed under a prospective payment system.
Hospitals receive a specific prospective payment for inpatient treatment services based upon the diagnosis of the patient.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Under Medicare&#8217;s prospective payment system
for hospital outpatient services, or OPPS, a hospital is paid for outpatient services on a rate per service basis that varies according
to the ambulatory payment classification group, or APC, to which the service is assigned rather than on a hospital&#8217;s costs.
Each year the Centers for Medicare and Medicaid Services, or CMS, publishes new APC rates that are determined in accordance with
the promulgated methodology.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Services provided in non-hospital based freestanding
facilities are paid under the Medicare Physician Fee Schedule, or MPFS. All of HMCA&#8217;s clients are presently in this category.
The MPFS is updated on an annual basis and sometimes modified more frequently.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have experienced reimbursement reductions
for radiology services provided to Medicare beneficiaries, including reductions pursuant to the Deficit Reduction Act, or DRA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">CMS&#8217; 2010 regulatory changes to the MPFS
included a downward adjustment to services primarily involving the technical component rather than the physician work component,
by adjusting downward malpractice payments for these services. These adjustments have been phased in over a four year period. For
our fiscal year ended June 30, 2022, Medicare revenues represented approximately 3.2% of the revenues for HMCA&#8217;s clients
and subsidiaries as compared to 3.4% for the fiscal year ended June 30, 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medicaid</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Medicaid program is a jointly-funded federal
and state program providing coverage for low-income persons. In addition to federally-mandated basic services, the services offered
and reimbursement methods vary from state to state. In many states, Medicaid reimbursement is patterned after the Medicare program;
however, an increasing number of states have established or are establishing payment methodologies intended to provide healthcare
services to Medicaid patients through managed care arrangements. In fiscal 2022, approximately 0.07% of the revenues of HMCA&#8217;s
clients were attributable to Medicaid, as compared to 0.09% in fiscal 2021. Four of the Florida facilities (those owned by HMCA
subsidiaries) do not participate in Medicaid.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Managed Care and Private Insurance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Health Maintenance Organizations, or HMO&#8217;s,
Preferred Provider Organizations, or PPOs, and other managed care organizations attempt to control the cost of healthcare services
by a variety of measures, including imposing lower payment rates, preauthorization requirements, limiting services and mandating
less costly treatment alternatives. Managed care contracting is competitive and reimbursement schedules in many cases can be at
or below Medicare reimbursement levels. Some managed care organizations have reduced or otherwise limited, and other managed care
organizations may reduce or otherwise limit, reimbursement in response to reductions in government reimbursement. These reductions
could have an adverse impact on our financial condition and results of operations. These reductions have been, and any future reductions
may be, similar to the reimbursement reductions previously proposed.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA COMPETITION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The physician and diagnostic management services
field is highly competitive. A number of large hospitals have acquired medical practices and this trend may continue. HMCA expects
that more competition will develop. Many competitors have greater financial and other resources than HMCA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">With respect to the diagnostic imaging facilities
managed by HMCA, the outpatient diagnostic imaging industry is highly competitive. Competition focuses primarily on attracting
physician referrals at the local market level and increasing referrals through relationships with managed care organizations, as
well as emphasizing to potential referral sources the advantages of Upright&#174; MRI scanning. HMCA believes that principal competitors
for the diagnostic imaging centers are hospitals and independent or management company-owned imaging centers. Competitive factors
include quality and timeliness of test results, ability to develop and maintain relationships with managed care organizations and
referring physicians, type and quality of equipment, facility location, convenience of scheduling and availability of patient appointment
times. HMCA believes that it will be able to effectively meet the competition in the outpatient diagnostic imaging industry with
the Fonar Upright&#174; MRI scanners and strategically placed high field MRI scanners at its facilities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">GOVERNMENT REGULATION APPLICABLE TO HMCA</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FEDERAL REGULATION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The healthcare industry is highly regulated
and changes in laws and regulations can be significant. Changes in the law or new interpretation of existing laws can have a material
effect on our permissible activities, the relative costs associated with doing business and the amount of reimbursement by government
and other third-party payors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Federal False Claims Act</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The federal False Claims Act and, in particular,
the False Claims Act&#8217;s &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; provisions allow a private individual to bring
actions in the name of the government alleging that a defendant has made false claims for payment from federal funds. After the
individual has initiated the lawsuit the government must decide whether to intervene in the lawsuit and to become the primary prosecutor.
If the government declines to join the lawsuit, the individual may choose to pursue the case alone, although the government must
be kept apprised of the progress of the lawsuit, and may intervene later. Whether or not the federal government intervenes in the
case, it will receive the majority of any recovery.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">When an entity is determined to have violated
the federal False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil penalties
for each separate false claim and the government&#8217;s attorneys&#8217; fees. Liability arises when an entity knowingly submits,
or causes someone else to submit, a false claim for reimbursement to the federal government. The False Claims Act defines the term
&#8220;knowingly&#8221; broadly, though simple negligence will not give rise to liability under the False Claims Act. Examples
of the other actions which may lead to liability under the False Claims Act are set forth below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Failure to comply with the many technical billing
requirements applicable to our Medicare and Medicaid business.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Failure to comply with the prohibition against
billing for services ordered or supervised by a physician who is excluded from any federal healthcare program, or the prohibition
against employing or contracting with any person or entity excluded from any federal healthcare program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Failure to comply with the Medicare physician
supervision requirements for the services we provide, or the Medicare documentation requirements concerning physician supervision.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fraud Enforcement and Recovery Act of 2009
expanded the scope of the False Claims Act by, among other things, broadening protections for whistleblowers and creating liability
for knowingly retaining a government overpayment, acting in deliberate ignorance of a government overpayment or acting in reckless
disregard of a government overpayment. The healthcare reform bills in the form of the Patient Protection and Affordable Care Act,
as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, &#8220;PPACA&#8221;) expanded on changes
made by the 2009 Fraud Enforcement and Recovery Act with regard to such &#8220;reverse false claims.&#8221; Under PPACA, the knowing
failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding cost report
is due, whichever is later, constitutes a violation of the False Claims Act. HMCA and its clients have never been sued under the
False Claims Act and believe they are in compliance with the law.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stark Law</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Under the federal Self-Referral Law, also referred
to as the &#8220;Stark Law&#8221;, which is applicable to Medicare and Medicaid patients, and the self-referral laws of various
States, certain health practitioners, including physicians, chiropractors and podiatrists, are prohibited from referring their
patients for the provision of designated health services, including diagnostic imaging and physical therapy services, to any entity
with which they or their immediate family members have a financial relationship, unless the referral fits within one of the specific
exceptions in the statutes or regulations. The federal government has taken the position that a violation of the federal Stark
Law is also a violation of the Federal False Claims Act. Statutory exceptions under the Stark Law include, among others, direct
physician services, in-office ancillary services rendered within a group practice, space and equipment rental and services rendered
to enrollees of certain prepaid health plans. Some of these exceptions are also available under the State self-referral laws. HMCA
believes that it and its clients are in compliance with these laws.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Anti-kickback Regulation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We are subject to federal and state laws which
govern financial and other arrangements between healthcare providers. These include the federal anti-kickback statute which, among
other things, prohibits the knowing and willful solicitation, offer, payment or receipt of any remuneration, direct or indirect,
in cash or in kind, in return for or to induce the referral of patients for items or services covered by Medicare, Medicaid and
certain other governmental health programs. Under PPACA, knowledge of the anti-kickback statute or the specific intent to violate
the law is not required. Violation of the anti-kickback statute may result in civil or criminal penalties and exclusion from the
Medicare, Medicaid and other federal healthcare programs, and according to PPACA, now provides a basis for liability under the
False Claims Act. In addition, it is possible that private parties may file &#8220;qui tam&#8221; actions based on claims resulting
from relationships that violate the anti-kickback statute, seeking significant financial rewards. Many states have enacted similar
statutes, which are not limited to items and services paid for under Medicare or a federally funded healthcare program. Neither
HMCA nor its clients engage in this practice.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In fiscal 2022, approximately 3.2% of the revenues
of HMCA&#8217;s clients were attributable to Medicare and 0.07% were attributable to Medicaid. In fiscal 2021, approximately 3.4%
of the revenues of HMCA&#8217;s clients were attributable to Medicare and 0.09% were attributable to Medicaid.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Deficit Reduction Act (DRA)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On February 8, 2006, the President signed into
law the DRA. Effective January 1, 2007, the DRA provides that Medicare reimbursement for the technical component for imaging services
(excluding diagnostic and screening mammography) performed in freestanding facilities will be capped. Payment is the lesser of
the Medicare Physician Fee Schedule or the Hospital Outpatient Prospective Payment System (OPPS) rates. Implementation of these
reimbursement reductions contained in the DRA has had an adverse effect on our business. We have been able to counter this effect
by increasing our clients&#8217; scan volumes through our vigorous marketing efforts and reducing our operating expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The DRA also codified the reduction in reimbursement
for multiple images on contiguous body parts previously announced by CMS, the agency responsible for administering the Medicare
program. In November 2005, CMS announced that it would pay 100% of the technical component of the higher priced imaging procedure
and 50% of the technical component of each additional imaging procedure for imaging procedures involving contiguous body parts
within a family of codes when performed in the same session. CMS had indicated that it would phase in this 50% rate reduction over
two years, so that the reduction was 25% for each additional imaging procedure in 2006 and another 25% reduction in 2007. However,
for services furnished on or after July 1, 2010, the PPACA requires the full 50% reduction to be implemented.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Health Insurance Portability and Accountability
Act</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Congress enacted the Health Insurance Portability
and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217;
individually identifiable healthcare information. HIPAA, among other things, amends existing crimes and criminal penalties for
Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-governmental healthcare benefit
programs by means of false or fraudulent representations in connection with the delivery of healthcare services is subject to a
fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities
that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services to
federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business,
financial condition and results of operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Further, HIPAA requires healthcare providers
and their business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;).
HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting
the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed
into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business
associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity,
(2) substantive security and privacy obligations, including new federal security breach notification requirements to affected individuals,
DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition
on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties
that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per occurrence. In
2013 additional legal requirements were adopted to provide further protection for PHI.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, many states have enacted comparable
privacy and security statues or regulations that, in some cases, are most stringent than HIPAA requirements. In those cases it
may be necessary to modify our operations and procedures to comply with the more stringent state laws, which may entail significant
and costly changes for us. We believe that we are in compliance with such state laws and regulations. However, if we fail to comply
with applicable state laws and regulations, we could be subject to sanctions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe that we are in compliance with the
current HIPAA requirements, as amended by HITECH, together with other legislation and regulations, and comparable state laws, but
we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement
agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations
of our contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards may result
in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs,
including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results
of operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Civil Money Penalty Law and Other Federal Statutes</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Civil Money Penalty, or CMP, law covers
a variety of practices. It provides a means of administrative enforcement of the anti-kickback statute, and prohibits false claims,
claims for medically unnecessary services, violations of Medicare participating provider or assignment agreements and other practices.
The statute gives the Office of Inspector General of the HHS the power to seek substantial civil fines, exclusion and other sanctions
against providers or others who violate the CMP prohibitions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, in 1996, Congress created a new
federal crime: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly
and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute
is a felony and may result in fines, imprisonment or exclusion from government sponsored programs such as the Medicare and Medicaid
programs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certificates of Need</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Some states require hospitals and certain other
healthcare facilities and providers to obtain a certificate of need, or CON, or similar regulatory approval prior to establishing
certain healthcare operations or services, incurring certain capital projects and/or the acquisition of major medical equipment
including MRI and PET/CT systems. We are not operating in any such states.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Patient Protection and Affordable Care Act</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 23, 2010, President Obama signed into
law healthcare reform legislation in the form of PPACA. The implementation of this law has had a significant impact on the healthcare
industry. Most of the provisions of PPACA are being phased in over time and can be conceptualized as a broad framework not only
to provide health insurance coverage to millions of Americans, but to fundamentally change the delivery of care by bringing together
elements of health information technology, evidence-based medicine, chronic disease management, medical &#8220;homes,&#8221; care
collaboration and shared financial risk in a way that will accelerate industry adoption and change. We are unable to predict the
full impact of PPACA at this time primarily due to the previous administration&#8217;s efforts to repeal and replace the PPACA,
or to utilize executive action to modify the Act&#8217;s provisions where possible.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">State Regulation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to the federal self-referral law
and federal Anti-kickback statute, many States, including those in which HMCA and its clients operate, have their own versions
of self-referral and anti-kickback laws. These laws are not limited in their applicability, as are the federal laws, to specific
programs. HMCA believes that it and its clients are in compliance with these laws.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Various States prohibit business corporations
from practicing medicine. Various States, including New York, also prohibit the sharing of professional fees or fee splitting.
Consequently, in New York HMCA leases space and equipment to clients and provides clients with a range of non-medical administrative
and managerial services for agreed upon fees. Under Florida law a business entity can bill patients and third party payors directly
if that entity is properly licensed through AHCA. All of the eight facilities in Florida are licensed healthcare clinics through
AHCA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA&#8217;s clients and subsidiaries generate
revenue from patients covered by no-fault insurance and workers&#8217; compensation programs. For the fiscal year ended June 30,
2022 approximately 57.7% of our clients&#8217; receipts were from patients covered by no-fault insurance and approximately 8.6%
of our client&#8217;s receipts were from patients covered by workers&#8217; compensation programs. For the fiscal year ended June
30, 2021, approximately 55.5.% of HMCA&#8217;s clients&#8217; receipts were from patients covered by no-fault insurance and approximately
9.4% of HMCA&#8217;s clients&#8217; receipts were from patients covered by workers&#8217; compensation programs. The foregoing
numbers do not include payments from third party administrators. In the event that changes in these laws alter the fee structures
or methods of providing service, or impose additional or different requirements, HMCA could be required to modify its business
practices and services in ways that could be more costly to HMCA or in ways that decrease the revenues which HMCA receives from
its clients.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Compliance Program</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We maintain a program to monitor compliance
with federal and state laws and regulations applicable to the healthcare entities. The compliance program includes the adoption
of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others
may report regulatory or ethical concerns. We believe that our compliance program meets the relevant standards provided by the
Office of Inspector General of the Department of Health and Human Services.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An important part of our compliance program
consists of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We
also assist our clients with educational programs designed to familiarize them with the regulatory requirements and specific elements
of our compliance program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA believes that it and its clients are in
compliance with applicable Federal, State and local laws. HMCA does not believe that such laws will have any adverse material effect
on its business.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">EMPLOYEES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar and HMCA had approximately 484 employees
as of September 12, 2022. This total number included employees engaged in production, customer support, research and development,
information technology, employees engaged in marketing and sales, billing and collection, legal and compliance matters, as well
as transcriptionists, Florida technologists, field service technicians and individuals in various administrative positions. A significant
number of employees were employed at the MRI facilities managed or owned by HMCA, primarily in administrative positions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_002"></span>ITEM 1A. RISK FACTORS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">An investment in our securities is subject to
various risks, the most significant of which are summarized below.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">1.</td><td style="text-align: justify">Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business
conducted by HMCA. We are experiencing lower reimbursement rates from Medicare, other government programs and private insurance
companies. To date, we have been able to counter the impact of these reductions by increasing our volume of scans notwithstanding
the Covid-19 pandemic, and reducing our operating expenses, thereby maintaining profitability in this business segment. There is,
however, no assurance that we will be able to continue to do so.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">2.</td><td style="text-align: justify">Demand for MRI Scanners. The reduced reimbursement rates also affects our sales of MRI scanners
negatively. With lower revenue projections, prospective customers would demand lower prices for scanners. Although the reduced
reimbursements may not affect foreign demand, a lower number of sales in the aggregate could reduce economies of scale and consequently,
profit margins.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">3.</td><td style="text-align: justify">Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly
greater financial resources, production capacity, and other resources than we do. Such competitors would include General Electric,
Siemens, Hitachi and Phillips. Although Fonar is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;)
MRI scanner, potential customers must be convinced that the purchase of a Fonar scanner is their best choice. We believe that with
time, that objective will be reached, particularly with customers scanning patients having neck, back, knee and various orthopedic
issues who would benefit from being scanned in weight-bearing positions.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">4.</td><td style="text-align: justify">Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly,
from fees charged for the diagnostic imaging services performed at the facilities. We depend on referrals of patients from unaffiliated
physicians and other third parties to the facilities we manage or own for the services we perform. If these physicians and other
third parties were to reduce the number of patients they refer or discontinue referring patients, scan volumes could decrease,
which would reduce our net revenue and operating margins.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">5.</td><td style="text-align: justify">Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations
and preferred provider organizations is to control the cost of healthcare services. Healthcare providers participating in managed
care plans may be required to refer diagnostic imaging tests to certain providers depending on the plan in which a covered patient
is enrolled. In addition, managed care contracting has become very competitive. The expansion of health maintenance organizations,
preferred provider organizations and other managed care organizations within New York or Florida could have a negative impact on
the utilization and pricing of services performed at the facilities HMCA manages or owns to the extent these organizations exert
control over patients&#8217; access to diagnostic imaging services, selections of the provider of such services and reimbursement
rates for those services.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">6.</td><td style="text-align: justify">Scanning Facility Competition. The market for diagnostic imaging services is highly competitive.
The facilities we manage or own compete for patients on the basis of reputation, location and the quality of diagnostic imaging
services. Groups of radiologists, established hospitals, clinics and other independent organizations that own and operate imaging
equipment are the principal competitors.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">7.</td><td style="text-align: justify">Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare
through private employers, the number of patients who are uninsured or participate in governmental programs may increase. Healthcare
reform legislation will increase the participation of individuals in the Medicaid program in states that elect to participate in
the expanded Medicaid coverage. A shift in payor mix from managed care and other private payors to government payors or an increase
in the number of uninsured patients may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables
or uncompensated care, with a corresponding decrease in net revenue. Policies now being offered under various insurance plans are
expected to reduce demand for MRI scans as they become less affordable. Changes in the eligibility requirements for governmental
programs such as the Medicaid program and state decisions on whether to participate in the expansion of such programs also could
increase the number of patients who participate in such programs and the number of uninsured patients. Even for those patients
who remain in private insurance plans, changes to those plans could increase patient financial responsibility, resulting in a greater
risk of uncollectible receivables. These factors and events could have a material adverse effect on our business, financial condition,
and results of operations.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">8.</td><td style="text-align: justify">Possible changes in Florida Insurance Law. In early 2019, two senate bills and one house bill in
Florida were introduced, all of them calling for the repeal of PIP and replacing PIP with $25,000 Bodily Injury Coverage and Property
Damage Liability Coverage. Another Florida senate bill was introduced that would preserve PIP but dramatically cut reimbursement
rates. None of the proposed bills made it onto the 2019 legislative agenda. During Fonar&#8217;s fiscal 2021, the Florida house
and senate reached an agreement and passed similar legislation. It was, however, vetoed by the Governor. We cannot predict whether
such efforts by the Florida legislature will continue or be successful. Currently, drivers and passengers get car damages and PIP,
paid for up to $10,000, no matter who is at fault in an accident. Drivers have to pay an additional cost to insurance companies
to pay for bodily injuries which covers them if they are at fault. While PIP is required, coverage for bodily injury is not.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt"></td><td style="text-align: justify">Over the past several years there have been various bills introduced by a number of Florida legislators
to eliminate PIP and instead mandate coverage including some combination of a minimum of bodily injury and a reduced or no amount
of medical payments (Medpay coverage). Eliminating PIP would mean that the $10,000 drivers now get paid toward medical costs through
their insurers might not be there for them to pay for injured drivers. Importantly, payments would be reduced by approximately
60% due to claims being paid at commercial rates or through legal settlements instead of at the presently prevailing PIP fee schedule.
This would negatively impact our Florida diagnostic imaging facilities (both those we own and those we manage) with more unpaid
bills, lower reimbursement rates and elongated waiting times. To date proponents of these changes have been unsuccessful.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">9.</td><td style="text-align: justify">Federal and state privacy and information security laws. We must comply with numerous federal and
state laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and
its implementing privacy and security regulations, as amended by the federal HITECH Act. If we fail to comply with applicable privacy
and security laws, regulations and standards, properly maintain the integrity of our data, protect our proprietary rights to our
systems, or defend against cybersecurity attacks, our business, reputation, results of operations, financial position and cash
flows could be materially and adversely affected.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify">Information security risks have significantly
increased because of the proliferation of new technologies, the use of the internet and telecommunications technologies to conduct
our operations, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties,
including foreign state agents. Our operations rely on the secure processing, transmission and storage of confidential, proprietary
and other information in our computer systems and networks.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">10.</td><td style="text-align: justify">COVID-19. Although we believe we have taken the proper steps and made a good recovery from the
impact of the first wave of the COVID-19 virus, new strains of the disease have developed and future variants may continue to develop.
The relatively recent new variants are particularly contagious and coupled with New York State requirements that medical employees
must be vaccinated if they care for patients, including our technicians and support staff caring for scanning patients, has resulted
in fewer available employees and adversely affected our ability to staff a full number of shifts. The course and severity of the
virus in the following months, and the ultimate economic and medical impact it will have worldwide and at home, is uncertain.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 36pt">11.</td><td style="text-align: justify">Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from
adverse changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of
credit markets. Turbulence and uncertainty in the United States and international markets and economies may adversely affect our
liquidity, financial condition, revenues, profitability and business operations generally.</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -36pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_003"></span>ITEM 1B. UNRESOLVED STAFF COMMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">None.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_004"></span>ITEM 2. PROPERTIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar and HMCA currently lease approximately
78,000 square feet of office and plant space at its principal offices in Melville, New York. The term of the lease runs through
November, 2026. Management believes that the premises will be adequate for its current needs. HMCA also maintains office space
for the Facilities owned by its subsidiaries in Florida and for its clients at the clients&#8217; sites in New York and Florida
under leases having various terms. HMCA owns the building for the client&#8217;s premises in Tallahassee, Florida. The Company
received approval from the Suffolk County IDA on February 29, 2016 of a 50% property tax abatement, valued at $440,000, over a
10 year period commencing January, 2017.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_005"></span>ITEM 3. LEGAL PROCEEDINGS.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">There are no material legal proceedings threatened or pending against
the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_006"></span>ITEM 4. MINE SAFETY DISCLOSURES.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;<br />
Not Applicable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">PART II</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_007"></span>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY
AND RELATED STOCKHOLDER&#160;MATTERS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our Common Stock is traded in the Nasdaq SmallCap
market under the National Association of Securities Dealers Automated Quotation System, also referred to as &#8220;NASDAQ&#8221;,
under the symbol FONR. The following table sets forth the high and low trades reported in NASDAQ System for the periods shown.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="8" style="border-bottom: Black 1pt solid; text-align: center">Fiscal Quarter</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">High</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Low</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">January -</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">March</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2018</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">29.95</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">22.15</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">April -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">June</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2018</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">30.10</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">25.31</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">July -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">September</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2018</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">28.80</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">23.70</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">October -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">December</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2018</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">25.77</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">19.63</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">January</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">March</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2019</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">23.85</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20.01</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">April -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">June</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2019</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">23.00</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18.85</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">July -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">September</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2019</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">25.25</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20.44</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">October -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">December</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2019</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20.94</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">19.07</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">January -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">March</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20.24</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">11.00</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">March -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">June</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">25.99</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">13.85</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">July -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">September</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">26.49</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20.31</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">October -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">December</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">22.49</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16.74</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">January -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">March</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20.40</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17.31</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">April -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">June</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">19.18</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16.58</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">July -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">September</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18.04</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15.22</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">October -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">December</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18.94</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">14.32</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">January -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">March</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">19.32</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">14.24</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">April -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">June</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">19.13</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">14.80</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">July -</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">September 14,</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15.44</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">13.56</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Performance Graph</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following graph compares the annual change
in the Company&#8217;s cumulative total shareholder return on its Common Stock during a period commencing on June 29, 2018 and
ending on June 30, 2022 (as measured by dividing (i) the sum of (A) the cumulative amount of dividends for the measurement period,
assuming dividend reinvestment and (B) the difference between the Company&#8217;s share price at the end and the beginning of the
measurement period; by (ii) the share price at the beginning of the measurement period) with the cumulative total return of each
of: (a) the CRSP Composite Total Return Index for Nasdaq (&#8220;Nasdaq&#8221;); and (b) the CRSP Total Return Index for Nasdaq
Healthcare companies (&#8220;Nas-Hea.&#8221;) during such period, assuming a $100 investment on June 29, 2018. The stock price
performance on the graph below is not necessarily indicative of future price performance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="text-align: center">Relative Dollar Values</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="21" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">TOTAL RETURN</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 29, &#160; <span style="text-decoration: none">2018</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 28, &#160; <span style="text-decoration: none">2019</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, &#160; <span style="text-decoration: none">2020</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, &#160; <span style="text-decoration: none">2021</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, &#160; <span style="text-decoration: none; font-style: normal; font-weight: normal">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left; text-indent: -11pt; padding-left: 11pt">Fonar Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">81</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">67</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">57</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt">Nasdaq Composite</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">108</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt">Nasdaq Health</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">163</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">199</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11pt; padding-left: 11pt">Nasdaq Medical Equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">127</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">154</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><img src="fonar_chart.jpg" alt="" style="height: 264pt; width: 468pt" /></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On September 14, 2022, we had approximately
1,006 stockholders of record of our Common Stock, 12 stockholders of record of our Class B Common Stock, 3 stockholders of record
of our Class C Common Stock and 1,155 stockholders of record of our Class A Non-voting Preferred Stock<span style="color: red">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At the present time, the only class of our securities
for which there is a market is the Common Stock.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We currently have a policy of retaining earnings
to finance the development and expansion of our business. We expect to continue this policy for the foreseeable future.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_008"></span>ITEM 6. SELECTED FINANCIAL DATA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following selected consolidated financial
data has been extracted from our consolidated financial statements for the five years ended June 30, 2022. This consolidated selected
financial data should be read in conjunction with our consolidated financial statements and the related notes included in Item
8 of this form.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: left">STATEMENT OF OPERATIONS For the periods ending June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center">2021</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center">2020</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center">2019</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center">2018</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; width: 35%; text-indent: -11pt">Revenues</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 2%">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">97,592,145</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 2%">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">89,929,765</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 2%">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">85,690,462</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 2%">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">87,192,887</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 2%">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">81,515,994</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Cost of</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">50,578,201</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">46,456,127</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">43,296,825</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">43,984,593</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">41,950,770</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Research and</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1,494,181</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1,635,979</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">2,025,376</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1,812,347</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1,755,747</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic Net</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">17,234,388</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">13,673,811</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">11,704,733</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">20,513,674</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">25,452,185</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic Net</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1.78</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1.47</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1.20</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">2.26</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">3.16</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Income per common</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Diluted Net</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1.75</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1.45</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">1.18</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">2.22</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">3.10</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Income per common</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Basic</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,554,209</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,505,283</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,443,713</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,354,103</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,287,510</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average numbe r of shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,681,713</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,632,787</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,571,217</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,481,607</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left"></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">6,415,014</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average number of shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">BALANCE SHEET DATA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Working</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">101,937,320</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">88,534,063</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">77,226,104</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">70,998,783</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">52,497,840</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Assets</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">199,341,982</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">189,506,195</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">180,259,380</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">133,560,210</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: right">118,310,945</td><td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Long-term debt and obligations under capital leases</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">993,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,808,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,116,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">273,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">306,035</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Stockholder&#8217;s equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">146,236,281</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">135,370,125</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">126,242,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">118,112,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,234,471</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_009"></span>ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATION.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">INTRODUCTION.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar was formed in 1978 to engage in the business
of designing, manufacturing and selling MRI scanners. HMCA, a subsidiary of Fonar, provides management services to diagnostic imaging
facilities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s principal MRI product is its Upright&#174;
MRI (also called Stand-Up&#174; MRI) scanner. The Upright&#174; MRI allows patients to be scanned for the first time under weight-bearing
conditions. The Stand-Up&#174; MRI is the only MRI capable of producing images in the weight-bearing state.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At 0.6 Tesla field strength, the Upright&#174;
MRI is among the highest field open MRI scanners in the industry, offering non-claustrophobic MRI together with high-field image
quality. Fonar&#8217;s open MRI scanners were the first high field strength open MRI scanners in the industry.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">HMCA generates revenues from providing comprehensive
management services, including development, administration, accounting, billing and collection services, together with office space,
medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form of fees which are earned under contracts
with HMCA&#8217;s clients except for its three Florida subsidiaries which engage in the practice of medicine, and bill and collect
fees from patients, insurers and other third party payors directly.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The most significant adverse impact on on our
Company in fiscal 2020 has been the COVID-19 pandemic. Although it had seemed the worst had passed, events have shown a spike in
new cases due primarily to the new Delta strain in the viruses. This is by no means a problem confined to our Company, but regardless
of our best efforts, our results of operation and financial condition are potentially volatible and severe.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Since March, 2020 the global pandemic of COVID-19
has caused turbulence and uncertainty in the United States and international economies which have adversely affected our workforce,
liquidity, financial conditions, revenues, profitability and business operations. Generally COVID-19 had caused us to require that
much of our workforce work from home and has restricted the ability of our personnel to travel for marketing purposes or to service
our customers. At the end of fiscal 2020, the Company was able to enact certain decisions to allow the Company to survive during
the global pandemic and from further losses or additional decreases in scan volume. The Company also received some government stimulus
funds from the Paycheck Protection Program (&#8220;PPP) and Medicare advances/stimulus payments. During fiscal 2022, the PPP loan
was forgiven in its entirety. During fiscal 2022, the Company had to deal with increased strictness in the enforcement of COVID-19
mandates, such as the requirement that employees in healthcare facilities be vaccinated, along with the newer variants that are
more transmissible. As a result, the Company experienced absences due to illness and the loss of unvaccinated employees whose duties
required them to be in contact with patients. Due to these conditions, The Company was sometimes unable to keep scanning facilities
open for all shifts and as a result there was a slight decrease in scans during the second quarter of fiscal 2022. The Company
has been able to navigate through these challenges and avoid any significant disruption of the business and the volume has risen
back almost to pre-COVID-19 levels. Although we are unable to predict if there will be additional consequences on our operations
from the continuing global pandemic of COVID-19, the Company believes with the positive cash flows, low debt and cash on hand,
it will be able to continue operations going forward.&#160;
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Critical Accounting Policies</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our discussion and analysis of financial condition
and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S. generally
accepted accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements. These
estimates and assumptions affect various matters, including:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">our reported amounts of assets and liabilities
in our consolidated balance sheets at the dates of the financial statements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">our disclosure of contingent assets and liabilities
at the dates of the financial statements; and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">our reported amounts of net revenue and expenses
in our consolidated statements of operations during the reporting periods</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">These estimates involve judgments with respect
to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could
differ materially from these estimates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Securities and Exchange Commission defines
critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and
results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need
to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. In the notes
to our consolidated financial statements, we discuss our significant accounting policies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe the following critical accounting
policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.
We recognize revenue and related costs of revenue from sales contracts for our MRI scanners and major upgrades, under the percentage-of-completion
method. Under this method, we recognize revenue and related costs of revenue, as each sub-assembly is completed. Amounts received
in advance of our commencement of production are recorded as customer advances.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We continuously, qualitatively and quantitatively
evaluate the realizability (including both positive and negative evidence) of the net deferred tax assets and assess the valuation
allowance periodically. Our evaluation considers the financial condition of the Company and both the business conditions and regulatory
environment of the industry. If future taxable income or other factors are not consistent with our expectations, an adjustment
to our allowance for net deferred tax assets may be required. For net deferred tax assets we consider estimates of future taxable
income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.
Our ability to project future taxable income may be significantly affected by our ability to determine the impact of regulatory
changes which could adversely affect our future profits. As a result, the benefits of our net operating loss carry forwards could
expire before they are utilized.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At June 30, 2021, the net deferred tax asset
was valued at $15,958,961<span style="color: red">. </span>At June 30, 2022,<span style="color: red"> </span>the net deferred tax
asset was valued at<span style="color: red"> </span>$12,842,478.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We depreciate our long-lived assets over their
estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful lives
or the lease term of the facility for which these assets are associated.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company provides for medical receivables
that could become uncollectible by establishing an allowance for doubtful accounts in order to adjust medical receivables to estimated
net realizable value. In evaluating the collectability of medical receivables, the Company considers a number of factors, including
the age of the account, historical collection experiences, payor type, current economic conditions and other relevant factors.
There are various factors that impact collection trends, such as payor mix, changes in the economy, increase burden on copayments
to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and
can have an impact on collection trends and the estimation process.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We amortize our intangible assets, including
patents, and capitalized software development costs, over the shorter of the contractual/legal life or the estimated economic life.
Our amortization life for patents and capitalized software development costs is 15 to 17 years and 5 years, respectively. Our amortization
of the non-competition agreements entered into with certain individuals in connection with the HDM transaction are depreciated
over seven years, and customer relationships are amortized over 20 years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Goodwill is recorded as a result of business
combinations. Management evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances
suggest that the carrying amount may not be recoverable. Impairment of goodwill is tested by comparing the reporting unit&#8217;s
carrying amount, including goodwill, to the fair value of the reporting unit. The fair value of a reporting unit is estimated using
a combination of the income or discounted cash flows approach and the market approach, which uses comparable market data. If the
carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to
measure the amount of impairment loss, if any. Based on our test for goodwill impairment, we noted no impairment related to goodwill.
However, if estimates or the related assumptions change in the future, we may be required to record impairment charges to reduce
the carrying amount of goodwill.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We periodically assess the recoverability of
long-lived assets, including property and equipment, intangibles and management agreements, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">RESULTS OF OPERATIONS. FISCAL 2022 COMPARED
TO FISCAL 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In fiscal 2022, we recognized net income of
$17.2 million on revenues of $97.6 million, as compared to net income of $13.7 million on revenues of $89.9 million for fiscal
2021. This represents an increase in revenues of 8.5%. Patient fee revenue net of contractual allowances increased by 26.9%. Total
costs and expenses increased by 3.8%. Our consolidated operating results increased by 28.7% to an operating income of $22.0 million
for fiscal 2022 as compared to operating income of $17.1 million for fiscal 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Discussion of Operating Results of Medical Equipment
Segment</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fiscal 2022 Compared to Fiscal 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenues attributable to our medical equipment
segment decreased by 9.1% to $8.2 million in fiscal 2022 from $9.0 million in fiscal 2021, with product sales revenues decreasing
by 59.8% from $1.3 million in fiscal 2021 to $518,000 in fiscal 2022. Service revenue remained constant from $7.7 million in fiscal
2021 and in fiscal 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Upright&#174; MRI is unique in that it permits
MRI scans to be performed on patients upright in the weight-bearing state and in multiple positions that correlate with symptoms.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Product sales to unrelated parties decreased
by 59.8% in fiscal 2022 from $1.3 million in fiscal 2021 to $518,000 in fiscal 2022. There were no product sales to related parties
in fiscal 2022 or 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe that one of our principal challenges
in achieving greater market penetration is attributable to the better name recognition and larger sales forces of our larger competitors
such as General Electric, Siemens, Hitachi, Philips and Toshiba and the ability of some of our competitors to offer attractive
financing terms through affiliates, such as G.E. Capital.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, lower reimbursement rates have
reduced the demand for our MRI products, resulting in lower sales volumes. As a result of fewer sales, service revenues have decreased
since as older scanners are taken out of service, there are fewer new scanners available to sign service contracts.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The operating loss for the medical equipment
segment increased from an operating loss of $3.4 million in fiscal 2021 to an operating loss of $4.6 million in fiscal 2022. The
losses are attributable most significantly to the fact that costs increased by a greater amount than revenues. The increase in
costs was primarily due to the increase in business activity which resulted in our increased revenues.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We recognized revenues of $62,000 from the sale
of our Upright&#174; MRI scanners in fiscal 2022, while in fiscal 2021, we recognized revenues of $733,000 from the sale of Upright&#174;
MRI scanners.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development expenses decreased
to $1.5 million in fiscal 2022 from $1.6 million in fiscal 2021. Our expenses for fiscal 2021 represented continued research and
development of various upgrades for the Upright&#174; MRI scanner. The reason for the decrease in research and development was due
mainly to supply chain related delays due to the COVID-19 pandemic.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Discussion of Operating Results of Physician and Diagnostic Services
Management Segment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Fiscal 2022 Compared to Fiscal 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenues attributable to the Company&#8217;s physician and diagnostic
services management segment, HMCA, increased to $89.4 million in fiscal 2022 as compared to $80.9 million in fiscal 2021. The increase
in revenues was due to an increase of $6.3 million of patient fees (net of contractual allowances and discounts less provision
for bad debts) from patient and third party payors recognized by five of the facilities in Florida. Also management and other fees
increased by $2.2 million due to two additional scanners being installed in existing facilities.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cost of revenues as a percentage of the related
revenues for our physician and diagnostic services management segment increased from $42.6 million or 52.7% of related revenues
for the year ended June 30, 2021 to $47.1 million, or 52.7% of related revenues for the year ended June 30, 2022. The revenues
increased more than the costs relating to these revenues.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Operating results of this segment increased
from operating income of $20.5 million in fiscal 2021 to operating income of $26.6 million in fiscal 2022. We believe that our
efforts to expand and improve the operation of our physician and diagnostic services management segment are directly responsible
for the profitability of this segment and our company as a whole.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the fiscal years ended June 30, 2022 and
June 30, 2021 11.8% and 12.2%, respectively, of total revenues were derived from contracts with facilities owned by Dr. Raymond
V. Damadian, the Chairman of the Board and principal stockholder of Fonar. The agreements with these MRI facilities are for one-year
terms which renew automatically on an annual basis, unless terminated. The fees for these sites, which are located in Florida,
are flat monthly fees.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Discussion of Certain Consolidated Results of
Operations</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fiscal 2022 Compared to Fiscal 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Interest and investment income decreased in
2022 compared to 2021. We recognized interest income of $247,158 in 2022 as compared to $311,931 in fiscal 2021, representing a
decrease of 20.8%.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Interest expense of $346,552 was recognized
in fiscal 2022, as compared to interest expense of $248,665 in fiscal 2021. The increase in interest expense is attributable to
an assessment of additional taxes and interest in connection with a state income tax audit.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The 29.2% noncontrolling interest allocations
of $4,793,000 and $3,466,000 for fiscal 2022 and fiscal 2021 respectively, have been calculated by Income from operations, and
adding depreciation and amortization net of miscellaneous losses and other income from the Physician and Diagnostic Service Management
segment (See Note 17).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">While revenue increased by 8.5% selling, general
and administrative expenses decreased by 5.0% to $23.5 million in fiscal 2022 from $24.7 million in fiscal 2021. This increase
in revenues was almost exclusively due to less reserves placed on service contracts and management fees and other receivables resulting
from the COVID-19 pandemic as compared to fiscal 2021. It is too early to know how much of these reserves will be recovered. Also
Fonar resolved certain sales tax liabilities during the year and was able to reverse accrued interest and penalties of $119,000
which was recorded under selling, general and administrative expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The compensatory element of stock issuances
decreased from $83,277 in fiscal 2021 to $0 in fiscal 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from service and repair fees remained
constant at $7.7 million in fiscal 2021 to and fiscal 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Continuing our tradition as the originator of
MRI, we remain committed to maintaining our position as the leading innovator of the industry through investing in research and
development. In fiscal 2022 we continued our investment in the development of various upgrades for the UPRIGHT&#174; MRI, with an
investment of $1,494,181 in research and development, none of which was capitalized, as compared to $1,635,979, none of which was
capitalized, in fiscal 2021. The research and development expenditures were approximately 18.2% of revenues attributable to our
medical equipment segment and 1.5% of total revenues in 2022, and 18.1% of medical equipment segment revenues and 1.8% of total
revenues in fiscal 2021. This represented a 8.7% decrease in research and development expenditures in fiscal 2022 as compared to
fiscal 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the physician and diagnostic services management
segment, HMCA, revenues increased to $89.3 million in fiscal 2022 as compared to $80.9 million in fiscal 2021. This is primarily
attributable to an increase in patient scans resulting from our marketing efforts.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For the fiscal year 2022 the Company recorded
an income tax expense of $5.5 million compared with an income tax expense of $4.0 million for 2021. The income tax benefits are
attributable to the expected tax benefits associated with the projected realization and utilization of our net operating losses
in future periods. The Company has recorded a deferred tax asset of $12.8 million as of June 30, 2022, primarily relating to the
tax benefits from the net operating loss carry forwards available to offset future taxable income. The utilization of these tax
benefits is dependent on the Company generating future taxable income. Although the Company is expecting to generate taxable income
in future periods, they cannot accurately measure the full impact of the adoption of healthcare regulations, including the impact
of continuing changes in MRI scanning reimbursement rates, and the severity and the duration of the COVID-19 virus, which could
materially impact operations. A partial valuation allowance will be maintained until evidence exists to support that it is no longer
needed.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have been taking steps to improve HMCA revenues
by our marketing efforts, which focus on the unique capability of our Upright&#174; MRI scanners to scan patients in different positions.
We have also been increasing the number of health insurance plans in which our clients participate. The utilization of these tax
benefits is dependent on the Company generating future taxable income and other factors. A partial valuation allowance will be
maintained until evidence exists to support that it is no longer needed, (principally related to research and development credits).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our management fees are dependent on collection
by our clients of fees from reimbursements from Medicare, Medicaid, private insurance, no fault and workers&#8217; compensation
carriers, self&#8211;pay and other third-party payors. The health care industry is experiencing the effects of the federal and
state governments&#8217; trend toward cost containment, as governments and other third-party payors seek to impose lower reimbursement
and utilization rates and negotiate reduced payment schedules with providers. The cost-containment measures, consolidated with
the increasing influence of managed-care payors and competition for patients, have resulted in reduced rates of reimbursement for
services provided by our clients from time to time. Our future revenues and results of operations may be adversely impacted by
future reductions in reimbursement rates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain third-party payors have proposed and
implemented changes in the methods and rates of reimbursement that have had the effect of substantially decreasing reimbursement
for diagnostic imaging services that HMCA&#8217;s clients provide. To the extent reimbursement from third-party payors is reduced,
it will likely have an adverse impact on the rates they pay us, as they would need to reduce the management fees they pay HMCA
to offset such decreased reimbursement rates. Furthermore, many commercial health care insurance arrangements are changing, so
that individuals bear greater financial responsibility through high deductible plans, co-insurance and higher co-payments, which
may result in patients delaying or foregoing medical procedures. More frequently, however, patients are scanned and we experience
difficulty in collecting deductibles and co-payments. We expect that any further changes to the rates or methods of reimbursement
for services, which reduce the reimbursement per scan of our clients may partially offset the increases in scan volume we are working
to achieve for our clients, and indirectly will result in a decline in our revenues.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On March 23, 2010, President Obama signed into law healthcare reform
legislation in the form of the Patient Protection and Affordable Care Act, or PPACA. The ultimate impact of the PPACA is uncertain
but to date has reduced our revenues from what they otherwise would have been.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, the use of radiology benefit managers,
or RBM&#8217;s has increased in recent years. It is common practice for health insurance carriers to contract with RBMs to manage
utilization of diagnostic imaging procedures for their insureds. In many cases, this leads to lower utilization of imaging procedures
based on a determination of medical necessity. The efficacy of RBMs is still a highly controversial topic. We cannot predict whether
the healthcare legislation or the use of RBMs will negatively impact our business, but it is possible that our financial position
and results of operations could be negatively affected.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">LIQUIDITY AND CAPITAL RESOURCES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash, and cash equivalents increased by 9.6%
from $44.5 million at June 30, 2021 to $48.7 million at June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash provided by operating activities for fiscal
2022 approximated $15.3 million. Cash provided by operating activities was attributable to the net income of $17.2 million, depreciation
and amortization of $4.5 million, deferred income tax expense benefit of $3.1 million which was offset by the increase in accounts,
and medical and management fee receivables of $5.6 million.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash used in investing activities for fiscal
2022 approximated $5.2 million. The cash used in investing activities was attributable to purchases of property and equipment of
$4.5 million, purchase of noncontrolling interests of $546,000 and costs of patents of $88,000.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash used in financing activities for fiscal
2021 approximated $5.9 million. The principal uses of cash used in financing activities included the repayment of borrowings and
capital lease obligations of $37,000, and distributions to non-controlling interests of $5.8 million.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Total liabilities decreased slightly by 1.9%
during fiscal 2022, from approximately $54.1 million at June 30, 2021 to approximately $53.1 million at June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At June 30, 2022, we had working capital of
approximately $101.9 million as compared to working capital of $88.5 million at June 30, 2021, and stockholders&#8217; equity of
$146.2 million at June 30, 2022 as compared to stockholders&#8217; equity of $135.4 million at June 30, 2021. For the year ended
June 30, 2022, we realized a net income of $17.2 million.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our principal sources of liquidity are derived
from revenues.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our business plan includes a program for manufacturing
and selling our Upright&#174; MRI scanners. In addition, we are enhancing our revenue by participating in the physician and diagnostic
services management business through our subsidiary, HMCA and have upgraded the facilities which it manages, most significantly
by the replacement of the original MRI scanners with new Upright&#174; MRI scanners. As of June 30, 2022, HMCA manages a total of
41 MRI scanners of which 26 MRI scanners are located in New York and 15 are located in Florida. We have also intensified our marketing
activities through the hiring of additional marketers for HMCA&#8217;s clients.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our business plan also calls for a continuing
emphasis on providing our customers with enhanced equipment service and maintenance capabilities and delivering state-of-the-art,
innovative and high quality equipment upgrades at competitive prices. Fees for on-going service and maintenance from our installed
base of scanners were $7.7 million for the year ended June 30, 2021 and $7.7 million for the year ended June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In order to promote profitability and to reduce
demands on our cash and other liquid reserves, we maintain an aggressive program of cost cutting. Previously, these measures included
consolidating HMCA&#8217;s office space with Fonar&#8217;s office space and reducing the size of our workforce, compensation and
benefits. We continue to reduce and contain expenses across the board. The cost reductions are intended to enable us to withstand
periods of low volumes of MRI scanner sales, by keeping expenditures at levels which can be supported by service revenues and HMCA
revenues.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Current economic credit conditions have contributed
to a slower than optimal business environment. As a result our business may suffer, should the credit markets not improve in the
near future. The direct impact of these conditions is not fully known.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenues from HMCA have been the principal reason
for our profitability, and we have so far been able to maintain and increase such revenues by increasing the number of scans being
performed by the sites we manage and those we own, notwithstanding reductions in reimbursement rates from third party payors. The
likelihood and effect of any subsequent reductions is not fully known.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Capital expenditures for fiscal 2022 approximated $4.6 million. Capitalized
patent costs were approximately $88,000. Purchases of property and equipment were approximately $4.5 million.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar is committed to making capital expenditures
in the 2023 fiscal year, for placing two scanners at facilities located in Florida and New York. The facility in Florida will be
a new stand-alone facility and the facility in New York will also be a new stand-alone facility. The current estimated costs of
these capital expenditures is approximately $3.1 million.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company believes that its business plan
has been responsible for the past five consecutive fiscal years of profitability (fiscal 2022, fiscal 2021, fiscal 2020, fiscal
2019 and fiscal 2018) and that its capital resources will be adequate to support operations at current levels through September
30, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a
stock repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On
September 26, 2022, the Board of Directors has approved up to $9 million to be repurchased under the plan which will be purchased on
the publicly traded open market at prevailing prices.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During August 2021 the Company renewed their
revolving credit agreement. The terms include borrowing limits of up to $10,000,000 and the agreement was extended to August 2022.
The interest rate on unpaid principal remains at 4% along with certain financial covenants still applicable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">ITEM 7A. QUALITATIVE AND QUANTITATIVE DISCLOSURES
ABOUT MARKET RISK</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company does not have any investments in
marketable securities, foreign currencies, mutual funds, certificates of deposit or other fixed rate instruments. All of our funds
are in cash accounts or money market accounts which are liquid.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All of our revenue, expense and capital purchasing activities are
transacted in United States dollars.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See Note 11 to the consolidated Financial Statements for information
on long-term debt.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-indent: 0pt"><span id="a_010"></span>&#160;ITEM 8. FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-indent: 0pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">PAGE.</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 90%"><a href="#b_001"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></a></td>
    <td style="text-align: right; width: 10%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">46</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#b_002"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">CONSOLIDATED BALANCE SHEETS</span></a></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">49</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">At June 30, 2022 and 2021</span></td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#b_003"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF INCOME</span></a></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">52</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">For the Years Ended June 30, 2022 and 2021</span></td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#b_004"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></a></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">54</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">For the Years Ended June 30, 2022 and 2021</span></td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#b_005"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></a></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">56</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">For the Years Ended June 30, 2022 and 2021</span></td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#b_006"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></a></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">58</span></td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b><span id="b_001"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</b></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">To the Shareholders and Board of Directors
of FONAR Corporation and Subsidiaries<b> </b></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Opinion on the Financial Statements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="color: black">We have audited the
accompanying consolidated balance sheets of FONAR Corporation and Subsidiaries (the &#8220;Company&#8221;) as of June 30, 2022
and 2021, the related consolidated statements of income</span>,<span style="color: black"> stockholders&#8217; equity and cash
flows for each of the two years in the period ended June 30, 2022, and the related notes (collectively referred to as the &#8220;financial
statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of
the Company as of June 30, 2022 and 2021 and the results of its operations and its cash flows for each of the two years in the
period ended June 30, 2022, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basis for Opinion</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based
on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about
whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required
to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are
required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our audits included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures
in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made
by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit<b>s</b> provides
a reasonable basis for our opinion.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Critical Audit Matters</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The critical audit matters communicated
below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated
to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved
our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any
way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below,
providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Patient Accounts Receivable Reserve
&#8211; Refer to Note 3 to the financial statements </span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Critical Audit Matter Description
</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Patient accounts receivable is recorded
at net realizable value based on the estimated amounts the Company expects to receive from patients and third-party payers. Estimates
of&#160;contractual allowances under managed care, commercial, and governmental insurance plans are based upon the payment terms
specified in the related contractual agreements or as mandated under government payer programs. Management continually reviews
the contractual allowance estimation process to consider and incorporate updates to laws and regulations and the frequent changes
in managed care&#160;contractual terms resulting from contract renegotiations and renewals. Receivables related to uninsured patients
and uninsured copayment and deductible amounts for patients who have health insurance coverage may have discounts applied. The
Company also records estimated implicit price concessions&#160;(based on historical experience) related to accounts to record the
accounts receivable at the amount the Company expects to collect from patients and third-party payers. This implied concession
requires extensive judgment and subjective assumptions. Implicit price concessions relate primarily to amounts due directly from
patients and are based upon management&#8217;s assessment of historical write-offs and expected net collections, business and economic
conditions, trends in federal, state, and private employer health care coverage, and other collection indicators. Auditing management&#8217;s
estimate of the price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized
in determining the net realizable value of accounts receivable.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">How the Critical Audit Matter Was
Addressed in the Audit</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our audit procedures related to the net
realizable value of patient accounts receivable included the following:</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We obtained an understanding, evaluated
the design, and tested the operating effectiveness of certain controls that address the risks of material misstatement relating
to the measurement of service fee revenue and receivables. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested informational technology general
controls around the Company&#8217;s billing system and associated database. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We evaluated management&#8217;s methodology
and related assumptions, including cash collections, by comparing actual results to management&#8217;s historical estimates. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We evaluated management&#8217;s methodology
and related assumptions, including cash collections, by comparing actual results to management&#8217;s historical estimates. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested the underlying data related to
the recognition of patient level charges and the subsequent activities, including cash collections and non-cash adjustments. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested the contractual rates set forth
by the third-party payers which are input into the Company&#8217;s billing system and then billed to patients and/or third-party
payers. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested the mathematical accuracy of
the estimates applied to period-end accounts receivable. </span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt">&#9679;</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We evaluated the appropriateness of the
industry, economic, and Company factors that were used in determining the net realizable value of patient accounts receivable.
</span></td></tr></table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Management Fee Accounts Receivable
Reserve &#8211; Refer to Note 3 to the financial statements. </span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Management fee accounts receivable is
related to fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under management agreements.
Payment of the outstanding fees is dependent on the PCs ability to collect fees from third-party payers and patients because the
management fees are collateralized by the PCs accounts receivable. The Company records the management fee accounts receivables
net of the estimated implicit price concessions based on the PCs likelihood to collect on the accounts. Implicit price concessions
on the PCs are estimated by management in the same manner the patient accounts receivable are analyzed. This implied concession
requires extensive judgment and subjective assumptions. Implicit price concessions relate primarily to amounts due directly from
patients and are based upon management&#8217;s assessment of historical write-offs and expected net collections, business and economic
conditions, trends in federal, state, and private employer health care coverage, and other collection indicators. Auditing management&#8217;s
estimate of the price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized
in determining the net realizable value of accounts receivable.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">How the Critical Audit Matter Was
Addressed in the Audit</span></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our audit procedures related to the management
fee accounts receivable reserve are consistent with the audit procedures associated with the patient fee accounts receivable reserve.
In addition, we traced the management fees to the underlying agreements and the general ledger.</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">/s/ <span id="xdx_903_edei--AuditorName_c20210701__20220630_z009Dp3vZ3Pb"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AuditorName">Marcum LLP</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Marcum LLP</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have served as the Company&#8217;s auditor
since 1990, such date takes into account the merger of Tabb, Conigliaro, McGann, P.C. (&#8220;Tabb&#8221;) into another firm in
approximately 2001 and the former partners of Tabb joining Marcum LLP in 2002.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_edei--AuditorLocation_c20210701__20220630_zqgdDaluqRrj"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AuditorLocation">New York, New York</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">September 28, 2022</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_907_edei--AuditorFirmId_c20210701__20220630_zngEvTNW7sDg" style="display: none"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="dei:AuditorFirmId">688</ix:nonNumeric></span></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="b_002"></span>&#160;CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">ASSETS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_111_zk3dOVA9Nb2e" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_495_20220630_zp8luQVs7Yq6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49B_20210630_ztzXxgvhTzKl" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrentAbstract_iB_z7Gum5EQeGVb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Current Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_maCzTQ1_zQFiId4zKZI4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Cash and cash equivalents</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,722,977</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,460,411</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ShortTermInvestments_i01I_maCzTQ1_z2KmOispvntl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Short term investments</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,326</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,177</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccountsReceivableServiceAndRepairFees_i01I_maCzTQ1_zg8gvFrAwJA3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accounts receivable &#8211; net of allowances for doubtful accounts of $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20220630_z2btQwFEpQO5" title="Allowance for Doubtful Accounts Receivables"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,597</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20210630_zXb1wVKWZrK2" title="Allowance for Doubtful Accounts Receivables"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">442,270</ix:nonFraction></span> at June 30, 2022 and 2021, respectively</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,335,956</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,525,435</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AccountReceivableRelatedParties_i01I_maCzTQ1_z7BH1GV7jdFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accounts receivable &#8211; related party</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0075">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,977</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--MedicalReceivable_i01I_maCzTQ1_zjQpNh62R9n8" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Medical receivables &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,108,989</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,900,489</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ManagementAndOtherFees_i01I_maCzTQ1_z6n0c02CrIui" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $<span id="xdx_909_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_c20220630_zgciLp9Z5luk" title="Management and other receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,627,917</ix:nonFraction></span> and $<span id="xdx_903_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_c20210630_zHnx0vtjIkDa" title="Management and other receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,786,878</ix:nonFraction></span> at June 30, 2022 and 2021, respectively</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,419,219</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,947,863</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_maCzTQ1_zbrckjMmsBx5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $<span id="xdx_908_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_c20220630_zM3SnZuwYKwa" title="Related party receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,686,893</ix:nonFraction></span> and $<span id="xdx_905_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_c20210630_z0nUdAtokdj2" title="Related party receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,184,399</ix:nonFraction></span> at June 30, 2022 and 2021, respectively</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,602,561</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,814,250</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_maCzTQ1_z3A302lVgOl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Inventories</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,359,821</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,663,419</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzTQ1_zDt1ES49CiY4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Prepaid expenses and other current assets</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,104,325</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,227,463</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i01TI_mtCzTQ1_maCzYx7_zAWtPZAXXERb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Current Assets</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,686,174</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,583,484</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccountsReceivableNetLongTerm_i01I_maCzYx7_z0RULdPh8nok" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accounts receivable &#8211; long term</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,871,890</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,879,946</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maCzYx7_zBclLj9PPw96" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Deferred income tax asset</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,842,478</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,958,961</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzYx7_zLjSZrtN35oe" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Property and equipment &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,281,791</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,850,139</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzYx7_zfwo1zzgnZOk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Right-of-use-asset &#8211; operating leases</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,232,109</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,133,285</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maCzYx7_zhBM20KeXJsc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Right-of-use-asset &#8211; financing lease</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">928,109</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,126,990</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Goodwill_i01I_maCzYx7_zYuwJKNUoTQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Goodwill</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzYx7_z13kPZsGv3u5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other intangible assets &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,703,885</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,037,599</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherAssets_i01I_maCzYx7_zptDsfBXqOG4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other assets</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">526,269</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">666,514</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Assets_i01TI_mtCzYx7_zTg440xPKQPk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Assets</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,341,982</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">189,506,195</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">LIABILITIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrentAbstract_iB_zjbMb9d12rV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_i01I_maCzrkj_zC0UdVa7nj6l" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Current portion of long-term debt and capital leases</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,078</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173,206</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableCurrent_i01I_maCzrkj_z5b4QHWb2crd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accounts payable</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,551,269</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,866,035</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherLiabilitiesCurrent_i01I_maCzrkj_zlwAl6BkPFb7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other current liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,417,227</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,162,118</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maCzrkj_zznplW13D2qe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Operating lease liability &#8211; current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,880,129</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,533,656</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_maCzrkj_zTa0AraeSBC9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Financing lease liability &#8211; current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,140</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,741</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredRevenueCurrent_i01I_maCzrkj_zQaV3SqNThwc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Unearned revenue on service contracts</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,288,766</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,365,825</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CustomerDeposits_i01I_maCzrkj_zLAxgvB06OKc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Customer deposits</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">361,245</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,101</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ContractWithCustomerLiabilityCurrent_i01I_maCzrkj_zjBV7OrLwdTb" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Contract liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0155">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,739</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrent_i01TI_mtCzrkj_maCzVtF_zGAVtLukc8Me" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Current Liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,748,854</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,049,421</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zx5ImFsMguJf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Long-Term Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredRevenueNoncurrent_i01I_maCz0SB_znyztqdflTtb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Unearned revenue on service contracts</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,857,257</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,800,522</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maCz0SB_zehJnHmEAfV7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Deferred income tax liability</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,726</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,316</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccountsPayableRelatedPartiesNoncurrent_i01I_maCz0SB_zQvcLxtpz3H7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Due to related party medical practices</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCz0SB_zrKDCNpHUSU6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Operating lease liability &#8211; net of current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,090,990</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,975,132</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maCz0SB_zI0wlOYdxD54" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Financing lease liability &#8211; net of current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">838,291</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,048,431</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtAndCapitalLeaseObligations_i01I_maCz0SB_zAHyG3K316ed" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Long-term debt and capital leases, less current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">155,379</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,254</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilities_i01I_maCz0SB_zIVW27aiJPla" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,541</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,331</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesNoncurrent_i01TI_mtCz0SB_maCzVtF_zNY3SL23c474" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Long-Term Liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,356,847</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,086,649</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Liabilities_i01TI_mtCzVtF_maCzzGW_zUTqW74lChk3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,105,701</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,136,070</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Commitments, Contingencies and Other Matters</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">STOCKHOLDERS&#8217; EQUITY</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_iB_zz998vwPPX5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stockholders&#8217; Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">&#160;Class A non-voting preferred stock $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zfc57NhZrLQd" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z89PXYJxfBrb" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zxQX9DDW35D5" title="Preferred Stock, Shares Authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zQs0TlKtQ8B6" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2022 and 2021, <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zTEiOqgakTM5" title="Preferred Stock, Shares Issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zffqyWITy4oj" title="Preferred Stock, Shares Outstanding"><span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zfLpE2HdePIf" title="Preferred Stock, Shares Issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z6j3yfWUJjXe" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2022 and 2021</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--PreferredStockValue_pp0p0_maCzskF_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zCk3NhR2CuPi" title="Preferred Stock Value" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--PreferredStockValue_pp0p0_maCzskF_c20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zH4cgylrEAog" title="Preferred Stock Value" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">&#160;Preferred stock $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zhN7vTrsA5v7" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zWIAHehh9yB6" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zQMGpwswLAZg" title="Preferred Stock, Shares Authorized"><span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z01RDWaL8kVh" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2022 and 2021, issued and outstanding &#8211; <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_dn_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z5m5sOisj9yb" title="Preferred Stock, Shares Issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z68miShsgQsh" title="Preferred Stock, Shares Outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_dn_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zUUIDCJ8VDKh" title="Preferred Stock, Shares Issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zfebbUeXEkal" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PreferredStockValue_pdp0_maCzskF_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z0zncguxDgvi" title="Preferred Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0230">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PreferredStockValue_pdp0_maCzskF_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zMwTM1rlsV8f" title="Preferred Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0232">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Common stock $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znqyOYAbUVB7" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zl8Dt5Xm6fUi" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLkMsCzOwK4f" title="Common Stock, Shares Authorized"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRnAKvvjBai1" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2022 and 2021, <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Common Stock, Shares, Issued"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Common Stock, Shares, Issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,565,853</ix:nonFraction></ix:nonFraction></span></span> issued at June 30, 2022 and 2021,<span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Common Stock, Shares, Outstanding"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></ix:nonFraction></span></span> outstanding at June 30, 2022 and 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--CommonStockValue_pp0p0_maCzskF_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zn2ehvQIzulh" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">657</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CommonStockValue_pp0p0_maCzskF_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbaXxlCbcZne" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">657</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Class B convertible common stock (10 votes per share) $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwdzBPRF7Cyh" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDwgrsFuFBb6" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zAr2OOAzLHP3" title="Common Stock, Shares Authorized"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zClsl6pq4Cne" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2022 and 2021, <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zxD3ymIn6STj" title="Common Stock, Shares, Issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zoKoJZCmjWti" title="Common Stock, Shares, Outstanding"><span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUasL0CiTWY5" title="Common Stock, Shares, Issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zX1gfCNOvrSl" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2022 and 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockValue_pdp0_maCzskF_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9bSJdxX4uL5" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--CommonStockValue_pdp0_maCzskF_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zqzTnG1D68v" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0272">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Class C common stock (25 votes per share) $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z69oZFvGI0C4" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCttU5aK1Vv1" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlDtLN30fgDc" title="Common Stock, Shares Authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLt8A7dWb5yj" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2022 and 2021, <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zywtlGk7ecze" title="Common Stock, Shares, Issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zDvLiqIlrZma" title="Common Stock, Shares, Outstanding"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1Tia525DS81" title="Common Stock, Shares, Issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6V3BLyNblk1" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2022 and 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--CommonStockValue_pp0p0_maCzskF_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdBr2KMSASRi" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CommonStockValue_pp0p0_maCzskF_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNGQeBn4vqe1" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_iI_maCzskF_z6pMzMtkqNml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Paid-in capital in excess of par value</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,531,535</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,100,976</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maCzskF_zp6hp8zLA7va" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accumulated deficit</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,566,757</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,007,663</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--TreasuryStockValue_iNI_di_msCzskF_zufOo0Sojgug" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Treasury stock, at cost &#8211; <span id="xdx_90C_eus-gaap--TreasuryStockShares_iI_c20220630_zakwYDmA9XQ1" title="Treasury stock, shares"><span id="xdx_90F_eus-gaap--TreasuryStockShares_iI_c20210630_z5HsL15N0cxc" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,643</ix:nonFraction></ix:nonFraction></span></span> shares of common stock at June 30, 2022 and 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,390</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,390</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--StockholdersEquity_iTI_mtCzskF_maCzUIK_zTTworG47BJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,290,114</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,418,649</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--MinorityInterest_iI_maCzUIK_zFOaTGyjmJH3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,053,833</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,048,524</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_mtCzUIK_maCzzGW_zYBGLNMn5u63" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Stockholders&#8217; Equity</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,236,281</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,370,125</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzzGW_zBswTnhsBAh6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,341,982</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">189,506,195</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="b_003"></span>CONSOLIDATED STATEMENTS OF INCOME</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_302_113_z0WfaxIVSQJ7" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF INCOME" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_498_20210701__20220630_zovK8kFGQKd7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_497_20200701__20210630_z8ePebrSs3P" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenuesAbstract_iB_zdSI0SVDuU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCzclE_z2v9c6jlPlJ7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Patient fee revenue, net of contractual allowances and discounts</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,582,238</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,307,389</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ProductSalesNet_i01_maCzclE_zGuxxlztNoQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Product sales &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">517,939</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,288,483</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ServiceAndRepairFeesNet_i01_maCzclE_zjFnzPMCOa26" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Service and repair fees &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,590,865</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,638,608</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCzclE_zZoASiKA9aI9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Service and repair fees &#8211; related parties &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--ManagementAndOtherFeesNet_i01_maCzclE_znVBbRl42Zjk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Management and other fees &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,226,787</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,609,449</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCzclE_zQdlOON9H4pj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Management and other fees &#8211; related party medical practices &#8211; net</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,564,316</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,975,836</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_i01T_mtCzclE_maCzG0T_zOT0RK848Tcl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Revenues &#8211; Net</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,592,145</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,929,765</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CostsAndExpensesAbstract_iB_zD1wFvWiIwjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs and Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--CostsRelatedToProductSales_i01_maCzXJS_zrQNa92df3y2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs related to product sales</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,814</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,032,676</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzXJS_z79Ai9TMbe2d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs related to service and repair fees</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,991,069</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,740,625</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzXJS_z7zavtaRJU6a" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs related to service and repair fees &#8211; related parties</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,344</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,466</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzXJS_zWHPeh5PP82" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs related to patient fee revenue</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,307,819</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,917,635</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzXJS_zPAGcYsbg4g6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs related to management and other fees</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,251,268</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,384,557</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCzXJS_zTD1g7RFBC2j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Costs related to management and other fees &#8211; related party medical practices</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,567,887</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,341,168</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzXJS_zu4iuHQ4U1Q1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Research and development</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,494,181</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,635,979</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzXJS_zl61dbU74Mp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Selling, general and administrative, inclusive of compensatory element of stock issuances of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_c20210701__20220630_zQrKtoYjkvra" title="Stock Issued During Period, Value, Employee Benefit Plan"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_c20200701__20210630_zUkLyNrocc4a" title="Stock Issued During Period, Value, Employee Benefit Plan"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction></span> for the years ended June 30, 2022 and 2021 respectively</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,512,581</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,740,044</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CostsAndExpenses_i01T_mtCzXJS_msCzG0T_zib0N7UVt4w4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Total Costs and Expenses</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,584,963</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,832,150</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzG0T_maCz3RH_zwtzXCwZenCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Income from Operations</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,007,182</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,097,615</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherExpensesAbstract_iB_z9AX9JBHF4r" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other Income and (Expenses):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--InterestExpense_iN_di_msCz3RH_zI9kxaVZg70l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Interest expense</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">346,552</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,665</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--InvestmentIncomeNet_maCz3RH_zpbWaRLB1HZ1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Investment income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,158</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">311,931</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherNonoperatingIncomeExpense_maCz3RH_zLEVK41VIXti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other income</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">861,087</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">504,450</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCz3RH_maCz05j_zynzprpRDwXf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Income before provision for income taxes and noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,768,875</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,665,331</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCz05j_zF10NwF056R6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Provision for Income Taxes</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,534,487</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,991,520</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--ProfitLoss_iT_mtCz05j_zPYjdPKAQfb3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,234,388</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673,811</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_zQdSQFvPf9T9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income &#8211; Noncontrolling Interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,793,482</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,466,223</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_zuZZd3BipCNd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income &#8211; Attributable to FONAR</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,440,906</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,207,588</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF INCOME (Continued)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zKPatAWm2g9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income Available to Common&#160;Stockholders</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,690,796</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,592,134</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income Available to Class A Non-Voting Preferred Stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredMember_zroHa3ddUDLi" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">559,072</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredMember_zHd5rDFAG389" title="Net Income - Attributable to FONAR" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">458,710</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income Available to Class C Common&#160;Stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpUHxt5KJNYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,038</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYI0g6xvpaOd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,744</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Basic Net Income Per Common Share Available to Common Stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_c20210701__20220630_zCxzLaFmKJ6j" title="Basic Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.78</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--EarningsPerShareBasic_c20200701__20210630_zzkMDTudOfyj" title="Basic Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Diluted Net Income Per Common Share Available to Common Stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_c20210701__20220630_zxibwweOh815" title="Diluted Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.75</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_c20200701__20210630_zlBypwuVOSh3" title="Diluted Net Income Per Common Share Available to Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.45</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Basic and Diluted Income Per Share &#8211;&#160;Class C Common</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedIncomePerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMI4xbQq05mj" title="Basic and Diluted Income Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:BasicAndDilutedIncomePerShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedIncomePerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAEhHFOCTVic" title="Basic And Diluted Income Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:BasicAndDilutedIncomePerShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Weighted Average Basic Shares Outstanding &#8211; Common Stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20210701__20220630_zPTxSCyNZ79d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200701__20210630_zvwdjUCM1n43" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Weighted Average Diluted Shares Outstanding &#8211; Common Stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20210701__20220630_zM1TDu3lIrxb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,681,713</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200701__20210630_zWuKVkSznXBi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,632,787</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Weighted Average Basic and Diluted Shares Outstanding &#8211; Class C Common</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WeightedAverageBasicAndDilutedSharesOutstanding_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6DCjjhraT5" title="Weighted Average Basic and Diluted Shares Outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageBasicAndDilutedSharesOutstanding" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageBasicAndDilutedSharesOutstanding_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTMvrpWgPMD7" title="Weighted Average Basic and Diluted Shares Outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageBasicAndDilutedSharesOutstanding" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="b_004"></span>&#160;CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217;
EQUITY</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2022 AND 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_301_114_zcpUlwAgvqCd" summary="xdx: Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_custom--ClassANonVotingPreferredMember_zuFph06ZdTN1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zQXzzcI7erYe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_custom--ClassCCommonStockMember_zdMAhn3dj4Hc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Class A Non-Voting Preferred</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Common Shares</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Stock Amount</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Class C Common Stock</td></tr>
  <tr id="xdx_437_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zD6zWyFlr9ph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, July 1, 2020</td><td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaQHvbVNnkR" title="Beginning Balance, Shares" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,447,463</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0444">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued to employees under stock bonus plans</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0446">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBv3Wx3pXzEk" title="Stock issued to employees under stock bonus plans, Shares" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">106,747</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PaymentsOnNotesReceivableFromEmployeeStockholders_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Payments on notes receivable from employee stockholders</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0454">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z6y5sKmBcvAh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, June 30, 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkMg8DtZQYBl" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember51888171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember51888171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProfitLoss_zSwkHlGUjUee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0466">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zVselK32oyr2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued to employees under stock bonus plans</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0471">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--BuyoutOfNoncontrollingInterests_z9fypvsbbuVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Buyout of noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0474">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zpdMKGjBC7v7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0478">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zjhvbLx3K0Ec" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, June 30, 2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfvo6b1MRdIf" title="Ending Balance, Shares" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember51888218" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember51888218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zgEndd9HMcNb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zkFFO3UK51Yj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Paid-in Capital in Excess of Par Value</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Accumulated Deficit</td></tr>
  <tr id="xdx_436_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zjm112Al1QM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, July 1, 2020</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,076,888</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">56,215,251</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--ProfitLoss_zYeZZIIQQ7j4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,207,588</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zgRMGU64IJm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued to employees under stock bonus plans</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,024,088</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_z2ylcGuPpFp6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zU66AxGRSmG7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, June 30, 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,100,976</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,007,663</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_zRMpmwIEIHb5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0502">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,440,906</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zDJ4dMpE0YK1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued to employees under stock bonus plans</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--BuyoutOfNoncontrollingInterests_zrFC5iFM8cI9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Buyout of noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">569,441</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_ziRbWMN1faJg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Distributions to noncontrolling &#160; interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0511">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0512">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_43F_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z3Hb6uJeZA0a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, June 30, 2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,531,535</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,566,757</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2022 AND 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zcm8xH8rYP52" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zTkHqq2EyCW7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" id="xdx_4B9_zNJJ5b3JX2Q6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Treasury Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Noncontrolling Interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
  <tr id="xdx_433_c20200701__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zEgMuLcDIYEh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, July 1, 2020</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,253</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,242,216</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ProfitLoss_zzG99CUUkcmf" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,466,223</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673,811</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zKPiffj1vaI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued to employees under stock bonus plans</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0525">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0526">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,024,098</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zjIzlMadjNSh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0529">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,570,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,570,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_435_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zXeGeY44Aomi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, June 30, 2021</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,048,524</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,370,125</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_zANrhfmAiAKh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net income</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,793,482</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,234,388</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zu53VoPG92jl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued to employees under stock bonus plans</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0541">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--BuyoutOfNoncontrollingInterests_z4Rv5gBi46B1" style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Buyout of noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,441</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">546,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zI31cgIKZVvk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0549">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z5D7oD0lTW43" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Balance, June 30, 2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,053,833</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,236,281</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="b_005"></span>CONSOLIDATED STATEMENTS OF CASH FLOWS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_112_zv68driaWNl4" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_499_20210701_20220630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_497_20200701_20210630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30,</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zjzp5oZcI9Ok" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">CASH FLOWS FROM OPERATING ACTIVITIES</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_40F_eus-gaap--ProfitLoss_maCzrrt_zCI3KlZ2Hg99" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Net Income</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,234,388</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,673,811</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zpst2qXCGNLe" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Adjustments to reconcile net income to net cash provided by operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherDepreciationAndAmortization_i01_maCzrrt_zqaQycfGmQJl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Depreciation and amortization</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,535,236</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,081,687</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ProvisionForBadDebts_i01_maCzrrt_zPIpDVi6rIHl" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Provision for bad debts</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,343,533</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,585,989</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCzrrt_zAWnFM9ke4Ng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Deferred income tax - net</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,093,893</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,855,006</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxCreditsAndAdjustments_i01_maCzrrt_z1LZQVScPUF9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Income tax receivable</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0575">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxCreditsAndAdjustments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">671,185</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_maCzrrt_zyo7xzXb8d39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Amortization on right-of-use assets</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000,131</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,458,053</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CompensatoryElementOfStockIssuances_i01_maCzrrt_z7bZy7W0l6xh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Compensatory element of stock issuances</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0581">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CompensatoryElementOfStockIssuances" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,277</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i01_maCzrrt_zXIJvrAtpTak" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Stock issued for costs and expenses</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,940,821</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_i01N_di_msCzrrt_zWIAMfauj6Tc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Abandoned patents</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">534</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--GainOnForgivenessOfPppLoan_i01N_di_msCzrrt_zVFTRXSv7RW8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Gain on forgiveness of PPP loan</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700,764</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0591">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zPlDBfQ7cJS3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">&#160;(Increase) decrease in operating assets, net:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzrrt_zmpBQa8aprJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accounts, medical and management fee receivables</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,602,188</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,110,859</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInReceivables_i01N_di_msCzrrt_zCLo7gbmPit3" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Notes receivable</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">43,334</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,944</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInCommodityContractAssetsAndLiabilities_i01N_di_msCzrrt_zg5jQddCjPd1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Contract assets</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0602">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,833</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzrrt_zop7t1GQrVDd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Inventories</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">696,402</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,649</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzrrt_z9pYVexpG5f3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Prepaid expenses and other current assets</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">90,638</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">526,425</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCzrrt_zSavYX8DbcU1" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other assets</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">129,411</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,087</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB_zMWZ0ZdkxdXj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Increase (decrease) in operating liabilities, net:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzrrt_zP0gPeuRirw4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Accounts payable</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">314,766</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">99,224</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maCzrrt_zYzRkyso4XI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other current liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,765,215</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,382,497</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maCzrrt_zc1T1qWooHD4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Customer advances</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">369,856</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">123,478</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingLiabilities_i01_maCzrrt_zwSWTRaDGuTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Operating lease liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,437,743</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">965,825</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_di_msCzrrt_zEf3cpiSgOYa" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Financing lease liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,741</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,698</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--IncreaseDecreaseInContractLiabilities_i01_maCzrrt_zXjZF4wGk81l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Contract liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,739</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,739</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_maCzrrt_zqiu3F8DyTf7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Other liabilities</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">64,790</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,020</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzrrt_maCzSxu_zVXtJfpOGRrg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">NET CASH PROVIDED BY OPERATING ACTIVITIES</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,301,360</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,088,001</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;CONSOLIDATED STATEMENTS OF CASH FLOWS</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Continued</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zJi8ufzwxC93" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzcjT_zYupfEC9xemk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Purchases of property and equipment</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,545,292</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,533,091</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsForProceedsFromShortTermInvestments_i01N_di_msCzcjT_zGbeiDvNUH02" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Proceeds of Short term investment</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--PurchaseOfImagingCenter_i01N_di_msCzcjT_zQo9v53BZVG9" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Purchase of imaging center</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0650">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:PurchaseOfImagingCenter" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,122,508</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--PurchaseOfNoncontrollingInterests_i01N_di_msCzcjT_zStJdVg73Zb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Purchase of noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:PurchaseOfNoncontrollingInterests" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0654">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCzcjT_zKShcmitvRrj" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -11pt">Cost of patents</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,882</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,705</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzcjT_maCzSxu_z4ctLuUmyMH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">NET CASH USED IN INVESTING ACTIVITIES</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,179,323</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,819,597</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zjwPNlXBK1Ae" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;&#160;CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCztaE_zhSFlClJACOi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Repayment of borrowings and capital lease obligations</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,239</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,335</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromIssuanceOfDebt_i01_maCztaE_z8sAf1vHMPri" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Proceeds from debt</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0668">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msCztaE_zZ5HgfUtZKEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Distributions to noncontrolling interests</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,822,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,570,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCztaE_maCzSxu_zK9OAtr46zif" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">NET CASH USED IN FINANCING ACTIVITIES</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,859,471</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,610,335</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCzSxu_zqy8V8lhvSr6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">&#160;&#160;NET INCREASE IN CASH AND CASH EQUIVALENTS</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,262,566</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,658,069</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_ztVioH7tmq9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,460,411</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,802,342</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_z3mRZ2bYt1z5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">CASH AND CASH EQUIVALENTS - END OF YEAR</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,722,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,460,411</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span id="b_006"></span>&#160;NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z6FWKRWWwiti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 1 - <span id="xdx_824_zcWilvpZw2v8">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Description of Business</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR Corporation (the &#8220;Company&#8221;
or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development,
production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (&#8220;MRI&#8221;)
for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue
is also generated from our installed-base of customers through our service and upgrade programs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR, through its wholly-owned subsidiary Health
Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services to diagnostic imaging facilities.
The services provided by the Company include development, administration, leasing of office space, facilities and medical equipment,
provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and
the development and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On July 1, 2015, the Company restructured the
corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured
to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its
assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a <span id="xdx_908_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zVledUT1JIld" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span>% interest in
HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_904_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zbsjXz6Cl608" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span>% in HDM, and the original investors
in HDM retained a <span id="xdx_908_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zbAn3tom4SHe" title="The ownership interest of the original investors of HDM"><ix:nonFraction name="FONR:OwnershipInterestOfOriginalInvestorsOfHdm" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span>% ownership interest in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased
noncontrolling interests for $<span id="xdx_903_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zYdU0FUmKFo1" title="Direct purchase of Noncontrolling Interests"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction></span> giving the Company a direct ownership interest of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zWm28rgveXs4" title="Direct ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; a <span id="xdx_909_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvf3LZCAv4g4" title="Investors ownership interest percentage"><ix:nonFraction name="FONR:InvestorsOwnershipInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Since March 2020 the global pandemic of COVID-19
has caused turbulence and uncertainty in the United States and international markets and economies which has adversely effected
our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally COVID-19 had caused
us to require that much of our workforce work from home and has restricted the ability of our personnel to travel for marketing
purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and the Company
has been steadily recovering to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able to enact
certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in
scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#8216;PPP&#8217;)
program and Medicare advances/stimulus payments. The Company has been able to navigate through these challenges and avoid any significant
disruption of the business and the volume has risen back almost to pre-COVID-19 levels. Although we are unable to predict if there
will be additional consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with the
positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 58; Value: 1 -->
    <div id="xdx_238_zkknjhD7YVe7" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_233_zb0I3embJu08" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zOYH9EAF2F3k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zNRAtSTtpls7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_237_zxi39u7aRig7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zI3BVsZSvd9j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zsRtFJt3erUc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zFJ3Ghytmqf8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 2 - <span id="xdx_823_zEmq0lRkCRYb">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zhbi3hTxA9j3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_z4V2tXknNPO">Principles of Consolidation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries
are included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and
transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84D_eus-gaap--UseOfEstimates_zW2tjBTF4hlf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zAuKG9x0bGG8">Use of Estimates</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances,
intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results
could differ from those estimates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:InventoryWorkInProcessPolicy"><p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zjn9coHxVAZ3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zOgHJgwbyVjc">Inventories</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or
market.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdGbWiADEDZd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zXtiZqdmIKmf">Property and Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Property and equipment procured in the normal
course of business is stated at cost. Property and equipment purchased in connection with an acquisition is stated at its estimated
fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes using
the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the
useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair
expenses totaled approximately $<span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zDFmObhw18Y4" title="Cost of Property Repairs and Maintenance"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,783,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20200701__20210630_zScKC7zCQdh7" title="Cost of Property Repairs and Maintenance"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,051,000</ix:nonFraction></span> for the years ended June 30, 2022 and 2021 respectively. The estimated
useful lives in years are generally as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span><span><span id="xdx_8BD_zvpahj8xZRla" style="display: none">Estimated Useful Life in Years for Property and Equipment</span></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">13</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">2</ix:nonNumeric></span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">9</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 70%; text-align: left">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">28</ix:nonNumeric></span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zITbjaKe7DUb" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><p id="xdx_236_zXfSkSbMe3Jc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zC5ViXZRDfZk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zzLp1NM0zX8b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 59; Value: 1 -->
    <div id="xdx_234_zE4nbQByINY8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_zTA3yVkma7h4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_233_zzu2cYkcsLNe" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zbHYZ4Q6fyO" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zpUBLvUjdOs3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zcxZO3PB8Qm8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zXEgFFc2kZU5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zbb2Qo60ewyd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zTgp84Ejbop4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zbQGBeB2H6c1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zynPpkCYR1Fb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zcqFm0Pfc9Rd">Long-Lived Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrmYFHssiwJg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_864_zf3iIAtJQRzh">Other Intangible Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization is calculated on the straight-line
basis over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlJfGCwryDV7" title="Finite-Lived Intangible Asset, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_IntellectualPropertyMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric></span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The non-competition agreements are being amortized
on the straight-line basis over the length of the agreement (<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zKDhj6ZLxGui" title="Finite-Lived Intangible Asset, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric></span> years).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization is calculated on the straight line
basis over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z2gqdw2o34q6" title="Finite-Lived Intangible Asset, Useful Life"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric></span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_846_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdGP3Qctnpu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zdJtbSSD5BEi">Goodwill</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Generally accepted accounting principles in
the United States require the Company to perform a goodwill impairment test annually at the end of each fiscal year and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing
the reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount
of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure
the amount of impairment loss, if any.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock"><p id="xdx_84B_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_z5e26zwQH4Ei" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_z96kijWctiH4">Acquired assets and assumed liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Pursuant to ASC No. 805, if the initial accounting
for a business combination is incomplete by the end of the reporting period in which the combination occurs, but during the allowed
measurement period not to exceed one year from the acquisition date, the Company adjusts the provisional amounts recognized at
the acquisition date by means of adjusting the amount recognized for goodwill.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_236_zZhPSuaWEoMe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 -->
    <div id="xdx_23F_zHP4QR3FeVz9" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23C_zp0A3YoZQQW9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zLVXBVfIMwOh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z3Gw4270qhcd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zxXYBjnK5j2g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_231_z6fqlfvti0qj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_238_zfAFmLazQs64" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zdDzyNOlC3v" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_234_z7UaxjrW58ji" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zvSI8n2XqeMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86D_zQlfzqL2fKec">Revenue Recognition</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type and Production-Type Contracts&#8221;.
The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation
take approximately three to six months.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements
with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2022, the Company has <span id="xdx_90D_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20220630_z6L6C4gwEBP" title="Management Agreements With Company Total Medical Practices"><ix:nonFraction name="FONR:ManagementAgreementsWithCompanyTotalMedicalPractices" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">22</ix:nonFraction></span> management agreements of which
<span id="xdx_90E_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20220630_zsk0ew7HMJk5" title="Scanners With Management Agreements With Company Owned By Related Party"><ix:nonFraction name="FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3</ix:nonFraction></span> were with PC&#8217;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August
2022 (&#8220;the Related medical practices&#8221;) and <span id="xdx_90C_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20220630_zpBwKMne0bT" title="Scanners With Management With Company Located In New York State"><ix:nonFraction name="FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">19</ix:nonFraction></span> are with PC&#8217;s, which are all located in the state of New York (&#8220;the
New York PC&#8217;s&#8221;), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists
of fixed monthly fees per diagnostic imaging facility ranging from approximately $<span id="xdx_901_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zm43feHIJr3l" title="Contractual Fees For Services Rendered Minimum"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMinimum" contextRef="AsOf2022-06-30_custom_DiagnosticImagingFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,000</ix:nonFraction></span> to $<span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zBy7pd9XrXg8" title="Contractual Fees For Services Rendered Maximum"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMaximum" contextRef="AsOf2022-06-30_custom_DiagnosticImagingFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">447,000</ix:nonFraction></span>. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts for estimated uncollectible
fees, which is reflected in other operating expenses on the Statement of Operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in
accordance with the recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and
codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive
model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred
to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#8217;s
revenue recognition policies and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23E_zyG65IHpFUG6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 -->
    <div id="xdx_230_zjIpWBsAkD6a" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_zCbnFV5OL5J6" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zLMditeXo6d9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zDPd3kye6qD3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zoK6ofLCdNol" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zfe6v4xqlolf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zJgRyQ9VchMk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z2iDlwgoEkr6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_238_z6VcIBgxigle" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zWRQdmrrBu3e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue Recognition (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zidN4NyKBjA5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our revenues generally relate to net patient
fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are
satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The
contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health
plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices
for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health
plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services
we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for
payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed
care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net
of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2022 and 2021 are summarized
in the following table.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_z9YdlB0MD1B2" style="display: none">Patient Fee Revenue - Net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" title="Net Patient Fee Revenue" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,248,708</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" title="Net Patient Fee Revenue" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,100,440</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Medicare/Medicaid</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" title="Net Patient Fee Revenue" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,060,920</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" title="Net Patient Fee Revenue" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">968,055</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Workers&#8217; Compensation/Personal Injury</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" title="Net Patient Fee Revenue" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,907,335</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" title="Net Patient Fee Revenue" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,011,111</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,365,275</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,227,783</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Patient Fee Revenue</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,582,238</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,307,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AD_zx5VssEByjTi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zp2w9ck6KI3g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zfdYqShhr9A4">Research and Development Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development costs are charged to
expense as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have
alternative future uses (either in research and development, marketing or production), are classified as property and equipment
and depreciated over their estimated useful lives.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_238_zSidfpIf30hl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div id="xdx_23F_zk4wMC8c9ROl" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_233_zQJ7i7l8LAk2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zOxDjKLnbXY9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zX51i02XkWch" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z9DHvgn9l8m7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zPwuPRxKhN75" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_237_z9ELVmVDHLki" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zXLHfEKbIxd6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_233_z8hnEChivJEe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_840_eus-gaap--AdvertisingCostsPolicyTextBlock_zgiPSJaqHakj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_866_zyTu0TXPoUU3">Advertising Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
Advertising expense approximated $<span id="xdx_90A_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zEDwvMXUE5sc" title="Advertising Expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">634,000</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20200701__20210630_zuylYwrTstAf" title="Advertising Expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">633,000</ix:nonFraction></span> and for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:ShippingsAndHandlingCostPolicyTextBlock"><p id="xdx_84B_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zok9ZtT4i2X3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zrstrd7HC9we">Shipping Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s shipping and handling costs
are included in revenue from product sales and the related expense included in costs related to product sales is $<span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20210701__20220630_zPTs1J6quhqf" title="Shipping and Handling Costs"><ix:nonFraction name="FONR:ShippingAndHandlingExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,391</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20200701__20210630_z2QSYSqKf0i5" title="Shipping and Handling Costs"><ix:nonFraction name="FONR:ShippingAndHandlingExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,215</ix:nonFraction></span>
for the years ended June 30, 2022 and 2021 respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zTjT6586g2me" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_869_zaQ5rvhbATwi">Income Taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted
tax rates in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:CustomerAdvancesPolicyTextBlock"><p id="xdx_84D_ecustom--CustomerAdvancesPolicyTextBlock_zKENiTEA65vc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zKXf0DeR9vhf">Customer Advances</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash advances and progress payments received
on sales orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zut1uWwG07eh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_860_zs5Ug5vMExW">Earnings Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;)
is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding
during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company
used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings
per share for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the years ended June 30, 2022 and 2021, diluted EPS for common shareholders includes <span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20200701__20210630_zHBoHY9qoXLl" title="Diluted EPS"><span id="xdx_90E_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_z9cegbWLW887"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></ix:nonFraction></span></span>
shares upon conversion of Class C Common.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zYfvoaam4Lla" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 -->
    <div id="xdx_232_zWoLvpmVQoJh" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23A_zC4K522RAAsj" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_z3gh3IIociCf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zngdQl30qurb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zsUe8NemGzr8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zTxsNDk03kji" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_232_zEWS1wN7tgi6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zZjwOUbdYODh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zVXrqwdHoQ3f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zEbkKzl3SzSe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Earnings Per Share (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_236_zKcBbYGEk98l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,440,906</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,690,796</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,038</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.90</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.78</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,681,713</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.75</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Net income available to common stockholders</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,207,588</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,592,134</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,744</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Weighted average shares outstanding</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Basic income per common share</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.57</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" title="Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,505,283</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,632,787</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.45</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A0_z43u6FJd66Gc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zlFV42B3YLs1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86F_zZ3ADZgTaWm2">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand,
cash in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zZnQRRbHt0w4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 -->
    <div id="xdx_234_zRyQiII6WETf" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_234_zQeEgrqdRkTb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zBWiJYObHFva" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zYYexrQy75xd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zgCAMvpGSFWf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_z7GSiQseKmbk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_232_zFG5K8kTAgcl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zqWAnVKwlxxl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zZzLCpyPW2Da" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlNuzplzPZIj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zK94v8u2l1u1">Short Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Short term investments include certificates
of deposit with original maturities of greater than 90 days.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zYpbmJyCMqud" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zX4Gt6CN9Wpc">Concentration of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash
equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2022, the
Company had cash on deposit of approximately $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20220630_z3Fmvc96KSof" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">46,834,000</ix:nonFraction></span> in excess of federally insured limits of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220630_z3qXwL6lOTo5" title="Cash, FDIC Insured Amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYZs5IumK6p5" title="Concentration Risk, Percentage"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zY8R7dIiJkOc" title="Concentration Risk, Percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></ix:nonFraction></span></span>% of the consolidated net revenues for the years ended June 30, 2022 and 2021. Net management fee
receivables from the related party medical practices accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zYMlAs1KlfHh" title="Concentration Risk, Percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zV7jmF8YrJib" title="Concentration Risk, Percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012022-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></ix:nonFraction></span></span>% of the consolidated accounts receivable for
the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUCYmnRf7fB8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zAo126oFXqSf">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The financial statements include various estimated
fair value information at June 30, 2022 and 2021, as required by ASC topic 820, &#8220;Disclosures about Fair Value of Financial
Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based on the requirements
set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable
inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are
either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists,
therefore requiring an entity to develop its own assumptions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following methods and assumptions were used
to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount
approximates fair value because of the short-term maturity of those instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Short term investments: The carrying amount
approximates fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits
with original maturities greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23F_z7YtTpd4wxVl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 -->
    <div id="xdx_237_zsCOEt1nn3Pe" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23A_zcUDaXCUaTJ8" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zs15glnONNFa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zWknaXdL2Zu" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zpOtpkmSD6K5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_233_zqFONJHVVWm5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_236_zMU68jueCne7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zGNlSRrm1Lsk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_239_znpnjesPtpgi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_z7P2iNaRk6ci" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fair Value of Financial Instruments (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zc7ZzOMjh7Ce" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying
amounts approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the
amounts due to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying
amounts of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to
market indices and/or due to the interest rates not being significantly different from the current market rates available to the
Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments
are held for purposes other than trading.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBTGGEVqUq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zUO6VH7x33s7">Recent Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2022 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any of those standards
will have a significant impact on our consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_809_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zV2iPfee0oM1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">NOTE 3 &#8211; <span id="xdx_826_z8pUwDtbudd7">ACCOUNTS
RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Accounts Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&#8217;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior
to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair
fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable
become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its
credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing
credit authorizations before a product sales contract is entered into or service and repair fees are provided.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23A_zwpNqVt1Xwy" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 -->
    <div id="xdx_235_z3MIpugGxr56" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_z7ecaGilz487" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zMOrXATGWCj9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zsJ88a3lCXkk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z5NYS1bMaNHj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_238_zHq2seENx7pg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_239_z1ad7sjEJbAc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_z5xrWaZbhaCh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z6b7nolVb8l6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long Term Accounts Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company will generate revenue from long-term,
non-cancellable contracts to provide service and repair services. Future revenue to be recognized over the following three years
at June 30, 2022 is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoieH8Q6lgu8" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B0_z0hZTqGVMa11">Receivables - Non Current - net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">2024</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--ContractReceivableDueTwoToThreeYears_c20220630_pp0p0" title="2024" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,097,015</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--ContractReceivableDueThreeToFourYears_c20220630_pp0p0" title="2025" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">620,230</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2026</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--ContractReceivableDueFourToFiveYears_c20220630_pp0p0" title="2026" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueFourToFiveYears" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,012</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Total</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220630_pp0p0" title="Total" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,857,257</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A4_zVb7DU1HZK01" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient&#8217;s legal counsel and
directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical
receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that will not be collected.
The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings, specific payor
collection issues that have been identified and based on payor classifications and historical experience at each site.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Management and Other Fees Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s receivables from the related
and non-related professional corporations (&#8220;PCs&#8221;) substantially consist of fees outstanding under management agreements.
Payment of the outstanding fees is dependent on collection by the PCs of fees from third party medical reimbursement organizations,
principally insurance companies and health management organizations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Payment of the management fee receivables from
the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner their medical fees from the third
party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20220630_zRSWoZCAHA02" title="Percentage of PCs net revenues"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66</ix:nonFraction></span>% and <span id="xdx_905_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20210630_zeL6IHw2HSV6"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction></span>%, respectively, of
the PCs&#8217; 2022 and 2021 net revenues were derived from no-fault and personal injury protection claims. The Company considers
the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#8217;s expectations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23A_zsJnKIcwcCH9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z3lSLJt1KvP8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 -->
    <div id="xdx_23A_z327lhTYoRxj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_234_zxNtqGDfzFG" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zL5F7zUkSGGd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_ztwJFtEf1o6d" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zEMtk7U5dvM" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zcMqXmqGLsE8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zMgG644Lm0Y3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zckEW6xnzfQc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zg0OAEyhjLxb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Net revenues from
management and other fees charged to the related party medical practices accounted for approximately <span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20220630_z7QA4Zm1OIm5" title="Consolidated net revenues percentage"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% and <span id="xdx_907_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20210630_zavyesENYdf2" title="Consolidated net revenues percentage"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%, of the consolidated
net revenues for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, PA,
Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical practices) entered into
a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have
arisen under each individual management agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following table sets forth the number of
our facilities for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Total Facilities</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_z220HegS9AJf" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zqw4ZAFy4gjb" style="display: none">Schedule of total
facilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20210701__20220630_zQLXmaszV5Ek" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49C_20200701__20210630_zK7lN5H1rqIa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Facilities Owned or Managed (at Beginning of Year)</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">25</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Facilities Added by:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ManagedFacilitiesAddedAcquisition_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Acquisition</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesAddedAcquisition" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Internal development</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0987">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ManagedFacilitiesClosedDuringYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Managed Facilities Closed</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0990">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0991">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Facilities Owned or Managed (at End of Year)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A4_zDdzmdy6tr27" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock"><p id="xdx_801_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_zCzaaaXfily6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 4 &#8211; <span id="xdx_820_ziqH03uE6Azc">CONTRACT ASSETS AND LIABILITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Information relating to uncompleted contracts
as of June 30, 2022 and 2021 about contract assets and contract (liabilities) is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_ziENGJQDrkQa" summary="xdx: Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zuG711ZzNlJg" style="display: none">Schedule
of costs and estimated earnings on uncompleted contracts</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_490_20220630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_497_20210630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40D_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzjsI_zjpnaTisn11d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Costs incurred on uncompleted contracts</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsIncurredOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">294,783</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzjsI_zPex8fv42mFj" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Estimated earnings</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1003">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:EstimatedEarnings" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">567,978</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzjsI_maCAEEIz0V3_zLFRRjWlECLc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Costs and estimated earnings on uncompleted contracts</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1006">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:CostsAndEstimatedEarningsOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">862,761</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz0V3_zXwEIpXbvRUi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Billings to date</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1009">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:BillingsToDate" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">877,500</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz0V3_zQ0CAjWq7vZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Costs and estimated earnings in excess of billings on uncompleted contracts</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">&#8212;</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,739</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<ix:exclude><p id="xdx_234_zn6eTD8fU4Ec" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zw9OoccU0Xwb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 -->
    <div id="xdx_231_zZ2ufmNA5Cf9" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23F_z7GfiVboRvF9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zkFs0tsivjxl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zByowiXYENA4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zvZyCHLkaho4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_230_zNn12QEBqT21" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_239_zzOEbrPRkAo" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80B_eus-gaap--InventoryDisclosureTextBlock_z0U5QOHSO1l8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 5 &#8211; <span id="xdx_82C_z3wh0DvYmL">INVENTORIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Inventories included in the accompanying consolidated
balance sheets consist of:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEp6UsuPt7m3" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zPR9RWmY79ok" style="display: none">Schedule
of inventories</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49B_20220630_zCkx1QVSc0ee" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_495_20210630_zaOGokP0WOa6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40F_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzqFk_zZGwlOlI8DWa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Purchased parts, components and supplies</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,125,805</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,393,329</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzqFk_zTGYFkSy3jT7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Work-in-process</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,016</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">270,090</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzqFk_zn4VHTS6lbn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Inventories</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,359,821</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,663,419</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zioNwRl9ubBj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0">NOTE 6 - <span id="xdx_825_zaLAlVMGppzc">PROPERTY
AND EQUIPMENT</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2022 and 2021, is comprised of:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zu291D1iv4ri" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zExjxTJiSFE7" style="display: none">Schedule of property
and equipment</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diagnostic equipment</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,304,258</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,826,829</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Research, development and demonstration equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,199,941</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,029,551</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Machinery and equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Furniture and fixtures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,484,525</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,450,664</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Leasehold improvements</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,087,581</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,961,887</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Building</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">939,614</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">939,614</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,084,974</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" title="Property and Equipment Before Accumulated depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,277,600</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Accumulated depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" title="Less: Accumulated depreciation and amortization of property and equipment" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,803,183</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20210630_pp0p0" title="Less: Accumulated depreciation and amortization of property and equipment" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,427,461</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" title="Property and Equipment AfterAccumulated depreciation and amortization" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,281,791</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" title="Property and Equipment AfterAccumulated depreciation and amortization" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,850,139</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Depreciation and amortization of property and
equipment for the years ended June 30, 2022 and 2021 was $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20210701__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFP7X7AgrdTb" title="Depreciation and amortization"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,113,640</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_pp0p0_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_znfgKwcIdhDd"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,696,986</ix:nonFraction></span>, respectively. During fiscal year ended June
30 2022, the Company wrote off fully depreciated assets of $<span id="xdx_902_ecustom--DepreciatedAssetsWriteoff_c20210701__20220630_z5SP41UlOc8e" title="Depreciated assets write-off"><ix:nonFraction name="FONR:DepreciatedAssetsWriteoff" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,737,918</ix:nonFraction></span> that related to a location that was previously closed.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23E_zapvmUcDEQT1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 -->
    <div id="xdx_23D_z2HN70M3V6Wl" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_235_zfOvpWZOS6pa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_z7tGasz3wbef" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zf8OPvcBhKSl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z89qNVM0l6Ji" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_234_zdljt1dYYfke" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_231_zMefL0rgmafa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80D_eus-gaap--LesseeOperatingLeasesTextBlock_zYxyepEVEZ8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 7 &#8211; <span id="xdx_82C_z728n27cDSE4">OPERATING &amp; FINANCING LEASES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In July 2019, the Company adopted ASU 2016-02,
Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying leases as either finance or operating
leases based upon the principle of whether or not the lease is effectively a financed purchase by the lessee.. We have elected
the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to
the comparative periods presented in the consolidated financial statements. We have also elected the transition package of thee
practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about lease
identification, lease classification and indirect costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company accounts for its various operating
leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211; Lease, as updated by ASU 2016-02. At
the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value
of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease.
Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord, we have
a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets
and liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates
available to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities
recognized as of June 30, 2022 is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zuokFkINHq9b" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B2_zI4YVarfHbek">Reconciliation of operating and financing lease payments</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Year Ending June 30,</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Operating Lease Payments</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Financing Lease Payments</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqV4MW3JRCDa" title="2023" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,512,691</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhltFN9b1xF2" title="2023" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2024</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_za4QAsA2IOL8" title="2024" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,355,310</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zrdyDzoPKQ82" title="2024" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxTCWqrdASJ" title="2025" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,256,243</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zvjKRJJwZtel" title="2025" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2026</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zofyEX1gbo9c" title="2026" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,829,443</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhC8at9t0k3c" title="2026" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2027</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zMLCK3lmJ3H" title="2027" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,781,761</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTBG8WAjjvP8" title="2027" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">162,897</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zF5i7CDZ6Pdj" title="Thereafter" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,529,257</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z2cFtDTgTNRb" title="Thereafter" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1112">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Present value discount</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--PresentValueDiscount_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zbMIUlZc2mfe" title="Present Value discount, Operating Lease" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,293,586</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGPGVvnSuQm6" title="Present Value discount, Financing Lease" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">91,838</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Total lease liability</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDAG60pTm3hc" title="Total lease liability" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,971,119</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zMSMi7r6EtVl" title="Total lease liability" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,048,431</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_234_znOC9HHL7i15" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 70; Value: 1 -->
    <div id="xdx_234_zOW49qw5tKMg" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_239_zaRlMSja1Zj1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zN3MjPgnllU8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zVcc9458aQ7h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z04HvsIiATf5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z1rZAHgqwz75" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z2PGVkHTKQt2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zeSo5DErZ6f8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 7 &#8211; OPERATING &amp; FINANCING LEASES
(CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_230_zSXOpdi4AAQi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Weighted Average Remaining Lease Term</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zgeO7t64m2K9" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B5_zQDFEFMVHsSa" style="display: none">Schedule of Weighted Average Remaining Lease Term</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases - years</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zzwfFFJ07oCf" title="Operating Lease, Weighted Average Remaining Lease Term"><ix:nonNumeric contextRef="AsOf2022-06-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">10.9</ix:nonNumeric></span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Finance lease - years</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_900_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zeyLo2ywX913" title="Finance Lease, Weighted Average Remaining Lease Term"><ix:nonNumeric contextRef="AsOf2022-06-30" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">4.6</ix:nonNumeric></span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Weighted Average Discount Rate</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z2mkStrDykxh" title="Operating Lease, Weighted Average Discount Rate, Percent"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.9</ix:nonFraction></span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Finance lease</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_906_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z6CCKsmHZN33" title="Finance Lease, Weighted Average Discount Rate, Percent"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.6</ix:nonFraction></span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The components of lease expense were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_ztXFJoQGHYU7" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zVUPKUHnDlFc">Components of lease expense</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_490_20210701__20220630_zqEg6kdv209l" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_496_20200701__20210630_zqgvgciXNQUh" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating lease cost</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,668,199</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,145,701</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;<br />&#160;<br />Finance lease cost:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation of leased equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Interest on lease liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,603</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,472</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total finance lease cost</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,484</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">246,353</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A3_zo3oZIfzhA51" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Supplemental cash flow information related to
leases was as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9DV53it9TV5" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zqGxWrXRW3o2">Supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_497_20210701__20220630_zXsmRwWQ3Mj8" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20200701__20210630_zxzP40d39na7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For year ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating cash flows from operating leases</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,133,369</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,970,934</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zG68pFJ1s8Hi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Financing cash flows from financing leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,344</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,038</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_z2aSZYXPO3n2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right-of-use &amp; equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,900,074</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,531,889</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AC_zM2IgQM5pgsi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:exclude><p id="xdx_230_zLFy0uScDGh1" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 -->
    <div id="xdx_23D_z3zY0FfTub54" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23E_zRhZgqUbZNO" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zl9NfwadloG2" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zia8D1vFsxN7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zLszqfjrCUx4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_230_zmVN99QO6AOe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_230_zjyaykPB6Rui" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_801_eus-gaap--IntangibleAssetsDisclosureTextBlock_zW6YjjFEFgzd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - <span id="xdx_820_z3HDNR1J7843">OTHER INTANGIBLE ASSETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated
amortization, at June 30, 2022 and 2021 are comprised of:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zYy6UyZkIAD9" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B1_z7UUsm5bP4bb" style="display: none">Schedule of other
intangible assets - net</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capitalized software development costs</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" title="Other intangible assets - gross" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004,847</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" title="Other intangible assets - gross" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004,847</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Patents and copyrights</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - gross" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,332,774</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - gross" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,244,892</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Non-competition agreements</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Other intangible assets - gross" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,150,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Other intangible assets - gross" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,150,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Customer relationships</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - gross" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,900,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - gross" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,900,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" title="Other intangible assets - gross" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,387,621</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" title="Other intangible assets - gross" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,299,739</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Accumulated amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,683,736</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pp0p0" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,262,140</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_c20210630_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A2_zv30CAXi5GQk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The estimated amortization of other intangible
assets for the five years ending June 30, 2027 and thereafter is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zOUZvovKLx46" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B2_zEfwCMD5Xdt5">Schedule Of Other Intangible Assets</span> For the Years Ending June 30,</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Patents and Copyrights</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Customer Relationships</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 32%; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630_pp0p0" title="2023" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">386,747</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">186,747</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2024</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">386,446</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">186,446</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2025</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">381,491</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">181,491</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2026</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">378,866</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,866</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2027</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">368,206</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">168,206</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630_pp0p0" title="2023" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,802,129</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">687,962</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,114,167</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" title="2023" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2023" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,589,718</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2023" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,114,167</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zsVHoD7iB4wi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 -->
    <div id="xdx_23F_zQ6gOXCzYD25" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_234_zXRcoRjWujS5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zCabC5MaTtuf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zj5bnOrckds6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;FONAR CORPORATION
AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zbmZy0LGg5N4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zjQYkLgYKRVg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_239_zKdGMdlFFLda" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zREx22n3e4d9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - OTHER INTANGIBLE ASSETS (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_234_zM2U9Xi8b21a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The weighted average amortization period for
other intangible assets is <span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20210701__20220630_zSqjszyHoUs7" title="Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">10.9</ix:nonNumeric></span> years and they have no expected residual value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Information related to the above intangible
assets for the years ended June 30, 2022 and 2021 is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zfJwNtZ5vqcc" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B5_zW8RYz3a5CA3">Other Intangible Assets</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Balance &#8211; Beginning of Year</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zMF57x7uF8t2" title="Balance - Beginning of Year" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_z8EMvqKC79n9" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,109,129</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Amounts capitalized</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" title="Amounts capitalized" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,882</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" title="Amounts capitalized" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">313,705</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Software or patents written off</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" title="Software or patents written off" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pdp0" title="Software or patents written off" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">534</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" title="Amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">421,596</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" title="Amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">384,701</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Balance &#8211; End of Year</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zVzbYL94aumk" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_ztLkDlEZ0g2d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A8_zpofDHOVEQUg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization of patents and copyrights for the
years ended June 30, 2022 and 2021 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zbZBuofw2MZa" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">184,096</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZnixVPrbwVl"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,701</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization of non-competition agreements for
the years ended June 30, 2022 and 2021 amounted to $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,500</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,500</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization of customer relationships for the
years ended June 30, 2022 and 2021 amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">192,500</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:CapitalStockAndOptionsDisclosureTextblock"><p id="xdx_804_ecustom--CapitalStockAndOptionsDisclosureTextblock_zIdjSgaMr44g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 9 - <span id="xdx_827_zmVWXarWVxWd">CAPITAL STOCK</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Common Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90C_eus-gaap--DividendsPayableNature_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Dividends Payable, Nature"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" name="us-gaap:DividendsPayableNature">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common
stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class B Common Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90F_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" title="Stockholders&apos; Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonClassBMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class B common stock is convertible into shares
of common stock on a one-for-one basis.</ix:nonNumeric></span> <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" title="Common Stock, Voting Rights"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonClassBMember" name="us-gaap:CommonStockVotingRights">Class B common stock has 10 votes per share.</ix:nonNumeric></span> There were <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common Stock, Shares, Outstanding"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKN7B3ynmEE8" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></span></span> of such shares outstanding
at June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_zb5t51kDdkm" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 73; Value: 1 -->
    <div id="xdx_23E_zlH8nlDLASD8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zwJs2aFMVYw6" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zJW3x5OTIdQ2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zsiD8y7P5Suc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zwacj482TGrg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_z7fnaWaN4aR8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_233_z73GJogJbJ6l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zDTOI60zceOj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 9 - CAPITAL STOCK (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zDPItb1wHjSi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class C Common Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" title="Common Stock, Voting Rights"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" name="us-gaap:CommonStockVotingRights">The Class C common stock has 25 votes per share</ix:nonNumeric></span>,
as compared to 10 votes per share for the Class B common stock and <span id="xdx_905_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Common Stock, Voting Rights"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" name="us-gaap:CommonStockVotingRights">one vote per share for the common stock.</ix:nonNumeric></span> <span id="xdx_90E_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" title="Stockholders&apos; Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">The Class C common
stock was offered on a three-for-one basis to the holders of the Class B common stock.</ix:nonNumeric></span> Although having greater voting power, each
share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions.
<span id="xdx_90E_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Stockholders&apos; Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class C common stock is convertible into shares of common stock on a three-for-one basis.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified
a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the
declaration of a stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" title="Common Stock, Voting Rights"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_PreferredClassAMember" name="us-gaap:CommonStockVotingRights">one share of Class A non-voting preferred stock
for every five shares of common stock.</ix:nonNumeric></span> <span id="xdx_904_eus-gaap--DividendsPayableNature_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" title="Dividends Payable, Nature"><ix:nonNumeric contextRef="From2021-07-012022-06-30_us-gaap_PreferredClassAMember" name="us-gaap:DividendsPayableNature">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting
preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million
of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#8217;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#8217;s
patents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution
rights, liquidation rights and other rights and preferences (other than the voting rights).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stock Bonus Plans</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010
Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Common Stock, Capital Shares Reserved for Future Issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of common stock. On August 10, 2010, the Company filed
Form S-8 to register the <span id="xdx_908_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zZVgXl748154" title="Shares registered"><ix:nonFraction name="FONR:SharesRegistered" contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares. As of June 30, 2022, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2022-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,177</ix:nonFraction></span> shares of common stock of FONAR were available for future
grant under this plan. For the years ended June 30, 2022 and 2021, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zac32CiCK557" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">106,747</ix:nonFraction></span> shares were issued respectively, of which $<span id="xdx_905_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20210701__20220630_pp0p0" title="Other Selling, General and Administrative Expense"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and
$<span id="xdx_907_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_pp0p0_c20200701__20210630_zPOnM6MdYxj9" title="Other Selling, General and Administrative Expense"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction></span> were expensed and included in selling, general and administrative expenses for the years ended June 30, 2022 and 2021,
respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23A_ztCs5ag0hoG8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 74; Value: 1 -->
    <div id="xdx_23A_z5LPDjY3P5Q4" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_239_z8QLqdtIzBHc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zydM3FO7KXQj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zWWXVem8mu3f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z0Hxf72hQM2h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_233_zUawZMc1WN8a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_238_zPRQCoKkD7ml" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zuHFHTlSJFjh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 9 - CAPITAL STOCK (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zOxPH5zVjJ7k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Options</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company had stock option plans, which provided
for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the
success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically
three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair
value of the Company&#8217;s common stock at the date of grant. The options had to be exercised within ten years from the date
of grant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zKh7yiN9IQ" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 10 &#8211; <span id="xdx_828_zYX4EBgdMaT3">CONTROLLING AND NONCONTROLLING
INTERESTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On February 13, 2013, the Company entered into
an agreement with outside investors to acquire a <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMEquityMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember_zpDTSxC1ow5i" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_HDMEquityMember_custom_ClassBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.5</ix:nonFraction></span>% controlling interest in a newly formed limited liability company, Health
Diagnostics Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members;
Class A members and one Class B member. The Class A members have an ownership interest of <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_zN2dzJtSovAf" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49.5</ix:nonFraction></span>% of HDM. The Class B member (HMCA)
has an ownership of <span id="xdx_908_ecustom--OwnershipPercentageAcquired_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMEquityMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember_zJpgAznnwlMg" title="Ownership Percentage Acquired"><ix:nonFraction name="FONR:OwnershipPercentageAcquired" contextRef="AsOf2013-02-13_custom_HDMEquityMember_custom_ClassBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.5</ix:nonFraction></span>% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes
equal to their percentage of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations
of the Company will be allocated among the members in the same proportions as their membership interests in the Company bear to
all the Class A and Class B membership interests of the Company in the aggregate outstanding. All of the depreciation and amortization
of the assets of the Company will be allocated solely to the Class A members, unless and until their interests have been redeemed
by the Company in full pursuant to the provisions of the operating agreement. The Company contributed $<span id="xdx_905_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember_pp0p0" title="Proceeds from Contributions from Affiliates"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-012013-02-13_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,200,000</ix:nonFraction></span> to HDM and the
group of outside investors contributed $<span id="xdx_907_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OutsideInvestorsMember_pp0p0" title="Proceeds from Contributions from Affiliates"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,800,000</ix:nonFraction></span> for its non-controlling membership interest.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 5, 2013 HDM purchased from Health Diagnostics,
LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve (<span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zFleqcbCn4Ac" title="Purchase Of Standup Mri Centers"><ix:nonFraction name="FONR:PurchaseOfStandupMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">12</ix:nonFraction></span>) Stand-Up MRI Centers and two (<span id="xdx_906_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z2PR5mp07MOb" title="Purchase Of Other Mri Centers"><ix:nonFraction name="FONR:PurchaseOfOtherMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">2</ix:nonFraction></span>) other
scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_904_ecustom--ConsiderationToOutsideInvestors_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zd7jf6653Mmk" title="Consideration To Outside Investors"><ix:nonFraction name="FONR:ConsiderationToOutsideInvestors" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million
to outside investors) aggregating $<span id="xdx_90A_ecustom--TotalPurchasePrice_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zqrT8rD4weJh" title="Total Purchase Price"><ix:nonFraction name="FONR:TotalPurchasePrice" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">35.9</ix:nonFraction></span> million. Concurrently with the acquisition, HDM entered into several consulting and non-competition
agreements for a consideration of $<span id="xdx_902_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zXSMxFaDwrz9" title="Consideration For Noncompetition And Consulting Agreements"><ix:nonFraction name="FONR:ConsiderationForNoncompetitionAndConsultingAgreements" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.1</ix:nonFraction></span> million. The acquisition was accounted for using the purchase method in accordance with
ASC 805, &#8220;Business Combinations&#8221;. The Company recognized and measured goodwill as of the acquisition date, as the excess
of the fair value of the consideration paid over the fair value of the identified net assets acquired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zkXdYhX8zxZk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 75; Value: 1 -->
    <div id="xdx_23E_zNVeuYNDyYX8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zP0TB8bL5Ctf" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zLd5au7E2yD4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zG8JUE5HEp36" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zkOkuUYXIp34" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zxJcaB1SegOc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_238_zrkXk8bQQ6Qj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zVML89XzbLBg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 10 &#8211; CONTROLLING AND NONCONTROLLING
INTERESTS (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zl7ekgbcWgK6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On January 8, 2015,
the Company purchased 20% of the Class A members ownership interest at a cost of $<span id="xdx_908_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20150108__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_pp0p0" title="Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" contextRef="AsOf2015-01-08_custom_HDMMember_custom_ClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,971,094</ix:nonFraction></span>. The Company has a <span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20150108__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_zoLt8vVrR9D" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2015-01-08_custom_HDMMember_custom_ClassAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60.4</ix:nonFraction></span>% ownership
interest in HDM after this transaction. During the year ended June 30, 2022, the Company purchased noncontrolling interests for
$<span id="xdx_90F_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_z8R4jSdJGuqd" title="Direct purchase of Noncontrolling Interests"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction></span> giving the Company a direct ownership interest of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_z2YEPx0s2c3f" title="Direct ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; a <span id="xdx_903_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvQbWkDbPuMl" title="Investors ownership interest percentage"><ix:nonFraction name="FONR:InvestorsOwnershipInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>% ownership interest.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amount of each class of HDM members&#8217; equity
as of June 30, 2022 and 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zol9vgOyaCG5" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black"><span id="xdx_8BE_zZIjEoVUnRck" style="display: none">class a and b members' equity (hdm acquisition)</span>
</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class A Members</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class B Member</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class A Members</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class B Member</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; color: black; text-align: left">Opening Members&#8217; Equity</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">($</td>
<td id="xdx_988_ecustom--OpeningMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zaTzu15e54Y5" title="Opening Members Equity" style="width: 10%; color: black; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,048,524</ix:nonFraction></td>
<td style="width: 1%; color: black; text-align: left">)</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; color: black; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,923,380</ix:nonFraction></td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; color: black; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,253</ix:nonFraction></td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; color: black; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,850,419</ix:nonFraction></td>
<td style="width: 1%; color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Share of Net Income</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zxygZUVL8NAg" title="Share of Net Income" style="color: black; text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,793,482</ix:nonFraction></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="color: black; text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,228,693</ix:nonFraction></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="color: black; text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,466,223</ix:nonFraction></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="color: black; text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,402,961</ix:nonFraction></td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black; text-align: left">Buyout of noncontrolling interests</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8z2ziYRZS8d" title="Buyout of noncontrolling interests" style="color: black; text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,441</ix:nonFraction></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWtntnpNRNBc" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1406">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWI2wwpP85oc" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1407">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z0QXicdRUfh9" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1408">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Distributions</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_981_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zU24hLztaNDg" title="Distributions" style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_98E_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZPMWnwd9qu6" title="Distributions" style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,860,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_982_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zhhcO5Wgu91c" title="Distributions" style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,570,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVynIlqjZNIc" title="Distributions" style="border-bottom: Black 1pt solid; color: black; text-align: right"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,330,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black">Ending Members&#8217; Equity</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">($</td>
<td id="xdx_98B_ecustom--EndingMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z264L4T1aId2" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,053,833</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td>
<td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,292,073</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">($</td>
<td id="xdx_987_ecustom--EndingMembersEquity_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zLCagUZosal7" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,048,524</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td>
<td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; color: black; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,923,380</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zZhyvvSgon89" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 76; Value: 1 -->
    <div id="xdx_231_zP5IVgmk52C1" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23A_zaBPbkKj85sk" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_ziX6Gpv6gQ0b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zUWJDCVDBVL5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zniA6pgQOfG7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zKm9KZD8hoQj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zF8kDIWtCXrk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock"><p id="xdx_803_eus-gaap--DebtAndCapitalLeasesDisclosuresTextBlock_z3v7buxihaBj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 11 - <span id="xdx_821_zcNIywVHkei">LONG-TERM DEBT, NOTES PAYABLE AND
CAPITAL LEASES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long-term debt, notes payable and capital leases
consist of the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zX7n74WmV0L5" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B3_zFLZhe9jqk3b">Long-term debt, notes payable and capital leases</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Note payable requiring monthly payments of interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zO2EeGvyRq8"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2021-07-012022-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>% until May 2009 followed by <span id="xdx_905_ecustom--NumberOfInstallment_uInteger_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zN40WApOwA2c" title="Number of installment"><ix:nonFraction name="FONR:NumberOfInstallment" contextRef="From2021-07-012022-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">240</ix:nonFraction></span> <span id="xdx_908_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" title="Debt Instrument, Frequency of Periodic Payment"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_NotePayable1Member" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment">monthly</ix:nonNumeric></span> payments of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Debt Instrument, Periodic Payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2021-07-012022-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,472</ix:nonFraction></span> through <span id="xdx_904_ecustom--MaturityDate_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_ze7iAlf2gKz7" title="Maturity date"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_NotePayable1Member" name="FONR:MaturityDate">October 2026</ix:nonNumeric></span>. The loan is collateralized by a building with a net book value of $<span id="xdx_904_ecustom--BookValueOfBuilding_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zoJNxqNlEDc8" title="Book Value Of Building"><ix:nonFraction name="FONR:BookValueOfBuilding" contextRef="AsOf2022-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">379,163</ix:nonFraction></span> as of June 30, 2022.</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zuLdBxon1sYa" title="Long Term Debt, Notes Payable and Capital Leases" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,457</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z7KWN2PtpU87" title="Long Term Debt, Notes Payable and Capital Leases" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">232,696</ix:nonFraction></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Note payable received under the Paycheck Protection Program (&#8216;PPP&#8217;) which was established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;Cares Act&#8217;) that provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven portion of the PPP loan is payable over <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_ztRmTIaUwSU5" title="Debt Instrument, Term"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_NotePayable2Member" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">5</ix:nonNumeric></span> five years at an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zTpkkMth0Ay5" title="Debt Instrument, Interest Rate During Period"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2021-07-012022-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>%, with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note was forgiven in August 2021.</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zul68mZAvYO4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zRmUnCPMfMB" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,764</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">The revolving credit note was extended to October 26, 2022. The Company can borrow up to $<span id="xdx_907_eus-gaap--ProceedsFromLinesOfCredit_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Proceeds from Lines of Credit"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2021-07-012022-06-30_custom_NotePayable3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000,000</ix:nonFraction></span> and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zaYUkWzqZuCf" title="Debt Instrument, Interest Rate During Period"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2021-07-012022-06-30_custom_NotePayable3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span>% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zul4yBn5CSk1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1460">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_z3FsXHpNI5ci" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1461">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630_z26nNXCs8oZ6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,457</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630_z7dhJ1KdRoE9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">933,460</ix:nonFraction></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" title="Current portion of Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,078</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20210630_zBt5gnywqX35" title="Current portion of Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,206</ix:nonFraction></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,379</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20210630_zKAqWnjmNtsl" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">760,254</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zR4Np13AsfK1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_ze0uQBJLlnH5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 77; Value: 1 -->
    <div id="xdx_236_zF9UQnkH8FWd" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_235_zbFHzqag4RMa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zICFlULOxFhf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_z9PRtUwdJfo3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z7s0nCggjIcj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z7JZoCc4jir3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_239_zUpLE0bDn8Z7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zn7pbL0bOXOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 11 - LONG-TERM DEBT, NOTES PAYABLE AND
CAPITAL LEASES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zZbqG5Z7A2cd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The maturities of debt over the next five years
are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zbrBBLC9C8qk" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BA_zJSkMcVpxsPj">Maturities Of Long-Term Debt</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Years Ending June 30,</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">2023</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_c20220630_zkvIRjSK1Xod" title="2023" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,078</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2024</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_c20220630_zFXF3rOEYc4g" title="2024" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,766</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_c20220630_z0nmFtJpRBg8" title="2025" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,002</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2026</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_c20220630_zQTRqUSoUJL" title="2026" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,448</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2027</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_c20220630_zBu5pBVlLsS3" title="2027" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,163</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: white">Long-Term Debt Over Five Years and Thereafter</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_c20220630_zhqdguY0FVOe" title="Thereafter" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,457</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AC_z2LY4ffuXtH7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zIyQ5dqOR9a2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12 - <span id="xdx_824_zjBndFeM5hc7">INCOME TAXES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">ASC topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon
examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit
recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized (or
amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result
of applying the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings
and therefore it has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In accordance with ASC topic 740, interest costs
related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense,
net. Penalties if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company files corporate income tax returns
in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject
to federal, state and local income tax examinations by tax authorities for years prior to 2017 for federal and 2016 for state.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has recorded a deferred tax asset
of $<span id="xdx_907_eus-gaap--DeferredTaxAssetsNet_c20220630_pp0p0" title="Deferred Tax Assets, Net of Valuation Allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,842,478</ix:nonFraction></span> and a deferred tax liability of $<span id="xdx_90E_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20220630_pp0p0" title="Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders&apos; Surplus"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,726</ix:nonFraction></span> as of June 30, 2022, primarily relating to its net Federal operating loss
carryforwards of approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_c20220630_pp0p0" title="Operating Loss Carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,048,000</ix:nonFraction></span> available to offset future taxable income through 2031. In addition the Company has
state operating loss carryforwards of approximately $<span id="xdx_908_eus-gaap--OperatingIncomeLoss_c20210701__20220630_pp0p0" title="Operating Income (Loss)"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,309,000</ix:nonFraction></span> and city operating loss carryforwards of approximately $<span id="xdx_902_eus-gaap--OtherOperatingIncome_c20210701__20220630_pp0p0" title="Other Operating Income"><ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,853,000</ix:nonFraction></span>.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_237_zIBKEmyDYDel" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zeNfn68ZVP96" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 78; Value: 1 -->
    <div id="xdx_237_z3KxTu3Xldf3" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zy6NjjU0mbg" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_z3ukwi5GUTgi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z0XUKCtC7D4k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zT9lGPHV6mYc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zqIOtchxaHJc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_232_zrPjDbSjPvah" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zYpL0vf01LWf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12 - INCOME TAXES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_231_zRbLaTBSrO69" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Future ownership changes as determined under
Section 382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30,
2022, no such changes in ownership have occurred.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets
is dependent on the generation of future taxable income during the periods in which temporary differences become deductible or
when such net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment
of the industry, and tax planning strategies in making this assessment. At present, the Company believes that it is more likely
than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this
inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The valuation allowance for deferred tax assets
decreased during the year ended June 30, 2022, by approximately $<span id="xdx_901_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20220630_pp0p0" title="Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">448,000</ix:nonFraction></span>. The valuation allowance decreased by approximately $<span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20210630_pp0p0" title="Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,547,000</ix:nonFraction></span>
during the year ended June 30, 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Components of the provision (benefit) for income
taxes are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zU5SRqoMeQq1" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B6_zBN5rHJdBRx1">Components Of The Provision For Income Taxes</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_497_20210701__20220630_zk6s9Q0xz282" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20200701__20210630_zOa06S83jKZe" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Years Ended June 30,</td></tr>
<tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zs8e3rhFfUSl" style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Current:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Federal</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_986_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200701__20210630_zINRoT6zONi6" title="Federal" style="color: rgb(204,238,255); width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zgdcahftBFtk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">State</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,440,594</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,136,514</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_zJjfkQKwYX62" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Subtotal</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,440,594</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,136,514</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqPTwpVGJAR7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Deferred:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zbWuLn4DTBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Federal deferred taxes</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,935,921</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,718,046</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zgeh85TD8us" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">State deferred taxes</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,972</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,960</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zQLLTvv4FYQe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Subtotal</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,093,893</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,855,006</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zyEBQOSMMlU7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">Provision (Benefit) for Income Taxes - Net</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,534,487</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,991,520</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A5_ziHQ49reXaFi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_zjuvbjoxJm6f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div id="xdx_232_z6IYh1OGaQQ5" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_238_zpN6wPjtsqL1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zGhQTgHLdKH7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zHIfjUy6XP8c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zCjWIEEc9Vl5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zHxlRIOYJ1Ue" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_234_zRG7hyXl9Ygj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zx4IKWqEulVe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12 - INCOME TAXES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_233_zKWPDczugvVb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A reconciliation of the federal statutory income
tax rate to the Company&#8217;s effective tax rate as reported is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXVsq0CdJpj" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left"><span id="xdx_8BB_ztR03Z7IvpMc">Reconciliation Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_494_20210701__20220630_zsNv9qmR2dw9" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49A_20200701__20210630_zllnwR89Fd49" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zwJKJYOzLRx7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; text-align: left">Taxes at federal statutory rate</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td>
<td style="width: 1%; text-align: left">%</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td>
<td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zdJM2gqp2706" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">State and local income taxes (benefit), net of federal benefit</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.2</ix:nonFraction></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.3</ix:nonFraction></td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zlS7qpvPMatk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Non Controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></td>
<td style="text-align: left">)%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.9</ix:nonFraction></td>
<td style="text-align: left">)%</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zT6GfK1JotBg" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Expiration of tax credits</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iP3us-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20200701__20210630_zAJIXZyDrLK1" title="Expiration of tax credits"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.6</ix:nonFraction></ix:nonFraction></span></td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zpZ0Ual3lTK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Return to provision adjustments</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.1</ix:nonFraction></td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zRyWHf5m0dF8" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">NYS Audit Settlement</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.5</ix:nonFraction></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.2</ix:nonFraction></td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_z63DKhh2NC5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Change in the valuation allowance</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.0</ix:nonFraction></td>
<td style="text-align: left">)%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">20.0</ix:nonFraction></td>
<td style="text-align: left">)%</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_z7zSZP3olEBc" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.6</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)%</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.3</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">%</td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zGfJi9FcS8E2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Effective income tax rate</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.3</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22.6</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A1_zsbgoUsA9BIe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of June 30, 2022, the Company has net operating
loss (&#8220;NOL&#8221;) carryforwards of approximately $20,048,000 that will be available to offset future taxable income. The
utilization of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal
Revenue Code.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has, for federal income tax purposes,
research and development tax credits and investments tax credits carryforwards aggregating $<span id="xdx_903_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_c20220630_pp0p0" title="Deferred Tax Assets, Tax Credit Carryforwards, Research"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,347,000</ix:nonFraction></span>. However, the realization
of these credits may be limited as a result of expiring prior to their utilization. These credits can only be applied after all
net operating losses have been used, which expire through 2031. As such, the Company has established a valuation reserve for anticipated
unused credits of $<span id="xdx_909_eus-gaap--ValuationAllowancesAndReservesBalance_iI_pp0p0_c20220630_zk0SzwVRREFk" title="Valuation Allowances and Reserves, Amount"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">442,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, for New York State income tax purposes,
the Company has tax credit carryforwards aggregating approximately $<span id="xdx_907_eus-gaap--TaxCreditCarryforwardAmount_c20220630_pp0p0" title="Tax Credit Carryforward, Amount"><ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,000</ix:nonFraction></span> which, are accounted for under the flow-through method.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company was also under audit with New York
State for income tax and was assessed additional taxes of $<span id="xdx_905_ecustom--AdditionalTaxes_pp0p0_c20210701__20220630_zSeJuiNkKKvd" title="Additional Taxes"><ix:nonFraction name="FONR:AdditionalTaxes" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,014,071</ix:nonFraction></span> plus interest and penalties. These amounts were paid during
fiscal year ending June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23B_zyyPA32cNMwb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div id="xdx_23F_zrn3khwSGlYf" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23E_z4KXkNEuTrY1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zgU2qfsvQEM5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z4I4dUaTSQq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zd0TnoC72nmk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zbgq8KE0BFv7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_236_znLTBinUGkt4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zeNNePuuXdMb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12 - INCOME TAXES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_237_zV3Gx3UQISZi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Significant components of the Company&#8217;s
deferred tax assets and liabilities at June 30, 2022 and 2021 are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhUOUyMuFbMc" summary="xdx: Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zViAdR8ww5Hb"><span id="xdx_8B3_z5sbFMsCeMTc"><span id="xdx_8B3_zg2ZVwhm4yZ1" style="display: none">Components Of Company&#8217;s Deferred Tax Assets And Liabilities</span></span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49A_20220630_z1r5QRMAPLX9" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_492_20210630_zdZX8w765Je7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Deferred tax assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zP7Vg3dV5tsg" style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Allowance for doubtful accounts</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,239,903</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,827,382</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zE07pX08AZG4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Non-deductible accruals</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,400</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">749,902</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zV6NCZ51AGYe" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net operating carryforwards</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,820,010</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,285,163</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zHp19WTme3ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Tax credits</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,346,509</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,732,650</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_z2QnWtrJAyO" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Inventory</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,945</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,316</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_zhE5E8eNehyb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Property and equipment and depreciation</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,576</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">187,632</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zny48cNmv5Xg" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">Deferred Tax Assets - gross</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,284,343</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,849,045</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zlM0ct2VgPP7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Valuation allowance</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">441,865</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">890,084</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_msDTLzHqA_maDTALNzFAZ_zIsuIZewdbzd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total deferred tax assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,842,478</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,958,961</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzHqA_maDTLzexF_zkRufmNS1n17" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intangibles</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,726</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,316</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzexF_msDTALNzFAZ_zcZWT7LcwZb" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total deferred tax liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,726</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,316</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zS7JAQjhJMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net deferred tax asset</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,626,752</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,720,645</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A6_zwJWO8PX9b1k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zcHnlN8DGfWk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 13 - <span id="xdx_82A_z7kIbNMr7y5i">OTHER CURRENT LIABILITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Included in other current liabilities are the
following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRHrxNCrmzL1" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B8_z47T7equK4g5"><span id="xdx_8BF_zKun2NP1YPv6" style="display: none">Other Current Liabilities</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49C_20220630_zDitV1yH9M65" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49E_20210630_zF8aYmKcwsA4" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accrued salaries, commissions and payroll taxes</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,652,173</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,406,982</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Litigation accruals</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1651">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">900,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Sales tax payable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">248,702</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">644,623</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">State income taxes payable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">382,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">774,234</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Legal and other professional fees</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,707</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,827</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounting fees</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">120,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,262</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Self-funded health insurance reserve</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,167</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,548</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accrued interest and penalty</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59,516</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">493,042</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">854,962</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">715,600</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other current liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,417,227</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,162,118</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zH5w0E8Fokz1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div id="xdx_230_zALUwNdjhIxc" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_233_zpFTFcCB1Qqj" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zFQNpCRcJd7e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zaHfqXLVT4B1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zozqhl7EqiS4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_z12T2gzrbHx5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zCkk2QdaLbx4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zNwrTfQ2Bvf4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 14 - <span id="xdx_82C_zsNADuEDXwce">COMMITMENTS AND CONTINGENCIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Leases</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company rents its operating facilities and
certain equipment, pursuant to operating lease agreements expiring at various dates through March 2030. The leases for certain
facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated
$<span id="xdx_90C_eus-gaap--LeaseAndRentalExpense_c20210701__20220630_pp0p0" title="Operating Leases, Rent Expense"><ix:nonFraction name="us-gaap:LeaseAndRentalExpense" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,668,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20200701__20210630_pp0p0" title="Operating Leases, Rent Expense"><ix:nonFraction name="us-gaap:LeaseAndRentalExpense" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,146,000</ix:nonFraction></span>, for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company received approval from the Suffolk
County IDA on February 29, 2016 of a <span id="xdx_90E_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160201__20160229_zOmEfBNidIn4" title="Property Tax Abatement From Suffolk County IDA"><ix:nonFraction name="FONR:PropertyTaxAbatementFromSuffolkCountyIda" contextRef="From2016-02-012016-02-29" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% property tax abatement, valued at $<span id="xdx_904_ecustom--PropertyTaxAbatement_pp0p0_c20160201__20160229_zq9RzYiquwAf" title="Property Tax Abatement"><ix:nonFraction name="FONR:PropertyTaxAbatement" contextRef="From2016-02-012016-02-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">440,000</ix:nonFraction></span>, over a 10 year period commencing January 2017.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Employee Benefit Plans</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has a non-contributory 401(k) Plan
(the &#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum
service requirements. There were $<span id="xdx_90D_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20210701__20220630_pp0p0" title="Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20200701__20210630_pp0p0" title="Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,799</ix:nonFraction></span> employer contributions to the Plan for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The stockholders of the Company approved the
2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217; meeting in April 2000.
The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has
not been put into effect as of June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Litigation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_906_ecustom--LitigationSettelementDescription_c20200701__20210630" title="Litigation Settelement Description"><ix:nonNumeric contextRef="From2020-07-012021-06-30" name="FONR:LitigationSettelementDescription">In September 2019, The Company was notified
by one of its landlords that it was required to vacate the premises within 180 days under the demolition clause in the lease. The
Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated in February 2018. The
Company is in the process of relocating to a new location but the original lease provided for penalty payments in the event that
the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course of the arbitration
proceedings. The Company settled the case for $900,000 for the leasehold holdover charges which was paid in August 2021.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_ecustom--LitigationSettelementDescription_c20210701__20220630" title="Litigation Settelement Description"><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" name="FONR:LitigationSettelementDescription">In September 2020, the Company entered into
a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The
settlement was for $1.2 million of which $900,000 was paid by the Company&#8217;s insurance on September 15, 2020 with the remaining
$315,000 paid by the Company on September 28, 2020.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23E_zQUgwSRrNSo3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div id="xdx_235_zcZe1Bc6lyA9" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_233_zM4khMUeeiFb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zRYXgkz1ThJ5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zBTIuhsy9kH" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zxUPOkt4iljl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_zyRVcRmGulOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zBplcCitCv8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zxozNNR6kxQl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 14 - COMMITMENTS AND CONTINGENCIES (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_232_zbksZ3QPwnx8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other Matters</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The Company is subject
to other legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract
and employment claims besides the claim above. In the opinion of management, and with consultation with legal council, the aggregate
liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial position
or results of operations of the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims
to $<span id="xdx_902_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pp0p0_c20210701__20220630_zxvpd57mit11" title="Liability for individual claims"><ix:nonFraction name="FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,000</ix:nonFraction></span> per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the
Company considers historical and projected medical utilization data when estimating its health insurance program liability and
related expense. As of June 30, 2022 and 2021, the Company had approximately $<span id="xdx_907_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20220630_pp0p0" title="Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20210630_pp0p0" title="Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,000</ix:nonFraction></span>, respectively, in reserve for
its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the consolidated
balance sheets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves
for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance
programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves
such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid dates,
and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded
in the years covered by this report.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_806_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z3RCR2C1kOoi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 15 - <span id="xdx_82E_zWKh3OxZ8Fs4">SUPPLEMENTAL CASH FLOW INFORMATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021
the Company paid $<span id="xdx_900_eus-gaap--InterestPaid_c20210701__20220630_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">617,029</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--InterestPaid_c20200701__20210630_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,178</ix:nonFraction></span> for interest, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021
the Company paid $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20210701__20220630_pp0p0" title="Income Taxes Paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,408,145</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20200701__20210630_pp0p0" title="Income Taxes Paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">261,032</ix:nonFraction></span> for income taxes, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021,
the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210701__20220630_pdd" title="Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> and <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20200701__20210630_pdd" title="Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,364</ix:nonFraction></span> shares of common stock for costs and expenses totaling $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210701__20220630_pp0p0" title="Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200701__20210630_pp0p0" title="Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,940,821</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021,
the Company resolved certain sales tax liabilities and was able to reverse accrued interest and penalties in the amount of $<span id="xdx_90B_ecustom--SellingGeneralAndAdministrativeExpenses_c20210701__20220630_pp0p0" title="Selling, General and Administrative Expenses"><ix:nonFraction name="FONR:SellingGeneralAndAdministrativeExpenses" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,000</ix:nonFraction></span>
and $<span id="xdx_90D_ecustom--SellingGeneralAndAdministrativeExpenses_c20200701__20210630_pp0p0" title="Selling, General and Administrative Expenses"><ix:nonFraction name="FONR:SellingGeneralAndAdministrativeExpenses" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">602,000</ix:nonFraction></span>, respectively, which has been recorded under selling, general and administrative expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_233_z0RBs5MA18Y8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div id="xdx_232_zqFfGVMrn2E8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23A_zbMpkm0IERod" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zgag6MH06H5f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z9frX6L4Cuoe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z1JYbhQ8PkD1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zG61VMzdA55a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zLYaavzixgIj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4o8YHIwi4Ug" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 16 &#8211; <span id="xdx_82B_zbq8AZQNln8c">RELATED PARTY TRANSACTIONS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90F_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210701__20220630__dei--LegalEntityAxis__custom--ABillingCompanyMember" title="Related Party Transaction, Description of Transaction"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_ABillingCompanyMember" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">The CEO and President of the Company is a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#8217; Compensation
claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000. The Company terminated this agreement
on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the
billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2022 for another year.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_906_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210701__20220630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember" title="Related Party Transaction, Description of Transaction"><ix:nonNumeric contextRef="From2021-07-012022-06-30_custom_BensonhurstMRILimitedPartnershipMember" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Bensonhurst MRI Limited Partnership, in which
the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80B_eus-gaap--SegmentReportingDisclosureTextBlock_zkVR6W8H39sh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 17 - <span id="xdx_821_zHE7a5AGLtm9">SEGMENT AND RELATED INFORMATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company provides segment data in accordance
with the provisions of ASC topic 280, &#8220;Disclosures about Segments of an Enterprise and Related Information&#8221;.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company operates in two industry segments
- manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accounting policies of the segments are
the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company
evaluates performance based on income or loss from operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_234_z9Tz3H6Cdqmf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div id="xdx_23E_zAPjWZlvEOFc" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23C_zF7W0MuAQ4I9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zrmpXWV5FfK7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_z6jsCrQY9mrb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z4duZdE8XXK1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zhSBz2i5j8q7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z6cebAyNZCPj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zCJGSgIguJvj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0">&#160;NOTE 17 - SEGMENT
AND RELATED INFORMATION (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_233_zIOFzczr9IW7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized financial information concerning
the Company&#8217;s reportable segments is shown in the following table:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized Segment Financial Information</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z3rkDoZogLv" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left"><span id="xdx_8BA_zDz8vTAtaUua" style="display: none">Schedule of summarized segment financial information</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Manufacturing and Servicing of Medical</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Management of Diagnostic Imaging</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Fiscal 2022:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Center</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Totals</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net revenues from external customers</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total Revenues - Net" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,218,804</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total Revenues - Net" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,373,341</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--Revenues_c20210701__20220630_pp0p0" title="Total Revenues - Net" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">97,592,145</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intersegment net revenues *</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zb7igEbrTuzg" title="Intersegment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="Fact001768" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">965,417</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zTvXeUDL9mRg" title="Intersegment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zAgoyxuVEaFk" title="Intersegment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-01to2022-06-30" id="Fact001772" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">965,417</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">(Loss) Income from operations</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,604,305</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,611,487</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630_pp0p0" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,007,182</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,559</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,271,677</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630_pp0p0" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,535,236</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Compensatory element of stock issuances</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_z6qvuiQl4D15" title="Compensatory element of stock issuances" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zRaYkbCm0dV5" title="Compensatory element of stock issuances" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630_zY5Uml3zRRHc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2021-07-01to2022-06-30" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total identifiable assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total identifiable assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,259,937</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total identifiable assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,082,045</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_980_eus-gaap--AssetsNet_c20220630_pp0p0" title="Total identifiable assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,341,982</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capital expenditures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258,271</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,374,903</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630_pp0p0" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,633,174</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Fiscal 2021:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net revenues from external customers</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Total Revenues - Net" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,037,091</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Total Revenues - Net" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,892,674</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" title="Total Revenues - Net" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,929,765</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intersegment net revenues *</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zSvp60x9cvfi" title="Intersegment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="Fact001809" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">901,250</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_ecustom--IntersegmentNetRevenues_pdp0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zrJprfqqlBr9" title="Intersegment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____zqqbYZoareDj" title="Intersegment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2020-07-012021-06-30" id="Fact001813" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">901,250</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">(Loss) Income from operations</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,410,189</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,507,804</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,097,615</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,830</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,816,857</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,081,687</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Compensatory element of stock issuances</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pdp0" title="Compensatory element of stock issuances" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zn0A5bT5Bbt9" title="Compensatory element of stock issuances" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" title="Compensatory element of stock issuances" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,277</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total identifiable assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zY3qCC8yoCY4" title="Total identifiable assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,592,582</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zGu26UdMLcDb" title="Total identifiable assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">164,913,613</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20210630_zJ1gLlln9j8e" title="Total identifiable assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,506,195</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capital expenditures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">291,294</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,405,502</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,696,796</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td id="xdx_F00_zbhlTO5DaAO6" style="width: 4px; padding-left: 11pt; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">*</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F1A_zBTwIqequJ48" style="font: 11pt Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote001844" xml:lang="en-US">Amounts eliminated in consolidation</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A2_zcnahpWwxEqb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s areas of operations are
principally in the United States. The Company had export sales of medical equipment amounting to <span id="xdx_90D_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20210701__20220630_z1VgNxYJna2d" title="Export Sales Of Medical Equipment Percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.9</ix:nonFraction></span>% and <span id="xdx_90D_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20200701__20210630_zjltUOjtiS99" title="Export Sales Of Medical Equipment Percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.3</ix:nonFraction></span>% of product sales
revenues to third parties for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23D_zowhZEQaBUVd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div id="xdx_23C_zGMDZGIdbXn8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_237_zkfv1RsJxNS5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zQxDYj0MhuTe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_z4tUTlVcw6il" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z8E9hiW4artb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zakm2pqcjNXj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zO7og40sc5J3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z2rHhEaPKHrd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 17 - SEGMENT AND RELATED INFORMATION (CONTINUED)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z1JndOX7c9J2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of
product sales to unrelated parties, were made to customers in the following countries:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:ExportProductSalesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ExportProductSalesTableTextBlock_zDeYK6aoxxkk" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black"><span id="xdx_8B6_z73CEuWiSHOj" style="display: none">Schedule of export product sales</span></td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; color: black; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">2022</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; color: black; text-align: left">Dominican Republic</td>
<td style="width: 8%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 12%; color: black; text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zmb28pnmEVf7" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_DO" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.0</ix:nonFraction></span></td>
<td style="width: 1%; color: black; text-align: left">%</td>
<td style="width: 8%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 12%; color: black; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_ztJMHCmXZHC1" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_DO" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.0</ix:nonFraction></span></td>
<td style="width: 1%; color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Canada</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zugms5m0sJE1" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td>
<td style="color: black; text-align: left">%</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zJed0aRajlC9" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td>
<td style="color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black">Germany</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--ForeignProductSales_dp0_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zEelWrPrUDn9" title="Foreign Product Sales" style="color: black; text-align: right"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_DE" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_90F_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zpfvAufYPZg5" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.1</ix:nonFraction></span></td>
<td style="color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black; text-align: left">Puerto Rico</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zVvbxCcrzLi5" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">36.3</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">%</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_z9Q7WROcfPWd" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20210701__20220630_zCUDH9e2hE" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.9</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">%</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_ecustom--ForeignProductSales_dp_c20200701__20210630_ziIRNZzMkkVk" title="Foreign Product Sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.3</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">%</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A0_z1GMoLYS7DYe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s areas of service and repair
are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to
<span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20210701__20220630_zhoI2B1mDANe" title="Foreign Revenues Of Service And Repair Of Medical Equipment Percentage"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.4</ix:nonFraction></span>% and <span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20200701__20210630_zhQdyN6o1Pvd" title="Foreign Revenues Of Service And Repair Of Medical Equipment Percentage"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.5</ix:nonFraction></span>% of consolidated net service and repair fees for the years ended June 30, 2022 and 2021 respectively. Foreign service
and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0">&#160;Foreign Service and
Repair Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="FONR:ExportServiceRevenuesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ExportServiceRevenuesTableTextBlock_zT5QF8LMouK2" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td><span id="xdx_8B2_zikxvsNFp2u8" style="display: none">Schedule of foreign service and repair fees</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; text-align: left">Puerto Rico</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_z31Vn7FJCoQ1" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left">%</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zUylr2Y8uyog" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Switzerland</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z4yRUNT1iuE7" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_CH" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zLbEcAucwF8h" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_CH" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Germany</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_z1Z1fJLR4GSl" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zsNnM6HXW2Aa" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>England</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zCRQdGkwmCn2"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_GB" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_znKmWFaRGhs8" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_GB" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Canada</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zA0GeeSJRHNl" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Greece</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_z8SVYRz71vfe" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_GR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zg97RRszEc9j" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30_country_GR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Australia</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zHD8n0OU1767" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_AU" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zdlrzyu4C4r5" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.4</ix:nonFraction></span></td>
<td style="text-align: left; padding-bottom: 2.5pt">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zbyRtsu1CFIk" title="Foreign Service and Repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2020-07-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.5</ix:nonFraction></span></td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>




</ix:nonNumeric><p id="xdx_8A9_zmM6xXAQ6t4l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<ix:exclude><p id="xdx_23C_zWdx2fTXyc61" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zZMYo8p8daG9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0">&#160;The Company does not
have any material assets outside of the United States.</p></ix:exclude>

<ix:exclude><p id="xdx_235_ziuedES0TOF5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zJwFYZbHy6Yj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div id="xdx_23E_zv9NGS3Dg5z1" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23E_zppqDBDYhkNk" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_z6p9sZka1Srg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zhrXcg176Sr7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zrrBHEodNV06" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zyEMGVoECEub" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_239_zaFpo6mkBo74" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z7H3Gzcu5rS5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 18 &#8211; <span id="xdx_82E_zl3etC04lJlc">ACQUISTION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 29, 2021, the Company completed the
acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company used an incremental borrowing
rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We made a fair value determination
of the acquired assets and assumed liabilities as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zFeaYR9KTqsd" summary="xdx: Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BA_zLpLxZiUaiHf"><span id="xdx_8B3_zeYkDSkU531g" style="display: none">Fair value assets and assumed liabilities</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49D_20210329" style="text-align: center">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Property and equipment</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">650,000</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right to use assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">434,219</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intangible assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--SecurityDeposit_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Security Deposit</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38,628</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right to use liability</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<ix:nonFraction name="FONR:PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">434,219</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Goodwill</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">283,880</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total purchase consideration</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,122,508</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A0_zS23UHZoUZ94" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In accordance with ASC 805-10-25-1, Business
Combinations &#8211; Overall Recognition, the Company recorded the transaction as a business combination. ASC 805-10-25-1 provides
the requirements of recording the transaction by applying the acquisition method. The acquisition method requires the Company to
determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must be determined if there is
a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and must be able to recognized
and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded as a business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The net assets acquired and consideration is
as follow:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zzZTztpWvhvg" summary="xdx: Disclosure - ACQUISTION - Net assets acquired (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zEPw0ZYlDYob"><span id="xdx_8B9_zMRs5MswHotj" style="display: none">Net assets acquired</span></span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Leasehold Improvements</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Intangible assets" style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">550,000</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diagnostic Equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_pp0p0" title="Intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Customer Lists</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_pp0p0" title="Intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Covenant Not to Compete</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_pp0p0" title="Intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Security Deposit</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--SecurityDeposit_c20210329_pp0p0" title="Security Deposit" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38,628</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Closing costs - expensed</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--ClosingCostsExpensed_c20210329_pp0p0" title="Closing costs - expensed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:ClosingCostsExpensed" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,478</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Goodwill</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--GoodwillGross_c20210329_pp0p0" title="Goodwill" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:GoodwillGross" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">283,880</ix:nonFraction></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Cash Consideration Paid</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_ecustom--BusinessCombinationContingentConsiderationAsset1_c20210329_pp0p0" title="Cash Consideration Paid" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:BusinessCombinationContingentConsiderationAsset1" contextRef="AsOf2021-03-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,125,986</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A6_z9hIo9M4UJuf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The results of operations of Rockland Management
Group were diminutive and did not affect the pro forma results of operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_233_zDY4LnMIDCr5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div id="xdx_23C_zdiC8vx0B9R5" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_z818sYMbkri6" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zHdZZEnU8GAa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zXRQR3e0qV54" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zc1D7b4Gm9R" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_234_z7oKofCp8Nk9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_236_zr7KB1XIuFWe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"><p id="xdx_80E_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zP3z3G9fvkuh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 19 &#8211; <span id="xdx_821_zryHW8DNJSHj">ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following represents a summary of allowance
for doubtful accounts for the years ended June 30, 2022 and 2021 respectively:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zSFOe3M0ttN1" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="17" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B5_zlhcEixqViBf"><span style="display: none">Summary of Allowance For Doubtful Accounts</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Description</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance <br /> June 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Additions (1)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Deductions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance <br /> June 30, 2022</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounts receivable</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zEApKT23dYLg" title="Beginning Balance" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">442,270</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zDdRJVoP62R1" title="Additions (Included in provision for bad debts)" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1970">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z2nUsFZQxnlh" title="Deductions" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">237,673</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zoFC9mqAP8dd" title="Ending Balance" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,597</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zk5jgUxoDy8l" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,786,878</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zUvS7HPj9Jr7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001976" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">841,039</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zPt9BmrWrZN6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1977">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zs502PWeS57c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,627,917</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable - related medical practices</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z8W4vKoG8hYa" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,184,399</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zwhHM38IkLz9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001980" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">502,494</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zaBchitOx0re" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1981">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhD1mJUnrN7j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,686,893</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Notes receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zLnLIGwSZKW7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zZZdEZluZNwc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1984">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zV3PlU22zt4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1985">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zahk6gotftya" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Description</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Additions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Deductions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounts receivable</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zvSjySkSphic" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,561</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z8yuEVtUTSY8" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1988">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zP66msPYHsed" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">72,291</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zQ29yoVXDab2" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">442,270</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zcY4Kdu4FlH" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,063,233</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zWLvGIAFs159" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001992" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,723,645</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zsl1WJCe5hwb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1993">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z85hWpmeFOof" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,786,878</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable - related medical practices</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zlj6BPQkuCL4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,322,055</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zCbUpBCkTChk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001996" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">862,344</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z05j2Dwfr9Wk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1997">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zWROejKsg326" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,184,399</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Notes receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjcY2mtFl1I2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2020-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zayjuj5hN0U2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2000">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlxPqyKUdo2h" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2001">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlPBHaXLD1rj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F0B_zOvIhHTENbWj" style="font: 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F13_z79FhlKyM4Fd" style="font: 11pt Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002003" xml:lang="en-US">Included in provision for bad debts.</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A1_z4e8Yu3OJg16" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_zLsrteD9NOIf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div id="xdx_23B_zu7jUq7ok9ac" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23B_zVwh0KbmeYJc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zXpc1UhuGmf7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zAqGDp6sxPSe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zDFxZDsdEM68" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_zk8gOptSZiJ5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">JUNE 30, 2022 and 2021</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zQETwxpPuMAd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:QuarterlyFinancialInformationTextBlock"><p id="xdx_803_eus-gaap--QuarterlyFinancialInformationTextBlock_zQN0QmbUO1M2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 20 - <span id="xdx_829_zqNRXSgkaWFh">QUARTERLY FINANCIAL DATA (UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">(000&#8217;s omitted, except per share data)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6shskmWuTRe" summary="xdx: Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zGgGNnKaZtL9"><span id="xdx_8BB_zATLAOyPJnpb" style="display: none">Quarterly Financial Data</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJwTG6BgkYSl" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_495_20211001__20211231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z7wdG7KlWy4" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49D_20220101__20220331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_znYtlutyG7Vc" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_499_20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjoaRJ3z2cJ1" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_494_20210701__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjqy8P3wphb7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">September 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">December 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">March 31, 2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
<tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Revenues &#8211; Net</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,730</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,479</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,571</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,812</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,592</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Costs and Expenses</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,989</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,996</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,933</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,667</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,585</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ProfitLoss_zRiZUa0CAyH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Income</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,182</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,137</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,262</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,653</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,234</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.56</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.58</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.33</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.31</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.78</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.57</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.32</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.31</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.75</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49C_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zNM2K0B19E32" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_493_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zMaWh6BYG5F1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_490_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zo1nN1CC9ic6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49B_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zaqtGBDgitb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_497_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvg3CWg8B3R6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">September 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">December 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">March 31, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
<tr id="xdx_409_eus-gaap--Revenues_zKmiy43yXAw2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Revenues &#8211; Net</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,979</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,164</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,090</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,697</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,930</ix:nonFraction></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CostsAndExpenses_zh2qvTSKHh23" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Costs and Expenses</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,829</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,182</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,968</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,853</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,832</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ProfitLoss_zBZH7c284aGc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Income</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,251</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,928</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,299</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,196</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,674</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zHnOsBLR9KPi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.37</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.45</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.55</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.47</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_znHqvVrGge2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.36</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.54</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.11</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.45</ix:nonFraction></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AF_zfrdhv49jSfd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-07-01to2022-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zF4g8zLYw6fa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 21 &#8211; <span id="xdx_821_z6aeQs9mM0v9">SUBSEQUENT EVENTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company evaluates events that have occurred
after the balance sheet date, but before the consolidated financial statements are issued.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During September 2022 the Company amended their
revolving credit agreement. The agreement was extended to October 26, 2022.&#160;The interest rate on borrowings remains at <span id="xdx_905_eus-gaap--DebtorInPossessionFinancingFeeOnUnusedBorrowings_iI_dp_c20220930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh80eVIF2W27" title="Debtor-in-Possession Financing, Fee on Unused Borrowings"><ix:nonFraction name="us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings" contextRef="AsOf2022-09-30_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span>%
along with certain financial covenants.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a
stock repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On
September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90C_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziM5MM43iuI7" title="Stock repurchase plan"><ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="AsOf2022-09-26_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">9</ix:nonFraction></span> million to be purchased under the plan which will be purchased on
the publicly traded open market at prevailing prices.</p>

</ix:nonNumeric><p id="xdx_810_z7PkhJ4x5eWb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_81B_zXv2BOcjUIEi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_011"></span>ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There have been no disagreements with our independent
registered public accounting firm or other matters requiring disclosure under Regulation S-K, Item 304(b).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_012"></span>ITEM 9A. CONTROLS AND PROCEDURES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Evaluation of Disclosure Controls and Procedures</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of the end of the period covered by this
Annual Report on Form 10-K, we performed an evaluation under the supervision of and with the participation of management, including
our Principal Executive Officer and our Acting Principal Financial Officer, of the design and effectiveness of our disclosure controls
and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934 as amended (the &#8220;Exchange
Act&#8221;). Based upon that evaluation, our Principal Executive Officer and Acting Principal Financial Officer concluded, as of
the end of the period covered by this Annual Report that our disclosure controls and procedures were effective.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Management&#8217;s Report on Internal Control
Over Financial Reporting</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our management is responsible for establishing
and maintaining adequate internal control over financial reporting, as is defined in the Exchange Act. Internal control over financial
reporting is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation
of financial statements for external reporting purposes in accordance with GAAP.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our management conducted an evaluation of the
effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO-2013). Based on this evaluation, our management
concluded that our internal control over financial reporting was effective at June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Based on the COSO criteria, management concluded
that our internal controls were effective to prevent material misstatements of the Company&#8217;s annual or interim financial
statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Changes in Internal Controls over Financial
Reporting</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There have been no changes in our internal control
over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the most recent fiscal quarter and year ended
June 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_013"></span>Item 9B. OTHER INFORMATION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">None.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">PART III</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_014"></span>ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Directors serve from the date of their election
until the next annual meeting of stockholders and until their successors are elected and qualify. During fiscal 2022, with the
exception of Dr. Raymond V. Damadian, who did not receive any fees for serving as a director, each director receives a base fee
of $20,000 per annum for his or her service as a director, with greater amounts for additional services on the Board of Directors.
Officers serve at the discretion of the Board of Directors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A majority of our board of directors is composed
of independent directors: consisting of, Ronald G. Lehman, Richard E. Turk and John Collins. The outside directors also serve as
the members of the audit committee, which is a standing committee of the board of directors having a charter describing its responsibilities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have adopted a code of ethics applicable
to, among other personnel, our principal executive officer, principal financial officer, controllers and persons performing similar
functions. The code is designed to deter wrongdoing and to promote: 1. honest and ethical conduct, including the ethical handling
of actual or apparent conflicts of interest between personal and professional relationships; 2. full, fair, accurate, timely and
understandable disclosure in reports and documents that we file or submit to the Securities and Exchange Commission and in other
public communications we make; 3. compliance with applicable governmental laws, rules and regulations; 4. the prompt internal reporting
of violations of the code to an appropriate person or persons identified in the code and 5. accountability for adherence to the
code. We will provide a copy of the code to any person who requests a copy. A person may request a copy by writing to Fonar Corporation,
110 Marcus Drive, Melville, New York 11747, to the attention of the Legal Department or Investor Relations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The officers and directors of the Company are
set forth below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 25%; text-align: left">Timothy R. Damadian</td>
<td style="width: 5%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 15%; text-align: left">58</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%">&#160;</td>
<td style="width: 48%; text-align: left">Chairman of the Board, President, Chief Executive Officer and Treasurer</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Luciano B. Bonanni</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: left">67</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">Executive Vice President, Chief Operating Officer and acting Principal Financial Officer</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Claudette J.V. Chan</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: left">84</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">Director</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Ronald J. Lehman</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: left">46</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">Director</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Richard E. Turk</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: left">38</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">Director</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">John Collins</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: left">41</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">Director</td></tr>
</table>






<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Raymond V. Damadian, M.D. was the founder of
Fonar and served as the Company&#8217;s Chairman of the Board until his unexpected death in August, 2022. He continued to work
and serve the Company as Chairman of The Board and Treasurer for the full 2022 fiscal year. Prior to founding Fonar, Dr. Damadian
was employed by the State University of New York, Downstate Medical Center, New York, as an Associate Professor of Biophysics and
Associate Professor of Internal Medicine from 1967 until September 1979. He received an M.D. degree in 1960 from Albert Einstein
College of Medicine, New York, and a B.S. degree in mathematics from the University of Wisconsin in 1956. In addition, Dr. Damadian
conducted post-graduate work at Harvard University, where he studied extensively in the fields of physics, mathematics and electronics.
Dr. Damadian is the author of numerous articles and books on the nuclear magnetic resonance effect in human tissue, which is the
theoretical basis for the Fonar MRI scanners. He was a 1988 recipient of the National Medal of Technology. In 1989 he was inducted
into the National Inventors Hall of Fame, for his contributions in conceiving and developing the application of magnetic resonance
technology to medical applications including whole body scanning and diagnostic imaging.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Timothy Damadian has been the Chariman of the
Board and Treasurer of Fonar since September 7, 2022 and the President and Chief Executive Officer of Fonar since February 11,
2016. From 2010 to 2016 he served as an independent consultant, with a focus on the Company&#8217;s MRI facility management business.
Timothy Damadian began his career at Fonar in 1985, installing MRI scanners and components for Fonar customers. Over the course
of the following 16 years, he held positions of increasing authority, eventually becoming Vice President of Operations. In 1997,
Timothy Damadian was appointed President of the newly formed Health Management Corporation of America (HMCA), a wholly-owned subsidiary
of Fonar that was formed to manage medical and diagnostic imaging offices. In 2001, Timothy Damadian left Fonar to form Integrity
Healthcare Management, Inc., a diagnostic imaging management company that would eventually manage MRI scanning centers in New York
and Florida. The company was a success and was sold to Health Diagnostics, LLC in 2007. Mr. Damadian returned to Fonar as a consultant
in 2010. He also serves as a Manager of Health Diagnostics Management, LLC, which are subsidiaries of HMCA.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Luciano B. Bonanni has served as Chief Operating
Officer (COO) and Executive Vice President (EVP) for Fonar Corporation since June 27, 2016. In September 2022, he was appointed
to fill the position of acting Principal Financial Officer. Prior to his appointment as COO, Mr. Bonanni had served the Company
as Vice President since 1989, during which time he oversaw general operations, research and development, manufacturing, service,
sales, finance, accounting and regulatory compliance. Prior to 1989, Mr. Bonanni held the title of Vice President of Production
and Engineering from the time of Fonar&#8217;s initial public offering in 1981. Mr. Bonanni joined the Company as an electrical
engineer in 1978. He holds a Bachelor of Electrical Engineering degree from Manhattan College.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Claudette J.V. Chan has been a Director of Fonar
since October 1987 and Secretary of Fonar since January 2008. Mrs. Chan was employed from 1992 through 1997 by Raymond V. Damadian,
M.D. MR Scanning Centers Management Company and since 1997 by HMCA, as &#8220;site inspector,&#8221; in which capacity she is responsible
for supervising and implementing standard procedures and policies for MRI scanning centers. From 1989 to 1994 Mrs. Chan was employed
by St. Matthew&#8217;s and St. Timothy&#8217;s Neighborhood Center, Inc., as the director of volunteers in the &#8220;Meals on
Wheels&#8221; program, a program which cares for the elderly.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">From approximately 1983 to 1989, Mrs. Chan was
President of the Claudette Penot Collection, a retail mail-order business specializing in women&#8217;s apparel and gifts. Mrs.
Chan practiced and taught in the field of nursing until 1973, when her son was born. She received a bachelor of science degree
in nursing from Cornell University in 1960.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Ronald G. Lehman has been a Director of Fonar
since April, 2012, when he was unanimously appointed by the remaining four Directors to fill the vacancy resulting from the death
of former Director Robert Djerejian. From October, 2009 to the present, Mr. Lehman has served as Managing Director of Investment
Banking with Bruderman Brothers, LLC, a private New York-based broker-dealer registered with the Securities and Exchange Commission
and which is a member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation
(SIPC). Mr. Lehman directly manages all facets of the firm&#8217;s transaction processes, from deal origination, to sourcing capital,
to negotiating deal structures, through documentation and closing. The firm provides buy and sell-side advisory, capital raising,
and consulting services to lower middle-market companies. Mr. Lehman specializes in advising healthcare services companies and
has recently completed several recapitalizations in the industry. He also participates in the firm&#8217;s merchant banking investments
and oversees many of these assignments. From May, 2008 to October, 2009, Mr. Lehman served as Senior Vice President of Acquisitions
at Health Diagnostics, LLC, where he managed the company&#8217;s acquisition and corporate finance activities. From March, 2000
to May, 2008, Mr. Lehman worked for various Bruderman entities as a buy and sell-side advisor and as a principal in several private
equity transactions. From September, 1998 to March, 2000, Mr. Lehman worked at Deutsche Bank Securities, Inc. and last held the
position of Associate in their Global Custody Group. Mr. Lehman graduated from Columbia University with a B.A. in 1998.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Richard E. Turk has been a Director of Fonar
since June, 2020, when he was appointed to fill the vacancies on the Board of Directors and Audit Committee of the Board of
Directors resulting from the death of his predecessor, Robert J. Janoff. Mr. Turk is the Chief Financial Officer of PRISM Vision
Group, a private equity-backed, multi-location, outpatient comprehensive eye care practice headquartered in Union, New Jersey. Mr.
Turk joined PRISM in November, 2018, as the Chief Development Officer and became CFO in March 2021. At PRISM, Mr. Turk has overseen
the sourcing, analysis and completion of 30 acquisitions. He spearheaded growth efforts that helped PRISM expand from a
single-speciality (retina) provider with 17 locations and 21 physicians to a comprehensive, vertically-integrated, multi-specialty,
eye care organization with approximately 180 physicians and more than 90 locations across New Jersey, Pennsylvania, Delaware,
Virgina, Washington DC and Maryland. Prior to his tenure at PRISM, Mr. Turk was employed by Professional Physical Therapy, a private
equity-backed outpatient physical and occupational therapy company headquartered in Uniondale, New Jersey with more than 180
locations across New York, New Jersey, Connecticut, Massachusetts and New Hampshire. During his four years at Professional Physical
Therapy, Mr. Turk sourced, analyzed, and completed 32 acquisitions comprised of 116 clinics, expanding the company&#8217;s services
and adding three states. From 2007 to 2014, Mr. Turk was employed by Bruderman Brothers, a broker dealer involved in investment
banking, merchant banking, investment advisory, and consulting for lower middle market companies ($10M-$250M of enterprise value) in
a variety of industries, including healthcare. Mr. Turk was Vice President of Bruderman Brothers from 2011 to 2014. Mr. Turk
graduated from Columbia University with a B.A. in American History in 2007.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">John Collins has been a<b> </b>Director of Fonar
since November 17, 2021, when he was unanimously appointed by the remaining four Directors to fill the vacancy resulting from the
death of his predecessor, Charles N. O&#8217;Data. Mr. Collins is an attorney with Bell Law Group where he handles the prosecution
and defense of personal injury, property damage, insurance coverage disputes and employment matters. He joined the firm in June
2022. Prior to joining the Bell Law Group, Mr. Collins was a partner at Brownell Partners, PLLC where he provided litigation defense
for the insureds of various commercial and personal lines insurance companies. Mr. Collins graduated <i>magna cum laude</i> from New York Law School in
2012, where he was a John Marshall Harlan Scholar and a staff editor for the New York Law School Law Review. In 2011, Mr. Collins
served as a judicial intern at the Southern District of New York, in the chambers of the Honorable Paul A. Crotty. Upon graduation,
Mr. Collins completed a Fellowship with the Corporation Counsel of the City of New York.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
<td colspan="5" style="border: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Board Diversity Matrix as of September 15, 2022&#160;</span></td></tr>
<tr>
<td colspan="3" style="border-left: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">&#160;Total Number of Directors</span></td>
<td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
<td style="border-right: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">5</span></td></tr>
<tr>
<td colspan="2" style="border-top: windowtext 1pt solid; border-right: black 1pt solid; border-bottom: windowtext 1pt solid; border-left: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">&#160;Part I: Gender Identity</span></td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Female</span></td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Male</span></td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Did not disclose gender</span></td></tr>
<tr>
<td style="border-bottom: windowtext 1pt solid; border-left: windowtext 1pt solid; white-space: nowrap; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
<td style="border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Directors</span></td>
<td style="border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">1</span></td>
<td style="border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">3</span></td>
<td style="border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">1</span></td></tr>
<tr>
<td colspan="3" style="border-left: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">&#160;Part II: Demographic Background</span></td>
<td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
<td style="border-right: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
<td style="border-top: windowtext 1pt solid; border-bottom: windowtext 1pt solid; border-left: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">White</span></td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">1</span></td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">3</span></td>
<td style="border-top: windowtext 1pt solid; border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
<td colspan="4" style="border-bottom: windowtext 1pt solid; border-left: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">&#160;Did Not Disclose Demographic Background</span></td>
<td style="border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">1</span></td></tr>
<tr>
<td colspan="2" style="border-bottom: windowtext 1pt solid; border-left: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">&#160;Director with Disabilities</span></td>
<td style="border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
<td style="border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
<td style="border-right: windowtext 1pt solid; border-bottom: windowtext 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">1</span></td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_015"></span>ITEM 11. EXECUTIVE COMPENSATION.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">With the exception of the Chief Executive Officer
and the Chairman of the Board of Directors, the compensation of the Company&#8217;s executive officers is based on a combination
of salary and bonuses based on performance. The Chairman of the Board&#8217;s compensation consists of a salary. The Chief Executive
Officer and the Chairman of the Board have no understandings with the Company with respect to bonuses, options or other incentives;
they are not subject to our general policy later discussed.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;The Board of Directors
does not have a compensation Committee. Dr. Raymond V. Damadian, Chairman of the Board, controls over 50% of the voting power of
our capital stock. Dr. Damadian is both an executive officer and a member of the Board of Directors. Dr. Damadian, the Chief Executive
Officer and the Chief Operating Officer, participate in the determination of compensation for the Company&#8217;s management and
other employees.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;The Board of Directors
has established an audit committee. The members of the committee are, Ronald G. Lehman, Richard E. Turk and John Collins.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;Our compensation policy
includes a combination of salary, commissions, bonuses, stock bonuses and stock options, designed to incentivize our employees.
There is no universal plan applicable to all of our employees. The fixed and variable components of our employees&#8217; compensation
tend to be individualized, based on a combination of the employees&#8217; performance, responsibilities and position, our assessment
of how best to motivate a person in such a position and the needs and preferences of the particular employees, as negotiated between
employees and their supervisors or management.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;There is set forth
in the following Summary Compensation Table the compensation provided by us during fiscal 2022, 2021 and 2020 to our Principal
Executive Officer, and our acting Principal Financial Officer. There is set forth in the following Outstanding Equity Awards Table
and Director Compensation Table the required information.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0">&#160;SUMMARY COMPENSATION TABLE</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0">&#160;(Reflects information up to end of Fiscal
2022)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Name and All Other Principal Position</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Year</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Salary<br /> ($)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Cash Bonuses<br /> ($)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Stock Awards<br /> ($)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total Compensation ($)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center; text-indent: -11pt">(a)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">(b)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">(c)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">(d)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">(e)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">(f)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Timothy R. Damadian</td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2022</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">305,800</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">305,800</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">President, Principal</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">155,800</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">155,800</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Executive Officer</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Raymond V. Damadian</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">153,095</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">305,800</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">458,895</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Chairman of the Board,</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">153,095</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">305,800</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">458,895</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Treasurer and</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">153,095</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">153,095</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Luciano Bonanni</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">148,572</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">305,800</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">454,372</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Chief Operating Officer and</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2021</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">146,038</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">152,931</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">298,969</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -11pt">Executive Vice President</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2020</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">146,496</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">152,902</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">299,398</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"><td style="width: 0pt">II</td><td>. OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</td></tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="color: black; text-align: center">Name</td>
<td style="color: black">&#160;</td>
<td colspan="3" style="color: black; text-align: center">Number Of Securities Underlying Unexercised Options (#) Exercisable</td>
<td style="color: black">&#160;</td>
<td colspan="3" style="color: black; text-align: center">Option Exercise Price ($)</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: center">Option Exercise Expiration Date</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black">&#160;</td>
<td colspan="3" style="color: black; text-align: center">(a)</td>
<td style="color: black">&#160;</td>
<td colspan="3" style="color: black; text-align: center">(b)</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: center">(c)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 36%; color: black; text-align: left">Raymond V. Damadian, Chairman of the Board, Treasurer and Principal Financial Officer</td>
<td style="width: 5%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 15%; color: black; text-align: center">0</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 5%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 15%; color: black; text-align: center">0</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 5%; color: black">&#160;</td>
<td style="width: 15%; color: black; text-align: left; padding-left: 5.4pt">N/A</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black; text-align: left">Timothy R. Damadian, President and Principal Executive Officer</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: center">0</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: center">0</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left; padding-left: 5.4pt">N/A</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black; text-align: left">Luciano Bonanni, Chief Operating Officer, Executive Vice President and acting Principal Financial Officer</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: center">0</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: center">0</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left; padding-left: 5.4pt">N/A</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">III</td><td>DIRECTOR COMPENSATION</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The following table shows the compensation paid to the Directors
for fiscal 2022:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left">Name</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Fees earned in pad in cash ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Stock awards ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Option awards ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Non-equity incentive plan compensation</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Nonqualified deferred compensation earnings <br />&#160; <br />($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">All other compensation ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Total<br />
($)</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; text-align: left">(a)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(b)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(c)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(d)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(e)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(f)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(g)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(h)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 37%; text-align: left">A. Claudette J.V. Chan</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right">20,000</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">38,880</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right">58,880</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">B. Ronald G. Lehman</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">20,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">60,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">80,000</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">C. Richard E. Turk</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">20,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">15,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">35,000</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">D. John Collins</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">20,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">1,538</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">21,538</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">E. Charles O&#8217;Data(Deceased)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">$</td>
<td style="border-bottom: Black 1pt solid; text-align: right">9,931</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">0</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">0</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">0</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">0</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">$</td>
<td style="border-bottom: Black 1pt solid; text-align: right">0</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">$</td>
<td style="border-bottom: Black 1pt solid; text-align: right">9,931</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">EMPLOYEE COMPENSATION PLANS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar&#8217;s 2005 Incentive Stock Option Plan,
adopted on February 15, 2005, was intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue
code of 1954, as amended. The Plan permits the issuance of stock options covering an aggregate of 80,000 shares of common stock
of Fonar. The options issued have an exercise price equal to the fair market value of the underlying stock on the date the option
is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary termination
of employment. The Plan terminated on February 14, 2015.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Fonar adopted its 2010 Stock Bonus Plan, on
June 28, 2010. This Plan permits Fonar to issue an aggregate of 2,000,000 shares of common stock of Fonar as bonus or compensation.
As of June 30, 2022, 450,177 shares were available for issuance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="a_016"></span>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The following table sets forth the number and percentage of shares
of Fonar&#8217;s securities held by each director, by each person known by us to own in excess of five percent of Fonar&#8217;s
voting securities and by all officers and directors as a group as of September 1, <b>2022</b>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Name and Address of Beneficial Owner (1)<span style="color: red"> </span>(2)</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Shares Beneficially Owned</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Percent of Class</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Estate of Raymond V. Damadian, M.D.</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">c/o Fonar Corporation, Melville, New York</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">5% + Stockholder</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">123,465</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.88</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class C Stock</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,447</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">99.98</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class A Preferred</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">19,093</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">6.09</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Kayne Anderson Rudnick</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Investment Management LLC</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">1800 Avenue of the Stars, 2nd Floor</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Los Angeles, CA 90067</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">752,006</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">11.45</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Renaissance Technologies LLC</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Renaissance Technologies Holding</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Corporation</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">800 Third Avenue</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">New York, New York 10022</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,716</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5.82</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Dimensional Fund Advisors LP</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Building One</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">6300 Bee Cave Road</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Austin, Texas 78746</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">392,907</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5.98</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Timothy R. Damadian,</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Chairman of the Board, President, <br />Chief Executive Officer and Treasurer</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">38,000</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">&#160;</td>
<td style="width: 1%; text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class A Preferred</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">800</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Continued:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Name and Address of Beneficial Owner (1) (2)</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Shares Beneficially Owned</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Percent of Class</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Luciano B. Bonanni,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Executive Vice President,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Chief Operating Officer<span style="color: red"><b> </b></span>and acting &#160; Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">49,553</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">*</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class A Preferred</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,285</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Claudette Chan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Director and Secretary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">106</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class A Preferred</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">32</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Ronald G. Lehman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,330</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Richard E. Turk</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">John Collins &#160; Director &#160; Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">*</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;&#160;All Officers and Directors &#160; as a Group (6 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">91,929</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">(3)</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3.20</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class C Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,447</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">99.98</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Class A Preferred</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">21,210</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">6.77</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">* Less than one percent</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">1. Address provided for each beneficial owner owning more than five
percent of the voting securities of Fonar.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2. Upon completion of the probate of Dr. Damadian&#8217;s
estate, the Class C Common Stock will be held in a Trust of which Timothy Damadian will be the Trustee and exercise the sole voting
power of the shares. The beneficial ownership, however, will be shared equally among Timothy Damadian and his brother and sister.
Mr. Damadian is also the Executor of Dr. Damadian&#8217;s estate and will have the power to vote the shares. A second Trust will
be established to hold, among other assets, the shares of the other Classes of Stock. The beneficial ownership will be shared equally
by the three children of Dr. Damadian.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">3. Does not include shares held in Dr Raymond Damadian&#8217;s Estate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_017"></span>ITEM 13.&#160;CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS AND DIRECTOR INDEPENDENCE.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Pursuant to HMCA&#8217;s management agreements
with its clients, HMCA provides comprehensive non-medical management and administrative services, including billing and collection
of accounts, payroll and accounts payable processing, office facilities, supplies and utilities. Under the management agreements,
HMCA also provides service for the Fonar Upright&#174; MRI scanners through Fonar. In total, as of September 15, 2022, 22 of our
clients had management agreements with HMCA. Five sites in Florida are owned and operated directly by HMCA subsidiaries.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The fees charged under the management agreements
are flat fees charged on a monthly basis. These fees ranged from $77,000 to $447,000 per month in fiscal 2022<span style="color: red">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Raymond Damadian, the Chairman of the Board
and principal stockholder of the Company<span style="color: red"> </span>during the 2022 fiscal year owned three of the imaging
facilities in Florida managed by HMCA. The facilities owned by Dr. Damadian in Florida paid HMCA flat rate monthly fees ranging
from $245,535 to $402,409 per month during fiscal 2022. These fees are renegotiable on an annual basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the fiscal years ended June 30, 2022
and June 30, 2021, the net revenues received by HMCA from the imaging facilities then owned by Dr. Damadian were approximately
$11.6 million, and $11.0 million respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Damadian owned a .75% interest in Health
Management Company of America&#8217;s Class A membership interests, which is now owned by his Estate<span style="color: red">.
</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Timothy Damadian, the Chairman of the Board,
President, Chief Executive Officer and Treasurer of Fonar, is one of the owners of a billing company, which performs billing and
collection services for HMCA with respect to No-Fault and Workers&#8217; Compensation claims of HMCA&#8217;s clients. The monthly
fee charged to HMCA is $85,000. These services were terminated on January 1, 2021. The amount charged in fiscal years ended June 30,
2022 and June 30, 2021 were $0 and $510,000, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On June 1, 2017, the Company also entered into a
one year renewable agreement to provide IT services to the billing company for a monthly fee of $23,884. Timothy Damadian is also a
Manager of Health Management Company of America. The agreement was renewed on June 1, 2021 and June 1, 2022. The company billed them
$286,608 in both fiscal years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Ronald Lehman, a Director of Fonar, holds a
..0378% interest in Health Management Company of America&#8217;s Class A membership interests.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Claudette J.V. Chan, a Director and the Secretary
of Fonar, owns a .0378% interest in Health Management Company of America&#8217;s Class A Membership interests.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_018"></span>ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Audit Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The aggregate fees billed by Marcum LLP for
the audit of our annual consolidated financial statements for the fiscal year ended June 30, 2022 and the reviews of the financial
statements included in our Forms 10-Q for the fiscal year ended June 30, 2022 were $379,000.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The aggregate fees billed by Marcum LLP for
the audit of our annual financial statements for the fiscal year ended June 30, 2021 and the reviews of the financial statements
included in our Forms 10-Q for the fiscal year ended June 30, 2021 were $390,000.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Audit Related Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for the fiscal
years ended June 30, 2022 or June 30, 2021 for services related to the Audit or review of our financial statements that are not
included under the caption &#8220;Audit Fees&#8221;.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for the fiscal
years ended June 30, 2021 or June 30, 2020 for designing, operating, supervising or implementing any of our financial information
systems or any hardware or software systems for our financial information</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Tax Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for tax compliance,
tax advice and tax planning in the fiscal year ended June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">No fees billed by Marcum LLP for tax compliance,
tax advice and tax planning in the fiscal year ended June 30, 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">All Other Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for any other
services during the fiscal years ended June 30, 2022 and June 30, 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Since January 1, 2003, the audit committee has
adopted policies and procedures for pre-approving all non-audit work performed by the auditors. Specifically, the committee must
pre-approve the use of the auditors for all such services. The audit committee has pre-approved all non-audit work since that time
and in making its determination has considered whether the provision of such services was compatible with the independence of the
auditors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our audit committee believes that the provision
by Marcum LLP of services in addition to audit services in previous years were compatible with maintaining their independence.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">PART IV</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="a_019"></span>ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES,
AND REPORTS ON FORM 8-K.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">a)</td><td style="text-align: justify">FINANCIAL STATEMENTS AND SCHEDULES</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following consolidated financial statements
are included in Part II, Item 8.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Report of Independent Registered Public Accounting
Firm</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Consolidated Balance Sheets as at June 30, 2022
and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Consolidated Statements of Income for the Years
Ended June 30, 2022 and 2021<span style="color: red">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Consolidated Statements of Stockholders&#8217;
Equity for the Years Ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Consolidated Statements of Cash Flows for the
Years Ended June 30, 2022 and 2021 .</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Notes to Consolidated Financial Statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Information required by schedules called for
under Regulation S-X is either not applicable or is included in the consolidated financial statements or notes to the financial
statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">b)</td><td style="text-align: justify">REPORTS ON FORM 8-K</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501921000032/fonar_8k.htm">1. Registrant&#8217;s Report on Form 8-K: Item 2.02, Results of Operations and Financial Condition&#160;for&#160;the&#160;Fiscal Year ended June 30, 2021, reported September 28, 2021. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501922000030/fonar_8-k.htm">2. Registrant&#8217;s Report on Form 8-K: Item 5.07, Submission of Matters to a Vote of Security Holders, at the annual meeting of stockholders, reported on May 24, 2022. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501922000026/fonar_8-k.htm">3. Registrant&#8217;s Report on Form 8-K: Item 2.02, Results of Operations and Financial Condition&#160;for&#160;the Fiscal Quarter ended March 31, 2022, reported May 16, 2022. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501922000036/fonar_8-k.htm">4. Registrant&#8217;s Report on Form 8-K: Item 5.02, Departure of Directors or Certain Officers, reported August 11, 2022. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">c)</td><td style="text-align: justify">EXHIBITS</td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3.1 Certificate of Incorporation, as amended,
of the Registrant incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s registration statement on Form S-1,Commission
File No. 33-13365.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-95-000015.txt">3.2 Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No. 33-62099.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501901500018/ex0403.txt">3.3 Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s registration statement on Form S-3, Commission File No. 333-63782.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501903000019/x033.txt">3.4 Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.3 of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3.5 By-Laws, as amended, of the Registrant incorporated
by reference to Exhibit 3.2 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">4.1 Specimen Common Stock Certificate incorporated
by reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">4.2 Specimen Class B Common Stock Certificate
incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">10.1 License Agreement between the Registrant
and Raymond V. Damadian incorporated by reference to Exhibit 10 (e) to Form 10-K for the fiscal year ended June 30, 1983, Commission
File No. 0-10248.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000036.txt">10.2 Stock Purchase Agreement, dated July 31, 1997, by and between U.S. Health Management Corporation, Raymond V. Damadian, M.D. MR Scanning Centers Management Company and Raymond V. Damadian, incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Form 8-K, July 31, 1997, commission File No: 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000029.txt">10.3 Merger Agreement and Supplemental Agreement dated June 17, 1997 and Letter of Amendment dated June 27, 1997 by and among U.S. Health Management Corporation and Affordable Diagnostics Inc. et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, June 30, 1997, Commission File No: 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000004.txt">10.4 Stock Purchase Agreement dated March 20, 1998 by and among Health Management Corporation of America, Fonar Corporation, Giovanni Marciano, Glenn Muraca et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, March 20, 1998, Commission File No: 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000013.txt">10.5 Stock Purchase Agreement dated August 20, 1998 by and among Health Management Corporation of America, Fonar Corporation, Stuart Blumberg and Steven Jonas, incorporated by reference to Exhibit 2 to the Registrant&#8217;s 8-K, September 3, 1998, Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501902000016/x99.txt">10.6 2002 Incentive Stock Option Plan incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No.: 333-96557.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501905000018/x2-50801.txt">10.7 Asset Purchase Agreement dated July 28, 2005 among Health Plus Management Services, L.L.C., Health Management Corporation of America, Dynamic Healthcare Management, Inc. and Fonar Corporation, incorporated by reference to Exhibit 2 to the Registrant&#8217;s Form 8-K, August 2, 2005, Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501908000021/x10.txt">10.8 Partnership Interest Purchase Agreement dated September 29, 2008 by and between Diagnostic Management, LLC and Raymond V. Damadian, M.D. MR Scanning Centers Management Company, incorporated by reference to Exhibit 10.35 to Form 10-K for the fiscal year ended June 30, 2008. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501910000014/x99.txt">10.9 2010 Stock Bonus Plan, incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No. 333-168771.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501911000020/fonar10x.txt">10.10 Operating Agreement for Imperial Management Services, LLC, incorporated by reference to Exhibit 10.37 to Form 10-K for the fiscal year ended June 30, 2011. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm">10.11 Operating Agreement for Health Diagnostics Management, LLC, incorporated by reference to Exhibit 10.38 to Form 10-K for the fiscal year ended June 30, 2013. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm">10.12 Modification to Operating Agreement for Health Diagnostics Management, LLC., See Exhibits. incorporated by reference to Exhibit 10.38 to Form 10-K for the fiscal year ended June 30, 2013. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000007/fonar_exhibit-10.htm">10.13 Purchase Agreement dated March 5, 2013 among Health Diagnostics Management, LLC, Health Diagnostics, LLC and others. Incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Form 8-K filed March 11, 2013. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501904000028/x141.txt">14.1 Code of Ethics, incorporated by reference to Exhibit 14.1 of Registrant&#8217;s Form 10-K for the fiscal year ended June 30, 2004, Commission File No.: 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="fonar_exhibit-21.htm">21.1 Subsidiaries of the Registrant. See Exhibits.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="fonar_exhibit-23.htm">23.1 Independent Registered Public Accounting Firms Report. See Exhibits.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="fonar_exhibit-31.htm">31.1 Section 302 Certification. See Exhibits.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="fonar_exhibit-32.htm">32.1 Section 906 Certification. See Exhibits.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">SIGNATURES.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Pursuant to the requirements of Section 13 or
15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 50%; line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">FONAR CORPORATION</span></td>
<td style="width: 5%; line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="width: 45%; line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Dated: September 28, 2022</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">By:</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">/s/Timothy Damadian</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Timothy Damadian,</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Chairman of the Board of Directors</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Chief Executive Officer</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">President and Treasurer</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">By</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">/s/Luciano B. Bonanni</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Luciano B. Bonanni</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Executive Vice President,</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Chief Operating Officer and</span></td></tr>
<tr style="vertical-align: top">
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
<td style="line-height: 107%"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Acting Principal Financial Officer</span></td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: windowtext 1pt solid; padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Signature</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: windowtext 1pt solid; padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Title</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Date</span></td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">/s/ Timothy R. Damadian </span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: top; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Chairman of the Board of Directors </span></td>
    <td style="padding: 0pt; vertical-align: top; width: 2%; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">September 28, 2022</span></td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Timothy R. Damadian</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: top; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Chief Executive Officer</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">President and Treasurer </span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">/s/Claudette J.V. Chan</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Director</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">September 28, 2022 </span></td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Claudette J.V. Chan</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">/s/Ronald G. Lehman</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Director</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">September 28, 2022 </span></td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Ronald G. Lehman</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">/s/Richard E. Turk</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Director</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">September 28, 2022 </span></td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Richard E. Turk</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">/s/John Collins</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Director</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">September 28, 2022 </span></td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
<tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">John Collins</span></td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: top; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; line-height: 107%; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; line-height: 107%; text-indent: 0pt">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Page <span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">104</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJztG+1y2zbyCfoOGE87uZtxXMlJrm3+6cNO1LMjneQ017m5HxAJSmgoggeQstU3ure83QVAUhJJUU5+3aSTqSxxd7HYXewneHFxefFO3cpYaPbP4fyOPYhNGvNMsLmIhBZJIABiNPn7Wwafc7GSJtM8yeirRxwpwBGA8+aq/2oJDwh0K40I37LeLz9e//zj9TXr997237DZ/cV3+HykkkiGIskkjxlPQjbTKtVSZFzvLIUH/qQStdnRUr8JbaRK3rL+Vc8+/i+77vWv2Qe15Y9Kfzbs7m508d0l/ffdxTut8hSXyU2mNuwmFhtYy1jU8h+xEhDM21HMjRl8UMlvKpPJaqZRAFqEi0wFn+/FZik0APd617DuoNdIZhAEKoel5iIQcsuXsVgIvZWBGCThXKRc6lshkJF+vw+Ueq9PUSoJzQVqJpxxncluJO5FKAMelyQ6IfGEr0hewPI0W4vOHBPmIeIR/46pmeZBBnIxH0Q2iGP1yMHYzhFMhTKQuFPJ6kHoTRcC1iqEHotUGUlm0b8+gTPjIPQkgx2BaYskxzWnEZhxhvvIeVzuAXY/lsbySKSvT5DWKsyDbMFjEkYXlDqb+gLUfcvqSKjeTr4IudlCutAcKZN5Eg+qKlUyirOwGw/tF1OpOcVn0Ww5nl+BToMGupD/JORqDbiDrdBAeciNDOgoxDn8ulhzLcw0z0wG7h4cLJIkZ9p700jygMYkCeDYzoQmYgWB4ehsp1748/4pf04URhDiNirZDwUnUQl8YkyO4r6BGKl2IOGPSQgbwEdDleRmFvPE/MbjHPfTO+kq+I4C2TT5oLKqb73VauOXIOJrFcM6qLjeKcUN853KwZmBmAL0ZyqOQVaTJIMEwHR2YRDvIULfKj3k4Vgss44muUlFYnim9M4F6WlUyK2MCCfIvOMymeLaKwm+WRgzjWZpeqd40oV5MCstuBFjYT8niQ8Qg3DLbQp0koVjIrcyAWSQ5J3kSxlLf9yfwY6LMgeETrE0y3WwBgLTaLLhK2BkJFCnnfRZoH6BUQyC/+QSDtvAGJEZOPXwR74RYWUbMxXLYPcgnrJhDEovTtWo2Scs1jJNgRUMs++BKLKFnu0ZpA7U/BxuRjyVGY/JZNGPphkcAoPhP1Ym1wKJLbsSe1BA6pYHTjjTx0SEU20ddfiAx/ws3u7gIAgxTcEdo/O7Q2Pyst/d8yzX8LlPNuikgTxN7Vnl8Yib9S0kPpMkUnrDcfdFhKEFzfl83zylSmcudrps69lkqmnA+TSOg2TpcsuEDxzPWOXLLMpjn5tedEgpK5nA7iuSfYbau4ji/fi+e+gbS75K4FDK4AZ8QIoCrEO+n09YCcoKWHhU9zP7lyXy71phGsHBaY3BXlTqNDYWELWxYkW7bOXEo7MSnwEBtkdhj8EzMdp4f78JOB52bcC3LeSf5LFBf1AblwbozoOB9CewHPR7aAnDYbNzOnbc3VVYMORRB1GG5g9BlifyT9oeWOh7weNsXbI5UhqOHT2dRgNwrpBHQhQRj/EODiT4axG+DzdnbOKIj2k01RLCGY8nyRa+Kw3hHmh2ITaGeBRkXyW6lYsfMtiFEShpjirKo1UBiDkoBmCshDsSknVN9HihYHuiTtEE5akwC9fwc5u5YjIM+pOoAIhx6KtcjBpBWl63cInBChTmcBgisQLrNGgLZ5+U/gy6KLJKMEKwNKPIVv7I9a6OOYfEqljMozGL1xGsjTdbUqF88FPWliAehnmgut/aFlkEPEFr/CSrZ3Kw0sI2wPB33ABPdpRdDHfVIHSB/S2KLn9D68txFaYitikoMV6QYo9Ai81GLwxTSIotd4wzDeQ00GMpErw6GVXrOKM0qKYCrfBGIMyltczmtY6jFmYd/Qau6mVX4etOBZyqUPBmv4M1LDL4+sUyyx4VyxNt1cA0D6WKFfZZTQOflZ4TVuzgg31omAusLaG6lYnc5OgQe2UrzP3IghKdRYDPIHFjxlEA/VkSLFMM3ALx2sBHGaGdHlzmWnvIKuHca82Dl2e/DajVH50UCH+qEYj98esJxFcmlcIEQh74CjKSslobbDCXYxCC9MoSNg6TOuFrh8uERSZ+cGnMCFR4yR7XEtIOdAkOwjCZBDn2NayBIbBa/gGRDsphNMZQxPAX+Cf4+xb8lQYDTG1ibHB9CR+BK4aadmdNG6pzauR8TBWWpVvbl59G1TYJFLBxHuJBcX2bmxSV4nooiF5pTpQtIAfMbmYLkHoUC2IO960yNygIEQT9bqTVhp6JJwwWICSQUVDwg/vksYcHGRgRYNorSVSw4YB4YQbLNraEVCBk8BUJctu9gvML7j4DKYEVIDmPQbtnquxjsRAow0epoSuQsWYciiTwYJBmsx0kioahIYXs1zwR7FXv0vLmthsR9+UCTj6oVpSkYf3rny7f9F775XOQ/sF2SQFsxKyUm3QostKzUeLhqw6DDaRqLDj0vw2JI6YoJUmXpRREGVJljiwjui6Mxayg3Ha0WyviQTYU4CQSkP40+h1kXNrTzxgjQCHOc7/Ac1xyVViP97p47BKVvPTf4WxEUEVJCu1BmdEa9pfZ4oX5KzP5EvWPRhnvUBMGHDaqgRxI1TpydB/10eCKLUB6oHs4stJaX0b2gkcbvyVFNIkKERTeIJIGxYi29RJMqzXUhqUIByFYIXVmjMQtfZNZR5kNd5Tfw+6w4IuVrwO/Se+E9EaxAv86Ji/57ZSe3/gbZDdJ+M3BNYjOdRJg8Wk0C3BU6ArZMcTiLdghiOKDingeY0NovxqcacgsAtw3RE+5KfMRKtxLysjgbGRYArvRrkwOLXkr6sQuQGJOfUkobUmYFouwgFbpsBHIrIyKZYi6KneEW9kL360MBxUae5wTxxV9oUYbSw0oQyYut5wmH3H+Rlc9Qp9zHwzsCaHMRmHPeYlTZNq0XEfQGq5uoELY4LZuuMbgf8BD8Zj55618lOCiJFcrCLCfo6UbhdI7FArahjhaq5E1PDDiCdIjg8pcSmpQGbYRPLFZMckNjxtOV+D/CEa/g7ultBTWucTfwQDBJuEUg4dQOrSyNiKOBZYBSx5Ti8WsBZCBRXmAUPQbFRPvBoPZJeCmkHhiGu5SXU5FzKU/13wFp35FS+LW7CLlZpZ5Bockg8OMa2wV5H1U+BRFB3Eaggj0RiJ2AyMNdjp04nlQY1uSV5rkrtpCEkDUS81m6sA6z6DgAgaFSEjK+3zhethPf8v8Evg0tIt0NpJJckOanEaeShezaai6URGBRPJ2rvYJ6hqhouii05iWdEjjZn9FpcuidXjleBMHDF2oWAxB8FZWS0Mbt27sFRBoHj8U+6Zyk2iE1Xb8ydH54epdcIohih9zUZm0P1ox3Rc/JLQvwk6E5njHQkW5EcXmrRlMlxnHk0O2tubJSkARSnSnOPlZ2fD+DNaftWKxYEXF/VMqtifVuJGq/FOERzbtQFiwB3NIaKGi7BFyjKme8Yyai3BG4I9pzSnxsNhASC00e7TgzJ6qQ+ofEHv/Akf364G2e2IvUmJb6aJoHzbLBZSGbsQuYlAL1Kqt+DgH4TpphlkYyqQED9aYeNg4snEAwgLYqOFaEleNhGp4ej++t8/q+gLw0LNQPH7Pxqz4ta2DjQLCgVFmb/vsb5SesmnEsO9gAZ6xS0tFVanUeRy86yqX1HA6GLzuPcKIcN76h5QPV76hzLpF3xbgy9VdS6cuvrbfEPLXl06OpqlJNawzGapliO2hYwfC8lZw9qZ39eYH6pbTjA3bd7Qo7gTsjDJJh9fWIqZ7YO0LD/YXfv1Lx4UHbQsXw8EyOffXYoqj3zb8hEJLhqKYNTZ04RwYK+DaWCqnnwus4fL0Xks3QSm90c+NLJXoNDc8DxkLG2DUFpsP6nB7Fx2yCKqVPRMzbM9SFDtledWFIU6RJW9SkVETDJI2BIASDtv3Rf3ahTDew5vxHZa1/Trt4L3kl5jWQna7hHw5wXt7EGl2thCGosDFMhb7kIwkmaPJ+m2qrCx+3X2yX8F6dQaW6/9PEij943jjx/fX7Rr3F07GflaG8C1JwFCpz+RPIFnOZexuip60ipsosuMO684f+NMcFpxDxZNgY4HU
     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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
M17AOP@X'R?)*&#Q6"I5ZL8KFG*";E+>3N];7>BZ*R/K[_A^1_P % O\ H=M!
M_P#"?3_XJD/_  7%_P""@)Z^-M!Y_P"I?3_XJOD,1R;=YC;;_>VG%(.@SUKE
M>=YPMZ\OO/;7AGX>O_F5T/\ P6C]B/\ @D/_ ,%1?'_[5'C36O@U^T'JVGR>
M(1!]LT"XM;5;=;B)1B2+:"<LO#?0GTK]!HW5^%8''H:_F7^#/Q9\7_ KXJ:#
M\7/ MZ8=4T#4H[NV.?E?:?F1AW5ERI'<,:_HP_9S^-_A#]HGX.Z#\9/!-T'L
M-<TZ.<1A@Q@DQB2%B/XD8%3]*_1^$<ZGF&&E0K2O4AK=[M/_ "?Z'\A^/7AW
MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
M&OD,L!U./K2%_P"Z12_MW-O^@B7WL7_$,_#W_H5T/_!:/KW_ (?A?\% _P#H
M?-$_\$$?^-'_  _"_P""@?\ T/>B?^""/_&OD/<O]X?G2Y!Z4+/,W_Z")?>/
M_B&?A]_T*Z'_ (+1]?VW_!<K_@H!;R"1O&'A^3!^[)X?7!_)A7M7[/W_  <+
M>-;"_MM(_:1^%=G?6;$+/JWAUFBE3G[QB<E2!Z!A7YK45TT.(\ZH5%)5F_)Z
MK\3S<S\(/#C-,/*C4RZG"_6"Y)+T<?UNO(_I8^ _Q_\ A/\ M(_#^S^)WP>\
M86NL:3=$KYD+C?!(,;HI4/S1N,C*L >0>A%=OO3^\/SK\ ?^"8'[97B?]D;]
MH_2G;5Y1X5\17D5CXDTYI"(F5VV)/CH&0MG/ID5^^<-U+<0I/!#N1U#(PZ$$
M9!K]3X?SF&=X3GM:<=)+]5Y,_A[Q5\/J_ASGZPRDZE"JG*G*VMNL96^U'J^N
MCLKG\X7[91*_M<_$['?X@ZQ_Z6RUYNQ(1"/6O2/VQ\?\-=?$\$9_XN#J_P#Z
M6RUYP,;!GUK\8QG^^5/\4O\ TIG^B?#J:X?PE_\ GU3_ /2(GLW_  3P\(^&
M?'O[;'PX\'^,]#MM3TO4/$:Q7MA>1AXIT*.=K ]1D"OW"A_X)_\ [&+97_AF
MCPAP.^DK7X6?L/?%7P9\#OVM/ GQ:^(5[+;:)H6NK=:C-!;M*Z1A&&0B\MR1
MP*_72+_@NC_P3SBR6^(.N'./^97NO_B:^ZX/Q.54<%-8J4%+FTYK7M9=_F?S
M)X^Y-QSF/%&&J9)1KSIJBD_9*;7-SSWY>MFOD>Q_\._/V,>G_#-'@_\ \%"4
MA_X)^?L9 \?LS^#_ /P4I7D(_P""ZO\ P3P(Y^(.NC_N5[K_ .)I?^'ZG_!/
M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
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M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
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H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>fonar_chart.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_chart.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0@Z17AI9@  34T *@    @  @$2  ,
M   !  $  .H<  <   @,    )@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #;1110 48HHH ,
M4444 %&*** "BBB@ HVT44 %%%% !1110 4444 &**** "BBB@ HHHH ,444
M4 %%%% !1110 4444 %%%% !BBBB@ HQ110 4444 &VBBB@ HHHH **** "B
MBB@ Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M &ES65V ZBH]S%Q4@.13N@"BBBF 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 44TL0:<#F@ HI-W-*3@4 %%%% !11G%% !11G-%
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M1J][]B\U=WE^;_;$>_'][8N?0=*_2#_@NE_RB,_:!_[$Z]Q_WP*_,G_@G/\
M\%S?VB/@#^PQ\*_!OAG]@'XU?$;0?#?AVVL+#Q-IDNI_9-;B1 %N(O+T>5-K
M#D;9''N:YZ.LIWZ6_(JI>T>7N[FY\0?'O[5O_!O;^U9\'_\ A8W[0&N?M'_
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M)''V/_P0[\7:?X(_X(H_!;6M6NK?3]+T?P;]MO+F=PD5M#&97>1R>BJH))[
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M'.,G/[ [<#WSQ1!<M-2>[U]/(TE)J;CT1^;_ /P1;_X*6_%?XF_'3XD?LO\
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ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !110!@4 %%%% !1110 4444 %%%% %<R,R
M\=>W'6@2<K_=[>_^17Y[_P#!9/\ :I^*6F?M"_L^_LW_  C\7+\-=>^/VJ7\
M6I>,A:QW5QHMA9Q)+(ENCD#SI!(<-D,/+ 5E+;E^4OV8OV//VE_V9/$OQ8\=
M?LX_%;XF?%;6O!?QFNM"\2^!?&NN6MQ:^.;!8+$S7;3W7DI#?XD.Z;<K.B1@
M'**LDT[2"?NG[;F7 R*=YAQ^%?G_ /\ !7?QM^T_\3OB%\*_@;^SK:ZYX';X
MD"YN?%GQ(;2)[BS\'V<2AA"+J-6BCGD"R #(<L(@K*7\Q?C/]J#X2?MB?\$!
M="\/_&Y_VH_%W[1WPUL]<M+'QGX>\513^8MI,^P-$;JZNM@+,J!XI8V21X\K
M(F_:*5W9]=B=>6Z/W,=\=L>]-+'=7YZ_\%J?VX?BCX%LO@S\%OV?=0M=)^+7
M[16JM8Z;K=Q&I70--A2.2ZN]K(X4A)5)?:61%E*J9-F/DKX\?"S]L3_@@?\
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MW]B#_@KS^QY\5O%EGK&H>'?!=EJ]Y>V^D1137LJ-B(")99(T8AG'WG48SSG
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M^)/CQ^R;K6KRZUI.IZ#NDU'PF)"/,\T*KF/"!%=9=D,C*KI*C/(C?N1C.?\
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MASX"^&OC/X&^)['Q++=>&/#MIIDEQ:^<B9<6\2^9Y4_V>4;\A4CD(ZD'F_\
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MHIH=0*-_NM #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **3<*1FH =034;R?(3Z50UO7;7P[I-Q>7DT=O:V<3332
MN?EC506+'V YK*I6C"//+8#29L"EZ5Q_PQ^+FA_%S1'U+0;P7UI',UNS;&C9
M74 D%6 ;HRGGG# ]#78 Y%*C6C4CS0=T 4445L 4444 %%%% !1110!\M?\
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M1OX _P#AX]7_ /F7H_X6'^U-_P!$;^ /_AY-7_\ F7KZ"HH ^??^%A_M3?\
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M_AY-7_\ F7H_X6'^U-_T1OX _P#AY-7_ /F7KZ"HH ^??^%A_M3?]$;^ /\
MX>35_P#YEZ/^%A_M3?\ 1&_@#_X>35__ )EZ^@J* /GW_A8?[4W_ $1OX _^
M'DU?_P"9>C_A8?[4W_1&_@#_ .'DU?\ ^9>OH*B@#Y]_X6-^U-_T1OX _P#A
MX]7_ /F7H_X6'^U-_P!$;^ /_AY-7_\ F7KZ"HH ^??^%A_M3?\ 1&_@#_X>
M35__ )EZ/^%A_M3?]$;^ /\ X>35_P#YEZ^@J* /GW_A8?[4W_1&_@#_ .'D
MU?\ ^9>C_A8?[4W_ $1OX _^'DU?_P"9>OH*B@#Y]_X6'^U-_P!$;^ /_AY-
M7_\ F7KP_P#:L\=?M(3_ !X_9G;4/A3\$K2[A^)5X^F1V_Q6U2>.[N/^$/\
M$JM',[>'$,,8@,[B15E)>../8%D:6/[RKY^_;(_Y.*_9/_[*K??^H1XKH 3_
M (6-^U-_T1OX _\ AX]7_P#F7H'Q%_:F _Y(W\ ?_#QZO_\ ,O7T%10!\^GX
MB?M3-_S1OX _^'CU?_YEZ/\ A8W[4W_1&_@#_P"'CU?_ .9>OH*B@#Y]_P"%
MC?M3?]$;^ /_ (>/5_\ YEZ!\1?VI@/^2-_ '_P\>K__ #+U]!44 ?/I^(G[
M4S?\T;^ /_AX]7_^9>@?$3]J9?\ FC?P!_\ #QZO_P#,O7T%10!\^_\ "P_V
MIO\ HC?P!_\ #R:O_P#,O1_PL/\ :F_Z(W\ ?_#R:O\ _,O7T%10!\^_\+&_
M:F_Z(W\ ?_#QZO\ _,O1_P +&_:F_P"B-_ '_P /'J__ ,R]?05% 'S[_P +
M#_:F_P"B-_ '_P /)J__ ,R]'_"P_P!J;_HC?P!_\/)J_P#\R]?05% 'S[_P
ML3]J;_HC?P!_\/'J_P#\R] ^(G[4P_YHW\ ?_#QZO_\ ,Q7T%10!\^CXB?M3
M*?\ DC?P!_\ #QZO_P#,O1_PL;]J;_HC?P!_\/'J_P#\R]?05% 'S[_PL/\
M:F_Z(W\ ?_#R:O\ _,O1_P +&_:F_P"B-_ '_P /'J__ ,R]?05% 'SZ?B)^
MU,?^:-_ '_P\>K__ #+T?\+&_:F_Z(W\ ?\ P\>K_P#S+U]!44 ?/O\ PL/]
MJ;_HC?P!_P##R:O_ /,O1_PL/]J;_HC?P!_\/)J__P R]?05% 'S[_PL/]J;
M_HC?P!_\/)J__P R]'_"P_VIO^B-_ '_ ,/)J_\ \R]?0.X4;A0!\_?\+#_:
MF_Z(W\ ?_#R:O_\ ,O1_PL/]J;_HC?P!_P##R:O_ /,O7T 7XIKO\M '@/\
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MO7T%10!\^_\ "P_VIO\ HC?P!_\ #R:O_P#,O1_PL/\ :F_Z(W\ ?_#R:O\
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M].\-+X.O?AO\%]/N-603W+6'Q4U.Z=(-V0IW:!%MWLN<J6^5"" &!/TKX6^
MOBKPQ^T=K'C*^\3_ &C0;M9MMMN<S.CX*Q%,;46,G@AF/[M> 6:OC3XM?$>X
M^*OQ(U37[E9(VO)B(E?Y?*1?ECC/;<$XR.#R>I.?E>),TKTJ#A&%[^OZ6,:\
MFHZ&;^QO^TE\>OAG\1ETNU^'OPENH?$CBV2&Y^)&HVL F5CL?*Z'(5)WNN @
MW9!/"@U]A?#']H_XS7'[9/A+X>_$3P/\,/"VA^)?!.O^);>?PWXOOO$5U/<:
M=?:';JK-/IU@D$>S5)"0%F,AV_-$(R)?BUKEU=)(Q(DRD,'0X92K!@1@9!#
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MH **** "BBB@ HHHH *^?_\ @I7_ ,F[>'?^RJ_#C_U-]"KZ KY__P""E?\
MR;MX=_[*K\./_4WT*@#Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^?_B-_P I3O@W
M_P!DJ\>?^G?P97T!7S_\1O\ E*=\&_\ LE7CS_T[^#* /H"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "OG[]LC_DXK]D__LJM]_ZA'BNOH&OG[]LC_DXK]D__ +*K??\ J$>*
MZ /H&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***"<"@ HII?B
M@N O^- "[14<GS<TUY=B_KGTK,\1>)['POILUYJ%U!9VENC22S32"..- ,LQ
M)X  !))Z5,I)*[*C%R=HZFE+)MW8W<\ #UJG=:W;V)'G7$2?,$!9PN26V@?]
M]$*/<U\??'#_ (*OZ;-XD;PG\']#OOB9XLF)C5K)&-C$W(+;U!,BJ0I)4K'M
M.?- Z\UX$_X)]_$S]JCQ%9^)/C]XNO&L87$]MX6TJ;RK6'N ^TA5X^4A"SD'
MF6N?V_,[1/0CEKA#VE9\OEU/NJ:4SV_[MN2IP0<\_A_C_C7Q3H?_  2]\4?&
MKQ]_PD7QV\<7'C*:WF8VNCZ7)):Z;$FXX'\+!"N!M15(.<R2=:^VK.T\F%5R
MWR@#GK4S1G'3CICUJO9W^(YJ.*E1;]F<O\//A;H/PK\.V^C^'=)L=)T^U&(K
M>U@$4:\DDX QN.22QY8\\UTT5OA<GK3@=N!_#_*A_P!UWK:$4OA,)5)3=V]1
MP7<:)'"+DY]/K4,EVJI][;P>?3G&?PKXF_:A_P""Q?A[X=^(+KPQ\/='N/&G
MB2.9[3SV1UL(9P2FU0F9;@A\#"A58'*R$'C2G1E-Z!&-SZF^/?@>P^)?P:\3
M:#JE_P#V5I^K:=-;W5\"H^R1-&P:0E_E&U<G)X':OQW_ &JOBW\-?V-OV8OC
MYX5^'>O:I\1(_'GPYUO0M3N6@6WM+(M8W4<4T,J_ZT*SN"JH48,N)%P=WZ:_
MLN)X^_:9_9>UBQ^-F@II-UXB:YL_LB1-:W#V,B#!D3.8WW&0#(!PJG;_ !-\
MW_MA?\$S/ W[/'_!/K]IKQ#'86^H75E\,O$XT@W+FYDM$&D71\]Y''S7#<<J
M$1%"A5W;WD[:-2-.,H3-HR458V?BQ^RWX1_;[\,P_'3QEXP;P%X?O+)8K.(F
M.-+.R25E1IYI#M\YW>1L8*KO11OP6D^SOA+X_P##/BCPG8KX:U[1]>L;6*.V
M$]A=Q31_*NT?<)P?EZ'IC'7BN!^('[&^C^.].U+PS)'&OP_\2 S:CI"2O;MI
MUXK"5+NQ9#^Y8RJ&DCQL9OWF0WF++\S>*_\ @APWA_7%U+X>_$K5M#N(<",7
MT'^D+R#\MQ;M&5Z=E)&2,@8 B4H5(M2=K; W&6A^@RSF0_+T'N*<DK,5X/U_
MS_G^5>"?'[Q%\3O@#^RGIK>"=/\ ^%C>--)MK2PNIKF!YGN@(E26Z,*.))'9
MESL5B07W$$!C7S1X-_X+=ZSX+U-=/^)WPUO=+NT^:=[*1K:6(].+:X /YR8]
MQD <\</*2O$S]FNA^BS<BF^4/+'MZ5R.K_&KPQX7\#V/B36O$&E:%H>H)$]O
M>ZG<I90R>8A9%#2%1EE!(4\\?0UN:%XKTWQ1IL-YIU]:ZA:S?ZN>VF6:.0=<
MAE)!'XFH4)=3/D>Y>:%-W:FWD/FPM_M# ]^]/67/WE./ITI[GD=/QJ-U9E<S
MNFSX1\3_ +,'[27[-?B"[U;X;?$B\^(&DM*TYT;Q+/YD[#L@>0E6SD$E'@!Q
MT& *O>!O^"NZ^ M4CT'XU>"_$'P]UIOE^U_9GDL9L#YG (\P+G@;!*I[.U?;
MLD>1QC'TKFO'_P +-!^).@R:;KVE:?JUC(,20WD"RQGWPV<?45R^QDI7BSU:
M>.I3CR5H+U6C*OPN^-WA?XR:&NI>&=>TK7K.0?ZVQN4F53@':=I)4CJ0W(S^
M%=<LF-N3]XG'^?QKYN^%_P#P3'^'WP9^.MAXZ\*MK_A^ZLQ(DFG6U[FRN@ZN
MI$BL"[ %MP4/M!0'&17MOQ.\<1_"OX?ZMXAN+/4M2M]&M)+Q[6QA\ZZN%C0L
M5120"QZ@$CGN*TA)Q^,XJU.GSVHG51-N:G#=7S3\!/\ @J/\)?CS-':PZ\OA
M_5)" MCK(6SD8DX"JQ)C=CV578^U?1%OJ27,0:-ED1N58'.>_P"/X54JT7LS
M.KAZE/XD7BWO37E _K7-^.OB3H_PVT3^TM<U"WTVR5MHEF/WFVLV,#DG:K-@
M=E-9GQ'^*4?A+X37_BK38?[8M[>S^VP)"X/GQX!# YQLVG<6SC:">G(PEBHQ
MOKL8G:M<?*?TSWJ&.<,/KQV'^<=*\R_9J^-M]\>?AO-K%UIJZ3<6]W)9_*6D
MBEVJA\Q20#M^8@]#E3T[8?[,?P6\<?#3Q)XBNO%/B1M8AU @0QM/+-O()/FD
M, $)_NKP<D8&VL8XF4VN1:,GF.RC_:&\+W'Q3;P:FH[]<7<IC6%C'O"ERF_[
MI8*K$XX!!'W@5KBOC]\9_''@/XG>&]+\.^'6U;2]0V?:91 \AF8RLKQ*X.V-
ME4!@SG;ENIP:[:V_9X\+VGQ2D\9)IRC7I.LQ9BK,4*%RN=NXJ<9Q^O-=L;19
M5"M]WIT_K1[.M-/F^0<QY;^TW\"KSX_^";73K;5&TN2VNQ<DE69)<*P.X CU
M!7L.IR>G6^'_ (;VMI\-;'PUJFW6K6WM$M+@W*AA=A5Q\XY!SU]B!76K#C[W
MKD<=*7R]IXJXX.-VY=2C"\'^!]-\!:)'I^D6-OI]G&1B.-<;L@#)/5CT&3S@
M 5M)"%?/U_4U+L%&P5U4Z,8*R0"+$J]J=116NH#57%.HHHY4 4444P"BBB@
MKY_^(G_*4SX-_P#9*O'G_IW\&5] 5\__ !%_Y2F?!K_LE7CS_P!._@R@#Z H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG_P#X*5_\F[>'?^RJ
M_#C_ -3?0J^@*^?_ /@I7_R;MX=_[*K\./\ U-]"H ^@**** "BBB@ HHHH
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M\3:3KGBIFM+!)"EW8QJ")$5Y00S2?*%$C1+GC[N<'#V=:<5.&PM?B1ZQ\?\
MX5_!W]HWX_2>!]<\$R+KDQ\MM>M$%K.)/*\P NH#.N.!O!7_ &=IW'#TO]BG
MXI?LHNMK\-_%_B;Q-HK,9;6SN+Z.$V(0#;&8Y)%ADSR=P50Q&&&!\WUAJMWX
M0T/X@6;WDWANQ\47L6R!IVACOYH\D;5R1(1QVR#MQQ72Q%6 VMROOVZ;21[_
M $_$"O-EEM2HG[1^C.J.,K<G++5'R5\*O'OBC]MN:^\"?%GX8^)O >KZ&JZC
M%K%DK?V?,Z,JE8Y6!57._*J&D^X6W JN?I_P1X*L?A_X2T_1=.61;/385MHA
M(V^1@.I+'J<Y)[9)K6$"J!M90QSZ#<?P'/X8_&O._P!J#X.ZY\<_A5>:'X=\
M9:UX'U2:2*2'5=,9A*H5B<$(Z-L(X^5UR<9XR#U1PL*:NMS.7+4FK:(]%L8U
MC$?EJJ@#L>O/8=/\.E6(T\HJ%7H-OTQ7P0OQ8_:H_9 D;_A*/#UK\7_#,)/^
MFZ6Q_M"-1PH(6-6)"C))B8#H9,UZO\!?^"KOPK^,=S'8W6K2>%=89O+-EK2B
MV)8$+M63_5'YN "X8G^'M6T:D%:+T.JIE=11YX:KR/J8'%.XVU1T_4XM4B$E
MO()(SSP>H_\ U'/'7UJX7!45T)IJZ/-DFG9[DF<T5&#FEW+5 /HI-PI: "BB
MB@ HHHH **** "BBB@ KY_\ B+_RE,^#7_9*O'G_ *=_!E?0%?/_ ,1?^4IG
MP:_[)5X\_P#3OX,H ^@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KY_P#^"E?_ ";MX=_[*K\./_4WT*OH"OG_ /X*5_\ )NWAW_LJOPX_]3?0
MJ /H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KY_P#B-_RE.^#?_9*O'G_IW\&5] 5\
M_P#Q&_Y2G?!O_LE7CS_T[^#* /H"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG[]LC_DXK]D
M_P#[*K??^H1XKKZ!KY^_;(_Y.*_9/_[*K??^H1XKH ^@:*** "BBB@ HHHH
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M2?IU7FN7VE2&LD=<L#0JKFH2U[/0^^%D!/RE3SU]?I4R9KS;]F[XV_\ "_\
MX5:;XH&BZQH(U ,/L>IP>1,A1F5B!W0E>".HP< 'GT%;E5(^8?-TR?\ /I6T
M975T>5*G*,N5EJBH3<8I?,SZU6Q)+13=RM0K# H =12*V:6@ HHHH *^?_B+
M_P I3/@U_P!DJ\>?^G?P97T!7S_\1?\ E*9\&O\ LE7CS_T[^#* /H"BBB@
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M_P#V56^_]0CQ77T#7S]^V1_R<5^R?_V56^_]0CQ70!] T444 %%%% !1110
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M[B@!:*3/N*,^XH 6BDS[BC/N* %HI,^XHS[B@!:*3/N*,^XH 6BDS[BC/N*
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M!G:PR,@Y!(/)_P##-WA__H)>//\ PN-;_P#DNN^HI%' _P##-WA__H)>//\
MPN-;_P#DNC_AF[P__P!!+QY_X7&M_P#R77?44 <#_P ,W>'_ /H)>//_  N-
M;_\ DNC_ (9N\/\ _02\>?\ A<:W_P#)==]10!P/_#-WA_\ Z"7CS_PN-;_^
M2Z/^&;O#_P#T$O'G_A<:W_\ )==]10!P/_#-WA__ *"7CS_PN-;_ /DNC_AF
M[P__ -!+QY_X7&M__)==]10!P/\ PS=X?_Z"7CS_ ,+C6_\ Y+H_X9N\/_\
M02\>?^%QK?\ \EUWU% ' _\ #-WA_P#Z"7CS_P +C6__ )+H_P"&;O#_ /T$
MO'G_ (7&M_\ R77?44 <#_PS=X?_ .@EX\_\+C6__DNC_AF[P_\ ]!+QY_X7
M&M__ "77?44 <#_PS=X?_P"@EX\_\+C6_P#Y+H_X9N\/_P#02\>?^%QK?_R7
M7?44 <#_ ,,W>'_^@EX\_P#"XUO_ .2Z/^&;O#__ $$O'G_A<:W_ /)==]10
M!P/_  S=X?\ ^@EX\_\ "XUO_P"2Z/\ AF[P_P#]!+QY_P"%QK?_ ,EUWU%
M' _\,W>'_P#H)>//_"XUO_Y+H_X9N\/_ /02\>?^%QK?_P EUWU% ' _\,W>
M'_\ H)>//_"XUO\ ^2Z/^&;O#_\ T$O'G_A<:W_\EUWU% ' _P##-WA__H)>
M//\ PN-;_P#DNC_AF[P__P!!+QY_X7&M_P#R77?44 <#_P ,W>'_ /H)>//_
M  N-;_\ DNC_ (9N\/\ _02\>?\ A<:W_P#)==]10!P/_#-WA_\ Z"7CS_PN
M-;_^2Z/^&;O#_P#T$O'G_A<:W_\ )==]10!P/_#-WA__ *"7CS_PN-;_ /DN
MO!?B#\ -#@_X*;_".S6^\;&*X^&'CB9B?&.KM*&35?"  60W6]5/F-E5(5B%
M+ E%(^N*^?\ XC?\I3O@W_V2KQY_Z=_!E 'H7_#-WA__ *"7CS_PN-;_ /DN
MC_AF[P__ -!+QY_X7&M__)==]10!P/\ PS=X?_Z"7CS_ ,+C6_\ Y+H_X9N\
M/_\ 02\>?^%QK?\ \EUWU% ' _\ #-WA_P#Z"7CS_P +C6__ )+H_P"&;O#_
M /T$O'G_ (7&M_\ R77?44 <#_PS=X?_ .@EX\_\+C6__DNC_AF[P_\ ]!+Q
MY_X7&M__ "77?44 <#_PS=X?_P"@EX\_\+C6_P#Y+H_X9N\/_P#02\>?^%QK
M?_R77?44 <#_ ,,W>'_^@EX\_P#"XUO_ .2Z/^&;O#__ $$O'G_A<:W_ /)=
M=]10!P/_  S=X?\ ^@EX\_\ "XUO_P"2Z/\ AF[P_P#]!+QY_P"%QK?_ ,EU
MWU% ' _\,W>'_P#H)>//_"XUO_Y+H_X9N\/_ /02\>?^%QK?_P EUWU% ' _
M\,W>'_\ H)>//_"XUO\ ^2Z/^&;O#_\ T$O'G_A<:W_\EUWU% ' _P##-WA_
M_H)>//\ PN-;_P#DNC_AF[P__P!!+QY_X7&M_P#R77?44 <#_P ,W>'_ /H)
M>//_  N-;_\ DNC_ (9N\/\ _02\>?\ A<:W_P#)==]10!P/_#-WA_\ Z"7C
MS_PN-;_^2Z/^&;O#_P#T$O'G_A<:W_\ )==]10!P/_#-WA__ *"7CS_PN-;_
M /DNC_AF[P__ -!+QY_X7&M__)==]10!P/\ PS=X?_Z"7CS_ ,+C6_\ Y+H_
MX9N\/_\ 02\>?^%QK?\ \EUWU% ' _\ #-WA_P#Z"7CS_P +C6__ )+H_P"&
M;O#_ /T$O'G_ (7&M_\ R77?4$X% ' _\,W>'_\ H)>//_"XUO\ ^2Z\%_:[
M^ 6AV'[07[+,4=_XU*WOQ/O89#)XQU>1E4>"_%#Y1FN28VR@&Y"&*EESM9@?
MK4R8KP#]LAL_M$_LG_\ 95;[_P!0CQ70!Z(/V;_#Q_YB7CW_ ,+C6_\ Y+H_
MX9N\/_\ 02\>?^%QK?\ \EUW0;;0SKCGC\* .#/[-_A\#_D(>/O_  N-:_\
MDNH9/V>/#X7Y=2\>;NV?'.M#)]#_ *57>37"JI_O#MZU\4?&G_@I_JGC/QSJ
M'@7X(^#[[QSXFMY&AN+Z6%H].M&# ;B21E<[ER[1IG:0SKFLYSY5<Z<+A9UI
M<L3W7XC>"? /PK\,3:QKWB;Q5I.EV_+7%UX\UB*/&.!DW0RQ/  R3T]J\3^
M7[2/@/\ :8^.LGA7P?IOQ<U30[6)I+GQ'_PEVN1V<+!=R#:;G(#@84MM8G^
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M,W>'_P#H)>//_"XUO_Y+H_X9N\/_ /02\>?^%QK?_P EUWU% ' _\,W>'_\
MH)>//_"XUO\ ^2Z/^&;O#_\ T$O'G_A<:W_\EUWU% ' _P##-WA__H)>//\
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M>6&\MM\FGV;;F4LODX4J&<--./*K&F*Q=;$2YJKN?45%%%:'*%%%% !1110
M4444 1D8-&Q5;M\W4U)10 U5P?:EV"EHH 3:* F*6B@!-@I"G/\ 2G44  &!
M7S__ ,%*_P#DW;P[_P!E5^''_J;Z%7T!7S__ ,%*_P#DW;P[_P!E5^''_J;Z
M%0!] 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?/_Q&_P"4IWP;_P"R5>//_3OX,KZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 -*@"O ?AQQ_P5-^,G_9*O ?_ *=_&=?0%?/_ ,-_^4IG
MQD_[)5X#_P#3OXRH ^@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KY_P#^"E?_ ";MX=_[*K\./_4WT*OH"OG_ /X*5_\ )NWAW_LJOPX_]3?0
MJ /H"B@G I%;- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5\_\ Q&_Y2G?!O_LE7CS_ -._
M@ROH"OG_ .(W_*4[X-_]DJ\>?^G?P90!] 449Q2*V: %HHHH **** "BBB@
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MM2P$"-\V/?BFB4$?PY]/P_\ U_E7.^"/B=H_Q,TI[[0=2M]2MXI#$TD+9VL
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MEO\ LE7BC_TT75 'T!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:_:BL/BGHNL>(/C)(NE6U[!/>V\7B*_NB\<94E/LYB2!MP7!!*@AL'-??BQ
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M]S^5>5_LN7'CV[\ 7'_"=1R+?-=G[-O2-9A"54'<%RN _F8)YP.X*YQ_@O\
M!+QQX)^-WB37M:\2+J6CZB)1%;?:99&8F16C)1_E3:H(X.%QM7"UG]:G*S2=
M@/6=1\56&F7\=E->6L5[<9,4+RA9)L=2B]6Q[9QTXK\M_P#@H%^T%>>//VU/
M@CKFDWC"UT#QW<0Z65Y7$?A[6CO.<#YV)/(R4*C(Q7TU_P %#/A_9Z3XCT_Q
M5_;%Q'JEX%MHK#RMZD1@GS5;</+5<CJI&]AC!9B?A3X\-YGQ3^""MNVKXUN5
M!Z\#P]K>?Q_KGZ#X?.L^K_6O81T24OPBSCK5FG9'ZG^)/BIX@\?_ +-P\1>
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MV$O@_P##\QR:;\._"L<UORDUS9"ZG3Z22[G_ "-.FZ2^((\O4R?VBOVI=:\
M_LQ6/C[P/X1O_%UQK$=I<6EGY,FZW@N(]ZS31QJ7PF55E&,%@=P%?*=G^UE^
MV5\8;^-M!^':^'XQ)A/-T-K6-QC^)KR0[E.#RI7)XR<5^BRVRPQ;5"J@ 7
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M7R_,QLQG;MQ\V<9#<5,L7226NYPZWN>Q;MK<G#>F>M.#+C&W&.,^E>'?M/\
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M0\O6?B5>6=P#=LVY!X/\33#'I\\2GZ9'>ONC:!7@'[9 S^T5^R?_ -E5OO\
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M3V]L)'*Q[D9A7KO_  <+%?$7QN_8A\)W\ENN@ZY\;=-FOXYP#'.8I(E6,@D
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M_@F_\==/U+R8[*Y\ :UYK3HK)%BQF97(. =A ;KP5%5M>7GH3>Z2\CV#X?\
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MG/6?\-1?# G_ )*-X!]/^1@M/_BZ%_:B^&"]/B-X#'?CQ!:?K^\JHX&+33;
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M^&'_ $4;P'_X4%I_\<H [VBN"_X:H^&'_11O ?\ X4%I_P#'*/\ AJCX8?\
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MH+3_ ..4?\-4?##_ **-X#_\*"T_^.4 =[17!?\ #5'PP_Z*-X#_ /"@M/\
MXY1_PU1\,/\ HHW@/_PH+3_XY0!WM%<%_P -4?##_HHW@/\ \*"T_P#CE'_#
M5'PP_P"BC> __"@M/_CE '>T5P7_  U1\,/^BC> _P#PH+3_ ..4?\-4?##_
M **-X#_\*"T_^.4 =[17!?\ #5'PP_Z*-X#_ /"@M/\ XY1_PU1\,/\ HHW@
M/_PH+3_XY0!WM%<%_P -4?##_HHW@/\ \*"T_P#CE'_#5'PP_P"BC> __"@M
M/_CE '>T5P7_  U1\,/^BC> _P#PH+3_ ..4?\-4?##_ **-X#_\*"T_^.4
M=[17!?\ #5'PP_Z*-X#_ /"@M/\ XY1_PU1\,/\ HHW@/_PH+3_XY0!WM%<%
M_P -4?##_HHW@/\ \*"T_P#CE'_#5'PP_P"BC> __"@M/_CE '>T5P7_  U1
M\,/^BC> _P#PH+3_ ..4?\-4?##_ **-X#_\*"T_^.4 =[17!?\ #5'PP_Z*
M-X#_ /"@M/\ XY1_PU1\,/\ HHW@/_PH+3_XY0!WM%<%_P -4?##_HHW@/\
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M8Y(?@-X+._"_\+<^'@8;,9_XK#1SD'/')_3GGFOIHQ<=!_C7S;_P5$BQ\!O
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M4;!2T4 )L%&P4M% ";!1L%+10 FP4;!2T4 )L%> ?MCC/[17[)__ &56^_\
M4(\5U] 5\_?MD?\ )Q7[)_\ V56^_P#4(\5T ?0&P4;!2T4 )L%&P4M% ";!
M1L%+10 FP4;!2T4 )L%&P4M% ";!1L%+10 FP4;!2T4 )L%&P4M% ";!1L%+
M10 FP4;!2T4 )L%&P4M% ";!1L%+10 FP4;!2T4 )L%&P4M% ";!1L%+10 F
MP5X!_P %85Q_P2R_:6_[)5XH_P#31=5] 5\__P#!6+_E%E^TM_V2KQ1_Z:+J
M@#W_ &"C8*6B@!-@HV"EHH 38*-@I:* $V"C8*6B@!-@HV"EHH 38*-@I:*
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M3O?^".WP5N)5:/2=7M5Q@I%JDVTGURQ)I<F'[L7M,5V/H0?&3PG_ -#)H/\
MX'Q?_%4?\+@\*_\ 0QZ'_P"!\7_Q5?.O_#FKX+_\^.O?^#22C_AS7\%_^@?K
MG_@TDJN2A_,_N-/:8G^4^B_^%P>%?^ABT/\ \#XO_BJ0_&+PJ/\ F8M"_P#
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M>'(_^)M\$]&O&4A6^P7B\]SC;<2]J=)_P4>^,&AR*-4_9L\9F/YMTEG+<3*
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M] 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[8=P$^BVTF#ZC<AHYZ#^S^(>SQ*ZG&Z+_P %$?@SKC*L'Q!\.QY./W\QM\
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M88I)!XUT3:KN%<HI. 6"L0,G:>A(W:CS!R^]H?1B/N-.KSM/$7Q.W?\ (H^
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M_P K* /0**\__M[XH?\ 0H^ _P#PK[O_ .5E']O?%#_H4? ?_A7W?_RLH ]
MHKS_ /M[XH?]"CX#_P#"ON__ )64?V]\4/\ H4? ?_A7W?\ \K* /0**\_\
M[>^*'_0H^ __  K[O_Y64?V]\4/^A1\!_P#A7W?_ ,K* /0**\__ +>^*'_0
MH^ __"ON_P#Y64?V]\4/^A1\!_\ A7W?_P K* /0**\__M[XH?\ 0H^ _P#P
MK[O_ .5E']O?%#_H4? ?_A7W?_RLH ] HKS_ /M[XH?]"CX#_P#"ON__ )64
M?V]\4/\ H4? ?_A7W?\ \K* /0**\_\ [>^*'_0H^ __  K[O_Y64?V]\4/^
MA1\!_P#A7W?_ ,K* /0**\__ +>^*'_0H^ __"ON_P#Y64?V]\4/^A1\!_\
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MM[XH?]"CX#_\*^[_ /E90!Z!17G_ /;WQ0_Z%'P'_P"%?=__ "LH_M[XH?\
M0H^ _P#PK[O_ .5E 'H%%>?_ -O?%#_H4? ?_A7W?_RLH_M[XH?]"CX#_P#"
MON__ )64 >@45Y__ &]\4/\ H4? ?_A7W?\ \K*/[>^*'_0H^ __  K[O_Y6
M4 >@45Y__;WQ0_Z%'P'_ .%?=_\ RLH_M[XH?]"CX#_\*^[_ /E90!Z!17G_
M /;WQ0_Z%'P'_P"%?=__ "LH_M[XH?\ 0H^ _P#PK[O_ .5E 'H%%>?_ -O?
M%#_H4? ?_A7W?_RLH_M[XH?]"CX#_P#"ON__ )64 >@45Y__ &]\4/\ H4?
M?_A7W?\ \K*/[>^*'_0H^ __  K[O_Y64 >@45Y__;WQ0_Z%'P'_ .%?=_\
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MT*/@/_PK[O\ ^5E']O?%#_H4? ?_ (5]W_\ *R@#T"BO/_[>^*'_ $*/@/\
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M?=__ "LH_M[XH?\ 0H^ _P#PK[O_ .5E 'H%(5&*X#^WOBA_T*/@/_PK[O\
M^5E']O?%#_H4? ?_ (5]W_\ *R@#OE..]'RUP/\ ;WQ0_P"A1\!_^%?=_P#R
MLH_M[XH?]"CX#_\ "ON__E90!Z !@4P#!_\ KUP7]O?%#_H4? ?_ (5]W_\
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M]IECC\Z9&U-2P6--B2P@KR'>YRE)W;"G3C!6B?<;'YA3J**DL**** "BBB@
MHHHH *#THHH AE0/"5]>*_*'_@K3_P $6=:T'X:_'#XD?L[^.?'WA'5/B8D=
M[XP^'^E:,NOZ;XQN/M",9(+8CS;><NS2L\>_G?@(I)K]8RF:0Q U/+K<KF/C
MG]@S_@E-;_LM_''Q%\8_B%\1O$7QP^.'BVP73+OQ9K%I#81:?9JVX6UA9PDQ
MVL;$+N578'8-H0%PWB?[9G_!NI;_ !D_:3USXN? OX\?$3]FGQMXRD:7Q/)X
M9,TEGK#L=S2B."ZM9(WD;YG'FLC'G8&+,WZ8^5]*41+5=C.-TK'QC_P2U_X(
MT^!_^"9T_B3Q)%XB\1_$GXJ>-SGQ#XU\0OYE]>KNWF.,$L8XV<!VW/([O@L[
M!$"^6?M^?\&^%C^T_P#M4:A\;?A'\:OB!^SG\4O$%LEIKNJ^&?-:'544*I8I
M#/;2QR.L<0?;,4;RD8Q[]SO^D.W_  I/+]>GI4RU:94=#X[_ ."4?_!'KP3_
M ,$M=%\47UEX@U[XA?$;QY<B[\3>,-=VF\U%PS-L099HXR[,Y#R.[NY+.V%"
M^B?\%+?^3=?#O_95?ASW_P"IWT*O?V13\W;O7SU_P4RNH[?]GSPNC-M:X^*_
MPY1!_>;_ (371&Q^ 4U7-<#Z%1 &W8_&I*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG
M_P"'/_*4[XR?]DJ\!_\ IW\9U] 5\_\ PY_Y2G?&3_LE7@/_ -._C.@#Z HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KY^_;(_P"3BOV3_P#LJM]_ZA'BNOH&OG[]LC_DXK]D
M_P#[*K??^H1XKH ^@:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^?_P#@K%_RBR_:6_[)5XH_
M]-%U7T!7S_\ \%8O^467[2W_ &2KQ1_Z:+J@#Z HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
M./:EHH :8E(Z5\O_ +$B#_AM[]LC_L?]"_\ 4-T&OJ(G KY?_8D.?VW_ -LK
M_L?]!_\ 4-T&@#Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $V
M"OFS_@J-_P D&\"_]E?^'?\ ZF&D5]*5\U_\%1O^2#>!?^RO_#O_ -3#2* /
MI2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OG[]LC_DXK]D__ +*K??\ J$>*Z^@:^?OVR/\ DXK]D_\ [*K??^H1
MXKH ^@:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *^?_\ @K%_RBR_:6_[)5XH_P#31=5] 5\_
M_P#!6+_E%E^TM_V2KQ1_Z:+J@#Z HHHH **** "BBB@ HHHH **** "BBB@
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MZ4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *^?\ X<_\I3OC)_V2KP'_ .G?QG7T!7S_
M /#G_E*=\9/^R5> _P#T[^,Z /H"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG[]LC_DXK]D
M_P#[*K??^H1XKKZ!KY^_;(_Y.*_9/_[*K??^H1XKH ^@:*** "BBB@ HHHH
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MQ70!] T4BMNI,Y>@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  [2^'?_ $,G[0'_ (?;QO\ _+:@#Z HKY__ .':7P[_ .AD_: _\/MXW_\
MEM1_P[2^'?\ T,G[0'_A]O&__P MJ /H"BOG_P#X=I?#O_H9/V@/_#[>-_\
MY;4?\.TOAW_T,G[0'_A]O&__ ,MJ /H"BOG_ /X=I?#O_H9/V@/_  ^WC?\
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M.TOAW_T,G[0'_A]O&_\ \MJ/^':7P[_Z&3]H#_P^WC?_ .6U 'T!17S_ /\
M#M+X=_\ 0R?M ?\ A]O&_P#\MJ/^':7P[_Z&3]H#_P /MXW_ /EM0!] 45\_
M_P##M+X=_P#0R?M ?^'V\;__ "VH_P"':7P[_P"AD_: _P##[>-__EM0!] 4
M5\__ /#M+X=_]#)^T!_X?;QO_P#+:C_AVE\._P#H9/V@/_#[>-__ );4 ?0%
M%?/_ /P[2^'?_0R?M ?^'V\;_P#RVH_X=I?#O_H9/V@/_#[>-_\ Y;4 ?0%%
M?/\ _P .TOAW_P!#)^T!_P"'V\;_ /RVH_X=I?#O_H9/V@/_  ^WC?\ ^6U
M'T!17S__ ,.TOAW_ -#)^T!_X?;QO_\ +:C_ (=I?#O_ *&3]H#_ ,/MXW_^
M6U 'T!17S_\ \.TOAW_T,G[0'_A]O&__ ,MJ/^':7P[_ .AD_: _\/MXW_\
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M/MXW_P#EM1_P[2^'?_0R?M ?^'V\;_\ RVH ^@**^?\ _AVE\._^AD_: _\
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M ?25%?/_ /P[2^'?_0R?M ?^'V\;_P#RVH_X=I?#O_H9/V@/_#[>-_\ Y;4
M?0%%?/\ _P .TOAW_P!#)^T!_P"'V\;_ /RVH_X=I?#O_H9/V@/_  ^WC?\
M^6U 'T!17S__ ,.T_AU_T,G[0'_A]O&__P MJ/\ AVE\._\ H9/V@/\ P^WC
M?_Y;4 ?0%%?/_P#P[2^'?_0R?M ?^'V\;_\ RVH_X=I?#O\ Z&3]H#_P^WC?
M_P"6U 'T!17S_P#\.TOAW_T,G[0'_A]O&_\ \MJ/^':7P[_Z&3]H#_P^WC?_
M .6U 'T!17S_ /\ #M+X=_\ 0R?M ?\ A]O&_P#\MJ/^':7P[_Z&3]H#_P /
MMXW_ /EM0!] 45\__P##M+X=_P#0R?M ?^'V\;__ "VH_P"':7P[_P"AD_:
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M\._^AD_: _\ #[>-_P#Y;4 ?0%%?/_\ P[2^'?\ T,G[0'_A]O&__P MJ/\
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M !I_P<C?#76/V+=/T/\ X1'PSX>NU^*E]X.B$/A&%'CG2..,QJ+=F?\ <?\
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MZI-L^DM/^/'@[4_@Q'\1(?$^B'P'+I(UQ=?-VBZ?]A,7F_:3,QV"+R_FW$X
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MB+QEXBO+W5UN=5US49M0OK@)J-PB!YIG9VVJ HR<   8Q7C'_!"GX Z_:?\
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M8;O^#OC2V[?\*F;C\):;\%#C_@[V^+/]X?"N#.#WQIE;7_!)/]F_X]?M2?\
M!2SQS^V5\>/A[+\'TU3PVOA?PGX1N7?[?';EXV,DZ28ECV+&0?,2-G>9B(T
M&>5_X*B_!;]HS]A#_@KUI/[7OP1^%M_\:O#.O>&8?#?BCP[I4#3:AA2%:,)$
MKS@,L=O(DT<<@1HV#KMP'FE^[=-2Z)W\K[&<XN?M.7K:WRW-K_@\!./V'_A/
MV_XNEIOX_P"AWU<3_P '7/PHM?CMXT_8W\#WUS<6=CXR\<R:)<7$(!D@CN7L
M86=0>-P5B1GN*\;_ ."N-S^V9_P5B_9M\">-M6_9W\7_  P\%^&O&5A%I_P_
MM;*\UWQ+JL\D5P9M5NU2"*2WMH%18D5X$^:Z<DD;:^N_^"_7P \=_&?]HO\
M8GOO!_@GQ=XLL?"OQ*@OM;N-'TBXOHM&MA<6#&:Y:)6$,>U7.^0J,(3G -%.
MC;EYOY[^BL5*3<M/Y6OG<WO^"G7_  1H_9?^'W_!*+XI0>'?@KX%\/W_ ('\
M&WVJZ1K.GZ:D.M0W%I:R2PM)?_\ 'S/EE&X322;QG<&XKXF_:-_:U\6> ?\
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M,/VZVCGV;]^S<H;&>^,XS@9K4!S^=#T=@C)-70ZBBB@84444 %%%% !1110
M4444 %%%% !110QP* (W! _E7DOA?]MKX7^,/VJ?$'P/TOQ=;77Q4\+Z:FL:
MKH MYUEL[5Q 5D,AC$1R+F [5<L/,'  ./6CR/ZU^:O_  5!_P"",WQ8^-7[
M9&A_M)_LO_%;3OA1\:-/TU-&U%=5B)TS5[=<A7D989\D+A&CE@E1Q'%PA3+9
M\UI+L/ENGW//?^"N<;:G_P '!?[!]O"4DFCEU"=XPXW*@<,203TPCX[$J1U%
M)_P4.MW'_!T3^QO(T;>6WA?4E5L'DB+4\C/? (.!R,Y/!KN?^">G_!&?XT:%
M^VK:_M(?M;?&/3_BU\4O#]A+IGARPT: QZ3HR.K1F9<P6ZAO+>0>7';1J&D9
MV9V.1V7_  6I_P"".NO_ /!1G5/A]\0?A?X^/PU^,WPIG>;0-6E$@MKA6=9%
MCD>/,D+)(H99%5^&D5HVW K7P.#?1M_>'QN7FK?<4_\ @Z-O8+3_ ((J?%2.
M::&.2XGT>*,2,%:1O[5M6VJ.[;03@=@>U?)O_!=KYO\ @V1_9]4C.Z'P<,$X
MS_Q*9*Z;]H3_ ((2?MB?M]?LO>)M-_:*_:*\)>/O'VGI"/ NC6*/I?A?3+K[
M3"9KZ\>UL86N)A:BXBC#6S[//?YOF)'T%_P4I_X)&?$C]L;_ ((]_"W]GWPS
MK7@FR\9^"4T!;Z\U6]NHM,E-C8O;S>5)';R2-EB"NZ)<CD[3Q1RKE?=R3^2'
MS>]%K[*?WL^TO '@71?!_P"RQHOAO2]-L[/P_IOAF'3K6P2+]Q%;):A%B"?W
M0HVX]*_ 7]CCQ1KGA3_@T8_:2FT.:ZAN/^$SGT]S W,-I--I$5RH'96ADD5L
M8R&8U_0]IOARXM?AQ;Z2S1-<Q:>MHQZH7$87TSC//(S_ "KX7_X)!_\ !'K6
M/V/O^";?C[X!_&R3P?XLM?'NM:G<7T>A7=S/:R6-W:V\&PR30PR+*#&Q!525
M.PALCA5-7/S2^=G<*<E%0]?PL>,_\$U-$_X* >'_ -@GX1V_PCM?V$;7X=2>
M%K&YT)+Y?$XO3!+"LN^Z\G]V;EF9FE*\&5G/>O3/^"5'_!-?]H;]F+_@H?\
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M\_?J=[]CS_@AK\7/&7[8/AGX]_ME_&:S^,GCCP'MD\,Z'I%MY.BZ3<*5=+D
M10)N1U#A([>,%TC=F;:%KW'_ (+ _P#!(RV_X*9>$_"&M>&O%U]\-?C#\,;P
MZCX2\5V8?=:N2K&&38ROL+QQLLB'=$Z[ER"Z/<?<Y92=VF_DGT)E%5&ULFDK
M^:[FQ_P7B^(%E\-_^"0WQ\OM0D6.&[\)W.E198+F6[Q;1 9ZG?*G%7_^"'GA
M2\\#?\$F/@'8WT4EO<-X/LKHQRIM95F3SEX_W9!_GBOAZ3_@AE^V/^WCXU\,
MZ/\ MG?M)^&?&'PC\+WT6HMX=\(P&&36G3@1S%+*S521D>:WG.H=]NTMNK]#
M?^"B=C\1O W[ ?CS_A1OB3P_\._&GAG1TO-'U74;:.2PTJVM'CEN 8V@G0@V
MD<R*#"P!*_=X83&*@I/=R:^Y X\SBOY;Z^I]"!R13E:O#O\ @G%\3?%GQH_8
M+^#?C#QQ>-J'B_Q3X.TK5M7NGMXK=KBXGM8Y9',42JD9);.U5 7.,"O;\;F^
MG2M.6SL$975R2BBB@H**** "BBB@ HHHH **** "BBB@ HHHH A=OD;IC'>O
MRT_X+@?M#?';_@GW^VM\%?VAO"\/Q"\8? 7P[9SZ9X[\*:+>R+I\;'SU6[GA
M7*EBEQE9)%V![2)6=-ZD_J<>3ZTC(I[>_-9RB[IK<J,DM]3\%_C9^W-<?\')
M_P"V+^SYX/\ @K\,?B%I7PW^%WC"W\5^+O%'B.R@B@M?)96,)\F2:)28U<(&
ME+R/*!Y852U?37_!SS\!/B)KOPE^"?Q@^'7A6X\::C\!?&T/B.]TNUADFF:V
M'ER>;Y<?S-$LEO&LA4%E5]W"JY'ZF&-3C\^*<R!UHE'1*.EG?YDQ^/FEJK6^
M1^(/[3?_  <#W'_!4_\ 8.^*7@'X!_!?XB6^M/X+U.;QMKOB:*WAT'PGIT5E
M++>[9X9)&GG>-7AA1TA+/(KX^4K57PX-G_!EK,W/R^'9R<<X_P"*A<?SK]R3
M&%%-"*.< M[T.*::[VO\F%]5_=O;YJQ\R?\ !'%6'_!*/]GON?\ A7^CX_\
M .*OSU_X(H_!JQ_:+^//_!3OP#J4C1Z;XV\9W^A7,B#>\<=S-K$)8=.0')'N
M*_:4*JC[N/6EQQP*J45*<I]U8F'NP4%T:?W'X)_L*?\ !8+Q-_P;X_"ZZ_9O
M_:J^$/Q$6P\&ZC=KX1\3>&;.*ZM=:M9II)VVM<RP1RH'=V22.0L%?RWC1HCG
M[H_X)D?\%-OCI_P4Q_:4U[Q!:_!T?#7]F/3=/']DZIXIL+B'Q)XAO6QL,)$P
M@\G:69MD<JKM $I9L+^@@0=>/2@C'S?A6D9=]6$E?8'R!D>E?E;^WG_P4?\
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MW'4444R@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;@$]/:F^7[5)10
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MFU[X>_"SQ0=2\*":9IY-,CEE>*YM3(3_  ,L*L,#]ZLS8)<FOUS)_G7XK?\
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M_P!+OV+/V1?"/["O[-'A'X6>";>:#0/"5D+6.28AKB\E)+RW$K  &265GD;
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M$FEQ#6M0TU;9IQ&)"1:3Q;R1$F"^[ !QC)S\_P#_ !"\_L+GK\#?_+R\0?\
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MIVTOBZZ_X*&^/H?'[J;W^Q[6"_\ ^$?^U%<^4,7BQ>3NR,BRQ@#]WU%>O?\
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M3J%PHU?;-+:!A')(OEQ_,P)'EQD'Y:^_?B[^TO\ #K]GJ72_^$^\?>"_ _\
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M*V^E>;I5[X;OH9YKF\\U 8I NIWA"^67;[BC*CYNQZC_ (('\_\ !'CX _\
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MZSFUR\L;/3+2"<P 1_9Y8I1B2.5$0R&)(UC547#$]U_P0]\ 6?Q1_P""A?\
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M3O%>E)K5WJ%CXITV:^MUVS)<R2,KQ7(MIDV%4!C.4SM9?J[]HO\ 9R@_:?\
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MG4KJ>V_99_:6O6OO"%S,=UMX6ULE$%LTA/R*-R0EF',;VCL_[N0UZ-XU./\
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M 5MS<,=O'8#<2!7I%O\ #S1[;Q))K$>DZ<FK3*8Y+Q;9!.RX"@%\;B !@#.
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M/C#7+6/3(-'VS?V7;ZM]K>Q=WY\T6JRQR2!=X9E*1^9EO,'QG_P4W_X) O\
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MW-N( UB]&/PQZTU%\K!]#]  <BB@=** "BBB@ HHHH ,<T444 '6DV"EHH
M,4%<T44 )LHV"EHH :4YJ.6%FJ:BBP$20[!2M&6J2B@"N]N2>_X=J3[(3_='
MT&/\_P JLT46L!7%IR?S'N?7_/\ 6@PL5''MR<XJQ1BE8"K]C;S<[FQV]O\
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MX\^%K>)-!A^)$%M;W_AGS[=]#L/(^XUK'Y(F0\R$[YG&97X^[M^L ,"CK0M
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>fonar_exhibit-21.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
21.1&#9;Subsidiaries of the Registrant</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Imperial
Management Services, LLC (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Health
Diagnostic Management, LLC d/b/a Health Management Company of America (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Health
Management Corporation of America (Delaware)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Fair
Haven Services, Inc. (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">HMCM,
Inc. (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Raymond
V. Damadian, M.D. MR Scanning Center Management Company (Delaware)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Dynamic
Services, Inc. (New York)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Central
Health Care Management Company, Inc. (Delaware)</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>fonar_exhibit-23.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit 23.1&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Independent Registered
Public Accounting Firm&rsquo;s Consent</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">We consent to the
incorporation by reference in the Registration Statement of FONAR Corporation and Subsidiaries on Form S-8 File No. 333-168771 of our
report dated September 28, 2022 with respect to our audits of the financial statements of FONAR Corporation and Subsidiaries as of June
30, 2022 and 2021 and for each of the two years in the period ended June 30, 2022 appearing in this Annual Report on Form 10-K of FONAR
Corporation and Subsidiaries for the year ended June 30, 2022.</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/ Marcum llp</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Marcum llp</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">New York, New York</FONT></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">September 28, 2022</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">I,
Timothy R. Damadian certify that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">I,
Luciano Bonanni, certify that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">1.I
have reviewed this annual report on Form 10-K of Fonar Corporation;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">2.Based
on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements made, not misleading with respect to the period
covered by this annual report; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">3.Based
on my knowledge, the financial statements, and other financial information, included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
annual report.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">4.I
am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financialreporting (as defined in Exchange Act Rules 13a-15(f) and 15(f)for the registrant and I have:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
my supervision, to provide reasonable assurance regarding the reliability of financial statements for external purposes in accordance
with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">5.I
have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and
the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">a)
all significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial data; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Date:
September 28, 2022</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Timothy R. Damadian</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
R. Damadian,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">President
and Principal Executive Officer</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Luciano Bonanni</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Luciano
Bonanni,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Executive
Vice President, COO and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">Acting
Principal Financial Officer&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">In
connection with the Annual Report of Fonar Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10K for the fiscal year ended
June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy Damadian,
President and Chief Executive Officer of the Company, and I, Luciano Bonanni, Executive Vice President, certify, pursuant to 18 U.S.C.
ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/
Timothy R. Damadian</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
R. Damadian,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">President
and Principal Executive Officer</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/
Luciano Bonanni</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
Bonanni,</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-variant: normal; font-weight: normal">Executive
Vice President, COO and</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">Acting
Principal Financial Officer</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">Date:September
28, 2022</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 11pt Arial, Helvetica, Sans-Serif">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>fonr-20220630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20220630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20220630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20220630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilities" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20220630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20220630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20220630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20220630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20220630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20220630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion" xlink:href="fonr-20220630.xsd#Acquistion" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialData" xlink:href="fonr-20220630.xsd#QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20220630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20220630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20220630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20220630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20220630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AcquistionTables" xlink:href="fonr-20220630.xsd#AcquistionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialDataTables" xlink:href="fonr-20220630.xsd#QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20220630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20220630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20220630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20220630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20220630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20220630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20220630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20220630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20220630.xsd#IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20220630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20220630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20220630.xsd#Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" xlink:href="fonr-20220630.xsd#Acquistion-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:href="fonr-20220630.xsd#QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20220630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000006 - Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="loc_us-gaapIncomeTaxCreditsAndAdjustments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeTaxCreditsAndAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CompensatoryElementOfStockIssuances" xlink:label="loc_FONRCompensatoryElementOfStockIssuances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRCompensatoryElementOfStockIssuances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfImagingCenter" xlink:label="loc_FONRPurchaseOfImagingCenter" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_FONRPurchaseOfImagingCenter" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="loc_FONRPurchaseOfNoncontrollingInterests" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_FONRPurchaseOfNoncontrollingInterests" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilities" xlink:title="00000011 - Disclosure - CONTRACT ASSETS AND LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000014 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000015 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="00000016 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="00000017 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000018 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000020 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000022 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="00000023 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000024 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion" xlink:title="00000025 - Disclosure - ACQUISTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:title="00000026 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialData" xlink:title="00000027 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" xlink:title="00000032 - Disclosure - CONTRACT ASSETS AND LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000033 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="00000037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000038 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="00000039 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000041 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AcquistionTables" xlink:title="00000042 - Disclosure - ACQUISTION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:title="00000043 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialDataTables" xlink:title="00000044 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000045 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000050 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000051 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000052 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000053 - Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BillingsToDate" xlink:label="loc_FONRBillingsToDate" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="loc_FONRBillingsToDate" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000054 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000055 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000056 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000057 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="00000058 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:title="00000059 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:title="00000060 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000061 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:title="00000062 - Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000063 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000064 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="00000065 - Disclosure - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000066 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000067 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000068 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000069 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="00000070 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000071 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000072 - Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000074 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000076 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000078 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000079 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000080 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000081 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000082 - Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" xlink:title="00000083 - Disclosure - ACQUISTION - Net assets acquired (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:title="00000084 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:title="00000085 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>fonr-20220630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20220630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20220630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20220630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilities" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20220630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20220630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20220630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20220630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20220630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20220630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion" xlink:href="fonr-20220630.xsd#Acquistion" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialData" xlink:href="fonr-20220630.xsd#QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20220630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20220630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20220630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20220630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20220630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AcquistionTables" xlink:href="fonr-20220630.xsd#AcquistionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialDataTables" xlink:href="fonr-20220630.xsd#QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20220630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20220630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20220630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20220630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20220630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20220630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20220630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20220630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20220630.xsd#IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20220630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20220630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20220630.xsd#Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" xlink:href="fonr-20220630.xsd#Acquistion-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:href="fonr-20220630.xsd#QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20220630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_70" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_70" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_70" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_70" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_70" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_70" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_70" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_70" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_70" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_70" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_70" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_70" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_70" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_70" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_70" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_70" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_70" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_70" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_70" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_70" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_70" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_70" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_70" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_70" xlink:type="arc" order="60" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountReceivableRelatedParties_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagementAndOtherFees_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="49" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares_130" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_FONRProductSalesNet_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_FONRServiceAndRepairFeesNet_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_FONRManagementAndOtherFeesNet_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_70" xlink:to="loc_us-gaapRevenues_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_FONRCostsRelatedToProductSales_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_70" xlink:to="loc_us-gaapCostsAndExpenses_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="loc_us-gaapOtherExpensesAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherExpensesAbstract_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BasicAndDilutedIncomePerShare" xlink:label="loc_FONRBasicAndDilutedIncomePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRBasicAndDilutedIncomePerShare_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageBasicAndDilutedSharesOutstanding" xlink:label="loc_FONRWeightedAverageBasicAndDilutedSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageBasicAndDilutedSharesOutstanding_70" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000006 - Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassANonVotingPreferredMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassCCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:label="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests_90" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilities" xlink:title="00000011 - Disclosure - CONTRACT ASSETS AND LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000014 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000015 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="00000016 - Disclosure - CAPITAL STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="00000017 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000018 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000020 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000022 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="00000023 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000024 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion" xlink:title="00000025 - Disclosure - ACQUISTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:title="00000026 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialData" xlink:title="00000027 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" xlink:title="00000032 - Disclosure - CONTRACT ASSETS AND LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000033 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="00000037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000038 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="00000039 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000041 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AcquistionTables" xlink:title="00000042 - Disclosure - ACQUISTION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:title="00000043 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialDataTables" xlink:title="00000044 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000045 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:label="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShippingAndHandlingExpense" xlink:label="loc_FONRShippingAndHandlingExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRShippingAndHandlingExpense_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_120" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000050 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000051 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000052 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000053 - Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000054 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000055 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000056 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DepreciatedAssetsWriteoff" xlink:label="loc_FONRDepreciatedAssetsWriteoff_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_FONRDepreciatedAssetsWriteoff_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000057 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDue_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="00000058 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:title="00000059 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:title="00000060 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000061 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:title="00000062 - Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_40" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000063 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000064 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_80" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="00000065 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_140" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000066 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapMinorityInterestTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000067 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassBMember" xlink:label="loc_FONRClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassAMember" xlink:label="loc_FONRClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OutsideInvestorsMember" xlink:label="loc_FONROutsideInvestorsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_FONROutsideInvestorsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipPercentageAcquired" xlink:label="loc_FONROwnershipPercentageAcquired_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONROwnershipPercentageAcquired_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest_100" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000068 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable3Member" xlink:label="loc_FONRNotePayable3Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable3Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NumberOfInstallment" xlink:label="loc_FONRNumberOfInstallment_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRNumberOfInstallment_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_120" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000069 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="00000070 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000071 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000072 - Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000074 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000076 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ABillingCompanyMember" xlink:label="loc_FONRABillingCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRABillingCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000078 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000079 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DO" xlink:label="loc_countryDO_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="loc_countryCA_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR" xlink:label="loc_countryPR_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000080 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR" xlink:label="loc_countryPR_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH" xlink:label="loc_countryCH_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB" xlink:label="loc_countryGB_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="loc_countryCA_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GR" xlink:label="loc_countryGR_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU" xlink:label="loc_countryAU_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees_150" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000081 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000082 - Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" xlink:title="00000083 - Disclosure - ACQUISTION - Net assets acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember" xlink:label="loc_us-gaapCustomerListsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerListsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CovenantNotToCompeteMember" xlink:label="loc_FONRCovenantNotToCompeteMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRCovenantNotToCompeteMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClosingCostsExpensed" xlink:label="loc_FONRClosingCostsExpensed_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRClosingCostsExpensed_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaapGoodwillGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwillGross_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BusinessCombinationContingentConsiderationAsset1" xlink:label="loc_FONRBusinessCombinationContingentConsiderationAsset1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRBusinessCombinationContingentConsiderationAsset1_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:title="00000084 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions_210" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:title="00000085 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_QuarterlyFinancialDataMember" xlink:label="loc_FONRQuarterlyFinancialDataMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRQuarterlyFinancialDataMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpenses_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_110" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:label="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_30" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>fonr-20220630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="FONR_ClassANonVotingPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredMember" xlink:to="FONR_ClassANonVotingPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredMember_lbl" xml:lang="en-US">Class A Non Voting Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassCCommonStockMember" xlink:label="FONR_ClassCCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassCCommonStockMember" xlink:to="FONR_ClassCCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassCCommonStockMember_lbl" xml:lang="en-US">Class C Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ControllingInterestMember" xlink:label="FONR_ControllingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ControllingInterestMember" xlink:to="FONR_ControllingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ControllingInterestMember_lbl" xml:lang="en-US">Controlling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="FONR_DiagnosticImagingFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticImagingFacilityMember_lbl" xml:lang="en-US">Diagnostic Imaging Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:label="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:to="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_lbl" xml:lang="en-US">Net Management Fee Receivables From Related Party Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="FONR_DiagnosticEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipmentMember_lbl" xml:lang="en-US">Diagnostic Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research Deveopment And Demonstration Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other Revenue Source [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="FONR_N2010StockBonusPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_N2010StockBonusPlanMember" xlink:to="FONR_N2010StockBonusPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_N2010StockBonusPlanMember_lbl" xml:lang="en-US">N 2010 Stock Bonus Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMEquityMember" xlink:label="FONR_HDMEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMEquityMember_lbl" xml:lang="en-US">H D M Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsByNameAxis" xlink:to="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xml:lang="en-US">Other Ownership Interests Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassBMember" xlink:label="FONR_ClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBMember" xlink:to="FONR_ClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassBMember_lbl" xml:lang="en-US">Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMMember" xlink:label="FONR_HDMMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMMember_lbl" xml:lang="en-US">H D M [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassAMember" xlink:label="FONR_ClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAMember" xlink:to="FONR_ClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassAMember_lbl" xml:lang="en-US">Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OutsideInvestorsMember" xlink:label="FONR_OutsideInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OutsideInvestorsMember" xlink:to="FONR_OutsideInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OutsideInvestorsMember_lbl" xml:lang="en-US">Outside Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable1Member" xlink:label="FONR_NotePayable1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable1Member_lbl" xml:lang="en-US">Note Payable 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable2Member" xlink:label="FONR_NotePayable2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable2Member" xlink:to="FONR_NotePayable2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable2Member_lbl" xml:lang="en-US">Note Payable 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable3Member" xlink:label="FONR_NotePayable3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable3Member" xlink:to="FONR_NotePayable3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable3Member_lbl" xml:lang="en-US">Note Payable 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ABillingCompanyMember" xlink:label="FONR_ABillingCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ABillingCompanyMember" xlink:to="FONR_ABillingCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ABillingCompanyMember_lbl" xml:lang="en-US">A Billing Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xml:lang="en-US">Bensonhurst M R I Limited Partnership [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:to="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_lbl" xml:lang="en-US">Manufacturing And Servicing Of Medical Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DO" xlink:label="country_DO" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DO" xlink:to="country_DO_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DO_lbl" xml:lang="en-US">DOMINICAN REPUBLIC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE" xlink:label="country_DE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US">GERMANY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR" xlink:label="country_PR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PR_lbl" xml:lang="en-US">PUERTO RICO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH" xlink:label="country_CH" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US">SWITZERLAND</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB" xlink:label="country_GB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GR" xlink:label="country_GR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GR" xlink:to="country_GR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GR_lbl" xml:lang="en-US">GREECE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RocklandManagementGroupMember" xlink:label="FONR_RocklandManagementGroupMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RocklandManagementGroupMember" xlink:to="FONR_RocklandManagementGroupMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RocklandManagementGroupMember_lbl" xml:lang="en-US">Rockland Management Group [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember" xlink:label="us-gaap_CustomerListsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerListsMember" xlink:to="us-gaap_CustomerListsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerListsMember_lbl" xml:lang="en-US">Customer Lists [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CovenantNotToCompeteMember" xlink:label="FONR_CovenantNotToCompeteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CovenantNotToCompeteMember" xlink:to="FONR_CovenantNotToCompeteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CovenantNotToCompeteMember_lbl" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="FONR_ManagementAndOtherFeesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableMember" xlink:to="FONR_ManagementAndOtherFeesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableMember_lbl" xml:lang="en-US">Management And Other Fees Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:to="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xml:lang="en-US">Management And Other Fees Receivable Related Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableMember" xlink:to="us-gaap_NotesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableMember_lbl" xml:lang="en-US">Notes Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_QuarterlyFinancialDataMember" xlink:label="FONR_QuarterlyFinancialDataMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_QuarterlyFinancialDataMember" xlink:to="FONR_QuarterlyFinancialDataMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_QuarterlyFinancialDataMember_lbl" xml:lang="en-US">Quarterly Financial Data [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">Accounts receivable &#8211; net of allowances for doubtful accounts of $204,597 and $442,270 at June 30, 2022 and 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $16,627,917 and $15,786,878 at June 30, 2022 and 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $4,686,893 and $4,184,399 at June 30, 2022 and 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long-term debt and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Due to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 11,643 shares of common stock at June 30, 2022 and 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Allowance for Doubtful Accounts Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Management and other receivable allowances for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Related party receivable allowances for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees &#8211; related party medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative, inclusive of compensatory element of stock issuances of $0 and $83,277 for the years ended June 30, 2022 and 2021 respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="us-gaap_OtherExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpensesAbstract_lbl" xml:lang="en-US">Other Income and (Expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before provision for income taxes and noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income &#8211; Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income - Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income Available to Common&#160;Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BasicAndDilutedIncomePerShare" xlink:label="FONR_BasicAndDilutedIncomePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BasicAndDilutedIncomePerShare" xlink:to="FONR_BasicAndDilutedIncomePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BasicAndDilutedIncomePerShare_lbl" xml:lang="en-US">Basic And Diluted Income Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageBasicAndDilutedSharesOutstanding" xlink:label="FONR_WeightedAverageBasicAndDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageBasicAndDilutedSharesOutstanding" xlink:to="FONR_WeightedAverageBasicAndDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageBasicAndDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Basic and Diluted Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:to="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_lbl" xml:lang="en-US">Stock issued to employees under stock bonus plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock issued to employees under stock bonus plans, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:label="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:to="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders_lbl" xml:lang="en-US">Payments on notes receivable from employee stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="FONR_BuyoutOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterests" xlink:to="FONR_BuyoutOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterests_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending Balance, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxCreditsAndAdjustments" xlink:to="us-gaap_IncomeTaxCreditsAndAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxCreditsAndAdjustments_lbl" xml:lang="en-US">Income tax receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CompensatoryElementOfStockIssuances" xlink:label="FONR_CompensatoryElementOfStockIssuances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CompensatoryElementOfStockIssuances" xlink:to="FONR_CompensatoryElementOfStockIssuances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CompensatoryElementOfStockIssuances_lbl" xml:lang="en-US">Compensatory element of stock issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock issued for costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:to="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_lbl" xml:lang="en-US">Abandoned patents</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="FONR_GainOnForgivenessOfPppLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnForgivenessOfPppLoan_lbl" xml:lang="en-US">Gain on forgiveness of PPP loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">&#160;(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:label="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_lbl" xml:lang="en-US">Contract assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="FONR_IncreaseDecreaseInContractLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xml:lang="en-US">Proceeds of Short term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfImagingCenter" xlink:label="FONR_PurchaseOfImagingCenter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfImagingCenter" xlink:to="FONR_PurchaseOfImagingCenter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PurchaseOfImagingCenter_lbl" xml:lang="en-US">Purchase of imaging center</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="FONR_PurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">&#160;&#160;CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">&#160;&#160;NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="us-gaap_RegulatedOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegulatedOperationsAbstract" xlink:to="us-gaap_RegulatedOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegulatedOperationsAbstract_lbl" xml:lang="en-US">Regulated Operations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:label="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:to="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_lbl" xml:lang="en-US">CONTRACT ASSETS AND LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="FONR_DisclosureCapitalStockAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureCapitalStockAbstract" xlink:to="FONR_DisclosureCapitalStockAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureCapitalStockAbstract_lbl" xml:lang="en-US">Capital Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:to="FONR_CapitalStockAndOptionsDisclosureTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock_lbl" xml:lang="en-US">CAPITAL STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">CONTROLLING AND NONCONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:to="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xml:lang="en-US">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">ACQUISTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">QUARTERLY FINANCIAL DATA (UNAUDITED)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="us-gaap_InventoryWorkInProcessPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryWorkInProcessPolicy_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:to="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US">Acquired assets and assumed liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShippingsAndHandlingCostPolicyTextBlock" xlink:label="FONR_ShippingsAndHandlingCostPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShippingsAndHandlingCostPolicyTextBlock" xlink:to="FONR_ShippingsAndHandlingCostPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShippingsAndHandlingCostPolicyTextBlock_lbl" xml:lang="en-US">Shipping Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="FONR_CustomerAdvancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesPolicyTextBlock" xlink:to="FONR_CustomerAdvancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesPolicyTextBlock_lbl" xml:lang="en-US">Customer Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Short Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:to="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Estimated Useful Life in Years for Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Patient Fee Revenue - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Receivables - Non Current - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Schedule of total facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:to="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xml:lang="en-US">Schedule of costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:label="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:to="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_lbl" xml:lang="en-US">Reconciliation of operating and financing lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:to="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Components of lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xml:lang="en-US">Supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule Of Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US">class a and b members' equity (hdm acquisition)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Maturities Of Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Components Of The Provision For Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Reconciliation Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Components Of Company&#8217;s Deferred Tax Assets And Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of summarized segment financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ExportProductSalesTableTextBlock" xlink:label="FONR_ExportProductSalesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportProductSalesTableTextBlock" xlink:to="FONR_ExportProductSalesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportProductSalesTableTextBlock_lbl" xml:lang="en-US">Schedule of export product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ExportServiceRevenuesTableTextBlock" xlink:label="FONR_ExportServiceRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportServiceRevenuesTableTextBlock" xlink:to="FONR_ExportServiceRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportServiceRevenuesTableTextBlock_lbl" xml:lang="en-US">Schedule of foreign service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xml:lang="en-US">Fair value assets and assumed liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US">Summary of Allowance For Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Quarterly Financial Data</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Direct purchase of Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Direct ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="FONR_InvestorsOwnershipInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestorsOwnershipInterest_lbl" xml:lang="en-US">Investors ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NetPatientFeeRevenue" xlink:label="FONR_NetPatientFeeRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetPatientFeeRevenue_lbl" xml:lang="en-US">Net Patient Fee Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Basic Numerator: Net Income Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="FONR_WeightedAverageSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageSharesOutstandingBasic" xlink:to="FONR_WeightedAverageSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageSharesOutstandingBasic_lbl" xml:lang="en-US">Basic Denominator: Weighted Average Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:to="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">Total Denominator for Diluted Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Income per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:to="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xml:lang="en-US">Cost of Property Repairs and Maintenance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xml:lang="en-US">Management Agreements With Company Total Medical Practices</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xml:lang="en-US">Scanners With Management Agreements With Company Owned By Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xml:lang="en-US">Scanners With Management With Company Located In New York State</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xml:lang="en-US">Contractual Fees For Services Rendered Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xml:lang="en-US">Contractual Fees For Services Rendered Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShippingAndHandlingExpense" xlink:label="FONR_ShippingAndHandlingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShippingAndHandlingExpense" xlink:to="FONR_ShippingAndHandlingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShippingAndHandlingExpense_lbl" xml:lang="en-US">Shipping and Handling Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xml:lang="en-US">Diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFourToFiveYears" xlink:to="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at Beginning of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagedFacilitiesAddedAcquisition" xlink:label="FONR_ManagedFacilitiesAddedAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedAcquisition" xlink:to="FONR_ManagedFacilitiesAddedAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedAcquisition_lbl" xml:lang="en-US">Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xml:lang="en-US">Internal development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="FONR_ManagedFacilitiesClosedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_lbl" xml:lang="en-US">Managed Facilities Closed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at End of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Percentage of PCs net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Consolidated net revenues percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="FONR_CostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Costs incurred on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EstimatedEarnings" xlink:label="FONR_EstimatedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedEarnings_lbl" xml:lang="en-US">Estimated earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_lbl" xml:lang="en-US">Costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BillingsToDate" xlink:label="FONR_BillingsToDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BillingsToDate_lbl" xml:lang="en-US">Less: Billings to date</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:label="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_lbl" xml:lang="en-US">Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and Equipment Before Accumulated depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation and amortization of property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and Equipment AfterAccumulated depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DepreciatedAssetsWriteoff" xlink:label="FONR_DepreciatedAssetsWriteoff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciatedAssetsWriteoff" xlink:to="FONR_DepreciatedAssetsWriteoff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciatedAssetsWriteoff_lbl" xml:lang="en-US">Depreciated assets write-off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present Value discount, Operating Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present Value discount, Financing Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_2_lbl" xml:lang="en-US">Operating Financing Leases - Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_3_lbl" xml:lang="en-US">Operating Financing Leases - Recent Accounting Pronouncements - Components Of Lease Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="FONR_FinanceLeaseCostsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCostsAbstract_lbl" xml:lang="en-US">&#160; &#160; Finance lease cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="FONR_DepreciationOfLeasedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciationOfLeasedEquipment_lbl" xml:lang="en-US">Depreciation of leased equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xml:lang="en-US">Interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinanceLeaseCost" xlink:label="FONR_FinanceLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCost_lbl" xml:lang="en-US">Total finance lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xml:lang="en-US">Operating cash flows from operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xml:lang="en-US">Financing cash flows from financing leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xml:lang="en-US">Right-of-use &amp; equipment assets obtained in exchange for lease obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xml:lang="en-US">Operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Other intangible assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">2023</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">2023</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_2_lbl" xml:lang="en-US">Balance - Beginning of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AmountsCapitalized" xlink:label="FONR_AmountsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AmountsCapitalized" xlink:to="FONR_AmountsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AmountsCapitalized_lbl" xml:lang="en-US">Amounts capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="FONR_SoftwareOrPatentsWrittenOff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareOrPatentsWrittenOff" xlink:to="FONR_SoftwareOrPatentsWrittenOff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareOrPatentsWrittenOff_lbl" xml:lang="en-US">Software or patents written off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_3_lbl" xml:lang="en-US">Balance - End of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableNature" xlink:label="us-gaap_DividendsPayableNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableNature" xlink:to="us-gaap_DividendsPayableNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableNature_lbl" xml:lang="en-US">Dividends Payable, Nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:to="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xml:lang="en-US">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common Stock, Voting Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SharesRegistered" xlink:label="FONR_SharesRegistered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesRegistered" xlink:to="FONR_SharesRegistered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesRegistered_lbl" xml:lang="en-US">Shares registered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other Selling, General and Administrative Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestTable_lbl" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OpeningMembersEquity" xlink:label="FONR_OpeningMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OpeningMembersEquity_lbl" xml:lang="en-US">Opening Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShareOfNetIncome" xlink:label="FONR_ShareOfNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShareOfNetIncome_lbl" xml:lang="en-US">Share of Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_Distributions" xlink:label="FONR_Distributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Distributions_lbl" xml:lang="en-US">Distributions</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EndingMembersEquity" xlink:label="FONR_EndingMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EndingMembersEquity_lbl" xml:lang="en-US">Ending Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipPercentageAcquired" xlink:label="FONR_OwnershipPercentageAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipPercentageAcquired" xlink:to="FONR_OwnershipPercentageAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipPercentageAcquired_lbl" xml:lang="en-US">Ownership Percentage Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="FONR_PurchaseOfStandupMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfStandupMriCenters" xlink:to="FONR_PurchaseOfStandupMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfStandupMriCenters_lbl" xml:lang="en-US">Purchase Of Standup Mri Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="FONR_PurchaseOfOtherMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfOtherMriCenters" xlink:to="FONR_PurchaseOfOtherMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfOtherMriCenters_lbl" xml:lang="en-US">Purchase Of Other Mri Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="FONR_ConsiderationToOutsideInvestors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationToOutsideInvestors" xlink:to="FONR_ConsiderationToOutsideInvestors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationToOutsideInvestors_lbl" xml:lang="en-US">Consideration To Outside Investors</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalPurchasePrice" xlink:label="FONR_TotalPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchasePrice" xlink:to="FONR_TotalPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalPurchasePrice_lbl" xml:lang="en-US">Total Purchase Price</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:to="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xml:lang="en-US">Consideration For Noncompetition And Consulting Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NumberOfInstallment" xlink:label="FONR_NumberOfInstallment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfInstallment" xlink:to="FONR_NumberOfInstallment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfInstallment_lbl" xml:lang="en-US">Number of installment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MaturityDate" xlink:label="FONR_MaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaturityDate" xlink:to="FONR_MaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BookValueOfBuilding" xlink:label="FONR_BookValueOfBuilding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BookValueOfBuilding" xlink:to="FONR_BookValueOfBuilding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BookValueOfBuilding_lbl" xml:lang="en-US">Book Value Of Building</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Long Term Debt, Notes Payable and Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt Instrument, Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2_lbl" xml:lang="en-US">Current portion of Long Term Debt, Notes Payable and Capital Leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_2_lbl" xml:lang="en-US">Long Term Debt, Notes Payable and Capital Leases less Current Portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Current:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Deferred:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State deferred taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision (Benefit) for Income Taxes - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Taxes at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local income taxes (benefit), net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Non Controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Expiration of tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Return to provision adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement_lbl" xml:lang="en-US">NYS Audit Settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in the valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Non-deductible accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_lbl" xml:lang="en-US">Other Operating Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xml:lang="en-US">Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US">Valuation Allowances and Reserves, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AdditionalTaxes" xlink:label="FONR_AdditionalTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AdditionalTaxes" xlink:to="FONR_AdditionalTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AdditionalTaxes_lbl" xml:lang="en-US">Additional Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Litigation accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xml:lang="en-US">Property Tax Abatement From Suffolk County IDA</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PropertyTaxAbatement" xlink:label="FONR_PropertyTaxAbatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatement_lbl" xml:lang="en-US">Property Tax Abatement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_LitigationSettelementDescription" xlink:label="FONR_LitigationSettelementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LitigationSettelementDescription" xlink:to="FONR_LitigationSettelementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LitigationSettelementDescription_lbl" xml:lang="en-US">Litigation Settelement Description</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xml:lang="en-US">Liability for individual claims</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SellingGeneralAndAdministrativeExpenses" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SellingGeneralAndAdministrativeExpenses" xlink:to="FONR_SellingGeneralAndAdministrativeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xml:lang="en-US">Related Party Transaction, Description of Transaction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total Revenues - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Intersegment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_lbl" xml:lang="en-US">Compensatory element of stock issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Total identifiable assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignProductSales" xlink:label="FONR_ForeignProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignProductSales_lbl" xml:lang="en-US">Foreign Product Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="FONR_ForeignServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignServiceAndRepairFees_lbl" xml:lang="en-US">Foreign Service and Repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:to="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Export Sales Of Medical Equipment Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:to="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Foreign Revenues Of Service And Repair Of Medical Equipment Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:label="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:to="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:label="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:to="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_lbl" xml:lang="en-US">Right to use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:label="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:to="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_lbl" xml:lang="en-US">Right to use liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xml:lang="en-US">Total purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClosingCostsExpensed" xlink:label="FONR_ClosingCostsExpensed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClosingCostsExpensed" xlink:to="FONR_ClosingCostsExpensed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClosingCostsExpensed_lbl" xml:lang="en-US">Closing costs - expensed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross" xlink:label="us-gaap_GoodwillGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillGross" xlink:to="us-gaap_GoodwillGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillGross_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BusinessCombinationContingentConsiderationAsset1" xlink:label="FONR_BusinessCombinationContingentConsiderationAsset1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BusinessCombinationContingentConsiderationAsset1" xlink:to="FONR_BusinessCombinationContingentConsiderationAsset1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BusinessCombinationContingentConsiderationAsset1_lbl" xml:lang="en-US">Cash Consideration Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xml:lang="en-US">Additions (Included in provision for bad debts)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xml:lang="en-US">Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_3_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:label="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:to="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings_lbl" xml:lang="en-US">Debtor-in-Possession Financing, Fee on Unused Borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Stock repurchase plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticEquipmentMember_doc" xml:lang="en-US">MRI Diagnostic Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_doc" xml:lang="en-US">Research Deveopment And Demonstration Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_doc" xml:lang="en-US">Number of management agreements with PC's owned by a relarted party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_doc" xml:lang="en-US">Total Imaging Centers with management agreements with Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_doc" xml:lang="en-US">Number of management agreements with PC's owned by two unrelated radiologists.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_doc" xml:lang="en-US">Minimum contractual fees for services rendered to the PC's.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticImagingFacilityMember_doc" xml:lang="en-US">Diagnostic Imaging Facility Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_doc" xml:lang="en-US">Maximum contractual fees for services rendered to the PC's.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShippingAndHandlingExpense" xlink:to="FONR_ShippingAndHandlingExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ShippingAndHandlingExpense_doc" xml:lang="en-US">Amount charged to shipping and handling expense for the period, which are expenses incurred with the objective of delivery of Fonar's products to its customers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_doc" xml:lang="en-US">Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedAcquisition" xlink:to="FONR_ManagedFacilitiesAddedAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesAddedAcquisition_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsIncurredOnUncompletedContracts_doc" xml:lang="en-US">Costs incurred on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EstimatedEarnings_doc" xml:lang="en-US">Estimated Earnings on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_doc" xml:lang="en-US">Costs and estimated earnings on uncompleted contracts in excess of billings means the current asset as of the closing date, as properly recorded on seller's balance sheet in accordance with GAAP, representing the amount, in the aggregate, earned on contracts but not yet invoiced to customers, as determined in accordance with GAAP.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BillingsToDate" xlink:to="FONR_BillingsToDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BillingsToDate_doc" xml:lang="en-US">Amount within current period that has been billed to customer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OpeningMembersEquity_doc" xml:lang="en-US">Opening Members Equity for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HDMEquityMember_doc" xml:lang="en-US">HDM Equity Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ShareOfNetIncome_doc" xml:lang="en-US">Share Of Net Income for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_Distributions_doc" xml:lang="en-US">Distributions to each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EndingMembersEquity_doc" xml:lang="en-US">Ending Members Equity for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBMember" xlink:to="FONR_ClassBMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassBMember_doc" xml:lang="en-US">The Class B Member havea 50.5% ownership interest of HDM.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAMember" xlink:to="FONR_ClassAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassAMember_doc" xml:lang="en-US">The Class A Member havea 49.5% ownership interest of HDM.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NotePayable1Member_doc" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_doc" xml:lang="en-US">The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PropertyTaxAbatement_doc" xml:lang="en-US">The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. The reserves are included in Other current liabilities' in the consolidated balance sheets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_doc" xml:lang="en-US">Bensonhurst MRI Limited Partnership.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ABillingCompanyMember" xlink:to="FONR_ABillingCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ABillingCompanyMember_doc" xml:lang="en-US">Company or entity owned by related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:to="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_doc" xml:lang="en-US">Manufacturing And Servicing Of Medical Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">Intersegment net revenues are the transfer or exchange of goods for monetary compensation between the management and diagnostic imaging center segment and the manufacturing and service segment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignProductSales_doc" xml:lang="en-US">Foreign Product Sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignServiceAndRepairFees_doc" xml:lang="en-US">Foreign Service And Repair Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_doc" xml:lang="en-US">Allowance For Doubtful Accounts Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_doc" xml:lang="en-US">Allowance For Doubtful Accounts Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:to="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent_2_lbl" xml:lang="en-US">Increase (Decrease) in Intangible Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnForgivenessOfPppLoan_2_lbl" xml:lang="en-US">GainOnForgivenessOfPppLoan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:to="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Commodity Contract Assets and Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInContractLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Short-Term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfImagingCenter" xlink:to="FONR_PurchaseOfImagingCenter_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfImagingCenter_2_lbl" xml:lang="en-US">PurchaseOfImagingCenter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfNoncontrollingInterests_2_lbl" xml:lang="en-US">PurchaseOfNoncontrollingInterests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xml:lang="en-US">Inventory Work in Process, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContracts_3_lbl" xml:lang="en-US">CostsAndEstimatedEarningsOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:to="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_2_lbl" xml:lang="en-US">CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_2_lbl" xml:lang="en-US">BuyoutOfNoncontrollingInterestsValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Repayments of Principal in Next 12 Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillGross" xlink:to="us-gaap_GoodwillGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillGross_2_lbl" xml:lang="en-US">Goodwill, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>fonr-20220630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20220630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20220630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20220630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20220630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilities" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20220630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20220630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20220630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20220630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20220630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20220630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion" xlink:href="fonr-20220630.xsd#Acquistion" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialData" xlink:href="fonr-20220630.xsd#QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20220630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20220630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20220630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20220630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20220630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AcquistionTables" xlink:href="fonr-20220630.xsd#AcquistionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialDataTables" xlink:href="fonr-20220630.xsd#QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20220630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20220630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:href="fonr-20220630.xsd#ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20220630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20220630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20220630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:href="fonr-20220630.xsd#OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20220630.xsd#OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20220630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20220630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20220630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20220630.xsd#Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20220630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20220630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20220630.xsd#IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20220630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20220630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20220630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20220630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:href="fonr-20220630.xsd#Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" xlink:href="fonr-20220630.xsd#Acquistion-NetAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20220630.xsd#AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:href="fonr-20220630.xsd#QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20220630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="loc_us-gaapOtherExpensesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BasicAndDilutedIncomePerShare" xlink:label="loc_FONRBasicAndDilutedIncomePerShare" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRBasicAndDilutedIncomePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageBasicAndDilutedSharesOutstanding" xlink:label="loc_FONRWeightedAverageBasicAndDilutedSharesOutstanding" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageBasicAndDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000006 - Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassANonVotingPreferredMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" xlink:label="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPaymentsOnNotesReceivableFromEmployeeStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxCreditsAndAdjustments" xlink:label="loc_us-gaapIncomeTaxCreditsAndAdjustments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeTaxCreditsAndAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CompensatoryElementOfStockIssuances" xlink:label="loc_FONRCompensatoryElementOfStockIssuances" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRCompensatoryElementOfStockIssuances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInIntangibleAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCommodityContractAssetsAndLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfImagingCenter" xlink:label="loc_FONRPurchaseOfImagingCenter" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_FONRPurchaseOfImagingCenter" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="loc_FONRPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_FONRPurchaseOfNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilities" xlink:title="00000011 - Disclosure - CONTRACT ASSETS AND LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_us-gaapScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="00000013 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000014 - Disclosure - OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000015 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="00000016 - Disclosure - CAPITAL STOCK">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:label="loc_FONRCapitalStockAndOptionsDisclosureTextblock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_FONRCapitalStockAndOptionsDisclosureTextblock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="00000017 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000018 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="loc_us-gaapDebtAndCapitalLeasesDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapDebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000019 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000020 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000022 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="00000023 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000024 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion" xlink:title="00000025 - Disclosure - ACQUISTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:title="00000026 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialData" xlink:title="00000027 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaapQuarterlyFinancialInformationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapQuarterlyFinancialInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="loc_us-gaapInventoryWorkInProcessPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:label="loc_FONRAcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRAcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShippingsAndHandlingCostPolicyTextBlock" xlink:label="loc_FONRShippingsAndHandlingCostPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRShippingsAndHandlingCostPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="loc_FONRCustomerAdvancesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRCustomerAdvancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" xlink:title="00000032 - Disclosure - CONTRACT ASSETS AND LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000033 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:label="loc_FONRLesseeOperatingLeaseLiabilityMaturityTableTextBlockc" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRLesseeOperatingLeaseLiabilityMaturityTableTextBlockc" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="00000037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000038 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="00000039 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000041 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ExportProductSalesTableTextBlock" xlink:label="loc_FONRExportProductSalesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportProductSalesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ExportServiceRevenuesTableTextBlock" xlink:label="loc_FONRExportServiceRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportServiceRevenuesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AcquistionTables" xlink:title="00000042 - Disclosure - ACQUISTION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:title="00000043 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialDataTables" xlink:title="00000044 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000045 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:label="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_FONRNetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShippingAndHandlingExpense" xlink:label="loc_FONRShippingAndHandlingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRShippingAndHandlingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000050 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000051 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagedFacilitiesAddedAcquisition" xlink:label="loc_FONRManagedFacilitiesAddedAcquisition" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="loc_FONRManagedFacilitiesAddedByInternalDevelopment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedByInternalDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="loc_FONRManagedFacilitiesClosedDuringYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesClosedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000052 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" xlink:title="00000053 - Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RegulatedOperationsAbstract" xlink:label="loc_us-gaapRegulatedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BillingsToDate" xlink:label="loc_FONRBillingsToDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRBillingsToDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:label="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRegulatedOperationsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000054 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000055 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000056 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DepreciatedAssetsWriteoff" xlink:label="loc_FONRDepreciatedAssetsWriteoff" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_FONRDepreciatedAssetsWriteoff" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000057 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="00000058 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" xlink:title="00000059 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="loc_FONRFinanceLeaseCostsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinanceLeaseCostsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="loc_FONRDepreciationOfLeasedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRDepreciationOfLeasedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaapFinanceLeaseInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_us-gaapFinanceLeaseInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinanceLeaseCost" xlink:label="loc_FONRFinanceLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRFinanceLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" xlink:title="00000060 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="loc_FONROperatingCashFlowsFromOperatingLeases" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONROperatingCashFlowsFromOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="loc_FONRFinancingCashFlowsFromFinancingLeases" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinancingCashFlowsFromFinancingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000061 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" xlink:title="00000062 - Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000063 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AmountsCapitalized" xlink:label="loc_FONRAmountsCapitalized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRAmountsCapitalized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="loc_FONRSoftwareOrPatentsWrittenOff" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRSoftwareOrPatentsWrittenOff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000064 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="00000065 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000066 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapMinorityInterestLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000067 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassBMember" xlink:label="loc_FONRClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClassAMember" xlink:label="loc_FONRClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OutsideInvestorsMember" xlink:label="loc_FONROutsideInvestorsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_FONROutsideInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_OwnershipPercentageAcquired" xlink:label="loc_FONROwnershipPercentageAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONROwnershipPercentageAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000068 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NotePayable3Member" xlink:label="loc_FONRNotePayable3Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_NumberOfInstallment" xlink:label="loc_FONRNumberOfInstallment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRNumberOfInstallment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000069 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="00000070 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000071 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:label="loc_FONREffectiveIncomeTaxRateReconciliationNysAuditSettlement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONREffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000072 - Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000073 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaapTaxCreditCarryforwardAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapTaxCreditCarryforwardAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AdditionalTaxes" xlink:label="loc_FONRAdditionalTaxes" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRAdditionalTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000074 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PropertyTaxAbatement" xlink:label="loc_FONRPropertyTaxAbatement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRPropertyTaxAbatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_LitigationSettelementDescription" xlink:label="loc_FONRLitigationSettelementDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRLitigationSettelementDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000076 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_SellingGeneralAndAdministrativeExpenses" xlink:label="loc_FONRSellingGeneralAndAdministrativeExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_FONRSellingGeneralAndAdministrativeExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ABillingCompanyMember" xlink:label="loc_FONRABillingCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRABillingCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000078 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000079 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DO" xlink:label="loc_countryDO" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000080 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH" xlink:label="loc_countryCH" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GR" xlink:label="loc_countryGR" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000081 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="loc_FONRExportSalesOfMedicalEquipmentPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportSalesOfMedicalEquipmentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" xlink:title="00000082 - Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:label="loc_us-gaapPublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapPublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:label="loc_FONRPublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_FONRPublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:label="loc_FONRPublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_FONRPublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAsset" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAsset" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" xlink:title="00000083 - Disclosure - ACQUISTION - Net assets acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_RocklandManagementGroupMember" xlink:label="loc_FONRRocklandManagementGroupMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRocklandManagementGroupMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerListsMember" xlink:label="loc_us-gaapCustomerListsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerListsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_CovenantNotToCompeteMember" xlink:label="loc_FONRCovenantNotToCompeteMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRCovenantNotToCompeteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ClosingCostsExpensed" xlink:label="loc_FONRClosingCostsExpensed" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRClosingCostsExpensed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaapGoodwillGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwillGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_BusinessCombinationContingentConsiderationAsset1" xlink:label="loc_FONRBusinessCombinationContingentConsiderationAsset1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_FONRBusinessCombinationContingentConsiderationAsset1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:title="00000084 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" xlink:title="00000085 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220630.xsd#FONR_QuarterlyFinancialDataMember" xlink:label="loc_FONRQuarterlyFinancialDataMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRQuarterlyFinancialDataMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:label="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtorInPossessionFinancingFeeOnUnusedBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>fonr-20220630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8KlZs7xRiXgen8uCandcSaWB+cPtxJFzqZkhv2pxfbnKTy0lqBz/MiSlQa9m8bIC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:FONR="http://fonar.com/20220630" elementFormDefault="qualified" targetNamespace="http://fonar.com/20220630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical" id="ConsolidatedStatementsOfIncomeParenthetical">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
	  <link:definition>00000006 - Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" id="DescriptionOfBusinessAndLiquidityAndCapitalResources">
	  <link:definition>00000008 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
	  <link:definition>00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ContractAssetsAndLiabilities" id="ContractAssetsAndLiabilities">
	  <link:definition>00000011 - Disclosure - CONTRACT ASSETS AND LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
	  <link:definition>00000012 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000013 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases" id="OperatingFinancingLeases">
	  <link:definition>00000014 - Disclosure - OPERATING &amp; FINANCING LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
	  <link:definition>00000015 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CapitalStock" id="CapitalStock">
	  <link:definition>00000016 - Disclosure - CAPITAL STOCK</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" id="ControllingAndNoncontrollingInterests">
	  <link:definition>00000017 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" id="Long-termDebtNotesPayableAndCapitalLeases">
	  <link:definition>00000018 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000019 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
	  <link:definition>00000020 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
	  <link:definition>00000022 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000023 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
	  <link:definition>00000024 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Acquistion" id="Acquistion">
	  <link:definition>00000025 - Disclosure - ACQUISTION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" id="AllowanceForDoubtfulAccounts">
	  <link:definition>00000026 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/QuarterlyFinancialData" id="QuarterlyFinancialData">
	  <link:definition>00000027 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000028 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
	  <link:definition>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ContractAssetsAndLiabilitiesTables" id="ContractAssetsAndLiabilitiesTables">
	  <link:definition>00000032 - Disclosure - CONTRACT ASSETS AND LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000033 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" id="OperatingFinancingLeasesTables">
	  <link:definition>00000035 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
	  <link:definition>00000036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" id="ControllingAndNoncontrollingInterestsTables">
	  <link:definition>00000037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" id="Long-termDebtNotesPayableAndCapitalLeasesTables">
	  <link:definition>00000038 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000039 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
	  <link:definition>00000040 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
	  <link:definition>00000041 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AcquistionTables" id="AcquistionTables">
	  <link:definition>00000042 - Disclosure - ACQUISTION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" id="AllowanceForDoubtfulAccountsTables">
	  <link:definition>00000043 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/QuarterlyFinancialDataTables" id="QuarterlyFinancialDataTables">
	  <link:definition>00000044 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" id="DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative">
	  <link:definition>00000045 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" id="SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details">
	  <link:definition>00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" id="SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1">
	  <link:definition>00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
	  <link:definition>00000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
	  <link:definition>00000050 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails">
	  <link:definition>00000051 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
	  <link:definition>00000052 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details" id="ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details">
	  <link:definition>00000053 - Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
	  <link:definition>00000054 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" id="PropertyAndEquipment-PropertyAndEquipmentDetails">
	  <link:definition>00000055 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000056 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
	  <link:definition>00000057 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" id="OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails">
	  <link:definition>00000058 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails" id="OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails">
	  <link:definition>00000059 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails" id="OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails">
	  <link:definition>00000060 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
	  <link:definition>00000061 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details" id="OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details">
	  <link:definition>00000062 - Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" id="OtherIntangibleAssets-ScheduleOfIntangleAssets-Details">
	  <link:definition>00000063 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000064 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" id="CapitalStockDetailsNarrative">
	  <link:definition>00000065 - Disclosure - CAPITAL STOCK (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" id="ControllingAndNoncontrollingInterests-HdmMembersEquityDetails">
	  <link:definition>00000066 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" id="ControllingAndNoncontrollingInterestsDetailsNarrative">
	  <link:definition>00000067 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details" id="Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details">
	  <link:definition>00000068 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" id="Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details">
	  <link:definition>00000069 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" id="IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails">
	  <link:definition>00000070 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" id="IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails">
	  <link:definition>00000071 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" id="IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details">
	  <link:definition>00000072 - Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000073 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
	  <link:definition>00000074 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
	  <link:definition>00000076 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" id="SegmentAndRelatedInformation-SumarizedSegments-Details">
	  <link:definition>00000078 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" id="SegmentAndRelatedInformation-ForeignProductSales-Details">
	  <link:definition>00000079 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" id="SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details">
	  <link:definition>00000080 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" id="SegmentAndRelatedInformationDetailsNarrative">
	  <link:definition>00000081 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails" id="Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails">
	  <link:definition>00000082 - Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails" id="Acquistion-NetAssetsAcquiredDetails">
	  <link:definition>00000083 - Disclosure - ACQUISTION - Net assets acquired (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" id="AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails">
	  <link:definition>00000084 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details" id="QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details">
	  <link:definition>00000085 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredMember" name="ClassANonVotingPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassCCommonStockMember" name="ClassCCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ControllingInterestMember" name="ControllingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticImagingFacilityMember" name="DiagnosticImagingFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" name="NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipmentMember" name="DiagnosticEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" name="ResearchDeveopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_N2010StockBonusPlanMember" name="N2010StockBonusPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMEquityMember" name="HDMEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassBMember" name="ClassBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMMember" name="HDMMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassAMember" name="ClassAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OutsideInvestorsMember" name="OutsideInvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable1Member" name="NotePayable1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable2Member" name="NotePayable2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable3Member" name="NotePayable3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ABillingCompanyMember" name="ABillingCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BensonhurstMRILimitedPartnershipMember" name="BensonhurstMRILimitedPartnershipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" name="ManufacturingAndServicingOfMedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RocklandManagementGroupMember" name="RocklandManagementGroupMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CovenantNotToCompeteMember" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableMember" name="ManagementAndOtherFeesReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" name="ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_QuarterlyFinancialDataMember" name="QuarterlyFinancialDataMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" name="ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" name="RelatedPartyReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BasicAndDilutedIncomePerShare" name="BasicAndDilutedIncomePerShare" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageBasicAndDilutedSharesOutstanding" name="WeightedAverageBasicAndDilutedSharesOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" name="StockIssuedToEmployeesUnderStockBonusPlansValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PaymentsOnNotesReceivableFromEmployeeStockholders" name="PaymentsOnNotesReceivableFromEmployeeStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterests" name="BuyoutOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CompensatoryElementOfStockIssuances" name="CompensatoryElementOfStockIssuances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnForgivenessOfPppLoan" name="GainOnForgivenessOfPppLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInContractLiabilities" name="IncreaseDecreaseInContractLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfImagingCenter" name="PurchaseOfImagingCenter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfNoncontrollingInterests" name="PurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingFinancingLeasesAbstract" name="DisclosureOperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureCapitalStockAbstract" name="DisclosureCapitalStockAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalStockAndOptionsDisclosureTextblock" name="CapitalStockAndOptionsDisclosureTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" name="AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShippingsAndHandlingCostPolicyTextBlock" name="ShippingsAndHandlingCostPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesPolicyTextBlock" name="CustomerAdvancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" name="EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" name="LesseeOperatingLeaseLiabilityMaturityTableTextBlockc" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportProductSalesTableTextBlock" name="ExportProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportServiceRevenuesTableTextBlock" name="ExportServiceRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" name="OwnershipInterestOfOriginalInvestorsOfHdm" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestorsOwnershipInterest" name="InvestorsOwnershipInterest" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetPatientFeeRevenue" name="NetPatientFeeRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageSharesOutstandingBasic" name="WeightedAverageSharesOutstandingBasic" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" name="IncrementalCommonSharesAttributableToConversionOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" name="ManagementAgreementsWithCompanyTotalMedicalPractices" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" name="ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" name="ScannersWithManagementWithCompanyLocatedInNewYorkState" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMinimum" name="ContractualFeesForServicesRenderedMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMaximum" name="ContractualFeesForServicesRenderedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShippingAndHandlingExpense" name="ShippingAndHandlingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" name="NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" name="TotalFacilitiesOwnedOrManagedAtBeginningOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedAcquisition" name="ManagedFacilitiesAddedAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedByInternalDevelopment" name="ManagedFacilitiesAddedByInternalDevelopment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesClosedDuringYear" name="ManagedFacilitiesClosedDuringYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" name="TotalFacilitiesOwnedOrManagedAtEndOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsIncurredOnUncompletedContracts" name="CostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedEarnings" name="EstimatedEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsOnUncompletedContracts" name="CostsAndEstimatedEarningsOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BillingsToDate" name="BillingsToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" name="CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciatedAssetsWriteoff" name="DepreciatedAssetsWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciationOfLeasedEquipment" name="DepreciationOfLeasedEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingCashFlowsFromOperatingLeases" name="OperatingCashFlowsFromOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingCashFlowsFromFinancingLeases" name="FinancingCashFlowsFromFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AmountsCapitalized" name="AmountsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareOrPatentsWrittenOff" name="SoftwareOrPatentsWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesRegistered" name="SharesRegistered" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OpeningMembersEquity" name="OpeningMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShareOfNetIncome" name="ShareOfNetIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterestsValue" name="BuyoutOfNoncontrollingInterestsValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Distributions" name="Distributions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EndingMembersEquity" name="EndingMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipPercentageAcquired" name="OwnershipPercentageAcquired" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfStandupMriCenters" name="PurchaseOfStandupMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfOtherMriCenters" name="PurchaseOfOtherMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationToOutsideInvestors" name="ConsiderationToOutsideInvestors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalPurchasePrice" name="TotalPurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" name="ConsiderationForNoncompetitionAndConsultingAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfInstallment" name="NumberOfInstallment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaturityDate" name="MaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BookValueOfBuilding" name="BookValueOfBuilding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" name="EffectiveIncomeTaxRateReconciliationNysAuditSettlement" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AdditionalTaxes" name="AdditionalTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatementFromSuffolkCountyIda" name="PropertyTaxAbatementFromSuffolkCountyIda" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatement" name="PropertyTaxAbatement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LitigationSettelementDescription" name="LitigationSettelementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" name="StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SellingGeneralAndAdministrativeExpenses" name="SellingGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignProductSales" name="ForeignProductSales" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignServiceAndRepairFees" name="ForeignServiceAndRepairFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportSalesOfMedicalEquipmentPercentage" name="ExportSalesOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" name="ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" name="PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" name="PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClosingCostsExpensed" name="ClosingCostsExpensed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BusinessCombinationContingentConsiderationAsset1" name="BusinessCombinationContingentConsiderationAsset1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsAdditions" name="AllowanceForDoubtfulAccountsAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsDeductions" name="AllowanceForDoubtfulAccountsDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888056832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887614320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 48,722,977<span></span>
</td>
<td class="nump">$ 44,460,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investments</a></td>
<td class="nump">32,326<span></span>
</td>
<td class="nump">32,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable &#8211; net of allowances for doubtful accounts of $204,597 and $442,270 at June 30, 2022 and 2021, respectively</a></td>
<td class="nump">4,335,956<span></span>
</td>
<td class="nump">4,525,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">Accounts receivable &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables &#8211; net</a></td>
<td class="nump">20,108,989<span></span>
</td>
<td class="nump">17,900,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $16,627,917 and $15,786,878 at June 30, 2022 and 2021, respectively</a></td>
<td class="nump">33,419,219<span></span>
</td>
<td class="nump">30,947,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $4,686,893 and $4,184,399 at June 30, 2022 and 2021, respectively</a></td>
<td class="nump">8,602,561<span></span>
</td>
<td class="nump">7,814,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">2,359,821<span></span>
</td>
<td class="nump">1,663,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,104,325<span></span>
</td>
<td class="nump">1,227,463<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">118,686,174<span></span>
</td>
<td class="nump">108,583,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">1,871,890<span></span>
</td>
<td class="nump">2,879,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">12,842,478<span></span>
</td>
<td class="nump">15,958,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment &#8211; net</a></td>
<td class="nump">22,281,791<span></span>
</td>
<td class="nump">21,850,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; operating leases</a></td>
<td class="nump">34,232,109<span></span>
</td>
<td class="nump">30,133,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; financing lease</a></td>
<td class="nump">928,109<span></span>
</td>
<td class="nump">1,126,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269,277<span></span>
</td>
<td class="nump">4,269,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">3,703,885<span></span>
</td>
<td class="nump">4,037,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">526,269<span></span>
</td>
<td class="nump">666,514<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">199,341,982<span></span>
</td>
<td class="nump">189,506,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and capital leases</a></td>
<td class="nump">40,078<span></span>
</td>
<td class="nump">173,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,551,269<span></span>
</td>
<td class="nump">1,866,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">6,417,227<span></span>
</td>
<td class="nump">9,162,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability &#8211; current portion</a></td>
<td class="nump">3,880,129<span></span>
</td>
<td class="nump">3,533,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability &#8211; current portion</a></td>
<td class="nump">210,140<span></span>
</td>
<td class="nump">202,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">4,288,766<span></span>
</td>
<td class="nump">4,365,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">361,245<span></span>
</td>
<td class="nump">731,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,739<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">16,748,854<span></span>
</td>
<td class="nump">20,049,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">1,857,257<span></span>
</td>
<td class="nump">2,800,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">215,726<span></span>
</td>
<td class="nump">238,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent', window );">Due to related party medical practices</a></td>
<td class="nump">92,663<span></span>
</td>
<td class="nump">92,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">33,090,990<span></span>
</td>
<td class="nump">28,975,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">838,291<span></span>
</td>
<td class="nump">1,048,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">155,379<span></span>
</td>
<td class="nump">760,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">106,541<span></span>
</td>
<td class="nump">171,331<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">36,356,847<span></span>
</td>
<td class="nump">34,086,649<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">53,105,701<span></span>
</td>
<td class="nump">54,136,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">184,531,535<span></span>
</td>
<td class="nump">185,100,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(33,566,757)<span></span>
</td>
<td class="num">(46,007,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 11,643 shares of common stock at June 30, 2022 and 2021</a></td>
<td class="num">(675,390)<span></span>
</td>
<td class="num">(675,390)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">150,290,114<span></span>
</td>
<td class="nump">138,418,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(4,053,833)<span></span>
</td>
<td class="num">(3,048,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">146,236,281<span></span>
</td>
<td class="nump">135,370,125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">199,341,982<span></span>
</td>
<td class="nump">189,506,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887536832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for Doubtful Accounts Receivables</a></td>
<td class="nump">$ 204,597<span></span>
</td>
<td class="nump">$ 442,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts', window );">Management and other receivable allowances for doubtful accounts</a></td>
<td class="nump">16,627,917<span></span>
</td>
<td class="nump">15,786,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts', window );">Related party receivable allowances for doubtful accounts</a></td>
<td class="nump">$ 4,686,893<span></span>
</td>
<td class="nump">$ 4,184,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">11,643<span></span>
</td>
<td class="nump">11,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">453,000<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,565,853<span></span>
</td>
<td class="nump">6,565,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,554,210<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887748208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 29,582,238<span></span>
</td>
<td class="nump">$ 23,307,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">517,939<span></span>
</td>
<td class="nump">1,288,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">7,590,865<span></span>
</td>
<td class="nump">7,638,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees &#8211; related parties &#8211; net</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">48,226,787<span></span>
</td>
<td class="nump">46,609,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees &#8211; related party medical practices &#8211; net</a></td>
<td class="nump">11,564,316<span></span>
</td>
<td class="nump">10,975,836<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">97,592,145<span></span>
</td>
<td class="nump">89,929,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">416,814<span></span>
</td>
<td class="nump">1,032,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">2,991,069<span></span>
</td>
<td class="nump">2,740,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees &#8211; related parties</a></td>
<td class="nump">43,344<span></span>
</td>
<td class="nump">39,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">13,307,819<span></span>
</td>
<td class="nump">10,917,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">27,251,268<span></span>
</td>
<td class="nump">25,384,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related party medical practices</a></td>
<td class="nump">6,567,887<span></span>
</td>
<td class="nump">6,341,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,494,181<span></span>
</td>
<td class="nump">1,635,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative, inclusive of compensatory element of stock issuances of $0 and $83,277 for the years ended June 30, 2022 and 2021 respectively</a></td>
<td class="nump">23,512,581<span></span>
</td>
<td class="nump">24,740,044<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">75,584,963<span></span>
</td>
<td class="nump">72,832,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income from Operations</a></td>
<td class="nump">22,007,182<span></span>
</td>
<td class="nump">17,097,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(346,552)<span></span>
</td>
<td class="num">(248,665)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">247,158<span></span>
</td>
<td class="nump">311,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">861,087<span></span>
</td>
<td class="nump">504,450<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes and noncontrolling interests</a></td>
<td class="nump">22,768,875<span></span>
</td>
<td class="nump">17,665,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(5,534,487)<span></span>
</td>
<td class="num">(3,991,520)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">17,234,388<span></span>
</td>
<td class="nump">13,673,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Noncontrolling Interests</a></td>
<td class="num">(4,793,482)<span></span>
</td>
<td class="num">(3,466,223)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">12,440,906<span></span>
</td>
<td class="nump">10,207,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common&#160;Stockholders</a></td>
<td class="nump">$ 11,690,796<span></span>
</td>
<td class="nump">$ 9,592,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">6,554,209<span></span>
</td>
<td class="nump">6,505,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">6,681,713<span></span>
</td>
<td class="nump">6,632,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredMember', window );">Class A Non Voting Preferred [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Attributable to FONAR</a></td>
<td class="nump">$ 559,072<span></span>
</td>
<td class="nump">$ 458,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common&#160;Stockholders</a></td>
<td class="nump">$ 191,038<span></span>
</td>
<td class="nump">$ 156,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BasicAndDilutedIncomePerShare', window );">Basic And Diluted Income Per Share</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageBasicAndDilutedSharesOutstanding', window );">Weighted Average Basic and Diluted Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BasicAndDilutedIncomePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BasicAndDilutedIncomePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageBasicAndDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageBasicAndDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888054416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Stock Issued During Period, Value, Employee Benefit Plan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 83,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888193696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Class A Non Voting Preferred [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Class C Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 183,076,888<span></span>
</td>
<td class="num">$ (56,215,251)<span></span>
</td>
<td class="num">$ (675,390)<span></span>
</td>
<td class="nump">$ 55,253<span></span>
</td>
<td class="nump">$ 126,242,216<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, Shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,447,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,207,588<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,466,223<span></span>
</td>
<td class="nump">13,673,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue', window );">Stock issued to employees under stock bonus plans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,024,088<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,024,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued to employees under stock bonus plans, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PaymentsOnNotesReceivableFromEmployeeStockholders', window );">Payments on notes receivable from employee stockholders</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,570,000)<span></span>
</td>
<td class="num">(6,570,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">185,100,976<span></span>
</td>
<td class="num">(46,007,663)<span></span>
</td>
<td class="num">(675,390)<span></span>
</td>
<td class="num">(3,048,524)<span></span>
</td>
<td class="nump">135,370,125<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,440,906<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,793,482<span></span>
</td>
<td class="nump">17,234,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue', window );">Stock issued to employees under stock bonus plans</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,822,232)<span></span>
</td>
<td class="num">(5,822,232)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterests', window );">Buyout of noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(569,441)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,441<span></span>
</td>
<td class="num">(546,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 184,531,535<span></span>
</td>
<td class="num">$ (33,566,757)<span></span>
</td>
<td class="num">$ (675,390)<span></span>
</td>
<td class="num">$ (4,053,833)<span></span>
</td>
<td class="nump">$ 146,236,281<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PaymentsOnNotesReceivableFromEmployeeStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PaymentsOnNotesReceivableFromEmployeeStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockIssuedToEmployeesUnderStockBonusPlansValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887463008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 17,234,388<span></span>
</td>
<td class="nump">$ 13,673,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,535,236<span></span>
</td>
<td class="nump">4,081,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="nump">1,343,533<span></span>
</td>
<td class="nump">5,585,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax - net</a></td>
<td class="nump">3,093,893<span></span>
</td>
<td class="nump">2,855,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxCreditsAndAdjustments', window );">Income tax receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">671,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">4,000,131<span></span>
</td>
<td class="nump">1,458,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CompensatoryElementOfStockIssuances', window );">Compensatory element of stock issuances</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">83,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock issued for costs and expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,940,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent', window );">Abandoned patents</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnForgivenessOfPppLoan', window );">Gain on forgiveness of PPP loan</a></td>
<td class="num">(700,764)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>&#160;(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivables</a></td>
<td class="num">(5,602,188)<span></span>
</td>
<td class="num">(12,110,859)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">43,334<span></span>
</td>
<td class="nump">46,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities', window );">Contract assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">152,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(696,402)<span></span>
</td>
<td class="num">(14,649)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">90,638<span></span>
</td>
<td class="nump">526,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">129,411<span></span>
</td>
<td class="num">(18,087)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(314,766)<span></span>
</td>
<td class="num">(99,224)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(3,765,215)<span></span>
</td>
<td class="nump">1,382,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer advances</a></td>
<td class="num">(369,856)<span></span>
</td>
<td class="num">(123,478)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(3,437,743)<span></span>
</td>
<td class="num">(965,825)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(202,741)<span></span>
</td>
<td class="num">(74,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInContractLiabilities', window );">Contract liabilities</a></td>
<td class="num">(14,739)<span></span>
</td>
<td class="nump">14,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(64,790)<span></span>
</td>
<td class="nump">21,020<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">15,301,360<span></span>
</td>
<td class="nump">19,088,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(4,545,292)<span></span>
</td>
<td class="num">(3,533,091)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Proceeds of Short term investment</a></td>
<td class="num">(149)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfImagingCenter', window );">Purchase of imaging center</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,122,508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfNoncontrollingInterests', window );">Purchase of noncontrolling interests</a></td>
<td class="num">(546,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(87,882)<span></span>
</td>
<td class="num">(163,705)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(5,179,323)<span></span>
</td>
<td class="num">(4,819,597)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>&#160;&#160;CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(37,239)<span></span>
</td>
<td class="num">(103,335)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">63,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(5,822,232)<span></span>
</td>
<td class="num">(6,570,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(5,859,471)<span></span>
</td>
<td class="num">(6,610,335)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">&#160;&#160;NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">4,262,566<span></span>
</td>
<td class="nump">7,658,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</a></td>
<td class="nump">44,460,411<span></span>
</td>
<td class="nump">36,802,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - END OF YEAR</a></td>
<td class="nump">$ 48,722,977<span></span>
</td>
<td class="nump">$ 44,460,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CompensatoryElementOfStockIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CompensatoryElementOfStockIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnForgivenessOfPppLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnForgivenessOfPppLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfImagingCenter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfImagingCenter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxCreditsAndAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxCreditsAndAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the assets (liabilities) created through trading commodity-based derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647894485168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z6FWKRWWwiti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 1 - <span id="xdx_824_zcWilvpZw2v8">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Description of Business</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR Corporation (the &#8220;Company&#8221;
or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development,
production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (&#8220;MRI&#8221;)
for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue
is also generated from our installed-base of customers through our service and upgrade programs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FONAR, through its wholly-owned subsidiary Health
Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services to diagnostic imaging facilities.
The services provided by the Company include development, administration, leasing of office space, facilities and medical equipment,
provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and
the development and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On July 1, 2015, the Company restructured the
corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured
to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its
assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a <span id="xdx_908_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zVledUT1JIld" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM">24.2</span>% interest in
HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_904_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zbsjXz6Cl608" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM">45.8</span>% in HDM, and the original investors
in HDM retained a <span id="xdx_908_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zbAn3tom4SHe" title="The ownership interest of the original investors of HDM">30.0</span>% ownership interest in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased
noncontrolling interests for $<span id="xdx_903_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zYdU0FUmKFo1" title="Direct purchase of Noncontrolling Interests">546,000</span> giving the Company a direct ownership interest of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zWm28rgveXs4" title="Direct ownership interest percentage">70.8</span>% and the investors&#8217; a <span id="xdx_909_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvf3LZCAv4g4" title="Investors ownership interest percentage">29.2</span>%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Since March 2020 the global pandemic of COVID-19
has caused turbulence and uncertainty in the United States and international markets and economies which has adversely effected
our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally COVID-19 had caused
us to require that much of our workforce work from home and has restricted the ability of our personnel to travel for marketing
purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and the Company
has been steadily recovering to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able to enact
certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in
scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#8216;PPP&#8217;)
program and Medicare advances/stimulus payments. The Company has been able to navigate through these challenges and avoid any significant
disruption of the business and the volume has risen back almost to pre-COVID-19 levels. Although we are unable to predict if there
will be additional consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with the
positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>













<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647894434064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zFJ3Ghytmqf8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 2 - <span id="xdx_823_zEmq0lRkCRYb">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zhbi3hTxA9j3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_z4V2tXknNPO">Principles of Consolidation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries
are included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and
transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--UseOfEstimates_zW2tjBTF4hlf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zAuKG9x0bGG8">Use of Estimates</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances,
intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results
could differ from those estimates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zjn9coHxVAZ3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zOgHJgwbyVjc">Inventories</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or
market.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdGbWiADEDZd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zXtiZqdmIKmf">Property and Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Property and equipment procured in the normal
course of business is stated at cost. Property and equipment purchased in connection with an acquisition is stated at its estimated
fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes using
the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the
useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair
expenses totaled approximately $<span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zDFmObhw18Y4" title="Cost of Property Repairs and Maintenance">2,783,000</span> and $<span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20200701__20210630_zScKC7zCQdh7" title="Cost of Property Repairs and Maintenance">2,051,000</span> for the years ended June 30, 2022 and 2021 respectively. The estimated
useful lives in years are generally as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span><span><span id="xdx_8BD_zvpahj8xZRla" style="display: none">Estimated Useful Life in Years for Property and Equipment</span></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life">5</span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life">13</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life">2</span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life">9</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life">3</span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life">10</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 70%; text-align: left">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life">28</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zITbjaKe7DUb" style="margin-top: 0; margin-bottom: 0">&#160;</p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zynPpkCYR1Fb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zcqFm0Pfc9Rd">Long-Lived Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrmYFHssiwJg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_864_zf3iIAtJQRzh">Other Intangible Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization is calculated on the straight-line
basis over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlJfGCwryDV7" title="Finite-Lived Intangible Asset, Useful Life">15</span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The non-competition agreements are being amortized
on the straight-line basis over the length of the agreement (<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zKDhj6ZLxGui" title="Finite-Lived Intangible Asset, Useful Life">7</span> years).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization is calculated on the straight line
basis over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z2gqdw2o34q6" title="Finite-Lived Intangible Asset, Useful Life">20</span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdGP3Qctnpu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zdJtbSSD5BEi">Goodwill</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Generally accepted accounting principles in
the United States require the Company to perform a goodwill impairment test annually at the end of each fiscal year and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing
the reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount
of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure
the amount of impairment loss, if any.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_z5e26zwQH4Ei" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_z96kijWctiH4">Acquired assets and assumed liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Pursuant to ASC No. 805, if the initial accounting
for a business combination is incomplete by the end of the reporting period in which the combination occurs, but during the allowed
measurement period not to exceed one year from the acquisition date, the Company adjusts the provisional amounts recognized at
the acquisition date by means of adjusting the amount recognized for goodwill.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zvSI8n2XqeMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86D_zQlfzqL2fKec">Revenue Recognition</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type and Production-Type Contracts&#8221;.
The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation
take approximately three to six months.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements
with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2022, the Company has <span id="xdx_90D_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20220630_z6L6C4gwEBP" title="Management Agreements With Company Total Medical Practices">22</span> management agreements of which
<span id="xdx_90E_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20220630_zsk0ew7HMJk5" title="Scanners With Management Agreements With Company Owned By Related Party">3</span> were with PC&#8217;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August
2022 (&#8220;the Related medical practices&#8221;) and <span id="xdx_90C_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20220630_zpBwKMne0bT" title="Scanners With Management With Company Located In New York State">19</span> are with PC&#8217;s, which are all located in the state of New York (&#8220;the
New York PC&#8217;s&#8221;), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists
of fixed monthly fees per diagnostic imaging facility ranging from approximately $<span id="xdx_901_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zm43feHIJr3l" title="Contractual Fees For Services Rendered Minimum">77,000</span> to $<span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zBy7pd9XrXg8" title="Contractual Fees For Services Rendered Maximum">447,000</span>. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts for estimated uncollectible
fees, which is reflected in other operating expenses on the Statement of Operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in
accordance with the recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and
codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive
model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred
to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#8217;s
revenue recognition policies and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our revenues generally relate to net patient
fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are
satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The
contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health
plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices
for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health
plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services
we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for
payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed
care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net
of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2022 and 2021 are summarized
in the following table.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_z9YdlB0MD1B2" style="display: none">Patient Fee Revenue - Net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">4,248,708</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">4,100,440</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Medicare/Medicaid</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">1,060,920</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">968,055</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Workers&#8217; Compensation/Personal Injury</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">17,907,335</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">15,011,111</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">6,365,275</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">3,227,783</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Patient Fee Revenue</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">29,582,238</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">23,307,389</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AD_zx5VssEByjTi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zp2w9ck6KI3g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zfdYqShhr9A4">Research and Development Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development costs are charged to
expense as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have
alternative future uses (either in research and development, marketing or production), are classified as property and equipment
and depreciated over their estimated useful lives.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p id="xdx_840_eus-gaap--AdvertisingCostsPolicyTextBlock_zgiPSJaqHakj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_866_zyTu0TXPoUU3">Advertising Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
Advertising expense approximated $<span id="xdx_90A_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zEDwvMXUE5sc" title="Advertising Expense">634,000</span> and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20200701__20210630_zuylYwrTstAf" title="Advertising Expense">633,000</span> and for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zok9ZtT4i2X3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zrstrd7HC9we">Shipping Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s shipping and handling costs
are included in revenue from product sales and the related expense included in costs related to product sales is $<span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20210701__20220630_zPTs1J6quhqf" title="Shipping and Handling Costs">7,391</span> and $<span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20200701__20210630_z2QSYSqKf0i5" title="Shipping and Handling Costs">8,215</span>
for the years ended June 30, 2022 and 2021 respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zTjT6586g2me" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_869_zaQ5rvhbATwi">Income Taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted
tax rates in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_ecustom--CustomerAdvancesPolicyTextBlock_zKENiTEA65vc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zKXf0DeR9vhf">Customer Advances</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash advances and progress payments received
on sales orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zut1uWwG07eh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_860_zs5Ug5vMExW">Earnings Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;)
is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding
during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company
used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings
per share for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the years ended June 30, 2022 and 2021, diluted EPS for common shareholders includes <span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20200701__20210630_zHBoHY9qoXLl" title="Diluted EPS"><span id="xdx_90E_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_z9cegbWLW887">127,504</span></span>
shares upon conversion of Class C Common.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>























<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">12,440,906</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">11,690,796</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">191,038</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right">6,554,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right">6,554,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right">1.90</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right">1.78</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right">6,554,209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right">6,681,713</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right">1.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Net income available to common stockholders</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders">10,207,588</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,592,134</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">156,744</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Weighted average shares outstanding</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding">6,505,283</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,505,283</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Basic income per common share</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Income Per Common Share">1.57</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.47</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.41</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Weighted average shares outstanding">6,505,283</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">127,504</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share">6,632,787</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share">1.45</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.41</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A0_z43u6FJd66Gc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zlFV42B3YLs1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86F_zZ3ADZgTaWm2">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand,
cash in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlNuzplzPZIj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zK94v8u2l1u1">Short Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Short term investments include certificates
of deposit with original maturities of greater than 90 days.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zYpbmJyCMqud" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zX4Gt6CN9Wpc">Concentration of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash
equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2022, the
Company had cash on deposit of approximately $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20220630_z3Fmvc96KSof" title="Cash">46,834,000</span> in excess of federally insured limits of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220630_z3qXwL6lOTo5" title="Cash, FDIC Insured Amount">250,000</span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYZs5IumK6p5" title="Concentration Risk, Percentage"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zY8R7dIiJkOc" title="Concentration Risk, Percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2022 and 2021. Net management fee
receivables from the related party medical practices accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zYMlAs1KlfHh" title="Concentration Risk, Percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zV7jmF8YrJib" title="Concentration Risk, Percentage">13</span></span>% of the consolidated accounts receivable for
the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUCYmnRf7fB8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zAo126oFXqSf">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The financial statements include various estimated
fair value information at June 30, 2022 and 2021, as required by ASC topic 820, &#8220;Disclosures about Fair Value of Financial
Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based on the requirements
set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable
inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are
either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists,
therefore requiring an entity to develop its own assumptions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following methods and assumptions were used
to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount
approximates fair value because of the short-term maturity of those instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Short term investments: The carrying amount
approximates fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits
with original maturities greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying
amounts approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the
amounts due to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying
amounts of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to
market indices and/or due to the interest rates not being significantly different from the current market rates available to the
Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments
are held for purposes other than trading.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBTGGEVqUq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zUO6VH7x33s7">Recent Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2022 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any of those standards
will have a significant impact on our consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647890569984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zV2iPfee0oM1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">NOTE 3 &#8211; <span id="xdx_826_z8pUwDtbudd7">ACCOUNTS
RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Accounts Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&#8217;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior
to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair
fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable
become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its
credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing
credit authorizations before a product sales contract is entered into or service and repair fees are provided.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long Term Accounts Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company will generate revenue from long-term,
non-cancellable contracts to provide service and repair services. Future revenue to be recognized over the following three years
at June 30, 2022 is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoieH8Q6lgu8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
<tr style="vertical-align: bottom">
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B0_z0hZTqGVMa11">Receivables - Non Current - net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">2024</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--ContractReceivableDueTwoToThreeYears_c20220630_pp0p0" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">1,097,015</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--ContractReceivableDueThreeToFourYears_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">620,230</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2026</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--ContractReceivableDueFourToFiveYears_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">140,012</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Total</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total">1,857,257</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A4_zVb7DU1HZK01" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient&#8217;s legal counsel and
directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical
receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that will not be collected.
The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings, specific payor
collection issues that have been identified and based on payor classifications and historical experience at each site.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Management and Other Fees Receivable</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s receivables from the related
and non-related professional corporations (&#8220;PCs&#8221;) substantially consist of fees outstanding under management agreements.
Payment of the outstanding fees is dependent on collection by the PCs of fees from third party medical reimbursement organizations,
principally insurance companies and health management organizations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Payment of the management fee receivables from
the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner their medical fees from the third
party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20220630_zRSWoZCAHA02" title="Percentage of PCs net revenues">66</span>% and <span id="xdx_905_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20210630_zeL6IHw2HSV6">65</span>%, respectively, of
the PCs&#8217; 2022 and 2021 net revenues were derived from no-fault and personal injury protection claims. The Company considers
the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#8217;s expectations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>





















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Net revenues from
management and other fees charged to the related party medical practices accounted for approximately <span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20220630_z7QA4Zm1OIm5" title="Consolidated net revenues percentage">12</span>% and <span id="xdx_907_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20210630_zavyesENYdf2" title="Consolidated net revenues percentage">12</span>%, of the consolidated
net revenues for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, PA,
Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical practices) entered into
a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have
arisen under each individual management agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following table sets forth the number of
our facilities for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Total Facilities</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_z220HegS9AJf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zqw4ZAFy4gjb" style="display: none">Schedule of total
facilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20210701__20220630_zQLXmaszV5Ek" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49C_20200701__20210630_zK7lN5H1rqIa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Facilities Owned or Managed (at Beginning of Year)</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">27</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">25</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Facilities Added by:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ManagedFacilitiesAddedAcquisition_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Acquisition</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Internal development</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0987">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ManagedFacilitiesClosedDuringYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Managed Facilities Closed</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0990">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0991">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Facilities Owned or Managed (at End of Year)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">27</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">27</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A4_zDdzmdy6tr27" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647983434400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTRACT ASSETS AND LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock', window );">CONTRACT ASSETS AND LIABILITIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_zCzaaaXfily6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 4 &#8211; <span id="xdx_820_ziqH03uE6Azc">CONTRACT ASSETS AND LIABILITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Information relating to uncompleted contracts
as of June 30, 2022 and 2021 about contract assets and contract (liabilities) is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_ziENGJQDrkQa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zuG711ZzNlJg" style="display: none">Schedule
of costs and estimated earnings on uncompleted contracts</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_490_20220630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_497_20210630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40D_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzjsI_zjpnaTisn11d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Costs incurred on uncompleted contracts</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">294,783</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzjsI_zPex8fv42mFj" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Estimated earnings</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1003">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">567,978</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzjsI_maCAEEIz0V3_zLFRRjWlECLc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Costs and estimated earnings on uncompleted contracts</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1006">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">862,761</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz0V3_zXwEIpXbvRUi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Billings to date</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1009">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">877,500</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz0V3_zQ0CAjWq7vZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Costs and estimated earnings in excess of billings on uncompleted contracts</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">&#8212;</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(14,739</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"/>

















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for detailed information about regulatory assets and liabilities, including current and noncurrent assets created when regulatory agencies permit the deferral of costs to the balance sheet that would otherwise be required to appear on the company's income statement and would be charged against current expenses or revenues, as well as current and noncurrent liabilities created when regulatory agencies permit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889497584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--InventoryDisclosureTextBlock_z0U5QOHSO1l8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 5 &#8211; <span id="xdx_82C_z3wh0DvYmL">INVENTORIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Inventories included in the accompanying consolidated
balance sheets consist of:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEp6UsuPt7m3" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zPR9RWmY79ok" style="display: none">Schedule
of inventories</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49B_20220630_zCkx1QVSc0ee" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_495_20210630_zaOGokP0WOa6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40F_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzqFk_zZGwlOlI8DWa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Purchased parts, components and supplies</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,125,805</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,393,329</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzqFk_zTGYFkSy3jT7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Work-in-process</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">234,016</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">270,090</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzqFk_zn4VHTS6lbn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Inventories</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,359,821</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,663,419</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889553968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zioNwRl9ubBj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0">NOTE 6 - <span id="xdx_825_zaLAlVMGppzc">PROPERTY
AND EQUIPMENT</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2022 and 2021, is comprised of:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zu291D1iv4ri" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zExjxTJiSFE7" style="display: none">Schedule of property
and equipment</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diagnostic equipment</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">31,304,258</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">29,826,829</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Research, development and demonstration equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">6,199,941</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">6,029,551</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Machinery and equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">2,069,055</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">2,069,055</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Furniture and fixtures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">3,484,525</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">3,450,664</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Leasehold improvements</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">14,087,581</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">12,961,887</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Building</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">939,614</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">939,614</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">58,084,974</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">55,277,600</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Accumulated depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment">35,803,183</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment">33,427,461</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization">22,281,791</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization">21,850,139</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Depreciation and amortization of property and
equipment for the years ended June 30, 2022 and 2021 was $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20210701__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFP7X7AgrdTb" title="Depreciation and amortization">4,113,640</span> and $<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_pp0p0_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_znfgKwcIdhDd">3,696,986</span>, respectively. During fiscal year ended June
30 2022, the Company wrote off fully depreciated assets of $<span id="xdx_902_ecustom--DepreciatedAssetsWriteoff_c20210701__20220630_z5SP41UlOc8e" title="Depreciated assets write-off">1,737,918</span> that related to a location that was previously closed.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889596112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--LesseeOperatingLeasesTextBlock_zYxyepEVEZ8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 7 &#8211; <span id="xdx_82C_z728n27cDSE4">OPERATING &amp; FINANCING LEASES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In July 2019, the Company adopted ASU 2016-02,
Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying leases as either finance or operating
leases based upon the principle of whether or not the lease is effectively a financed purchase by the lessee.. We have elected
the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to
the comparative periods presented in the consolidated financial statements. We have also elected the transition package of thee
practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about lease
identification, lease classification and indirect costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company accounts for its various operating
leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211; Lease, as updated by ASU 2016-02. At
the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value
of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease.
Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord, we have
a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets
and liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates
available to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities
recognized as of June 30, 2022 is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zuokFkINHq9b" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B2_zI4YVarfHbek">Reconciliation of operating and financing lease payments</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Year Ending June 30,</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Operating Lease Payments</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Financing Lease Payments</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqV4MW3JRCDa" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">5,512,691</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhltFN9b1xF2" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">244,343</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2024</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_za4QAsA2IOL8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">5,355,310</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zrdyDzoPKQ82" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">244,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxTCWqrdASJ" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">5,256,243</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zvjKRJJwZtel" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">244,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2026</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zofyEX1gbo9c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">4,829,443</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhC8at9t0k3c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">244,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2027</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zMLCK3lmJ3H" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027">3,781,761</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTBG8WAjjvP8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027">162,897</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zF5i7CDZ6Pdj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter">22,529,257</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z2cFtDTgTNRb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="-sec-ix-hidden: xdx2ixbrl1112">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Present value discount</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--PresentValueDiscount_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zbMIUlZc2mfe" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Operating Lease">(10,293,586</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGPGVvnSuQm6" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Financing Lease">(91,838</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Total lease liability</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDAG60pTm3hc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability">36,971,119</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zMSMi7r6EtVl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability">1,048,431</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Weighted Average Remaining Lease Term</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zgeO7t64m2K9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B5_zQDFEFMVHsSa" style="display: none">Schedule of Weighted Average Remaining Lease Term</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases - years</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zzwfFFJ07oCf" title="Operating Lease, Weighted Average Remaining Lease Term">10.9</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Finance lease - years</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_900_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zeyLo2ywX913" title="Finance Lease, Weighted Average Remaining Lease Term">4.6</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Weighted Average Discount Rate</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z2mkStrDykxh" title="Operating Lease, Weighted Average Discount Rate, Percent">4.9</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Finance lease</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_906_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z6CCKsmHZN33" title="Finance Lease, Weighted Average Discount Rate, Percent">3.6</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The components of lease expense were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_ztXFJoQGHYU7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zVUPKUHnDlFc">Components of lease expense</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_490_20210701__20220630_zqEg6kdv209l" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_496_20200701__20210630_zqgvgciXNQUh" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating lease cost</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,668,199</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,145,701</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;<br/>&#160;<br/>Finance lease cost:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation of leased equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">198,881</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">198,881</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Interest on lease liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">41,603</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">47,472</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total finance lease cost</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">240,484</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">246,353</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A3_zo3oZIfzhA51" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Supplemental cash flow information related to
leases was as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9DV53it9TV5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zqGxWrXRW3o2">Supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_497_20210701__20220630_zXsmRwWQ3Mj8" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20200701__20210630_zxzP40d39na7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For year ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating cash flows from operating leases</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,133,369</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,970,934</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zG68pFJ1s8Hi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Financing cash flows from financing leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">244,344</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">130,038</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_z2aSZYXPO3n2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right-of-use &amp; equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">7,900,074</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,531,889</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AC_zM2IgQM5pgsi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647893515648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--IntangibleAssetsDisclosureTextBlock_zW6YjjFEFgzd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - <span id="xdx_820_z3HDNR1J7843">OTHER INTANGIBLE ASSETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated
amortization, at June 30, 2022 and 2021 are comprised of:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zYy6UyZkIAD9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B1_z7UUsm5bP4bb" style="display: none">Schedule of other
intangible assets - net</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capitalized software development costs</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">7,004,847</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">7,004,847</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Patents and copyrights</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">5,332,774</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">5,244,892</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Non-competition agreements</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">4,150,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">4,150,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Customer relationships</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">3,900,000</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">3,900,000</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">20,387,621</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">20,299,739</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Accumulated amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization">16,683,736</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization">16,262,140</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net">3,703,885</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net">4,037,599</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A2_zv30CAXi5GQk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The estimated amortization of other intangible
assets for the five years ending June 30, 2027 and thereafter is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zOUZvovKLx46" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B2_zEfwCMD5Xdt5">Schedule Of Other Intangible Assets</span> For the Years Ending June 30,</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Patents and Copyrights</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Customer Relationships</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 32%; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">386,747</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">186,747</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2024</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">386,446</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">186,446</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2025</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">381,491</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">181,491</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2026</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">378,866</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">178,866</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2027</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">368,206</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">168,206</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">1,802,129</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">687,962</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">1,114,167</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">3,703,885</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">1,589,718</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">2,114,167</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zsVHoD7iB4wi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The weighted average amortization period for
other intangible assets is <span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20210701__20220630_zSqjszyHoUs7" title="Acquired Finite-lived Intangible Assets, Weighted Average Useful Life">10.9</span> years and they have no expected residual value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Information related to the above intangible
assets for the years ended June 30, 2022 and 2021 is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zfJwNtZ5vqcc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B5_zW8RYz3a5CA3">Other Intangible Assets</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Balance &#8211; Beginning of Year</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zMF57x7uF8t2" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - Beginning of Year">4,037,599</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_z8EMvqKC79n9" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,109,129</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Amounts capitalized</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized">87,882</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized">313,705</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Software or patents written off</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off">(534</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization">(421,596</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization">(384,701</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Balance &#8211; End of Year</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zVzbYL94aumk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - End of Year">3,703,885</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_ztLkDlEZ0g2d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,037,599</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A8_zpofDHOVEQUg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization of patents and copyrights for the
years ended June 30, 2022 and 2021 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zbZBuofw2MZa" title="Amortization of Intangible Assets">184,096</span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZnixVPrbwVl">179,701</span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization of non-competition agreements for
the years ended June 30, 2022 and 2021 amounted to $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Amortization of Intangible Assets">37,500</span> and $<span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Amortization of Intangible Assets">12,500</span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization of customer relationships for the
years ended June 30, 2022 and 2021 amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Amortization of Intangible Assets">200,000</span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Amortization of Intangible Assets">192,500</span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889559824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureCapitalStockAbstract', window );"><strong>Capital Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalStockAndOptionsDisclosureTextblock', window );">CAPITAL STOCK</a></td>
<td class="text"><p id="xdx_804_ecustom--CapitalStockAndOptionsDisclosureTextblock_zIdjSgaMr44g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 9 - <span id="xdx_827_zmVWXarWVxWd">CAPITAL STOCK</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Common Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90C_eus-gaap--DividendsPayableNature_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Dividends Payable, Nature">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common
stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class B Common Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90F_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" title="Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share">Class B common stock is convertible into shares
of common stock on a one-for-one basis.</span> <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" title="Common Stock, Voting Rights">Class B common stock has 10 votes per share.</span> There were <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common Stock, Shares, Outstanding"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKN7B3ynmEE8" title="Common Stock, Shares, Outstanding">146</span></span> of such shares outstanding
at June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class C Common Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" title="Common Stock, Voting Rights">The Class C common stock has 25 votes per share</span>,
as compared to 10 votes per share for the Class B common stock and <span id="xdx_905_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Common Stock, Voting Rights">one vote per share for the common stock.</span> <span id="xdx_90E_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" title="Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share">The Class C common
stock was offered on a three-for-one basis to the holders of the Class B common stock.</span> Although having greater voting power, each
share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions.
<span id="xdx_90E_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share">Class C common stock is convertible into shares of common stock on a three-for-one basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified
a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the
declaration of a stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" title="Common Stock, Voting Rights">one share of Class A non-voting preferred stock
for every five shares of common stock.</span> <span id="xdx_904_eus-gaap--DividendsPayableNature_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" title="Dividends Payable, Nature">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting
preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million
of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#8217;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#8217;s
patents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution
rights, liquidation rights and other rights and preferences (other than the voting rights).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stock Bonus Plans</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010
Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Common Stock, Capital Shares Reserved for Future Issuance">2,000,000</span> shares of common stock. On August 10, 2010, the Company filed
Form S-8 to register the <span id="xdx_908_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zZVgXl748154" title="Shares registered">2,000,000</span> shares. As of June 30, 2022, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant">450,177</span> shares of common stock of FONAR were available for future
grant under this plan. For the years ended June 30, 2022 and 2021, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period">0</span> and <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zac32CiCK557" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period">106,747</span> shares were issued respectively, of which $<span id="xdx_905_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20210701__20220630_pp0p0" title="Other Selling, General and Administrative Expense">0</span> and
$<span id="xdx_907_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_pp0p0_c20200701__20210630_zPOnM6MdYxj9" title="Other Selling, General and Administrative Expense">83,277</span> were expensed and included in selling, general and administrative expenses for the years ended June 30, 2022 and 2021,
respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Options</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company had stock option plans, which provided
for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the
success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically
three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair
value of the Company&#8217;s common stock at the date of grant. The options had to be exercised within ten years from the date
of grant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalStockAndOptionsDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalStockAndOptionsDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureCapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureCapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889596112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">CONTROLLING AND NONCONTROLLING INTERESTS</a></td>
<td class="text"><p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zKh7yiN9IQ" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 10 &#8211; <span id="xdx_828_zYX4EBgdMaT3">CONTROLLING AND NONCONTROLLING
INTERESTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On February 13, 2013, the Company entered into
an agreement with outside investors to acquire a <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMEquityMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember_zpDTSxC1ow5i" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners">50.5</span>% controlling interest in a newly formed limited liability company, Health
Diagnostics Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members;
Class A members and one Class B member. The Class A members have an ownership interest of <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_zN2dzJtSovAf" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners">49.5</span>% of HDM. The Class B member (HMCA)
has an ownership of <span id="xdx_908_ecustom--OwnershipPercentageAcquired_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMEquityMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember_zJpgAznnwlMg" title="Ownership Percentage Acquired">50.5</span>% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes
equal to their percentage of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations
of the Company will be allocated among the members in the same proportions as their membership interests in the Company bear to
all the Class A and Class B membership interests of the Company in the aggregate outstanding. All of the depreciation and amortization
of the assets of the Company will be allocated solely to the Class A members, unless and until their interests have been redeemed
by the Company in full pursuant to the provisions of the operating agreement. The Company contributed $<span id="xdx_905_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember_pp0p0" title="Proceeds from Contributions from Affiliates">20,200,000</span> to HDM and the
group of outside investors contributed $<span id="xdx_907_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OutsideInvestorsMember_pp0p0" title="Proceeds from Contributions from Affiliates">19,800,000</span> for its non-controlling membership interest.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 5, 2013 HDM purchased from Health Diagnostics,
LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve (<span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zFleqcbCn4Ac" title="Purchase Of Standup Mri Centers">12</span>) Stand-Up MRI Centers and two (<span id="xdx_906_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z2PR5mp07MOb" title="Purchase Of Other Mri Centers">2</span>) other
scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_904_ecustom--ConsiderationToOutsideInvestors_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zd7jf6653Mmk" title="Consideration To Outside Investors">1.5</span> million
to outside investors) aggregating $<span id="xdx_90A_ecustom--TotalPurchasePrice_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zqrT8rD4weJh" title="Total Purchase Price">35.9</span> million. Concurrently with the acquisition, HDM entered into several consulting and non-competition
agreements for a consideration of $<span id="xdx_902_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zXSMxFaDwrz9" title="Consideration For Noncompetition And Consulting Agreements">4.1</span> million. The acquisition was accounted for using the purchase method in accordance with
ASC 805, &#8220;Business Combinations&#8221;. The Company recognized and measured goodwill as of the acquisition date, as the excess
of the fair value of the consideration paid over the fair value of the identified net assets acquired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On January 8, 2015,
the Company purchased 20% of the Class A members ownership interest at a cost of $<span id="xdx_908_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20150108__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_pp0p0" title="Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value">4,971,094</span>. The Company has a <span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20150108__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_zoLt8vVrR9D" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners">60.4</span>% ownership
interest in HDM after this transaction. During the year ended June 30, 2022, the Company purchased noncontrolling interests for
$<span id="xdx_90F_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_z8R4jSdJGuqd" title="Direct purchase of Noncontrolling Interests">546,000</span> giving the Company a direct ownership interest of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_z2YEPx0s2c3f" title="Direct ownership interest percentage">70.8</span>% and the investors&#8217; a <span id="xdx_903_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvQbWkDbPuMl" title="Investors ownership interest percentage">29.2</span>% ownership interest.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amount of each class of HDM members&#8217; equity
as of June 30, 2022 and 2021</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zol9vgOyaCG5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black"><span id="xdx_8BE_zZIjEoVUnRck" style="display: none">class a and b members' equity (hdm acquisition)</span>
</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class A Members</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class B Member</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class A Members</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class B Member</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; color: black; text-align: left">Opening Members&#8217; Equity</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">($</td>
<td id="xdx_988_ecustom--OpeningMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zaTzu15e54Y5" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">3,048,524</td>
<td style="width: 1%; color: black; text-align: left">)</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">41,923,380</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">55,253</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">39,850,419</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Share of Net Income</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zxygZUVL8NAg" style="color: black; text-align: right" title="Share of Net Income">4,793,482</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income">22,228,693</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income">3,466,223</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income">17,402,961</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black; text-align: left">Buyout of noncontrolling interests</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8z2ziYRZS8d" style="color: black; text-align: right" title="Buyout of noncontrolling interests">23,441</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWtntnpNRNBc" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1406">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWI2wwpP85oc" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1407">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z0QXicdRUfh9" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1408">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Distributions</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_981_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zU24hLztaNDg" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">5,822,232</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_98E_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZPMWnwd9qu6" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">13,860,000</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_982_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zhhcO5Wgu91c" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">6,570,000</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVynIlqjZNIc" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">15,330,000</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black">Ending Members&#8217; Equity</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">($</td>
<td id="xdx_98B_ecustom--EndingMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z264L4T1aId2" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">4,053,833</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td>
<td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">50,292,073</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">($</td>
<td id="xdx_987_ecustom--EndingMembersEquity_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zLCagUZosal7" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">3,048,524</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td>
<td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">41,923,380</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647894255376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--DebtAndCapitalLeasesDisclosuresTextBlock_z3v7buxihaBj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 11 - <span id="xdx_821_zcNIywVHkei">LONG-TERM DEBT, NOTES PAYABLE AND
CAPITAL LEASES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long-term debt, notes payable and capital leases
consist of the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zX7n74WmV0L5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B3_zFLZhe9jqk3b">Long-term debt, notes payable and capital leases</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Note payable requiring monthly payments of interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zO2EeGvyRq8">7</span>% until May 2009 followed by <span id="xdx_905_ecustom--NumberOfInstallment_uInteger_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zN40WApOwA2c" title="Number of installment">240</span> <span id="xdx_908_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" title="Debt Instrument, Frequency of Periodic Payment">monthly</span> payments of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Debt Instrument, Periodic Payment">4,472</span> through <span id="xdx_904_ecustom--MaturityDate_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_ze7iAlf2gKz7" title="Maturity date">October 2026</span>. The loan is collateralized by a building with a net book value of $<span id="xdx_904_ecustom--BookValueOfBuilding_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zoJNxqNlEDc8" title="Book Value Of Building">379,163</span> as of June 30, 2022.</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zuLdBxon1sYa" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases">195,457</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z7KWN2PtpU87" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases">232,696</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Note payable received under the Paycheck Protection Program (&#8216;PPP&#8217;) which was established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;Cares Act&#8217;) that provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven portion of the PPP loan is payable over <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_ztRmTIaUwSU5" title="Debt Instrument, Term">5</span> five years at an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zTpkkMth0Ay5" title="Debt Instrument, Interest Rate During Period">1</span>%, with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note was forgiven in August 2021.</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zul68mZAvYO4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zRmUnCPMfMB" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">700,764</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">The revolving credit note was extended to October 26, 2022. The Company can borrow up to $<span id="xdx_907_eus-gaap--ProceedsFromLinesOfCredit_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Proceeds from Lines of Credit">10,000,000</span> and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zaYUkWzqZuCf" title="Debt Instrument, Interest Rate During Period">5.5</span>% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zul4yBn5CSk1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1460">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_z3FsXHpNI5ci" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1461">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630_z26nNXCs8oZ6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">195,457</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630_z7dhJ1KdRoE9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">933,460</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases">40,078</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20210630_zBt5gnywqX35" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases">173,206</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion">155,379</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20210630_zKAqWnjmNtsl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion">760,254</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_zR4Np13AsfK1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The maturities of debt over the next five years
are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zbrBBLC9C8qk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BA_zJSkMcVpxsPj">Maturities Of Long-Term Debt</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Years Ending June 30,</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">2023</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_c20220630_zkvIRjSK1Xod" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">40,078</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2024</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_c20220630_zFXF3rOEYc4g" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">43,766</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_c20220630_z0nmFtJpRBg8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">47,002</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2026</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_c20220630_zQTRqUSoUJL" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">50,448</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2027</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_c20220630_zBu5pBVlLsS3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027">14,163</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: white">Long-Term Debt Over Five Years and Thereafter</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_c20220630_zhqdguY0FVOe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter">195,457</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AC_z2LY4ffuXtH7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI https://asc.fasb.org/topic&amp;trid=2208923<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889637808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zIyQ5dqOR9a2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12 - <span id="xdx_824_zjBndFeM5hc7">INCOME TAXES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">ASC topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon
examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit
recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized (or
amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result
of applying the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings
and therefore it has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In accordance with ASC topic 740, interest costs
related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense,
net. Penalties if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company files corporate income tax returns
in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject
to federal, state and local income tax examinations by tax authorities for years prior to 2017 for federal and 2016 for state.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has recorded a deferred tax asset
of $<span id="xdx_907_eus-gaap--DeferredTaxAssetsNet_c20220630_pp0p0" title="Deferred Tax Assets, Net of Valuation Allowance">12,842,478</span> and a deferred tax liability of $<span id="xdx_90E_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20220630_pp0p0" title="Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus">215,726</span> as of June 30, 2022, primarily relating to its net Federal operating loss
carryforwards of approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_c20220630_pp0p0" title="Operating Loss Carryforwards">20,048,000</span> available to offset future taxable income through 2031. In addition the Company has
state operating loss carryforwards of approximately $<span id="xdx_908_eus-gaap--OperatingIncomeLoss_c20210701__20220630_pp0p0" title="Operating Income (Loss)">5,309,000</span> and city operating loss carryforwards of approximately $<span id="xdx_902_eus-gaap--OtherOperatingIncome_c20210701__20220630_pp0p0" title="Other Operating Income">1,853,000</span>.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>





















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Future ownership changes as determined under
Section 382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30,
2022, no such changes in ownership have occurred.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets
is dependent on the generation of future taxable income during the periods in which temporary differences become deductible or
when such net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment
of the industry, and tax planning strategies in making this assessment. At present, the Company believes that it is more likely
than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this
inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The valuation allowance for deferred tax assets
decreased during the year ended June 30, 2022, by approximately $<span id="xdx_901_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20220630_pp0p0" title="Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital">448,000</span>. The valuation allowance decreased by approximately $<span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20210630_pp0p0" title="Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital">3,547,000</span>
during the year ended June 30, 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Components of the provision (benefit) for income
taxes are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zU5SRqoMeQq1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B6_zBN5rHJdBRx1">Components Of The Provision For Income Taxes</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_497_20210701__20220630_zk6s9Q0xz282" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20200701__20210630_zOa06S83jKZe" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Years Ended June 30,</td></tr>
<tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zs8e3rhFfUSl" style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Current:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Federal</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"/>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_986_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200701__20210630_zINRoT6zONi6" style="color: rgb(204,238,255); width: 12%; text-align: right" title="Federal"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zgdcahftBFtk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">State</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,440,594</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,136,514</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_zJjfkQKwYX62" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Subtotal</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,440,594</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,136,514</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqPTwpVGJAR7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Deferred:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zbWuLn4DTBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Federal deferred taxes</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,935,921</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,718,046</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zgeh85TD8us" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">State deferred taxes</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">157,972</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">136,960</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zQLLTvv4FYQe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Subtotal</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,093,893</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,855,006</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zyEBQOSMMlU7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">Provision (Benefit) for Income Taxes - Net</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,534,487</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,991,520</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A5_ziHQ49reXaFi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A reconciliation of the federal statutory income
tax rate to the Company&#8217;s effective tax rate as reported is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXVsq0CdJpj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
<tr style="vertical-align: bottom">
<td style="text-align: left"><span id="xdx_8BB_ztR03Z7IvpMc">Reconciliation Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_494_20210701__20220630_zsNv9qmR2dw9" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49A_20200701__20210630_zllnwR89Fd49" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zwJKJYOzLRx7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; text-align: left">Taxes at federal statutory rate</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">21.0</td>
<td style="width: 1%; text-align: left">%</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">21.0</td>
<td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zdJM2gqp2706" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">State and local income taxes (benefit), net of federal benefit</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">4.2</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3.3</td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zlS7qpvPMatk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Non Controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(5.5</td>
<td style="text-align: left">)%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(4.9</td>
<td style="text-align: left">)%</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zT6GfK1JotBg" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Expiration of tax credits</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">2.0</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iP3us-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20200701__20210630_zAJIXZyDrLK1" title="Expiration of tax credits">4.6</span></td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zpZ0Ual3lTK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Return to provision adjustments</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0.7</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">6.1</td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zRyWHf5m0dF8" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">NYS Audit Settlement</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">4.5</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3.2</td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_z63DKhh2NC5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Change in the valuation allowance</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(2.0</td>
<td style="text-align: left">)%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(20.0</td>
<td style="text-align: left">)%</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_z7zSZP3olEBc" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(0.6</td>
<td style="padding-bottom: 1pt; text-align: left">)%</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">9.3</td>
<td style="padding-bottom: 1pt; text-align: left">%</td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zGfJi9FcS8E2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Effective income tax rate</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">24.3</td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">22.6</td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>


<p id="xdx_8A1_zsbgoUsA9BIe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As of June 30, 2022, the Company has net operating
loss (&#8220;NOL&#8221;) carryforwards of approximately $20,048,000 that will be available to offset future taxable income. The
utilization of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal
Revenue Code.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has, for federal income tax purposes,
research and development tax credits and investments tax credits carryforwards aggregating $<span id="xdx_903_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_c20220630_pp0p0" title="Deferred Tax Assets, Tax Credit Carryforwards, Research">3,347,000</span>. However, the realization
of these credits may be limited as a result of expiring prior to their utilization. These credits can only be applied after all
net operating losses have been used, which expire through 2031. As such, the Company has established a valuation reserve for anticipated
unused credits of $<span id="xdx_909_eus-gaap--ValuationAllowancesAndReservesBalance_iI_pp0p0_c20220630_zk0SzwVRREFk" title="Valuation Allowances and Reserves, Amount">442,000</span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, for New York State income tax purposes,
the Company has tax credit carryforwards aggregating approximately $<span id="xdx_907_eus-gaap--TaxCreditCarryforwardAmount_c20220630_pp0p0" title="Tax Credit Carryforward, Amount">27,000</span> which, are accounted for under the flow-through method.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company was also under audit with New York
State for income tax and was assessed additional taxes of $<span id="xdx_905_ecustom--AdditionalTaxes_pp0p0_c20210701__20220630_zSeJuiNkKKvd" title="Additional Taxes">1,014,071</span> plus interest and penalties. These amounts were paid during
fiscal year ending June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Significant components of the Company&#8217;s
deferred tax assets and liabilities at June 30, 2022 and 2021 are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhUOUyMuFbMc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zViAdR8ww5Hb"><span id="xdx_8B3_z5sbFMsCeMTc"><span id="xdx_8B3_zg2ZVwhm4yZ1" style="display: none">Components Of Company&#8217;s Deferred Tax Assets And Liabilities</span></span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49A_20220630_z1r5QRMAPLX9" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_492_20210630_zdZX8w765Je7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Deferred tax assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zP7Vg3dV5tsg" style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Allowance for doubtful accounts</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,239,903</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,827,382</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zE07pX08AZG4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Non-deductible accruals</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">707,400</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">749,902</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zV6NCZ51AGYe" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net operating carryforwards</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,820,010</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">8,285,163</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zHp19WTme3ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Tax credits</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,346,509</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,732,650</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_z2QnWtrJAyO" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Inventory</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">98,945</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">66,316</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_zhE5E8eNehyb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Property and equipment and depreciation</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">71,576</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">187,632</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zny48cNmv5Xg" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">Deferred Tax Assets - gross</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">13,284,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,849,045</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zlM0ct2VgPP7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Valuation allowance</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(441,865</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(890,084</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_msDTLzHqA_maDTALNzFAZ_zIsuIZewdbzd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total deferred tax assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">12,842,478</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,958,961</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzHqA_maDTLzexF_zkRufmNS1n17" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intangibles</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(215,726</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(238,316</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzexF_msDTALNzFAZ_zcZWT7LcwZb" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total deferred tax liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(215,726</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(238,316</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zS7JAQjhJMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net deferred tax asset</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">12,626,752</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,720,645</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A6_zwJWO8PX9b1k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888169024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zcHnlN8DGfWk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 13 - <span id="xdx_82A_z7kIbNMr7y5i">OTHER CURRENT LIABILITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Included in other current liabilities are the
following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRHrxNCrmzL1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B8_z47T7equK4g5"><span id="xdx_8BF_zKun2NP1YPv6" style="display: none">Other Current Liabilities</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49C_20220630_zDitV1yH9M65" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49E_20210630_zF8aYmKcwsA4" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accrued salaries, commissions and payroll taxes</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,652,173</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,406,982</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Litigation accruals</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1651">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">900,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Sales tax payable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">248,702</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">644,623</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">State income taxes payable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">774,234</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Legal and other professional fees</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,707</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">37,827</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounting fees</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">120,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">127,262</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Self-funded health insurance reserve</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">79,167</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">62,548</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accrued interest and penalty</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">59,516</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">493,042</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">854,962</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">715,600</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other current liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,417,227</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,162,118</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889706368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zNwrTfQ2Bvf4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 14 - <span id="xdx_82C_zsNADuEDXwce">COMMITMENTS AND CONTINGENCIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Leases</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company rents its operating facilities and
certain equipment, pursuant to operating lease agreements expiring at various dates through March 2030. The leases for certain
facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated
$<span id="xdx_90C_eus-gaap--LeaseAndRentalExpense_c20210701__20220630_pp0p0" title="Operating Leases, Rent Expense">5,668,000</span> and $<span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20200701__20210630_pp0p0" title="Operating Leases, Rent Expense">6,146,000</span>, for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company received approval from the Suffolk
County IDA on February 29, 2016 of a <span id="xdx_90E_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160201__20160229_zOmEfBNidIn4" title="Property Tax Abatement From Suffolk County IDA">50</span>% property tax abatement, valued at $<span id="xdx_904_ecustom--PropertyTaxAbatement_pp0p0_c20160201__20160229_zq9RzYiquwAf" title="Property Tax Abatement">440,000</span>, over a 10 year period commencing January 2017.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Employee Benefit Plans</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has a non-contributory 401(k) Plan
(the &#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum
service requirements. There were $<span id="xdx_90D_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20210701__20220630_pp0p0" title="Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP">0</span> and $<span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20200701__20210630_pp0p0" title="Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP">36,799</span> employer contributions to the Plan for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The stockholders of the Company approved the
2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217; meeting in April 2000.
The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has
not been put into effect as of June 30, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Litigation</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_906_ecustom--LitigationSettelementDescription_c20200701__20210630" title="Litigation Settelement Description">In September 2019, The Company was notified
by one of its landlords that it was required to vacate the premises within 180 days under the demolition clause in the lease. The
Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated in February 2018. The
Company is in the process of relocating to a new location but the original lease provided for penalty payments in the event that
the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course of the arbitration
proceedings. The Company settled the case for $900,000 for the leasehold holdover charges which was paid in August 2021.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_909_ecustom--LitigationSettelementDescription_c20210701__20220630" title="Litigation Settelement Description">In September 2020, the Company entered into
a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The
settlement was for $1.2 million of which $900,000 was paid by the Company&#8217;s insurance on September 15, 2020 with the remaining
$315,000 paid by the Company on September 28, 2020.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other Matters</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The Company is subject
to other legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract
and employment claims besides the claim above. In the opinion of management, and with consultation with legal council, the aggregate
liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial position
or results of operations of the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims
to $<span id="xdx_902_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pp0p0_c20210701__20220630_zxvpd57mit11" title="Liability for individual claims">110,000</span> per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the
Company considers historical and projected medical utilization data when estimating its health insurance program liability and
related expense. As of June 30, 2022 and 2021, the Company had approximately $<span id="xdx_907_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20220630_pp0p0" title="Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health">79,000</span> and $<span id="xdx_904_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20210630_pp0p0" title="Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health">63,000</span>, respectively, in reserve for
its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the consolidated
balance sheets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves
for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance
programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves
such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid dates,
and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded
in the years covered by this report.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889526480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z3RCR2C1kOoi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 15 - <span id="xdx_82E_zWKh3OxZ8Fs4">SUPPLEMENTAL CASH FLOW INFORMATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021
the Company paid $<span id="xdx_900_eus-gaap--InterestPaid_c20210701__20220630_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">617,029</span> and $<span id="xdx_906_eus-gaap--InterestPaid_c20200701__20210630_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">75,178</span> for interest, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021
the Company paid $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20210701__20220630_pp0p0" title="Income Taxes Paid">2,408,145</span> and $<span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20200701__20210630_pp0p0" title="Income Taxes Paid">261,032</span> for income taxes, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021,
the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210701__20220630_pdd" title="Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture">0</span> and <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20200701__20210630_pdd" title="Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture">102,364</span> shares of common stock for costs and expenses totaling $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210701__20220630_pp0p0" title="Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture">0</span> and $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200701__20210630_pp0p0" title="Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture">1,940,821</span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the years ended June 30, 2022 and 2021,
the Company resolved certain sales tax liabilities and was able to reverse accrued interest and penalties in the amount of $<span id="xdx_90B_ecustom--SellingGeneralAndAdministrativeExpenses_c20210701__20220630_pp0p0" title="Selling, General and Administrative Expenses">119,000</span>
and $<span id="xdx_90D_ecustom--SellingGeneralAndAdministrativeExpenses_c20200701__20210630_pp0p0" title="Selling, General and Administrative Expenses">602,000</span>, respectively, which has been recorded under selling, general and administrative expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889553968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4o8YHIwi4Ug" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 16 &#8211; <span id="xdx_82B_zbq8AZQNln8c">RELATED PARTY TRANSACTIONS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_90F_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210701__20220630__dei--LegalEntityAxis__custom--ABillingCompanyMember" title="Related Party Transaction, Description of Transaction">The CEO and President of the Company is a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#8217; Compensation
claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000. The Company terminated this agreement
on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the
billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2022 for another year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_906_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210701__20220630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember" title="Related Party Transaction, Description of Transaction">Bensonhurst MRI Limited Partnership, in which
the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889746784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SegmentReportingDisclosureTextBlock_zkVR6W8H39sh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 17 - <span id="xdx_821_zHE7a5AGLtm9">SEGMENT AND RELATED INFORMATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company provides segment data in accordance
with the provisions of ASC topic 280, &#8220;Disclosures about Segments of an Enterprise and Related Information&#8221;.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company operates in two industry segments
- manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accounting policies of the segments are
the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company
evaluates performance based on income or loss from operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized financial information concerning
the Company&#8217;s reportable segments is shown in the following table:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized Segment Financial Information</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z3rkDoZogLv" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
<tr style="vertical-align: bottom">
<td style="text-align: left"><span id="xdx_8BA_zDz8vTAtaUua" style="display: none">Schedule of summarized segment financial information</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Manufacturing and Servicing of Medical</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Management of Diagnostic Imaging</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Fiscal 2022:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Center</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Totals</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net revenues from external customers</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">8,218,804</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">89,373,341</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--Revenues_c20210701__20220630_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">97,592,145</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intersegment net revenues *</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zb7igEbrTuzg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">965,417</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zTvXeUDL9mRg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"><span style="-sec-ix-hidden: xdx2ixbrl1770">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zAgoyxuVEaFk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">965,417</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">(Loss) Income from operations</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">(4,604,305</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">26,611,487</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">22,007,182</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">263,559</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">4,271,677</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">4,535,236</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Compensatory element of stock issuances</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_z6qvuiQl4D15" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zRaYkbCm0dV5" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630_zY5Uml3zRRHc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total identifiable assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">10,259,937</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">189,082,045</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_980_eus-gaap--AssetsNet_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">199,341,982</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capital expenditures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">258,271</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">4,374,903</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">4,633,174</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Fiscal 2021:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net revenues from external customers</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">9,037,091</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">80,892,674</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">89,929,765</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intersegment net revenues *</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zSvp60x9cvfi" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">901,250</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_ecustom--IntersegmentNetRevenues_pdp0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zrJprfqqlBr9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"><span style="-sec-ix-hidden: xdx2ixbrl1811">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____zqqbYZoareDj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">901,250</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">(Loss) Income from operations</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">(3,410,189</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">20,507,804</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">17,097,615</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">264,830</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">3,816,857</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">4,081,687</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Compensatory element of stock issuances</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">83,277</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zn0A5bT5Bbt9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">83,277</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total identifiable assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zY3qCC8yoCY4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">24,592,582</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zGu26UdMLcDb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">164,913,613</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20210630_zJ1gLlln9j8e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">189,506,195</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capital expenditures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">291,294</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">3,405,502</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">3,696,796</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td id="xdx_F00_zbhlTO5DaAO6" style="width: 4px; padding-left: 11pt; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">*</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F1A_zBTwIqequJ48" style="font: 11pt Arial, Helvetica, Sans-Serif">Amounts eliminated in consolidation</span></td></tr>
</table>
<p id="xdx_8A2_zcnahpWwxEqb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s areas of operations are
principally in the United States. The Company had export sales of medical equipment amounting to <span id="xdx_90D_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20210701__20220630_z1VgNxYJna2d" title="Export Sales Of Medical Equipment Percentage">48.9</span>% and <span id="xdx_90D_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20200701__20210630_zjltUOjtiS99" title="Export Sales Of Medical Equipment Percentage">69.3</span>% of product sales
revenues to third parties for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of
product sales to unrelated parties, were made to customers in the following countries:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ExportProductSalesTableTextBlock_zDeYK6aoxxkk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black"><span id="xdx_8B6_z73CEuWiSHOj" style="display: none">Schedule of export product sales</span></td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; color: black; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">2022</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; color: black; text-align: left">Dominican Republic</td>
<td style="width: 8%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 12%; color: black; text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zmb28pnmEVf7" title="Foreign Product Sales">12.0</span></td>
<td style="width: 1%; color: black; text-align: left">%</td>
<td style="width: 8%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 12%; color: black; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_ztJMHCmXZHC1" title="Foreign Product Sales">67.0</span></td>
<td style="width: 1%; color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Canada</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zugms5m0sJE1" title="Foreign Product Sales">0.6</span></td>
<td style="color: black; text-align: left">%</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zJed0aRajlC9" title="Foreign Product Sales">0.1</span></td>
<td style="color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black">Germany</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--ForeignProductSales_dp0_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zEelWrPrUDn9" style="color: black; text-align: right" title="Foreign Product Sales">&#8212;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_90F_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zpfvAufYPZg5" title="Foreign Product Sales">2.1</span></td>
<td style="color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black; text-align: left">Puerto Rico</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zVvbxCcrzLi5" title="Foreign Product Sales">36.3</span></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">%</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_z9Q7WROcfPWd" title="Foreign Product Sales">0.1</span></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20210701__20220630_zCUDH9e2hE" title="Foreign Product Sales">48.9</span></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">%</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_ecustom--ForeignProductSales_dp_c20200701__20210630_ziIRNZzMkkVk" title="Foreign Product Sales">69.3</span></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">%</td></tr>
</table>


<p id="xdx_8A0_z1GMoLYS7DYe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s areas of service and repair
are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to
<span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20210701__20220630_zhoI2B1mDANe" title="Foreign Revenues Of Service And Repair Of Medical Equipment Percentage">4.4</span>% and <span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20200701__20210630_zhQdyN6o1Pvd" title="Foreign Revenues Of Service And Repair Of Medical Equipment Percentage">4.5</span>% of consolidated net service and repair fees for the years ended June 30, 2022 and 2021 respectively. Foreign service
and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0">&#160;Foreign Service and
Repair Fees</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ExportServiceRevenuesTableTextBlock_zT5QF8LMouK2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td><span id="xdx_8B2_zikxvsNFp2u8" style="display: none">Schedule of foreign service and repair fees</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; text-align: left">Puerto Rico</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_z31Vn7FJCoQ1" title="Foreign Service and Repair fees">1.5</span></td>
<td style="width: 1%; text-align: left">%</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zUylr2Y8uyog" title="Foreign Service and Repair fees">1.5</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Switzerland</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z4yRUNT1iuE7" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zLbEcAucwF8h" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Germany</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_z1Z1fJLR4GSl" title="Foreign Service and Repair fees">1.6</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zsNnM6HXW2Aa" title="Foreign Service and Repair fees">1.5</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>England</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zCRQdGkwmCn2">0.6</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_znKmWFaRGhs8" title="Foreign Service and Repair fees">0.6</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Canada</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zA0GeeSJRHNl" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Greece</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_z8SVYRz71vfe" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zg97RRszEc9j" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Australia</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zHD8n0OU1767" title="Foreign Service and Repair fees">0.1</span></td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zdlrzyu4C4r5" title="Foreign Service and Repair fees">4.4</span></td>
<td style="text-align: left; padding-bottom: 2.5pt">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zbyRtsu1CFIk" title="Foreign Service and Repair fees">4.5</span></td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>




<p id="xdx_8A9_zmM6xXAQ6t4l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>





















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889642592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISTION</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z7H3Gzcu5rS5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 18 &#8211; <span id="xdx_82E_zl3etC04lJlc">ACQUISTION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On March 29, 2021, the Company completed the
acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company used an incremental borrowing
rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We made a fair value determination
of the acquired assets and assumed liabilities as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zFeaYR9KTqsd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BA_zLpLxZiUaiHf"><span id="xdx_8B3_zeYkDSkU531g" style="display: none">Fair value assets and assumed liabilities</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49D_20210329" style="text-align: center">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Property and equipment</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">650,000</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right to use assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">434,219</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intangible assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">150,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--SecurityDeposit_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Security Deposit</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">38,628</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right to use liability</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(434,219</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Goodwill</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">283,880</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total purchase consideration</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,122,508</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A0_zS23UHZoUZ94" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In accordance with ASC 805-10-25-1, Business
Combinations &#8211; Overall Recognition, the Company recorded the transaction as a business combination. ASC 805-10-25-1 provides
the requirements of recording the transaction by applying the acquisition method. The acquisition method requires the Company to
determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must be determined if there is
a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and must be able to recognized
and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded as a business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The net assets acquired and consideration is
as follow:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zzZTztpWvhvg" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Net assets acquired (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zEPw0ZYlDYob"><span id="xdx_8B9_zMRs5MswHotj" style="display: none">Net assets acquired</span></span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Leasehold Improvements</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">550,000</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diagnostic Equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">100,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Customer Lists</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">100,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Covenant Not to Compete</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">50,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Security Deposit</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--SecurityDeposit_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Security Deposit">38,628</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Closing costs - expensed</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--ClosingCostsExpensed_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Closing costs - expensed">3,478</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Goodwill</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--GoodwillGross_c20210329_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Goodwill">283,880</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Cash Consideration Paid</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_ecustom--BusinessCombinationContingentConsiderationAsset1_c20210329_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Cash Consideration Paid">1,125,986</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A6_z9hIo9M4UJuf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The results of operations of Rockland Management
Group were diminutive and did not affect the pro forma results of operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889559824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLOWANCE FOR DOUBTFUL ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">ALLOWANCE FOR DOUBTFUL ACCOUNTS</a></td>
<td class="text"><p id="xdx_80E_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zP3z3G9fvkuh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 19 &#8211; <span id="xdx_821_zryHW8DNJSHj">ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following represents a summary of allowance
for doubtful accounts for the years ended June 30, 2022 and 2021 respectively:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zSFOe3M0ttN1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
<tr style="vertical-align: bottom">
<td colspan="17" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B5_zlhcEixqViBf"><span style="display: none">Summary of Allowance For Doubtful Accounts</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Description</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance <br/> June 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Additions (1)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Deductions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance <br/> June 30, 2022</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounts receivable</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zEApKT23dYLg" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Beginning Balance">442,270</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zDdRJVoP62R1" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Additions (Included in provision for bad debts)"><span style="-sec-ix-hidden: xdx2ixbrl1970">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z2nUsFZQxnlh" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Deductions">237,673</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zoFC9mqAP8dd" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Ending Balance">204,597</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zk5jgUxoDy8l" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,786,878</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zUvS7HPj9Jr7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">841,039</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zPt9BmrWrZN6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1977">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zs502PWeS57c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,627,917</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable - related medical practices</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z8W4vKoG8hYa" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,184,399</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zwhHM38IkLz9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">502,494</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zaBchitOx0re" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1981">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhD1mJUnrN7j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,686,893</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Notes receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zLnLIGwSZKW7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zZZdEZluZNwc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1984">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zV3PlU22zt4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1985">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zahk6gotftya" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Description</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Additions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Deductions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounts receivable</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zvSjySkSphic" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">514,561</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z8yuEVtUTSY8" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1988">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zP66msPYHsed" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">72,291</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zQ29yoVXDab2" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">442,270</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zcY4Kdu4FlH" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">11,063,233</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zWLvGIAFs159" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,723,645</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zsl1WJCe5hwb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1993">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z85hWpmeFOof" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,786,878</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable - related medical practices</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zlj6BPQkuCL4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,322,055</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zCbUpBCkTChk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">862,344</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z05j2Dwfr9Wk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1997">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zWROejKsg326" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,184,399</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Notes receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjcY2mtFl1I2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zayjuj5hN0U2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2000">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlxPqyKUdo2h" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2001">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlPBHaXLD1rj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F0B_zOvIhHTENbWj" style="font: 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F13_z79FhlKyM4Fd" style="font: 11pt Arial, Helvetica, Sans-Serif">Included in provision for bad debts.</span></td></tr>
</table>
<p id="xdx_8A1_z4e8Yu3OJg16" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889524480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>QUARTERLY FINANCIAL DATA (UNAUDITED)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">QUARTERLY FINANCIAL DATA (UNAUDITED)</a></td>
<td class="text"><p id="xdx_803_eus-gaap--QuarterlyFinancialInformationTextBlock_zQN0QmbUO1M2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 20 - <span id="xdx_829_zqNRXSgkaWFh">QUARTERLY FINANCIAL DATA (UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">(000&#8217;s omitted, except per share data)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6shskmWuTRe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zGgGNnKaZtL9"><span id="xdx_8BB_zATLAOyPJnpb" style="display: none">Quarterly Financial Data</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJwTG6BgkYSl" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_495_20211001__20211231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z7wdG7KlWy4" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49D_20220101__20220331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_znYtlutyG7Vc" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_499_20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjoaRJ3z2cJ1" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_494_20210701__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjqy8P3wphb7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">September 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">December 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">March 31, 2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
<tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Revenues &#8211; Net</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">23,730</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,479</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,571</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,812</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">97,592</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Costs and Expenses</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17,989</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17,996</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18,933</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,667</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">75,585</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ProfitLoss_zRiZUa0CAyH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Income</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,182</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,137</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,262</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,653</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17,234</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.56</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.58</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.33</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.31</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.78</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.55</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.57</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.32</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.31</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.75</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49C_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zNM2K0B19E32" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_493_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zMaWh6BYG5F1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_490_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zo1nN1CC9ic6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49B_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zaqtGBDgitb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_497_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvg3CWg8B3R6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">September 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">December 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">March 31, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
<tr id="xdx_409_eus-gaap--Revenues_zKmiy43yXAw2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Revenues &#8211; Net</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,979</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">21,164</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">23,090</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,697</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">89,930</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CostsAndExpenses_zh2qvTSKHh23" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Costs and Expenses</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,829</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,182</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18,968</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,853</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">72,832</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ProfitLoss_zBZH7c284aGc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Income</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,251</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,928</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,299</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,196</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">13,674</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zHnOsBLR9KPi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.37</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.45</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.55</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.10</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.47</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_znHqvVrGge2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.36</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.44</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.54</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.11</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.45</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AF_zfrdhv49jSfd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI https://asc.fasb.org/topic&amp;trid=2126967<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL124452896-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889553968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zF4g8zLYw6fa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 21 &#8211; <span id="xdx_821_z6aeQs9mM0v9">SUBSEQUENT EVENTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company evaluates events that have occurred
after the balance sheet date, but before the consolidated financial statements are issued.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During September 2022 the Company amended their
revolving credit agreement. The agreement was extended to October 26, 2022.&#160;The interest rate on borrowings remains at <span id="xdx_905_eus-gaap--DebtorInPossessionFinancingFeeOnUnusedBorrowings_iI_dp_c20220930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh80eVIF2W27" title="Debtor-in-Possession Financing, Fee on Unused Borrowings">5.5</span>%
along with certain financial covenants.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a
stock repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On
September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90C_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziM5MM43iuI7" title="Stock repurchase plan">9</span> million to be purchased under the plan which will be purchased on
the publicly traded open market at prevailing prices.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647892249856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zhbi3hTxA9j3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_z4V2tXknNPO">Principles of Consolidation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries
are included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and
transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--UseOfEstimates_zW2tjBTF4hlf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zAuKG9x0bGG8">Use of Estimates</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances,
intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results
could differ from those estimates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessPolicy', window );">Inventories</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zjn9coHxVAZ3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zOgHJgwbyVjc">Inventories</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or
market.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdGbWiADEDZd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zXtiZqdmIKmf">Property and Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Property and equipment procured in the normal
course of business is stated at cost. Property and equipment purchased in connection with an acquisition is stated at its estimated
fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes using
the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the
useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair
expenses totaled approximately $<span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zDFmObhw18Y4" title="Cost of Property Repairs and Maintenance">2,783,000</span> and $<span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20200701__20210630_zScKC7zCQdh7" title="Cost of Property Repairs and Maintenance">2,051,000</span> for the years ended June 30, 2022 and 2021 respectively. The estimated
useful lives in years are generally as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span><span><span id="xdx_8BD_zvpahj8xZRla" style="display: none">Estimated Useful Life in Years for Property and Equipment</span></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life">5</span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life">13</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life">2</span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life">9</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life">3</span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life">10</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 70%; text-align: left">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life">28</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zITbjaKe7DUb" style="margin-top: 0; margin-bottom: 0">&#160;</p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zynPpkCYR1Fb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zcqFm0Pfc9Rd">Long-Lived Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrmYFHssiwJg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_864_zf3iIAtJQRzh">Other Intangible Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization is calculated on the straight-line
basis over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlJfGCwryDV7" title="Finite-Lived Intangible Asset, Useful Life">15</span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The non-competition agreements are being amortized
on the straight-line basis over the length of the agreement (<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zKDhj6ZLxGui" title="Finite-Lived Intangible Asset, Useful Life">7</span> years).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Amortization is calculated on the straight line
basis over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z2gqdw2o34q6" title="Finite-Lived Intangible Asset, Useful Life">20</span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p id="xdx_846_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdGP3Qctnpu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zdJtbSSD5BEi">Goodwill</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Generally accepted accounting principles in
the United States require the Company to perform a goodwill impairment test annually at the end of each fiscal year and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing
the reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount
of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure
the amount of impairment loss, if any.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock', window );">Acquired assets and assumed liabilities</a></td>
<td class="text"><p id="xdx_84B_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_z5e26zwQH4Ei" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_z96kijWctiH4">Acquired assets and assumed liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Pursuant to ASC No. 805, if the initial accounting
for a business combination is incomplete by the end of the reporting period in which the combination occurs, but during the allowed
measurement period not to exceed one year from the acquisition date, the Company adjusts the provisional amounts recognized at
the acquisition date by means of adjusting the amount recognized for goodwill.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zvSI8n2XqeMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86D_zQlfzqL2fKec">Revenue Recognition</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type and Production-Type Contracts&#8221;.
The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation
take approximately three to six months.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements
with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2022, the Company has <span id="xdx_90D_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20220630_z6L6C4gwEBP" title="Management Agreements With Company Total Medical Practices">22</span> management agreements of which
<span id="xdx_90E_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20220630_zsk0ew7HMJk5" title="Scanners With Management Agreements With Company Owned By Related Party">3</span> were with PC&#8217;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August
2022 (&#8220;the Related medical practices&#8221;) and <span id="xdx_90C_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20220630_zpBwKMne0bT" title="Scanners With Management With Company Located In New York State">19</span> are with PC&#8217;s, which are all located in the state of New York (&#8220;the
New York PC&#8217;s&#8221;), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists
of fixed monthly fees per diagnostic imaging facility ranging from approximately $<span id="xdx_901_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zm43feHIJr3l" title="Contractual Fees For Services Rendered Minimum">77,000</span> to $<span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zBy7pd9XrXg8" title="Contractual Fees For Services Rendered Maximum">447,000</span>. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts for estimated uncollectible
fees, which is reflected in other operating expenses on the Statement of Operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in
accordance with the recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and
codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive
model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred
to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#8217;s
revenue recognition policies and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our revenues generally relate to net patient
fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are
satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The
contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health
plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices
for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health
plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services
we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for
payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed
care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net
of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2022 and 2021 are summarized
in the following table.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_z9YdlB0MD1B2" style="display: none">Patient Fee Revenue - Net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">4,248,708</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">4,100,440</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Medicare/Medicaid</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">1,060,920</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">968,055</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Workers&#8217; Compensation/Personal Injury</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">17,907,335</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">15,011,111</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">6,365,275</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">3,227,783</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Patient Fee Revenue</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">29,582,238</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">23,307,389</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AD_zx5VssEByjTi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zp2w9ck6KI3g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zfdYqShhr9A4">Research and Development Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Research and development costs are charged to
expense as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have
alternative future uses (either in research and development, marketing or production), are classified as property and equipment
and depreciated over their estimated useful lives.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><p id="xdx_840_eus-gaap--AdvertisingCostsPolicyTextBlock_zgiPSJaqHakj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_866_zyTu0TXPoUU3">Advertising Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
Advertising expense approximated $<span id="xdx_90A_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zEDwvMXUE5sc" title="Advertising Expense">634,000</span> and $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20200701__20210630_zuylYwrTstAf" title="Advertising Expense">633,000</span> and for the years ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShippingsAndHandlingCostPolicyTextBlock', window );">Shipping Costs</a></td>
<td class="text"><p id="xdx_84B_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zok9ZtT4i2X3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86E_zrstrd7HC9we">Shipping Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#8217;s shipping and handling costs
are included in revenue from product sales and the related expense included in costs related to product sales is $<span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20210701__20220630_zPTs1J6quhqf" title="Shipping and Handling Costs">7,391</span> and $<span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20200701__20210630_z2QSYSqKf0i5" title="Shipping and Handling Costs">8,215</span>
for the years ended June 30, 2022 and 2021 respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zTjT6586g2me" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_869_zaQ5rvhbATwi">Income Taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted
tax rates in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerAdvancesPolicyTextBlock', window );">Customer Advances</a></td>
<td class="text"><p id="xdx_84D_ecustom--CustomerAdvancesPolicyTextBlock_zKENiTEA65vc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zKXf0DeR9vhf">Customer Advances</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash advances and progress payments received
on sales orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zut1uWwG07eh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_860_zs5Ug5vMExW">Earnings Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;)
is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding
during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company
used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings
per share for the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the years ended June 30, 2022 and 2021, diluted EPS for common shareholders includes <span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20200701__20210630_zHBoHY9qoXLl" title="Diluted EPS"><span id="xdx_90E_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_z9cegbWLW887">127,504</span></span>
shares upon conversion of Class C Common.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>























<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">12,440,906</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">11,690,796</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">191,038</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right">6,554,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right">6,554,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right">1.90</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right">1.78</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right">6,554,209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right">6,681,713</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right">1.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Net income available to common stockholders</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders">10,207,588</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,592,134</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">156,744</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Weighted average shares outstanding</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding">6,505,283</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,505,283</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Basic income per common share</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Income Per Common Share">1.57</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.47</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.41</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Weighted average shares outstanding">6,505,283</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">127,504</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share">6,632,787</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share">1.45</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.41</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A0_z43u6FJd66Gc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zlFV42B3YLs1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_86F_zZ3ADZgTaWm2">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand,
cash in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.
</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>



















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short Term Investments</a></td>
<td class="text"><p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlNuzplzPZIj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_862_zK94v8u2l1u1">Short Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Short term investments include certificates
of deposit with original maturities of greater than 90 days.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zYpbmJyCMqud" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zX4Gt6CN9Wpc">Concentration of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash
equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2022, the
Company had cash on deposit of approximately $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20220630_z3Fmvc96KSof" title="Cash">46,834,000</span> in excess of federally insured limits of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220630_z3qXwL6lOTo5" title="Cash, FDIC Insured Amount">250,000</span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYZs5IumK6p5" title="Concentration Risk, Percentage"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zY8R7dIiJkOc" title="Concentration Risk, Percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2022 and 2021. Net management fee
receivables from the related party medical practices accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zYMlAs1KlfHh" title="Concentration Risk, Percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zV7jmF8YrJib" title="Concentration Risk, Percentage">13</span></span>% of the consolidated accounts receivable for
the years ended June 30, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUCYmnRf7fB8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_861_zAo126oFXqSf">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The financial statements include various estimated
fair value information at June 30, 2022 and 2021, as required by ASC topic 820, &#8220;Disclosures about Fair Value of Financial
Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based on the requirements
set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable
inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are
either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists,
therefore requiring an entity to develop its own assumptions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The following methods and assumptions were used
to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount
approximates fair value because of the short-term maturity of those instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Short term investments: The carrying amount
approximates fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits
with original maturities greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying
amounts approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the
amounts due to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying
amounts of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to
market indices and/or due to the interest rates not being significantly different from the current market rates available to the
Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments
are held for purposes other than trading.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBTGGEVqUq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_863_zUO6VH7x33s7">Recent Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2022 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any of those standards
will have a significant impact on our consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShippingsAndHandlingCostPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShippingsAndHandlingCostPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888163040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock', window );">Estimated Useful Life in Years for Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span><span><span id="xdx_8BD_zvpahj8xZRla" style="display: none">Estimated Useful Life in Years for Property and Equipment</span></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life">5</span>&#8211;<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life">13</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life">2</span>-<span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life">3</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life">9</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font: 11pt arial"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life">3</span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life">10</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="width: 70%; text-align: left">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life">28</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Patient Fee Revenue - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_z9YdlB0MD1B2" style="display: none">Patient Fee Revenue - Net</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">4,248,708</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">4,100,440</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Medicare/Medicaid</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">1,060,920</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">968,055</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Workers&#8217; Compensation/Personal Injury</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">17,907,335</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">15,011,111</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">6,365,275</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">3,227,783</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Patient Fee Revenue</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">29,582,238</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue">23,307,389</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"><span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt">Net income available to common stockholders</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">12,440,906</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">11,690,796</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">191,038</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right">6,554,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right">6,554,209</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right">1.90</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right">1.78</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right">6,554,209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right">382,513</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0873">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right">6,681,713</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right">1.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Common Stock</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Class C Common Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Numerator:</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Net income available to common stockholders</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders">10,207,588</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,592,134</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">156,744</td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Weighted average shares outstanding</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding">6,505,283</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,505,283</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Basic income per common share</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Income Per Common Share">1.57</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.47</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.41</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Weighted average shares outstanding">6,505,283</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">127,504</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0895">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share">6,632,787</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,513</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share">1.45</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.41</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647893499360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Receivables - Non Current - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoieH8Q6lgu8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
<tr style="vertical-align: bottom">
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B0_z0hZTqGVMa11">Receivables - Non Current - net</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">2024</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--ContractReceivableDueTwoToThreeYears_c20220630_pp0p0" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">1,097,015</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--ContractReceivableDueThreeToFourYears_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">620,230</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2026</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--ContractReceivableDueFourToFiveYears_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">140,012</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Total</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total">1,857,257</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Schedule of total facilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_z220HegS9AJf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zqw4ZAFy4gjb" style="display: none">Schedule of total
facilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20210701__20220630_zQLXmaszV5Ek" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49C_20200701__20210630_zK7lN5H1rqIa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For the Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Facilities Owned or Managed (at Beginning of Year)</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">27</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">25</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Facilities Added by:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ManagedFacilitiesAddedAcquisition_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Acquisition</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Internal development</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0987">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ManagedFacilitiesClosedDuringYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Managed Facilities Closed</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0990">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0991">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Facilities Owned or Managed (at End of Year)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">27</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">27</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889588816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTRACT ASSETS AND LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock', window );">Schedule of costs and estimated earnings on uncompleted contracts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_ziENGJQDrkQa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zuG711ZzNlJg" style="display: none">Schedule
of costs and estimated earnings on uncompleted contracts</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_490_20220630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_497_20210630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40D_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzjsI_zjpnaTisn11d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Costs incurred on uncompleted contracts</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">294,783</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzjsI_zPex8fv42mFj" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Estimated earnings</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1003">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">567,978</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzjsI_maCAEEIz0V3_zLFRRjWlECLc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Costs and estimated earnings on uncompleted contracts</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1006">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">862,761</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz0V3_zXwEIpXbvRUi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Billings to date</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1009">&#8212;</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">877,500</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz0V3_zQ0CAjWq7vZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Costs and estimated earnings in excess of billings on uncompleted contracts</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">&#8212;</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(14,739</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-term contract or program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889542880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEp6UsuPt7m3" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zPR9RWmY79ok" style="display: none">Schedule
of inventories</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49B_20220630_zCkx1QVSc0ee" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_495_20210630_zaOGokP0WOa6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40F_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzqFk_zZGwlOlI8DWa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Purchased parts, components and supplies</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,125,805</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,393,329</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzqFk_zTGYFkSy3jT7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Work-in-process</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">234,016</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">270,090</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzqFk_zn4VHTS6lbn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">Inventories</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,359,821</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,663,419</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889642592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zu291D1iv4ri" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zExjxTJiSFE7" style="display: none">Schedule of property
and equipment</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diagnostic equipment</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">31,304,258</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">29,826,829</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Research, development and demonstration equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">6,199,941</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">6,029,551</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Machinery and equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">2,069,055</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">2,069,055</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Furniture and fixtures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">3,484,525</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">3,450,664</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Leasehold improvements</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">14,087,581</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">12,961,887</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Building</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">939,614</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">939,614</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">58,084,974</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization">55,277,600</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Accumulated depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment">35,803,183</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment">33,427,461</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization">22,281,791</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization">21,850,139</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891226608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc', window );">Reconciliation of operating and financing lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zuokFkINHq9b" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B2_zI4YVarfHbek">Reconciliation of operating and financing lease payments</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Year Ending June 30,</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Operating Lease Payments</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Financing Lease Payments</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqV4MW3JRCDa" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">5,512,691</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhltFN9b1xF2" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">244,343</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2024</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_za4QAsA2IOL8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">5,355,310</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zrdyDzoPKQ82" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">244,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxTCWqrdASJ" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">5,256,243</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zvjKRJJwZtel" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">244,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2026</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zofyEX1gbo9c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">4,829,443</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhC8at9t0k3c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">244,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2027</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zMLCK3lmJ3H" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027">3,781,761</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTBG8WAjjvP8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027">162,897</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zF5i7CDZ6Pdj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter">22,529,257</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z2cFtDTgTNRb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="-sec-ix-hidden: xdx2ixbrl1112">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Present value discount</span></td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--PresentValueDiscount_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zbMIUlZc2mfe" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Operating Lease">(10,293,586</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGPGVvnSuQm6" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Financing Lease">(91,838</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Total lease liability</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDAG60pTm3hc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability">36,971,119</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zMSMi7r6EtVl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability">1,048,431</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock', window );">Schedule of Weighted Average Remaining Lease Term</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zgeO7t64m2K9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B5_zQDFEFMVHsSa" style="display: none">Schedule of Weighted Average Remaining Lease Term</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases - years</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zzwfFFJ07oCf" title="Operating Lease, Weighted Average Remaining Lease Term">10.9</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Finance lease - years</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_900_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zeyLo2ywX913" title="Finance Lease, Weighted Average Remaining Lease Term">4.6</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Weighted Average Discount Rate</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z2mkStrDykxh" title="Operating Lease, Weighted Average Discount Rate, Percent">4.9</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Finance lease</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_906_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z6CCKsmHZN33" title="Finance Lease, Weighted Average Discount Rate, Percent">3.6</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_ztXFJoQGHYU7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zVUPKUHnDlFc">Components of lease expense</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_490_20210701__20220630_zqEg6kdv209l" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_496_20200701__20210630_zqgvgciXNQUh" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating lease cost</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,668,199</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,145,701</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;<br/>&#160;<br/>Finance lease cost:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation of leased equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">198,881</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">198,881</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Interest on lease liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">41,603</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">47,472</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total finance lease cost</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">240,484</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">246,353</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9DV53it9TV5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zqGxWrXRW3o2">Supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_497_20210701__20220630_zXsmRwWQ3Mj8" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20200701__20210630_zxzP40d39na7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">For year ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating cash flows from operating leases</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,133,369</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,970,934</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zG68pFJ1s8Hi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Financing cash flows from financing leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">244,344</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">130,038</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_z2aSZYXPO3n2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right-of-use &amp; equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Operating leases</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">7,900,074</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,531,889</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888007104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of other intangible assets - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zYy6UyZkIAD9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B1_z7UUsm5bP4bb" style="display: none">Schedule of other
intangible assets - net</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capitalized software development costs</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">7,004,847</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">7,004,847</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Patents and copyrights</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">5,332,774</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">5,244,892</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Non-competition agreements</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">4,150,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">4,150,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Customer relationships</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">3,900,000</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">3,900,000</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">20,387,621</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross">20,299,739</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Accumulated amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization">16,683,736</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization">16,262,140</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net">3,703,885</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net">4,037,599</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Of Other Intangible Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zOUZvovKLx46" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B2_zEfwCMD5Xdt5">Schedule Of Other Intangible Assets</span> For the Years Ending June 30,</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Patents and Copyrights</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Customer Relationships</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 32%; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">386,747</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">186,747</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2024</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">386,446</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">186,446</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2025</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">381,491</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">181,491</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2026</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">378,866</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">178,866</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">2027</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">368,206</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">168,206</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">200,000</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">1,802,129</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">687,962</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">1,114,167</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: center"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">3,703,885</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">1,589,718</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">2,114,167</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zfJwNtZ5vqcc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B5_zW8RYz3a5CA3">Other Intangible Assets</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Balance &#8211; Beginning of Year</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zMF57x7uF8t2" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - Beginning of Year">4,037,599</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_z8EMvqKC79n9" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,109,129</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Amounts capitalized</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized">87,882</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized">313,705</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Software or patents written off</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off"><span style="-sec-ix-hidden: xdx2ixbrl1271">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off">(534</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization">(421,596</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization">(384,701</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Balance &#8211; End of Year</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zVzbYL94aumk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - End of Year">3,703,885</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_ztLkDlEZ0g2d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,037,599</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647890716192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">class a and b members' equity (hdm acquisition)</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zol9vgOyaCG5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black"><span id="xdx_8BE_zZIjEoVUnRck" style="display: none">class a and b members' equity (hdm acquisition)</span>
</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class A Members</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class B Member</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class A Members</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">Class B Member</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; color: black; text-align: left">Opening Members&#8217; Equity</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">($</td>
<td id="xdx_988_ecustom--OpeningMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zaTzu15e54Y5" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">3,048,524</td>
<td style="width: 1%; color: black; text-align: left">)</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">41,923,380</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">55,253</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 3%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">$</td>
<td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity">39,850,419</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Share of Net Income</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zxygZUVL8NAg" style="color: black; text-align: right" title="Share of Net Income">4,793,482</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income">22,228,693</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income">3,466,223</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income">17,402,961</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black; text-align: left">Buyout of noncontrolling interests</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">$</td>
<td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8z2ziYRZS8d" style="color: black; text-align: right" title="Buyout of noncontrolling interests">23,441</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWtntnpNRNBc" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1406">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWI2wwpP85oc" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1407">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z0QXicdRUfh9" style="color: black; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1408">&#8212;</span></td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Distributions</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_981_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zU24hLztaNDg" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">5,822,232</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_98E_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZPMWnwd9qu6" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">13,860,000</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_982_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zhhcO5Wgu91c" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">6,570,000</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">($</td>
<td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVynIlqjZNIc" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions">15,330,000</td>
<td style="padding-bottom: 1pt; color: black; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black">Ending Members&#8217; Equity</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">($</td>
<td id="xdx_98B_ecustom--EndingMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z264L4T1aId2" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">4,053,833</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td>
<td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">50,292,073</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">($</td>
<td id="xdx_987_ecustom--EndingMembersEquity_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zLCagUZosal7" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">3,048,524</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">)</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td>
<td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity">41,923,380</td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647892333760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term debt, notes payable and capital leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zX7n74WmV0L5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)">
<tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B3_zFLZhe9jqk3b">Long-term debt, notes payable and capital leases</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Note payable requiring monthly payments of interest at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zO2EeGvyRq8">7</span>% until May 2009 followed by <span id="xdx_905_ecustom--NumberOfInstallment_uInteger_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zN40WApOwA2c" title="Number of installment">240</span> <span id="xdx_908_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" title="Debt Instrument, Frequency of Periodic Payment">monthly</span> payments of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Debt Instrument, Periodic Payment">4,472</span> through <span id="xdx_904_ecustom--MaturityDate_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_ze7iAlf2gKz7" title="Maturity date">October 2026</span>. The loan is collateralized by a building with a net book value of $<span id="xdx_904_ecustom--BookValueOfBuilding_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zoJNxqNlEDc8" title="Book Value Of Building">379,163</span> as of June 30, 2022.</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zuLdBxon1sYa" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases">195,457</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z7KWN2PtpU87" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases">232,696</td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Note payable received under the Paycheck Protection Program (&#8216;PPP&#8217;) which was established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;Cares Act&#8217;) that provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven portion of the PPP loan is payable over <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_ztRmTIaUwSU5" title="Debt Instrument, Term">5</span> five years at an interest rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zTpkkMth0Ay5" title="Debt Instrument, Interest Rate During Period">1</span>%, with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note was forgiven in August 2021.</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zul68mZAvYO4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8212;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zRmUnCPMfMB" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">700,764</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">The revolving credit note was extended to October 26, 2022. The Company can borrow up to $<span id="xdx_907_eus-gaap--ProceedsFromLinesOfCredit_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Proceeds from Lines of Credit">10,000,000</span> and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zaYUkWzqZuCf" title="Debt Instrument, Interest Rate During Period">5.5</span>% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zul4yBn5CSk1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1460">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_z3FsXHpNI5ci" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1461">&#8212;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630_z26nNXCs8oZ6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">195,457</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630_z7dhJ1KdRoE9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">933,460</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Less: Current portion</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases">40,078</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20210630_zBt5gnywqX35" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases">173,206</td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion">155,379</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20210630_zKAqWnjmNtsl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion">760,254</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Maturities Of Long-Term Debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zbrBBLC9C8qk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
<tr style="vertical-align: bottom">
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BA_zJSkMcVpxsPj">Maturities Of Long-Term Debt</span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Years Ending June 30,</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">2023</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_c20220630_zkvIRjSK1Xod" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023">40,078</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2024</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_c20220630_zFXF3rOEYc4g" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024">43,766</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2025</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_c20220630_z0nmFtJpRBg8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025">47,002</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2026</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_c20220630_zQTRqUSoUJL" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026">50,448</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">2027</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_c20220630_zBu5pBVlLsS3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027">14,163</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"><span style="font: 11pt Arial, Helvetica, Sans-Serif; color: white">Long-Term Debt Over Five Years and Thereafter</span></td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_c20220630_zhqdguY0FVOe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter">195,457</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891270720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components Of The Provision For Income Taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zU5SRqoMeQq1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B6_zBN5rHJdBRx1">Components Of The Provision For Income Taxes</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_497_20210701__20220630_zk6s9Q0xz282" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20200701__20210630_zOa06S83jKZe" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Years Ended June 30,</td></tr>
<tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zs8e3rhFfUSl" style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Current:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Federal</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"/>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_986_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200701__20210630_zINRoT6zONi6" style="color: rgb(204,238,255); width: 12%; text-align: right" title="Federal"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zgdcahftBFtk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">State</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,440,594</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,136,514</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_zJjfkQKwYX62" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Subtotal</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,440,594</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,136,514</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqPTwpVGJAR7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Deferred:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zbWuLn4DTBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Federal deferred taxes</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,935,921</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,718,046</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zgeh85TD8us" style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">State deferred taxes</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">157,972</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">136,960</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zQLLTvv4FYQe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Subtotal</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,093,893</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,855,006</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zyEBQOSMMlU7" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">Provision (Benefit) for Income Taxes - Net</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,534,487</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,991,520</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXVsq0CdJpj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
<tr style="vertical-align: bottom">
<td style="text-align: left"><span id="xdx_8BB_ztR03Z7IvpMc">Reconciliation Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_494_20210701__20220630_zsNv9qmR2dw9" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49A_20200701__20210630_zllnwR89Fd49" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zwJKJYOzLRx7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; text-align: left">Taxes at federal statutory rate</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">21.0</td>
<td style="width: 1%; text-align: left">%</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">21.0</td>
<td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zdJM2gqp2706" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">State and local income taxes (benefit), net of federal benefit</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">4.2</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3.3</td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zlS7qpvPMatk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Non Controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(5.5</td>
<td style="text-align: left">)%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(4.9</td>
<td style="text-align: left">)%</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zT6GfK1JotBg" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Expiration of tax credits</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">2.0</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iP3us-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20200701__20210630_zAJIXZyDrLK1" title="Expiration of tax credits">4.6</span></td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zpZ0Ual3lTK4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Return to provision adjustments</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0.7</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">6.1</td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zRyWHf5m0dF8" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">NYS Audit Settlement</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">4.5</td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3.2</td>
<td style="text-align: left">%</td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_z63DKhh2NC5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Change in the valuation allowance</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(2.0</td>
<td style="text-align: left">)%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(20.0</td>
<td style="text-align: left">)%</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_z7zSZP3olEBc" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(0.6</td>
<td style="padding-bottom: 1pt; text-align: left">)%</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">9.3</td>
<td style="padding-bottom: 1pt; text-align: left">%</td></tr>
<tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zGfJi9FcS8E2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Effective income tax rate</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">24.3</td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">22.6</td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components Of Company&#8217;s Deferred Tax Assets And Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhUOUyMuFbMc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BB_zViAdR8ww5Hb"><span id="xdx_8B3_z5sbFMsCeMTc"><span id="xdx_8B3_zg2ZVwhm4yZ1" style="display: none">Components Of Company&#8217;s Deferred Tax Assets And Liabilities</span></span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49A_20220630_z1r5QRMAPLX9" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_492_20210630_zdZX8w765Je7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Deferred tax assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zP7Vg3dV5tsg" style="vertical-align: bottom; background-color: White">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Allowance for doubtful accounts</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,239,903</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,827,382</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zE07pX08AZG4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Non-deductible accruals</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">707,400</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">749,902</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zV6NCZ51AGYe" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net operating carryforwards</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,820,010</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">8,285,163</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zHp19WTme3ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Tax credits</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,346,509</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,732,650</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_z2QnWtrJAyO" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Inventory</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">98,945</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">66,316</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_zhE5E8eNehyb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Property and equipment and depreciation</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">71,576</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">187,632</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zny48cNmv5Xg" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left">Deferred Tax Assets - gross</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">13,284,343</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,849,045</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zlM0ct2VgPP7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Valuation allowance</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(441,865</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(890,084</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_msDTLzHqA_maDTALNzFAZ_zIsuIZewdbzd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total deferred tax assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">12,842,478</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,958,961</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzHqA_maDTLzexF_zkRufmNS1n17" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intangibles</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(215,726</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(238,316</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzexF_msDTALNzFAZ_zcZWT7LcwZb" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total deferred tax liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(215,726</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(238,316</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zS7JAQjhJMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net deferred tax asset</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">12,626,752</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,720,645</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647894481184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRHrxNCrmzL1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B8_z47T7equK4g5"><span id="xdx_8BF_zKun2NP1YPv6" style="display: none">Other Current Liabilities</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49C_20220630_zDitV1yH9M65" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49E_20210630_zF8aYmKcwsA4" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2021</td></tr>
<tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accrued salaries, commissions and payroll taxes</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,652,173</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,406,982</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Litigation accruals</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1651">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">900,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Sales tax payable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">248,702</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">644,623</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">State income taxes payable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">382,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">774,234</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Legal and other professional fees</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,707</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">37,827</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounting fees</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">120,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">127,262</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Self-funded health insurance reserve</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">79,167</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">62,548</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accrued interest and penalty</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">59,516</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">493,042</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">854,962</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">715,600</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Other current liabilities</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">6,417,227</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,162,118</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889515248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarized segment financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z3rkDoZogLv" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
<tr style="vertical-align: bottom">
<td style="text-align: left"><span id="xdx_8BA_zDz8vTAtaUua" style="display: none">Schedule of summarized segment financial information</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Manufacturing and Servicing of Medical</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Management of Diagnostic Imaging</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Fiscal 2022:</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Center</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Totals</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net revenues from external customers</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">8,218,804</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">89,373,341</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--Revenues_c20210701__20220630_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">97,592,145</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intersegment net revenues *</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zb7igEbrTuzg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">965,417</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zTvXeUDL9mRg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"><span style="-sec-ix-hidden: xdx2ixbrl1770">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zAgoyxuVEaFk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">965,417</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">(Loss) Income from operations</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">(4,604,305</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">26,611,487</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">22,007,182</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">263,559</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">4,271,677</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">4,535,236</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Compensatory element of stock issuances</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_z6qvuiQl4D15" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zRaYkbCm0dV5" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630_zY5Uml3zRRHc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total identifiable assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">10,259,937</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">189,082,045</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_980_eus-gaap--AssetsNet_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">199,341,982</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capital expenditures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">258,271</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">4,374,903</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">4,633,174</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Fiscal 2021:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net revenues from external customers</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">9,037,091</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">80,892,674</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net">89,929,765</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intersegment net revenues *</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zSvp60x9cvfi" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">901,250</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_ecustom--IntersegmentNetRevenues_pdp0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zrJprfqqlBr9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"><span style="-sec-ix-hidden: xdx2ixbrl1811">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____zqqbYZoareDj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues">901,250</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">(Loss) Income from operations</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">(3,410,189</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">20,507,804</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations">17,097,615</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Depreciation and amortization</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">264,830</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">3,816,857</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization">4,081,687</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Compensatory element of stock issuances</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">83,277</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zn0A5bT5Bbt9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">&#8212;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances">83,277</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total identifiable assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zY3qCC8yoCY4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">24,592,582</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zGu26UdMLcDb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">164,913,613</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20210630_zJ1gLlln9j8e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets">189,506,195</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Capital expenditures</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">291,294</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">3,405,502</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures">3,696,796</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td id="xdx_F00_zbhlTO5DaAO6" style="width: 4px; padding-left: 11pt; text-align: justify"><span style="font: 11pt Arial, Helvetica, Sans-Serif">*</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F1A_zBTwIqequJ48" style="font: 11pt Arial, Helvetica, Sans-Serif">Amounts eliminated in consolidation</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportProductSalesTableTextBlock', window );">Schedule of export product sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ExportProductSalesTableTextBlock_zDeYK6aoxxkk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black"><span id="xdx_8B6_z73CEuWiSHOj" style="display: none">Schedule of export product sales</span></td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right">&#160;</td>
<td style="color: black; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; color: black; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">2022</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; color: black; text-align: left">Dominican Republic</td>
<td style="width: 8%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 12%; color: black; text-align: right"><span id="xdx_908_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zmb28pnmEVf7" title="Foreign Product Sales">12.0</span></td>
<td style="width: 1%; color: black; text-align: left">%</td>
<td style="width: 8%; color: black">&#160;</td>
<td style="width: 1%; color: black; text-align: left">&#160;</td>
<td style="width: 12%; color: black; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_ztJMHCmXZHC1" title="Foreign Product Sales">67.0</span></td>
<td style="width: 1%; color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black">Canada</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zugms5m0sJE1" title="Foreign Product Sales">0.6</span></td>
<td style="color: black; text-align: left">%</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zJed0aRajlC9" title="Foreign Product Sales">0.1</span></td>
<td style="color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="color: black">Germany</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--ForeignProductSales_dp0_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zEelWrPrUDn9" style="color: black; text-align: right" title="Foreign Product Sales">&#8212;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black">&#160;</td>
<td style="color: black; text-align: left">&#160;</td>
<td style="color: black; text-align: right"><span id="xdx_90F_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zpfvAufYPZg5" title="Foreign Product Sales">2.1</span></td>
<td style="color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="color: black; text-align: left">Puerto Rico</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zVvbxCcrzLi5" title="Foreign Product Sales">36.3</span></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">%</td>
<td style="color: black; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; color: black; text-align: right"><span id="xdx_904_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_z9Q7WROcfPWd" title="Foreign Product Sales">0.1</span></td>
<td style="padding-bottom: 1pt; color: black; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20210701__20220630_zCUDH9e2hE" title="Foreign Product Sales">48.9</span></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">%</td>
<td style="color: black; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; color: black; text-align: right"><span id="xdx_905_ecustom--ForeignProductSales_dp_c20200701__20210630_ziIRNZzMkkVk" title="Foreign Product Sales">69.3</span></td>
<td style="padding-bottom: 2.5pt; color: black; text-align: left">%</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportServiceRevenuesTableTextBlock', window );">Schedule of foreign service and repair fees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ExportServiceRevenuesTableTextBlock_zT5QF8LMouK2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td><span id="xdx_8B2_zikxvsNFp2u8" style="display: none">Schedule of foreign service and repair fees</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 56%; text-align: left">Puerto Rico</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_z31Vn7FJCoQ1" title="Foreign Service and Repair fees">1.5</span></td>
<td style="width: 1%; text-align: left">%</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zUylr2Y8uyog" title="Foreign Service and Repair fees">1.5</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Switzerland</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z4yRUNT1iuE7" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zLbEcAucwF8h" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Germany</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_z1Z1fJLR4GSl" title="Foreign Service and Repair fees">1.6</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zsNnM6HXW2Aa" title="Foreign Service and Repair fees">1.5</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>England</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zCRQdGkwmCn2">0.6</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_znKmWFaRGhs8" title="Foreign Service and Repair fees">0.6</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Canada</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zA0GeeSJRHNl" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Greece</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_z8SVYRz71vfe" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zg97RRszEc9j" title="Foreign Service and Repair fees">0.3</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Australia</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zHD8n0OU1767" title="Foreign Service and Repair fees">0.1</span></td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#160;&#8212;</td>
<td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zdlrzyu4C4r5" title="Foreign Service and Repair fees">4.4</span></td>
<td style="text-align: left; padding-bottom: 2.5pt">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zbyRtsu1CFIk" title="Foreign Service and Repair fees">4.5</span></td>
<td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>




<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportServiceRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportServiceRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647890658400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISTION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Fair value assets and assumed liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zFeaYR9KTqsd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BA_zLpLxZiUaiHf"><span id="xdx_8B3_zeYkDSkU531g" style="display: none">Fair value assets and assumed liabilities</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_49D_20210329" style="text-align: center">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Property and equipment</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">650,000</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right to use assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">434,219</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Intangible assets</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">150,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--SecurityDeposit_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Security Deposit</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">38,628</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Right to use liability</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">(434,219</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Goodwill</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right">283,880</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total purchase consideration</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,122,508</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Net assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zzZTztpWvhvg" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Net assets acquired (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8BE_zEPw0ZYlDYob"><span id="xdx_8B9_zMRs5MswHotj" style="display: none">Net assets acquired</span></span></td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Leasehold Improvements</td>
<td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">550,000</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diagnostic Equipment</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">100,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Customer Lists</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">100,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Covenant Not to Compete</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets">50,000</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Security Deposit</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--SecurityDeposit_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Security Deposit">38,628</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Closing costs - expensed</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_ecustom--ClosingCostsExpensed_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Closing costs - expensed">3,478</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Goodwill</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--GoodwillGross_c20210329_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Goodwill">283,880</td>
<td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Cash Consideration Paid</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_ecustom--BusinessCombinationContingentConsiderationAsset1_c20210329_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Cash Consideration Paid">1,125,986</td>
<td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891604896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Summary of Allowance For Doubtful Accounts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zSFOe3M0ttN1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
<tr style="vertical-align: bottom">
<td colspan="17" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8B5_zlhcEixqViBf"><span style="display: none">Summary of Allowance For Doubtful Accounts</span></span></td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Description</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance <br/> June 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Additions (1)</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Deductions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance <br/> June 30, 2022</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounts receivable</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zEApKT23dYLg" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Beginning Balance">442,270</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zDdRJVoP62R1" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Additions (Included in provision for bad debts)"><span style="-sec-ix-hidden: xdx2ixbrl1970">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z2nUsFZQxnlh" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Deductions">237,673</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zoFC9mqAP8dd" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Ending Balance">204,597</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zk5jgUxoDy8l" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,786,878</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zUvS7HPj9Jr7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">841,039</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zPt9BmrWrZN6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1977">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zs502PWeS57c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,627,917</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable - related medical practices</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z8W4vKoG8hYa" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,184,399</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zwhHM38IkLz9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">502,494</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zaBchitOx0re" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1981">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhD1mJUnrN7j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,686,893</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Notes receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zLnLIGwSZKW7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zZZdEZluZNwc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1984">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zV3PlU22zt4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1985">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zahk6gotftya" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Description</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Additions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Deductions</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Accounts receivable</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zvSjySkSphic" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">514,561</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z8yuEVtUTSY8" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1988">&#8212;</span></td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zP66msPYHsed" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">72,291</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zQ29yoVXDab2" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">442,270</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zcY4Kdu4FlH" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">11,063,233</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zWLvGIAFs159" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,723,645</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zsl1WJCe5hwb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1993">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z85hWpmeFOof" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">15,786,878</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Management and other fees receivable - related medical practices</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zlj6BPQkuCL4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,322,055</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zCbUpBCkTChk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">862,344</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z05j2Dwfr9Wk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1997">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zWROejKsg326" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,184,399</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Notes receivable</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjcY2mtFl1I2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zayjuj5hN0U2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2000">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlxPqyKUdo2h" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2001">&#8212;</span></td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlPBHaXLD1rj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">777,354</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 11pt; text-align: justify"><span id="xdx_F0B_zOvIhHTENbWj" style="font: 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
    <td style="padding-left: 11pt; text-align: justify"><span id="xdx_F13_z79FhlKyM4Fd" style="font: 11pt Arial, Helvetica, Sans-Serif">Included in provision for bad debts.</span></td></tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889725472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Data</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6shskmWuTRe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)">
<tr style="vertical-align: bottom">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span id="xdx_8B0_zGgGNnKaZtL9"><span id="xdx_8BB_zATLAOyPJnpb" style="display: none">Quarterly Financial Data</span></span></td>
<td>&#160;</td>
<td colspan="3" id="xdx_493_20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJwTG6BgkYSl" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_495_20211001__20211231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z7wdG7KlWy4" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_49D_20220101__20220331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_znYtlutyG7Vc" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_499_20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjoaRJ3z2cJ1" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" id="xdx_494_20210701__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjqy8P3wphb7" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">September 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">December 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">March 31, 2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2022</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
<tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Revenues &#8211; Net</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">23,730</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,479</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,571</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,812</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">97,592</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Costs and Expenses</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17,989</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17,996</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18,933</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,667</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">75,585</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ProfitLoss_zRiZUa0CAyH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Income</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,182</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5,137</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,262</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,653</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">17,234</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.56</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.58</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.33</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.31</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.78</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.55</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.57</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.32</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.31</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.75</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49C_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zNM2K0B19E32" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_493_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zMaWh6BYG5F1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_490_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zo1nN1CC9ic6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_49B_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zaqtGBDgitb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td id="xdx_497_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvg3CWg8B3R6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">September 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">December 30, 2020</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">March 31, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">June 30, 2021</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Total</td></tr>
<tr id="xdx_409_eus-gaap--Revenues_zKmiy43yXAw2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Revenues &#8211; Net</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,979</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">21,164</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">23,090</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">24,697</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">89,930</td>
<td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CostsAndExpenses_zh2qvTSKHh23" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Total Costs and Expenses</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,829</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">16,182</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">18,968</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">20,853</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">72,832</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ProfitLoss_zBZH7c284aGc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Net Income</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,251</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">3,928</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">4,299</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,196</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">13,674</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zHnOsBLR9KPi" style="vertical-align: bottom; background-color: White">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.37</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.45</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.55</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.10</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.47</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_znHqvVrGge2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.36</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.44</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.54</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">0.11</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.45</td>
<td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887496832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Direct purchase of Noncontrolling Interests</a></td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Direct ownership interest percentage</a></td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm', window );">The ownership interest of the original investors of HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestorsOwnershipInterest', window );">Investors ownership interest percentage</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestorsOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestorsOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestOfOriginalInvestorsOfHdm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887614160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">28 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883024928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 29,582,238<span></span>
</td>
<td class="nump">$ 23,307,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">4,248,708<span></span>
</td>
<td class="nump">4,100,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">1,060,920<span></span>
</td>
<td class="nump">968,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">17,907,335<span></span>
</td>
<td class="nump">15,011,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other Revenue Source [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 6,365,275<span></span>
</td>
<td class="nump">$ 3,227,783<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetPatientFeeRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetPatientFeeRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887875024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 12,440,906<span></span>
</td>
<td class="nump">$ 10,207,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">6,554,209<span></span>
</td>
<td class="nump">6,505,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 11,690,796<span></span>
</td>
<td class="nump">$ 9,592,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">6,554,209<span></span>
</td>
<td class="nump">6,505,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">6,554,209<span></span>
</td>
<td class="nump">6,505,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">6,681,713<span></span>
</td>
<td class="nump">6,632,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 191,038<span></span>
</td>
<td class="nump">$ 156,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647882983552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfPropertyRepairsAndMaintenance', window );">Cost of Property Repairs and Maintenance</a></td>
<td class="nump">$ 2,783,000<span></span>
</td>
<td class="nump">$ 2,051,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices', window );">Management Agreements With Company Total Medical Practices</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty', window );">Scanners With Management Agreements With Company Owned By Related Party</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState', window );">Scanners With Management With Company Located In New York State</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="nump">$ 634,000<span></span>
</td>
<td class="nump">633,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShippingAndHandlingExpense', window );">Shipping and Handling Costs</a></td>
<td class="nump">$ 7,391<span></span>
</td>
<td class="nump">$ 8,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders', window );">Diluted EPS | shares</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 46,834,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC Insured Amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember', window );">Net Management Fee Receivables From Related Party Medical Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember', window );">Diagnostic Imaging Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMinimum', window );">Contractual Fees For Services Rendered Minimum</a></td>
<td class="nump">$ 77,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMaximum', window );">Contractual Fees For Services Rendered Maximum</a></td>
<td class="nump">$ 447,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual fees for services rendered to the PC's.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum contractual fees for services rendered to the PC's.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Imaging Centers with management agreements with Company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAgreementsWithCompanyTotalMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of management agreements with PC's owned by a relarted party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of management agreements with PC's owned by two unrelated radiologists.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShippingAndHandlingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to shipping and handling expense for the period, which are expenses incurred with the objective of delivery of Fonar's products to its customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShippingAndHandlingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfPropertyRepairsAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfPropertyRepairsAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883120608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2024</a></td>
<td class="nump">$ 1,097,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2025</a></td>
<td class="nump">620,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFourToFiveYears', window );">2026</a></td>
<td class="nump">140,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 1,857,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFourToFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFourToFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887891248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details) - Integer<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear', window );">Total Facilities Owned or Managed (at Beginning of Year)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedAcquisition', window );">Acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedByInternalDevelopment', window );">Internal development</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesClosedDuringYear', window );">Managed Facilities Closed</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear', window );">Total Facilities Owned or Managed (at End of Year)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedByInternalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedByInternalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesClosedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesClosedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647889722400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Percentage of PCs net revenues</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Consolidated net revenues percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887891744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RegulatedOperationsAbstract', window );"><strong>Regulated Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsIncurredOnUncompletedContracts', window );">Costs incurred on uncompleted contracts</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 294,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EstimatedEarnings', window );">Estimated earnings</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">567,978<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsOnUncompletedContracts', window );">Costs and estimated earnings on uncompleted contracts</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">862,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BillingsToDate', window );">Less: Billings to date</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">877,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (14,739)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BillingsToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount within current period that has been billed to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BillingsToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs and estimated earnings on uncompleted contracts in excess of billings means the current asset as of the closing date, as properly recorded on seller's balance sheet in accordance with GAAP, representing the amount, in the aggregate, earned on contracts but not yet invoiced to customers, as determined in accordance with GAAP.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Earnings on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891226864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,125,805<span></span>
</td>
<td class="nump">$ 1,393,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">234,016<span></span>
</td>
<td class="nump">270,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">$ 2,359,821<span></span>
</td>
<td class="nump">$ 1,663,419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883050128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">$ 58,084,974<span></span>
</td>
<td class="nump">$ 55,277,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization of property and equipment</a></td>
<td class="nump">35,803,183<span></span>
</td>
<td class="nump">33,427,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment AfterAccumulated depreciation and amortization</a></td>
<td class="nump">22,281,791<span></span>
</td>
<td class="nump">21,850,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">31,304,258<span></span>
</td>
<td class="nump">29,826,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">6,199,941<span></span>
</td>
<td class="nump">6,029,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">2,069,055<span></span>
</td>
<td class="nump">2,069,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">3,484,525<span></span>
</td>
<td class="nump">3,450,664<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">14,087,581<span></span>
</td>
<td class="nump">12,961,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment Before Accumulated depreciation and amortization</a></td>
<td class="nump">$ 939,614<span></span>
</td>
<td class="nump">$ 939,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647894598736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciatedAssetsWriteoff', window );">Depreciated assets write-off</a></td>
<td class="nump">$ 1,737,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 4,113,640<span></span>
</td>
<td class="nump">$ 3,696,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciatedAssetsWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciatedAssetsWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883110240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 5,512,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">5,355,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">5,256,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,829,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">3,781,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">22,529,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present Value discount, Operating Lease</a></td>
<td class="num">(10,293,586)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">36,971,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">162,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present Value discount, Financing Lease</a></td>
<td class="num">(91,838)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease liability</a></td>
<td class="nump">$ 1,048,431<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891613440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647988430000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 5,668,199<span></span>
</td>
<td class="nump">$ 6,145,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCostsAbstract', window );"><strong>&#160; &#160; Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciationOfLeasedEquipment', window );">Depreciation of leased equipment</a></td>
<td class="nump">198,881<span></span>
</td>
<td class="nump">198,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">41,603<span></span>
</td>
<td class="nump">47,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 240,484<span></span>
</td>
<td class="nump">$ 246,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciationOfLeasedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciationOfLeasedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891013328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OperatingCashFlowsFromOperatingLeases', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 5,133,369<span></span>
</td>
<td class="nump">$ 4,970,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinancingCashFlowsFromFinancingLeases', window );">Financing cash flows from financing leases</a></td>
<td class="nump">244,344<span></span>
</td>
<td class="nump">130,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use &amp; equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases', window );">Operating leases</a></td>
<td class="nump">$ 7,900,074<span></span>
</td>
<td class="nump">$ 1,531,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinancingCashFlowsFromFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinancingCashFlowsFromFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OperatingCashFlowsFromOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OperatingCashFlowsFromOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647882900416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">$ 20,387,621<span></span>
</td>
<td class="nump">$ 20,299,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">16,683,736<span></span>
</td>
<td class="nump">16,262,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets - net</a></td>
<td class="nump">3,703,885<span></span>
</td>
<td class="nump">4,037,599<span></span>
</td>
<td class="nump">$ 4,109,129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">7,004,847<span></span>
</td>
<td class="nump">7,004,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">5,332,774<span></span>
</td>
<td class="nump">5,244,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">4,150,000<span></span>
</td>
<td class="nump">4,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887793040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 386,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">386,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">381,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">378,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2023</a></td>
<td class="nump">368,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2023</a></td>
<td class="nump">1,802,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">2023</a></td>
<td class="nump">3,703,885<span></span>
</td>
<td class="nump">$ 4,037,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">186,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">186,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">181,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">178,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2023</a></td>
<td class="nump">168,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2023</a></td>
<td class="nump">687,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">2023</a></td>
<td class="nump">1,589,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2023</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2023</a></td>
<td class="nump">1,114,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">2023</a></td>
<td class="nump">$ 2,114,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647890464528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - Beginning of Year</a></td>
<td class="nump">$ 4,037,599<span></span>
</td>
<td class="nump">$ 4,109,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AmountsCapitalized', window );">Amounts capitalized</a></td>
<td class="nump">87,882<span></span>
</td>
<td class="nump">313,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SoftwareOrPatentsWrittenOff', window );">Software or patents written off</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="num">(421,596)<span></span>
</td>
<td class="num">(384,701)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - End of Year</a></td>
<td class="nump">$ 3,703,885<span></span>
</td>
<td class="nump">$ 4,037,599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AmountsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AmountsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareOrPatentsWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareOrPatentsWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647888149040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 184,096<span></span>
</td>
<td class="nump">$ 179,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 192,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887305776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Aug. 10, 2010</div></th>
<th class="th"><div>Apr. 23, 2010</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Other Selling, General and Administrative Expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 83,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember', window );">N 2010 Stock Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SharesRegistered', window );">Shares registered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">450,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">106,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common
stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">Class C common stock is convertible into shares of common stock on a three-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">one vote per share for the common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,554,210<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">Class B common stock is convertible into shares
of common stock on a one-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">Class B common stock has 10 votes per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">The Class C common
stock was offered on a three-for-one basis to the holders of the Class B common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">The Class C common stock has 25 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting
preferred stock issued pursuant to such stock dividend approximates 313,000 shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">one share of Class A non-voting preferred stock
for every five shares of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesRegistered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesRegistered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21550-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891205776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details) - H D M Equity [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">$ 3,048,524<span></span>
</td>
<td class="nump">$ 55,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">4,793,482<span></span>
</td>
<td class="nump">3,466,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="nump">23,441<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="nump">5,822,232<span></span>
</td>
<td class="nump">6,570,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">4,053,833<span></span>
</td>
<td class="nump">3,048,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">41,923,380<span></span>
</td>
<td class="nump">39,850,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">22,228,693<span></span>
</td>
<td class="nump">17,402,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="nump">13,860,000<span></span>
</td>
<td class="nump">15,330,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">$ 50,292,073<span></span>
</td>
<td class="nump">$ 41,923,380<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterestsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterestsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Distributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Distributions to each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Distributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EndingMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ending Members Equity for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EndingMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OpeningMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Opening Members Equity for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OpeningMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShareOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Of Net Income for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShareOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887108880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 13, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 08, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2013 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Direct purchase of Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Direct ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestorsOwnershipInterest', window );">Investors ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">H D M [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfStandupMriCenters', window );">Purchase Of Standup Mri Centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfOtherMriCenters', window );">Purchase Of Other Mri Centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationToOutsideInvestors', window );">Consideration To Outside Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalPurchasePrice', window );">Total Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements', window );">Consideration For Noncompetition And Consulting Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMEquityMember', window );">H D M Equity [Member] | Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</a></td>
<td class="nump">50.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipPercentageAcquired', window );">Ownership Percentage Acquired</a></td>
<td class="nump">50.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMMember', window );">H D M [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Proceeds from Contributions from Affiliates</a></td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMMember', window );">H D M [Member] | Outside Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Proceeds from Contributions from Affiliates</a></td>
<td class="nump">$ 19,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=FONR_HDMMember', window );">H D M [Member] | Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</a></td>
<td class="nump">49.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,971,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationForNoncompetitionAndConsultingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationToOutsideInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationToOutsideInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestorsOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestorsOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipPercentageAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipPercentageAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfOtherMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfOtherMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfStandupMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfStandupMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_OutsideInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_OutsideInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887306704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 195,457<span></span>
</td>
<td class="nump">$ 933,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">40,078<span></span>
</td>
<td class="nump">173,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long Term Debt, Notes Payable and Capital Leases less Current Portion</a></td>
<td class="nump">$ 155,379<span></span>
</td>
<td class="nump">760,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NumberOfInstallment', window );">Number of installment | Integer</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt Instrument, Frequency of Periodic Payment</a></td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="nump">$ 4,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MaturityDate', window );">Maturity date</a></td>
<td class="text">October 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BookValueOfBuilding', window );">Book Value Of Building</a></td>
<td class="nump">$ 379,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 195,457<span></span>
</td>
<td class="nump">232,696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">700,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable3Member', window );">Note Payable 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from Lines of Credit</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BookValueOfBuilding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BookValueOfBuilding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfInstallment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfInstallment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647892354736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 40,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">43,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">47,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">50,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">14,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 195,457<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883039248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Components Of Provision For Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">$ 2,440,594<span></span>
</td>
<td class="nump">1,136,514<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">2,440,594<span></span>
</td>
<td class="nump">1,136,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred taxes</a></td>
<td class="nump">2,935,921<span></span>
</td>
<td class="nump">2,718,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred taxes</a></td>
<td class="nump">157,972<span></span>
</td>
<td class="nump">136,960<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">3,093,893<span></span>
</td>
<td class="nump">2,855,006<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (Benefit) for Income Taxes - Net</a></td>
<td class="nump">$ 5,534,487<span></span>
</td>
<td class="nump">$ 3,991,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883052208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Taxes at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (benefit), net of federal benefit</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Non Controlling interest</a></td>
<td class="num">(5.50%)<span></span>
</td>
<td class="num">(4.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Expiration of tax credits</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Return to provision adjustments</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement', window );">NYS Audit Settlement</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in the valuation allowance</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">24.30%<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887648976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 4,239,903<span></span>
</td>
<td class="nump">$ 3,827,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Non-deductible accruals</a></td>
<td class="nump">707,400<span></span>
</td>
<td class="nump">749,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating carryforwards</a></td>
<td class="nump">4,820,010<span></span>
</td>
<td class="nump">8,285,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">3,346,509<span></span>
</td>
<td class="nump">3,732,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">98,945<span></span>
</td>
<td class="nump">66,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment and depreciation</a></td>
<td class="nump">71,576<span></span>
</td>
<td class="nump">187,632<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets - gross</a></td>
<td class="nump">13,284,343<span></span>
</td>
<td class="nump">16,849,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(441,865)<span></span>
</td>
<td class="num">(890,084)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">12,842,478<span></span>
</td>
<td class="nump">15,958,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(215,726)<span></span>
</td>
<td class="num">(238,316)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(215,726)<span></span>
</td>
<td class="num">(238,316)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 12,626,752<span></span>
</td>
<td class="nump">$ 15,720,645<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647882866032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="nump">$ 12,842,478<span></span>
</td>
<td class="nump">$ 15,958,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</a></td>
<td class="nump">215,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">20,048,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">5,309,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Other Operating Income</a></td>
<td class="nump">1,853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital', window );">Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital</a></td>
<td class="nump">448,000<span></span>
</td>
<td class="nump">$ 3,547,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Deferred Tax Assets, Tax Credit Carryforwards, Research</a></td>
<td class="nump">3,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Valuation Allowances and Reserves, Amount</a></td>
<td class="nump">442,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AdditionalTaxes', window );">Additional Taxes</a></td>
<td class="nump">$ 1,014,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AdditionalTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AdditionalTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647882869584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 4,652,173<span></span>
</td>
<td class="nump">$ 5,406,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Litigation accruals</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">248,702<span></span>
</td>
<td class="nump">644,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">State income taxes payable</a></td>
<td class="nump">382,000<span></span>
</td>
<td class="nump">774,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">20,707<span></span>
</td>
<td class="nump">37,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">127,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">79,167<span></span>
</td>
<td class="nump">62,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">59,516<span></span>
</td>
<td class="nump">493,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">854,962<span></span>
</td>
<td class="nump">715,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 6,417,227<span></span>
</td>
<td class="nump">$ 9,162,118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891216256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2016</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,668,000<span></span>
</td>
<td class="nump">$ 6,146,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda', window );">Property Tax Abatement From Suffolk County IDA</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyTaxAbatement', window );">Property Tax Abatement</a></td>
<td class="nump">$ 440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 36,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LitigationSettelementDescription', window );">Litigation Settelement Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In September 2020, the Company entered into
a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The
settlement was for $1.2 million of which $900,000 was paid by the Company&#8217;s insurance on September 15, 2020 with the remaining
$315,000 paid by the Company on September 28, 2020.<span></span>
</td>
<td class="text">In September 2019, The Company was notified
by one of its landlords that it was required to vacate the premises within 180 days under the demolition clause in the lease. The
Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated in February 2018. The
Company is in the process of relocating to a new location but the original lease provided for penalty payments in the event that
the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course of the arbitration
proceedings. The Company settled the case for $900,000 for the leasehold holdover charges which was paid in August 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims', window );">Liability for individual claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth', window );">Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000<span></span>
</td>
<td class="nump">$ 63,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LitigationSettelementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LitigationSettelementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatementFromSuffolkCountyIda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. The reserves are included in Other current liabilities' in the consolidated balance sheets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887831200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</a></td>
<td class="nump">$ 617,029<span></span>
</td>
<td class="nump">$ 75,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="nump">$ 2,408,145<span></span>
</td>
<td class="nump">$ 261,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">102,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,940,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SellingGeneralAndAdministrativeExpenses', window );">Selling, General and Administrative Expenses</a></td>
<td class="nump">$ 119,000<span></span>
</td>
<td class="nump">$ 602,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647892333760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_ABillingCompanyMember', window );">A Billing Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related Party Transaction, Description of Transaction</a></td>
<td class="text">The CEO and President of the Company is a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#8217; Compensation
claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000. The Company terminated this agreement
on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the
billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2022 for another year.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember', window );">Bensonhurst M R I Limited Partnership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related Party Transaction, Description of Transaction</a></td>
<td class="text">Bensonhurst MRI Limited Partnership, in which
the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123395306&amp;loc=d3e36975-112693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919370-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918703-209980<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919784-209982<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_ABillingCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_ABillingCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887331888">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 97,592,145<span></span>
</td>
<td class="nump">$ 89,929,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">965,417<span></span>
</td>
<td class="nump">901,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,007,182<span></span>
</td>
<td class="nump">17,097,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,535,236<span></span>
</td>
<td class="nump">4,081,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">83,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">199,341,982<span></span>
</td>
<td class="nump">189,506,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,633,174<span></span>
</td>
<td class="nump">3,696,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember', window );">Manufacturing And Servicing Of Medical Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,218,804<span></span>
</td>
<td class="nump">9,037,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">965,417<span></span>
</td>
<td class="nump">901,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,604,305)<span></span>
</td>
<td class="num">(3,410,189)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">263,559<span></span>
</td>
<td class="nump">264,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">83,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,259,937<span></span>
</td>
<td class="nump">24,592,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">258,271<span></span>
</td>
<td class="nump">291,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">89,373,341<span></span>
</td>
<td class="nump">80,892,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,611,487<span></span>
</td>
<td class="nump">20,507,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,271,677<span></span>
</td>
<td class="nump">3,816,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">189,082,045<span></span>
</td>
<td class="nump">164,913,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,374,903<span></span>
</td>
<td class="nump">$ 3,405,502<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts eliminated in consolidation</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intersegment net revenues are the transfer or exchange of goods for monetary compensation between the management and diagnostic imaging center segment and the manufacturing and service segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887634480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">48.90%<span></span>
</td>
<td class="nump">69.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DO', window );">DOMINICAN REPUBLIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">36.30%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Product Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647883093600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GR', window );">GREECE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service and Repair fees</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Service And Repair Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647893673392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportSalesOfMedicalEquipmentPercentage', window );">Export Sales Of Medical Equipment Percentage</a></td>
<td class="nump">48.90%<span></span>
</td>
<td class="nump">69.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage', window );">Foreign Revenues Of Service And Repair Of Medical Equipment Percentage</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportSalesOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportSalesOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891053856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISTION - Fair value assets and assumed liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1', window );">Right to use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1', window );">Right to use liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,219)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,269,277<span></span>
</td>
<td class="nump">$ 4,269,277<span></span>
</td>
<td class="nump">283,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,122,508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition adjustments included in property, plant and equipment (PPE) for utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887961744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISTION - Net assets acquired (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 29, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="nump">38,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ClosingCostsExpensed', window );">Closing costs - expensed</a></td>
<td class="nump">3,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">283,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BusinessCombinationContingentConsiderationAsset1', window );">Cash Consideration Paid</a></td>
<td class="nump">1,125,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Customer Lists [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember', window );">Rockland Management Group [Member] | Covenant Not To Compete [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BusinessCombinationContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BusinessCombinationContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ClosingCostsExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ClosingCostsExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_RocklandManagementGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887338096">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 442,270<span></span>
</td>
<td class="nump">$ 514,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">237,673<span></span>
</td>
<td class="nump">72,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">204,597<span></span>
</td>
<td class="nump">442,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember', window );">Management And Other Fees Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,786,878<span></span>
</td>
<td class="nump">11,063,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">841,039<span></span>
</td>
<td class="nump">4,723,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,627,917<span></span>
</td>
<td class="nump">15,786,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember', window );">Management And Other Fees Receivable Related Medical Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,184,399<span></span>
</td>
<td class="nump">3,322,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">502,494<span></span>
</td>
<td class="nump">862,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,686,893<span></span>
</td>
<td class="nump">4,184,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">777,354<span></span>
</td>
<td class="nump">777,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 777,354<span></span>
</td>
<td class="nump">$ 777,354<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Included in provision for bad debts.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Deductions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647891586576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,592,145<span></span>
</td>
<td class="nump">$ 89,929,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,584,963<span></span>
</td>
<td class="nump">72,832,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,234,388<span></span>
</td>
<td class="nump">$ 13,673,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_QuarterlyFinancialDataMember', window );">Quarterly Financial Data [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">$ 24,812<span></span>
</td>
<td class="nump">$ 24,571<span></span>
</td>
<td class="nump">$ 24,479<span></span>
</td>
<td class="nump">$ 23,730<span></span>
</td>
<td class="nump">$ 24,697<span></span>
</td>
<td class="nump">$ 23,090<span></span>
</td>
<td class="nump">$ 21,164<span></span>
</td>
<td class="nump">$ 20,979<span></span>
</td>
<td class="nump">$ 97,592<span></span>
</td>
<td class="nump">$ 89,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">20,667<span></span>
</td>
<td class="nump">18,933<span></span>
</td>
<td class="nump">17,996<span></span>
</td>
<td class="nump">17,989<span></span>
</td>
<td class="nump">20,853<span></span>
</td>
<td class="nump">18,968<span></span>
</td>
<td class="nump">16,182<span></span>
</td>
<td class="nump">16,829<span></span>
</td>
<td class="nump">75,585<span></span>
</td>
<td class="nump">72,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 3,653<span></span>
</td>
<td class="nump">$ 3,262<span></span>
</td>
<td class="nump">$ 5,137<span></span>
</td>
<td class="nump">$ 5,182<span></span>
</td>
<td class="nump">$ 2,196<span></span>
</td>
<td class="nump">$ 4,299<span></span>
</td>
<td class="nump">$ 3,928<span></span>
</td>
<td class="nump">$ 3,251<span></span>
</td>
<td class="nump">$ 17,234<span></span>
</td>
<td class="nump">$ 13,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 0.57<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_QuarterlyFinancialDataMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_QuarterlyFinancialDataMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140647887097232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings', window );">Debtor-in-Possession Financing, Fee on Unused Borrowings</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of fee on unused borrowings under debtor-in-possession financing arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124437977&amp;loc=SL2890576-112764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>fonar_10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20220630"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20220630.xsd" xlink:type="simple"/>
    <context id="From2021-07-01to2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-09-01_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-01</instant>
        </period>
    </context>
    <context id="AsOf2022-09-01_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-01</instant>
        </period>
    </context>
    <context id="AsOf2022-09-01_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-01</instant>
        </period>
    </context>
    <context id="AsOf2022-09-01_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-01</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember51888171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember51888218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_DiagnosticImagingFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">FONR:NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-04-23</instant>
        </period>
    </context>
    <context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-08-10</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMEquityMember_custom_ClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="From2013-02-012013-02-13_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-01</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:OutsideInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-01</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2013-03-05_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-03-05</instant>
        </period>
    </context>
    <context id="AsOf2015-01-08_custom_HDMMember_custom_ClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-08</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_NotePayable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NotePayable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_NotePayable3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2016-02-012016-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2016-02-01</startDate>
            <endDate>2016-02-29</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ABillingCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:ABillingCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_BensonhurstMRILimitedPartnershipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:RocklandManagementGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:QuarterlyFinancialDataMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-26_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>FONR:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-07-01to2022-06-30">0000355019</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-07-01to2022-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2021-07-01to2022-06-30">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-07-01to2022-06-30">FY</dei:DocumentFiscalPeriodFocus>
    <FONR:AccountReceivableRelatedParties
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0075"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0155"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0232"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0446"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PaymentsOnNotesReceivableFromEmployeeStockholders
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PaymentsOnNotesReceivableFromEmployeeStockholders
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PaymentsOnNotesReceivableFromEmployeeStockholders
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0471"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember51888187"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0505"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxCreditsAndAdjustments
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CompensatoryElementOfStockIssuances
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0587"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0602"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfImagingCenter
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfNoncontrollingInterests
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0654"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0668"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0873"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0895"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesAddedAcquisition
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0984"
      unitRef="Integer"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0987"
      unitRef="Integer"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl0990"
      unitRef="Integer"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl0991"
      unitRef="Integer"
      xsi:nil="true"/>
    <FONR:CostsIncurredOnUncompletedContracts
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1000"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:EstimatedEarnings
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1003"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContracts
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1006"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BillingsToDate
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1009"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1012"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl1112"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2021-07-01to2022-06-30"
      id="xdx2ixbrl1271"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      id="xdx2ixbrl1406"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      id="xdx2ixbrl1407"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      id="xdx2ixbrl1408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-06-30_custom_NotePayable2Member"
      id="xdx2ixbrl1454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-06-30_custom_NotePayable3Member"
      id="xdx2ixbrl1460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-06-30_custom_NotePayable3Member"
      id="xdx2ixbrl1461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      id="xdx2ixbrl1525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1651"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1770"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1811"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember"
      id="xdx2ixbrl1970"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      id="xdx2ixbrl1977"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      id="xdx2ixbrl1981"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1984"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1985"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember"
      id="xdx2ixbrl1988"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      id="xdx2ixbrl1993"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      id="xdx2ixbrl1997"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl2000"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl2001"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-07-01to2022-06-30">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2021-07-01to2022-06-30">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-07-01to2022-06-30">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-07-01to2022-06-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2021-07-01to2022-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-07-01to2022-06-30">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-07-01to2022-06-30">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-07-01to2022-06-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-07-01to2022-06-30">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-07-01to2022-06-30">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-07-01to2022-06-30">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-07-01to2022-06-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-07-01to2022-06-30">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-07-01to2022-06-30">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-07-01to2022-06-30">694-2929</dei:LocalPhoneNumber>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-07-01to2022-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-07-01to2022-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2021-07-01to2022-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-07-01to2022-06-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2021-07-01to2022-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-07-01to2022-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-07-01to2022-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2021-07-01to2022-06-30">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">95000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-09-01_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-09-01_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-09-01_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-09-01_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="From2021-07-01to2022-06-30">Marcum LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-07-01to2022-06-30">New York, New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2021-07-01to2022-06-30">688</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">48722977</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">44460411</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">32326</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">32177</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">204597</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">442270</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4335956</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4525435</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">11977</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20108989</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">17900489</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16627917</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15786878</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherFees contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33419219</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">30947863</FONR:ManagementAndOtherFees>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4686893</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4184399</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">8602561</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">7814250</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2359821</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1663419</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1104325</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1227463</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">118686174</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">108583484</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1871890</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2879946</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12842478</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15958961</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">22281791</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">21850139</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">34232109</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">30133285</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">928109</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1126990</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">526269</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">666514</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">199341982</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">189506195</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">40078</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">173206</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1551269</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1866035</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">6417227</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9162118</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3880129</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3533656</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">210140</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">202741</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4288766</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4365825</us-gaap:DeferredRevenueCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">361245</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">731101</FONR:CustomerDeposits>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">14739</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16748854</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">20049421</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1857257</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">2800522</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">92663</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">92663</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33090990</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">28975132</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">838291</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1048431</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">155379</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">760254</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">106541</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">171331</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">36356847</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">34086649</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">53105701</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">54136070</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6565853</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6565853</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">657</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">657</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">184531535</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">185100976</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-33566757</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-46007663</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">11643</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-06-30" decimals="INF" unitRef="Shares">11643</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">675390</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">675390</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">150290114</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">138418649</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-4053833</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-3048524</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">146236281</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">135370125</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">199341982</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">189506195</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">29582238</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">23307389</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">517939</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1288483</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">7590865</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">7638608</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">48226787</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">46609449</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">11564316</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">10975836</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">97592145</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">89929765</us-gaap:Revenues>
    <FONR:CostsRelatedToProductSales
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">416814</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1032676</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">2991069</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2740625</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">43344</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">39466</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">13307819</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">10917635</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">27251268</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">25384557</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">6567887</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">6341168</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">1494181</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1635979</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">83277</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">23512581</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">24740044</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">75584963</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">72832150</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">22007182</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">17097615</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">346552</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">248665</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">247158</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">311931</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">861087</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">504450</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">22768875</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">17665331</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5534487</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">3991520</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">17234388</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">13673811</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4793482</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">3466223</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">12440906</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">10207588</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">11690796</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">9592134</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">559072</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012021-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">458710</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">191038</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">156744</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">1.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">1.75</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">1.45</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <FONR:BasicAndDilutedIncomePerShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.50</FONR:BasicAndDilutedIncomePerShare>
    <FONR:BasicAndDilutedIncomePerShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</FONR:BasicAndDilutedIncomePerShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">6554209</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">6505283</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">6681713</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">6632787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:WeightedAverageBasicAndDilutedSharesOutstanding
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageBasicAndDilutedSharesOutstanding>
    <FONR:WeightedAverageBasicAndDilutedSharesOutstanding
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageBasicAndDilutedSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6447463</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">647</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">106747</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">10</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember51888171"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember51888171"
      decimals="0"
      unitRef="USD">657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember51888218"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember51888218"
      decimals="0"
      unitRef="USD">657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">183076888</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-56215251</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">10207588</us-gaap:ProfitLoss>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2024088</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">185100976</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-46007663</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">12440906</us-gaap:ProfitLoss>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-569441</FONR:BuyoutOfNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">184531535</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-33566757</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">55253</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">126242216</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">3466223</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">13673811</us-gaap:ProfitLoss>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2024098</FONR:StockIssuedToEmployeesUnderStockBonusPlansValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">6570000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">6570000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-3048524</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">135370125</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">4793482</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">17234388</us-gaap:ProfitLoss>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">23441</FONR:BuyoutOfNoncontrollingInterests>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-546000</FONR:BuyoutOfNoncontrollingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">5822232</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5822232</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-4053833</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">146236281</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">17234388</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">13673811</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4535236</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">4081687</us-gaap:OtherDepreciationAndAmortization>
    <FONR:ProvisionForBadDebts
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">1343533</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">5585989</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">3093893</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2855006</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxCreditsAndAdjustments
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">671185</us-gaap:IncomeTaxCreditsAndAdjustments>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4000131</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1458053</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:CompensatoryElementOfStockIssuances
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">83277</FONR:CompensatoryElementOfStockIssuances>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1940821</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-534</us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">700764</FONR:GainOnForgivenessOfPppLoan>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5602188</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">12110859</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-43334</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-46944</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-152833</us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">696402</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">14649</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-90638</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-526425</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-129411</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">18087</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-314766</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-99224</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-3765215</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1382497</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-369856</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-123478</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-3437743</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-965825</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">202741</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">74698</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-14739</FONR:IncreaseDecreaseInContractLiabilities>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">14739</FONR:IncreaseDecreaseInContractLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-64790</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">21020</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">15301360</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">19088001</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4545292</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">3533091</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">149</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">293</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <FONR:PurchaseOfImagingCenter
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1122508</FONR:PurchaseOfImagingCenter>
    <FONR:PurchaseOfNoncontrollingInterests
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">546000</FONR:PurchaseOfNoncontrollingInterests>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">87882</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">163705</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5179323</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-4819597</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">37239</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">103335</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">63000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5822232</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">6570000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5859471</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-6610335</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4262566</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">7658069</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">44460411</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">36802342</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">48722977</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">44460411</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80C_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z6FWKRWWwiti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 1 - &lt;span id="xdx_824_zcWilvpZw2v8"&gt;DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Description of Business&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;FONAR Corporation (the &#x201c;Company&#x201d;
or &#x201c;FONAR&#x201d;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development,
production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (&#x201c;MRI&#x201d;)
for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue
is also generated from our installed-base of customers through our service and upgrade programs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;FONAR, through its wholly-owned subsidiary Health
Management Corporation of America (&#x201c;HMCA&#x201d;) provides comprehensive management services to diagnostic imaging facilities.
The services provided by the Company include development, administration, leasing of office space, facilities and medical equipment,
provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and
the development and implementation of practice growth and marketing strategies.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On July 1, 2015, the Company restructured the
corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured
to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its
assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a &lt;span id="xdx_908_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zVledUT1JIld" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"&gt;24.2&lt;/span&gt;% interest in
HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_904_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zbsjXz6Cl608" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"&gt;45.8&lt;/span&gt;% in HDM, and the original investors
in HDM retained a &lt;span id="xdx_908_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zbAn3tom4SHe" title="The ownership interest of the original investors of HDM"&gt;30.0&lt;/span&gt;% ownership interest in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased
noncontrolling interests for $&lt;span id="xdx_903_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zYdU0FUmKFo1" title="Direct purchase of Noncontrolling Interests"&gt;546,000&lt;/span&gt; giving the Company a direct ownership interest of &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zWm28rgveXs4" title="Direct ownership interest percentage"&gt;70.8&lt;/span&gt;% and the investors&#x2019; a &lt;span id="xdx_909_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvf3LZCAv4g4" title="Investors ownership interest percentage"&gt;29.2&lt;/span&gt;%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Since March 2020 the global pandemic of COVID-19
has caused turbulence and uncertainty in the United States and international markets and economies which has adversely effected
our workforce, liquidity, financial conditions, revenues, profitability and business operations. Generally COVID-19 had caused
us to require that much of our workforce work from home and has restricted the ability of our personnel to travel for marketing
purposes or to service our customers. The Company experienced a sudden drop in scan volume for a short term period and the Company
has been steadily recovering to pre-COVID-19 levels. At the end of fiscal year ending June 30, 2020, the Company was able to enact
certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in
scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#x2018;PPP&#x2019;)
program and Medicare advances/stimulus payments. The Company has been able to navigate through these challenges and avoid any significant
disruption of the business and the volume has risen back almost to pre-COVID-19 levels. Although we are unable to predict if there
will be additional consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with the
positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.
&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;













</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestOfOriginalInvestorsOfHdm
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.300</FONR:OwnershipInterestOfOriginalInvestorsOfHdm>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember"
      decimals="0"
      unitRef="USD">546000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FONR:InvestorsOwnershipInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.292</FONR:InvestorsOwnershipInterest>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zFJ3Ghytmqf8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 2 - &lt;span id="xdx_823_zEmq0lRkCRYb"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zhbi3hTxA9j3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_z4V2tXknNPO"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries
are included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and
transactions have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_zW2tjBTF4hlf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zAuKG9x0bGG8"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances,
intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results
could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zjn9coHxVAZ3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zOgHJgwbyVjc"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or
market.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdGbWiADEDZd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zXtiZqdmIKmf"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Property and equipment procured in the normal
course of business is stated at cost. Property and equipment purchased in connection with an acquisition is stated at its estimated
fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes using
the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the
useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair
expenses totaled approximately $&lt;span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zDFmObhw18Y4" title="Cost of Property Repairs and Maintenance"&gt;2,783,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20200701__20210630_zScKC7zCQdh7" title="Cost of Property Repairs and Maintenance"&gt;2,051,000&lt;/span&gt; for the years ended June 30, 2022 and 2021 respectively. The estimated
useful lives in years are generally as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;span&gt;&lt;span id="xdx_8BD_zvpahj8xZRla" style="display: none"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life"&gt;2&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;&#x2013;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 70%; text-align: left"&gt;Building&lt;/td&gt;
&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life"&gt;28&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zITbjaKe7DUb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zynPpkCYR1Fb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zcqFm0Pfc9Rd"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrmYFHssiwJg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_864_zf3iIAtJQRzh"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;1) Patents and Copyrights&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization is calculated on the straight-line
basis over &lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlJfGCwryDV7" title="Finite-Lived Intangible Asset, Useful Life"&gt;15&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;2) Non-Competition Agreements&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The non-competition agreements are being amortized
on the straight-line basis over the length of the agreement (&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zKDhj6ZLxGui" title="Finite-Lived Intangible Asset, Useful Life"&gt;7&lt;/span&gt; years).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;3) Customer Relationships&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization is calculated on the straight line
basis over &lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z2gqdw2o34q6" title="Finite-Lived Intangible Asset, Useful Life"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdGP3Qctnpu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zdJtbSSD5BEi"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Generally accepted accounting principles in
the United States require the Company to perform a goodwill impairment test annually at the end of each fiscal year and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing
the reporting unit&#x2019;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount
of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure
the amount of impairment loss, if any.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_z5e26zwQH4Ei" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_z96kijWctiH4"&gt;Acquired assets and assumed liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Pursuant to ASC No. 805, if the initial accounting
for a business combination is incomplete by the end of the reporting period in which the combination occurs, but during the allowed
measurement period not to exceed one year from the acquisition date, the Company adjusts the provisional amounts recognized at
the acquisition date by means of adjusting the amount recognized for goodwill.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zvSI8n2XqeMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86D_zQlfzqL2fKec"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue on sales contracts for scanners, included
in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type and Production-Type Contracts&#x201d;.
The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation
take approximately three to six months.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue from product sales (upgrades and supplies)
is recognized upon shipment.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements
with various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2022, the Company has &lt;span id="xdx_90D_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20220630_z6L6C4gwEBP" title="Management Agreements With Company Total Medical Practices"&gt;22&lt;/span&gt; management agreements of which
&lt;span id="xdx_90E_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20220630_zsk0ew7HMJk5" title="Scanners With Management Agreements With Company Owned By Related Party"&gt;3&lt;/span&gt; were with PC&#x2019;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August
2022 (&#x201c;the Related medical practices&#x201d;) and &lt;span id="xdx_90C_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20220630_zpBwKMne0bT" title="Scanners With Management With Company Located In New York State"&gt;19&lt;/span&gt; are with PC&#x2019;s, which are all located in the state of New York (&#x201c;the
New York PC&#x2019;s&#x201d;), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists
of fixed monthly fees per diagnostic imaging facility ranging from approximately $&lt;span id="xdx_901_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zm43feHIJr3l" title="Contractual Fees For Services Rendered Minimum"&gt;77,000&lt;/span&gt; to $&lt;span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zBy7pd9XrXg8" title="Contractual Fees For Services Rendered Maximum"&gt;447,000&lt;/span&gt;. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts for estimated uncollectible
fees, which is reflected in other operating expenses on the Statement of Operations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company currently recognizes revenue in
accordance with the recognition accounting standard issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) and
codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines a single comprehensive
model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred
to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#x2019;s
revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Our revenues generally relate to net patient
fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are
satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The
contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health
plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices
for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health
plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services
we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for
payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed
care contractual terms resulting from contract renegotiations and renewals.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s patient fee revenues, net
of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2022 and 2021 are summarized
in the following table.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_z9YdlB0MD1B2" style="display: none"&gt;Patient Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;4,248,708&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;4,100,440&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;1,060,920&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;968,055&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;17,907,335&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;15,011,111&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;6,365,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;3,227,783&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Patient Fee Revenue&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;29,582,238&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;23,307,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AD_zx5VssEByjTi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zp2w9ck6KI3g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zfdYqShhr9A4"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Research and development costs are charged to
expense as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have
alternative future uses (either in research and development, marketing or production), are classified as property and equipment
and depreciated over their estimated useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p id="xdx_840_eus-gaap--AdvertisingCostsPolicyTextBlock_zgiPSJaqHakj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_zyTu0TXPoUU3"&gt;Advertising Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Advertising costs are expensed as incurred.
Advertising expense approximated $&lt;span id="xdx_90A_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zEDwvMXUE5sc" title="Advertising Expense"&gt;634,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20200701__20210630_zuylYwrTstAf" title="Advertising Expense"&gt;633,000&lt;/span&gt; and for the years ended June 30, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zok9ZtT4i2X3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_zrstrd7HC9we"&gt;Shipping Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s shipping and handling costs
are included in revenue from product sales and the related expense included in costs related to product sales is $&lt;span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20210701__20220630_zPTs1J6quhqf" title="Shipping and Handling Costs"&gt;7,391&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20200701__20210630_z2QSYSqKf0i5" title="Shipping and Handling Costs"&gt;8,215&lt;/span&gt;
for the years ended June 30, 2022 and 2021 respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zTjT6586g2me" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zaQ5rvhbATwi"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted
tax rates in effect in the years in which the differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--CustomerAdvancesPolicyTextBlock_zKENiTEA65vc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zKXf0DeR9vhf"&gt;Customer Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash advances and progress payments received
on sales orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zut1uWwG07eh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zs5Ug5vMExW"&gt;Earnings Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&#x201c;EPS&#x201d;)
is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding
during the period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class Method&#x201d;, the Company
used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings
per share for the years ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the years ended June 30, 2022 and 2021, diluted EPS for common shareholders includes &lt;span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20200701__20210630_zHBoHY9qoXLl" title="Diluted EPS"&gt;&lt;span id="xdx_90E_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_z9cegbWLW887"&gt;127,504&lt;/span&gt;&lt;/span&gt;
shares upon conversion of Class C Common.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;12,440,906&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;11,690,796&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;191,038&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.78&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0873"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,681,713&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;10,207,588&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;9,592,134&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;156,744&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;6,505,283&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,505,283&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Income Per Common Share"&gt;1.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Weighted average shares outstanding"&gt;6,505,283&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0895"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;6,632,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A0_z43u6FJd66Gc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zlFV42B3YLs1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86F_zZ3ADZgTaWm2"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents includes cash on hand,
cash in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.
&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlNuzplzPZIj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zK94v8u2l1u1"&gt;Short Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Short term investments include certificates
of deposit with original maturities of greater than 90 days.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zYpbmJyCMqud" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zX4Gt6CN9Wpc"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash: The Company maintains its cash and cash
equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2022, the
Company had cash on deposit of approximately $&lt;span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20220630_z3Fmvc96KSof" title="Cash"&gt;46,834,000&lt;/span&gt; in excess of federally insured limits of $&lt;span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220630_z3qXwL6lOTo5" title="Cash, FDIC Insured Amount"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Related Parties: Net revenues from related parties
accounted for approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYZs5IumK6p5" title="Concentration Risk, Percentage"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zY8R7dIiJkOc" title="Concentration Risk, Percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2022 and 2021. Net management fee
receivables from the related party medical practices accounted for approximately &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zYMlAs1KlfHh" title="Concentration Risk, Percentage"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zV7jmF8YrJib" title="Concentration Risk, Percentage"&gt;13&lt;/span&gt;&lt;/span&gt;% of the consolidated accounts receivable for
the years ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;See Note 3 regarding the Company&#x2019;s concentrations
in the healthcare industry.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUCYmnRf7fB8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zAo126oFXqSf"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The financial statements include various estimated
fair value information at June 30, 2022 and 2021, as required by ASC topic 820, &#x201c;Disclosures about Fair Value of Financial
Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based on the requirements
set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The standard establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable
inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are
either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists,
therefore requiring an entity to develop its own assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The following methods and assumptions were used
to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents: The carrying amount
approximates fair value because of the short-term maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Short term investments: The carrying amount
approximates fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits
with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Receivable and accounts payable: The carrying
amounts approximate fair value because of the short maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the
amounts due to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Long-term debt and notes payable: The carrying
amounts of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to
market indices and/or due to the interest rates not being significantly different from the current market rates available to the
Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;All of the Company&#x2019;s financial instruments
are held for purposes other than trading.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBTGGEVqUq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zUO6VH7x33s7"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2022 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any of those standards
will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84A_eus-gaap--ConsolidationPolicyTextBlock_zhbi3hTxA9j3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_z4V2tXknNPO"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries
are included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and
transactions have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84D_eus-gaap--UseOfEstimates_zW2tjBTF4hlf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zAuKG9x0bGG8"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances,
intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will
continue to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results
could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:InventoryWorkInProcessPolicy contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84F_eus-gaap--InventoryWorkInProcessPolicy_zjn9coHxVAZ3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zOgHJgwbyVjc"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or
market.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryWorkInProcessPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zdGbWiADEDZd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zXtiZqdmIKmf"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Property and equipment procured in the normal
course of business is stated at cost. Property and equipment purchased in connection with an acquisition is stated at its estimated
fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes using
the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the
useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated
depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations.
Expenses for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair
expenses totaled approximately $&lt;span id="xdx_90E_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zDFmObhw18Y4" title="Cost of Property Repairs and Maintenance"&gt;2,783,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20200701__20210630_zScKC7zCQdh7" title="Cost of Property Repairs and Maintenance"&gt;2,051,000&lt;/span&gt; for the years ended June 30, 2022 and 2021 respectively. The estimated
useful lives in years are generally as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;span&gt;&lt;span id="xdx_8BD_zvpahj8xZRla" style="display: none"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life"&gt;2&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;&#x2013;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 70%; text-align: left"&gt;Building&lt;/td&gt;
&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life"&gt;28&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zITbjaKe7DUb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">2783000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2051000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zm3Bfi1SN8t4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;span&gt;&lt;span id="xdx_8BD_zvpahj8xZRla" style="display: none"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zmk1LmrXr2jk" title="Property, Plant and Equipment, Useful Life"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zi1weE3fdUs3" title="Property, Plant and Equipment, Useful Life"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z05RtXtktq58" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zEEQVlFB6RY7" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zzQJn8mvrVze" title="Property, Plant and Equipment, Useful Life"&gt;2&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_znRbjlH49t49" title="Property, Plant and Equipment, Useful Life"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zlUIOp2aLBXa" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuS9UWJGwBJ6" title="Property, Plant and Equipment, Useful Life"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font: 11pt arial"&gt;&lt;span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zHYgcwsVtNv9" title="Property, Plant and Equipment, Useful Life"&gt;3&lt;/span&gt;&#x2013;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zjztVfJWehYf" title="Property, Plant and Equipment, Useful Life"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 70%; text-align: left"&gt;Building&lt;/td&gt;
&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210701__20220630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_z3aETwZug7P2" title="Property, Plant and Equipment, Useful Life"&gt;28&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2021-07-012022-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">P28Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zynPpkCYR1Fb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zcqFm0Pfc9Rd"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company periodically assesses the recoverability
of long-lived assets, including property and equipment and intangibles, other than goodwill, when there are indications of potential
impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated
discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such
factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zrmYFHssiwJg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_864_zf3iIAtJQRzh"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;1) Patents and Copyrights&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization is calculated on the straight-line
basis over &lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zlJfGCwryDV7" title="Finite-Lived Intangible Asset, Useful Life"&gt;15&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;2) Non-Competition Agreements&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The non-competition agreements are being amortized
on the straight-line basis over the length of the agreement (&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zKDhj6ZLxGui" title="Finite-Lived Intangible Asset, Useful Life"&gt;7&lt;/span&gt; years).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;3) Customer Relationships&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization is calculated on the straight line
basis over &lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z2gqdw2o34q6" title="Finite-Lived Intangible Asset, Useful Life"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-07-012022-06-30_us-gaap_IntellectualPropertyMember">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_846_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdGP3Qctnpu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zdJtbSSD5BEi"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Generally accepted accounting principles in
the United States require the Company to perform a goodwill impairment test annually at the end of each fiscal year and more frequently
when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing
the reporting unit&#x2019;s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount
of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure
the amount of impairment loss, if any.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84B_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_z5e26zwQH4Ei" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_z96kijWctiH4"&gt;Acquired assets and assumed liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Pursuant to ASC No. 805, if the initial accounting
for a business combination is incomplete by the end of the reporting period in which the combination occurs, but during the allowed
measurement period not to exceed one year from the acquisition date, the Company adjusts the provisional amounts recognized at
the acquisition date by means of adjusting the amount recognized for goodwill.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















</FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zvSI8n2XqeMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86D_zQlfzqL2fKec"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue on sales contracts for scanners, included
in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type and Production-Type Contracts&#x201d;.
The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation
take approximately three to six months.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue from product sales (upgrades and supplies)
is recognized upon shipment.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Revenue under management contracts is recognized
based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements
with various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2022, the Company has &lt;span id="xdx_90D_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20220630_z6L6C4gwEBP" title="Management Agreements With Company Total Medical Practices"&gt;22&lt;/span&gt; management agreements of which
&lt;span id="xdx_90E_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20220630_zsk0ew7HMJk5" title="Scanners With Management Agreements With Company Owned By Related Party"&gt;3&lt;/span&gt; were with PC&#x2019;s owned by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August
2022 (&#x201c;the Related medical practices&#x201d;) and &lt;span id="xdx_90C_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20220630_zpBwKMne0bT" title="Scanners With Management With Company Located In New York State"&gt;19&lt;/span&gt; are with PC&#x2019;s, which are all located in the state of New York (&#x201c;the
New York PC&#x2019;s&#x201d;), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists
of fixed monthly fees per diagnostic imaging facility ranging from approximately $&lt;span id="xdx_901_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zm43feHIJr3l" title="Contractual Fees For Services Rendered Minimum"&gt;77,000&lt;/span&gt; to $&lt;span id="xdx_90C_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20220630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zBy7pd9XrXg8" title="Contractual Fees For Services Rendered Maximum"&gt;447,000&lt;/span&gt;. All fees are re-negotiable
at the anniversary of the agreements and each year thereafter. The Company records a provision for bad debts for estimated uncollectible
fees, which is reflected in other operating expenses on the Statement of Operations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company currently recognizes revenue in
accordance with the recognition accounting standard issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) and
codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines a single comprehensive
model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred
to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company&#x2019;s
revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Our revenues generally relate to net patient
fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are
satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The
contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health
plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices
for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health
plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services
we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for
payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed
care contractual terms resulting from contract renegotiations and renewals.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s patient fee revenues, net
of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2022 and 2021 are summarized
in the following table.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_z9YdlB0MD1B2" style="display: none"&gt;Patient Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;4,248,708&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;4,100,440&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;1,060,920&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;968,055&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;17,907,335&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;15,011,111&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;6,365,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;3,227,783&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Patient Fee Revenue&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;29,582,238&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;23,307,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AD_zx5VssEByjTi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <FONR:ManagementAgreementsWithCompanyTotalMedicalPractices contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">22</FONR:ManagementAgreementsWithCompanyTotalMedicalPractices>
    <FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">3</FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty>
    <FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">19</FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState>
    <FONR:ContractualFeesForServicesRenderedMinimum
      contextRef="AsOf2022-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      unitRef="USD">77000</FONR:ContractualFeesForServicesRenderedMinimum>
    <FONR:ContractualFeesForServicesRenderedMaximum
      contextRef="AsOf2022-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      unitRef="USD">447000</FONR:ContractualFeesForServicesRenderedMaximum>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zdWJ6LdrS4e1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_z9YdlB0MD1B2" style="display: none"&gt;Patient Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;4,248,708&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;4,100,440&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;1,060,920&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;968,055&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;17,907,335&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;15,011,111&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;6,365,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20200701__20210630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;3,227,783&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Patient Fee Revenue&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;29,582,238&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20200701__20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net Patient Fee Revenue"&gt;23,307,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      unitRef="USD">4248708</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      unitRef="USD">4100440</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      unitRef="USD">1060920</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      unitRef="USD">968055</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      unitRef="USD">17907335</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      unitRef="USD">15011111</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      unitRef="USD">6365275</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      unitRef="USD">3227783</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">29582238</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">23307389</FONR:NetPatientFeeRevenue>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_845_eus-gaap--ResearchAndDevelopmentExpensePolicy_zp2w9ck6KI3g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zfdYqShhr9A4"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Research and development costs are charged to
expense as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have
alternative future uses (either in research and development, marketing or production), are classified as property and equipment
and depreciated over their estimated useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_840_eus-gaap--AdvertisingCostsPolicyTextBlock_zgiPSJaqHakj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_zyTu0TXPoUU3"&gt;Advertising Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Advertising costs are expensed as incurred.
Advertising expense approximated $&lt;span id="xdx_90A_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zEDwvMXUE5sc" title="Advertising Expense"&gt;634,000&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20200701__20210630_zuylYwrTstAf" title="Advertising Expense"&gt;633,000&lt;/span&gt; and for the years ended June 30, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">634000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">633000</us-gaap:AdvertisingExpense>
    <FONR:ShippingsAndHandlingCostPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84B_ecustom--ShippingsAndHandlingCostPolicyTextBlock_zok9ZtT4i2X3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_zrstrd7HC9we"&gt;Shipping Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s shipping and handling costs
are included in revenue from product sales and the related expense included in costs related to product sales is $&lt;span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20210701__20220630_zPTs1J6quhqf" title="Shipping and Handling Costs"&gt;7,391&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--ShippingAndHandlingExpense_pp0p0_c20200701__20210630_z2QSYSqKf0i5" title="Shipping and Handling Costs"&gt;8,215&lt;/span&gt;
for the years ended June 30, 2022 and 2021 respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:ShippingsAndHandlingCostPolicyTextBlock>
    <FONR:ShippingAndHandlingExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">7391</FONR:ShippingAndHandlingExpense>
    <FONR:ShippingAndHandlingExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">8215</FONR:ShippingAndHandlingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zTjT6586g2me" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zaQ5rvhbATwi"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted
tax rates in effect in the years in which the differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <FONR:CustomerAdvancesPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84D_ecustom--CustomerAdvancesPolicyTextBlock_zKENiTEA65vc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zKXf0DeR9vhf"&gt;Customer Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash advances and progress payments received
on sales orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:CustomerAdvancesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zut1uWwG07eh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_860_zs5Ug5vMExW"&gt;Earnings Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&#x201c;EPS&#x201d;)
is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding
during the period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class Method&#x201d;, the Company
used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings
per share for the years ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the years ended June 30, 2022 and 2021, diluted EPS for common shareholders includes &lt;span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20200701__20210630_zHBoHY9qoXLl" title="Diluted EPS"&gt;&lt;span id="xdx_90E_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_z9cegbWLW887"&gt;127,504&lt;/span&gt;&lt;/span&gt;
shares upon conversion of Class C Common.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;























&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;12,440,906&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;11,690,796&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;191,038&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.78&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0873"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,681,713&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;10,207,588&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;9,592,134&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;156,744&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;6,505,283&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,505,283&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Income Per Common Share"&gt;1.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Weighted average shares outstanding"&gt;6,505,283&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0895"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;6,632,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A0_z43u6FJd66Gc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zPLrt5Z1KVpk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;&lt;span id="xdx_8BB_zqg5d6Y7TVV7" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: center; text-indent: -11pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; width: 46%; text-align: left; text-indent: -11pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630_zot6UeBS5E4l" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;12,440,906&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXuiPLMJXoyl" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;11,690,796&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPULtp6biBD9" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;191,038&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_zlOvafbDy2mc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmqWj57wxIs1" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zXURyyPiw03h" style="border-bottom: Black 2.5pt double; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_zX5Mv03dbCXl" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGJTHy3Sxkdf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.78&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zznlbhy4TQyc" style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcJS6l6P9Ac6" style="text-align: right"&gt;6,554,209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLLxMi65LRmb" style="text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYSBzliomis7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zyK1KuuGJ4Ul" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0873"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-align: left; text-indent: -11pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zzbWEcOwIjff" style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,681,713&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu2595796GCf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 11pt; text-indent: -11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxcBijxbydce" style="border-bottom: Black 2.5pt double; text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgM2CivJwYb5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630_zpHk5ySLdDG4" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;10,207,588&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMiDpvuRJhL" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;9,592,134&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pp0p0_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8D6Pgv321rc" style="border-bottom: Black 2.5pt double; width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;156,744&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630_zvCt8EVMjCrb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;6,505,283&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkyC0aOv3Byd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,505,283&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfHjvZSubxTc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630_zdVmVDul4O0d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Income Per Common Share"&gt;1.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4tl44pSErba" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEPqX19RSZAl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSmeJhn2GNIe" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Weighted average shares outstanding"&gt;6,505,283&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z18A1pGsnn2i" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z6c8VtJhAjHl" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaZWJ4bQH4Wh" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0895"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziqqf6fsCtcf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;6,632,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcGfJC8vpcvd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zfYLMqvESkk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--EarningsPerShareDiluted_c20200701__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8Z9KjouDsLc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.41&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">12440906</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="0"
      unitRef="USD">11690796</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">191038</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">6554209</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="INF"
      unitRef="Shares">6554209</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">1.90</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="INF"
      unitRef="USDPShares">1.78</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="INF"
      unitRef="Shares">6554209</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="INF"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="INF"
      unitRef="Shares">6681713</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171"
      decimals="INF"
      unitRef="USDPShares">1.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">10207588</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="0"
      unitRef="USD">9592134</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">156744</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">6505283</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="INF"
      unitRef="Shares">6505283</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">1.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="INF"
      unitRef="Shares">6505283</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="INF"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="INF"
      unitRef="Shares">6632787</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonStockMember51890187"
      decimals="INF"
      unitRef="USDPShares">1.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zlFV42B3YLs1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_86F_zZ3ADZgTaWm2"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents includes cash on hand,
cash in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.
&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_843_eus-gaap--InvestmentPolicyTextBlock_zlNuzplzPZIj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zK94v8u2l1u1"&gt;Short Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Short term investments include certificates
of deposit with original maturities of greater than 90 days.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zYpbmJyCMqud" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zX4Gt6CN9Wpc"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash: The Company maintains its cash and cash
equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2022, the
Company had cash on deposit of approximately $&lt;span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20220630_z3Fmvc96KSof" title="Cash"&gt;46,834,000&lt;/span&gt; in excess of federally insured limits of $&lt;span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220630_z3qXwL6lOTo5" title="Cash, FDIC Insured Amount"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Related Parties: Net revenues from related parties
accounted for approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYZs5IumK6p5" title="Concentration Risk, Percentage"&gt;&lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zY8R7dIiJkOc" title="Concentration Risk, Percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2022 and 2021. Net management fee
receivables from the related party medical practices accounted for approximately &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zYMlAs1KlfHh" title="Concentration Risk, Percentage"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember_zV7jmF8YrJib" title="Concentration Risk, Percentage"&gt;13&lt;/span&gt;&lt;/span&gt;% of the consolidated accounts receivable for
the years ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;See Note 3 regarding the Company&#x2019;s concentrations
in the healthcare industry.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">46834000</us-gaap:Cash>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012021-06-30_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012021-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012022-06-30_custom_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zUCYmnRf7fB8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_zAo126oFXqSf"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The financial statements include various estimated
fair value information at June 30, 2022 and 2021, as required by ASC topic 820, &#x201c;Disclosures about Fair Value of Financial
Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based on the requirements
set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The standard establishes a three-tier fair value
hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable
inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are
either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists,
therefore requiring an entity to develop its own assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The following methods and assumptions were used
to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents: The carrying amount
approximates fair value because of the short-term maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Short term investments: The carrying amount
approximates fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits
with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Receivable and accounts payable: The carrying
amounts approximate fair value because of the short maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Notes receivable: The carrying amount approximates
fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the
amounts due to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Long-term debt and notes payable: The carrying
amounts of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to
market indices and/or due to the interest rates not being significantly different from the current market rates available to the
Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;All of the Company&#x2019;s financial instruments
are held for purposes other than trading.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zuBTGGEVqUq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zUO6VH7x33s7"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2022 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any of those standards
will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_809_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zV2iPfee0oM1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;NOTE 3 &#x2013; &lt;span id="xdx_826_z8pUwDtbudd7"&gt;ACCOUNTS
RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Accounts Receivable&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Credit risk with respect to the Company&#x2019;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior
to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair
fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable
become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its
credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing
credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Long Term Accounts Receivable&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company will generate revenue from long-term,
non-cancellable contracts to provide service and repair services. Future revenue to be recognized over the following three years
at June 30, 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoieH8Q6lgu8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B0_z0hZTqGVMa11"&gt;Receivables - Non Current - net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2024&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--ContractReceivableDueTwoToThreeYears_c20220630_pp0p0" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;1,097,015&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2025&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--ContractReceivableDueThreeToFourYears_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;620,230&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2026&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--ContractReceivableDueFourToFiveYears_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;140,012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total"&gt;1,857,257&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A4_zVb7DU1HZK01" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Medical Receivable&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Medical receivables are due under fee-for-service
contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient&#x2019;s legal counsel and
directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical
receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that will not be collected.
The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings, specific payor
collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Management and Other Fees Receivable&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s receivables from the related
and non-related professional corporations (&#x201c;PCs&#x201d;) substantially consist of fees outstanding under management agreements.
Payment of the outstanding fees is dependent on collection by the PCs of fees from third party medical reimbursement organizations,
principally insurance companies and health management organizations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Payment of the management fee receivables from
the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner their medical fees from the third
party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20220630_zRSWoZCAHA02" title="Percentage of PCs net revenues"&gt;66&lt;/span&gt;% and &lt;span id="xdx_905_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20200701__20210630_zeL6IHw2HSV6"&gt;65&lt;/span&gt;%, respectively, of
the PCs&#x2019; 2022 and 2021 net revenues were derived from no-fault and personal injury protection claims. The Company considers
the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#x2019;s expectations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;Net revenues from
management and other fees charged to the related party medical practices accounted for approximately &lt;span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20220630_z7QA4Zm1OIm5" title="Consolidated net revenues percentage"&gt;12&lt;/span&gt;% and &lt;span id="xdx_907_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20200701__20210630_zavyesENYdf2" title="Consolidated net revenues percentage"&gt;12&lt;/span&gt;%, of the consolidated
net revenues for the years ended June 30, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Tallahassee Magnetic Resonance Imaging, PA,
Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related party medical practices) entered into
a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have
arisen under each individual management agreement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The following table sets forth the number of
our facilities for the years ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Total Facilities&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_z220HegS9AJf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_zqw4ZAFy4gjb" style="display: none"&gt;Schedule of total
facilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20210701__20220630_zQLXmaszV5Ek" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49C_20200701__20210630_zK7lN5H1rqIa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For the Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Facilities Owned or Managed (at Beginning of Year)&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;25&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Facilities Added by:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--ManagedFacilitiesAddedAcquisition_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Acquisition&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Internal development&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0987"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--ManagedFacilitiesClosedDuringYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Managed Facilities Closed&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0991"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Facilities Owned or Managed (at End of Year)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A4_zDdzmdy6tr27" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zoieH8Q6lgu8" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B0_z0hZTqGVMa11"&gt;Receivables - Non Current - net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2024&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--ContractReceivableDueTwoToThreeYears_c20220630_pp0p0" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;1,097,015&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2025&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--ContractReceivableDueThreeToFourYears_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;620,230&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2026&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--ContractReceivableDueFourToFiveYears_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;140,012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total"&gt;1,857,257&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1097015</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">620230</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:ContractReceivableDueFourToFiveYears contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">140012</us-gaap:ContractReceivableDueFourToFiveYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1857257</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.66</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.65</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_z220HegS9AJf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_zqw4ZAFy4gjb" style="display: none"&gt;Schedule of total
facilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20210701__20220630_zQLXmaszV5Ek" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49C_20200701__20210630_zK7lN5H1rqIa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For the Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Facilities Owned or Managed (at Beginning of Year)&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;25&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Facilities Added by:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--ManagedFacilitiesAddedAcquisition_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Acquisition&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Internal development&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0987"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--ManagedFacilitiesClosedDuringYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Managed Facilities Closed&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0991"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Facilities Owned or Managed (at End of Year)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Integer">25</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:ManagedFacilitiesAddedAcquisition
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Integer">1</FONR:ManagedFacilitiesAddedAcquisition>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Integer">1</FONR:ManagedFacilitiesAddedByInternalDevelopment>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_801_eus-gaap--ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock_zCzaaaXfily6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 4 &#x2013; &lt;span id="xdx_820_ziqH03uE6Azc"&gt;CONTRACT ASSETS AND LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Information relating to uncompleted contracts
as of June 30, 2022 and 2021 about contract assets and contract (liabilities) is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_ziENGJQDrkQa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BE_zuG711ZzNlJg" style="display: none"&gt;Schedule
of costs and estimated earnings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_490_20220630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_497_20210630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzjsI_zjpnaTisn11d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Costs incurred on uncompleted contracts&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1000"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;294,783&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzjsI_zPex8fv42mFj" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Estimated earnings&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1003"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;567,978&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzjsI_maCAEEIz0V3_zLFRRjWlECLc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;Costs and estimated earnings on uncompleted contracts&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1006"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;862,761&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz0V3_zXwEIpXbvRUi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Billings to date&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1009"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;877,500&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz0V3_zQ0CAjWq7vZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(14,739&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"/&gt;

















</us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock>
    <us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_ziENGJQDrkQa" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BE_zuG711ZzNlJg" style="display: none"&gt;Schedule
of costs and estimated earnings on uncompleted contracts&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_490_20220630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_497_20210630" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--CostsIncurredOnUncompletedContracts_iI_pp0p0_maCAEEOzjsI_zjpnaTisn11d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Costs incurred on uncompleted contracts&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1000"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;294,783&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--EstimatedEarnings_iI_pp0p0_maCAEEOzjsI_zPex8fv42mFj" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Estimated earnings&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1003"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;567,978&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--CostsAndEstimatedEarningsOnUncompletedContracts_iTI_pp0p0_mtCAEEOzjsI_maCAEEIz0V3_zLFRRjWlECLc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;Costs and estimated earnings on uncompleted contracts&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1006"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;862,761&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--BillingsToDate_iI_pp0p0_msCAEEIz0V3_zXwEIpXbvRUi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Billings to date&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1009"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;877,500&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts_iTI_pp0p0_mtCAEEIz0V3_zQ0CAjWq7vZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(14,739&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">294783</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:EstimatedEarnings contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">567978</FONR:EstimatedEarnings>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">862761</FONR:CostsAndEstimatedEarningsOnUncompletedContracts>
    <FONR:BillingsToDate contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">877500</FONR:BillingsToDate>
    <FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-14739</FONR:CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80B_eus-gaap--InventoryDisclosureTextBlock_z0U5QOHSO1l8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 5 &#x2013; &lt;span id="xdx_82C_z3wh0DvYmL"&gt;INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Inventories included in the accompanying consolidated
balance sheets consist of:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEp6UsuPt7m3" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BE_zPR9RWmY79ok" style="display: none"&gt;Schedule
of inventories&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49B_20220630_zCkx1QVSc0ee" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_495_20210630_zaOGokP0WOa6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzqFk_zZGwlOlI8DWa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Purchased parts, components and supplies&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,125,805&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,393,329&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzqFk_zTGYFkSy3jT7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Work-in-process&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;234,016&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;270,090&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzqFk_zn4VHTS6lbn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;Inventories&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,359,821&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,663,419&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zEp6UsuPt7m3" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0; padding-right: 0; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BE_zPR9RWmY79ok" style="display: none"&gt;Schedule
of inventories&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49B_20220630_zCkx1QVSc0ee" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_495_20210630_zaOGokP0WOa6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzqFk_zZGwlOlI8DWa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Purchased parts, components and supplies&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,125,805&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,393,329&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzqFk_zTGYFkSy3jT7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Work-in-process&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;234,016&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;270,090&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzqFk_zn4VHTS6lbn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;Inventories&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,359,821&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,663,419&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2125805</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1393329</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">234016</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">270090</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2359821</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">1663419</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zioNwRl9ubBj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;NOTE 6 - &lt;span id="xdx_825_zaLAlVMGppzc"&gt;PROPERTY
AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2022 and 2021, is comprised of:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zu291D1iv4ri" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BB_zExjxTJiSFE7" style="display: none"&gt;Schedule of property
and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;31,304,258&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;29,826,829&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;6,199,941&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;6,029,551&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Machinery and equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;2,069,055&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;2,069,055&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;3,484,525&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;3,450,664&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Leasehold improvements&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;14,087,581&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;12,961,887&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Building&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;58,084,974&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;55,277,600&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;35,803,183&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;33,427,461&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;22,281,791&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;21,850,139&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Depreciation and amortization of property and
equipment for the years ended June 30, 2022 and 2021 was $&lt;span id="xdx_90D_eus-gaap--DepreciationAndAmortization_pp0p0_c20210701__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zFP7X7AgrdTb" title="Depreciation and amortization"&gt;4,113,640&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DepreciationAndAmortization_pp0p0_c20200701__20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_znfgKwcIdhDd"&gt;3,696,986&lt;/span&gt;, respectively. During fiscal year ended June
30 2022, the Company wrote off fully depreciated assets of $&lt;span id="xdx_902_ecustom--DepreciatedAssetsWriteoff_c20210701__20220630_z5SP41UlOc8e" title="Depreciated assets write-off"&gt;1,737,918&lt;/span&gt; that related to a location that was previously closed.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--PropertyPlantAndEquipmentTextBlock_zu291D1iv4ri" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BB_zExjxTJiSFE7" style="display: none"&gt;Schedule of property
and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;31,304,258&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;29,826,829&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;6,199,941&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;6,029,551&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Machinery and equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;2,069,055&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;2,069,055&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;3,484,525&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;3,450,664&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Leasehold improvements&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;14,087,581&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;12,961,887&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Building&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20210630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;58,084,974&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment Before Accumulated depreciation and amortization"&gt;55,277,600&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;35,803,183&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated depreciation and amortization of property and equipment"&gt;33,427,461&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;22,281,791&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Property and Equipment AfterAccumulated depreciation and amortization"&gt;21,850,139&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">31304258</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">29826829</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">6199941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">6029551</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">3484525</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">3450664</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">14087581</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">12961887</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-06-30_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">58084974</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">55277600</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">35803183</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">33427461</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">22281791</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">21850139</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">4113640</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-07-012021-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">3696986</us-gaap:DepreciationAndAmortization>
    <FONR:DepreciatedAssetsWriteoff
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">1737918</FONR:DepreciatedAssetsWriteoff>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80D_eus-gaap--LesseeOperatingLeasesTextBlock_zYxyepEVEZ8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 7 &#x2013; &lt;span id="xdx_82C_z728n27cDSE4"&gt;OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In July 2019, the Company adopted ASU 2016-02,
Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying leases as either finance or operating
leases based upon the principle of whether or not the lease is effectively a financed purchase by the lessee.. We have elected
the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to
the comparative periods presented in the consolidated financial statements. We have also elected the transition package of thee
practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about lease
identification, lease classification and indirect costs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company accounts for its various operating
leases in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013; Lease, as updated by ASU 2016-02. At
the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value
of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease.
Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord, we have
a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets
and liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates
available to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities
recognized as of June 30, 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zuokFkINHq9b" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B2_zI4YVarfHbek"&gt;Reconciliation of operating and financing lease payments&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Year Ending June 30,&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Operating Lease Payments&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Financing Lease Payments&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2023&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqV4MW3JRCDa" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;5,512,691&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhltFN9b1xF2" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;244,343&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2024&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_za4QAsA2IOL8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;5,355,310&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zrdyDzoPKQ82" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;244,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxTCWqrdASJ" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;5,256,243&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zvjKRJJwZtel" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;244,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2026&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zofyEX1gbo9c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;4,829,443&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhC8at9t0k3c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;244,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2027&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zMLCK3lmJ3H" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;3,781,761&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTBG8WAjjvP8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;162,897&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zF5i7CDZ6Pdj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;22,529,257&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z2cFtDTgTNRb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1112"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--PresentValueDiscount_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zbMIUlZc2mfe" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Operating Lease"&gt;(10,293,586&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGPGVvnSuQm6" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Financing Lease"&gt;(91,838&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDAG60pTm3hc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;36,971,119&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zMSMi7r6EtVl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;1,048,431&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Weighted Average Remaining Lease Term&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zgeO7t64m2K9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B5_zQDFEFMVHsSa" style="display: none"&gt;Schedule of Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating leases - years&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zzwfFFJ07oCf" title="Operating Lease, Weighted Average Remaining Lease Term"&gt;10.9&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Finance lease - years&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zeyLo2ywX913" title="Finance Lease, Weighted Average Remaining Lease Term"&gt;4.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Weighted Average Discount Rate&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating leases&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z2mkStrDykxh" title="Operating Lease, Weighted Average Discount Rate, Percent"&gt;4.9&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Finance lease&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z6CCKsmHZN33" title="Finance Lease, Weighted Average Discount Rate, Percent"&gt;3.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The components of lease expense were as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_ztXFJoQGHYU7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BB_zVUPKUHnDlFc"&gt;Components of lease expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_490_20210701__20220630_zqEg6kdv209l" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_496_20200701__20210630_zqgvgciXNQUh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating lease cost&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,668,199&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,145,701&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;br/&gt;&#160;&lt;br/&gt;Finance lease cost:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Depreciation of leased equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Interest on lease liabilities&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;41,603&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;47,472&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total finance lease cost&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;240,484&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;246,353&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A3_zo3oZIfzhA51" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Supplemental cash flow information related to
leases was as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9DV53it9TV5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_zqGxWrXRW3o2"&gt;Supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_497_20210701__20220630_zXsmRwWQ3Mj8" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_493_20200701__20210630_zxzP40d39na7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For year ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating cash flows from operating leases&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,133,369&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,970,934&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zG68pFJ1s8Hi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Financing cash flows from financing leases&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;244,344&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;130,038&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_z2aSZYXPO3n2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Right-of-use &amp;amp; equipment assets obtained in exchange for lease obligations:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating leases&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;7,900,074&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,531,889&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AC_zM2IgQM5pgsi" style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;















</us-gaap:LesseeOperatingLeasesTextBlock>
    <FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--LesseeOperatingLeaseLiabilityMaturityTableTextBlockc_zuokFkINHq9b" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B2_zI4YVarfHbek"&gt;Reconciliation of operating and financing lease payments&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Year Ending June 30,&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Operating Lease Payments&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Financing Lease Payments&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2023&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zqV4MW3JRCDa" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;5,512,691&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhltFN9b1xF2" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;244,343&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2024&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_za4QAsA2IOL8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;5,355,310&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zrdyDzoPKQ82" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;244,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zxTCWqrdASJ" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;5,256,243&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zvjKRJJwZtel" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;244,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2026&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zofyEX1gbo9c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;4,829,443&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zhC8at9t0k3c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;244,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2027&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zMLCK3lmJ3H" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;3,781,761&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zTBG8WAjjvP8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;162,897&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zF5i7CDZ6Pdj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;22,529,257&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z2cFtDTgTNRb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1112"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--PresentValueDiscount_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zbMIUlZc2mfe" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Operating Lease"&gt;(10,293,586&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zGPGVvnSuQm6" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present Value discount, Financing Lease"&gt;(91,838&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDAG60pTm3hc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;36,971,119&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_pp0p0_c20220630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zMSMi7r6EtVl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;1,048,431&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">5512691</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">5355310</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">5256243</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">4829443</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">3781761</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">162897</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">22529257</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">-10293586</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">-91838</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2022-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">36971119</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="AsOf2022-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">1048431</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zgeO7t64m2K9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B5_zQDFEFMVHsSa" style="display: none"&gt;Schedule of Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating leases - years&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zzwfFFJ07oCf" title="Operating Lease, Weighted Average Remaining Lease Term"&gt;10.9&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Finance lease - years&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zeyLo2ywX913" title="Finance Lease, Weighted Average Remaining Lease Term"&gt;4.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Weighted Average Discount Rate&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating leases&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z2mkStrDykxh" title="Operating Lease, Weighted Average Discount Rate, Percent"&gt;4.9&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Finance lease&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z6CCKsmHZN33" title="Finance Lease, Weighted Average Discount Rate, Percent"&gt;3.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-06-30">P10Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-06-30">P4Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">0.049</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LeaseCostTableTextBlock_ztXFJoQGHYU7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BB_zVUPKUHnDlFc"&gt;Components of lease expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_490_20210701__20220630_zqEg6kdv209l" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_496_20200701__20210630_zqgvgciXNQUh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating lease cost&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,668,199&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,145,701&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;br/&gt;&#160;&lt;br/&gt;Finance lease cost:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Depreciation of leased equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Interest on lease liabilities&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;41,603&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;47,472&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--FinanceLeaseCost_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total finance lease cost&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;240,484&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;246,353&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5668199</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">6145701</us-gaap:OperatingLeaseCost>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">41603</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">47472</us-gaap:FinanceLeaseInterestExpense>
    <FONR:FinanceLeaseCost
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">240484</FONR:FinanceLeaseCost>
    <FONR:FinanceLeaseCost
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">246353</FONR:FinanceLeaseCost>
    <FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9DV53it9TV5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_zqGxWrXRW3o2"&gt;Supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_497_20210701__20220630_zXsmRwWQ3Mj8" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_493_20200701__20210630_zxzP40d39na7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;For year ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--OperatingCashFlowsFromOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating cash flows from operating leases&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,133,369&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,970,934&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zG68pFJ1s8Hi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Financing cash flows from financing leases&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;244,344&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;130,038&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_z2aSZYXPO3n2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Right-of-use &amp;amp; equipment assets obtained in exchange for lease obligations:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Operating leases&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;7,900,074&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,531,889&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5133369</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">4970934</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">244344</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">130038</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">7900074</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1531889</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_801_eus-gaap--IntangibleAssetsDisclosureTextBlock_zW6YjjFEFgzd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 8 - &lt;span id="xdx_820_z3HDNR1J7843"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Other intangible assets, net of accumulated
amortization, at June 30, 2022 and 2021 are comprised of:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zYy6UyZkIAD9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B1_z7UUsm5bP4bb" style="display: none"&gt;Schedule of other
intangible assets - net&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Capitalized software development costs&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Patents and copyrights&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;5,332,774&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;5,244,892&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Non-competition agreements&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;4,150,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;4,150,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Customer relationships&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;20,387,621&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;20,299,739&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Accumulated amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;16,683,736&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;16,262,140&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net"&gt;3,703,885&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net"&gt;4,037,599&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A2_zv30CAXi5GQk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The estimated amortization of other intangible
assets for the five years ending June 30, 2027 and thereafter is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zOUZvovKLx46" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B2_zEfwCMD5Xdt5"&gt;Schedule Of Other Intangible Assets&lt;/span&gt; For the Years Ending June 30,&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Patents and Copyrights&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Customer Relationships&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 32%; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;386,747&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;186,747&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;386,446&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;186,446&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;381,491&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;181,491&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;378,866&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;178,866&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2027&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;368,206&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;168,206&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;1,802,129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;687,962&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;1,114,167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black"&gt;Other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;3,703,885&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;1,589,718&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;2,114,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zsVHoD7iB4wi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The weighted average amortization period for
other intangible assets is &lt;span id="xdx_905_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20210701__20220630_zSqjszyHoUs7" title="Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"&gt;10.9&lt;/span&gt; years and they have no expected residual value.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Information related to the above intangible
assets for the years ended June 30, 2022 and 2021 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zfJwNtZ5vqcc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B5_zW8RYz3a5CA3"&gt;Other Intangible Assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Balance &#x2013; Beginning of Year&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zMF57x7uF8t2" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - Beginning of Year"&gt;4,037,599&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_z8EMvqKC79n9" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,109,129&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Amounts capitalized&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized"&gt;87,882&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized"&gt;313,705&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Software or patents written off&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off"&gt;(534&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization"&gt;(421,596&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization"&gt;(384,701&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Balance &#x2013; End of Year&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zVzbYL94aumk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - End of Year"&gt;3,703,885&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_ztLkDlEZ0g2d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,037,599&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A8_zpofDHOVEQUg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization of patents and copyrights for the
years ended June 30, 2022 and 2021 amounted to $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zbZBuofw2MZa" title="Amortization of Intangible Assets"&gt;184,096&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zZnixVPrbwVl"&gt;179,701&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization of non-competition agreements for
the years ended June 30, 2022 and 2021 amounted to $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Amortization of Intangible Assets"&gt;37,500&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Amortization of Intangible Assets"&gt;12,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amortization of customer relationships for the
years ended June 30, 2022 and 2021 amounted to $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Amortization of Intangible Assets"&gt;200,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_c20200701__20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Amortization of Intangible Assets"&gt;192,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zYy6UyZkIAD9" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B1_z7UUsm5bP4bb" style="display: none"&gt;Schedule of other
intangible assets - net&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Capitalized software development costs&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Patents and copyrights&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;5,332,774&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;5,244,892&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Non-competition agreements&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;4,150,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;4,150,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Customer relationships&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;20,387,621&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - gross"&gt;20,299,739&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Accumulated amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;16,683,736&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;16,262,140&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net"&gt;3,703,885&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets - net"&gt;4,037,599&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">5332774</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">5244892</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20387621</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">20299739</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16683736</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16262140</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zOUZvovKLx46" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B2_zEfwCMD5Xdt5"&gt;Schedule Of Other Intangible Assets&lt;/span&gt; For the Years Ending June 30,&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Patents and Copyrights&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Customer Relationships&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 32%; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;386,747&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;186,747&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;386,446&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;186,446&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;381,491&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;181,491&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;378,866&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;178,866&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2027&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;368,206&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;168,206&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;200,000&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;1,802,129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;687,962&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;1,114,167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: center"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif; color: black"&gt;Other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;3,703,885&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;1,589,718&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;2,114,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">386747</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">186747</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">386446</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">186446</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">381491</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">181491</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">378866</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">178866</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">368206</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">168206</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1802129</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">687962</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">1114167</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">1589718</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">2114167</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2021-07-01to2022-06-30">P10Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zfJwNtZ5vqcc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B5_zW8RYz3a5CA3"&gt;Other Intangible Assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Balance &#x2013; Beginning of Year&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zMF57x7uF8t2" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - Beginning of Year"&gt;4,037,599&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20200701__20210630_z8EMvqKC79n9" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,109,129&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Amounts capitalized&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized"&gt;87,882&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AmountsCapitalized_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amounts capitalized"&gt;313,705&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Software or patents written off&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_c20200701__20210630_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Software or patents written off"&gt;(534&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization"&gt;(421,596&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--AdjustmentForAmortization_c20200701__20210630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Amortization"&gt;(384,701&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Balance &#x2013; End of Year&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zVzbYL94aumk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Balance - End of Year"&gt;3,703,885&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20200701__20210630_ztLkDlEZ0g2d" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,037,599&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">4109129</us-gaap:OtherIntangibleAssetsNet>
    <FONR:AmountsCapitalized
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">87882</FONR:AmountsCapitalized>
    <FONR:AmountsCapitalized
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">313705</FONR:AmountsCapitalized>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-534</FONR:SoftwareOrPatentsWrittenOff>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">-421596</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">-384701</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">184096</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012021-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">179701</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">37500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012021-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">12500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012021-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">192500</us-gaap:AmortizationOfIntangibleAssets>
    <FONR:CapitalStockAndOptionsDisclosureTextblock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_804_ecustom--CapitalStockAndOptionsDisclosureTextblock_zIdjSgaMr44g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 9 - &lt;span id="xdx_827_zmVWXarWVxWd"&gt;CAPITAL STOCK&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90C_eus-gaap--DividendsPayableNature_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Dividends Payable, Nature"&gt;Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common
stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Class B Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90F_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" title="Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"&gt;Class B common stock is convertible into shares
of common stock on a one-for-one basis.&lt;/span&gt; &lt;span id="xdx_906_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember" title="Common Stock, Voting Rights"&gt;Class B common stock has 10 votes per share.&lt;/span&gt; There were &lt;span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common Stock, Shares, Outstanding"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKN7B3ynmEE8" title="Common Stock, Shares, Outstanding"&gt;146&lt;/span&gt;&lt;/span&gt; of such shares outstanding
at June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Class C Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" title="Common Stock, Voting Rights"&gt;The Class C common stock has 25 votes per share&lt;/span&gt;,
as compared to 10 votes per share for the Class B common stock and &lt;span id="xdx_905_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Common Stock, Voting Rights"&gt;one vote per share for the common stock.&lt;/span&gt; &lt;span id="xdx_90E_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember" title="Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"&gt;The Class C common
stock was offered on a three-for-one basis to the holders of the Class B common stock.&lt;/span&gt; Although having greater voting power, each
share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions.
&lt;span id="xdx_90E_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember" title="Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"&gt;Class C common stock is convertible into shares of common stock on a three-for-one basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Class A Non-Voting Preferred Stock&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On April 3, 1995, the stockholders ratified
a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the
declaration of a stock dividend on the Company&#x2019;s common stock consisting of &lt;span id="xdx_906_eus-gaap--CommonStockVotingRights_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" title="Common Stock, Voting Rights"&gt;one share of Class A non-voting preferred stock
for every five shares of common stock.&lt;/span&gt; &lt;span id="xdx_904_eus-gaap--DividendsPayableNature_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember" title="Dividends Payable, Nature"&gt;The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting
preferred stock issued pursuant to such stock dividend approximates 313,000 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million
of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#x2019;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#x2019;s
patents.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution
rights, liquidation rights and other rights and preferences (other than the voting rights).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Stock Bonus Plans&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On April 23, 2010, the Board approved the 2010
Stock Bonus Plan. The plan entitles the Company to reserve &lt;span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Common Stock, Capital Shares Reserved for Future Issuance"&gt;2,000,000&lt;/span&gt; shares of common stock. On August 10, 2010, the Company filed
Form S-8 to register the &lt;span id="xdx_908_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zZVgXl748154" title="Shares registered"&gt;2,000,000&lt;/span&gt; shares. As of June 30, 2022, &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"&gt;450,177&lt;/span&gt; shares of common stock of FONAR were available for future
grant under this plan. For the years ended June 30, 2022 and 2021, &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"&gt;0&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20200701__20210630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zac32CiCK557" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"&gt;106,747&lt;/span&gt; shares were issued respectively, of which $&lt;span id="xdx_905_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_c20210701__20220630_pp0p0" title="Other Selling, General and Administrative Expense"&gt;0&lt;/span&gt; and
$&lt;span id="xdx_907_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_pp0p0_c20200701__20210630_zPOnM6MdYxj9" title="Other Selling, General and Administrative Expense"&gt;83,277&lt;/span&gt; were expensed and included in selling, general and administrative expenses for the years ended June 30, 2022 and 2021,
respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Options&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company had stock option plans, which provided
for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the
success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically
three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair
value of the Company&#x2019;s common stock at the date of grant. The options had to be exercised within ten years from the date
of grant.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:CapitalStockAndOptionsDisclosureTextblock>
    <us-gaap:DividendsPayableNature contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common
stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</us-gaap:DividendsPayableNature>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2021-07-012022-06-30_us-gaap_CommonClassBMember">Class B common stock is convertible into shares
of common stock on a one-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2021-07-012022-06-30_us-gaap_CommonClassBMember">Class B common stock has 10 votes per share.</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember">The Class C common stock has 25 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockVotingRights contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171">one vote per share for the common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember">The Class C common
stock was offered on a three-for-one basis to the holders of the Class B common stock.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember51890171">Class C common stock is convertible into shares of common stock on a three-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2021-07-012022-06-30_us-gaap_PreferredClassAMember">one share of Class A non-voting preferred stock
for every five shares of common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:DividendsPayableNature contextRef="From2021-07-012022-06-30_us-gaap_PreferredClassAMember">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting
preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</us-gaap:DividendsPayableNature>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <FONR:SharesRegistered
      contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">2000000</FONR:SharesRegistered>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2022-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">450177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2020-07-012021-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">106747</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">83277</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zKh7yiN9IQ" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 10 &#x2013; &lt;span id="xdx_828_zYX4EBgdMaT3"&gt;CONTROLLING AND NONCONTROLLING
INTERESTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On February 13, 2013, the Company entered into
an agreement with outside investors to acquire a &lt;span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMEquityMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember_zpDTSxC1ow5i" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"&gt;50.5&lt;/span&gt;% controlling interest in a newly formed limited liability company, Health
Diagnostics Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members;
Class A members and one Class B member. The Class A members have an ownership interest of &lt;span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_zN2dzJtSovAf" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"&gt;49.5&lt;/span&gt;% of HDM. The Class B member (HMCA)
has an ownership of &lt;span id="xdx_908_ecustom--OwnershipPercentageAcquired_iI_dp_c20130213__srt--OwnershipAxis__custom--HDMEquityMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBMember_zJpgAznnwlMg" title="Ownership Percentage Acquired"&gt;50.5&lt;/span&gt;% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes
equal to their percentage of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations
of the Company will be allocated among the members in the same proportions as their membership interests in the Company bear to
all the Class A and Class B membership interests of the Company in the aggregate outstanding. All of the depreciation and amortization
of the assets of the Company will be allocated solely to the Class A members, unless and until their interests have been redeemed
by the Company in full pursuant to the provisions of the operating agreement. The Company contributed $&lt;span id="xdx_905_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember_pp0p0" title="Proceeds from Contributions from Affiliates"&gt;20,200,000&lt;/span&gt; to HDM and the
group of outside investors contributed $&lt;span id="xdx_907_eus-gaap--ProceedsFromContributionsFromAffiliates_c20130201__20130213__srt--OwnershipAxis__custom--HDMMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OutsideInvestorsMember_pp0p0" title="Proceeds from Contributions from Affiliates"&gt;19,800,000&lt;/span&gt; for its non-controlling membership interest.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On March 5, 2013 HDM purchased from Health Diagnostics,
LLC (&#x201c;HD&#x201d;) and certain of its subsidiaries, a business managing twelve (&lt;span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zFleqcbCn4Ac" title="Purchase Of Standup Mri Centers"&gt;12&lt;/span&gt;) Stand-Up MRI Centers and two (&lt;span id="xdx_906_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z2PR5mp07MOb" title="Purchase Of Other Mri Centers"&gt;2&lt;/span&gt;) other
scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $&lt;span id="xdx_904_ecustom--ConsiderationToOutsideInvestors_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zd7jf6653Mmk" title="Consideration To Outside Investors"&gt;1.5&lt;/span&gt; million
to outside investors) aggregating $&lt;span id="xdx_90A_ecustom--TotalPurchasePrice_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zqrT8rD4weJh" title="Total Purchase Price"&gt;35.9&lt;/span&gt; million. Concurrently with the acquisition, HDM entered into several consulting and non-competition
agreements for a consideration of $&lt;span id="xdx_902_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn3n3_dm_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zXSMxFaDwrz9" title="Consideration For Noncompetition And Consulting Agreements"&gt;4.1&lt;/span&gt; million. The acquisition was accounted for using the purchase method in accordance with
ASC 805, &#x201c;Business Combinations&#x201d;. The Company recognized and measured goodwill as of the acquisition date, as the excess
of the fair value of the consideration paid over the fair value of the identified net assets acquired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;On January 8, 2015,
the Company purchased 20% of the Class A members ownership interest at a cost of $&lt;span id="xdx_908_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_c20150108__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_pp0p0" title="Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value"&gt;4,971,094&lt;/span&gt;. The Company has a &lt;span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20150108__srt--OwnershipAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAMember_zoLt8vVrR9D" title="Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"&gt;60.4&lt;/span&gt;% ownership
interest in HDM after this transaction. During the year ended June 30, 2022, the Company purchased noncontrolling interests for
$&lt;span id="xdx_90F_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_z8R4jSdJGuqd" title="Direct purchase of Noncontrolling Interests"&gt;546,000&lt;/span&gt; giving the Company a direct ownership interest of &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_z2YEPx0s2c3f" title="Direct ownership interest percentage"&gt;70.8&lt;/span&gt;% and the investors&#x2019; a &lt;span id="xdx_903_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvQbWkDbPuMl" title="Investors ownership interest percentage"&gt;29.2&lt;/span&gt;% ownership interest.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Amount of each class of HDM members&#x2019; equity
as of June 30, 2022 and 2021&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zol9vgOyaCG5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;&lt;span id="xdx_8BE_zZIjEoVUnRck" style="display: none"&gt;class a and b members' equity (hdm acquisition)&lt;/span&gt;
&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class B Member&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 40%; color: black; text-align: left"&gt;Opening Members&#x2019; Equity&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_988_ecustom--OpeningMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zaTzu15e54Y5" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;3,048,524&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;41,923,380&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;55,253&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;39,850,419&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;Share of Net Income&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zxygZUVL8NAg" style="color: black; text-align: right" title="Share of Net Income"&gt;4,793,482&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income"&gt;22,228,693&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income"&gt;3,466,223&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income"&gt;17,402,961&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="color: black; text-align: left"&gt;Buyout of noncontrolling interests&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8z2ziYRZS8d" style="color: black; text-align: right" title="Buyout of noncontrolling interests"&gt;23,441&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWtntnpNRNBc" style="color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1406"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWI2wwpP85oc" style="color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1407"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z0QXicdRUfh9" style="color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1408"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;Distributions&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_981_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zU24hLztaNDg" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;5,822,232&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZPMWnwd9qu6" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;13,860,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_982_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zhhcO5Wgu91c" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;6,570,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVynIlqjZNIc" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;15,330,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="color: black"&gt;Ending Members&#x2019; Equity&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--EndingMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z264L4T1aId2" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;4,053,833&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;50,292,073&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_987_ecustom--EndingMembersEquity_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zLCagUZosal7" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;3,048,524&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;41,923,380&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_HDMEquityMember_custom_ClassBMember"
      decimals="INF"
      unitRef="Pure">0.505</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAMember"
      decimals="INF"
      unitRef="Pure">0.495</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <FONR:OwnershipPercentageAcquired
      contextRef="AsOf2013-02-13_custom_HDMEquityMember_custom_ClassBMember"
      decimals="INF"
      unitRef="Pure">0.505</FONR:OwnershipPercentageAcquired>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-012013-02-13_custom_HDMMember"
      decimals="0"
      unitRef="USD">20200000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-012013-02-13_custom_HDMMember_custom_OutsideInvestorsMember"
      decimals="0"
      unitRef="USD">19800000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <FONR:PurchaseOfStandupMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      unitRef="Integer">12</FONR:PurchaseOfStandupMriCenters>
    <FONR:PurchaseOfOtherMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      unitRef="Integer">2</FONR:PurchaseOfOtherMriCenters>
    <FONR:ConsiderationToOutsideInvestors
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-3"
      unitRef="USD">1500000</FONR:ConsiderationToOutsideInvestors>
    <FONR:TotalPurchasePrice
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-3"
      unitRef="USD">35900000</FONR:TotalPurchasePrice>
    <FONR:ConsiderationForNoncompetitionAndConsultingAgreements
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-3"
      unitRef="USD">4100000</FONR:ConsiderationForNoncompetitionAndConsultingAgreements>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="AsOf2015-01-08_custom_HDMMember_custom_ClassAMember"
      decimals="0"
      unitRef="USD">4971094</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2015-01-08_custom_HDMMember_custom_ClassAMember"
      decimals="INF"
      unitRef="Pure">0.604</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember"
      decimals="0"
      unitRef="USD">546000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FONR:InvestorsOwnershipInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.292</FONR:InvestorsOwnershipInterest>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zol9vgOyaCG5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;&lt;span id="xdx_8BE_zZIjEoVUnRck" style="display: none"&gt;class a and b members' equity (hdm acquisition)&lt;/span&gt;
&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class B Member&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 40%; color: black; text-align: left"&gt;Opening Members&#x2019; Equity&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_988_ecustom--OpeningMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zaTzu15e54Y5" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;3,048,524&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;41,923,380&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;55,253&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; color: black; text-align: right" title="Opening Members Equity"&gt;39,850,419&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;Share of Net Income&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zxygZUVL8NAg" style="color: black; text-align: right" title="Share of Net Income"&gt;4,793,482&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income"&gt;22,228,693&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income"&gt;3,466,223&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--ShareOfNetIncome_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="color: black; text-align: right" title="Share of Net Income"&gt;17,402,961&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="color: black; text-align: left"&gt;Buyout of noncontrolling interests&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8z2ziYRZS8d" style="color: black; text-align: right" title="Buyout of noncontrolling interests"&gt;23,441&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWtntnpNRNBc" style="color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1406"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWI2wwpP85oc" style="color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1407"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_z0QXicdRUfh9" style="color: black; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1408"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;Distributions&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_981_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zU24hLztaNDg" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;5,822,232&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--Distributions_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZPMWnwd9qu6" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;13,860,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_982_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zhhcO5Wgu91c" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;6,570,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVynIlqjZNIc" style="border-bottom: Black 1pt solid; color: black; text-align: right" title="Distributions"&gt;15,330,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="color: black"&gt;Ending Members&#x2019; Equity&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--EndingMembersEquity_iI_pp0p0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z264L4T1aId2" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;4,053,833&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;50,292,073&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_987_ecustom--EndingMembersEquity_iI_pp0p0_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zLCagUZosal7" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;3,048,524&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20210630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; color: black; text-align: right" title="Ending Members Equity"&gt;41,923,380&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">3048524</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">41923380</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">55253</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">39850419</FONR:OpeningMembersEquity>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">4793482</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">22228693</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">3466223</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">17402961</FONR:ShareOfNetIncome>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">23441</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:Distributions
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">5822232</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">13860000</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">6570000</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">15330000</FONR:Distributions>
    <FONR:EndingMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">4053833</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">50292073</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">3048524</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">41923380</FONR:EndingMembersEquity>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_803_eus-gaap--DebtAndCapitalLeasesDisclosuresTextBlock_z3v7buxihaBj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 11 - &lt;span id="xdx_821_zcNIywVHkei"&gt;LONG-TERM DEBT, NOTES PAYABLE AND
CAPITAL LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Long-term debt, notes payable and capital leases
consist of the following:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zX7n74WmV0L5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B3_zFLZhe9jqk3b"&gt;Long-term debt, notes payable and capital leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Note payable requiring monthly payments of interest at a rate of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zO2EeGvyRq8"&gt;7&lt;/span&gt;% until May 2009 followed by &lt;span id="xdx_905_ecustom--NumberOfInstallment_uInteger_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zN40WApOwA2c" title="Number of installment"&gt;240&lt;/span&gt; &lt;span id="xdx_908_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" title="Debt Instrument, Frequency of Periodic Payment"&gt;monthly&lt;/span&gt; payments of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Debt Instrument, Periodic Payment"&gt;4,472&lt;/span&gt; through &lt;span id="xdx_904_ecustom--MaturityDate_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_ze7iAlf2gKz7" title="Maturity date"&gt;October 2026&lt;/span&gt;. The loan is collateralized by a building with a net book value of $&lt;span id="xdx_904_ecustom--BookValueOfBuilding_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zoJNxqNlEDc8" title="Book Value Of Building"&gt;379,163&lt;/span&gt; as of June 30, 2022.&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zuLdBxon1sYa" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;195,457&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z7KWN2PtpU87" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;232,696&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Note payable received under the Paycheck Protection Program (&#x2018;PPP&#x2019;) which was established as part of the Coronavirus Aid, Relief and Economic Security Act (&#x201c;Cares Act&#x2019;) that provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven portion of the PPP loan is payable over &lt;span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_ztRmTIaUwSU5" title="Debt Instrument, Term"&gt;5&lt;/span&gt; five years at an interest rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zTpkkMth0Ay5" title="Debt Instrument, Interest Rate During Period"&gt;1&lt;/span&gt;%, with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note was forgiven in August 2021.&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zul68mZAvYO4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1454"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zRmUnCPMfMB" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;700,764&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;The revolving credit note was extended to October 26, 2022. The Company can borrow up to $&lt;span id="xdx_907_eus-gaap--ProceedsFromLinesOfCredit_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Proceeds from Lines of Credit"&gt;10,000,000&lt;/span&gt; and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zaYUkWzqZuCf" title="Debt Instrument, Interest Rate During Period"&gt;5.5&lt;/span&gt;% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zul4yBn5CSk1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1460"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_z3FsXHpNI5ci" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1461"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630_z26nNXCs8oZ6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;195,457&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630_z7dhJ1KdRoE9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;933,460&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Current portion&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;40,078&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20210630_zBt5gnywqX35" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;173,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;155,379&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20210630_zKAqWnjmNtsl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;760,254&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zR4Np13AsfK1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The maturities of debt over the next five years
are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zbrBBLC9C8qk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp;amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BA_zJSkMcVpxsPj"&gt;Maturities Of Long-Term Debt&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Years Ending June 30,&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2023&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_c20220630_zkvIRjSK1Xod" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;40,078&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2024&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_c20220630_zFXF3rOEYc4g" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;43,766&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2025&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_c20220630_z0nmFtJpRBg8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;47,002&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2026&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_c20220630_zQTRqUSoUJL" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;50,448&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2027&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_c20220630_zBu5pBVlLsS3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;14,163&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif; color: white"&gt;Long-Term Debt Over Five Years and Thereafter&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_c20220630_zhqdguY0FVOe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;195,457&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AC_z2LY4ffuXtH7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zX7n74WmV0L5" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B3_zFLZhe9jqk3b"&gt;Long-term debt, notes payable and capital leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Note payable requiring monthly payments of interest at a rate of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zO2EeGvyRq8"&gt;7&lt;/span&gt;% until May 2009 followed by &lt;span id="xdx_905_ecustom--NumberOfInstallment_uInteger_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zN40WApOwA2c" title="Number of installment"&gt;240&lt;/span&gt; &lt;span id="xdx_908_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member" title="Debt Instrument, Frequency of Periodic Payment"&gt;monthly&lt;/span&gt; payments of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0" title="Debt Instrument, Periodic Payment"&gt;4,472&lt;/span&gt; through &lt;span id="xdx_904_ecustom--MaturityDate_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_ze7iAlf2gKz7" title="Maturity date"&gt;October 2026&lt;/span&gt;. The loan is collateralized by a building with a net book value of $&lt;span id="xdx_904_ecustom--BookValueOfBuilding_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zoJNxqNlEDc8" title="Book Value Of Building"&gt;379,163&lt;/span&gt; as of June 30, 2022.&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zuLdBxon1sYa" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;195,457&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z7KWN2PtpU87" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;232,696&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Note payable received under the Paycheck Protection Program (&#x2018;PPP&#x2019;) which was established as part of the Coronavirus Aid, Relief and Economic Security Act (&#x201c;Cares Act&#x2019;) that provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll, benefits, rent and utilities and maintains certain payroll levels. The unforgiven portion of the PPP loan is payable over &lt;span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_ztRmTIaUwSU5" title="Debt Instrument, Term"&gt;5&lt;/span&gt; five years at an interest rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zTpkkMth0Ay5" title="Debt Instrument, Interest Rate During Period"&gt;1&lt;/span&gt;%, with a deferral of payments for the first six months. The proceeds from the note payable were received on June 30, 2020. This note was forgiven in August 2021.&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zul68mZAvYO4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1454"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zRmUnCPMfMB" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;700,764&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;The revolving credit note was extended to October 26, 2022. The Company can borrow up to $&lt;span id="xdx_907_eus-gaap--ProceedsFromLinesOfCredit_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_pp0p0" title="Proceeds from Lines of Credit"&gt;10,000,000&lt;/span&gt; and prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210701__20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zaYUkWzqZuCf" title="Debt Instrument, Interest Rate During Period"&gt;5.5&lt;/span&gt;% per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_zul4yBn5CSk1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1460"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable3Member_z3FsXHpNI5ci" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1461"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630_z26nNXCs8oZ6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;195,457&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20210630_z7dhJ1KdRoE9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;933,460&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Less: Current portion&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;40,078&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_iI_pp0p0_c20210630_zBt5gnywqX35" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;173,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;155,379&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligations_iI_pp0p0_c20210630_zKAqWnjmNtsl" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;760,254&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2021-07-012022-06-30_custom_NotePayable1Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <FONR:NumberOfInstallment
      contextRef="From2021-07-012022-06-30_custom_NotePayable1Member"
      decimals="INF"
      unitRef="Integer">240</FONR:NumberOfInstallment>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="From2021-07-012022-06-30_custom_NotePayable1Member">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2021-07-012022-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">4472</us-gaap:DebtInstrumentPeriodicPayment>
    <FONR:MaturityDate contextRef="From2021-07-012022-06-30_custom_NotePayable1Member">October 2026</FONR:MaturityDate>
    <FONR:BookValueOfBuilding
      contextRef="AsOf2022-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">379163</FONR:BookValueOfBuilding>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">195457</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">232696</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentTerm contextRef="From2021-07-012022-06-30_custom_NotePayable2Member">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2021-07-012022-06-30_custom_NotePayable2Member"
      decimals="INF"
      unitRef="Pure">0.01</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-06-30_custom_NotePayable2Member"
      decimals="0"
      unitRef="USD">700764</us-gaap:LongTermDebtCurrent>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2021-07-012022-06-30_custom_NotePayable3Member"
      decimals="0"
      unitRef="USD">10000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2021-07-012022-06-30_custom_NotePayable3Member"
      decimals="INF"
      unitRef="Pure">0.055</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">195457</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">933460</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">40078</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">173206</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">155379</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">760254</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zbrBBLC9C8qk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp;amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BA_zJSkMcVpxsPj"&gt;Maturities Of Long-Term Debt&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Years Ending June 30,&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2023&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_c20220630_zkvIRjSK1Xod" style="width: 43%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2023"&gt;40,078&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2024&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_c20220630_zFXF3rOEYc4g" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;43,766&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2025&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_c20220630_z0nmFtJpRBg8" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;47,002&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2026&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_c20220630_zQTRqUSoUJL" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;50,448&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;2027&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_c20220630_zBu5pBVlLsS3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;14,163&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif; color: white"&gt;Long-Term Debt Over Five Years and Thereafter&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_c20220630_zhqdguY0FVOe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;195,457&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">40078</us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">43766</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">47002</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">50448</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">14163</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">195457</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zIyQ5dqOR9a2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 12 - &lt;span id="xdx_824_zjBndFeM5hc7"&gt;INCOME TAXES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;ASC topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon
examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit
recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized (or
amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result
of applying the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings
and therefore it has not recorded a liability for unrecognized tax benefits.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In accordance with ASC topic 740, interest costs
related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#x201c;Interest expense,
net. Penalties if incurred would be recognized as a component of &#x201c;Selling, general and administrative&#x201d; expenses.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company files corporate income tax returns
in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject
to federal, state and local income tax examinations by tax authorities for years prior to 2017 for federal and 2016 for state.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company has recorded a deferred tax asset
of $&lt;span id="xdx_907_eus-gaap--DeferredTaxAssetsNet_c20220630_pp0p0" title="Deferred Tax Assets, Net of Valuation Allowance"&gt;12,842,478&lt;/span&gt; and a deferred tax liability of $&lt;span id="xdx_90E_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20220630_pp0p0" title="Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus"&gt;215,726&lt;/span&gt; as of June 30, 2022, primarily relating to its net Federal operating loss
carryforwards of approximately $&lt;span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_c20220630_pp0p0" title="Operating Loss Carryforwards"&gt;20,048,000&lt;/span&gt; available to offset future taxable income through 2031. In addition the Company has
state operating loss carryforwards of approximately $&lt;span id="xdx_908_eus-gaap--OperatingIncomeLoss_c20210701__20220630_pp0p0" title="Operating Income (Loss)"&gt;5,309,000&lt;/span&gt; and city operating loss carryforwards of approximately $&lt;span id="xdx_902_eus-gaap--OtherOperatingIncome_c20210701__20220630_pp0p0" title="Other Operating Income"&gt;1,853,000&lt;/span&gt;.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Future ownership changes as determined under
Section 382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30,
2022, no such changes in ownership have occurred.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The ultimate realization of deferred tax assets
is dependent on the generation of future taxable income during the periods in which temporary differences become deductible or
when such net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment
of the industry, and tax planning strategies in making this assessment. At present, the Company believes that it is more likely
than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this
inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The valuation allowance for deferred tax assets
decreased during the year ended June 30, 2022, by approximately $&lt;span id="xdx_901_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20220630_pp0p0" title="Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital"&gt;448,000&lt;/span&gt;. The valuation allowance decreased by approximately $&lt;span id="xdx_900_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_c20210630_pp0p0" title="Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital"&gt;3,547,000&lt;/span&gt;
during the year ended June 30, 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Components of the provision (benefit) for income
taxes are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zU5SRqoMeQq1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B6_zBN5rHJdBRx1"&gt;Components Of The Provision For Income Taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_497_20210701__20220630_zk6s9Q0xz282" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_493_20200701__20210630_zOa06S83jKZe" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zs8e3rhFfUSl" style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Current:&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Federal&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"/&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200701__20210630_zINRoT6zONi6" style="color: rgb(204,238,255); width: 12%; text-align: right" title="Federal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;-&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zgdcahftBFtk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;State&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,440,594&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,136,514&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_zJjfkQKwYX62" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Subtotal&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,440,594&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,136,514&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqPTwpVGJAR7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Deferred:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zbWuLn4DTBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Federal deferred taxes&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,935,921&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,718,046&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zgeh85TD8us" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;State deferred taxes&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;157,972&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;136,960&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zQLLTvv4FYQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Subtotal&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,093,893&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,855,006&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zyEBQOSMMlU7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;Provision (Benefit) for Income Taxes - Net&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,534,487&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,991,520&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A5_ziHQ49reXaFi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;A reconciliation of the federal statutory income
tax rate to the Company&#x2019;s effective tax rate as reported is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXVsq0CdJpj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_ztR03Z7IvpMc"&gt;Reconciliation Of Federal Statutory Income Tax Rate To Company&#x2019;s Effective Tax Rate&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_494_20210701__20220630_zsNv9qmR2dw9" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49A_20200701__20210630_zllnwR89Fd49" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zwJKJYOzLRx7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; text-align: left"&gt;Taxes at federal statutory rate&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zdJM2gqp2706" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;State and local income taxes (benefit), net of federal benefit&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;4.2&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3.3&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zlS7qpvPMatk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Non Controlling interest&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(5.5&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(4.9&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zT6GfK1JotBg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Expiration of tax credits&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;2.0&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iP3us-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20200701__20210630_zAJIXZyDrLK1" title="Expiration of tax credits"&gt;4.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zpZ0Ual3lTK4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Return to provision adjustments&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;0.7&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;6.1&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zRyWHf5m0dF8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;NYS Audit Settlement&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;4.5&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3.2&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_z63DKhh2NC5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Change in the valuation allowance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(2.0&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(20.0&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_z7zSZP3olEBc" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Other&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.6&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9.3&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zGfJi9FcS8E2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Effective income tax rate&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;24.3&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;22.6&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A1_zsbgoUsA9BIe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;As of June 30, 2022, the Company has net operating
loss (&#x201c;NOL&#x201d;) carryforwards of approximately $20,048,000 that will be available to offset future taxable income. The
utilization of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal
Revenue Code.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company has, for federal income tax purposes,
research and development tax credits and investments tax credits carryforwards aggregating $&lt;span id="xdx_903_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_c20220630_pp0p0" title="Deferred Tax Assets, Tax Credit Carryforwards, Research"&gt;3,347,000&lt;/span&gt;. However, the realization
of these credits may be limited as a result of expiring prior to their utilization. These credits can only be applied after all
net operating losses have been used, which expire through 2031. As such, the Company has established a valuation reserve for anticipated
unused credits of $&lt;span id="xdx_909_eus-gaap--ValuationAllowancesAndReservesBalance_iI_pp0p0_c20220630_zk0SzwVRREFk" title="Valuation Allowances and Reserves, Amount"&gt;442,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In addition, for New York State income tax purposes,
the Company has tax credit carryforwards aggregating approximately $&lt;span id="xdx_907_eus-gaap--TaxCreditCarryforwardAmount_c20220630_pp0p0" title="Tax Credit Carryforward, Amount"&gt;27,000&lt;/span&gt; which, are accounted for under the flow-through method.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company was also under audit with New York
State for income tax and was assessed additional taxes of $&lt;span id="xdx_905_ecustom--AdditionalTaxes_pp0p0_c20210701__20220630_zSeJuiNkKKvd" title="Additional Taxes"&gt;1,014,071&lt;/span&gt; plus interest and penalties. These amounts were paid during
fiscal year ending June 30, 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Significant components of the Company&#x2019;s
deferred tax assets and liabilities at June 30, 2022 and 2021 are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhUOUyMuFbMc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BB_zViAdR8ww5Hb"&gt;&lt;span id="xdx_8B3_z5sbFMsCeMTc"&gt;&lt;span id="xdx_8B3_zg2ZVwhm4yZ1" style="display: none"&gt;Components Of Company&#x2019;s Deferred Tax Assets And Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49A_20220630_z1r5QRMAPLX9" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_492_20210630_zdZX8w765Je7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zP7Vg3dV5tsg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,239,903&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,827,382&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zE07pX08AZG4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Non-deductible accruals&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;707,400&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;749,902&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zV6NCZ51AGYe" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net operating carryforwards&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,820,010&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;8,285,163&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zHp19WTme3ua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Tax credits&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,346,509&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,732,650&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_z2QnWtrJAyO" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Inventory&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;98,945&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;66,316&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_zhE5E8eNehyb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Property and equipment and depreciation&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;71,576&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;187,632&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zny48cNmv5Xg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;Deferred Tax Assets - gross&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;13,284,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,849,045&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zlM0ct2VgPP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Valuation allowance&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(441,865&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(890,084&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_msDTLzHqA_maDTALNzFAZ_zIsuIZewdbzd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total deferred tax assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;12,842,478&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,958,961&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzHqA_maDTLzexF_zkRufmNS1n17" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intangibles&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(215,726&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(238,316&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzexF_msDTALNzFAZ_zcZWT7LcwZb" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total deferred tax liabilities&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(215,726&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(238,316&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zS7JAQjhJMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net deferred tax asset&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;12,626,752&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,720,645&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zwJWO8PX9b1k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12842478</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20048000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5309000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherOperatingIncome
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">1853000</us-gaap:OtherOperatingIncome>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">448000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3547000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zU5SRqoMeQq1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B6_zBN5rHJdBRx1"&gt;Components Of The Provision For Income Taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_497_20210701__20220630_zk6s9Q0xz282" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_493_20200701__20210630_zOa06S83jKZe" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zs8e3rhFfUSl" style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Current:&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Federal&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"/&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200701__20210630_zINRoT6zONi6" style="color: rgb(204,238,255); width: 12%; text-align: right" title="Federal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1525"&gt;-&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zgdcahftBFtk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;State&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,440,594&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,136,514&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_zJjfkQKwYX62" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Subtotal&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,440,594&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,136,514&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqPTwpVGJAR7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Deferred:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zbWuLn4DTBS4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Federal deferred taxes&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,935,921&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,718,046&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zgeh85TD8us" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;State deferred taxes&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;157,972&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;136,960&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zQLLTvv4FYQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Subtotal&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,093,893&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,855,006&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zyEBQOSMMlU7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;Provision (Benefit) for Income Taxes - Net&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,534,487&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,991,520&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">2440594</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1136514</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">2440594</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1136514</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">2935921</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2718046</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">157972</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">136960</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">3093893</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">2855006</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5534487</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">3991520</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXVsq0CdJpj" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_ztR03Z7IvpMc"&gt;Reconciliation Of Federal Statutory Income Tax Rate To Company&#x2019;s Effective Tax Rate&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_494_20210701__20220630_zsNv9qmR2dw9" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49A_20200701__20210630_zllnwR89Fd49" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zwJKJYOzLRx7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; text-align: left"&gt;Taxes at federal statutory rate&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;21.0&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zdJM2gqp2706" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;State and local income taxes (benefit), net of federal benefit&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;4.2&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3.3&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zlS7qpvPMatk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Non Controlling interest&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(5.5&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(4.9&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zT6GfK1JotBg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Expiration of tax credits&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;2.0&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iP3us-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20200701__20210630_zAJIXZyDrLK1" title="Expiration of tax credits"&gt;4.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_zpZ0Ual3lTK4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Return to provision adjustments&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;0.7&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;6.1&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zRyWHf5m0dF8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;NYS Audit Settlement&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;4.5&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3.2&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_z63DKhh2NC5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Change in the valuation allowance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(2.0&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(20.0&lt;/td&gt;
&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_z7zSZP3olEBc" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;Other&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.6&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9.3&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zGfJi9FcS8E2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="text-align: left"&gt;Effective income tax rate&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;24.3&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;22.6&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.042</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.033</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.055</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.049</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.061</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.045</FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement>
    <FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.032</FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">-0.020</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">-0.200</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.093</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.243</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.226</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3347000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">442000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">27000</us-gaap:TaxCreditCarryforwardAmount>
    <FONR:AdditionalTaxes
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">1014071</FONR:AdditionalTaxes>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhUOUyMuFbMc" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BB_zViAdR8ww5Hb"&gt;&lt;span id="xdx_8B3_z5sbFMsCeMTc"&gt;&lt;span id="xdx_8B3_zg2ZVwhm4yZ1" style="display: none"&gt;Components Of Company&#x2019;s Deferred Tax Assets And Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49A_20220630_z1r5QRMAPLX9" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_492_20210630_zdZX8w765Je7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zP7Vg3dV5tsg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,239,903&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,827,382&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zE07pX08AZG4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Non-deductible accruals&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;707,400&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;749,902&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zV6NCZ51AGYe" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net operating carryforwards&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,820,010&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;8,285,163&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zHp19WTme3ua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Tax credits&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,346,509&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,732,650&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_z2QnWtrJAyO" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Inventory&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;98,945&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;66,316&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_zhE5E8eNehyb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Property and equipment and depreciation&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;71,576&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;187,632&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zny48cNmv5Xg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; color: white; text-align: left"&gt;Deferred Tax Assets - gross&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;13,284,343&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,849,045&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zlM0ct2VgPP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Valuation allowance&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(441,865&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(890,084&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_msDTLzHqA_maDTALNzFAZ_zIsuIZewdbzd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total deferred tax assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;12,842,478&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,958,961&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzHqA_maDTLzexF_zkRufmNS1n17" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intangibles&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(215,726&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(238,316&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_mtDTLzexF_msDTALNzFAZ_zcZWT7LcwZb" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total deferred tax liabilities&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(215,726&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(238,316&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zS7JAQjhJMy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net deferred tax asset&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;12,626,752&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,720,645&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4239903</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3827382</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">707400</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">749902</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4820010</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">8285163</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3346509</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3732650</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">98945</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">66316</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">71576</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">187632</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13284343</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">16849045</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">441865</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">890084</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12842478</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15958961</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">238316</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12626752</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">15720645</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_806_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zcHnlN8DGfWk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 13 - &lt;span id="xdx_82A_z7kIbNMr7y5i"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Included in other current liabilities are the
following:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRHrxNCrmzL1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B8_z47T7equK4g5"&gt;&lt;span id="xdx_8BF_zKun2NP1YPv6" style="display: none"&gt;Other Current Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49C_20220630_zDitV1yH9M65" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49E_20210630_zF8aYmKcwsA4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,652,173&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,406,982&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Litigation accruals&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1651"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;900,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Sales tax payable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;248,702&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;644,623&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;State income taxes payable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;774,234&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Legal and other professional fees&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,707&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;37,827&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accounting fees&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;120,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;127,262&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Self-funded health insurance reserve&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;79,167&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;62,548&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accrued interest and penalty&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;59,516&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;493,042&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;854,962&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;715,600&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other current liabilities&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,417,227&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;9,162,118&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRHrxNCrmzL1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B8_z47T7equK4g5"&gt;&lt;span id="xdx_8BF_zKun2NP1YPv6" style="display: none"&gt;Other Current Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49C_20220630_zDitV1yH9M65" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49E_20210630_zF8aYmKcwsA4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,652,173&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,406,982&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Litigation accruals&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1651"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;900,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Sales tax payable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;248,702&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;644,623&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;State income taxes payable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;382,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;774,234&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Legal and other professional fees&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,707&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;37,827&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accounting fees&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;120,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;127,262&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Self-funded health insurance reserve&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;79,167&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;62,548&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accrued interest and penalty&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;59,516&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;493,042&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;854,962&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;715,600&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Other current liabilities&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;6,417,227&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;9,162,118&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4652173</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">5406982</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">900000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">248702</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">644623</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">382000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">774234</us-gaap:TaxesPayableCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20707</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">37827</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">120000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">127262</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">79167</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">62548</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">59516</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">493042</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">854962</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">715600</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">6417227</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">9162118</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zNwrTfQ2Bvf4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 14 - &lt;span id="xdx_82C_zsNADuEDXwce"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Leases&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company rents its operating facilities and
certain equipment, pursuant to operating lease agreements expiring at various dates through March 2030. The leases for certain
facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Rent expense for operating leases approximated
$&lt;span id="xdx_90C_eus-gaap--LeaseAndRentalExpense_c20210701__20220630_pp0p0" title="Operating Leases, Rent Expense"&gt;5,668,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20200701__20210630_pp0p0" title="Operating Leases, Rent Expense"&gt;6,146,000&lt;/span&gt;, for the years ended June 30, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company received approval from the Suffolk
County IDA on February 29, 2016 of a &lt;span id="xdx_90E_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160201__20160229_zOmEfBNidIn4" title="Property Tax Abatement From Suffolk County IDA"&gt;50&lt;/span&gt;% property tax abatement, valued at $&lt;span id="xdx_904_ecustom--PropertyTaxAbatement_pp0p0_c20160201__20160229_zq9RzYiquwAf" title="Property Tax Abatement"&gt;440,000&lt;/span&gt;, over a 10 year period commencing January 2017.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Employee Benefit Plans&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company has a non-contributory 401(k) Plan
(the &#x201c;401(k) Plan&#x201d;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum
service requirements. There were $&lt;span id="xdx_90D_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20210701__20220630_pp0p0" title="Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_c20200701__20210630_pp0p0" title="Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP"&gt;36,799&lt;/span&gt; employer contributions to the Plan for the years ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The stockholders of the Company approved the
2000 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) at the Company&#x2019;s annual stockholders&#x2019; meeting in April 2000.
The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has
not been put into effect as of June 30, 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Litigation&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_906_ecustom--LitigationSettelementDescription_c20200701__20210630" title="Litigation Settelement Description"&gt;In September 2019, The Company was notified
by one of its landlords that it was required to vacate the premises within 180 days under the demolition clause in the lease. The
Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated in February 2018. The
Company is in the process of relocating to a new location but the original lease provided for penalty payments in the event that
the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course of the arbitration
proceedings. The Company settled the case for $900,000 for the leasehold holdover charges which was paid in August 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_909_ecustom--LitigationSettelementDescription_c20210701__20220630" title="Litigation Settelement Description"&gt;In September 2020, the Company entered into
a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The
settlement was for $1.2 million of which $900,000 was paid by the Company&#x2019;s insurance on September 15, 2020 with the remaining
$315,000 paid by the Company on September 28, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Other Matters&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;The Company is subject
to other legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract
and employment claims besides the claim above. In the opinion of management, and with consultation with legal council, the aggregate
liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial position
or results of operations of the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims
to $&lt;span id="xdx_902_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pp0p0_c20210701__20220630_zxvpd57mit11" title="Liability for individual claims"&gt;110,000&lt;/span&gt; per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the
Company considers historical and projected medical utilization data when estimating its health insurance program liability and
related expense. As of June 30, 2022 and 2021, the Company had approximately $&lt;span id="xdx_907_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20220630_pp0p0" title="Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health"&gt;79,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_c20210630_pp0p0" title="Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health"&gt;63,000&lt;/span&gt;, respectively, in reserve for
its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d; in the consolidated
balance sheets.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company regularly analyzes its reserves
for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance
programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves
such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid dates,
and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded
in the years covered by this report.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseAndRentalExpense
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">5668000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">6146000</us-gaap:LeaseAndRentalExpense>
    <FONR:PropertyTaxAbatementFromSuffolkCountyIda
      contextRef="From2016-02-012016-02-29"
      decimals="INF"
      unitRef="Pure">0.50</FONR:PropertyTaxAbatementFromSuffolkCountyIda>
    <FONR:PropertyTaxAbatement
      contextRef="From2016-02-012016-02-29"
      decimals="0"
      unitRef="USD">440000</FONR:PropertyTaxAbatement>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">36799</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <FONR:LitigationSettelementDescription contextRef="From2020-07-012021-06-30">In September 2019, The Company was notified
by one of its landlords that it was required to vacate the premises within 180 days under the demolition clause in the lease. The
Company believes the lease renewal which was not negotiated in good faith since the renewal was negotiated in February 2018. The
Company is in the process of relocating to a new location but the original lease provided for penalty payments in the event that
the Company had not vacated the leased space. The Company has been making normal rent payments throughout the course of the arbitration
proceedings. The Company settled the case for $900,000 for the leasehold holdover charges which was paid in August 2021.</FONR:LitigationSettelementDescription>
    <FONR:LitigationSettelementDescription contextRef="From2021-07-01to2022-06-30">In September 2020, the Company entered into
a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The
settlement was for $1.2 million of which $900,000 was paid by the Company&#x2019;s insurance on September 15, 2020 with the remaining
$315,000 paid by the Company on September 28, 2020.</FONR:LitigationSettelementDescription>
    <FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">79000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">63000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_806_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z3RCR2C1kOoi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 15 - &lt;span id="xdx_82E_zWKh3OxZ8Fs4"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2022 and 2021
the Company paid $&lt;span id="xdx_900_eus-gaap--InterestPaid_c20210701__20220630_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities"&gt;617,029&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--InterestPaid_c20200701__20210630_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities"&gt;75,178&lt;/span&gt; for interest, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2022 and 2021
the Company paid $&lt;span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20210701__20220630_pp0p0" title="Income Taxes Paid"&gt;2,408,145&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20200701__20210630_pp0p0" title="Income Taxes Paid"&gt;261,032&lt;/span&gt; for income taxes, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2022 and 2021,
the Company issued &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20210701__20220630_pdd" title="Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"&gt;0&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20200701__20210630_pdd" title="Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"&gt;102,364&lt;/span&gt; shares of common stock for costs and expenses totaling $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210701__20220630_pp0p0" title="Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"&gt;0&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20200701__20210630_pp0p0" title="Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"&gt;1,940,821&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2022 and 2021,
the Company resolved certain sales tax liabilities and was able to reverse accrued interest and penalties in the amount of $&lt;span id="xdx_90B_ecustom--SellingGeneralAndAdministrativeExpenses_c20210701__20220630_pp0p0" title="Selling, General and Administrative Expenses"&gt;119,000&lt;/span&gt;
and $&lt;span id="xdx_90D_ecustom--SellingGeneralAndAdministrativeExpenses_c20200701__20210630_pp0p0" title="Selling, General and Administrative Expenses"&gt;602,000&lt;/span&gt;, respectively, which has been recorded under selling, general and administrative expenses.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaid
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">617029</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">75178</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">2408145</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">261032</us-gaap:IncomeTaxesPaid>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Shares">102364</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">1940821</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <FONR:SellingGeneralAndAdministrativeExpenses
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">119000</FONR:SellingGeneralAndAdministrativeExpenses>
    <FONR:SellingGeneralAndAdministrativeExpenses
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">602000</FONR:SellingGeneralAndAdministrativeExpenses>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4o8YHIwi4Ug" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 16 &#x2013; &lt;span id="xdx_82B_zbq8AZQNln8c"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90F_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210701__20220630__dei--LegalEntityAxis__custom--ABillingCompanyMember" title="Related Party Transaction, Description of Transaction"&gt;The CEO and President of the Company is a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#x2019; Compensation
claims of the Company&#x2019;s clients. The monthly fee charged to the Company was $85,000. The Company terminated this agreement
on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the
billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2022 for another year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_906_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20210701__20220630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember" title="Related Party Transaction, Description of Transaction"&gt;Bensonhurst MRI Limited Partnership, in which
the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2021-07-012022-06-30_custom_ABillingCompanyMember">The CEO and President of the Company is a minority
owner of a billing company, which performs billing and collection services with respect to No-Fault and Workers&#x2019; Compensation
claims of the Company&#x2019;s clients. The monthly fee charged to the Company was $85,000. The Company terminated this agreement
on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the
billing company for a monthly fee of $23,884. The agreement was renewed on June 1, 2022 for another year.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2021-07-012022-06-30_custom_BensonhurstMRILimitedPartnershipMember">Bensonhurst MRI Limited Partnership, in which
the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80B_eus-gaap--SegmentReportingDisclosureTextBlock_zkVR6W8H39sh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 17 - &lt;span id="xdx_821_zHE7a5AGLtm9"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company provides segment data in accordance
with the provisions of ASC topic 280, &#x201c;Disclosures about Segments of an Enterprise and Related Information&#x201d;.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company operates in two industry segments
- manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The accounting policies of the segments are
the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company
evaluates performance based on income or loss from operations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Summarized financial information concerning
the Company&#x2019;s reportable segments is shown in the following table:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Summarized Segment Financial Information&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z3rkDoZogLv" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&lt;span id="xdx_8BA_zDz8vTAtaUua" style="display: none"&gt;Schedule of summarized segment financial information&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Manufacturing and Servicing of Medical&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Management of Diagnostic Imaging&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Fiscal 2022:&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Center&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Totals&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net revenues from external customers&lt;/td&gt;
&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;8,218,804&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;89,373,341&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--Revenues_c20210701__20220630_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;97,592,145&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intersegment net revenues *&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zb7igEbrTuzg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;965,417&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zTvXeUDL9mRg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zAgoyxuVEaFk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;965,417&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;(Loss) Income from operations&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;(4,604,305&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;26,611,487&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;22,007,182&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;263,559&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;4,271,677&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;4,535,236&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Compensatory element of stock issuances&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_z6qvuiQl4D15" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zRaYkbCm0dV5" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630_zY5Uml3zRRHc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total identifiable assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;10,259,937&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;189,082,045&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AssetsNet_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;199,341,982&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Capital expenditures&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;258,271&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;4,374,903&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;4,633,174&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Fiscal 2021:&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net revenues from external customers&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;9,037,091&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;80,892,674&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;89,929,765&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intersegment net revenues *&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zSvp60x9cvfi" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;901,250&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pdp0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zrJprfqqlBr9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____zqqbYZoareDj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;901,250&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;(Loss) Income from operations&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;(3,410,189&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;20,507,804&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;17,097,615&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;264,830&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;3,816,857&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;4,081,687&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Compensatory element of stock issuances&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;83,277&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zn0A5bT5Bbt9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;83,277&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total identifiable assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zY3qCC8yoCY4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;24,592,582&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zGu26UdMLcDb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;164,913,613&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20210630_zJ1gLlln9j8e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;189,506,195&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Capital expenditures&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;291,294&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;3,405,502&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;3,696,796&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_zbhlTO5DaAO6" style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F1A_zBTwIqequJ48" style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts eliminated in consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A2_zcnahpWwxEqb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Export Product Sales&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s areas of operations are
principally in the United States. The Company had export sales of medical equipment amounting to &lt;span id="xdx_90D_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20210701__20220630_z1VgNxYJna2d" title="Export Sales Of Medical Equipment Percentage"&gt;48.9&lt;/span&gt;% and &lt;span id="xdx_90D_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20200701__20210630_zjltUOjtiS99" title="Export Sales Of Medical Equipment Percentage"&gt;69.3&lt;/span&gt;% of product sales
revenues to third parties for the years ended June 30, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Export Product Sales&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The foreign product sales, as a percentage of
product sales to unrelated parties, were made to customers in the following countries:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ExportProductSalesTableTextBlock_zDeYK6aoxxkk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;&lt;span id="xdx_8B6_z73CEuWiSHOj" style="display: none"&gt;Schedule of export product sales&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; color: black; text-align: left"&gt;Dominican Republic&lt;/td&gt;
&lt;td style="width: 8%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zmb28pnmEVf7" title="Foreign Product Sales"&gt;12.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="width: 8%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_ztJMHCmXZHC1" title="Foreign Product Sales"&gt;67.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;Canada&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zugms5m0sJE1" title="Foreign Product Sales"&gt;0.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zJed0aRajlC9" title="Foreign Product Sales"&gt;0.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="color: black"&gt;Germany&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ForeignProductSales_dp0_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zEelWrPrUDn9" style="color: black; text-align: right" title="Foreign Product Sales"&gt;&#x2014;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zpfvAufYPZg5" title="Foreign Product Sales"&gt;2.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black; text-align: left"&gt;Puerto Rico&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zVvbxCcrzLi5" title="Foreign Product Sales"&gt;36.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_z9Q7WROcfPWd" title="Foreign Product Sales"&gt;0.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20210701__20220630_zCUDH9e2hE" title="Foreign Product Sales"&gt;48.9&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignProductSales_dp_c20200701__20210630_ziIRNZzMkkVk" title="Foreign Product Sales"&gt;69.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A0_z1GMoLYS7DYe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Foreign Service and Repair Fees&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s areas of service and repair
are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to
&lt;span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20210701__20220630_zhoI2B1mDANe" title="Foreign Revenues Of Service And Repair Of Medical Equipment Percentage"&gt;4.4&lt;/span&gt;% and &lt;span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20200701__20210630_zhQdyN6o1Pvd" title="Foreign Revenues Of Service And Repair Of Medical Equipment Percentage"&gt;4.5&lt;/span&gt;% of consolidated net service and repair fees for the years ended June 30, 2022 and 2021 respectively. Foreign service
and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&#160;Foreign Service and
Repair Fees&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ExportServiceRevenuesTableTextBlock_zT5QF8LMouK2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;&lt;span id="xdx_8B2_zikxvsNFp2u8" style="display: none"&gt;Schedule of foreign service and repair fees&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; text-align: left"&gt;Puerto Rico&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_z31Vn7FJCoQ1" title="Foreign Service and Repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zUylr2Y8uyog" title="Foreign Service and Repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;Switzerland&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z4yRUNT1iuE7" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zLbEcAucwF8h" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;Germany&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_z1Z1fJLR4GSl" title="Foreign Service and Repair fees"&gt;1.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zsNnM6HXW2Aa" title="Foreign Service and Repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;England&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zCRQdGkwmCn2"&gt;0.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_znKmWFaRGhs8" title="Foreign Service and Repair fees"&gt;0.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;Canada&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zA0GeeSJRHNl" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;Greece&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_z8SVYRz71vfe" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zg97RRszEc9j" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;Australia&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zHD8n0OU1767" title="Foreign Service and Repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zdlrzyu4C4r5" title="Foreign Service and Repair fees"&gt;4.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zbyRtsu1CFIk" title="Foreign Service and Repair fees"&gt;4.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




&lt;p id="xdx_8A9_zmM6xXAQ6t4l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;





















</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z3rkDoZogLv" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&lt;span id="xdx_8BA_zDz8vTAtaUua" style="display: none"&gt;Schedule of summarized segment financial information&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Manufacturing and Servicing of Medical&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Management of Diagnostic Imaging&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Fiscal 2022:&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Center&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Totals&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net revenues from external customers&lt;/td&gt;
&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;8,218,804&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--Revenues_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;89,373,341&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--Revenues_c20210701__20220630_pp0p0" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;97,592,145&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intersegment net revenues *&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zb7igEbrTuzg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;965,417&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zTvXeUDL9mRg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zAgoyxuVEaFk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;965,417&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;(Loss) Income from operations&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;(4,604,305&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;26,611,487&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;22,007,182&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;263,559&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;4,271,677&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;4,535,236&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Compensatory element of stock issuances&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_z6qvuiQl4D15" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zRaYkbCm0dV5" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20210701__20220630_zY5Uml3zRRHc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total identifiable assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;10,259,937&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AssetsNet_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;189,082,045&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AssetsNet_c20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;199,341,982&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Capital expenditures&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;258,271&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;4,374,903&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_c20210701__20220630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;4,633,174&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Fiscal 2021:&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net revenues from external customers&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;9,037,091&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--Revenues_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;80,892,674&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--Revenues_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Revenues - Net"&gt;89,929,765&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intersegment net revenues *&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zSvp60x9cvfi" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;901,250&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pdp0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zrJprfqqlBr9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_ecustom--IntersegmentNetRevenues_pp0p0_c20200701__20210630_fKg_____zqqbYZoareDj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intersegment net revenues"&gt;901,250&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;(Loss) Income from operations&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;(3,410,189&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;20,507,804&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;17,097,615&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;264,830&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;3,816,857&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;4,081,687&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Compensatory element of stock issuances&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pdp0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;83,277&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_pp0p0_d0_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zn0A5bT5Bbt9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;&#x2014;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Compensatory element of stock issuances"&gt;83,277&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total identifiable assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zY3qCC8yoCY4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;24,592,582&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zGu26UdMLcDb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;164,913,613&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AssetsNet_iI_pp0p0_c20210630_zJ1gLlln9j8e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total identifiable assets"&gt;189,506,195&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0 0 0 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Capital expenditures&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;291,294&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;3,405,502&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--PaymentsToAcquireProductiveAssets_c20200701__20210630_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;3,696,796&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F00_zbhlTO5DaAO6" style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F1A_zBTwIqequJ48" style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts eliminated in consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">8218804</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">89373341</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">97592145</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      id="Fact001768"
      unitRef="USD">965417</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      id="Fact001772"
      unitRef="USD">965417</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">-4604305</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">26611487</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">22007182</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">263559</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4271677</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4535236</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:AssetsNet
      contextRef="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">10259937</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">189082045</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">199341982</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">258271</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4374903</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-07-01to2022-06-30"
      decimals="0"
      unitRef="USD">4633174</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">9037091</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">80892674</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">89929765</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      id="Fact001809"
      unitRef="USD">901250</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      id="Fact001813"
      unitRef="USD">901250</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">-3410189</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">20507804</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">17097615</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">264830</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">3816857</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">4081687</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">83277</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">83277</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:AssetsNet
      contextRef="AsOf2021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">24592582</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">164913613</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">189506195</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-07-012021-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">291294</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-07-012021-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">3405502</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2020-07-012021-06-30"
      decimals="0"
      unitRef="USD">3696796</us-gaap:PaymentsToAcquireProductiveAssets>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.489</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.693</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportProductSalesTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ExportProductSalesTableTextBlock_zDeYK6aoxxkk" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;&lt;span id="xdx_8B6_z73CEuWiSHOj" style="display: none"&gt;Schedule of export product sales&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; color: black; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; color: black; text-align: left"&gt;Dominican Republic&lt;/td&gt;
&lt;td style="width: 8%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zmb28pnmEVf7" title="Foreign Product Sales"&gt;12.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="width: 8%; color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; color: black; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DO_ztJMHCmXZHC1" title="Foreign Product Sales"&gt;67.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black"&gt;Canada&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zugms5m0sJE1" title="Foreign Product Sales"&gt;0.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zJed0aRajlC9" title="Foreign Product Sales"&gt;0.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="color: black"&gt;Germany&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ForeignProductSales_dp0_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zEelWrPrUDn9" style="color: black; text-align: right" title="Foreign Product Sales"&gt;&#x2014;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zpfvAufYPZg5" title="Foreign Product Sales"&gt;2.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="color: black; text-align: left"&gt;Puerto Rico&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zVvbxCcrzLi5" title="Foreign Product Sales"&gt;36.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; color: black; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignProductSales_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_z9Q7WROcfPWd" title="Foreign Product Sales"&gt;0.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20210701__20220630_zCUDH9e2hE" title="Foreign Product Sales"&gt;48.9&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="color: black; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; color: black; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignProductSales_dp_c20200701__20210630_ziIRNZzMkkVk" title="Foreign Product Sales"&gt;69.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; color: black; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:ExportProductSalesTableTextBlock>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0.120</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0.670</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.021</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.363</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.489</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.693</FONR:ForeignProductSales>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.044</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.045</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ExportServiceRevenuesTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ExportServiceRevenuesTableTextBlock_zT5QF8LMouK2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;&lt;span id="xdx_8B2_zikxvsNFp2u8" style="display: none"&gt;Schedule of foreign service and repair fees&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2022&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 56%; text-align: left"&gt;Puerto Rico&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_z31Vn7FJCoQ1" title="Foreign Service and Repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--PR_zUylr2Y8uyog" title="Foreign Service and Repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;Switzerland&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z4yRUNT1iuE7" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CH_zLbEcAucwF8h" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;Germany&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_z1Z1fJLR4GSl" title="Foreign Service and Repair fees"&gt;1.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--DE_zsNnM6HXW2Aa" title="Foreign Service and Repair fees"&gt;1.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;England&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zCRQdGkwmCn2"&gt;0.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GB_znKmWFaRGhs8" title="Foreign Service and Repair fees"&gt;0.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;Canada&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--CA_zA0GeeSJRHNl" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;Greece&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_z8SVYRz71vfe" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630__srt--StatementGeographicalAxis__country--GR_zg97RRszEc9j" title="Foreign Service and Repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td&gt;Australia&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zHD8n0OU1767" title="Foreign Service and Repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zdlrzyu4C4r5" title="Foreign Service and Repair fees"&gt;4.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20200701__20210630_zbyRtsu1CFIk" title="Foreign Service and Repair fees"&gt;4.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




</FONR:ExportServiceRevenuesTableTextBlock>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_CH"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_CH"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.016</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_GB"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_GB"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_GR"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30_country_GR"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.044</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2020-07-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.045</FONR:ForeignServiceAndRepairFees>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z7H3Gzcu5rS5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 18 &#x2013; &lt;span id="xdx_82E_zl3etC04lJlc"&gt;ACQUISTION&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On March 29, 2021, the Company completed the
acquisition of certain assets of Rockland Management Group, located in West Yonkers. The Company used an incremental borrowing
rate of 4% to value the right to use asset in connection with the assumed operating lease obligation. We made a fair value determination
of the acquired assets and assumed liabilities as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zFeaYR9KTqsd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BA_zLpLxZiUaiHf"&gt;&lt;span id="xdx_8B3_zeYkDSkU531g" style="display: none"&gt;Fair value assets and assumed liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49D_20210329" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Property and equipment&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;650,000&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Right to use assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;434,219&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intangible assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;150,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--SecurityDeposit_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Security Deposit&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;38,628&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Right to use liability&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(434,219&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Goodwill&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;283,880&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total purchase consideration&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,122,508&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A0_zS23UHZoUZ94" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 805-10-25-1, Business
Combinations &#x2013; Overall Recognition, the Company recorded the transaction as a business combination. ASC 805-10-25-1 provides
the requirements of recording the transaction by applying the acquisition method. The acquisition method requires the Company to
determine if the assets and liabilities acquired are a business or not. Under ASC 805-10-25-1, it must be determined if there is
a specific acquisition party, acquisition date, identifiable assets acquired and liabilities assumed and must be able to recognized
and measure goodwill or a gain from the purchase. Based upon this guidance, the acquisition had been recorded as a business combination.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The net assets acquired and consideration is
as follow:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zzZTztpWvhvg" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Net assets acquired (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BE_zEPw0ZYlDYob"&gt;&lt;span id="xdx_8B9_zMRs5MswHotj" style="display: none"&gt;Net assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Leasehold Improvements&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;550,000&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diagnostic Equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;100,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Customer Lists&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;100,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Covenant Not to Compete&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;50,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Security Deposit&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--SecurityDeposit_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Security Deposit"&gt;38,628&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Closing costs - expensed&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ClosingCostsExpensed_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Closing costs - expensed"&gt;3,478&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Goodwill&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--GoodwillGross_c20210329_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Goodwill"&gt;283,880&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Cash Consideration Paid&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_ecustom--BusinessCombinationContingentConsiderationAsset1_c20210329_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Cash Consideration Paid"&gt;1,125,986&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_z9hIo9M4UJuf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The results of operations of Rockland Management
Group were diminutive and did not affect the pro forma results of operations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_zFeaYR9KTqsd" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BA_zLpLxZiUaiHf"&gt;&lt;span id="xdx_8B3_zeYkDSkU531g" style="display: none"&gt;Fair value assets and assumed liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49D_20210329" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Property and equipment&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;650,000&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Right to use assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;434,219&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Intangible assets&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;150,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--SecurityDeposit_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Security Deposit&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;38,628&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Right to use liability&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;(434,219&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Goodwill&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;283,880&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total purchase consideration&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1,122,508&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">650000</us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1>
    <FONR:PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">434219</FONR:PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">150000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:SecurityDeposit contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">38628</us-gaap:SecurityDeposit>
    <FONR:PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">-434219</FONR:PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1>
    <us-gaap:Goodwill contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">283880</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">1122508</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zzZTztpWvhvg" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISTION - Net assets acquired (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8BE_zEPw0ZYlDYob"&gt;&lt;span id="xdx_8B9_zMRs5MswHotj" style="display: none"&gt;Net assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Leasehold Improvements&lt;/td&gt;
&lt;td style="width: 10%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="width: 18%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;550,000&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diagnostic Equipment&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DiagnosticEquipmentMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;100,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Customer Lists&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;100,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Covenant Not to Compete&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_c20210329__us-gaap--BusinessAcquisitionAxis__custom--RocklandManagementGroupMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CovenantNotToCompeteMember_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Intangible assets"&gt;50,000&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Security Deposit&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--SecurityDeposit_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Security Deposit"&gt;38,628&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Closing costs - expensed&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--ClosingCostsExpensed_c20210329_pp0p0" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Closing costs - expensed"&gt;3,478&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Goodwill&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--GoodwillGross_c20210329_pp0p0" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Goodwill"&gt;283,880&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Cash Consideration Paid&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_ecustom--BusinessCombinationContingentConsiderationAsset1_c20210329_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Cash Consideration Paid"&gt;1,125,986&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_us-gaap_CustomerListsMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2021-03-29_custom_RocklandManagementGroupMember_custom_CovenantNotToCompeteMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:SecurityDeposit contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">38628</us-gaap:SecurityDeposit>
    <FONR:ClosingCostsExpensed contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">3478</FONR:ClosingCostsExpensed>
    <us-gaap:GoodwillGross contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">283880</us-gaap:GoodwillGross>
    <FONR:BusinessCombinationContingentConsiderationAsset1 contextRef="AsOf2021-03-29" decimals="0" unitRef="USD">1125986</FONR:BusinessCombinationContingentConsiderationAsset1>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80E_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zP3z3G9fvkuh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 19 &#x2013; &lt;span id="xdx_821_zryHW8DNJSHj"&gt;ALLOWANCE FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The following represents a summary of allowance
for doubtful accounts for the years ended June 30, 2022 and 2021 respectively:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zSFOe3M0ttN1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="17" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B5_zlhcEixqViBf"&gt;&lt;span style="display: none"&gt;Summary of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Description&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Additions (1)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2022&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zEApKT23dYLg" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Beginning Balance"&gt;442,270&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zDdRJVoP62R1" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1970"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z2nUsFZQxnlh" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Deductions"&gt;237,673&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zoFC9mqAP8dd" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Ending Balance"&gt;204,597&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zk5jgUxoDy8l" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,786,878&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zUvS7HPj9Jr7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;841,039&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zPt9BmrWrZN6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1977"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zs502PWeS57c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,627,917&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z8W4vKoG8hYa" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,184,399&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zwhHM38IkLz9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;502,494&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zaBchitOx0re" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1981"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhD1mJUnrN7j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,686,893&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Notes receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zLnLIGwSZKW7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zZZdEZluZNwc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1984"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zV3PlU22zt4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1985"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zahk6gotftya" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Description&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2020&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Additions&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zvSjySkSphic" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;514,561&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z8yuEVtUTSY8" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1988"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zP66msPYHsed" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;72,291&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zQ29yoVXDab2" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;442,270&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zcY4Kdu4FlH" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;11,063,233&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zWLvGIAFs159" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,723,645&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zsl1WJCe5hwb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1993"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z85hWpmeFOof" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,786,878&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zlj6BPQkuCL4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,322,055&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zCbUpBCkTChk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;862,344&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z05j2Dwfr9Wk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1997"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zWROejKsg326" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,184,399&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Notes receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjcY2mtFl1I2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zayjuj5hN0U2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2000"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlxPqyKUdo2h" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2001"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlPBHaXLD1rj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F0B_zOvIhHTENbWj" style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F13_z79FhlKyM4Fd" style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Included in provision for bad debts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A1_z4e8Yu3OJg16" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;















</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zSFOe3M0ttN1" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="17" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8B5_zlhcEixqViBf"&gt;&lt;span style="display: none"&gt;Summary of Allowance For Doubtful Accounts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Description&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Additions (1)&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2022&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zEApKT23dYLg" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Beginning Balance"&gt;442,270&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zDdRJVoP62R1" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1970"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z2nUsFZQxnlh" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Deductions"&gt;237,673&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zoFC9mqAP8dd" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Ending Balance"&gt;204,597&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zk5jgUxoDy8l" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,786,878&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zUvS7HPj9Jr7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;841,039&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zPt9BmrWrZN6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1977"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zs502PWeS57c" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,627,917&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z8W4vKoG8hYa" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,184,399&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zwhHM38IkLz9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;502,494&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zaBchitOx0re" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1981"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zhD1mJUnrN7j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,686,893&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Notes receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zLnLIGwSZKW7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zZZdEZluZNwc" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1984"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zV3PlU22zt4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1985"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zahk6gotftya" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Balance&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Description&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2020&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Additions&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zvSjySkSphic" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;514,561&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z8yuEVtUTSY8" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1988"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zP66msPYHsed" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;72,291&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zQ29yoVXDab2" style="width: 10%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;442,270&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zcY4Kdu4FlH" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;11,063,233&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zWLvGIAFs159" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,723,645&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zsl1WJCe5hwb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1993"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z85hWpmeFOof" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;15,786,878&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zlj6BPQkuCL4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,322,055&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zCbUpBCkTChk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;862,344&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_z05j2Dwfr9Wk" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1997"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zWROejKsg326" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,184,399&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Notes receivable&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zjcY2mtFl1I2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zayjuj5hN0U2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2000"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlxPqyKUdo2h" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2001"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20200701__20210630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zlPBHaXLD1rj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F0B_zOvIhHTENbWj" style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 11pt; text-align: justify"&gt;&lt;span id="xdx_F13_z79FhlKyM4Fd" style="font: 11pt Arial, Helvetica, Sans-Serif"&gt;Included in provision for bad debts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">442270</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">237673</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">204597</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">15786878</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001976"
      unitRef="USD">841039</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">16627917</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4184399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001980"
      unitRef="USD">502494</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4686893</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">514561</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012021-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">72291</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">442270</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">11063233</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001992"
      unitRef="USD">4723645</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">15786878</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">3322055</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2020-07-012021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001996"
      unitRef="USD">862344</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4184399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2020-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_803_eus-gaap--QuarterlyFinancialInformationTextBlock_zQN0QmbUO1M2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 20 - &lt;span id="xdx_829_zqNRXSgkaWFh"&gt;QUARTERLY FINANCIAL DATA (UNAUDITED)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;(000&#x2019;s omitted, except per share data)&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6shskmWuTRe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_zGgGNnKaZtL9"&gt;&lt;span id="xdx_8BB_zATLAOyPJnpb" style="display: none"&gt;Quarterly Financial Data&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_493_20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJwTG6BgkYSl" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_495_20211001__20211231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z7wdG7KlWy4" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49D_20220101__20220331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_znYtlutyG7Vc" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_499_20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjoaRJ3z2cJ1" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_494_20210701__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjqy8P3wphb7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;September 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;December 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Revenues &#x2013; Net&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;23,730&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,479&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,571&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,812&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;97,592&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Costs and Expenses&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;17,989&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;17,996&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;18,933&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,667&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;75,585&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--ProfitLoss_zRiZUa0CAyH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Income&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,182&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,137&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,262&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,653&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;17,234&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.56&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.58&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.33&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.31&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.78&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.55&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.57&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.32&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.31&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.75&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49C_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zNM2K0B19E32" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_493_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zMaWh6BYG5F1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_490_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zo1nN1CC9ic6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49B_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zaqtGBDgitb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_497_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvg3CWg8B3R6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;September 30, 2020&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;December 30, 2020&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;March 31, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--Revenues_zKmiy43yXAw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Revenues &#x2013; Net&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,979&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;21,164&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;23,090&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,697&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;89,930&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--CostsAndExpenses_zh2qvTSKHh23" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Costs and Expenses&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,829&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,182&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;18,968&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,853&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;72,832&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--ProfitLoss_zBZH7c284aGc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Income&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,251&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,928&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,299&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,196&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;13,674&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zHnOsBLR9KPi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.37&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.45&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.55&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.10&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.47&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_znHqvVrGge2a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.36&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.44&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.54&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.11&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.45&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AF_zfrdhv49jSfd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2021-07-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6shskmWuTRe" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span id="xdx_8B0_zGgGNnKaZtL9"&gt;&lt;span id="xdx_8BB_zATLAOyPJnpb" style="display: none"&gt;Quarterly Financial Data&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_493_20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zJwTG6BgkYSl" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_495_20211001__20211231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_z7wdG7KlWy4" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_49D_20220101__20220331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_znYtlutyG7Vc" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_499_20220401__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjoaRJ3z2cJ1" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" id="xdx_494_20210701__20220630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zjqy8P3wphb7" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;September 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;December 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;March 31, 2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2022&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--Revenues_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Revenues &#x2013; Net&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;23,730&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,479&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,571&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,812&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;97,592&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--CostsAndExpenses_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Costs and Expenses&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;17,989&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;17,996&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;18,933&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,667&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;75,585&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--ProfitLoss_zRiZUa0CAyH5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Income&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,182&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;5,137&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,262&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,653&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;17,234&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.56&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.58&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.33&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.31&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.78&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.55&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.57&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.32&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.31&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.75&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49C_20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zNM2K0B19E32" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_493_20201001__20201231__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zMaWh6BYG5F1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_490_20210101__20210331__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zo1nN1CC9ic6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49B_20210401__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zaqtGBDgitb" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_497_20200701__20210630__us-gaap--IncomeStatementLocationAxis__custom--QuarterlyFinancialDataMember_zvg3CWg8B3R6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;September 30, 2020&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;December 30, 2020&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;March 31, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;June 30, 2021&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--Revenues_zKmiy43yXAw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Revenues &#x2013; Net&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,979&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;21,164&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;23,090&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;24,697&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;89,930&lt;/td&gt;
&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--CostsAndExpenses_zh2qvTSKHh23" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Total Costs and Expenses&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,829&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;16,182&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;18,968&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;20,853&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;72,832&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--ProfitLoss_zBZH7c284aGc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Net Income&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,251&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;3,928&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;4,299&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;2,196&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;13,674&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zHnOsBLR9KPi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.37&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.45&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.55&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.10&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.47&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_znHqvVrGge2a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.36&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.44&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.54&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;0.11&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;1.45&lt;/td&gt;
&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">23730</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">24479</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">24571</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">24812</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">97592</us-gaap:Revenues>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">17989</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">17996</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">18933</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20667</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">75585</us-gaap:CostsAndExpenses>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">5182</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">5137</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">3262</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">3653</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">17234</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-10-012021-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20979</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">21164</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">23090</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">24697</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">89930</us-gaap:Revenues>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">16829</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">16182</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">18968</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">20853</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">72832</us-gaap:CostsAndExpenses>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">3251</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">3928</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">4299</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">2196</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="0"
      unitRef="USD">13674</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-10-012020-12-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-03-31_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012021-06-30_custom_QuarterlyFinancialDataMember"
      decimals="INF"
      unitRef="USDPShares">1.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-07-01to2022-06-30">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zF4g8zLYw6fa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 21 &#x2013; &lt;span id="xdx_821_z6aeQs9mM0v9"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company evaluates events that have occurred
after the balance sheet date, but before the consolidated financial statements are issued.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During September 2022 the Company amended their
revolving credit agreement. The agreement was extended to October 26, 2022.&#160;The interest rate on borrowings remains at &lt;span id="xdx_905_eus-gaap--DebtorInPossessionFinancingFeeOnUnusedBorrowings_iI_dp_c20220930__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh80eVIF2W27" title="Debtor-in-Possession Financing, Fee on Unused Borrowings"&gt;5.5&lt;/span&gt;%
along with certain financial covenants.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On September 13, 2022, the Company adopted a
stock repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On
September 26, 2022, the Board of Directors has approved up to $&lt;span id="xdx_90C_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziM5MM43iuI7" title="Stock repurchase plan"&gt;9&lt;/span&gt; million to be purchased under the plan which will be purchased on
the publicly traded open market at prevailing prices.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings
      contextRef="AsOf2022-09-30_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.055</us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="AsOf2022-09-26_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="USD">9000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001768"
          xlink:label="Fact001768"
          xlink:type="locator"/>
        <link:footnote id="Footnote001844" xlink:label="Footnote001844" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts eliminated in consolidation</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001768"
          xlink:to="Footnote001844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1770"
          xlink:label="xdx2ixbrl1770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1770"
          xlink:to="Footnote001844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001772"
          xlink:label="Fact001772"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001772"
          xlink:to="Footnote001844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001809"
          xlink:label="Fact001809"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001809"
          xlink:to="Footnote001844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1811"
          xlink:label="xdx2ixbrl1811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1811"
          xlink:to="Footnote001844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001813"
          xlink:label="Fact001813"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001813"
          xlink:to="Footnote001844"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1970"
          xlink:label="xdx2ixbrl1970"
          xlink:type="locator"/>
        <link:footnote id="Footnote002003" xlink:label="Footnote002003" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included in provision for bad debts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1970"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001976"
          xlink:label="Fact001976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001976"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001980"
          xlink:label="Fact001980"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001980"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1984"
          xlink:label="xdx2ixbrl1984"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1984"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1988"
          xlink:label="xdx2ixbrl1988"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1988"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001992"
          xlink:label="Fact001992"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001992"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001996"
          xlink:label="Fact001996"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001996"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2000"
          xlink:label="xdx2ixbrl2000"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2000"
          xlink:to="Footnote002003"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>100
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MQ_K/U2O5]KG\!S0EW$F64<H3WI\4P(X3SBB'IT7LID7\\K14*D\;-8]6:=6
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M#1FB,4\\Q4TL%DD8BYO(_5PA+NXX$7K6>A$"=D((CCUMFE@JDC 5-U3QTX0
M/$L2PV-)^C$"IC+A2.#$L\'(WCG^N(/\^RR]S?*LT3(#/LT/>YS_.\[SQ"*4
M'#C1;Y->Z:.RN?K2XM&0\ZP]-<_5;;,][J\RLX;^%DE<4#*$'#P!9CBF!'EP
M2BQ.21BG.RFP2G\8'0#&"+&18V G (92".0[U!++4!)FZ*>.%LQMI8'QND 4
M#,=:ZO7C=0T3+'3;DIYX+3A)&)R?NG3<1?QCUQ=GW0("\P"@*"7"Q)EWP)!3
M*KBO/"P\21B>;[N$_,4\@',X1ICU12-DA[0^]R@P8A%*P@C]4JBT*K1FK)0^
M":U5I#>L:0GZF!C-RJ(Q1T:XDB!L2AF+_FT.9*CG7Q)?Y5N^DC!?I^U]LR[^
MN5J5=>:)$Z"IP(3U80K8Q50?ECPS3"U+:9BET^TL'MJ:83<G7#%1X"S*8I_B
MI9:Y]!CF D@#LP&H*F*F14S_- =8$H18PHAOZBU^:1B_[PUV/AOL' (P'13
M0WGKIKUWHQX&\"_O:0J=87E,N'.]#IUA$>*$>);,0I>>?H;==58P9A>L!.N8
M^VT(LJ.28@\'J.4O#?/WM9[@ICQTY0:&#C"6B+TKEVWDA\RZ@5L0TZ>">'L]
M> 3'*(!9BA*4.-<?@"612<PQ]=6.)3)]*I%/2,@%KJ22.#<,@!U&3#+J:UZ6
MS#1,YO>'-/-8_U_71R7C(EBK5!KWQ1)@%YO[6,]QC5I2TV-.PH< Z!(8(\&9
M,^6 78RI;\:9)34+DWH#.! :X!,^E[-44"XDZ[=+R)(A+?^9!\K,0ID= ^5#
MD;J(Y10C'J/^W$*6#%.!8L]E#;,P9F$8WS3E[*_[,I^KJF[W8_PR>O-MK;<G
M2&0V*)&'\M;-W1*9A8E\G6;SLZS8;6#]4GV?F=VKNY$F1O20YFOP@,D@)#.]
M>ISV%2QHRC%"2>R!'-M[['WP++Q>KC>$FZM%-LO JROF0O:,ZBTA8D="0*9,
MZ/.]EVS,(IF%D?RYT@UR7?V(:E-S8_.$:E;6]G(3X[%@-*KO4[W8+1#*Y=*(
M)&/N?YX%9NS"^4QG2QWN'6'8S=9RG(4YOFD!;\M"U]&TK#0'4@."[1ZK(__&
M Q,"GE!S1!*$<5^Y0Z94,BS]?<VRG(59_K$L6JE:YKD!>E9H$JK:\U$+E\%G
M#'&M[OI2"K*D&M><>!#'+*Y9&->;53AQK@$N,T&H(-)IS( IU0A'V'>.9I;.
M+$QGAR%MQ9^8"@!ESX4K9!J^<.46X?S 83M/=5.]BG3Y1%_+5MQ>5S^/%&U&
MT7\_J.6MJOX'?D+E%\[@?N@,Y:T[%U8:<#PD<'E0:)R<^T#>NKE;L<'#3YW[
MB_[5QU?N/DNF_;T7MNE&:"4!/R )3BG+H*N3EV8@;]W$K93@;-"R# J3DW,?
MR%LW][T/YAUZWGUL60;]G' 9.("C;JY6EO"P+)EN--41U?T+GZT+K/! WKI9
M6]W"XT&K.ZB"3LY](&_=W*T$XF$)U%EQ?VF[2D8XIX,#1MT K=#A!QX8; +<
MB(17X:(,>CIY80;RUOW<JU5% @U9E&)0%324MV[N5@6)\ 7)<449=G+*YWN?
M[JB;J)4\(BQY.L4]#19WV-/)"_QWW*T(*Z0$';2X!]520WGKYFZUE A?RQQ9
MW!LG^]^&H/U/481M-N%-]KZW8[XT]2&M[K*BCG*UT(/0\UBWZVKS/:3-FZ9<
MM5_EN2V;IERV+^]5JA?*&.C?+\JR^?G&?#MH]VVPR_\#4$L#!!0    (  IZ
M/%4%UW_UY 0  '\9   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULM9E=
M;^(X&(7_BI5=K6:D;A,['X0N(%':U70U;5'I="]6>V&"*5'SP=A.F>ZO7^>#
M!">I Y2Y:1-XWS?/<3@Y) PV,7UA*T(X^!$&$1MJ*\[7%[K.O!4),3N/UR02
M[RQC&F(N=NFSSM:4X$76% 8Z,@Q'#[$?::-!]MJ4C@9QP@,_(E,*6!*&F+Y=
MDB#>##6H;5]X\)]7/'U!'PW6^)G,"/^VGE*QIY=3%GY((N;'$:!D.=3&\&)B
M&FE#5O'DDPW;V0:IE'D<OZ0[-XNA9J1$)" >3T=@\>^53$@0I),$Q_=BJ%8>
M,VW<W=Y._S,3+\3,,2.3./C;7_#54',UL"!+G 3\(=Y\(84@.YWGQ0'+_H)-
M7NO8&O 2QN.P:!8$H1_E__&/8B%V&J#U3@,J&M"^#6;18&9"<[),UA7F>#2@
M\0;0M%I,2S>RM<FZA1H_2D_CC%/QKB_Z^&AR?S>[_WIS-7Z\O@*7XZ_CN\DU
MF'VYOGZ<@4]33$G$5X3['@X^@]_!M]D5^/3KYX'.Q:'3 ;I7'.8R/PQZYS!_
M)=$Y,(TS@ R$6MHG^[=#N5T7@DO5J%2-LGGF._/&@?CXXL@C0!@!7,7)G"^3
M (P]+TXBSL #\8C_BN<!86U:\^%6-CSUR>L(&9;=[PWTUUU-S3++0JAGE&42
MNUFRFTKV6QP)?PDG<8"C!8C%^:'"4%M@@+?:6"9NL16'"W%M@O(CVCNDT'%0
MKP_KDEH*[9[KN#VW7915BK*4HAY(@#E9@#6F_.VC:JSFNCN"L6_6Q+340=<R
M^_UV+7:IQ59J>1274Y;0-R#,Z[V< ;82-FH%M9NK"1VKCME5)4$Z):2CA)P$
MF#$P!G?B4OH4<S]Z!E-Q 264BK,P2\'!/[<DG!/Z;QNY<G@:/1=LC3TRU$2V
M,$)?B3;Z[1?H&'^T>?]$PZ1UZ)7KT%.N0TWT&1#7/" ^:#.>?1Z?<) 0,!4.
MFZ5GL6TI\OF]G=-CG!N& 6MGL;-,PG=+?/<P_ Q3G-B$KV+J_T<6;<ANXQ-E
MV:: J2%WEDG(_1*Y?Q3R#6-).VZ_P6%"TS+=&FYGF80+C2HAC:. [Q/.N+@$
M"^^T!J*Q'W9WG<R]D^SP$&ZEG]6C#C7TJ:;)PJMPA^IT_[BGBP.X-;?6/=U9
M)@NH$AZJ(_XX5\-F.-M.KVGK[CH9N\IPJ [QPYU=#-Q%:="J2F30*J"A.J&/
M=70SB1NTJA*9MDIJV!'5<1B*E-[#Q"=-Y5--DU57N0S5P;RK^A@'[QG+W74R
M?Q7,4)W,,O]^!FX&KFL;1HN#NPMEZBJ;H3J<VZC/5 9NAJYC.[9KU[_$[E$H
MW\E5\8S4\=R.W&%EU Q=Q[8M!.M+O4>AS%W%,U+'<\&=?Q&_5!I;/>E08Y]J
MFJQ[Y]9;G<X?-'8QO=/8W74R?Q7.2!W.1Q@;-1,W?0[0\'5WG<Q<)3-2)_.A
MMD;-T(664Z=5%\FH538C=38?9^>6>^0FK[I(YJW2&>V5SKF-)VH;GS2?3S5-
MUEWE,_JI^8SVS.?N.IF_RF=T\GQ&S=AM_8+=72<S5^F,3IO.J.66V$4VK(=S
M=YW\I++*9O,G9+/9<D/<1MU=EU/K.T_'TY\F;C%]]B,& K(4C<9Y3TR@^=/^
M?(?'Z^R!^3SF/ ZSS17!"T+3 O'^,H[Y=B=]!E_^YC+Z'U!+ P04    "  *
M>CQ5-HHH\S$(  "W)   &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;+5:
M:V_C-A;]*X0[*%H@&8L/O=+$0.)DL%DT#\1I^V&Q'Q2;CH611*]$.Y-_OY>2
M;<HBQ3BH.Q\FMGQY?0XO><^AK/,W47ZO%IQ+]"//BNIBL)!R>38<5M,%SY/J
MJUCR CZ9BS)/)+PM7X?5LN3)K!Z49T/B><$P3])B,#JOKSV6HW.QDEE:\,<2
M5:L\3\KW*YZ)MXL!'FPO/*6O"ZDN#$?GR^253[C\8_E8PKOA+LLLS7E1I:)
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M']2S=^O,F:Z 4%C2OCEUED@&;=)KM9[]$Z7V#^00_W"8)!/3$X2^'[$XH!W
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MU>S5ZX6:?<8JW:5<I\=>7WW+D$Z*0!P7B.,!<69FZQ'#ZLFV63//^4 !@W9
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MKCH#?#%DMAQ06CQ$_#D_^HYD* LA?LH?X^55QY*(>,S#0KH(X..)#WD<2T^
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M-^/*R[)6H-"ZUMG>8)_S'3[NTJ]L;DU[;I@W\[:9C./33_/Y/%R=X9019W%
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MS<HM86LVD#RNNKC(T_V*[08@LLVD+KRXO807#M39<,J$:"E#U4@/@B4+UG8
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MH)9$2O[T':[)1)X@$0DX$)-(G@6^4'E3\N&:F4)WGFW9J)(X8MI>H<(6[D7
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M;FM Z- ^ABU(_+VD4X+,?V-,O-M4"# Z"7T?@JIV]S2.&_^^<O$4J; K^(!
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MA@;@^:)"J'!?:('P%OKK_P502P,$%     @ "GH\5?#*2;!/"   A!,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULO5A9;]M($G[GKRAH%L$$D'7Y
MRO@"9$6>\2(^8#NS6"SVH46VQ-Z0W4QW4XKFU^]7S<.4XWCF8;% 8I'LNH^O
MBCS;&/O%I5)Z^I9GVIWW4N^+D^'0Q:G,A1N80FJ<+(W-A<>M70U=8:5( E.>
M#2>CT=$P%TKW+L["LWM[<69*GRDM[RVY,L^%W5[*S&S.>^->\^!!K5+/#X87
M9X58R4?I/Q?W%G?#5DJB<JF=,IJL7)[WIN.3RP.F#P2_*[EQG6MB3Q;&?.&;
MZ^2\-V*#9"9CSQ($?M9R)K.,!<&,K[7,7JN2&;O7C?2KX#M\60@G9R;[ATI\
M>M[[T*-$+D69^0>S^4W6_ARRO-AD+ORE34T[ZE%<.F_RFAD6Y$I7O^);'8>_
MPC"I&2;![DI1L/*C\.+BS)H-6::&-+X(K@9N&*<T)^716YPJ\/F+Z6QV]_GV
MZ9$>YK/Y]>_3RT_S/MW,/U[/II\ZSVAZ^Y%NIK?37^<W\]NG<'OW]-O\@:[F
M\R[SV=##*I8]C&L++BL+)C^P8#RA&Z-]ZFBN$YGL"AC"G=:G2>/3Y>1-B7\O
M]8#V1WV:C":3-^3MMS':#_*.?B#O0<92K<4BDX[^-5TX;U%+_W[-TTK._NMR
MN+].7"%B>=Y# SEIU[)W\>ZG\='H] TK#UHK#]Z2_G_)Y)L6O.[?[=W3G/;I
MW4\?)N/Q*3561O\C*VD:QZ;4WM%SEFAF9:(\6>6^H)U\"O1P!6" O"&?XMSD
MA=#;8-/QJ8M$(\,^R[ R$UXFS%)8DY3@=H(K0.B$V#<5RW!M92&4I:7$F7*4
MJ5PQ7U+*1EW5QM*22-9"Q[+1 ZK"*F.CAL[D@+M8XH\GLPQX1H6T#+V@965,
MME 9(K]B"I%7=D- HP0&.D#L8D\X)_-%IMAD&X07F81E WK\SOHH6,]D+!RZ
M&"\IY[;,MF0L?2V%]=+B!A"H7&M+'4E*#/BU\5"CO=+P'4%;JX3M!)V33<@0
M(YC]?;RCA82%8!/.<^P&]-01SU(MD([B-S+[6A:7UN0_S)9/K2E7*2GOHEJP
M7(NL%&%>P &8Z_J-SI!8W"(JRAO+G@62I+1U56 H.J.A=TLN-9:#D373!\'+
MW:Y3=68=@KTR$-?8($H/;O5',,/10H(*QK\HPQ 2X!#7'.I%@I>41AB0K1\Y
MS FN\L)E\ EZZ0EVO=I#74LW* I:22TM6@(2UY(S'&*;0<@>.]>/M-%[,==W
ME@4)C86N[B%6^YII364,Z*KT"&:K &P+OHO-2JL_N"K7:"(NNR4":S95<5DI
M:2N%11M[ O3+%OHY-&B&BMB=1%T<WZ-;9&566LO-MD=:^@@\!_0W&O='OQSW
M1^-#?G!(1Y-1?[(_XILC&A^,<#*)GHP76:#]<'C<GQP>TPUR%^-9)X3-(]O1
MRRE@:"@QZT)6]I#=O3H$T7/(0G!]JBPP JV':A%;8U%^KHQ3]BHUKE P H]6
M'!<=4,,5*!G#M9!*D?DTKE.^LB('98&: ED#?)3)%>SCY&-/XIQ$B8*U'A4<
M#*CID9K'$G-/H+=%AD/\"7EH,E6!997HFH4[L^I_I>DJ0T$GHJI_V&2W?%"A
M%^,8R\JK:$6=[E4L!34/=Q90JEFOV7")@0/9Q@+'_>6P$&ELD'G7M84$D."_
MRKEF:QTM7C)WJ&K&K(5L.A5M$74+/Y%<VAAS[EDU%Y1MB[M$_$3R'X!O'KSF
MNBYUT_CL1 M+O#P&9&7$4DL5DU@A#)S3YD%(<M2!#>5<*6M[4[$&/DN)IPET
M@:$>"JW@P$YQ!NAG<36 ,$FJ'&,65Z/\!N!1/&<(0J5 .3E,K '=M$$,+'<(
MF*4KQHW78:$-=;>^Z[IMYV?$HA@9FGF*8EP"5F%9J#Q;&%O;^3,+G(Q.[V<N
M7(U/W_,@ZY0=@H[A$RHFX!E>,O@T5%G54'G'AQ60(21E$-V+;3-4V;8N7S.W
M$XGWG"00Z2YPH_"8!4:U:K_KS;QM=)4O2NOJ"6Y70C<PWH\PZG6LBN"(TJZT
MH8[C$$M53Y"J:;M>[ @9T M'.H2P[+M$1)7E;:)RL>5B5SGC;M543*$PLU2F
MX$@MML/"FT45#.YC0>@G"0>@6%=8# !OW.\&1U8!BG;!B^]47&;"[@8!B*!X
M=8D9R0(TE%AF#*R2*)Z]\(X5 L0K4468(UVNFM0H>(4Q6F]</)%@6E%%*HJW
M<;.U6;4RF/A(MZ[>9JLBM/)KB7 \]V\LK<?K+)G0 8ERH?<1KTK1@*8%JOA;
M0!;X<71$1X=T*WT#AW7P\]U^JJ2%&,6IL*MJM^RTRHMB*AA>PL94(P@H&'G$
MCG*\/>'?$RP4*6]\F#IBA6$&,'F0O(UP?*_S@#1]NI_VHT>N?/I<T,W#-2?\
MTL2"'H0WFL^#J3LD[T1>G-)'!;'&L=Q96#<"\<\\"/[$_/<[ZTDD:(5=$BV]
M?>Y0% :ZIL1##LDF5< D! 8-;XUS#8-DN(.^W:)W-7T8=&(;0&IWS>_7%(R?
MD<#J" 2MT"* GP(.8#5A('\-/:J9U5DX@@8G?9@#/AA*NLP7D&>6D2F18Q%S
M.ZEZ5#!!6%"( 29YL:-PI'$QAIZP4URUS-%CG&+Z9=7TXL/H67)T54O^)R17
M;\ZMX"@(9J'12YETM]$\*VR-]@E2Z.E2HCQT_4[! M_3Y)@FAU&'<9HD 3%.
MHFF,?L'(X-8+.#$YI7%TS4GF=DK0!)DI0A2?CQMU'8FSS/#<:FCJW[]H\IP[
MJFOL,;WV#CWL?!G!R]$J?/]Q8>/QU4>2]FG[B6E:?5EY)J^^3]V@9P%9V)F6
M8!T-C@][C"AI>^--$;ZS+(P'>(5+X#GJC EPOC3&-S>LH/WP=O%?4$L#!!0
M   (  IZ/%5TIB6*\@(  .X&   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;)V5VVX:,1"&[WF*T;:J6@EE#Q @!)" 4I4J3:) VXNJ%V9W *M>>VM[
M0_KV'7MAFZJ!'FYV?9CY_(_''@]V2G\U6T0+#[F09AALK2WZ86C2+>;,G*D"
M)<VLE<Z9I:[>A*;0R#+OE(LPB:).F#,N@]' C]WJT4"55G")MQI,F>=,?Y^@
M4+MA$ >'@3N^V5HW$(X&!=O@ NV'XE93+ZPI&<]1&JXD:%P/@W'<G[2=O3?X
MR'%G'K7!1;)2ZJOKS+-A$#E!*#"UCL#H=X]3%,*!2,:W/3.HEW2.C]L'^AL?
M.\6R8@:G2GSBF=T.@UX &:Y9*>R=VKW%?3SGCI<J8?P7=I5M*PD@+8U5^=Z9
M%.1<5G_VL-^'1PZ]Z(A#LG=(O.YJ(:_R-;-L--!J!]I9$\TU?*C>F\1QZ9*R
ML)IF.?G9T?3F>GDWGBYAO%C,E@L87[^&J_EX,K^:+^>SQ2"TM(@S#=,]<%(!
MDR/ .('W2MJM@9G,,/L5$)*Z6F)RD#A)3A+?E?(,6E$3DBA)3O!:=<@MS^L<
MX=WAIA3,8@8W!6KF#H>!S^.5L9K.R)>G0JZ K:>![M[T3<%2' 9T,0SJ>PQ&
M+Y[%G>CRA-QV+;=]BOX_&3H-O+Y9SJ -+Y[UDCB^A#_P82ZKJU_=0MHX+C=@
M%90R57DAT&UD2AEWFV<:S(!: Z4,ZY0!DYEKQ,!65!9J8V#&H#5^NAY[*3A;
M<<$M1_,*.,T:6"M!M</T&PLJ25DIL$%+I,KL?=%8GOM\(M.2U)$$>43>^!=Y
M#2_/26M,/8[+M-2:/(X!X'FU;\DEM9*+=K/;:S5FOPLX&)UWNLV+;F^/_T>U
M-:7729K=3MRX0F/Z,.%">#]*0D:DGV;=;O,\BDXOQB7@0TH@MQ&K ^JOXGT9
M4[RM"WCUU*D.']6@'/7&5UI#I%+:JAS5HW4Q'U<U[*=Y]1*\9WK#Z4X*7)-K
M=-8]#T!7U;7J6%7XBK92ENJC;V[I04+M#&A^K90]=-P"]1,W^@%02P,$%
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M&MOLM9G;Z8K*!=CSE91FY[@+VGD]^0-02P,$%     @ "GH\559>H/N/ P
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MVAU$'5#-]=LH1F[=E;>4!B]0)V;XQR*478#S:RG-7K$.#O] DW\!4$L#!!0
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MTWT--0O0_E)1W;0O;*"[ 8[_!E!+ P04    "  *>CQ5UC.Q*_4*  ! &@
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M<UEFT^/= '381H<#SU5@E*%-+N_4";6(\2==04XH1U[O/#AAX2^%W?*E8+Y
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MWN5Y *9]9]J%TY6?[2OMZ*7PGSD]S6C8@,[76KO]@@,<'OOQOU!+ P04
M"  *>CQ5T(XN)+\&  #P#P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6R=5]MNXS80?==7$-ZF: NNK?LE-\";.&V*33:(TQ9%T0=&HFUB)5$EJ3C9
MK^\,)3EVUTG:/B0FJ9GAF3G#&?)X+=5GO>+<D,>JK/7):&5,<SB9Z'S%*Z;'
MLN$U?%E(53$#4[6<Z$9Q5EBEJISXKAM/*B;JT>FQ7;M1I\>R-:6H^8TBNJTJ
MIIX^\%*N3T;>:%BX%<N5P87)Z7'#EGS.S2_-C8+99&.E$!6OM9 U47QQ,IIZ
MAQ]"E+<"OPJ^UEMC@I[<2_D9)Y?%R<A%0+SDN4$+#'X>^!DO2S0$,/[J;8XV
M6Z+B]GBP?F%]!U_NF>9GLOQ-%&9U,DI'I. +UI;F5JY_XKT_$=K+9:GM?[+N
M9 -_1/)6&UGURH"@$G7WRQ[[.&PII.X+"GZOX%O<W486Y3DS[/18R351* W6
M<&!=M=H 3M1(RMPH^"I SYS.9S]>S:[OR/3ZG-S./D[O9N?D\OKBT^W5].[R
MT_7QQ, F*#K)>X,?.H/^"P8]GUS)VJPTF=4%+W8-3 #=!J(_0/S@OVKQY[8>
MD\"EQ'=]_Q5[P<;EP-J+7W*9+R&K#+GEC51&U$ORQ_1>&P4)\N<^?SMKP7YK
M>&@.=<-R?C*"4Z&Y>N"CTV_?>;%[] K6<(,U?,WZ_Z'G58/[X5Y_NIL1+R'O
MR1O[D;L5)V>R:EC]1!HE'T3!-=%]0 M(0"+PI.52%:S.N;,69D4,*%EA/,F:
MR 69SL^(D8W(B9\"L=^^2WW?/3H7.B^E;@$78?=004A/E=5A-624X:I10G.8
M%4!@R0POR&7=%2>P;BUY1^,=H%#!% AJQ&;6$GX*.%CJ:0"NG?=PI.IV 1G0
M*DP(M(ZH,3XBQQ4 4/%"Y*PD_*]6--9A% -%*%YV"C*%8,M::@.>B8HM43/G
MB%IWD# T;6V3KI$EF.;6MVZOWE>FN&,76 4*&CY*<!@"G2MQ#^ZB%_BY*Z.H
MKL6R%@L AYB^WF%,IF4):@BCITJSDMN= +_ZS,U[K&S%3M@<_L#*UL8-XF<C
M#(S:$E@0J*>BSB4 E(H 9YHLE*SZ2"/+8S*W^,07D%Z(&G0%0Q ;JD@NP9ZJ
M :EUM]\6&?22(PT5'X\GNR^W0B,@V59R70\Q6,@2N@KZ:@4/MS<=COG%9O.M
M/''FT-V*%FQC^)Z5AOCL1>Q<?94D\^T$N>H3Y&HG)<Z?4^*R2PGG A(=Y+">
M'9+9)IW.;*:0.VE8J9UKZ,B*/_"ZY7UT^2-\KD&QZPO )OF&I-3W4IJZ(8XS
M&B0!#4(/)EE"H\RG7A@YE]O4U]MV?T#!.*(AG/YO[#GT_*/G->>[C\#M]Q Y
MR_4_. :Y[T(:NR$-W(A\#U,_IK'GT3!%:[Y/73>A7NH[YQR*#82S:\00-U9A
MZ?W2+:!>0*,H@U%(_<2C<9+8<11$U ]B!W,#+@+,2$AXZ.A#;"$,^6?("MUB
M;NH=%[X:.3:P!$H6'(^%L)G%M.8&]3R7^E%&LP W]B"0;@KPPPAG688AI1DX
M<L8:@4;X(^ IA+&U"O!'*>*VF(,DI)D;V'$<!-1+PBW"O<-_2RQ "!+J9F@5
MBF0*7,9)SW+F9S2)WR36]< I=Y?8;NUM8@/@WP7RLHY8ET; 99=F'L)*@.GH
M7Q ;TC1 " %-O9BF44>LFP+):?(?B$T#B/!NDG9+K]+JA_801*F/N %,Y@4
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M*WB2<X4"\'TAI1DFN,'FD7_Z-U!+ P04    "  *>CQ59/WP)1(%  "7"P
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M^'+WW!V?$T_#M53W>H%HX+%M.CWR%L8L#X- EPMLA3Z02^SHY%:J5AA:JKM
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M,[MY>R>>W%:%6BAIGKXXJ6%K!'"RL-N\YFW&![89C<7[JJS71KPM<YFW 9P
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M^83^NYDCCCWM((E#;0CI&@RR*+E T^>H9\^"81J6)",:4WF5!#671'"XAD@
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MN%+!_@<82I3%_($U-,E#O2KPC7GEMO0VR57^4*&0X"'PL4$.[AOO%?817?L
MM"1B\L<>K%%$#H"(".R!L27//%Y+2#&,X>H-FNX\VY%0);'%U*V,E"3<D8!J
M$-1_6X"UQ4(%RJ J[RM@!"9$:Z7S8^Q[[)AIXLE[,H4: CF^4KDKCN2".EC<
MS$JV169;3:"QH!ED:, 9-IJ(P.$&M4VBFE7!@=R2K#=XQJI9L65CH-%ZIV3F
MJ2_L1JUI-/5 1@J:R2LZNEJV<2\FEUOT%* ,Y&4(AL2>FW\*+*4_,.WCSOP4
M#0+DD57-Y7NBZI/_A Y/>?]]@ML2F0TO &V-IV;%M79_?X78/W7R(+V\6AUP
M@4!0O]W6%ATY[-GYB 9S6Q>/1](&0NTM%]>X^91!:J,X*?' (J\.9CQJ>&FJ
M"FQEMSZ0FH1*GY3' /78Q42:.XSOVT&%LF4"L%@X")783K77"UNG9'&A-AU2
MQQEL&[PM[(P'!"[;G%"$9XKLP35F5TVQUU5UU09A!914C 4C(<&(<6!Y"RT)
M,I/>&T$ 8$7,[Z!MWV 0!PN^A&#9B03RACI%JYSL=W=]W]OW_5L<CM(Q$J=Y
MAN7\>1V$:T<= TDNJA7M$$"X&+&SHU$Y"NBL>UE6N#=96&SG#Y);B_2UE#Y*
M/!8? .EKNQ=W)][&>R6T%6Z3S()>W3B].K'"D(L98O&+.$W'IQ?I^?""KD?#
M87IZ.DR<;I\XO1:C='@V3"_'0W%Y=I$.I]/DMTI_!:VR-":20_!!+#FYA1N4
ML-Z4OS=Z)T;GZ>7P/)U,IF(T38>C43H:C1*NCYZED[-I.CZ?BDDZ'I]C=R:!
M0XJNX_\BQI?I]&*<CB>(\'B23A#LQ65OTAKFQ$:]@UVO7,N&6/4FZMK,0.VZ
MBR$_,2G6OXMHW8Y;1PNZW>Z=N787!F2@E!@;V_")G\;ZG^]Q\!",ML4"="4V
M$*.,T=8!]*'MP_05U^UQR"D!4RYUR55#6\AOL#'S1"IBKBH/ D3WB%UZE'C.
M&&UZ^)3#P461&<.A=&8.M&T2AAG:Q3_0[>V3E#"C-^H?TKO*82,(/A#YP\+Q
M$[-YCP"+^)L@ I;O>8OQ2?RLEXR05N>@,V>34\JISB;<!.TC1YA"&_6/H=U!
M"+7MI\5/3*&UH78:=N,>88DL\\*3Z=%,H#Z<N8<>.+M_1[MX.=/>#TU5>R @
M2?]%@"VZ'(F+=#R:]A(V#/:,OC?90T-;GW%HJY.L/S7;$V""_>&$+4R!=4S
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M3Q7Q!PC'Z>>!YE5=5QNZA!0(LD-\ .XO*S!I]@-NX'\PZM7_ 5!+ P04
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M  ACH/>7G*O=Q 2H_RGQ;U!+ P04    "  *>CQ5QV.!RX@"  !D!0  &0
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M8@7?#*Z= 9QOE+('Q04X?H6FOP!02P,$%     @ "GH\50*!0U&3!   H0L
M !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULK599;]LX$'[7KQBX!UJ
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M.3L5K:[*AE])4&U=,_EPSBNQ/1MYH\>#ZW*UUN9@.CO=L!6_X?JWS97$W71
MR<N:-ZH4#4A>G(WFWLEY9.2MP,>2;]63-1A/ED)\-INW^=G(-81XQ3-M$!@^
M[OB"5Y4!0AI?>LS18-(H/ET_HK^VOJ,O2Z;X0E2_E[E>GXV2$>2\8&VEK\7V
M#>_]"0U>)BIE?V';R[HCR%JE1=TK(X.Z;+HGN^_C\",*M%>@EG=GR+*\8)K-
M3J78@C32B&86UE6KC>3*QB3E1DM\6Z*>GKU]O_CP[A)NYW]<WL#XEBTKKHY.
MIQJAC< TZV'..QCZ'1B/PCO1Z+6"RR;G^;\!ILAI($8?B9W3@XB_M,T$?)<
M=2D]@.</COH6+_J>HTTF:@ZW[!XN2I550K62PY_SI=(22^.O?3YWB/Y^1-,N
M)VK#,GXVPGY07-[QT>SE,R]R7QW@&PQ\@T/HLX6H-Z+AC5;PH8#;-8<K*>Y*
MVPQ8C[#SAZM]W ^B[^?^,R:=3YS)/MN N>(F5\ZBE1+U3VS2S(_GO.8YEZR"
MY_AW[-QHICE0$@0N"=, /.+Y$0F]P+EIEUIH%-SW\H(7')'SDP$N[T] &S:H
ME/HA2:F'J]A+B!M$O:VO!+TP)FE,P2"GD;LSZQ,W]4F2^HB0A"'!H>;LW!^?
M\X87I3Z"XJM P#&\Q]GY'$(2^@$)DAC7/DE3CX34A0.5$ Z5$!ZLA&N>B28K
MJY+9.8:I>0R"\;#50CX\8037QNM; 2:;K'EX^2RA7OP*4U44W([ 06I?V?Q/
M5/:7TZZ*NE S#45O3PWVI*TH;^+"B_[19YXU.50B0^&RH]15P'C9IY) @XD3
MQ8#9OX!@0A'+G_@(]1[=7.!DDZ+"8*P02G-L& WC<!+"T0L8!Y,4G\[E_::4
M75@0$DU!AE578B]12RV81 AWS74K&] "-D-ML?QOG/.U[3MW$J-L-/&,Z4\W
M,&\1 O#3J"MN)! FM-R0H;-8LV;%D1)H[-4[5K6=?5;AIY8U&8>QL6U(4M<N
MG \H*6'L(AD\3JV+NVSLXM1'-3 "0*GA?J"2HZ&2HY^8:5]7Q6.3VZ*8*\51
M;(XY_+5D2RPY7>X?= =-_LB@^P\\G#TE>O%DT "S:B?.?$B%F1NYP&E3M!7>
M13+1&O//(2#43TGJ^G9L)#0F?D)-V1UC*[28%_PB&WG9LDI![,8D<%V( Z.#
M<J:"-]P4'A9GQJ1\0$-;)G.%R EUB>NYD!":A,2+?--'0UWZQ ]PO+HIKF*?
MDBATG;?-'8;%M%6:D#0((8J([]E)B%;T@VTJ_J4M-[8:S2[G&-BLGP@Q3KTX
M B^)2>139U\HCV$EA<))[".K #GXX$4D08?<('0^[JOB(/!($F&[P3A)T:4D
M@"/GUH[M_-NH@X<3/,#/2)S@N"=IB)Y$'KJFL5U,.'$&4'P1T\@@4C\Q+NY'
MK'8Y_XZ2R<"W)#"9R"*B$8E#:C9&TR411G1?'TV?7.!J+E?VFJK %DEWEQM.
MAYOPO+L [L2[:_0[)E=EHZ#B!:KB/,&)+KNK:;?18F.O@TNA\7)IEVN\S7-I
M!/!](81^W!@#P_\'LW\ 4$L#!!0    (  IZ/%7CH4BG. ,  )P&   9
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;'U548_:.!!^YU>,TE-UE7*;Q E)
MV (2[&U53O2Z@NW=0]4'DPP0U8FI[93=?W]C)] ]B>4%V^.9;[[Y)A[&1ZF^
MZSVB@:=:-'KB[8TYW :!+O98<WTC#]C0S5:JFALZJEV@#PIYZ8)J$; P3(.:
M5XTW'3O;@YJ.96M$U>"# MW6-5?/<Q3R./$B[V185;N]L89@.C[P':[1?#D\
M*#H%9Y2RJK'1E6Q X7;BS:+;>6+]G<,_%1[UBSW82C92?K>'13GQ0DL(!1;&
M(G!:?N(="F&!B,:/'M,[I[2!+_<G] ^N=JIEPS7>2?%O59K]Q,L]*''+6V%6
M\O@1^WJ&%J^00KM?.':^\="#HM5&UGTP,:BKIEOY4Z_#BX \?"6 ]0',\>X2
M.99_<L.G8R6/H*PWH=F-*]5%$[FJL4U9&T6W%<69Z>?'C_<KN/NR6MW__0C+
MQ6R^6"X>%_=K^/V1;P3J=^/ 4![K'10]YKS#9*]@1@P^R<;L-=PW)9;_!PB(
MX)DE.[&<LZN(?[7-#<2A#RQD[ I>?*XZ=GCI*W@/_-D5![PI8584JN5"P]?9
M1AM%W\FW2S5WB/%E1/MV;O6!%SCQZ'%H5#_1F[Y]$Z7A^RM\DS/?Y!KZ]+/9
MHX*[5BEL#"PKOJE$92K4EXA>A;I,]%7\ 2F/5OF!5=[*'PV<7EB"YH(K\O&A
MD'5=:?M..T4/_%E)(<#P)]+X-TC\=,C\*(MI/_23,/5'.1LL*<..]V^S;\';
M-SF+V'L8A:$?AN%@S6V7",=BVI8!2W(_"QFD":&R>+ VW"!4#7' /N')-<Z9
M!8$L2WP6)X,E[KAP!*6K]Z#D%AUM,F^1(EE(V!G$F9^SS!8JV\94S:Z[C9@C
M16OFLY0-UBBV?VQ;^XW#'KDP>^*A6\6; J'7%K*1'Z49I,P?)OE9NZHQ2!ZF
MDPN)@'F&X<@?1BDDH]@/$S;HFI(/$W^4,LBBH9^2(IVUZ%LE?K6*M$W])")J
M+*.]34N:1SE<^OZ"%Q.C1K5S<U&#J[<;'F?K>?3.NHGSR[V;VY^XVE'9('!+
MH>%-1I-.=;.P.QAY</-G(PU-,[<EM4I4UH'NMU*:T\$F./\A3?\#4$L#!!0
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M^-@)G%V$DZ2 48QI%N(TR_PXB1),HS0X40WT9L.LT@\(^MRFME"&\C,2QK3
M%C=/4OC7*/"%1:("8S$3;K<C9@RWSBXDF"8%+B+G.(1"DAS"CQ,W*PI74EQ
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M,LQ@8>ON MI-K%KZ2]^=LM [_7 !=W:NG0)\GREE-Q/GH/\7,/X'4$L#!!0
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M9(D'NITP[<:J;=/5E\KBC&C$#0YEKIT"_E\IS'R_<0ZZ,3_^!5!+ P04
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M;6O6ZB^K5D*-"^WJZZIQ0-AV9Q>*K[L6,^=*-ZQNNM)_""C, ?U\P;G:+TR
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M8E)UM%GNU @%KA/4^88Q>0IT6]=#.?P'4$L#!!0    (  IZ/%4ZBLOZ  ,
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M.IJ0R)IQ-E%\E?:S&5>Z.Z;#I?Y_ 6$,]/Z<<[6;F .*/R+O#U!+ P04
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MG<$'I8S7C:\.)"M-[U@SJ3J1&6;J7P%<%ZCY#6/R$.@%VK]/\!M02P,$%
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MJR+XNN-<3R0KJRYOS*3J&:OA0G7IA.L'U/T98_)UHAO'NN\?_ 902P,$%
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M4?'JD/%D"\>K=&L'O:V!Z'_\%PW_Q8F7,*8J%2NN84:T69^B3)'K?1ZJ2NW
ME;(-<9T$K:![&?OK/8110QB==,+OYXOV\G6B?_C\G89B>_-W(I>4*RAP8?*"
M5L_XE%6_JP(M2M=CGH4V'<L-<_.)0&DWF/6%$'H;V+;5?'22/U!+ P04
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MG0Q^WS]]1V<XRZ_1W?W3X&FDYP^W@^GM%%VB"41 )1I$$2NH)'2!QIQ1-8Y
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MFS@4Q;^*AG9VVIDV(($!9VUF$B=MO9.VF3C=?=CI@VQDFRE_7$F.N]^^$B:
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M/00P"P&H'P+4^.<( :@) <@L!*!^"%#CGR,$H"8$(+,0@/HA0(U_CA" FA"
MS$( ZH< -?XY0@!J0@ R"P%($0(@]*#?3<!Z?5/^)@4@LQ10E;7O%Y&:_Z0Q
MP&X]KY4/RS]BNDIR!E*R%/+.12 &2O?/G_<[O-B4CW#G!1=V6FZN"8X)E2>(
MUY=%P9]WY%/A^K\ T4]02P,$%     @ "GH\5=UH^0<A P  E0@  !D   !X
M;"]W;W)K<VAE971S+W-H965T-C,N>&ULK59M;],P$/XK5D ()%C>FB8;;:1V
M&V.(P;0.$$)\<)-+:^'8P787V*_GG'19UV:%#WQ)_'+WW/.<+[Z,:JE^Z"6
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M*5OK4^RY;8N\AVD;]@55^$5JPJ% 2.\@QNRIM@FV$R.KIH_,I<&NU R7^-\
MRAK@?B&EN9O8 -V?2/H'4$L#!!0    (  IZ/%5[[Y\C=@,  %$.   9
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MB<;G5X/S;^/AZ1$:3"9'5Q.T=0@2DTB@<\PYUE)OHUUT/3E$6Y^W>[941VL
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M?Y(,*$EP00.>_ ?;K*UE@$7,!0VS8)E!Z$?I)_Z6#<1>@'TL &4!J!* T)$
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M +D.4/LQ8_)UHGM3\V<)_P-02P,$%     @ "GH\517,/N(N P  J0H  !D
M  !X;"]W;W)K<VAE971S+W-H965T-S N>&ULK59K;]HP%/TK5C9-K;0V[X0P
MB%2@U3JI+2KMMJ^&W$"TQ&:V@>[?SW8@O$+65?T"L7//\3G7-_;MK"C[Q6<
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MVBT2ZF2LL]PZWH[(]2-UQ.QM1TU<:+<L+ZC?CJ@2&OV[@E\A,SJN!C^,0N=
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M0+':'WKW$R.W[;EQ*0V<0MOA!OXH<&4-X/Y*2O,TL4?1[J_'[%]02P,$%
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MZOQ;0WYC5>I.WTME\2SO+B/ S4W3 GR_4LH^W9""\HO/^#]02P,$%     @
M"GH\53J:E/-? P   @D  !D   !X;"]W;W)K<VAE971S+W-H965T-S8N>&UL
MK59M;^(X$/XKH]SIM"NQS0L0: \BI93><NH+*NWNA]-]<,D UB9VUG:@N[]^
MQPGD**3<G;1?DG@\\_AYQO9,!ANION@5HH&7+!5ZZ*R,R2]<5\]7F#%])G,4
M-+.0*F.&AFKIZEPA2\J@+'4#SPO=C''A1(/2-E710!8FY0*G"G2194Q]N\14
M;H:.[^P,#WRY,M;@1H.<+7&&YBF?*AJY-4K",Q2:2P$*%T,G]B]&?>M?.GSB
MN-%[WV"5/$OYQ0XFR=#Q+"%,<6XL J/7&D>8IA:(:'S=8CKUDC9P_WN'?EUJ
M)RW/3.-(II]Y8E9#I^] @@M6I.9!;C[B5D_7XLUEJLLG;+:^G@/S0AN9;8.)
M0<9%]68OVSSL!?CA&P'!-B X#.B\$=#>!K1+H16S4M85,RP:*+D!9;T)S7Z4
MN2FC20T7=A=G1M$LIS@3S9ZFTYOQ[?CN,;Z!43S["-<W]Y]A<G=]_W ;/T[N
M[^#=%1K&4PUW3"EFL_X>/L#3[ K>_?I^X!IB8;'<^7;%RVK%X(T5_0!NI3 K
M#6.18/(:P"7ZM89@I^$R.(GX9R'.H.VU(/""H('0Z+^'^R?HM.N4MDN\\*V4
M%GF>(IUTPU(8,;V":[HK,*YL&OZ*G[51='[_;DI>A=UNQK9W^D+G;(Y#ARZM
M1K5&)_KM%S_T?F\2_I/ 7J6A4Z>A<PH]F@B#A&I@RGC2@HF8IT7"Q9)2DG-*
M#?^.">R<6G"?HSU<-,^$M:_):D>QO>?<<-1-V:HH=$H*MF"MH]#O><'YP%WO
MY^'8K=?U>_W:ZY7 ;BVP^R\"YS)#>&0OJ$N1302[1RL'':_O=[H'#!O\0M]K
M!\T4PYIB>)+B;,4HNS#1ND#:@VJX?7^PU2\AXM_LL828[K98ED>T!6Q!VP)4
M)Q?(3:&P25FU<G>/L7>@Z=C#]X)VV&G6U*LU]?Z/ID\L+? G2>H=;<*AI&,/
M_YSVT]:-)DW]6E/_M"9J8W386_ '"KH&:7D'XH3J/;>EPM9<&+]0Y];-UZ!_
M3,L_][Q#]L=NH1?LNU7DW;UVDJ%:EEU6PUP6PE15N;;6C3PN^]>!_9(:?-6/
M_X&I_@YNF5IRH2'%!4%Z9STZ):KJN-7 R+QL6L_24 LL/U?TDX+*.M#\0DJS
M&]@%ZM^>Z =02P,$%     @ "GH\5=D;$'_2 P  0@D  !D   !X;"]W;W)K
M<VAE971S+W-H965T-S<N>&ULO591;R(W$'[G5XSV3J=6HNRR!()R@ 1)3LWI
MDB#@>JJJ/IAE8*W;M;>VR1[_OC->V) J655]Z NL[9EOOAE_8WM4:O/=IH@.
M?N29LN,@=:ZX"D.;I)@+V]$%*EK9:I,+1T.S"VUA4&R\4YZ%<10-PEQ(%4Q&
M?FYN)B.]=YE4.#=@]WDNS&&&F2['03<X32SD+G4\$4Y&A=CA$MW78FYH%-8H
M&YFCLE(K,+@=!]/NU6S ]M[@-XFE/?L&SF2M]7<>W&W&0<2$,,/$,8*@OR>\
MQBQC(*+QUQ$SJ$.RX_GW"?V3SYUR60N+USK[)C<N'0?# #:X%?O,+73Y*Q[S
MZ3->HC/K?Z&L;/L7 21[ZW1^="8&N535O_AQK,.9PS!ZPR$^.L2>=Q7(L[P1
M3DQ&1I=@V)K0^,.GZKV)G%2\*4MG:%62GYLL;K],5[<W,)\N5K_#:C%]6$ZO
M5W>/#TOXZ0:=D)F%!V&,X.+]/ H=Q63/,#GBSRK\^ W\;@SW6KG4PJW:X.8E
M0$AD:\;QB?$L;D3\O%<=Z$5MB*,X;L#KU17H>;S>&WA3F,F,)G=PK?-"J /\
M<8_Y&LV?KV7;B,4==&4+D> XH!:Q:)XPF'QXUQU$'QN87M1,+QJ9+C 3#C<P
M%\8=8&6$LL)KNPTW:!,C"R]TO3U?>RV)YC"K%.'Z]A&$HE"4A=R@<HSJ>.%8
M(VE!L!ZUD>[0TJ5"PR8"UL=B)I5A&\I4)BD4:/@$L?4ZHY-X3]W)M9()6I*_
M2ZG;;4$+X#0\Z%\^<8MYAV_4X6CLAW?#N'OYT9.A\T$P0BO)A"3\ESR/EA:2
M3%(6M@.<7<Z*S ZP180D%69'1:50Y_F5PL+[8;\=15'E<UIP:"AMOP\NY2KL
M#"*=4JY%67P6:D]'&W2].KL=>*2YO<)JHGO9?A%#9%8#>:(A,*F(@0!-Q@<4
MADJ@L!3K#)\C,,?"Z"?:$+A;/9>LHM[Z1^6!ZLU[=)8KU>9]W&L/AQ=53L_(
MG*Z/2$ST.><XKG"4IA#&4^LT2+E?2[G?J+$9;9M6Z=Y8!_>P@#OX(G-Y$C>)
MR::R:&S$1OS_V(B#FOW@_VG$YC OBK1XM41MTDW582WW;]HVU=F&-*M8;B0[
MZ]K<R87/@_6GSC7!G7CNS$+@\5%X/A+?^PZ54 FV*)9T%KX6AJ]"3WF9",5'
M0Z5%6D@J%7:[$;<6'PL$H_;YJZ(*S^ZU'*E-^?:F7M9[Y:HKKIZM'PC3ZEY\
M-J]>%_?4Y5)9R'!+KE'GDO1CJAN[&CA=^%MRK1W=N?XSI4<.&C:@]:W6[C3@
M /6S:?(W4$L#!!0    (  IZ/%7V32OG> 4  '06   9    >&PO=V]R:W-H
M965T<R]S:&5E=#<X+GAM;*V8;6_;-A#'OPKA#4,*K#5)/6>. <=.MPQU6B3I
M]J+8"T:B;:*2Z$I4DO;3[R@[EBU13(SF32)1=\?_D=3]Y!L]R.)KN>)<H<<L
MS<NSP4JI]>EP6,8KGK'RG5SS')XL9)$Q!;?%<EBN"\Z2VBE+AQ1C?Y@QD0_&
MHWKL4S$>R4JE(N>?"E166<:*[^<\E0]G S)X&K@6RY72 \/Q:,V6_(:KS^M/
M!=P-=U$2D?&\%#)'!5^<#2;D=$8#[5!;_"/X0[EWC70J=U)^U3>7R=D :T4\
MY;'2(1C\N^=3GJ8Z$NCXM@TZV,VI'?>OGZ*_KY.'9.Y8R:<R_5<D:G4V" <H
MX0M6I>I:/OS%MPEY.EXLT[+^BQXVMH$W0'%5*IEMG4%!)O+-?_:X78@]!^+T
M.-"M VT[^#T.SM;!:3NX/0[NUL&M5V:32KT.,Z;8>%3(!U1H:XBF+^K%K+TA
M?9'K?;]1!3P5X*?&-Q=_SB^N;M'D:H:N+SY,;B]FZ/+J_<?K^>3V\N,5>HMN
M*C@0X@=/T U?PHZK$@9/9EPQD99OX/KSS0R=_/IF-%2@1T<=QMNYIYNY:<_<
MA**YS-6J1!=YPI/# $-(9)<-?<IF2JT1_Z[R=\C!OR.**34(FKW<G5CD.+O%
M=>IX3D^\6ZE8BJ[Y/<\KKI?MBBO3,FVBN'44_:+>CZ/ BRAQO='P?E]^US",
M(AH%?F-X(-3="76M0B]SQ8MRL[THAVI3;#4;U)[;0WTA_YE2W#AY^RGZGDN"
M5H(&,TRHA\WI>;OT/*NFDP^RA*-ZF<<RXVA1R Q!X2R8KCRF%*=>1P:%0AJ0
MD+;T=@U)@&$_2,^&^#O%OE7QC$,5CP7;U,8\02R3A1(_Z@&38K\CQ/4<CSI^
M2[#!#H?$#P.SWF"G-[#JG<H,2%0R)8OO"(IZ?9#D D']BK\B4985RV/C<9H&
M'46XI;EK$3HTZ%$<[A2'+W@W10)"Q4*PNY0C5I9<&36&W6V.(L<E4>= &"S#
MR,,^B7I.1+33&]E7F*V%5LP?8:$3H:K"O)Q1=X-]QR&!VQ+:M7/\R \BWRR3
MX 8HV"ITSO)J 3BO"I$OT237W"CN1:SO/B[0G"<BACPNOE5B71^3+W.>W?'"
M6#;L<^F/HM-RS6)^-H#WI81Y^&#\VR_$QW^8JO]K13M<F3W4DE?!P3;,P8&G
M) QQ>P\-AA%VH "1GDVDC53Z>D!X)E8/$;9>SR+!9&=A FG@3.QT/IH*VWC[
M2MZZ/G8=W.:TR1+*!89:T*.Z(36Q\_5H,I N4ZGO>%[4UFRR<T.G;YT;^!([
M?7^"#:3+US8<#"86.I &P,1.X*/X0+I8)9AZP(C.:>Y:4A>^];P]DAPJ;A!,
MGF'P"PE!NCS5TP>D+=5@%Q$:N3U"&_(2.WJ!$/"3LCX& (298,M<EDK$Z#)C
M2XV)*:_+CYT,UCF.)L,K13M<D8;MQ [W%Y.A2^T0SI@#M:6]>09+'$;4#WJV
MCS: IW; '\6&9V+UL,'N9=X.9/R]]_.!#E>I@3VUP_YHNM NS*GO$^*&[1IB
MLL0>#O8_$ Y5-]RG=E8?31?:I;,+I<0/.J*[AH[^X>'U5&K:<)S:.?X3?*%=
M3K?Y8C4Y5-PPG-H9?A1;:)?+\!F!0XH[[0&3J>]&Q/&)TZ.YH3A]AN(OI,LV
MS'Z/PG4"%[Y+VV*[AHZ+/0_W@)!J=!^.-&BD=C1"F9EDLM*]*YZ*3.1,\02)
M',7P,LI4)(;SO9EJN-=:RWBQK%N4)?A!L$U_93>Z:X.>U\V_UOB4G,Z(87Q"
M_=,IY&9Z$L"3NJ,Z;*;>]&/GK !2EBCE"Y"!W^D&9K%I<6YNE%S73;\[J93,
MZLL59PDOM $\7TBIGF[T!+M&\_A_4$L#!!0    (  IZ/%5K'338C@,  +40
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;,58VV[;.!#]%4(%BBW0
M1J*4*'%J"Y O;;WP#4[2Q6+1!\8:VT(ETB5I._OW)25%MKRTL 8$Q ^V2'$.
MYQP>*3-I[QG_*=8 $KVD"14=:RWEYMZVQ6(-*1%7; -4W5DRGA*IAGQEBPT'
M$F5!:6*[CN/;*8FI%;2SN1D/VFPKDYC"C".Q35/"_^U"PO8="UNO$_-XM99Z
MP@[:&[*"!Y!/FQE7([M$B>(4J(@911R6'2O$]SWLZX!LQ?<8]N+H&FDJSXS]
MU(-AU+$<G1$DL) :@JB?'?0@2322RN-7 6J5>^K X^M7]"\9>47FF0CHL>2O
M.)+KCG5GH0B69)O(.=M_@X+0C<9;L$1DWVB?K_75XL562)86P2J#-*;Y+WDI
MA#@*4$3- 6X1X)X&7)\)\(H +R.:9Y;1ZA-)@C9G>\3U:H6F+S)MLFC%)J;Z
M&!\D5W=C%2>#A\'7\6#RB,))'\T'H_!QT$?#R9?I?!P^#J<3] DIM906%,TX
MB[8+B1Y( D+-_]$'2>)$?&C;4B6BX>Q%L6DWW]0]LREVT9A1N19H0".(J@"V
M8E#2<%]I=-U:Q#^W] IYSD?D.JYK2*CW_\-Q33I>J:J7X?EG\.:P [I5,BTY
M2]'@10*G)$&][#R!"T1HA$:,KCZ-E(DC% H!4J!_1@H'#26DXH=)U7Q3S[RI
M?N#OQ88LH&.I)UH WX$5O'^'?>>S29&&P"KZ7)?Z7->A!T9/F1CG,-C)</0K
M:1<X5]=WK;:].^9B7.:WW-;QIXRII'Q3IGQ3FW)_.AY.AKUPHAZ3V5-W-.R9
M\JW%N/2$&@*KT/5+NOY;.-AO4I^&P"KZW);ZW#;CX!P&XXHUL7MB8.,J_]9L
MV;LRQ[O:')59PWYH2JHV[M)C: BL0K%54FR]A4U;3>K3$%A%'^P<_KX[S1BU
MP#EYB:IJ\,2JY]9ALUGQ426":S/].E!%Q^1O8VZUD9<>2%-H59[N@:?[%IXM
M=FU*HX;0JAH=ZB=<6WY<X%K/\.8\=:QG=*Q[SK&'*@;7ES&SI\'\<8KFP][4
MF%MM],4GTA!:E>NA_,$W;^+:1BNFIM"J&AUJ)EQ;<ES@6M_D2,_W3IUK7/??
M=ZU]U "JPUAE?;% "[:E,F^BRMFR]PZSCO-DOJM[\JRQ/,#D#?V8\%5,!4I@
MJ2"=JULE-<][Y'P@V29K,Y^95([(+M= (N!Z@;J_9$R^#O0&Y7\J@M]02P,$
M%     @ "GH\5:HNT,HO!   =QD  !D   !X;"]W;W)K<VAE971S+W-H965T
M.# N>&ULQ5EKC^(V%/TK5BI56ZD[B<UK9@I(&<C,LN4Q"LRNVJH?,L1 M$G,
MV@:F_[[.8Q),@UF0*[Y G-Q[?,_UP1PY[1VAW]@*8P[>HC!F'6/%^?K>--E\
MA2./W9 UCL63!:&1Q\60+DVVIMCSTZ0H-)%E-<W("V*CVT[O/=-NFVQX&,3X
MF0*VB2*/_O. 0[+K&-!XO^$&RQ5/;IC=]MI;XBGF+^MG*D9F@>('$8Y90&)
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MTR;ITY^0]2N,?Z4"SV*#)N]3>^)_D0W&Q0$#)+GFZG]R@)WNV,5LJ@D-3F
M:XDZ5G-3@:B]!+W, /O%R&J IAI1>SEZF0$P_V<,W]P*33X*;*<Y:+ [P<I[
M[*HV-8Z&)W#"*4H8;6H8M5:<%SJAOW<";"L([LYAWUR<\)2]Y)DB"2PPSCOK
MH95D>1<I&UKDQ?E_+C1N]N)QA?<WD&8 OE\(H9\;YDI1WPA'WP%02P,$%
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MKA/.P/LIX3B,V <1^_PT!>_??>CK7)26+:#[11F371FHI0R(P"U-^)*!STE
M AE %YQ*8NB%V 0I$?]:)Q? -#X"9"#44-#T]'2H*,<L^VSF>&9;GU_:]4A\
M$F[P+"+@VRV)9R3]IZE=2K1,#"[9"OMDH(FKG9%T0[3A[[]!Q_BCB6I'8!)Q
MJR1NY>C.$>(?P1WE1'S=4)PP@), 7(6)F*LP64A-N1$ X)J3F#4VQNJR,1V!
M28VQR\;8RHD8DT68)!G[,8ZRZZN)[0["RB$R"=\,+0LAU^CKFWT>AV$VM&P'
MEF%2A4Y9H:.>V2 (,W$6U_AUXD=K<6&", &KE&["7/?%;4>(;B!T=L99TU4_
M5B_P#3:>8F52\UD!36?W]3A2V]RR;:Z2U90$Z_RFQIK([7+MO5.%3-=QS=H9
M/0QS$>JUG%"OK,Q35B:T]<B\>8?5&9;=<VO5'8;5QE(JKU>6UU.6=XL3836$
MJ>!@).3AGB])"JX(.5DTE?#G:D-'8%(GH%'=EHTWE<UBN8YZTQ6:W)P]SP)?
M+YT%QOZ00MOU',_U:M/<% D-QT2FV3S0$%65HO];0H^LT**A1=8^)\^"AMFK
M<S^,LUQD.I;=0KTR/%#M>-0RJ$X^0^0[ )()5L8&*NW!"6I: $B#Y3C([<&Z
MH#9%UH=5+K.R&5#M,TY2U4<282YF\Y8$H8\C\)!F?\A\$:326_7*9XM*1VAR
MGRJS YVW5=Q?L!^*YG2$)C>GLC10[6E.4]Q#TV)!SS)[!Z)S&&B:"!EVF^A4
M!@>J'4X7>JM>H4UO#RV1;2"K9]6I'\9Y#C(MJX5YY9V@VCP=D=M?<#/-<OMZ
M(/GO?.6(D-)4G""W!8 T?X[0T%[=7#<%U@95+K)R)DCM3'+I.-6NJK'.58BN
MT&3FE=-!Z$WE$REMS]G-Z0A-;D[EA9#:"YTDGP6&])_/=4V[+B''X^0J*T.#
MU(:F _$\LD*+>*JSSE"G#H#DWE4N"ZE=EEI^U<GG$'P]D$RPLD=(_:SF!/EU
M#IY"-<_OT3BYQ,RDR'LJ.X".WJQ/F.2+I@;I>\_48Y(N\G<3#.0BMWOZ6>XM
MWW^,\Z?^M?T3>#F%#?M'R+V<"')-1SQQ)'^5HE=+[U[$W.)42 D#$9F+,HP+
M5PQ$NGNWL=O@=)4_[9]1SFF<_UP2') T"Q#'YU3(<[&1+5"^81K^!U!+ P04
M    "  *>CQ5E@C@_H\%  !Q(0  &0   'AL+W=O<FMS:&5E=',O<VAE970X
M-2YX;6S%6FMOHS@4_2L6LQIUI)T&FW<GC92&/$BG5:>/7:U6^X$F;H,&< :<
MMO/OUQ!*$W.#Z(ZE[8>&QSG'KWML+J;_S++O^8I2CEZ2.,U/M17GZY->+U^L
M:!+FQVQ-4W'G@65)R,5I]MC+UQD-ER4IB7M$U^U>$D:I-NB7UZZR09]M>!RE
M]"I#^29)PNSG&8W9\ZF&M=<+U]'CBA<7>H/^.GRD-Y3?K:\R<=:K59910M,\
M8BG*Z,.I-L0GYY@4A!+Q1T2?\YUC5#3EGK'OQ4FP/-7THD8TI@M>2(3BYXF.
M:!P72J(>/RI1K2ZS(.X>OZI/RL:+QMR'.1VQ^,]HR5>GFJNA)7T(-S&_9L\S
M6C7(*O06+,[+_^BYPNH:6FQRSI**+&J01.GV-WRI.F*'('1@ JD(1":8!PA&
M13"Z$LR*8'8E6!7!ZDJP*X+=E>!4!*<KP:T(;E>"5Q$\F6 ?&CC]=>3TKF7@
M>K"W0;>-DC+$_)"'@W[&GE%6X(5><5#&:<D7D16EA:5N>";N1H+'!]_NAM>W
MX^NO?Z%)<#F\' 7#K\@?W@[1T=WE\,X/;L?^)_09W:7A9AEQND3?-F'&:1;_
M1),H#=-%%,;H-KR/:?X9'?F4AU&<EXP;'QW]]JG?XZ*615F]156CLVV-R($:
M&>B"I7R5HW&ZI$N /V_G8](BT!/=4_<1>>VC,]*J.-^DQ\C0?T=$)P2HT*B=
M?A%F@HX/TOUVND\7-1T#]'$[_8:NZ\I#]$GWMD/T:?>V0_19][;K #WHWG:(
M/O^U<3__SUVW%X9&;56CU#,.Z-TR+KQV39]HNJ$Y^OC!)1A_09>40R9KU2H6
MZI-\'2[HJ296XIQF3U0;?/R ;?T+%. JQ7R58F.58A.58E.58C.58H%*L?E6
MS"S%BN>WIX'G6![!IM7O/>V:I0ET/8]XCOT&W+.%6=O"[&"+$<MYCL)TB<8O
MXG$SISEDBE:E]YI"I9BO4FRL4FRB4FRJ4FRF4BQ0*3;?BED[L>Y8EFMZMB&9
M @ 2UR#8TF%36+4IK%93B$4!!>F")12R02OWO390*>:K%!NK%)NH%)NJ%)NI
M% M4BLVMQI2/'6*8ANM*-@" ANT8+L:P#>S:!G:K#<["/%J@-S.@*YJ)I2))
M1#)_LPHSBH9/(F$ITA?$67V'L\7W%8N7- -7D=8RWVL?E6*^2K&Q2K&)2K&I
M2K&92K% I=A\*^;MNN+8D:T#@4P'MHU3V\9IM0V4XQ=O%]#?%S2YI]D_D"M:
M)=_K"I5BODJQL4JQB4JQJ4JQF4JQ0*787*78N2*Q/9>YM<M<A?F\VU@BB>EB
MLC\;C""4Y>!]E ^A3,?;1XT!E.$8^CYJ FG9GK./FD):NB=IS0 4QK:YCPH
ME.[)M9\W465>*LV>391(2HT##]]>/;">LHS4:R0 1+=MJ?M&311V/4-*)GP
MY7B>+0TKB'*E[IM ]7(MJ<0I6"];6J)F ,K&KC04 81RB3RL35216<GO&@!4
MD5;!PXKUMW?E^B]D515Y-Y@,6^ZR$80BMM09/H"RL"&%Q1A$R1T[ 5 $RV$Q
M!5 F\:3NGT&U]X@TX '81DN:A>8 JDP/I+&$8"(Y, \,YL[&!_X?<H.JT-WG
M,?W8P'(0@"C9SR#*<N4@ %&VOON'Y9" .%B."%#8DB,"0LDO_P*XP8X<$4T4
M\,0+H@X]\F+R%@^D-1[\*-X4&US*(X)TB@@0U9@6()35F!9 E"7' (3"C2
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M5>?@SGD4-N=4N/X%;?0#4$L#!!0    (  IZ/%67BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ "GH\5< K17AX!@
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MG[+^&,?#/XY?GFEOVN$Y/UO^/''S"U!+ 0(4 Q0    (  IZ/%4'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ "GH\5=!2A*#O    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ "GH\59E<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  *
M>CQ5QX8(?U8'   M,P  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ "GH\57;LP3LH"@  &38  !@
M         ("!F@\  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   (  IZ/%4%UW_UY 0  '\9   8              " @?@9  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  *>CQ5-HHH\S$(  "W)
M&               @($2'P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ "GH\56D/$6*" @  R 4  !@              ("!>2<  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (  IZ/%6>D>_ /P8
M +8I   8              " @3$J  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    "  *>CQ5S B+>)T(  "I)0  &               @(&F
M,   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ "GH\5=OK
M[0^/!P  T1   !@              ("!>3D  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    (  IZ/%60FS3Z@18  )$^   8
M  " @3Y!  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  *
M>CQ5\,I)L$\(  "$$P  &0              @('U5P  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (  IZ/%5TIB6*\@(  .X&   9
M          " @7M@  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#
M%     @ "GH\590^9C6W @  NP4  !D              ("!I&,  'AL+W=O
M<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  *>CQ55EZ@^X\#  "@
M!P  &0              @(&29@  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;%!+ 0(4 Q0    (  IZ/%4*6MNRTP<  "$2   9              " @5AJ
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ "GH\5>4J
M*6W)!   JPL  !D              ("!8G(  'AL+W=O<FMS:&5E=',O<VAE
M970Q-2YX;6Q02P$"% ,4    "  *>CQ5N7/LB2\&  "P#P  &0
M    @(%B=P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M  IZ/%50P_[1/ 0   \)   9              " @<A]  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ "GH\52,3YDW.!   #0H  !D
M             ("!.X(  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    "  *>CQ5UC.Q*_4*  ! &@  &0              @(% AP  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (  IZ/%52O%:D40,
M / &   9              " @6R2  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ "GH\59B"=0E]"   MQ(  !D              ("!
M])4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    "  *>CQ5
MEHXI.-D"  "V!@  &0              @(&HG@  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    (  IZ/%6AB>5'GP,  /@'   9
M      " @;BA  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ "GH\5=".+B2_!@  \ \  !D              ("!CJ4  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  *>CQ59/WP)1(%  "7"P
M&0              @(&$K   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    (  IZ/%7W(M]&J@,  *,(   9              " @<VQ  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ "GH\598C;%^H
M P  W@@  !D              ("!KK4  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    "  *>CQ55S+JW#H#  #2!@  &0
M@(&-N0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (  IZ
M/%5.KJ<G_!<  #Q*   9              " @?Z\  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ "GH\56>>IL#!!   70P  !D
M         ("!,=4  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    "  *>CQ57I$PBPH#   D!P  &0              @($IV@  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (  IZ/%6BQ1G)NP(  %\&
M   9              " @6K=  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ "GH\5<=C@<N( @  9 4  !D              ("!7.
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  *>CQ5UACS
MXC4#  "1!@  &0              @($;XP  >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    (  IZ/%4"@4-1DP0  *$+   9
M  " @8?F  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
M"GH\598?_>\<!   !0H  !D              ("!4>L  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    "  *>CQ5+0H3N!T#  #K!@  &0
M            @(&D[P  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    (  IZ/%7)@T@?KP0  /8)   9              " @?CR  !X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ "GH\5:R\*,,:!0
M*PP  !D              ("!WO<  'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    "  *>CQ5XZ%(IS@#  "<!@  &0              @($O
M_0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (  IZ/%4T
MYLO2#P4  !$,   9              " @9X  0!X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ "GH\5:#F5H0P P  6P<  !D
M     ("!Y 4! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
M"  *>CQ52SA([V@#  #R!P  &0              @(%+"0$ >&PO=V]R:W-H
M965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (  IZ/%4_.=_!AP,  '\(   9
M              " @>H, 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L!
M A0#%     @ "GH\52,.KF>  P  T@L  !D              ("!J! ! 'AL
M+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  *>CQ5W\_(6T\$
M  "*&P  &0              @(%?% $ >&PO=V]R:W-H965T<R]S:&5E=#0V
M+GAM;%!+ 0(4 Q0    (  IZ/%55,>CJU ,  +D0   9              "
M@>48 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ "GH\
M54R3.5>U!   4!,  !D              ("!\!P! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    "  *>CQ5@4"@1MX%  "4'@  &0
M        @('<(0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   (  IZ/%5.9/PT:@(  * %   9              " @?$G 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ "GH\53J*R_H  P  '0D
M !D              ("!DBH! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    "  *>CQ5Y9W"NIH"  ")!@  &0              @(')+0$
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (  IZ/%5RWQ"M
MVP(  -H(   9              " @9HP 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ "GH\55QDV*=_ @  3P8  !D
M ("!K#,! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    "  *
M>CQ5LREG.5 $  !8&   &0              @(%B-@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (  IZ/%68G,Q#S0(  )L(   9
M          " @>DZ 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#
M%     @ "GH\5<&' NY6 P   PP  !D              ("![3T! 'AL+W=O
M<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  *>CQ5=RUF,&L"  "
M!@  &0              @(%Z00$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM
M;%!+ 0(4 Q0    (  IZ/%6"61KV%0,  /X(   9              " @1Q$
M 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ "GH\56Y5
MU-0+ P  >P@  !D              ("!:$<! 'AL+W=O<FMS:&5E=',O<VAE
M970V,"YX;6Q02P$"% ,4    "  *>CQ5 ZYV@!L$  #"%@  &0
M    @(&J2@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    (
M  IZ/%5T@!V,'00  !$8   9              " @?Q. 0!X;"]W;W)K<VAE
M971S+W-H965T-C(N>&UL4$L! A0#%     @ "GH\5=UH^0<A P  E0@  !D
M             ("!4%,! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"
M% ,4    "  *>CQ5>^^?(W8#  !1#@  &0              @(&H5@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (  IZ/%40@U@^% <
M &(J   9              " @55: 0!X;"]W;W)K<VAE971S+W-H965T-C4N
M>&UL4$L! A0#%     @ "GH\50[7]IJN P  E0X  !D              ("!
MH&$! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    "  *>CQ5
MP/)U,WX&  #_,@  &0              @(&%90$ >&PO=V]R:W-H965T<R]S
M:&5E=#8W+GAM;%!+ 0(4 Q0    (  IZ/%5T\%<G^00   (9   9
M      " @3IL 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%
M  @ "GH\50X(#,B1 @  908  !D              ("!:G$! 'AL+W=O<FMS
M:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    "  *>CQ5%<P^XBX#  "I"@
M&0              @($R= $ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+
M 0(4 Q0    (  IZ/%6#DF2OJ ,  )D+   9              " @9=W 0!X
M;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ "GH\5>D"GA#:
M P  A@P  !D              ("!=GL! 'AL+W=O<FMS:&5E=',O<VAE970W
M,BYX;6Q02P$"% ,4    "  *>CQ5$::B&]T#  "D#0  &0
M@(&'?P$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    (  IZ
M/%7>3@F:J0,  $<+   9              " @9N# 0!X;"]W;W)K<VAE971S
M+W-H965T-S0N>&UL4$L! A0#%     @ "GH\58PI+L[B!0  _1$  !D
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M=#<Y+GAM;%!+ 0(4 Q0    (  IZ/%6J+M#*+P0  '<9   9
M  " @:>> 0!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @
M"GH\52_ZI4.C @  GP8  !D              ("!#:,! 'AL+W=O<FMS:&5E
M=',O<VAE970X,2YX;6Q02P$"% ,4    "  *>CQ50UU,8S8#  "=#   &0
M            @('GI0$ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4
M Q0    (  IZ/%5%^I8/@P,  !T.   9              " @52I 0!X;"]W
M;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ "GH\50+9H/ 1!0
M;1H  !D              ("!#JT! 'AL+W=O<FMS:&5E=',O<VAE970X-"YX
M;6Q02P$"% ,4    "  *>CQ5E@C@_H\%  !Q(0  &0              @(%6
ML@$ >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (  IZ/%5&
MK;&#>@(  #H&   9              " @1RX 0!X;"]W;W)K<VAE971S+W-H
M965T.#8N>&UL4$L! A0#%     @ "GH\51>,*%PY P  3A,   T
M     ( !S;H! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  *>CQ5EXJ[',
M   3 @  "P              @ $QO@$ 7W)E;',O+G)E;'-02P$"% ,4
M"  *>CQ5P"M%>'@&  #_.   #P              @ $:OP$ >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ "GH\55(UQJ.* @  N3(  !H
M ( !O\4! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M"GH\58/1K $N @  1#$  !,              ( !@<@! %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     %X 7@#)&0  X,H!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>209</ContextCount>
  <ElementCount>443</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>75</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - CONTRACT ASSETS AND LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ContractAssetsAndLiabilities</Role>
      <ShortName>CONTRACT ASSETS AND LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStock</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - ACQUISTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Acquistion</Role>
      <ShortName>ACQUISTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AllowanceForDoubtfulAccounts</Role>
      <ShortName>ALLOWANCE FOR DOUBTFUL ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/QuarterlyFinancialData</Role>
      <ShortName>QUARTERLY FINANCIAL DATA (UNAUDITED)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - CONTRACT ASSETS AND LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ContractAssetsAndLiabilitiesTables</Role>
      <ShortName>CONTRACT ASSETS AND LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/ContractAssetsAndLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipment</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesTables</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingFinancingLeases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterests</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - ACQUISTION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AcquistionTables</Role>
      <ShortName>ACQUISTION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Acquistion</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AllowanceForDoubtfulAccountsTables</Role>
      <ShortName>ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AllowanceForDoubtfulAccounts</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/QuarterlyFinancialDataTables</Role>
      <ShortName>QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/QuarterlyFinancialData</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details</Role>
      <ShortName>CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - CAPITAL STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStockDetailsNarrative</Role>
      <ShortName>CAPITAL STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CapitalStock</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE &amp; CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Components Of Provision For Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details</Role>
      <ShortName>INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/RelatedPartyTransactions</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformationTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails</Role>
      <ShortName>ACQUISTION - Fair value assets and assumed liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - ACQUISTION - Net assets acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails</Role>
      <ShortName>ACQUISTION - Net assets acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails</Role>
      <ShortName>ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details</Role>
      <ShortName>QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/QuarterlyFinancialDataTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="fonar_10-k.htm">fonar_10-k.htm</File>
    <File>fonar_exhibit-21.htm</File>
    <File>fonar_exhibit-23.htm</File>
    <File>fonar_exhibit-31.htm</File>
    <File>fonar_exhibit-32.htm</File>
    <File>fonr-20220630.xsd</File>
    <File>fonr-20220630_cal.xml</File>
    <File>fonr-20220630_def.xml</File>
    <File>fonr-20220630_lab.xml</File>
    <File>fonr-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar_chart.jpg</File>
    <File>fonar_logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="759">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="35">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>105
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fonar_10-k.htm": {
   "axisCustom": 0,
   "axisStandard": 20,
   "contextCount": 209,
   "dts": {
    "calculationLink": {
     "local": [
      "fonr-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fonar_10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fonr-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 648,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 40,
    "http://fonar.com/20220630": 51,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 95
   },
   "keyCustom": 115,
   "keyStandard": 328,
   "memberCustom": 32,
   "memberStandard": 37,
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://fonar.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - CONTRACT ASSETS AND LIABILITIES",
     "role": "http://fonar.com/role/ContractAssetsAndLiabilities",
     "shortName": "CONTRACT ASSETS AND LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - INVENTORIES",
     "role": "http://fonar.com/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://fonar.com/role/PropertyAndEquipment",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - OPERATING & FINANCING LEASES",
     "role": "http://fonar.com/role/OperatingFinancingLeases",
     "shortName": "OPERATING & FINANCING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - OTHER INTANGIBLE ASSETS",
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:CapitalStockAndOptionsDisclosureTextblock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - CAPITAL STOCK",
     "role": "http://fonar.com/role/CapitalStock",
     "shortName": "CAPITAL STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:CapitalStockAndOptionsDisclosureTextblock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS",
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - INCOME TAXES",
     "role": "http://fonar.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://fonar.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - OTHER CURRENT LIABILITIES",
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "shortName": "OTHER CURRENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://fonar.com/role/RelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - ACQUISTION",
     "role": "http://fonar.com/role/Acquistion",
     "shortName": "ACQUISTION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS",
     "role": "http://fonar.com/role/AllowanceForDoubtfulAccounts",
     "shortName": "ALLOWANCE FOR DOUBTFUL ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED)",
     "role": "http://fonar.com/role/QuarterlyFinancialData",
     "shortName": "QUARTERLY FINANCIAL DATA (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://fonar.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - CONTRACT ASSETS AND LIABILITIES (Tables)",
     "role": "http://fonar.com/role/ContractAssetsAndLiabilitiesTables",
     "shortName": "CONTRACT ASSETS AND LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - INVENTORIES (Tables)",
     "role": "http://fonar.com/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://fonar.com/role/PropertyAndEquipmentTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - OPERATING & FINANCING LEASES (Tables)",
     "role": "http://fonar.com/role/OperatingFinancingLeasesTables",
     "shortName": "OPERATING & FINANCING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://fonar.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - ACQUISTION (Tables)",
     "role": "http://fonar.com/role/AcquistionTables",
     "shortName": "ACQUISTION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)",
     "role": "http://fonar.com/role/AllowanceForDoubtfulAccountsTables",
     "shortName": "ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)",
     "role": "http://fonar.com/role/QuarterlyFinancialDataTables",
     "shortName": "QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2015-07-01_custom_ControllingInterestMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2015-07-01_custom_ControllingInterestMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-012022-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-012022-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:NetPatientFeeRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:NetPatientFeeRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:CostsIncurredOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)",
     "role": "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details",
     "shortName": "CONTRACT ASSETS AND LIABILITIES - Costs, Earnings, Billings, Uncompleted Contracts - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:CostsIncurredOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - INVENTORIES - Inventories (Details)",
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "shortName": "INVENTORIES - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)",
     "role": "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
     "shortName": "PROPERTY AND EQUIPMENT - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:DepreciatedAssetsWriteoff",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "role": "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:DepreciatedAssetsWriteoff",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30_custom_OperatingLeasePaymentsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "shortName": "OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30_custom_OperatingLeasePaymentsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - OPERATING & FINANCING LEASES - Weighted Average Remaining Lease Term (Details)",
     "role": "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails",
     "shortName": "OPERATING & FINANCING LEASES - Weighted Average Remaining Lease Term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)",
     "role": "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails",
     "shortName": "OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Components of lease expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30_custom_ClassANonVotingPreferredMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement -  CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30_custom_ClassANonVotingPreferredMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)",
     "role": "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails",
     "shortName": "OPERATING & FINANCING LEASES - Recent Accounting Pronouncements - Related to leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "shortName": "OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)",
     "role": "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
     "shortName": "OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)",
     "role": "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details",
     "shortName": "OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "FONR:AmountsCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "FONR:CapitalStockAndOptionsDisclosureTextblock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherSellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - CAPITAL STOCK (Details Narrative)",
     "role": "http://fonar.com/role/CapitalStockDetailsNarrative",
     "shortName": "CAPITAL STOCK (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "FONR:CapitalStockAndOptionsDisclosureTextblock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherSellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OpeningMembersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)",
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:OpeningMembersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-012022-06-30_custom_ControllingInterestMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "FONR:DirectPurchaseOfNoncontrollingInterests",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "decimals": "INF",
      "lang": null,
      "name": "FONR:PurchaseOfStandupMriCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)",
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE & CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)",
     "role": "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE & CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)",
     "role": "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Components Of Provision For Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)",
     "role": "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails",
     "shortName": "INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "role": "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
     "shortName": "INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-012022-06-30_custom_ABillingCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "role": "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-012022-06-30_custom_ABillingCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
     "shortName": "SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "FONR:IntersegmentNetRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignProductSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignProductSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignServiceAndRepairFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ForeignServiceAndRepairFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative",
     "shortName": "SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - ACQUISTION - Fair value assets and assumed liabilities (Details)",
     "role": "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
     "shortName": "ACQUISTION - Fair value assets and assumed liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000083 - Disclosure - ACQUISTION - Net assets acquired (Details)",
     "role": "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
     "shortName": "ACQUISTION - Net assets acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-03-29",
      "decimals": "0",
      "lang": null,
      "name": "FONR:ClosingCostsExpensed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_AccountsReceivableMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000084 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)",
     "role": "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails",
     "shortName": "ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2020-06-30_us-gaap_AccountsReceivableMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000085 - Disclosure - QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)",
     "role": "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
     "shortName": "QUARTERLY FINANCIAL DATA (UNAUDITED) - Unaudited Quarterly Financial Tables- (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2022-04-012022-06-30_custom_QuarterlyFinancialDataMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-09-30_us-gaap_SubsequentEventMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000086 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "AsOf2022-09-30_us-gaap_SubsequentEventMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtorInPossessionFinancingFeeOnUnusedBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-k.htm",
      "contextRef": "From2021-07-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 75,
   "tag": {
    "FONR_ABillingCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company or entity owned by related party.",
        "label": "A Billing Company [Member]"
       }
      }
     },
     "localname": "ABillingCompanyMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_AccountReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 related party"
       }
      }
     },
     "localname": "AccountReceivableRelatedParties",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term"
       }
      }
     },
     "localname": "AccountsReceivableNetLongTerm",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net of allowances for doubtful accounts of $204,597 and $442,270 at June 30, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableServiceAndRepairFees",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired assets and assumed liabilities"
       }
      }
     },
     "localname": "AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_AdditionalTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Taxes"
       }
      }
     },
     "localname": "AdditionalTaxes",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AllowanceForDoubtfulAccountsAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts Additions",
        "label": "Additions (Included in provision for bad debts)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsAdditions",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AllowanceForDoubtfulAccountsDeductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts Deductions",
        "label": "Deductions"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsDeductions",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AmountsCapitalized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts capitalized"
       }
      }
     },
     "localname": "AmountsCapitalized",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BasicAndDilutedIncomePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic And Diluted Income Per Share"
       }
      }
     },
     "localname": "BasicAndDilutedIncomePerShare",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "FONR_BensonhurstMRILimitedPartnershipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bensonhurst MRI Limited Partnership.",
        "label": "Bensonhurst M R I Limited Partnership [Member]"
       }
      }
     },
     "localname": "BensonhurstMRILimitedPartnershipMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_BillingsToDate": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 2.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount within current period that has been billed to customer.",
        "label": "Less: Billings to date"
       }
      }
     },
     "localname": "BillingsToDate",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BookValueOfBuilding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Book Value Of Building"
       }
      }
     },
     "localname": "BookValueOfBuilding",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BusinessCombinationContingentConsiderationAsset1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Consideration Paid"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset1",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BuyoutOfNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Buyout of noncontrolling interests"
       }
      }
     },
     "localname": "BuyoutOfNoncontrollingInterests",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_BuyoutOfNoncontrollingInterestsValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BuyoutOfNoncontrollingInterestsValue",
        "verboseLabel": "Buyout of noncontrolling interests"
       }
      }
     },
     "localname": "BuyoutOfNoncontrollingInterestsValue",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CapitalStockAndOptionsDisclosureTextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAPITAL STOCK"
       }
      }
     },
     "localname": "CapitalStockAndOptionsDisclosureTextblock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Class A Member havea 49.5% ownership interest of HDM.",
        "label": "Class A [Member]"
       }
      }
     },
     "localname": "ClassAMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassANonVotingPreferredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredStockMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Class B Member havea 50.5% ownership interest of HDM.",
        "label": "Class B [Member]"
       }
      }
     },
     "localname": "ClassBMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassCCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock [Member]"
       }
      }
     },
     "localname": "ClassCCommonStockMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClosingCostsExpensed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing costs - expensed"
       }
      }
     },
     "localname": "ClosingCostsExpensed",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance Managed Care Member",
        "label": "Commercial Insurance Managed Care [Member]"
       }
      }
     },
     "localname": "CommercialInsuranceManagedCareMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CompensatoryElementOfStockIssuances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensatory element of stock issuances"
       }
      }
     },
     "localname": "CompensatoryElementOfStockIssuances",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ConsiderationForNoncompetitionAndConsultingAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration For Noncompetition And Consulting Agreements"
       }
      }
     },
     "localname": "ConsiderationForNoncompetitionAndConsultingAgreements",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ConsiderationToOutsideInvestors": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration To Outside Investors"
       }
      }
     },
     "localname": "ConsiderationToOutsideInvestors",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ContractualFeesForServicesRenderedMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum contractual fees for services rendered to the PC's.",
        "label": "Contractual Fees For Services Rendered Maximum"
       }
      }
     },
     "localname": "ContractualFeesForServicesRenderedMaximum",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ContractualFeesForServicesRenderedMinimum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum contractual fees for services rendered to the PC's.",
        "label": "Contractual Fees For Services Rendered Minimum"
       }
      }
     },
     "localname": "ContractualFeesForServicesRenderedMinimum",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ControllingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Controlling Interest [Member]"
       }
      }
     },
     "localname": "ControllingInterestMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
        "totalLabel": "Costs and estimated earnings in excess of billings on uncompleted contracts"
       }
      }
     },
     "localname": "CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsAndEstimatedEarningsOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 1.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsInExcessOfBillingsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs and estimated earnings on uncompleted contracts in excess of billings means the current asset as of the closing date, as properly recorded on seller's balance sheet in accordance with GAAP, representing the amount, in the aggregate, earned on contracts but not yet invoiced to customers, as determined in accordance with GAAP.",
        "label": "CostsAndEstimatedEarningsOnUncompletedContracts",
        "totalLabel": "Costs and estimated earnings on uncompleted contracts"
       }
      }
     },
     "localname": "CostsAndEstimatedEarningsOnUncompletedContracts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsIncurredOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 1.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred on uncompleted contracts.",
        "label": "Costs incurred on uncompleted contracts"
       }
      }
     },
     "localname": "CostsIncurredOnUncompletedContracts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFees",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related party medical practices"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToProductSales": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "localname": "CostsRelatedToProductSales",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFees",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees \u2013 related parties"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CovenantNotToCompeteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Covenant Not To Compete [Member]"
       }
      }
     },
     "localname": "CovenantNotToCompeteMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CustomerAdvancesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Advances"
       }
      }
     },
     "localname": "CustomerAdvancesPolicyTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_CustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDeposits",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DepreciatedAssetsWriteoff": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciated assets write-off"
       }
      }
     },
     "localname": "DepreciatedAssetsWriteoff",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DepreciationOfLeasedEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of leased equipment"
       }
      }
     },
     "localname": "DepreciationOfLeasedEquipment",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DiagnosticEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MRI Diagnostic Equipment",
        "label": "Diagnostic Equipment [Member]"
       }
      }
     },
     "localname": "DiagnosticEquipmentMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_DiagnosticImagingFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Imaging Facility Member",
        "label": "Diagnostic Imaging Facility [Member]"
       }
      }
     },
     "localname": "DiagnosticImagingFacilityMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct purchase of Noncontrolling Interests"
       }
      }
     },
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DisclosureCapitalStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock"
       }
      }
     },
     "localname": "DisclosureCapitalStockAbstract",
     "nsuri": "http://fonar.com/20220630",
     "xbrltype": "stringItemType"
    },
    "FONR_DisclosureOperatingFinancingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Financing Leases",
        "terseLabel": "Operating Financing Leases - Recent Accounting Pronouncements - Components Of Lease Expense",
        "verboseLabel": "Operating Financing Leases - Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "DisclosureOperatingFinancingLeasesAbstract",
     "nsuri": "http://fonar.com/20220630",
     "xbrltype": "stringItemType"
    },
    "FONR_Distributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions to each class of members equity as of June 30.",
        "label": "Distributions"
       }
      }
     },
     "localname": "Distributions",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NYS Audit Settlement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNysAuditSettlement",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_EndingMembersEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ending Members Equity for each class of members equity as of June 30.",
        "label": "Ending Members Equity"
       }
      }
     },
     "localname": "EndingMembersEquity",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_EstimatedEarnings": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details": {
       "order": 2.0,
       "parentTag": "FONR_CostsAndEstimatedEarningsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Earnings on uncompleted contracts.",
        "label": "Estimated earnings"
       }
      }
     },
     "localname": "EstimatedEarnings",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilities-CostsEarningsBillingsUncompletedContracts-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Useful Life in Years for Property and Equipment"
       }
      }
     },
     "localname": "EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ExportProductSalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of export product sales"
       }
      }
     },
     "localname": "ExportProductSalesTableTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ExportSalesOfMedicalEquipmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Export Sales Of Medical Equipment Percentage"
       }
      }
     },
     "localname": "ExportSalesOfMedicalEquipmentPercentage",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ExportServiceRevenuesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of foreign service and repair fees"
       }
      }
     },
     "localname": "ExportServiceRevenuesTableTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_FinanceLeaseCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_FinanceLeaseCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease cost:"
       }
      }
     },
     "localname": "FinanceLeaseCostsAbstract",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_FinancingCashFlowsFromFinancingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing cash flows from financing leases"
       }
      }
     },
     "localname": "FinancingCashFlowsFromFinancingLeases",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_FinancingLeasePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "localname": "FinancingLeasePaymentsMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ForeignProductSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Product Sales",
        "label": "Foreign Product Sales"
       }
      }
     },
     "localname": "ForeignProductSales",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Revenues Of Service And Repair Of Medical Equipment Percentage"
       }
      }
     },
     "localname": "ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ForeignServiceAndRepairFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Service And Repair Fees",
        "label": "Foreign Service and Repair fees"
       }
      }
     },
     "localname": "ForeignServiceAndRepairFees",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_GainOnForgivenessOfPppLoan": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnForgivenessOfPppLoan",
        "negatedLabel": "Gain on forgiveness of PPP loan"
       }
      }
     },
     "localname": "GainOnForgivenessOfPppLoan",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_HDMEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HDM Equity Member",
        "label": "H D M Equity [Member]"
       }
      }
     },
     "localname": "HDMEquityMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_HDMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "H D M [Member]"
       }
      }
     },
     "localname": "HDMMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "HmcaOwnershipSizeOfImperialManagementServicesPercent",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_IncreaseDecreaseInContractLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInContractLiabilities",
        "verboseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractLiabilities",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer advances"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInFinancingLiabilities",
        "negatedLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares included upon conversion of Class C Common to calculate a diluted EPS"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfCommonStock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_IntersegmentNetRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intersegment net revenues are the transfer or exchange of goods for monetary compensation between the management and diagnostic imaging center segment and the manufacturing and service segment.",
        "label": "Intersegment net revenues"
       }
      }
     },
     "localname": "IntersegmentNetRevenues",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_InvestorsOwnershipInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors ownership interest percentage"
       }
      }
     },
     "localname": "InvestorsOwnershipInterest",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_LesseeOperatingLeaseLiabilityMaturityTableTextBlockc": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of operating and financing lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlockc",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_LitigationSettelementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Settelement Description"
       }
      }
     },
     "localname": "LitigationSettelementDescription",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_ManagedFacilitiesAddedAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Acquisition"
       }
      }
     },
     "localname": "ManagedFacilitiesAddedAcquisition",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_ManagedFacilitiesAddedByInternalDevelopment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Internal development"
       }
      }
     },
     "localname": "ManagedFacilitiesAddedByInternalDevelopment",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_ManagedFacilitiesClosedDuringYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Managed Facilities Closed"
       }
      }
     },
     "localname": "ManagedFacilitiesClosedDuringYear",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_ManagementAgreementsWithCompanyTotalMedicalPractices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Imaging Centers with management agreements with Company.",
        "label": "Management Agreements With Company Total Medical Practices"
       }
      }
     },
     "localname": "ManagementAgreementsWithCompanyTotalMedicalPractices",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "FONR_ManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net of allowances for doubtful accounts of $16,627,917 and $15,786,878 at June 30, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "ManagementAndOtherFees",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesNet",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable [Member]"
       }
      }
     },
     "localname": "ManagementAndOtherFeesReceivableMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable Related Medical Practices [Member]"
       }
      }
     },
     "localname": "ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 related party medical practices \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other receivable allowances for doubtful accounts"
       }
      }
     },
     "localname": "ManagementAndOtherReceivableAllowancesForDoubtfulAccounts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management Of Diagnostic Imaging Centers",
        "label": "Management Of Diagnostic Imaging Centers [Member]"
       }
      }
     },
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related party medical practices \u2013 net of allowances for doubtful accounts of $4,686,893 and $4,184,399 at June 30, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManufacturingAndServicingOfMedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing And Servicing Of Medical Equipment",
        "label": "Manufacturing And Servicing Of Medical Equipment [Member]"
       }
      }
     },
     "localname": "ManufacturingAndServicingOfMedicalEquipmentMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_MaturityDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date"
       }
      }
     },
     "localname": "MaturityDate",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_MedicalReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivables \u2013 net"
       }
      }
     },
     "localname": "MedicalReceivable",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicareMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Medicaid",
        "label": "Medicare Medicaid [Member]"
       }
      }
     },
     "localname": "MedicareMedicaidMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_N2010StockBonusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "N 2010 Stock Bonus Plan [Member]"
       }
      }
     },
     "localname": "N2010StockBonusPlanMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Management Fee Receivables From Related Party Medical Practices [Member]"
       }
      }
     },
     "localname": "NetManagementFeeReceivablesFromRelatedPartyMedicalPracticesMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetPatientFeeRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Patient Fee Revenue"
       }
      }
     },
     "localname": "NetPatientFeeRevenue",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_NotePayable1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt, notes payable and capital leases",
        "label": "Note Payable 1 [Member]"
       }
      }
     },
     "localname": "NotePayable1Member",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NotePayable2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable 2 [Member]"
       }
      }
     },
     "localname": "NotePayable2Member",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NotePayable3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable 3 [Member]"
       }
      }
     },
     "localname": "NotePayable3Member",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NumberOfInstallment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of installment"
       }
      }
     },
     "localname": "NumberOfInstallment",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.",
        "label": "Diluted EPS"
       }
      }
     },
     "localname": "NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_OpeningMembersEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opening Members Equity for each class of members equity as of June 30.",
        "label": "Opening Members Equity"
       }
      }
     },
     "localname": "OpeningMembersEquity",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OperatingCashFlowsFromOperatingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingCashFlowsFromOperatingLeases",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OperatingLeasePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "localname": "OperatingLeasePaymentsMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OtherRevenueSourceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Revenue Source",
        "label": "Other Revenue Source [Member]"
       }
      }
     },
     "localname": "OtherRevenueSourceMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OutsideInvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outside Investors [Member]"
       }
      }
     },
     "localname": "OutsideInvestorsMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_OwnershipInterestOfOriginalInvestorsOfHdm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of the original investors of HDM"
       }
      }
     },
     "localname": "OwnershipInterestOfOriginalInvestorsOfHdm",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_OwnershipPercentageAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership Percentage Acquired"
       }
      }
     },
     "localname": "OwnershipPercentageAcquired",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue, net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PaymentsOnNotesReceivableFromEmployeeStockholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments on notes receivable from employee stockholders"
       }
      }
     },
     "localname": "PaymentsOnNotesReceivableFromEmployeeStockholders",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of consolidated net revenue from management fees.",
        "label": "Consolidated net revenues percentage"
       }
      }
     },
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims.",
        "label": "Percentage of PCs net revenues"
       }
      }
     },
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PresentValueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Present Value discount, Operating Lease"
       }
      }
     },
     "localname": "PresentValueDiscount",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Present Value discount, Financing Lease"
       }
      }
     },
     "localname": "PresentValueDiscountFinancingLease",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProductSalesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net"
       }
      }
     },
     "localname": "ProductSalesNet",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PropertyTaxAbatement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017",
        "label": "Property Tax Abatement"
       }
      }
     },
     "localname": "PropertyTaxAbatement",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PropertyTaxAbatementFromSuffolkCountyIda": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company has received preliminary approval from the Suffolk County IDA on August 27, 2015 of a 50% property tax abatement, valued at $440,000, over a 10 year period commencing January 2017",
        "label": "Property Tax Abatement From Suffolk County IDA"
       }
      }
     },
     "localname": "PropertyTaxAbatementFromSuffolkCountyIda",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_ProvisionForBadDebts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForBadDebts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right to use assets"
       }
      }
     },
     "localname": "PublicUtilitiesPropertyRightToUseAssetsAmountOfAcquisitionAdjustments1",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right to use liability"
       }
      }
     },
     "localname": "PublicUtilitiesPropertyRightToUseLiabilityAmountOfAcquisitionAdjustments1",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfImagingCenter": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchaseOfImagingCenter",
        "negatedLabel": "Purchase of imaging center"
       }
      }
     },
     "localname": "PurchaseOfImagingCenter",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfNoncontrollingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchaseOfNoncontrollingInterests",
        "negatedLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "PurchaseOfNoncontrollingInterests",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfOtherMriCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Of Other Mri Centers"
       }
      }
     },
     "localname": "PurchaseOfOtherMriCenters",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_PurchaseOfStandupMriCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Of Standup Mri Centers"
       }
      }
     },
     "localname": "PurchaseOfStandupMriCenters",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_QuarterlyFinancialDataMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Member]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party receivable allowances for doubtful accounts"
       }
      }
     },
     "localname": "RelatedPartyReceivableAllowancesForDoubtfulAccounts",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ResearchDeveopmentAndDemonstrationEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research Deveopment And Demonstration Equipment",
        "label": "Research Deveopment And Demonstration Equipment [Member]"
       }
      }
     },
     "localname": "ResearchDeveopmentAndDemonstrationEquipmentMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases"
       }
      }
     },
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use &amp; equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-RelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_RocklandManagementGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rockland Management Group [Member]"
       }
      }
     },
     "localname": "RocklandManagementGroupMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of management agreements with PC's owned by a relarted party.",
        "label": "Scanners With Management Agreements With Company Owned By Related Party"
       }
      }
     },
     "localname": "ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of management agreements with PC's owned by two unrelated radiologists.",
        "label": "Scanners With Management With Company Located In New York State"
       }
      }
     },
     "localname": "ScannersWithManagementWithCompanyLocatedInNewYorkState",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_SellingGeneralAndAdministrativeExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpenses",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesNet",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 related parties \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ShareOfNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Of Net Income for each class of members equity as of June 30.",
        "label": "Share of Net Income"
       }
      }
     },
     "localname": "ShareOfNetIncome",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_SharesRegistered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares registered"
       }
      }
     },
     "localname": "SharesRegistered",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_ShippingAndHandlingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to shipping and handling expense for the period, which are expenses incurred with the objective of delivery of Fonar's products to its customers.",
        "label": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "ShippingAndHandlingExpense",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ShippingsAndHandlingCostPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shipping Costs"
       }
      }
     },
     "localname": "ShippingsAndHandlingCostPolicyTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_SoftwareOrPatentsWrittenOff": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Software or patents written off"
       }
      }
     },
     "localname": "SoftwareOrPatentsWrittenOff",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StockIssuedToEmployeesUnderStockBonusPlansValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued to employees under stock bonus plans"
       }
      }
     },
     "localname": "StockIssuedToEmployeesUnderStockBonusPlansValue",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. The reserves are included in Other current liabilities' in the consolidated balance sheets.",
        "label": "Liability for individual claims"
       }
      }
     },
     "localname": "StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Total Facilities Owned or Managed (at Beginning of Year)"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.",
        "label": "Total Facilities Owned or Managed (at End of Year)"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedAtEndOfYear",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of total facilities"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_TotalPurchasePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Purchase Price"
       }
      }
     },
     "localname": "TotalPurchasePrice",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_WeightedAverageBasicAndDilutedSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Basic and Diluted Shares Outstanding"
       }
      }
     },
     "localname": "WeightedAverageBasicAndDilutedSharesOutstanding",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Denominator for Diluted Earnings Per Share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_WeightedAverageSharesOutstandingBasic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Denominator: Weighted Average Shares Outstanding"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingBasic",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers Compensation Personal Injury",
        "label": "Workers Compensation Personal Injury [Member]"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjuryMember",
     "nsuri": "http://fonar.com/20220630",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "domainItemType"
    },
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_DO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DOMINICAN REPUBLIC"
       }
      }
     },
     "localname": "DO",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GREECE"
       }
      }
     },
     "localname": "GR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r580",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r580",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r580",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r580",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r263",
      "r285",
      "r312",
      "r314",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r535",
      "r537",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r263",
      "r285",
      "r312",
      "r314",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r535",
      "r537",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r236",
      "r241",
      "r242",
      "r243",
      "r244",
      "r263",
      "r285",
      "r309",
      "r312",
      "r314",
      "r337",
      "r338",
      "r339",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r535",
      "r537",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r236",
      "r241",
      "r242",
      "r243",
      "r244",
      "r263",
      "r285",
      "r309",
      "r312",
      "r314",
      "r337",
      "r338",
      "r339",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r535",
      "r537",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "ALLOWANCE FOR DOUBTFUL ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r190",
      "r191",
      "r300",
      "r303",
      "r536",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r587",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r190",
      "r191",
      "r300",
      "r303",
      "r536",
      "r551",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r472",
      "r474",
      "r477",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance.",
        "label": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.",
        "label": "Due to related party medical practices"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "auth_ref": [
      "r480"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.",
        "label": "Total"
       }
      }
     },
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Legal and other professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r505",
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accounting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r6",
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued salaries, commissions and payroll taxes"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r13",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Less: Accumulated depreciation and amortization of property and equipment"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Paid-in capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r342",
      "r343",
      "r344",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r87",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r196",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Summary of Allowance For Doubtful Accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.",
        "label": "Allowance for Doubtful Accounts Receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r30",
      "r197",
      "r204",
      "r205",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r87",
      "r218",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r17",
      "r104",
      "r173",
      "r178",
      "r185",
      "r202",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r404",
      "r412",
      "r426",
      "r466",
      "r468",
      "r500",
      "r520"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r38",
      "r104",
      "r202",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r404",
      "r412",
      "r426",
      "r466",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r3",
      "r545",
      "r548",
      "r549",
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Total identifiable assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r311",
      "r313",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r311",
      "r313",
      "r382",
      "r383",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r393",
      "r394",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r387",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "ACQUISTION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r112",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r11",
      "r468",
      "r546",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r89",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS - END OF YEAR",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r427"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r102",
      "r104",
      "r129",
      "r130",
      "r137",
      "r140",
      "r142",
      "r151",
      "r152",
      "r153",
      "r202",
      "r249",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r426",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r245",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r159",
      "r160",
      "r193",
      "r424",
      "r425",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r193",
      "r424",
      "r425",
      "r544",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r156",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r159",
      "r160",
      "r193",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r410",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractReceivableDueFourToFiveYears": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "ContractReceivableDueFourToFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "ContractReceivableDueThreeToFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "ContractReceivableDueTwoToThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r298",
      "r299",
      "r301"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfPropertyRepairsAndMaintenance": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.",
        "label": "Cost of Property Repairs and Maintenance"
       }
      }
     },
     "localname": "CostOfPropertyRepairsAndMaintenance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Total Costs and Expenses",
        "totalLabel": "Total Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-term contract or program.",
        "label": "Schedule of costs and estimated earnings on uncompleted contracts"
       }
      }
     },
     "localname": "CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current:"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r365",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r365",
      "r372",
      "r374"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r365",
      "r372"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerListsMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.",
        "label": "Customer Lists [Member]"
       }
      }
     },
     "localname": "CustomerListsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": {
     "auth_ref": [
      "r282",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
        "label": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES"
       }
      }
     },
     "localname": "DebtAndCapitalLeasesDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r45",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r44",
      "r273",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r45",
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r103",
      "r108",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r289",
      "r290",
      "r291",
      "r292",
      "r436",
      "r437",
      "r439",
      "r440",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtorInPossessionFinancingFeeOnUnusedBorrowings": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fee on unused borrowings under debtor-in-possession financing arrangement.",
        "label": "Debtor-in-Possession Financing, Fee on Unused Borrowings"
       }
      }
     },
     "localname": "DebtorInPossessionFinancingFeeOnUnusedBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r366",
      "r372"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal deferred taxes"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred:"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r105",
      "r366",
      "r372",
      "r373",
      "r374"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred income tax - net",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r366",
      "r372"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State deferred taxes"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred Tax Assets - gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Non-deductible accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Property and equipment and depreciation"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r362",
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r362",
      "r363",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r351",
      "r359"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.",
        "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization.",
        "label": "Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital"
       }
      }
     },
     "localname": "DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r87",
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r87",
      "r171"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Patient Fee Revenue - Net"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableNature": {
     "auth_ref": [
      "r93",
      "r94",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.",
        "label": "Dividends Payable, Nature"
       }
      }
     },
     "localname": "DividendsPayableNature",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r126",
      "r129",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r420",
      "r421",
      "r511",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r129",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r420",
      "r421",
      "r511",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Income per Common Share",
        "verboseLabel": "Diluted Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r106",
      "r353",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Taxes at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r353",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Change in the valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r353",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "negatedLabel": "Non Controlling interest"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r353",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Return to provision adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r353",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Expiration of tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r353",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State and local income taxes (benefit), net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).",
        "label": "Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r125",
      "r150",
      "r203",
      "r288",
      "r294",
      "r342",
      "r343",
      "r344",
      "r368",
      "r369",
      "r419",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r457",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Direct ownership interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r445",
      "r446",
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r444"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Financing lease liability \u2013 current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r444"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Financing lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "verboseLabel": "Total lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Right-of-use-asset \u2013 financing lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r449",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r448",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r15",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r219",
      "r221",
      "r225",
      "r228",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r225",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Other intangible assets - gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r14",
      "r210",
      "r211",
      "r212",
      "r215",
      "r468",
      "r498"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r214",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r213",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r211",
      "r212",
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r67",
      "r88",
      "r118",
      "r119",
      "r120",
      "r121",
      "r138",
      "r142",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "(Loss) Income from operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r173",
      "r177",
      "r181",
      "r184",
      "r187",
      "r497",
      "r508",
      "r513",
      "r531"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes and noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "totalLabel": "Income from Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r59",
      "r64",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r129",
      "r140",
      "r141",
      "r421",
      "r507",
      "r509",
      "r511",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Income Per Common Share"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r59",
      "r64",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r129",
      "r140",
      "r141",
      "r142",
      "r421",
      "r511",
      "r526",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r234",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxCreditsAndAdjustments": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.",
        "label": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxCreditsAndAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r354",
      "r355",
      "r361",
      "r370",
      "r376",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r124",
      "r125",
      "r172",
      "r352",
      "r371",
      "r378",
      "r532"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for Income Taxes",
        "totalLabel": "Provision (Benefit) for Income Taxes - Net"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r55",
      "r349",
      "r350",
      "r355",
      "r356",
      "r360",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r84",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts, medical and management fee receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInCommodityContractAssetsAndLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the assets (liabilities) created through trading commodity-based derivative instruments.",
        "label": "Increase (Decrease) in Commodity Contract Assets and Liabilities",
        "negatedLabel": "Contract assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInCommodityContractAssetsAndLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).",
        "label": "Increase (Decrease) in Intangible Assets, Current",
        "negatedLabel": "Abandoned patents"
       }
      }
     },
     "localname": "IncreaseDecreaseInIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Notes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r135",
      "r136",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r217",
      "r223"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r60",
      "r170",
      "r435",
      "r438",
      "r512"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.",
        "label": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessPolicy": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).",
        "label": "Inventory Work in Process, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryWorkInProcessPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r72",
      "r73"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r201",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Short Term Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Stock issued for costs and expenses"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Components of lease expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails",
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "OPERATING &amp; FINANCING LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r41",
      "r104",
      "r179",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r405",
      "r412",
      "r413",
      "r426",
      "r466",
      "r467"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r104",
      "r202",
      "r426",
      "r468",
      "r502",
      "r523"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r43",
      "r104",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r405",
      "r412",
      "r413",
      "r426",
      "r466",
      "r467",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r19",
      "r20",
      "r104",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r405",
      "r412",
      "r413",
      "r426",
      "r466",
      "r467"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Long-Term Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth": {
     "auth_ref": [
      "r533",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term debt and capital leases, less current portion",
        "verboseLabel": "Long Term Debt, Notes Payable and Capital Leases less Current Portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Current portion of long-term debt and capital leases",
        "verboseLabel": "Current portion of Long Term Debt, Notes Payable and Capital Leases"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Repayments of Principal in Next 12 Months",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt, Notes Payable and Capital Leases"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r104",
      "r202",
      "r249",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r426",
      "r501",
      "r522"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "CONTROLLING AND NONCONTROLLING INTERESTS"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r51",
      "r68",
      "r401",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r85",
      "r88"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r53",
      "r54",
      "r58",
      "r63",
      "r88",
      "r104",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r138",
      "r173",
      "r177",
      "r181",
      "r184",
      "r187",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r421",
      "r426",
      "r510",
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income - Attributable to FONAR"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r54",
      "r58",
      "r124",
      "r125",
      "r408",
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net Income \u2013 Noncontrolling Interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r121",
      "r126",
      "r127",
      "r139",
      "r142",
      "r173",
      "r177",
      "r181",
      "r184",
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income Available to Common\u00a0Stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r128",
      "r131",
      "r132",
      "r133",
      "r134",
      "r139",
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Basic Numerator: Net Income Available to Common Stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r294",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r173",
      "r177",
      "r181",
      "r184",
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r447",
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RecentAccountingPronouncements-ComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r444"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liability \u2013 current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r444"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use-asset \u2013 operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization on right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r449",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r448",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Litigation accruals"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Accrued interest and penalty"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r16",
      "r499",
      "r519"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Costs related to patient fee revenue"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r70",
      "r87",
      "r230"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and (Expenses):"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other intangible assets - net",
        "periodEndLabel": "Balance - End of Year",
        "periodStartLabel": "Balance - Beginning of Year"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventorySupplies": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.",
        "label": "Purchased parts, components and supplies"
       }
      }
     },
     "localname": "OtherInventorySupplies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncome": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Operating Income"
       }
      }
     },
     "localname": "OtherOperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOwnershipInterestsByNameAxis": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by ownership interests about other units or shares or classes of ownership in a partnership. Excludes limited or general partners' ownership interests.",
        "label": "Other Ownership Interests Name [Axis]"
       }
      }
     },
     "localname": "OtherOwnershipInterestsByNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOwnershipInterestsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the ownership interest, which details special or unusual rights. Does not include limited or general partners' ownership interests."
       }
      }
     },
     "localname": "OtherOwnershipInterestsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expense classified as other.",
        "label": "Other Selling, General and Administrative Expense"
       }
      }
     },
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromShortTermInvestments": {
     "auth_ref": [
      "r75",
      "r76",
      "r90"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments for (Proceeds from) Short-Term Investments",
        "negatedLabel": "Proceeds of Short term investment"
       }
      }
     },
     "localname": "PaymentsForProceedsFromShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Cost of patents"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r77",
      "r396",
      "r397",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class A [Member]"
       }
      }
     },
     "localname": "PreferredClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r78",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesLong-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r53",
      "r54",
      "r58",
      "r82",
      "r104",
      "r116",
      "r124",
      "r125",
      "r173",
      "r177",
      "r181",
      "r184",
      "r187",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r403",
      "r407",
      "r409",
      "r415",
      "r416",
      "r421",
      "r426",
      "r513"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net Income",
        "verboseLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r235",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r12",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and Equipment Before Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r233",
      "r468",
      "r514",
      "r524"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment \u2013 net",
        "verboseLabel": "Property and Equipment AfterAccumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r233",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition adjustments included in property, plant and equipment (PPE) for utilities.",
        "label": "Property and equipment"
       }
      }
     },
     "localname": "PublicUtilitiesPropertyPlantAndEquipmentAmountOfAcquisitionAdjustments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "QUARTERLY FINANCIAL DATA (UNAUDITED)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/QuarterlyFinancialData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "class a and b members' equity (hdm acquisition)"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RegulatedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Regulated Operations [Abstract]"
       }
      }
     },
     "localname": "RegulatedOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r310",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "auth_ref": [
      "r20",
      "r441",
      "r452",
      "r455",
      "r456",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.",
        "label": "Related Party Transaction, Description of Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r310",
      "r460",
      "r462",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r458",
      "r459",
      "r461",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of borrowings and capital lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r348",
      "r481",
      "r568"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r294",
      "r468",
      "r521",
      "r541",
      "r542"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r125",
      "r203",
      "r342",
      "r343",
      "r344",
      "r368",
      "r369",
      "r419",
      "r538",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r61",
      "r104",
      "r168",
      "r169",
      "r176",
      "r182",
      "r183",
      "r189",
      "r190",
      "r193",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r426",
      "r513"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Total Revenues - Net",
        "totalLabel": "Total Revenues \u2013 Net",
        "verboseLabel": "Total Revenues \u2013 Net"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales tax payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r159",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r382",
      "r383",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Components Of The Provision For Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "auth_ref": [
      "r195",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.",
        "label": "Receivables - Non Current - net"
       }
      }
     },
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Long-term debt, notes payable and capital leases"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Components Of Company\u2019s Deferred Tax Assets And Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Fair value assets and assumed liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AcquistionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Reconciliation Of Federal Statutory Income Tax Rate To Company\u2019s Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r219",
      "r224",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ForwardLookingScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "verboseLabel": "Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of other intangible assets - net"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r7",
      "r33",
      "r34",
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Maturities Of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Net assets acquired"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AcquistionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/QuarterlyFinancialDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for detailed information about regulatory assets and liabilities, including current and noncurrent assets created when regulatory agencies permit the deferral of costs to the balance sheet that would otherwise be required to appear on the company's income statement and would be charged against current expenses or revenues, as well as current and noncurrent liabilities created when regulatory agencies permit.",
        "label": "CONTRACT ASSETS AND LIABILITIES"
       }
      }
     },
     "localname": "ScheduleOfRegulatoryAssetsAndLiabilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ContractAssetsAndLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r61",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r173",
      "r174",
      "r180",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of summarized segment financial information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule Of Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Acquistion-FairValueAssetsAndAssumedLiabilitiesDetails",
      "http://fonar.com/role/Acquistion-NetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r173",
      "r175",
      "r181",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r192",
      "r193",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "SEGMENT AND RELATED INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self-funded health insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative, inclusive of compensatory element of stock issuances of $0 and $83,277 for the years ended June 30, 2022 and 2021 respectively"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r37",
      "r503",
      "r504",
      "r518"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r98",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r102",
      "r104",
      "r129",
      "r130",
      "r137",
      "r140",
      "r142",
      "r151",
      "r152",
      "r153",
      "r202",
      "r249",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r426",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r49",
      "r56",
      "r57",
      "r58",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r125",
      "r150",
      "r203",
      "r288",
      "r294",
      "r342",
      "r343",
      "r344",
      "r368",
      "r369",
      "r419",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r457",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r150",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/QuarterlyFinancialData-UnauditedQuarterlyFinancialTables-Details",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock issued to employees under stock bonus plans, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r288",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Value, Employee Benefit Plan",
        "verboseLabel": "Compensatory element of stock issuances"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r294",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock repurchase plan"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r27",
      "r28",
      "r104",
      "r198",
      "r202",
      "r426",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r57",
      "r104",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r202",
      "r203",
      "r294",
      "r342",
      "r343",
      "r344",
      "r368",
      "r369",
      "r400",
      "r401",
      "r414",
      "r419",
      "r426",
      "r428",
      "r429",
      "r433",
      "r457",
      "r539",
      "r540"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Total Stockholders\u2019 Equity",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.",
        "label": "Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share"
       }
      }
     },
     "localname": "StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r434",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r434",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r434",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r434",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r469",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "State income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r48",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r48",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r48",
      "r296",
      "r297"
     ],
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost \u2013 11,643 shares of common stock at June 30, 2022 and 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r154",
      "r155",
      "r157",
      "r158",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r109",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r128",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r126",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "https://asc.fasb.org/topic&trid=2126967"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21550-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "https://asc.fasb.org/topic&trid=2208923"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918703-209980"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919784-209982"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=SL2890576-112764"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r569": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r570": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r571": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r572": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r573": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r574": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r575": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r576": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r577": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r578": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r579": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r580": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r581": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r582": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r583": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r584": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r585": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r586": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r587": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r588": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r589": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227"
  },
  "r590": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r591": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r592": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r593": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r594": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r595": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r596": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r597": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r598": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r599": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r600": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>106
<FILENAME>0000355019-22-000042-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-22-000042-xbrl.zip
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MHT4#N '0<Z3#F9(/WW2I+C=;!H9'8L.%%'=R)HN\3<+*;(]OV4<G'[OMA+X
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MV7TZD)A>AV<N8WPH**HIK5VN%BLD>Q\O*",*LLE]DJIQS@4N1U8V69U(AO-
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M/9L^>G>L-UL;.M 0 56-@1;!Q*[_8))+%IHTD!F@= :V,F&ZHF6SWTLIT8I
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M_E9)-E+JX2=TL;TBP_4PE?L4(Y7CU*W8]EE1QD2D 8MC/CF+TZ<!T>0OP-@
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MNYB**V$3#U\S)X*;7&49D>R46*&U*]&&!J:L/9R923U0:$#)F%FU*FHM9Z@
M;+E"93 <%[98]&HPJA+!P?GIQ='U";*0(B]G6>(A*;X(&$6<Q8<K.A"D5-G,
M4L50J<Y+R)%XLMZFH*[U9@ @RN>:8*B6=4H]91^<#)C$*Z5CI*37BT=MR2IN
M3'I=+Z9<N"S*:75%A5NO6Z=8JT.Q,L&T2/W"+/!$_?=TQ!;:L>7L\*D;*H@9
M8F7.6-6HOJ/"8=K<F5E4FWW578 H #-%U$9@?I'7I= P/058U-8OZQ:WF&)%
M)::B(\AQJ0U#5N;-Z@C;3SI]V3ZIV>?N O7UG5_P+3YG1JD9Z1IG^FE9$7QC
MFXFQU<9 ;DQ12:RM&DSBOS1I]7LXE6XHS4^Y0S/V1C89P[T@UHA+N28C<3:+
M[,6;&^N#KWY3WZS]\K;0=.MZ "[9_@T=ORK^1TWAZ*1#V6DK5N?# 6SX?'T/
MS^1$-B"0<)6]#=BZD[U)1J!CH"G7#B89 V-C?[+SD-]&Y0FQCS*WC.,"['R1
M9*'N/J?S*^3 L6>^,J-XNK[Z@Q<^'G/1 TRA]7/[1'=J=84O545A'@O_1S95
MB^5:@#@<Y18P)WTCUD$DH0)LY ..J<G(QK8,W(T%; K6#V+0;^]OYSY_NVY]
MY2JZO(^<*2!O%3?O5>N0\\$N0' 0VM7;\XM=KJG!13"-R.*<0(Y^$FZFH0O=
M,$K"-%$A#]+!IIMF8^7Y)GGM/2/F=: 14B2D40@03[6+N83CFSJ0A*JUN5ZS
MJ!OX6\LFXA%)/RR>6DID'@M*()LQ(V*+?!!3F7/JI3E'FW/JI3FG-.?,R1^@
M"_,;2EF6HS>J/)5TCPRT#5.N\(RVY0?(U.LH#*HMK %JJ117:Z"'@"1O7*4B
MZTB+33(Y<D>F&^6FS#$7;$111ANT1E&EH3C)%=@*59A9ELK0-VKCJ1JY0,_1
M8SY08M=Z4UO?6%VI6K7US6U)JY6LAV68;#]7>(),'-2SV"R&0<8#(.HLXP]6
MJ<!XGC30-96S0R*9B$+W91U'#AFX(UF>G&/Y%C99[VSM7%"#Z9/)!_=@ZZLP
MC)2?3/XHB^>A*6!.SOKJRJ4*3<!]-O=7)G(F'"/DCJY5K&=BU#ZL 0^DB0&Y
MKZ]OZ-V]RED;.5$HZ[MD%O]_8[0(@<G3(&]SWFI.*AH\5H6O"LMW,&X@C0Q.
MA^HR<^,*?63KUA==3IL-@"KG+9_ZY"7Y3*-,=83A:NL[O$3+Y5PY*IV9-?D9
MT90(WM+RVFFD>_>25$TN(@Z!G*6-CRRD"R^5J;JR=H-V)NDD:GS1Z$[(%)=#
M#83() 2O%[=8):6?I1IUX/+_@V%)/K?2 25I^-++<J.&C9"+G7I!IEG*TQL@
M/8@CLB<BS*D1#V,620PV(\*@6#B@*M%.KM72XA9.3G^@+Y!T#U++!IX6R822
M].3::\EF,7Q-P@@D0=#ZJ75,H86QZ_S^<W:5WLX<^H  #/95PIB1T;N7WSQN
ML<-Z3$;=9']P-R03Q[KU9E#?DE".4E]0SR"RR"@:!:@BNVS<[W(-=OGTT"3C
M#K4P;!(%)ALX-T&7Z-+]A]0 >)<'T,H$?W5%]W_6W=7XNLN&3]+N@:N@[E5V
MV\;D2]EUS7HCG1*,3]U :VC"\/JQUT@I VIFI"?GZ_./8[.#W;"SVR2ILI"5
M%F6HL;8])2"><M$^GB4VFBEXT[A+LBK?Z)@3 \.:,0RY+Y"?8\HN-U,82>7C
M]T7>E2O=BT$!7%%]XC Q6U@PR9([XA$>*7?1UH:)K"DEYSTB"<CJT\N8U_Q#
M6MH@!YB7[\Q.C5IS32609LB;A$V =;=Z$ (U*]3OYG,DNA^"3/&/$7:AUE;-
MDM&S%KPW7IQR#EN6+&S2216PY@7:I/3&F)1P]?7V5.M,S5Q1I%(MB:G3UDAY
MJ=#WZX3.'2N4H\ >Z^*=W.-+)-Q3"N@@NHNHJ#16#94-[RWL)GC+^^2BV9C;
M4NMSR,0H\T3R,A^&1FN#7)Y#Z<ABJNR!<6$!H3CAZM;9I+$T',$:[66Q-AD-
M-FG,RY44KD1B<,62_2>YH4E?-SYAWDBK1V%99N]F09#4*S!LQ@XI.J/@EYDF
M<U7@*3A7-8W6=<*R,DH2AV&<R&(B-R)7-P?[M S5@):M30H-1UG^#W;?D,Y#
M[K KJ87I+EY=D0X(!ZUUZ/^%X__,^J)U)"NPJZK:%>NB U)T+[;.UO]8KUC7
M8=SQFC9\S2$ U)7CBY>@PFQ^2*3PRD.?:6PUUC]CFDA>;\5:NC=*I>3*+5B%
M :W.'K5AX,H:DBR;\11$D_D2Y.+=4Z7\2HU-:@JQ#$[#2'#Y(9< J)"-^ 8M
MY^1C2@.I'U+]1JH<;[8&5B&95[AQIH*($19<5,*P@(ZS=^;LLFR#12."Q48$
MI3RN3S(XR&?9HE"QC"P!("><(#')Y$%.BY13"(34]P9?I"1&2?11C%(Q)!F1
M .[3IJ!^;,N$NJ5L+:_B73B*0HQ(C#",O=*?SK(;EFU@%L:83D+7[JN6VTJK
M0R4/93O8V![W8VQI.HBVD4Q8E]-$37Q'V:%UO@0RVH&S 4"XS(%10,2&+!Y0
M,.%[:5<76,!O$]7?$0:(2866"(Q1AS9D"$?:TK$Z,K7F9LD?3L=6F@0]5FQV
M.)7)>Z,T>6N3]T9I\BY-WO.S<&0\H:*-"UZBDZ:EVJ]B.7PR; /-I.)VJJN*
MPYIQ5]9]OV7IC7.JNN&-^I8D!WX$"2$_5C%Z=3.WSHJ]Y*S?Q+G)NJ;Z(,NV
M98I72H(-FM+ )YP(Z*$1D9?;3!-NXQ<GU%T"N[\1(T@C3@A7S,BQHX@R;6^]
M@G?D89;(F4>QS&8CVYVP7<XUR!LU6;A0>B#(#L@22>&DTZ(0&VX5J_5!S?<I
M=(;SG;E%A4I88EL7A\R#4M E?W&AM_7\^LO1I75RVOA\<O;9.CT_;'P]N7X2
MHO!2S4;R)1?1KLW2H)!=O-AR.4HY4L8B674ABP,>2 11EG9,IX>WM/M &6[8
M=P"2HZ"2[3*/0T:)R$R.II!Q*C*X2W@TEUXG3#AOE.Q[?A<KJF7]CS%A!=LZ
M232KAATR;5.&WJ#7SD;!'JA;'\A2@,(O*@B1$#(*!.D#)I_$V<1!'*695SEJ
M"B7<;M>6_CBL UE5;BLR.2H?UXBD6-XL<Z=9)I6_4+&=%2.%)[D-*==4]>J\
M">'T\<:'L;I_NCY%F)4KHU2TJ(LEL- ?D*O1R6>KIB>K$'M:430FIE0/7:L.
MSEC:H%46LYEX7.@[3V<;ZZ+C7:F: D@4?F591RY\X@79 :NX0J4/B&[/#_LJ
MXPRQ-;S9SV@VS:KDFU7Q!ZOF#TWBG0SDFJ%8?DY&'I:00>"\M_SS<-5Z_!G5
M&A[ZIKZ'TBK6T>*O/QZ8+6@XQ#%GW Y]%[7!+J?GR8; W&\3C[W?DY%HJF(+
M$XUF&*BX50&_Y*#003LO75)M[S+:^))R2=8'L@1DG@ME!,3A<Y8R(W*NPHG%
M>%84]9^%?AH1IDCD9*D%+@RBHUDIWDYYO >=3 %U*J;NE>323S1=EE23 EOC
M]:S0<U;F>31LIT.,1B_]+YZAA+%')NGW5I7/]76A>,-$,?=#)%O\==B5U1(X
M7]0RTT4!/=(:<W M;3$5[<SEBHFZNR)Q7HY51A==E.I".ZK2"2<XQ.P;1$>'
M#%<%*&1&5]G82D(+@S/0LV&&5_/].+C.FIJX+EP$Y6;5W:J4MP*5!C.B.M=(
M"MM7NY[> ;I,BG^KMMFY6A^8P&,S!\PB&' V<C'Y)I$^6L>RJ GR.J*B(LBE
M+CAH5'IM540M%HQHHN*1I12CCXRY*OT,VU,"74G0Z,\)W1&N9=TZX7H[((%[
MW$W8\!-A?('>!5U H(?)(D1;LK+AQ/SQU^I 920NE:W"(Y<%13AVX9C3C5 '
M8R(HWQUGJZ"L+&HD3G11=>"DGISH1@J8G.%X3.8HNEXB(WL7KA4+*SHZY-U5
ME,AHS,.2744#1 8MXPXW=6$Q @BIC? #V!2Y96%$#CA;E_V(Y")@2@[HHB1%
MJ6]+PO4LA&LS(UR'7IN2)XPKJZD1%F?5H&+F"= !@3W.E;SJRT:[&1N_,]GX
MNC7J'52<J)E)X+;9-B%38>A]KI'7*$T4*K )0\R4H$8H-Z@>4CF6BW4F:"ZL
MC!5KZ0?3$KEY4S,Q?$%P^>3OF\H&O%G:@+4->'.Y;,#/C=ZE,0DO.<?8RCC&
MF4HK1 L(6A&UNC;6KB23 5E%84N,)JU&%P*0:8A%J/ZY: T!#2NE)<1&["ZJ
M\E+\D_4;E2V'16/B$&,: YK*%G=3EAT(.,V0962RN)I!"U2&#2M)2C%Z=465
M+95QVQ@8M"!,8LFAN)U!\9N/>CG9\Y3,@J;LBJHL(XOYH\0B??HZQ)9_Q49"
M4,]\]G!S7PH\8( #/&!G72$9,;JN:4S-?!1VK4SMF@9?ZU;#![$];7>,&#".
MN,KB(ZA:($Q<2]-&O 1+T#9%=)&$PQ(7*P,QQ1*HC=%]/G! <K6X5! "+Q>-
M+Y-[I2<<I7[NE&-(4C+GS#2>]2+1#F"BJRLH'::EY/X\X-]9'_QZO&%4I[_D
M\)!]Z$X2_;$2RB"AS[L;AI(3,>$9S?%$97.Y$3[H])&,Q"$3?,^FQBO8=I7+
M,1AZ/_O'9/VI.(N$3!/MG$@PS%G>FI[*YX#74S?(7+ZD"7Y=.585*LX-:(T8
M3UXVLA+PW:*^@N(9T3Y8+>\YQ2P-I\_G?QQ=GF'/"NORZ/.WKXVB5W\X/FQ8
MEZ*=L@VJR"M!N]UQ&+*/_S!*VU;#I6#4),O&P=K/D6M3$6KB%M<>=G79J"OH
M'X0NF9B/A4O1@]G6('.DOX6*/U#9;2K4+PO\&ZK3DR^!>$VA87I@LM&A^<CQ
M[3@&6H%Q"K'V'$:BRB.CP0B#0:NYNCS9UR85D4YNQ1_)>Z.G1\0,-X'B''J8
M(<#^1\NWD=J@2P&+33=]V;()9YOMHZR#3,]SJ8!UZQQ5/>:&,EF,6C>:27:*
MGG53&3:I\B^,-6%P<70C/-^G;#$5\*%\?R-7B&_XCTR/NY)$.SLV['*DS,S_
MN;K4=F:R1E,P,>[U@8RM^ SX65TYS1WM!=>1IJK UL'GTPM9I?)4^CT/>2LN
MJ>@ANV-&6+I/#R_-,^?#@PEQ;6^5W@?GGT8,3V.MEBSG?$-V\$X6*,F]ANB=
MZN0D$LT%D#5(>6GYX/CU^3EQ\6;N(HE66ZS1D%0CM2P\66"-Q6X*>( WC*73
M"PG4(B_GFZZQ-@#&!M:;[ZHBK/7]W1W=<5-1-B25%::3")F#,.Y2\E'#23@\
M(H\8OM &A9+%T)!_D HJ&PNQQ]CA?<;29;3EUHDF,5@<)Z5.=!STJG4'7U_W
MS+NH49V[^<,0[ZD[^@&@+M]XHHB407 DU0<-F.SN9F8J*AN@Y;AQ1OIRJ_S
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M8]#?X!/B\$>4J[DDV8G?_S][[]K41I*M"W\G@O]0IX_[#3NB4$OBWKUG(FC
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M?:',*&K0>!9SX]S"O@IS256"A6;J3\>I\X4]I]DNLC).1-1K21FQ]7E<*H3
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M#/?I:,+DG> /F1:T/[+R=HRHW*8;8'4%!QM:9T-!CTSK8\OM*&JGW;&6V@:
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MNYI_B?.3F-&EE?/-$Z[Q)26VH/H%VAZ2^N#,1\*B&>/F2M71"?XY+Z&;7\&
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M&1<SRL#NE<WT2YGC?^%E?_EXTO^MDY'8L#/EES&5H_\:K/&F_D'.;O]^9_?
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MMLR^LCC U14G7=]@-TI^GF"V.%-J:^<1TZ^5_:'%]#OAX5.>U@\AAQ&N4\_
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M.UQOB]8?-G$[.^'F^D;8W?K^ U&/.F_;VV&_OQ7VNBU!V\/FK1ON[NZ$VS\
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M1N3B[N/3]H8E%57\_^R]>U/B6-<W_']7]7?(W<\U;\U4Q9Z<"=TS4X6 2JN
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M51S"DB:<:0!?R4: PUB^4<P/C9J%0@T4DJAP " V&5WTN^$8S:+I [4"^U$
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M9DG% CJN%WHOU]$P^K,]!0\=8A?)MDTX;0>\ ]ISZ"T= X.MN1G(93<#WLU
M[D/?#*SMU\[TTU[ZR3.I8=$5'HV*%)4[A \[;('X@"8>&(8MM!_GHJLI&9Y
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M56V;,OM^/'\$HIR A"QAA5CF5LL"+?(L^)^8J>HTGN^^@Z5ED689AL[GPJX
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MAWI;=A R3W.Y,,\?GT:?@+M.$;BK.@/N.CM%',2 ]DCM0AG4L]E=\1G%S8Q
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M3>1[Y[Y3Y9O;2NLA3E(TJ-9%F7HH%QI-JEPM@57]N*V6/;<1D097S\2UA@P
M(74 "/+6#?\MF'\:6],9V*CN4'Z]D*V'NL@=(^R!L#45PCTFEQRMYXO?O[GR
MM'B?.T9RY-MOU1\_Q [_XR=W(V7P#<>%8. **(4D])UN<E;^J$JB*>$#G*D)
M O]5"3,^.1R*\N!Z?-4M51[*NTP6CP2'0D@8AT(\(JB /9Y\\.3"/%1 B*^Q
M=V9!RHDTGU^/T!@Q2, 'YZG4L-0JQVW7G*H(82?6UQTG@FJ2L562;+5[W:A$
M<P)'<^SZPM$XV":\\*"\I'S][3R?+][>/G>'NXPJ2T-]:%:SONS^ETMN9MX'
M('H\D"5QV"R>%B2@@[B8VV6R\]_]_'<V+CPMY7A:9M<7+L9L4,[V:$JXK&O]
M_A,[42J[S'Y.6;UQUI^PKYG*^A,.0/0,!^-XT9?VQ%7*'QS0+'Z(GZ?*FWZM
M])ZJS5TRF6F(:[*ADVFJI>4.W$Z0'6\<^>ZH=,]!@CX;J#(U;!8,+>88FF&V
MGU24]39EW+J#DY%B1@R_41630UWZJ9ZK#X)0,(=:ZD/=#(#IT)>D\X;BD)>D
M![(#&9MLSR81^1-+RO5I1I!ID1,RCCEV9+?=L\Y 90!3SG+K&XMBSAP(2^XQ
M"U7KL3\L:(7+8XWWLWO,9;$WGQQ\[ <@>CS86W'<8PIT+L_3@LQE]YCI.G_'
M]#E@9YN2 U&-0/.'GZXA[W&3.1;Y.[-^GN>>]-2'=]E-9MR&2L@*;@Y ] R9
M\P!$YX\(WDYH3,3!J29(IS%@8.[0+!BYXHX1\NZ]\F]6<Y)(^4.TB(!Q!!D<
MOQ$,8,8.^^9%]^6'W8*.9>B/"%,^F23XTOK)F$M@*CS;'50N?]U-GH\_-LFJ
M8=)4#2-DU3#'>+R'K"^(VZHO*T(0:9GC@!9;GT3,JF$R;HW&YT@O*X;7PQ22
M@^042SFSQ.BM>X%/YSU=AL/YH3 .#UEA$R.Z8<::Q\^:L5;U"#0C\K3,K^\1
MS;@TA5QZ:";=^=97D( #!/XG;S]Y(VJ(X@P!=IL]><]:A?\J9OBO'OZK^+'Q
M7U?QWM\&5![ZIH^, P VDB7@=!F,HSIM!HY9(\FP%?BPQ4+S@CJ[JMW'O[J=
M(%G=H)!G^#;+<NVWB23WP"KNJ[H G(GQ$+QTBCX"1,'5--0)M=&6#XSXFM;*
MSZ.Y'O(R!OE\VTL8N/F"E*"A'O7]FT_@7-O#?'0A'X^$P-BM^D#HK[FDD$+/
M3(MR'E7J054LFRJ#G?>\M-2F5XU5U2DJ]F/=,B<:^/[I]-96>Q6C-E(MQ0$;
M+P!??*(YFFH7.K8#7?.V=MI^>WH;B>:O;B5?6W>7>&!=ZAL;ZJQ1NZ9J]3+T
M#JKG5*'8JMQ56L@O2)(]$@.2C3@QF;*ML9MR>* K9*@4WRS+:;\5*_RE_HN[
M&.23'W#J@C?N@FN[4=-();1IA+Q6/B+,2"YFS,A4%K<G@AR:<4&JH=J2@P$M
M!A1EH?<TMAV4*8()0. 55$ X9[?,A@KHTM5T%6@7K%P@M5KF+H[#R':XWS^+
MY]4K-9WW?6M5;(!,,.MFN<2A#*]A#]4C@7]!&E(C0B&J,Z5,ESJ4XI'GFWOZ
M*\5L4P$/8?_U'PQ[8)I6L[[ULP;\8*NDCL!I: I*:!N]PA#FMM_0/]L:")P\
M\_];N9EV^^?#FQ_OH$LGN&M*,7J4$MCW$<2X"72QK>..N,T_',,HPGN.K*PX
MU4<>F:T7:$9F:4E>/]$PN5Y&9*EML(8STSI5>B6UX]BS:K%>&97N-,FJ7.RB
M%M-@F[T]PG,#:^R!0^I\H&Z7Y87V8:<?>]1#\P(/5%^&.YVR,XY,SXFT*(MT
M7LX?6L]Q 5^PI/95RX+!"/3%6\IK^76D&K9ZJAHJB/1F=5[AWCB[SC^K0G7P
M'EQ!O',O#%%>J1,8B7QLX7!]@C6,$;<ZY&DF#^+_?*8.4WWB$:(KRZ)(,TR"
M7O_Z)(]'B2(@B^;8T"WV$QJSNI&]^G5SU^S6;\]VR9*GP1^L^'H0! *J-H$U
M#Q]&-#9LWLIEO<])Z:/5TA>O.I)R+,W*!P=LDX-9.S<=>@4;=1J0@K7^K:T6
M;%MU@M$Z4=NSZFEJYE[??G;D'I_\)5[T6>7 ;BGP_Q$[G9C]D[&M4@JDQP>/
M8KW$SI8\$W]NCV$8FN4SR(#C8H'H[O5H091A]T0*-*N;ZX.CS,'.%<>TIF4=
MU636^AZ8&6Q@FW/U<IU?T]P]HTNOQPJ7&=PRI>(]0P0<VP,Q0]O^,!*TH?,G
M9Q!EB>3F-I#(>-64S--<[N#W$6PP%"4;)W0 OO"]8ED*<(3/3 N\8Z(!HM2L
MHJYHPSEU];/R8V(5G%%+>0=0)C,PB_#>HFO:CHVN<E5LP#*M-:^UA$QK)16R
M;B.E<7M:>8&A9>[@LR[%V80:@IEPX28J1L5P%&.@=73LD-K%L64!>8<:K J!
MF(8VT6+WE<)U7QD_2:WND3I=A0[04J8!]-9(<6 *X\/(S*:**H,J3S"WMID@
M1C[N: FD'!_SA(RM(L)S13-J\&)XH$U40[7M6K\^&EV9BK&HE^[.6HV?S4FN
M<2\?OW<%-T[A@A!WZS LK-?KE YV_U%D9Q4(XW+>B#MYEF,8.B=]Q$DRAS1*
M^>1B_@VBP 6U[9>0(ZT]4SY>UTNG_9M<]T<SI7!1&S;W_NEN^R\H'N@G"NHI
MOSX<[9V&Q1M9@?B.!>*KV:S0[0+><.R&=S&\: F'H],;159&UH_>\5M"=\,T
M-51[< <HQ3!4#&6 LZ5]50U<DW\87WX-PM,FG!.WG11IB>%H-N[9*!_&4L9U
MY-&E.L!ILPPMBS%75JZ$I)96ZD^?%/:BXBQ>F;E!9UC7G&.UTU4$J_0!JX:V
ME(P &R2&UB[P-)]D=)V=^K:G'GTZ19#HO'#PC,KI2I58-(=#LZ<YTR)8!5PA
MB6",WI6F=#0=]7LN*LN!^'33ZQ6?ZKU=YM&DS,MTM_[1BI8VB[V!&Y<EA ^F
MM3:2SX3T&2MR&\&M)M@X$Y9!GP#9-JU0M66.<@Y[?F/=E78)CI.'[@YLYJ,(
MR-9Q3H!&<<>T4EZB ?]E$6TZ3SJZ4%:@)>&08>SJ-&#=4D>*U@M4F,]JN?SH
MX4Y]'9V+_5TBV90Y9V2S7ET1R@":L%6>ZN++T8_FMFTI-;/<DEC FV=HB4]P
M,')V\#L<? PE!!PPD=S!6W96YP$1T@8$C,(*!+O4BWJTJ4P>?LJE3O<VAJ&K
MB2A/M-%,/ZX4DU!F2$Q-LER>%C; 5\OT9'Q^Y>8<$)V'*=-,W% [>UR4^.U*
M?I)AIJCA^OX7\ZOW_-K[^73\+J:[?^I/M[#AK]G*!MVG0E;>L$]Y0W&C\H:Z
M,G5K&P)(3\R@KHX;FO4B'*DQ=K='C?#^,GV\YN::\$%BMI@'<7].BAG[(DOO
M['/LT0<L^3S-<<F4<Z['!%WBFY J\+D;.5\W/KPUGJ>V*?RL<,=OC6LSN9V
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MAO-C,KI/K?;;PWC4+Q?SK^IPEV$_.^3SB0D4I3_B@. 86]U'!6)OF'UJ1*B
MA_VX))@G/EF/O,UR5D?7KI'?;X/+F,5].K?[XS=+W6_.5?%/@10%D>;RZ^&,
MHB+]0L(^XY)XN"2RW I/BSR< ;\^M1(QCZQ/O+LD GXI($Y757LVW'WST;2<
MEFH-L4_@C0B?U<_G'54K3:JW%\P[:)ASMP^U,]H^^)0UI#2/ !^E3F%#H=J
M8V+/C">$+I:=^9YG'MUU9CZ9DO:E:!]N_9[KS-7ZE:$R #JJB.*P11UY8^8G
M(G_ZZ^Y\EUGE::A)<;<*%:.&-TNBSH\B'9M"_(I,!O&;2)7D$NF+NU67Y3A:
M9%)20>S3 &(NP7)!4]<!*2J0$D ;A_AK3>='[VZ0XW]U=M%%:?/7 FK)F*$
M\-D("3)9"<K*$CZ)?82-(-$,L[YX(?/4(K5%PH%'O>57)0'G!W0NZJK+YF-W
MJ#F3AK5+ VWR&.-%TW908F_/<;A9Q<SV:9UY;HI;H\DY6I;7)_RR6MT/P%;1
MN9<23^>8]7V[L7%5E/>&?I4N5.9>E:[0=:[&M\/I]85T_ ZH5Z5[VRR7J$IU
MY15B)K#1"^SF[)A8%X=(L[D\S7/KLU29<?A(O!;#5#1:9O.TN %P6,(&@U]O
M,+S6[R6%)D\O]:K^\_22+:C)^/Z;*7S,EJ0X<:Y\Y*Q2+52+L[H_PS?>L7XD
M>$'94$?$+X,)#$<-PAI[$:.CE-MOC\TSO:C_*!1KVO$[%]ZV84P)-)]EOH!7
MX[$M766D.8I.@$7,#GB6 B7_HZ>[7%V]C&7B#@OY'.">[$8R?6<<78S&P/FS
MA\16$H-9M<!5;,6VQQ"@K]8OJ1W':XM'BE&V"WUV<G%=MW91C*FX@G1K,_I@
MJ^" .A^F&&/3=*\D9U>/,2-U>'FBI6(7K_*1^/BO4=;[9D)(6A_L7H,.OM&S
MKS7#M#1GZMXN+;IIO\2+0?_6^759W@7:+65N6DD#88O6&2/WBW+,Z&\BL]A\
MX\3M"C:,_8Z3ECD.,&5V*9#Q5L1:GQ9SS$:*/^$\3WFG/(]_,0"-@7<Q<)FO
M%1Q+D-Z KW"<+NK";4!81BB3U,0SM"$\F.!M@"SF:2%W"$B%S"JDE]>BOPV0
M:(EE-DI-)&PE@OD*2#+X/]AU,U%T:%8;*O2?NX[:@W\H&+W97P0^60>O-WOS
M@%KEUZX^AOL!/SPJQD!M*(Y:[O?5KN-;&F1A?D_E.UE_G#2MY*^>M[]>@-:D
M4BTVRH5F&1H39%D@#@/ZH7QS6[DK7$$TA"PDA_*8+&?%WU+(21PMQCU"+\OI
MI(J!HH.YIB51IAGI0&"NB=W7K@2N2-,E9[I6$VZGY:CL-#2[S?:;<Z>9%SEG
M^#O_>/Q9OJ76ESJA3LOGE6H5AGFU,^JA7&AD?G<ZM?2LTBW8M?[^JE80:$%B
M-IH\GT$S9NP&;?Q>!082+3,<S0N'2#-G]OX]V?M<E/:^W'[CAXU?7.?!8=_$
M]VWOR^#7T5MZ[JNXD_)%WZ-ZYKBCJWO*]_\V4KV1O/! VG??L%RF<QQ'YW/;
ME]PBJJ7-W&<\]ZX=S*AY+@R7.1(TU-G,9X0PJQOB+N<RW&4/=SGWH7&7-\%8
MWO19<8 K[_=N7$H(7<!.FV$D*!VH4)#<.-1:Y2;5JE$SL,OD$KMP%0!@CF^%
M/VZK90B$2T%CC4K=,:II7.^;.VVL8*OC(?AR=^,<OVIWE1'TPJVQ^F7.GIR.
M;<U0;;L$/F1I(ZBW@04I=+O ^85=0W6@0+J::K? BTYUL_N,A,'UTF4(]^%Y
MZ5L_J_TFG=U?-N[O7S1'VQXI.B 5D#>@<J1\%D+KXX3V6_=>TR>C7R_<1/[R
M7ZG<+#8J=<38P$D^O6U6JN5F$S'Y507XT:5*ZX%XUO5*"[!5H]RLW3:*D.])
MU>K^AQVE&(,]^?2&O1CN,:1MH;,<_C2V':T_]12.:8U,"S6)4']"^&E8*LPQ
MWXOF$!!]BO[%?O_\R;3<OZ#OD=__16DVI5 E55=>%$L%DN$]C:9>'K7N(_6B
MV)1FN']0>Q1XT8^Q/J78'$VQ^9S\E<(K 4]2C0%0VSWP>82$;:FVJEC=1QKX
M01-5-Q$>(_WYT\@R>V/LI$%- #;ZK*(9Y. 0AFH/!I84$#W#@+_S$%3=!8TA
MSNK( FO21CJ&7+U6!@:D( 4\.!->U*L400^B_B2[OFY4W#U__M0G4-T]U5']
M=?0T\!C3UM C'\=#( \]S887/O97J@(^ [PP]&''!-^TM E\O@5V9HQ54K^.
M'JI9X*&4#5Q'M+9&);@'\OG/GR#A==ND!JJA8L*B)YAC$,L;MJ/HNMH[Z1 4
M'(P,I%HV> ,(KP>/Z'.V:DTTL%>X^/%H8"D]%:+/@A^&]M<8.2\9UJ:]O6J.
M#<[>U/7IB?EB $K9XXZM@>.RIN -BNX\?OYTK1B ]5!;55 D .T*2.DK'B=<
M7!<+'ON/<)V'#3A_.++41]6PM8D*%N@]C1 9E0 3#H&<YL*E]94NF?;U]?.G
M%CA^[_/DT3VJ,T5\0202"I,^[JDS,@%X:Z@9L.*8R!YL ",28?;[\)#A: "5
M#KP/RPX1%Y_#D'A--)OLWAZ/1CKX- T.20%/ L^$WP._ANMT/P6,XXG[*/ '
M($2&JL-5#* HDAV!57HFB:8Z&JZ#1FUKX&Q\0?K\"<N6MSWT&6T(I!7^RSN8
M$8IWP-8&EOGB/,[I D0+=0 )>\RL7'.U)71]6)&>80588VH!33BV )N /WS^
MY.E9RK0&BJ&]>=2"WPNP)?A-"#=B]\<&1S9P/P4518=8MJ]4"ZGEF6=#!>\O
M QR>20U-9 O@B3FJ/D6U[@.T*K@*$P\P@F7QX/E8 *GU\@>/]Z)T#53I$#P
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MO%!:%Z;K#:^@ATP@*C&+ +ZG\@3(D.0\%#+52^+M)T()UIJPQW8Q9HD,:?
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M=>,U=J4GLJ7T2Z^)F+.NF9%L'3(S!J=V!#R.)ZM_F%I'P$ E+ 8/,Z*LP_^
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M4F_JC=C8'QU#UU??>'D'HH[V:[F>R4)K:"Y3;VB,HW5P?N=G2VJP0_:ZJH+
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MW;C^BFA"OO2=[+7W\DXI73?"')_4/O(WC<PFN$;^W2F!U,2_U1?NO='ALIV
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ME4D*B-;#G#>\U'>!J_1,T6%A$%V$Q^P47TEHPP11##5!PACS^9E=/4]F8+Y
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M[P^3$V%<1<.!L\0:DH?_PC/L DWV]UB5*AQ[F7:?4SD9GK6CS"S"T&A]!(
M]4@A@@F:0U.%4Z[U C9FPP^.QSXU\WERT#5QB\:+OBV,;3S+(OJ-J,$)EH:\
MR<4) A#!^;C/29XA\,-FC?':$1IB$"@6LQDM $EM "DP*D.00K@F1H3%U?KX
M'""-+*^.I%0P!7O9P7TIL)H9HMG).IQEE(>RP)=5JLGYC0MB7('M%3Y4-\"7
MN!;:U73FIK7M>I?)C=V3$I>MY)EY5+-\#6/OF<(HUOYPG'%>U'H2!^,#(\+W
MK4HG8FB1>HC6Y\C%1*K8S*RK%3(O8^ETW<OU?+Q[[7*:\1S/.]7,'OE)Z\_
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M2+$G?.AJT9TY\*&1=(Q-IJ([SX7SS$;.6]ZR=7B9H=$>A.]4:Q"+= L?^Q#
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M;X3&07C'/VI]R[KK_'J.W;]$;RK9'&??G^'63F+I;L(R2V6-K$NA97"HYY'
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M7HZNQJ=!)HT?&=<'E4,>/LG"RK*0W4=96#ZMYU@E(] LGLB\')X#*-2;$(\
M9'AS1S'FTY"^S'*^>O%S9BLGQWL(#!Z?:T-E.1]P?^3<G';P[EXL-N-V^@=S
MVY*U1DMQV]8\N8/BW2"=MA-'3W-T:H\X>DU_[##Y>R]<KWWPMY8(W>VEZQ7_
MZ:HCOYGJZ*B"<)#.%TX\:/<KS,;2,Y+!3QSG$\?]5 =L$?\&YX*=N-J+JY=-
M4]T.5Q^'$[8TCY_<L$,,>R5^NLY8/YZ.XE%0^NHANEXX[X ]KV2*325.80)_
MPZP3_/9#':]%W!N8WW7B:4^>7C^/) ">/@JW:VD./WE=!Q[\2OYTY5'83'G
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M9&G8IM8Z?$:#V^ UO4TA(;WX3=>:&2G0)ACTSC/H'X<309<\XQ) H:%Q)C
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MRG0ZNR"8AR@QLOG-T2T?BFZ<1S?^ ^G&4;I%>HO,\LGT,JJQA!OA!,R,9=$
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M,3.,!19'NX>G9<I7CFXLUJM55RFB<O.U26 W,C_Q2 [;HCK5O?,=TY=E<FJ
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MDNW$R^R'Z/CSK/P3@I]5&7] )!S?O';-T%JZ"%N1U#!4VT%+:W9G2;"I5!#
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MR5+JN=QND?N]]L,*8J=SQT'..H?8P/D#1V,043@\\!+3@>NMGF)(L%L9>.[
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M1_4&J=2O#EM'5V>D5"[7KQB1[WSS+S2<> (PQI,,.@ #AZ7 2VX"*YHZ$KZ
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M8!)TSA33M*F<W&4P5FP#)"'Q*_.17Q@(7. "EV@R0 &>*<;^GD$?=/4!O^D
M6!6+2'<&93!)$L2)]T\RE  ?CY;SM4[J'4MG,^18074JR3>''RE8C4Q-BQ@
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M/;\)DRDDOA&0]V$4!5)^'DN&N"FNE](-.B9!\^@3D?D9+/[0U_$0E&(\#";
MF#[YP_-,F+DRHI)!F,.ROS?![>Z)M^G1M#HB$J-Y=":09DW?=!J!"K^G&++7
M9]]/+">&=IK<%PG%%X4X%.^&XHM"'(J/0_%+CC\=YDS[84X,XQ8/DZ3>.JDV
M2.WBJ-XX9QM=S[SKW,.%KJW'0%_OLBY+C1:IU6K16]DDTC.3L6U12))*K5$M
MM^H-'MRN_JR6KUJU'U52/SJJE:N-9N2@/2^%RLN$,*GQ@.Z(WN=.(4MFZO+,
M*4)5[LSN[^$IB,JS,F \UZ[L4\IL"$S1"!3X,+WO?0'CF'8'@R,X'_JW;%CF
M9LEH*JBP)  MMR@<"X)G;[C.*/A>CQTZ\ +P1I(TI%$?_#7R [Z4^I(,WBN\
MW\.3'IEY[&B1,"<#?/ NI3P<@KME<10,V<@.$!*$2IV>]T_W2WP%?3;\FGG)
M?Z6$A" (Z*HS /39D.@OX?^ASN@=.CTZVP7XVA(SB5A^!5\-7K"!>\*P#?_4
M=!V(V9R5Y/Z>$W)UD>;Z\0 Q@P8\U;"/=]GB*<$;O\&Y]4-C;7>#LD?'@ 6,
M8N@FVID8_?%/]ORWOK D2<5TB#9!&@A\F1PGR1GM]9&$&@J8N3!X-4E:-KCG
M2*.G>D\#ET)5%<WD^4RZ;9D8V?/GEU13=_%B\AAXG^7#>+Z99&/J8<=UVQ-.
ME@J+'H(KIK%88"?HU;/$S]FM@N'/:!B-?F9FRQ0H0&FS6*05B)]B.%&ANXW\
M:\?1\?+, $0R@PZU 'XLC4N%4=LJQ7!: AD,D<N.:8%3P7O0J,H=A(%WC$&]
MTP[=/?GQ?_0]!N]'QZ-07>'&!S;= RZ$O*GT%54R]O>ZML8C@)Q4V'*5R< P
M"Z"1H0$KE74OKLL"QGW=0JL]27J@O$V+'T'A3KE?@P&JP.$7/Z=S?@;W3%;Y
MB5B72!W+\?P!0)+AA!ZZ "H>+?#25]O4&J(3R;<$GSBG+5V>H<G\)GZ.;?:4
M@?DO225)UU8!I%U) =!(F*W,\I$MI8\.&GR/^@(5 5(U"WL'3G7 Q^2.&(>D
MK'?LOI\ /01QJ\ '**OM-K""&P0-G(OQ3MR.-QH(:.%S]'\1]?M[SA$^,I2M
M*1TG'@;C]Z5[L.+3R9FHIT])Y Y=1PW7!?M7I:&9( 8[O\,Y#.]D'Z"123H!
M>1C,\EU0S]=DR'A0='4R(,>H K8&Y@;+0P3J0\W+D<!"K@Z%*2C!E*[BGU.P
M3W$=V:2;H.">''"EPD+>'>I #B-V,DV2:\H3XMQ#"62DP6AV/2-W$:A,,;^!
MLN[G[.TD*;F_8AS8^=4=JCT"DE:8;(61CH!VL##8&.C\H"*QOR>* L$[N&P3
M=#AP7X*<@U2 5<%?%W1(;C @*HKY3#[AXAT3+;2@<CNC=P#?"IY_6'TG)%_3
M0%VCZFZXI+K3,H]I&%?7,R;Q9/]DG ^MJ?T]DUJ(>:#@-E7UX9?M;7TG+W]>
M[#*O%%[F-5N U%) 0/=&I.&;G7/O4LC^O= =%XN7O+D?A2\M6UCO- LL/U,(
M';C< \T UM2$/9H@EZ!OF#A+D')/H=TY.0=X5H&:PIANHK"6?F*SJSVS0==K
M.@&?_A!DEJ8I_G[G F!Q:,Z^F<N_9+PE)O#A^@/=D1FXUT&&2TQ.!^$N/9OK
ML3)"GF&]$$I2P6JFH +(:1(\/0SU;Q@YA<R&D>/Z9%NB;L?#.74]G V#+Y/;
M%? M38M3GN&& 9D.D>;1!.1B=!CTH3=-@R'WGFX>=!-UR.[_A)E@GS6LCU&7
MB$KN0, \?/R%SJK$^*S*.ZL2X[.J[5'GVSBJFN.IA<;'SY.5),O!82E(.C_<
MQY1=[JRC%<A"F#)QWIG.)PFU[)U0/P;";8T^#GAP7Z82>*2*1DKV'2S*R?"!
M[;!@FJ+9/!3&4YN\F2>]V\D)6]Z$$VX"BWJP#=DJ/SAP#Q$P]2")!BV^H/,-
MHXG+=IM@QP@N;/;W6&I2?Z#J(S_'JHD9,N1* U/:,)WXLQNG@._UH<9R:,@Y
ME5D$KLRPFPB\@T<!  +3U#LLP'/) VLZ*VL]5/1!;V2R*"8&S>:\YF6UL&FP
M.I8=UXC%7-X!?:!(MY@O,B [AQ@LEXVAG:?[(4+@0X$/45+A&XM402=;5 $@
MH(*F=RR\ZDXVL1MT$\!1:@:'ZP.>*?P'M^&=(TW"[!KP@1%IC4^?S6%^K7?\
M,8T)/P]OH)O6P9TAR2R]D:7+218YD8P'I )_#HRELY08"GQDRQ@L8U7\)KR@
MCMS 61>E%@NA.%!/3*R=15KQ9,K0-?AW<G\ON"P,X?(H/E;*XB :UH#J-AYI
MP?=N<+"MZ_?>*8YFPW,)\^?N-.1A#,VCB]EQD[MP:3T;Z=MBV7V!0P$6NH/_
MZ ;C?A7/HA33(W;.L>>-&E;1:AK @:%]R,Z>Q&*A@!2@#!06(>/,>B$YATV
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M#R1=MFU8$<A3X.D9J+7I'<(.R58"B6:@A.&[8+*JD,7C%A#S*JL'#S(<[UR
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M@<!DHJM5N?%S!*ZT(DOND2$?EPMS)WF"U\;!$_!Z&(0<3%2\)0(%G9V5<6P
M13Y)SH/J"[2(;3C'CXZUQT]U7 Y#0<\XD^D1_SC;Y"]RZ# >GYUX G:P!E>-
M.<4,'.&LE@"^!K+8:;D[&R]FDM<78E-!5B]O S/NZY^<X\OP""WY6/UQ^2D@
M28+,Q:4JRZ%-,0$M<CMJLA%2PM7@'D?S,A,\^^-U'5RX$'Y(_$S(-V ^HXAT
MQF34CSNMUQ.,S'Q >!Y$0#X#B9O3&^6;08LCX283<YK!4V3< I[ FM*0W%&0
MM6BN>+(L@98!2$PD,-^:X,0'3&=W\>S;8(5>3EH-"#U3 @LMX9SMTT2PM#MP
MIJN#MO*/A0.;YPN=V"I*:MPDZ\:"T)R5OV#&HQ7%,J@8VC6@+- Q+-')-979
MAEU1Z*DR10,LP;:=8VP0=/PSKI3$Y,1:?NLL?7O*=\(J%F;/H@3=WZ/.Y'R(
M?('Q.69L(7L?2AW8$#=LJ]Y'$PMV+'ZV;N!WD'D@-HCC,>PT1X><,OC&E.1E
M47E( FIBU.MV!P.$Y!D5-2EF8J'),V4*G0)9XF,0S 5$G>G,,N%T.EY=$3/C
MP;&XZS&%C;YHF#._O\?<NO,&:;K:I>QHEPGE[) #.M@.R_$Q40XS_]2I( :I
M@.Z<.>!9:TX-,1(+Y\N.A$>Z8%>9/3I5I;F_QW+KW%)NAZ44V!=;!,N.8:D@
MQD0=+TLT<:O,<(0P5>F8C,PU87Q8S,R!W_X>[*II 4B ,GMT&"B"D=ESQS3P
MGE]0Y:[7UHV>KLN>Z^YH?M-)K?,Q_Z"K("^HH[T#I=?GH Y-UEKHND>I:KJ0
M&_#62@E>'(I_>I TJ._(44R95$<[S4 +Q7E3<9S7B_.FXCAO7).P'N Q\<AR
MR!X5+(P"SP.$93IHM 2DY?[>C'OG:[]+BHG33*-W>&!.0K]!4E2LN%</&']Z
MSC1!50$K5\:.73($EU?SI2Y+.^2>VYW2Q1KI<Y;%S)8R8)W=.DX2N"6!MK,F
MXG0\PF8P;<*#G&"SI%F@3^/)UCH7_R UM"1I]H(A3SRE],P9$_0+,I=;[PRS
MN ,SC0LFMD;!. Z$+)T@Z4[+Y.G4YH4LFM+ 4%3F6J0\4#,HVV!H@OJT34SP
M]$(%3IB<MSME ,4T6[^X(.AW/$B@V3N8-(@.YX0%S(X*>!\#]/_]$4A#9P'J
MRF]JT-\*=I-DY.X87KA0H>AF"@[0*T ? "WCP)Y]QXS913AS</\\=Y#7-A]*
MVKWB-O4\-( MV-G#H<%R2DW'MT5]KCQ@1-KUX0]X;7?;T.]!@<%V5(IE!%X[
M*:^H_ODL5NXH!%+#>1:YRZR^@U;39$ UV)0-WW4IN0$B\O&H=M$H??(">(&)
MO61)\$XLSNA!-W-_[V.S=EG^E S"D1M"7E #T]U5C+11O_08&V1YS&\90*E.
M_TFG,P;SOA!Y"!X"JP1,."7F@$ 3"*?#S#YIH%A ]LQIU>B=#EZ0Q=T/UMW"
ML-&YP\%<(]G-(.9.,HO)J3JR-P^FL,9=3M(K,(#MV,+ \0<LA5^2P68%X"7<
MJ8DA,2,VP5'A1$B8$>L6:<#25'V(?< 465;I@=,ZDL=M,.,^"#M/3#HM-V3'
M1N[YH2=O8&\$?B"$Y,LK:U7'+Z7(=B9XO 9+,G:6[)7[.Q)4<6C##^7XO92H
MZ<O9 ,: [9 6+1"=G <4CR^<UD;,(:>L!83FY@V;K*,)"!ZG"\81=PY'C#,+
M@0[*G%4G>-/GRR;5T,V>]9]+G3^VXL1"81'6O)A7X/R'$ZCLA%RGJN']X9S8
M+:=ZZH8%6$#D@1=-N'L!L+#%"XPBO;U-; 5/IM"!@TT\2(:"AT*^]$ /B',\
MJRB:1X#\<(VWDG'#,8KFX=H1.>#&PQZL49##W+5Z<: $NDD,^H'EART8(%JA
MMF5V\&05\!X0$]P38HM2)=/RPAW[>\$ DG]BR6E*,<BQJK?Q*!1#X/*(' .3
M#B;XP3W/DUWUJ]K]MB(%]:\3ZS],EI)<%Q<+NZV+IXJ*%E'%&.=CIS#"I";V
MM>^L=E6>*B#C#;U8$5)YNLK(?7M_SW]]GJ+&;S 6"/I6IKRL+^$JZM,DACKT
M;I=CG&W6.3CE4='9_F$8)FO4FN? _ES_,8H):EE.\0>8>8:- ?JXJ@-5[W@-
M2BQL$><&Y W:XP>_A(XH\[4]8Q-%KNST)N#U%$!S. 3J\5.4;B.V[OT]MG G
MJL97AQ%[D(!]1Y:)!2](P#=6\:.0$UFUV).G#R\=U7$(QH^(5#%)2A8?.N&#
M"NG"$;-.IV)7+^+9NZ2.\ 38/752O9J_M! 4;?P@&+2.9.!^80=WACX$O-%N
MEY7=\+X+5!UXFZ./ QR5X5EB!'@'6LU57&A.X"&T)GUR%:G!653,$Q</?%TI
MT3E;!UN-J4EI$B<)XN85JJ,#Q>MRXR+5F=$:@>[UL*<'&MIXA3I!;Z<@!"=E
M_<'XG0@@;(I"<(4=0S?- +83Z/)HYDA]@!F IRM4E88P)TS_0T&6AF?7$FL\
M9L'DE3(;'9 X4N&/J=BX136L;Y)FT3J=6G(9K*ZZ9$N'/["KAS08!2C?%?8.
MZ0<I?>!^Q31SIV,/W,-YBP_C'2*%T[PLN34W'!(<L#[< *C[>Z&0XYD@01B6
ML<0.&<Q&XQOL 7"^;!,\2HX,?/5$Z@\ C ;UZGQ[+)<!O 5V]LF@%@858$47
M+!XX&4^P?H/($F/^EQRPC]*I"7[@)*BP]CQ=$.<Y,! 5C=D.G/#=1(1I>\$U
MR[C]PRM<T.RDE+=9,[WS;"'OG&=GGD![F$,A.4X#<9P&L+IT]8$C2@EX)HY5
MEIBQTQ*!UP*V[)3EBI9)T&(ETQ8K^?B7*)P?_)7*"N>LN!*C%PQH!'M!T4\$
MTX,D9MY0GM3C&)G,5O"3+WRK-CD)B5GK;A8>7 (!&$47G/X@^WO+&P[.6;1&
M3A23.4CNV>@N&Q,+!5O3<;#5"[:FXV!K'&Q=#_""50P!*_Z_]E?RW^?VU[G&
MO&LZ@L7$;'IQ>]&U_;WY5CLFB6'BXD62U!VMAQ?"<:'K;I.9G%B'BW%21\0>
M8L#T3!IR]\[WOED).C7=DFB393FX02V9=L$*9#Z'5VRN:+]MU%=8 @V6X8C(
M4A_HG^5<.8U26>-@Y E9,0>VY83.N&+M.RWQ+#?_,7 2S@(_(/#1D<+T,\P^
M]@PV?,]5^Y.;24QLGJ?@8/1$XZEAH*J&+%Q\R9^!\KO$K!L/!(Z%#&XS6!]W
MSCTW?.?\G)0':# !CR>CNA$#K%0'Y:ZX)?@NB%2,MD_ 8R+*Y*[4UX[_*5\Q
MAQ),;[M/6'#_O\_*5TX07I4U[K?9Z>FZRC2[%_'EF^#;9M0.UJ[9PW#?"= *
M$ )^I#K)XJQQ11>L!7 J=3\1.VP2_+-!'Q0Z=)*U1'$"TEC&[&4! L-A\C&C
M#\Q]=EN=-,$"[N&_*PI:'KPMMF^4N@7R/6FB\<:)KND&JU2^E&R58(MZL#<L
M\/6NL#&V SA>H1Z$J&]02N2(8KH>=D#P@[G!W)RR;@."5>],92I9?(L&AU^3
M':S!GJ[17G81@<+K)PJTG9ILIWX*GF+WI/]]R'Z8M#J^P'":##XIMA(2?9MC
MB)5D![AL&%/3AV#W_TN<51^P6S*_D&PR@RK7?8K9?=[#,-L"N>>@1_G'HHA%
MS;S+T[(0<*K=VF@H??C* R85S_ \EX >'WD']& Z?I8GTKHX<JXPG*BXFX96
M>@I:SAXW [(-@<>Y)D_'</J%=XV7I[J"@)BL*U]I._.+!!U(.B/L//5E%Z.D
MU#0E,9,U?/>3$&+SA/SLFKA/CK&S](HJG=2^D&/*"J-JK/6*-9I+K<M"]<EW
MG@;M#A'G$=BK*HV!MA30SF.0+0NRBM/HS^DM13%36,8F%4^(QO#@QWJEF6,J
MY?Y>5;"MHLQ>CFRW_\WJZU\/DI\S&;8"#;&P'#2VR ;B*T,F'UG(I%\7,NET
M9"$COC=/A%MV8-I5:!]3L0<]I8,U#TXKD_?LCP26^(RZ?-[^B*)[\ P*=L&H
MVA!KL,8]L=&Y7FT;PVLY'?R&X/64)/5T:F9:IT919JY/\:*3=@%.6L5UTI94
MP+M& UNTSF:B>V^=DIRS57;^ O0DN?W-GR.>2!#&,V;(+JPQ9L) C[\=RLR8
M<W5W=NIZ$S$9N-"D7#^_K%XT60+'3F=+7;NGM1,WB/AYNS-=;'BN@M-")Z39
M6? <*^&E#5+-E"8&GTHEG+EP@.55>%="LC39ME,0PRJA3$G%@G'>4DJS\;Y6
M[VWGU@'>HJ U;Z7>W!/K<R[ X->3.K.X@TS PV];\30\V.T,FD[\CO_ MF;P
ME-QI9H(/L&C<N=G4V56"Z .GUXWAW-J &3,:+L'\ER5!LS;G+-0;N!@54V'<
MUA"LB'Q$5';!"H:#;1,@M<-DZSQ46!<D>"F9533O4#64$O?W9!U(!('$K\N8
MQ+J7\)^<?WG.G*[=WIV4[#:]K/"W^_N#SJ\39FFE6#J *'%KJ-AU0$DRW4$-
MU$./]:689@<GG62RV"WD'IN)$1-A?!Q&MZ%-KQ/!HB@W=X3=S-%W&)$X5^-Z
M8'037*:Y.] 3B-5M<3IV<G]W^@*6EU BYL5Y=W;S#H13=]]P@3-U/XY_]0UF
MX+_D:A[4T+L*Z 7S>C-Q7J^7UYN)\WKCO-Y-"SF\(WQ"!W!C ]L(L'N<S4G;
MC7BF6X(+-%;0 E:.9^XPS>C9=*P4E#UQS*#$Q$51KBFDC"FS>'R5P@MC6"<>
M9GRQ3#2TA51^I9![DQ'68/$>G9/?.[71CTX'!DQ"Y8F#?C_#Z6\<=3<!#FS-
MR>^N:K.R8UBJ;+-B9S =PLU;5][/C!LP:Q,SEY@YW8),Q;^57,*B<I/7QV!V
MLSZ$19C,.NR#;<)J!R7WOB(LI;6Q8YC? ,VU#S2*F;C\VBO:Y9<G>5J)VP@V
M9KQZ"V:E?VYM.B9J\RNT]O>\-]RQ%;\M$KN])WB5^MNU"CA9>M<2L98;DSTO
MFW:_C^Y-.<A9+4ZPTQZ5EU#='A';=)O%3=P3B1GUO/Y02 FN=^!UM=O?FW'R
M>($4(Z(%6N#-;HG,[*AN6]XE?E5>HET:@K5B\FUQK]*+8<W9-UZHI? R/<8)
M^/-.D8E'$>[8S:OS\U+C9B*>0%JEP[-J1&]*G=G!QP;M8C\<,X@48@^0S%#T
M8:D'HT5>8_!IDVN)S,5;8-H\=U7(!]<&FAOK/)Q.,G7VPDPJ[W]QW?\2W,-!
M5^HKZNC+$I8H1@^G@'F  W[XBM8DKX@'[5AG_IHO RX=%<&#?_X&EEB%&[]T
M-RO.I .XP)F?;C$74"^$AFM.W5#)>*-;:S+;Z[^V03Y_)1__^O1&MUF6S!YV
M_T0;\LUOMLGL8ZY-W_QF><W$A'W@;9:?0KQ,]JY?MKI>?IAT_2B]'#^+HV)%
M4']L[\(B.[NP2'D7%DEW89'=97E]T;OM%I<';OXJ7C.Z=KMKW@6J(3>P+C/]
M' 1-CBBNMJ')#)^9T8LO'YT=?7_XBO[#G,$WN_0(@OJOC4%9B$&\:1"GA6RB
M(,2 CFEY]T&\15I>2>=[U[!NW/"?K]P#-TU[P91UVURKV5E/4??*REM<TXAK
M6>0&P3?#;&L68C'8%@&;F T53#'P8IK;69I[1:]W[<IPYM QBO2Q(4T8LU<L
ME6*PQ6"+P19E_R],:TVB\4FD+$H#(3!\_L6P >/5Q*M9?C5OR:8,*=R(HL3=
MD%4Y<S@2*ZS%G+9T0BAF8^"M,?P; R^V,#<&MDRVD"ALD&%W_IPAO%0QBI01
MGS1$B;%B31AKPE@3[A#8(JT)(^8;M@PJX:T2K/ ]BK01GS5$B;5B71B+\QAL
M.P&V3;/JSON#3U3O1C$B':\F7LV.G63$1X7Q:M[^:G9>$9[9> FVCJ7!DJ8I
M4;2-XK/!2)F6F4(BFX^!%T=$8U]P)\"6R682Z0TR[%N*B,YI_/G.XJ/Q6>$+
M-6,N(:0+,?!BX;[%0%\J44S'#/LR45<L)(JY8C0U8Q2<0[\@Z0>H0>(5ZT:1
M-N*SPBBQ%NK"3#$7 R_6A=O5A4(<F7BA+BPFTL7-&:^>+@S<B#/9]'2B]_ML
MYW=_N(UV- VT+9UJ1Q^VI"<T.WST(0A)9V#6^[U6\V+925*_:C5;I8M*[>*8
M5+]?U5HWI'1=:E2:I-0B1[5FN71&;JJEQD'UHN+#<A*.48/BXGUA%^I,& !C
M\,ZE29IS&Z)AGU:'W^9\-\65^%9(7[8%9K+9W2/U+FF"G63PKN-7>*N-.L+H
MP95&'ZG14;"G>=VYL^;C__F$-X_@4X3\=A;*)W?G14,.S3FW2^0RT[]XRNKC
M0#%X=\J*9-&@4%B6!,*F6V2AZX*FVZIR\Q.U-X@@KTWD@DA8-'HW*_+2>#'\
M_ 5Q7;',!4,3>8M/-6*?A8NSI.S?X5<&SOU 7& +SPTQ/6DX7H1-KB'>]Z+[
M?GK1W&4.O<#[XG-I9;[R?/^%.)I#(*1-9L+WV*<X);S3R%KES--X>1$]K&.R
M>"N;)-QG%,)SNYY*1DC,OXAM7F2*WPKW[ T=,8V\GZTL2.YS_*F%79Y7NI#*
M'7^AN^"R\5UPWEUPV?@NN.U19X2N@MN%L%&818J?307GW$D+/*;D!Y4JM4:U
MW*HW)BY1"H\=K0)O]C\X^\SI46&2JE>_M:DU<746QZ'9TX=FR.U?DL*NE\,?
M G>,XDVL@2O OFSD-JE=BZ;-:N+)Z-E"@8Q0AL<K[:AD:.QJ,M3 ^'\Z> G-
M1-CIQ1/P*UXD?F':>H9T0E9K'?-"UPXHO]S-NZ2:W[@8I-GU3/0'KU'L*@!Q
M&2\EQ%OA)A@#T<%NVN97XO"9G'^L9[=X,Q:_R;@3=AW-:H.S>V[X:O?WIFZX
M69;NG[N29Y8O0H-^SU\+-&=_R\S_9#1PNROHO/H*Y%=? 7WU%71??05WK[Z"
MWM:"U_F_P\1!*4G*JF3+U+(H.4W^2&*L6IN%BG?_P4*1UGFGO/-"FJ$I*PE!
M>#J6NG3T],6K7R J.S?](5Y]O/KWM7J00X5"5+:PM.#)KKCZ=9^7S$YVF"0-
M79-4F1PGR1GM]:4G#>^YXX2 9@E!_#P*EUC*(F_.YXUX*?%20I>2VP;M+L9&
MA9<L98-FX>R\91 K2J<G&3*I)DG+-NYCJ1(OY;TL93&R%;.1$2CIERQE\\9)
M)4E.]9Y&RKJJ*IH9BY!X*>]E*0N*D$36J:U\[96D7K*4K9HD51:.,E1JDOK_
M^W\**3'_;T6RI(\5VJ&225\>1'UQ^#P$LLL,XD"^Z-4Z/K?V95SE#6]]'2/-
MY\1X[_'>X[U':>_K$77O=-MKD_#_K3NMSQU]G5DMU?/+L_I-M3J1IT,NSTH7
M:\F'VEQ>UV_;M)3NZ,/7(UV3#,?$,$E*$+*DYN4Y\!P-)ZWB4I6TQ/Z>).L#
MB\H$GAS1MF%+QHB =\@^39"A9!)%LZ@F4Y;#PU,:1@0>2UH@@\)D(^M\9)9.
M86/9%=9AL4>95*KD%HW4\,A0DU32H ]4L^G^7D>7*?XJ%K.9!!N[SV9,$DPS
MPH62 37ZBL6SBQ33M"7,#81/@A.;I*.#$8<)2?"%='=GT#O)8J_QJ!4QP0@#
M&PP>=/1^'];%/M_?@P<,<'Q"=S2<![;=DV"#,*!;.T8&K%J+(BS<O*:NI!B(
MFWMJD0?,Z'0W:_O59\Y2-?9<QH59WF3[>XI)[@P)0",#! Q*-%T[L."!V:4&
M<@Q_2OU*-8()5!("1M%E>-V"'SN4RBP?BVID1"7#3+#\:XJU7K"6@3/Y@Z[:
MFH68MA"LFL27 $NF_8&JCP#Z5@#V[DO35))!*A&SR0V2\W;XA;A,@!0&6Q(<
M3CG4-=ODC$(00*>V1DFJP+8M(( 4<Y(Z^6A $XQT9J@PA43X!"$2EPZ1!]IL
M<GTR=2>YOU=BG[&EI(4$RYU+D$Q62(CYO#OND *ZI0=)43U*<9EFI[&U4%)U
M+DZJ]I*J<W%2]1;H,X)9U2M9*?]A2A!1Y/]]D&X%,8=\AT^^UEK5<R*FDJ19
M+5\UL#"^?GU1;31/:I>D?D3*U4:K5+L@A]6+ZE&M7"N=.;\S,)R7+DK'U?/J
M16LM(F@+Z<P4)#H0O]5C2E/CQ>6H3T'<(]B16-$$83+7-R(\Z\OTB]![0-^D
M/2)4ZO2(["1!)[PG,* )2N!>TX<:/@3!#TH$_Z%H3*V;3.AW6;(JGYQ,3[>_
M]Z"S,JO M+A8&$["-%!>:,6?N2LPF;%%,+HUP#]UK)P'3<AV*B;(?VVG,6O[
MZV:0MFOYV<]Y4"NUY^!LM]QF>8(X0VI)E@V'4 ZI1@'=K,!NJ $N/XJ?)D9W
M YE4_O"5.-S],?7)^6O6WUMB7QO+.WPA;+T$=6X:^:!11PPX\IO<[:4O)<JJ
M9)J;CGFO1/A5TW(LY-"N ^?)2G+39RHO'S1"ZUGWJ>A*2.U\UAUGIJP; YWW
M&@%DPO>*BO[L!1V2&_V%V1DQ:J/!NMF_R3_<6^[IJAPLY(X0\**VGG7SJ9L(
MBGU=5L)FF0<C&#YG]^1,4UAFEH6R7=?5U"QT_-3+)W!/NE/I1":7?;4MO#^
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M,=>2'M^+@("=LF0]!3!($Z"TX($DLV-?IFK@GP,5^Z(#]8 664#=OPF>W2+
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M9^<3"(;<J[SCE;(BBW?<PI2CZ-\W^L60+S./$,M1,':ZO5>)D3A8;Q285UT
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MJP/>QVI9'NN\NC!6V7OD8VE;-FV59S*.7N54C?)SE9KD\L#_J^U?4$L#!!0
M   (  IZ/%5-T2A7F)\! *3S 0 /    9F]N87)?8VAA<G0N:G!G[+P).)1M
MWS!^V;)&RI+(9$NRA221J61+<B-[C))L,5&6-,U(280)19$FV4F3/>MD3Y+L
MC!B&* PSU+@TVW=U/\O[O,]]?^_Q?._[_?_'\3_^SSE^QW$YS^O\+>=OG^N"
M,\:9!K:=,K<R![BXN  OZ -P9@2.F$7Z7P( &QM@/P   @ WUW: ![KB@C[
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ME3JO/X"L=EE-44Z7S7I''! \4:QNI!;4D YR-?BW.)-*W]605A#S-D?W?-E
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MWX,\T'YJI89M%>&,JETX:C">8J7A'L>4Z)FE+_LB,TKEV/ )W,( 5!JV[.,
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M2.\8I&:MT)\1?RL;]F97*&*LT VP!9?)%&78R_%Q^EC=LCQK1--TT6#O@PC
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M3%:;50\>^!FU9Z&T:-Y-RX+W6U=D)(3<?9Q=6=8Z,OV6%X:I2K:O\ B%Z0@
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MT')B2[R_O-H=&O9 I+\'QGHN=@.^\A,T]P1X=N_-/84V,Y8+D1BO_(*?/I<
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M<6R/8E8VUNQ)709WRY28OXMXE<JU(?F[O/VBO/PLQJE>6\\"OEY4P:V089>
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MK=3AW]%/J74X=%TN ;> FOQ]_1+,2*PJ**Q"KMK>SF-\1:Y$O7[3Y<NPOAJ
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M0^2[-:.>P;99]KZW@!S+LL3]N+C\A?E)(QKQZMH6R?/M0K-@5-#2*@//F]^
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M=";7]8SU;!1UM)?Q_.O+.'3Z$]OZ+[[^$LWAU3<EK@J\E'7Q4U\/7MY"Y9P
M/.<GO=H/I3"0J8)QX<B;_>-1EYSNS3 $#S0QQ5&,KV!*![F1)0;A1T7N? O
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M"LN,2*)T>T]*/6V7N7*:CCBX:)!$N;XHSWY-D9GZ(TKTD;O>S'Z>N8<'RUO
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MF@6^M//(]ZSG',^X-G^DOWA<J><'E]?G'_!]JY:5:?#^QHPI5?E&G03R1BG
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MON=S]#/N/<0.)A$+4^G]6R]_-?4HT";IQRT"L08&)*O$7@0=EAS5]>VJ[@F
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M  G%9)<3@)YP.YP,IN5^_ L@%HFC<8&\M 4P!8B%D[Y]P'E49!CXR+TH\,^
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MT4&S%Z9'17@LYFGMOAHE&ZKFE&A-'.PM4[EN/A43ZQA@K-QWUCPX1E:[E+4
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MOU6?_RM0MT^@Q5&I_^&L32#=SND._0XC/8#D_X&/$PW-GW)V@'?\9Y2"KI\
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MT)O"$Z6=EU>CFIW&7[/;*-)MV]Z]]%A+3D*P'E?.16Q%JTM?0H*'RVH K\7
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M]>Z(2@5-,\HGJ]4SI_BA54U93T_5RZI(K_6*UQZ:R3H<R+<ID2T)B\Q]Z9>
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M2H!92U?\U9E#0P%>%69W QJ?<DTG_!,@_FG>_WYX_<FVQ#_#5P(YRWJ\P8I
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M+U:'D>R\@R@][OJPM&Q(IO\DG[?\B=U> 3HU&Q)HA #"PK.V0772**Q$#W.
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M64##,K?UL3=WD4%H_QVV#$W&?@\-T8 +3U(]01.,0I]A7_\Q-3?B$+FMZ?A
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M_AL7TJ(Z*E_F;MGDN^*[4E'IU22W7+0T4O<LUOV.Q8_[M@O8QR!5'QR:9O/
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M/3!KVZA&ZW$E;X5'E$7)1\07SL 6WW6'45[H7Z!TACY:D?7RH*;H!(H*![Z
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M8("/<H3J36E*DG G?T?)^>8OV(7HNL?GA#D[2ON"?Z3RU6K<#8E1XCV@H):
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M5Y,B5JLO=$$;0'BF5D6CJ^NKX:S>F6Q9N2YS(ZG_N1P0ZY-#5,#=_+/NE]S
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M]I,ZCXGYR]G _;YH0N93PD6)OHH@[L</%VZN)<<I?((J$9>QP*51(C.KG#F
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MR7)PAPH?\M7XW91!F;"5<H%+26^,O[&?WCN6,-&Y5OJK$,A'"ZU<8LZ@CZ\
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M0H6SJ:TU*FUS;O?VK%=]&,*-- KE !(/)R0>0,08#RDB2U)QGSP<1<1N^%0
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M0$;^JOW]$ !-=/O+5]A?:^3>:D_][C_.?GHLN(1W_L6RY40KN^60D,3)H!B
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MMW;]G-6P3N*'6Y= 7&9I//4%5L?U_@#"Q5>A+6L,<.K5[Q:PA'QOQJD'?WA
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M%JF9(4G <A65^C]T<O(ZNLKZ9;0E(H$<S:_W\&=03J>*W8N1S?9B="<+FM"
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MQ%<66WS91B8&%J#*7SV:9REU?TOF>"#9>L=!C<EW!+ CY,#T^4BN7[")';Q
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M^,]?YN_ OKN>U?>U^EKW U!+ P04    "  *>CQ5'8#S?9(&  !7,@  %
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M#@I^<<.-D].8&6N[-7=A%S-"6[FP'VK:]7:[_+60\GLBY==)_@502P,$%
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M.Z=MUZ!#6RB&48CW0*#O]@(XG4M$+39'P_/  Y?X&@_)"A; QV#&P#$ZQ$#
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M1S,"C1#\IB;/_"Y8@[\E1UB SMD0+-!FN\ " C:1:=!;4K90HK%I!7.=!?2
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MTO\)-DF:1,"U^H7J3L</ZOF1XN7DM-%K32DE!8/9%E,R)4]P2 3) #_("0L
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M%HFK38_XMQCRZEO8.@L/![8#TUTY/;Q%+;\,>G8I:LA+#I]&][UU4%(_2AA
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M[HLER!GBUAW9X!&U9%&*+.*O3IRO(SYU+J\ZUY<O'KF=<KH/$ZD:]F,BSG<
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M*FV.^NN+^_:<6W=D@^'G_P%02P,$%     @ "GH\5;M+K.M='0  =VL! !4
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MJ]K:IRH3>^S8<9+-77'T8JM6(RF2)GY\7Z8X$J3AFB(4OHQ'^>L/ $F)$MD
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M"M#RQG*HI&:/" 6^F!!!QSJ)FU@><H-'%-@+RRE-:>XH%9--5R/:D,_XX]6
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MITWO\V;:>8 =JZL &)S%@"4H!M>-NCV,T<G8NI%#(=WV/F_VZ =#AF1P,>B
M0Z< #G';^Y_:@T.:9 B'G\KBD/5A],>C:70ZF"/L_HFC0+;X'I"_^="N$CWO
MW^HJ_"(,0%"\K61)^&CQXQH_O5PB.UH-Y(?#(B#_N$\LN#D9,0<+TB3=XOYG
M-3(7FQIYA$*RK>3H%8O6),0L*4%]QUKGR_:HB=;"S5):JUU00+JI!Y8"(:=:
MMD/6IP2#>DRS>\44K6T_\-@EU9XA_N:1VT5K$,24@]I,LVB8KAO2IU-;[ E
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M0!>M$1%3#L+1Z,WIG]@)W<#R6,BM!ZR-W*8M$'\>Q:#8&[TDC</*]R<7JX#
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MB7*F;&"Y:YLH.1%G9._M/2^<D+[I$,,AT[LU4,DS \*HS".1LM4XI]"A46M
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M@H^0?@@H=?43L^ZQ@;MP0NJ\G&"/2?:LD)UJQK__15>G</5L:J>.%[B=R3K
MM0<NEV)00VQ)T*+N4C\A%53R*D[E1A=I5'UBCGN;K8-W"/EW+OD6^],-=D-_
MXEBNSZJ\ !91P5'TQ:(L,Z#NI_0,BYCHAA[=<I%GX_@V+F$J#DJFO A.JP(C
MZ0ON.0R!ZF35:5UWT1V=.\(!32N0E'RDP4,);>F#%5B0A<?1%[7R[(":I:I%
M>6N[V&-Z4*3;=-&"6B^,BRY]O$Z5(1H2!BE#'T'0XT]4]05]IT,=C$(3I6P$
M,Q1L%^YP&(Q7P/MB*-R.WTM?I&2)AZ2?"C!6'@K2L?S'OH._'I@\"I3X63X
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MD(F8@3![KPRSF]!V:-9>$4S'[9JWK,^&)H\!V.36ST0[7-Z5T.P/G>^O=5-
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MX!,Q!CH,E>&7JA<O3I&5V[AUNB^'98WN75)4BA2:G*9J]%2>9$$,]-4XSX%
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M%:(J.8#V:!;A ]0^6[%&R3<Y/I;"0VF/;#F.((R5U<Z6FJ!\;*6'T![38IQ
M6)9-=]?H>NWCD!O=76PD[9$MQ1 $L+)$>3+SDP^L[ C: UJ($0C(LOGUFEVI
MJ8#$,U<J&4E[8$LQ! %<-HU?,RN5"ZSL"-H#6H@1"$AEJ?9DIZ.Y"I!7W7(]
M&DY[B,MSQ;NIU'/E2@)=:!CM 2[.3>6^9,"9/_&03XCXTW)"1(,L@ 2-M&U>
M4WTESZ48E&[%50SR"#B^1B@@Z^..[9-\#OT@#LI\-L F#&]40 =]X9&@&X1%
M6S=+^8-$>Z"D&  12SE3U,?\?4+V^I'&+#Z1!FLT1510R9]I\D]N'.#[$G&
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M"S>69_^-EG$K@76;>4\RZWV@)A&S]Q(K(FT2D1;)%XSD$^J?B%QLB8LM42=
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M%3%W4J!68HE6^Q\]$XC9@$/;.])CZ_8.C&2<)O0B>(/TO2\ AD8B5%QJ7LD
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M$Q*80U*,A "Q0HQ,0HM:&#%I1,2]$.,NBW9!]OH0K35=!2_HEAHRH$-NC*4
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M<<U;'?@Q867RH)BJ 6E#T:PR@/;$PJEX=(/#:!W$'6J1:P(A9UR1 FS9P4G
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MDD8DJ\^KLW6(O#0V=CW5GJEYF1?I#F>7>)_F$3=5)9%QMC-*!J_=##46\,X
M%2I^*%>)D6%;)><]8LQKNOT<%<\-.L,.RTS5:<D "V<&U0(,]+SS; )8CGZU
M*JA<W7BPYWN<9S;$\SRZT\ZP&X_NAOMXKV$RYI9\-MO9=Y&.)Q[)X4LHQ2N
MB4LF*,<<H].CYW1^%-9<_"B9Z]PQ2_[Z\AZ3:1ZV(I_NA)T2Z@5G3RD9D)EG
MUAQ0+\GUT2A6[5-^#+[@O#F-(VQ(FI=C;L8'(6V=%/'4U :8>#@1N,E>]78B
MPCN-1XL-P[H;6O8::WM<"-*YI%@9DJF"H:@=7HZ9)+86J>Y@MG>*2F:<M>0T
MT .P(J FI%8)#!5-D=HO#=0% :!-U0KGH[6DU&IY7R=0$U*C H:.9CCM%PR
MDM%LF\I!>UP@;C>:OL\(#%&MX J'WZIM1&?D?_,<'%W'2;3A;@:_VT),]H.
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MHJ^;R:+?#6>+XLX4^"FCN^!UTGQ1JP=CLFCDAME,4:T$[:R$*6#9'!':5V(
M6<?"?+VJ-&5,+M4'T+?+W3+HW7EE^*Q4 Q?W\$WFV0N1)UHU%,P,E'F1[G V
M"U_H6KUHE<M R=D:HK$#[5*B5L-[/VP%DYN=J:504(F]E43QH%S$>VA3.&2?
M$'HGX"2X7"CK,CV6!_H(9E=10MJ DFA6FA[#FLH516P3J4$9%-M#'G.L%?7(
ML68ZW)IB0D6?':?<$57GR6M!2<JL$4M7.H[(J].,4K,23UJ^$ZEZ'ZM*G-$.
M5T=Z4&@X ;-X6 ")A>:%)"1OP\8 S!(A(EZ::\.Z_MP:-[?Q8?&(6$V0N_O5
M3\O+Q26Z^,6Z*(A/YM)%Q_P8Q6Z4A@ PV<!1 T8KK( 9ODR&KBMVL[S]:?$
MC==-7=C'=+;^1QEEF/A-FF_Q2JL?%[,DI'7K]COYL0,; RYY;._8H-Z/L3:4
M8=%DY-S:-@'U'-!%[71#BXPPY>JH3*,)AK57:4;<6V,<LFMK'Y[3K'C$V:YJ
MK*HCV%86?/#6PC41<0W4H3+7'+J@) 53JZX?)&JH('HH:A5/59ND;C*KS7(7
M;$D?,<>T=J=H8"D5=5>A1 VV*U(BEH/"&@.,LLA&Z1%5\FC-%$[."XNRS 9*
M'KAB6II9JP&4/W95FOM,.E6A[^.G=N,CB*89!*_G-9&3N:',W\9*4&AH"YB?
M;,S96?PC'1-U.$X^>/@%=5Q\V'CX3<SPR'%+9W@^/2PNR1 8YBA8XF:[4'3H
M[([2$  6&SAJP&:%%>BS.WKHXM.MU?\=S_1<+6]GM_,AQ_UO5+S'^^8RH0T[
M<:;>GR@7=TE8'>@^+66RT/IZ#<XQTUIQVL\_I5F6?B9$K<X<K(-]1$)XO9"=
M/L71EA5_\I\(](?P70D76E!2E@$I%)SFFUK@H\+@$FDP(4\+43J-PNX%HU4]
M_;.I;3"7$0W<29B/+W32)-9*31_C&0-71",:A1JT.&<.V=MM6@XSQX,3$JB9
MXF$9XIL8[\AQ:\<[HES0.VNIC_3_T[6@ER#&K$P&;7)KTJ3I#[,D'/ZA)UE=
MF3K>E[+X4M]L1?[Q3-X(OB?A8;'98.E8R34(EZW'SPONMT"W"&"U8B^^JP:(
M-"HL;^?WB]G#@@8%%B%FMY?5/Q9_^;3\:7:]N'U\XY'A%)_C#;7;HS=##Y?C
M/11!5IRL;:EVRHB: SI'%XN/R]M;VG^NKM OB]F]I_NA@#$#X,6)QW'(AAL+
M\F<#5KBYUZHZ(<JN]HRCM<&-5 H%IW=):8$/;H&22H.9[]!"E!SNI0/+1@/2
M/8L791[1$I^7.%]GT;ZYIH?S\A%_*2X(A%\E[V6"'9<\G.QFGY[61L"P=BIR
M;NID\3"_7]X]+E>W-#9>?'I8WBX>'E@(O5Z2\'FY?/RE#JAWR\?9-;I?/*P^
MW<\!#$L?HFT2;:(UW:AH36]39:>WV5HY-+C7UD@3#'NMX'+5V3_=W,SN?Z%T
M?5A^O%U>+>>SVT<TF\]7GV[94O'=ZGHYAS!QTJOEJ.G>A9)N5\ZD4(>+9IP8
M&%;)L?%K9*TDI*Z;UO#.V1+?8Q:$F 1T=B:KA_8RRM=QFI<9UL6WB;9<4NX@
M=_NDG&0(#&T/0<_EIE40?""]]'Q!ACX7UXLS=+.X)"'RNO<WUJ'?S&YG'Q<W
M"QH[Z<CH\<?%/;I:+/K*WIO$/=Z6,5TYJD^)I8D^DBHTW$94+?1A9)6*@Z&J
M'B,?:6L-U*E "KD/ZV<<EC%>;6JD:?8J*E.K32?M[3C-+*>Z.4@R;8V X>U4
MY-SLTNKV\7XV)P'SX6'QV(R29A?+:Q@+=4U1V]>NQ]#61E1HN#VDKX4^/)LO
M%0?#.CU&65'B5]2I0(J6 H]T@5&MXIEARG"GDH?,,5T0HUNJ;Q]7]Q "EO2T
MJ29L&>@YW@1HYL9H+Z!:"0S)3)$*=@8RO3/$--D6U%874ER3.F@>Y^Q,@""G
M81RTT8=/6?,X>7=/2XO4L]]T)?&.CI5/=/:S@]660^E*E-$=);)AK[6VL].@
M]BZUQT+-5;T3;AI>>1W#KMI<I>@]-EYC,E#J_*I0:6<?-4I.IQF-'!C,)RHU
MO%/."B;'M+9<TF^#W?[/O0VGUW2[F?^4\&.:AI^C."9!>WRHU7A4:VG#)1LG
MN=<GIY4!,%R=@IJ[Q[2VP?+(S@JJS( =,LN\U8^<#33=#J"-71F.H[5J8&AJ
MCI6+JVSY9'G[.+O]N&1++&R*\.3IXKPZTE===FZ4(HHU/*2%*NB"5% D[ITX
MYABYN>3Z+":3/1%-!G"2<,7V"8U(_20(0;;*SLAC[5#+(V--&)2RA<OO@ZUV
M:ST\KN;_Y;T3%)?+T15'T"@Y/=YFY,#@2)M2PSO)K&#R%] .CE<V6I#2KO')
M4?.TRTC3)?<L7.D3T$ -# O-L0I79%?7U^S$Y.TENEW=]O]$\K'%_>(!P$DI
MY22>3,CM-(EL2DXL 88\1A-LE1"D"$4K*I">O>[H*WP=[[4S;.;J+DEDZU2?
M7J:Z8(AG"9BCY.KVXSD)3S?H<G'Q>$9"U^/B =W-?FEWZ#5)')"9N27I]7?X
M,?ABL;M$H>'X"@@=]-'-#S)Q,.S38Q3<EDDT$%$!.U?&N:2?)%.I>*:89EI,
M+@^99/KM)?/5S0(]SOXW@)!5E\K*J[-161G$NA1,J>&X\(\.^JC@CTP<#)OT
M&+DU^%J#3?DW.I!"UN@^6/ZRG68[?^]/O>G"Z@Y.79 []D,\G!<^\@L2G#$^
MTA/ -):3N"5>M9A_NK^GQT @;66>I[M=5)7OISEVRHX(XF0]\%(3RRUM.*T<
M,L6]03T(&P-@2#T%-5_#NK7!NH6!%:"9K9'?NF[ U@@X/BO#N)V%M\5H_2SF
MS<WR\8;5*6$#_Q4[R+RX!7&*^:'<[V-,70QB6H?E*DX_+ZH_Z+)I,U6G)Z$L
MG!D<?C+0 T-*"[#<Z?J>*J*ZB"JC1AM44*T]ZT.VF$$U5W==4LS&J7&-*!-=
M,#RU!,Q7@KB[NV8GF&?7J*VJCI:W5ZO[FQFM:>*=H_>8G7Z]"[+B]3$+DIRT
M'*-#S#HUMR>9S9P8'F=6ZX#AH"%0_F!S=:R9Z:&^(J00*7/./.FTL@"!E(;I
MIH4Z>*J:)YKWB^O9X^(2W<WHP9;'^]GM ZTSO+H%D&7B+>T [O$^S=A=,9K,
M4BKN-)O4@!YDD!)9,/32 .1ZWTH<M?*0 M_8%_. 9Z3IDV.& <Y #2SSS /:
MP^)C6\&F"6Z0\K^F3M\\W3U%2=#4Z:.;R]G-;7G$_J2.=;9&?-1AM'-05(31
MS (8SDZ"/:9O8P3UK%1K7=0.ZAF"%%P%KIO'5U-ESR0VC+)FFI!):U-<["^?
ME@^G"ZMY5O381_ZK8Q[YC[_]%,1ET\S^4@9QM'EE5VQ4RV22$&JCZ()Q]HY0
MMIEK>6>:-52^1Y^CIE[3&7KW_OS;[\]0:Y$%Q\XF:HR>/#QJR-E5F%([KX^3
M!UMS1>,CN-QP^P!3( A_.'XNUEY?KWZ>W<X7B.2RZ'+UZ>+QZM-U4^36_VB=
M^)85.(M?ZWH%0;Q,-FFV&W4IFL36VHK+I&"BB_WLP-*$=RX?AGO,X=8*:LV@
MGAV@2_5*WW7)K:DR&!XKDULSS;?!6EW _<NGV?WCXO[ZEZ8BQNP:7<X>9^CK
M3[>S3Y?+Q\7E[[QS\Z%\RO$_2IP4BQ>CU7>9N-L5=S7HX2J[6!8,QS0 ^=7T
M1AQ5\I BW=@7[<RH7-XGG]2SH#)AL(S2+WI?/"S^\HE.>BY^@G$)7)KD:1R%
M+,ZR6QQ>]5O95"IN-Z[IP0^WJ<GEP7#* "1?JS$B7>:>[K5/-VA@P#O!/N5D
M9+7(BXATY=*;<<="+DDD!MBGS5 "#%&$L,;4^$3OBM^@5LP[']JBMS^GV:_+
MA%U GN<5SR6.JE6\E"%6@!>6(1;(.^71"\Z>TAQ?*^AD@%56\CH"P"MIT5"S
M3LU<'43Y5X/.SE073#RS!"PK6#RL5.R=E\O=/H@R"F6574;Y/LV#>+6Y3I/M
M=?2"JS7'?)G45PZ/:YA5KIM1^"1/<AI=3_>J!D'Y^(\!TX9.YQM7 8'8/&=&
MZQJ.WEN:HDRE60.R,0"D[*@!W<VUP;#8&C)W-)*>K>3+C$*F:/.3,A.VT ="
M4+%;AOP<*D-+F&V!RTKBGJA^)-M_E#4Q/V#;F\K=X!2R.BQ.MN*LHN1T%]O2
MDO8FO$?)PW#S-V)7AE!056*FV7-0V4)Q9\Q[Z+S'9*Q9XGN\3K=)9#Y;::#G
M]N2#H1O#\PX:)>^<M$7*G\AA>JBG"(!Q.2:O\9G$]TL"+T[9@'+Q98^3'"N[
M:2--MZPS=F7(.ZT:(.:98N6Y5VFRT-?31?,T!Y SSD*2BQ113L9K#)!9V--J
M.:TC8^;"H#",6@4,[<QP<IUNIW4<EDERP(?G:+\G#Z'E#7XD](YKF :)G[&J
MLVS/TIDVQ3/4\TZI"6"Y]>5:&TCH:BO0&4Y@2L6]U (TF4J4R'KGDB% >97)
MPS-^V;4&95Z09V0D! ;D6YB,0;4J[JXP, /?75R@EO=.$PN07-F;6@LU:MZC
MS2+($AHY[W#V\!QDV"SH:+5<QAY#%_HA2*/BG6)V.,<L:[0044-,SSO-:-T3
M5CDZ?Z:KC"]!3'=^&6Z=,M-U7;/&V)UQP1JM(ACZV:#E;_O)J\$A^T=/W3L7
MZ0:,O##?Y:"0=[V-1@E[O(=&* R&6SJ$?):>9@5ZQ-D.=:K^R32G'RXI,K9O
M\#[*?YUG.(P*^B]9HU)I.-X(JH,^V@<J$P=#*CU&OK9F3X-M!&4:B*IX)]=5
M$&7T?!U>;7HG//(B*W==():\"D-=EX2S<J=//2-%,"2T03NF(]5E9W_9!M3^
M*;)6WSLK;_'G^G@G23+OLC0A_USCGF]FW:J]&:?WGTUT<G CFJ4-, R>")Q?
M(Z"A%76FT$-!,L(@"T\U3]+LV X_Y7A3QM?1!B^37W"0Y5=IUNQU[.^2?*25
MQI7S* >;=#;/<B3GVWF8 ^UY9_,1G>!&V(U55)E%U"Z*$L0LHTV:(: [:R^C
M/-AN,[QE"<]J4Z\A*]N!I:[3Z[=LW!G<O66BZ)W"4]#R-XH4$0W#5YCN%*AV
M#)RC6^R?BUT1B?$\UT601VNZ*!W%)6EE1NR<;,WI4<[#7!X<])QF"@RG#\//
M30_4UFC:C)OY3Q* 40YB_K-SMAI?7J=YCO.ZO.EC6B?ZR9:F3-$+NP&(WCE;
MWVEB1_\C/,%/DSC:JQ$WDX/- VPZQ_))E+K7FK2S2!-4WZ]#_BLYO.N0I.^/
M:1'$5\&ZWCZY^IS@<)7=!$FPU70"]NK.TO()3K4IN(6N=W).!*P*Y 6UAC:M
M.>]AG.T062:++_24YVIS$;'[P.FVD^:?W8],UBAT'VS5[:SQ45[!<&;Y()/>
MF7]</U0-8DVUV(@2MR/0-MLA0;JD6U'V,:9_9Q?6!VL $X9==]4>EYY/RFQT
MZG[2%C.GQ#F)6A<,LRT!JR@<O87C[Y,/OD,[\C[ML#L\ AI#55%OWY^2P\>:
MDI/DLM<DS&.\(@\,Z-0WNRR].6?T>A,494;^=]AZUJ*,:IH=9]GM(6ZV:>X4
M(]ZI>2ARP9"+O&NBV"Y%IXU91MA-,ZI#,7T*V@>O1UD/E.V";T/^SSC:/I.,
M8O9"X&SQ/=X%4=(X2S=DZ$=F!QASMU/^4(>[O?-3+<'@]*'P52&XL8AJDZBU
MB9A1ML''>U[ H- ,W2@_E4J[S  TD/O=OD34._G,\ DNQ]VG":LT2?A5A49<
M'6 [5604W#79J[O:3L,Q/]0S $>PYRX^'L'M+D0>8,P[48_E@?(FTC7=-KNA
M-Y%&O0K267T)7Y%65/<_ANH/#8?U'$B:WE1KL![G&UOR->2W=%4V^C<TXYWR
MAV-7904IJSP3=95GZK(*1UEK.!K#4[J=+RHPJ]\T=O^J+&A]^!V]SNN?K*W6
MIZBMJ'^<1_AH$\=\.:+&<@S[X%K1$9V2-J_5!D$M[-0%$\5KL.PZ+"SYZ3JL
M715W'<9FH!6 FN["6ZE7=H]#3$:U!!%==*>K,"E;_2%(,7FI9H-*6R-N"Z-,
M<7!8(\7& IBX/0GVF+;KF&0W*&!S>D]HAW=/.,O_!YN/+E[1U\_A#@7=+8@
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M:KM*8-B39T6114]ET:0V"<&5LQ%;+\T1+T4=8L_AXM_A;O>6!Z<;\T[C8WG
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M^B+E$.V#K,C/$.52FK"S_Y2(>:WNG4^M0S^GV:_+Y"Y+:5N0O *9L-O2O"K
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M4KRRZW[LS?CKULR=E/=W>AM .T)CX'*N,]&S-\+O?F2>S&Y;([ZZUVG,MK,
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M8+6ZQ.=;Y+6Z=N(D8[!9K:BK.,'2V^>TNN;BFZ2TLNC2)&/ *2TOPS3!TK\
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M_:FS<*)X=D=>QC.]MV7S4 1)6.YOLFB.:<@5SM$IQ9W%,P/0;3Q3R'HGD2%
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M.1$_3?3!L=0"M#"CM&"J@T\XX:O)?':[B4^;F9G"G9*<G?##6'R0-_(A;#_
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M@-XA=!R@>89):Q:68'-CF/#2B0-:8'^ZN7H([BGQJJ2$) K_#M70%7G1 ?N
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M<>[(V-:V'GC-R!%=?6):A$>'W0\=SPF?B?W1]^V0,O;9#[Z,/!XG5!F;GPX
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M)(^AN _X<2^Z+T;-.?HF>9KUB"='$*-2V1@*!V(5"1GYAN"0RWRD *'<$HH
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MAI!:RQJ]3VX O8D?L?0E6?E6%D&7D9,_OP5+L<8XQM@8TL586T#HR_'!\?R
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M'TZK7KCUK/!YZ/I?0U9%]U3M$)6; _:]3@5,@\$+;'M%&@I,2/="9=^K5]2
MTFD)H3FSL/UU3"W/0ZHUGKAB^D0W&H_8O!;AL^5MR- /.$G3)]?96*KRQ6ST
MI@:_4@=6DR(P;Q(X!RIA&V[3'[E2-U<;HC!$T4J*)4:4;.?))0E'=X??YGXY
M(=%TS5(:.5E.(ZEV]:ZD72T_#>:=T639G7P<W8\'69%X^A?VM<[A<YWD>QWZ
M0>;3.ODD=FTT5OCNJ^.Z7<\N"DVG7*CF,-B)3%G9OXB,G1=2(A><RE0]AAEY
M(FHA+$QLJN8:/R..A,:Q.D<.K+<9V.K/Z+(O L L?HX="9WW^P?KWW[0<ZTP
ME.?<T1KD[0-<YAD]7X^$VB.M$VNK3(2J/9 9<->8YG"\JQG'3I2Z\-?15XN7
M],E^[),7XOI<(>7^/E7*5(TAL!-?U)S@Q>-85V;H+O^9%1% (:1",^P\!,V@
M5<D[.B(3GZ52VI&(=#<!@=6IDO7!?A/>#%9JJ: #UXO#R-^2@+OEF2'^[.R4
MR$D[8;_8;08Z@%S0L9-PJJARI>Z)G+A+Q^B"ZRQFU;J2$)JKT 3+%UYG+(.U
MES,P5H@.'?5*CZ*T3I6X!W:"K3,05(G!3,?OT ^H>FR/??^+XVV.YG1U:ZD#
M^#W< 9Q^M9-^MI-]E[E_C\YA[\0[?'=S!=]<P3=7\,T5;)ZG\.8*?N, WUS!
M-U<POBNX52<AADI]]4Y"-%^3X2[=*_<UY<WL-/)<*]OX6>.^23^5AD2O.LV8
MG@@@&:GK#/=&_6!* ?[1IHXR87&] 0W6&%J8/F\FO;$^[\J4MK7&,UB%:7[Z
MO)D$N#585^5.K#4>=B+]R\X>0](K7GCVP--OUA_4X'B+9N>1<;DZ&ZA*6+I$
M&[RNW-AVO$WFHA?/&EAO['S\9TP/'?%<=5*]RBO(HYLW^1/L;O(#_&[R<!<Y
M77>R3]SN(/\8<05MK?8F+A8UX@OTEOJ.!(YO+R(KB%I(T4Q/K-B+PIZU<R++
M=7X_KOW"R\.JAMB.C+-P$S'5C/]3(.XLWGD:I!YS5MJ>_C ]%K<OR%W: ]L5
M<#8  'F@>Z*[]K_C,&*QM$,_@$7'2;I@F]]-['5*B:!CUMSA].M[?*.WS?.)
M\=?("37P;./4T50;G%@!>^N=L[].M,^_0+7/3+OL' :\Z9FM\WJ+=;O%NMUB
MW6ZQ;K=8MUNLVRW6[1;KAAX]96:L&]*#6(R+OMN#V$:"%#$N3]Y8D&)W]5OL
M4#-9PG$A_?YC2-:Q.W;6$FOEO%&O-T"Q"6GB3XF<.RR[!#O2+P%=T0_;UWX.
MKB"18#_ 3"\!%I&_^@+S&WU?]!OUNK/1LCON+);3WK\:\Q8I$P[G*0<G&:[N
MA.3BR8K5J=PXA7;(ZC]$H-6.F0(?^,X7<;E "0KF.58JYY%(^$:Y2@Y4<>5H
MNDZFD=0Q(NERC7"4N4!W;.1)4ODNJMH:!H-H:A45[PI.L/T-/7^[]3U.DM(T
M*C?%UIW$\Z@H>A&;Z&IM0AEGY!Z&P&E;;->/)@15C)J$04\#@YXI.<[J8- S
M#(-9=C.>N'25#M#JYM@>&C 24G;QP7 MC_F1Y'K2:2O#SF29:G1*>&Z'Q)6V
M2A,JMC-#XE5S12#OAI0>@=T^>?_=N^_XRKOWO3AD'Q7N(JR#I#UVYL/J&9&/
M[U,RB[Z'])T7QR:>'<ZL/5N+$RNBQKQX=HO:([M=Q09\89++^46'@\^59]^E
MP@I978]H/_$C,MKNK%4T7?=\[X7^@?L1Z<^L? =EV=TGOX^84W%!5C&K3T'"
MJ==WW#@B]L *6$'K<$:"Q;,E _<R7\<V1\!SY9)@H,^\G.WUL\^8X05F)'J%
ML .VK0/&5\&R29#PN1).XRB,+(\]I0+A4M$+._ZZ#CA"YDU"*/-_<UKG5*C!
M"[&'?C",V0$S"L.85;8$P08="CM&H0Z6>F)JZQE*^O6-$[("KJ(W/^5FV"X$
MM<2KZ39DN7#"[EE98U8GGGAA*KC HF<G8^M^?VQ"%31>U(RE8IW$3&FF%COG
MK/MB.2Y3WNB\^4C[2D*\V_LBM@\#KL6T+/3KG54)8VS/89?Z,_Z,HX6I5/T9
M;..U_?DC$R_ZI.'O91;$==FS=.*1P&)O#;KVUO$<=GG-XA645<VU!@$"_C=T
MP&N(!CUXA=I?] =&,2651ST>?C%*B[2'=Y_L;>)]2:TYZ9O\'TK1+=/)<CX=
MCUD![NZDWYE,)_E?C2;+P7RPX(_T/_4?.NF7.LFGL%_F5XM$_41*U0]G\3XX
M'BO"N<_H4<3-")J;X9B%(5-8H@*.\ -IBH25]AHU.F/3PFJDLTT!S/@69&,.
M.+=8FUNLC5:8@?)^NZHMMGN[3IB!:3?;MW";9C$(R>K/&__E6YLXB?CI#T>I
MTW_\.B8;RQUX5 ?>"TX$VJK4R(Q=!W0&5)'?:$R!6L;)IX6[.VURV@)9NE42
M*\GTE.)V0@:H.9584=) @5(KM(VX)):RBU; 4DO^[BDUUJEQ<6+\"J18W13Y
M=E]I5>1%*V.VS?N$Z7I"HA%[;UEEBA[\\B?-L'4%+<&*N&Q)J/?QWH\C^KUJ
M;\[/EAN+! WKBJTD: E?1QJ8Z57%K[6BP'F*^4M6 6J%-M@WU5KP5/+7TL(8
M\#MPR&9>V1+[UEA+KA)>K\+G#'M)^=?:OF9C4G*]+0<SQ3;T7<=.9@D)P^6S
MY7U^ID3NIU\]8B_BI]"Q'2O8S_B49[\,V O]C('!>DU6$34!>\_LFHQEFE,X
MJ5O\I!E66BU'=XM2P7>6M\%<:3>]S$P;F^:T;WT%7V"BCEN_/ B#*#=1Z;^.
MDY3^X]<#D0*7$&U3:/(' [\L@'8N$J X"7U+>4(-<2^592>6[<V_))*<*2XF
M^C65]-"=\V"Y&78;P@-R2GM4>+]7/_X#=/V#;=EPP:"_.!30"'F$".AJ!N[@
MN0W#K_WWBXI+2=:FUEUD:SY>\"S*;X)MW$C*!"J^:3]0HWO!WIK?MKY 3;MF
MY[D%6=!N$.V7@>6%U!!G#LS[??XO\A-&9PPSMIQ+'S4Z$LHYM?&GA.J0J6IK
M!L3Z$UN"6;OG"7O6YMADY+W0F>4'XM2G_&Y3T!C;IR^>-2<WLU)6T7?#^SAT
M/+H=\#R<H<-E)]WZA!W,6 27WN>$XLC-/G.039*M*A5I0%<ST%;,7@!6!;9:
M\[7 _ 0:A8=:>VX)GC>5_H/*TD+(D=^)1X@]Y/(]^D]%[0E%-S,F_J6W.850
M<G,2!^L"6:H-3M#<#&Q!\[: CX"AEKP!Y1M-N24K;H_](%0Z;TY,617/Z-M=
M]54SJ!S$N?#\B H/B!-#0"K& 1WVY1D)5DRR&W*_/^4D:2)&\(PAD2-<+Q(*
MH'BKI@U 6]'*93JRT@@BLUC6 ]O_>E%HE=(P9/'/ G]%B!T.J;3X>9+%3K)?
M=-=KQW7HR2_+:@D= -M;C+&R-:7;TCJ>Q<'JV0H)>P=E>7:\>PB<'F%<B2*
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MB)9\]-DK+78_]V1%/!75D#*WB-=KW_W28]<$^Y%M"9SW\.[8+JRS -)C]>*
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MCC"N^D&E+'8AB^J_)QY9.Q$+YZ\7\U$Y$'KT '0NU!3154\+0-YX_63QK87
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M_U!+ 0(4 Q0    (  IZ/%5N ;T:*H," .G4%P .              "  0
M  !F;VYA<E\Q,"UK+FAT;5!+ 0(4 Q0    (  IZ/%5-T2A7F)\! *3S 0 /
M              "  5:# @!F;VYA<E]C:&%R="YJ<&=02P$"% ,4    "  *
M>CQ5A^VNQK\!  "2"@  %               @ $;(P0 9F]N87)?97AH:6)I
M="TR,2YH=&U02P$"% ,4    "  *>CQ5NHU^2Q\"  #?"0  %
M    @ $,)00 9F]N87)?97AH:6)I="TR,RYH=&U02P$"% ,4    "  *>CQ5
M'8#S?9(&  !7,@  %               @ %=)P0 9F]N87)?97AH:6)I="TS
M,2YH=&U02P$"% ,4    "  *>CQ5.+ +7!,$  ! &   %
M@ $A+@0 9F]N87)?97AH:6)I="TS,BYH=&U02P$"% ,4    "  *>CQ5C5V:
M</<U  !H.   #@              @ %F,@0 9F]N87)?;&]G;RYJ<&=02P$"
M% ,4    "  *>CQ5W14\5QP;  !K) $ $0              @ &): 0 9F]N
M<BTR,#(R,#8S,"YX<V102P$"% ,4    "  *>CQ5NTNLZUT=  !W:P$ %0
M            @ '4@P0 9F]N<BTR,#(R,#8S,%]C86PN>&UL4$L! A0#%
M  @ "GH\50KWUT@310  <3 $ !4              ( !9*$$ &9O;G(M,C R
M,C V,S!?9&5F+GAM;%!+ 0(4 Q0    (  IZ/%7=B/>'XX4  (PR!P 5
M          "  :KF! !F;VYR+3(P,C(P-C,P7VQA8BYX;6Q02P$"% ,4
M"  *>CQ5?P;$CCM@  !G  8 %0              @ ' ; 4 9F]N<BTR,#(R
B,#8S,%]P<F4N>&UL4$L%!@     ,  P " ,  "[-!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
